Meeting Program - AUA2016 Annual Meeting

Transcription

AUA2016 Meeting Program
SHARING KNOWLEDGE. SETTING STANDARDS.®
www.AUA2016.org
meeting program
XTANDI (enzalutamide) capsules is indicated for the treatment of
patients with metastatic castration-resistant prostate cancer (CRPC).
ogression nts
r
p
e
s
a
e
is
ur patie
NDI at d
Start XTA static CRPC fo1 r yo
to meta
therapy*
on GnRH
y.1
iectom
al orch
bilater
r after
*O
Important Safety Information
Contraindications XTANDI is not indicated for women and is
contraindicated in women who are or may become pregnant. XTANDI
can cause fetal harm when administered to a pregnant woman.
Warnings and Precautions
Seizure In Study 1, conducted in patients with metastatic
castration-resistant prostate cancer (CRPC) who previously
received docetaxel, seizure occurred in 0.9% of XTANDI patients
and 0% of placebo patients. In Study 2, conducted in patients
with chemotherapy-naive metastatic CRPC, seizure occurred in
0.1% of XTANDI patients and 0.1% of placebo patients. There is
no clinical trial experience re-administering XTANDI to patients
who experienced a seizure, and limited safety data are available
in patients with predisposing factors for seizure. Study 1 excluded
the use of concomitant medications that may lower threshold;
Study 2 permitted the use of these medications. Because of the
risk of seizure associated with XTANDI use, patients should be
advised of the risk of engaging in any activity during which sudden
loss of consciousness could cause serious harm to themselves or
others. Permanently discontinue XTANDI in patients who develop
a seizure during treatment.
Posterior Reversible Encephalopathy Syndrome (PRES) In post
approval use, there have been reports of PRES in patients receiving
XTANDI. PRES is a neurological disorder which can present
with rapidly evolving symptoms including seizure, headache,
lethargy, confusion, blindness, and other visual and neurological
disturbances, with or without associated hypertension. A diagnosis
of PRES requires confirmation by brain imaging, preferably MRI.
Discontinue XTANDI in patients who develop PRES.
Adverse Reactions
The most common adverse reactions (≥ 10%) reported from two
combined clinical studies that occurred more commonly (≥ 2%
over placebo) in XTANDI patients were asthenia/fatigue, back
pain, decreased appetite, constipation, arthralgia, diarrhea, hot
flush, upper respiratory tract infection, peripheral edema, dyspnea,
musculoskeletal pain, weight decreased, headache, hypertension,
and dizziness/vertigo.
In Study 1, Grade 3 and higher adverse reactions were reported
among 47% of XTANDI patients and 53% of placebo patients.
Discontinuations due to adverse events were reported for 16% of
XTANDI patients and 18% of placebo patients. In Study 2, Grade 3-4
adverse reactions were reported in 44% of XTANDI patients and
37% of placebo patients. Discontinuations due to adverse events
were reported for 6% of both study groups.
•Lab Abnormalities: Grade 1-4 neutropenia occurred in 15% of
XTANDI patients (1% Grade 3-4) and 6% of placebo patients
(0.5% Grade 3-4). Grade 1-4 thrombocytopenia occurred in
6% of XTANDI patients (0.3% Grade 3-4) and 5% of placebo
patients (0.5% Grade 3-4). Grade 1-4 elevations in ALT
occurred in 10% of XTANDI patients (0.2% Grade 3-4) and 16%
of placebo patients (0.2% Grade 3-4). Grade 1-4 elevations in
bilirubin occurred in 3% of XTANDI patients (0.1% Grade 3-4)
and 2% of placebo patients (no Grade 3-4).
Significantly improved radiographic
progression-free survival†1
Significantly improved overall survival†‡§1
Updated overall survival analysis:
•23% reduction in risk of death with XTANDI + GnRH
therapy* vs placebo + GnRH therapy* (co-primary
endpoint: HR = 0.77 [95% CI, 0.67-0.88])
•83% reduction in risk of radiographic disease
progression or death with XTANDI + GnRH therapy*
vs placebo + GnRH therapy* (co-primary endpoint:
HR = 0.17 [95% CI, 0.14-0.21]; P < 0.0001)
•Median radiographic progression-free survival
was not reached (95% CI, 13.8-not reached)
for XTANDI + GnRH therapy* and was 3.7 months
(95% CI, 3.6-4.6) for placebo + GnRH therapy*
Significantly delayed the time to cytotoxic
chemotherapy initiation†1
• Delayed time to cytotoxic chemotherapy
initiation by a median of 28.0 months with
XTANDI + GnRH therapy* vs 10.8 months with
placebo + GnRH therapy* (HR = 0.35 [95%
CI, 0.30-0.40]; P < 0.0001)
•Median overall survival was 35.3 months with
XTANDI + GnRH therapy* (95% CI, 32.2-not
reached) vs 31.3 months with placebo + GnRH
therapy* (95% CI, 28.8-34.2)
‡At a prespecified interim analysis for overall survival
(co-primary endpoint): HR = 0.71 (95% CI, 0.60-0.84);
P < 0.00011
Oral, once-daily dosing with no required
steroid co-administration1
•Dosage: XTANDI 160 mg (four 40 mg capsules)
is administered orally, once daily
•Steroids were allowed but not required||
patient lives
94% ofareinsured
covered for XTANDI
¶3
¶As of February 2015. A product’s placement on a plan formulary involves
a variety of factors known only to the plan and is subject to eligibility.
To learn more, please visit XtandiHCP.com
•Infections: In Study 1, 1% of XTANDI patients compared to
0.3% of placebo patients died from infections or sepsis. In
Study 2, 1 patient in each treatment group (0.1%) had an
infection resulting in death.
•Falls (including fall-related injuries), occurred in 9% of XTANDI
patients and 4% of placebo patients. Falls were not associated
with loss of consciousness or seizure. Fall-related injuries were
more severe in XTANDI patients, and included non-pathologic
fractures, joint injuries, and hematomas.
•Hypertension occurred in 11% of XTANDI patients and 4% of
placebo patients. No patients experienced hypertensive crisis.
Medical history of hypertension was balanced between arms.
Hypertension led to study discontinuation in < 1% of all patients.
Drug Interactions
Effect of Other Drugs on XTANDI Avoid strong CYP2C8 inhibitors,
as they can increase the plasma exposure to XTANDI. If
co-administration is necessary, reduce the dose of XTANDI.
Avoid strong CYP3A4 inducers as they can decrease the plasma
exposure to XTANDI. If co-administration is necessary, increase the
dose of XTANDI.
© 2016 Astellas Pharma US, Inc. All rights reserved. Printed in USA. 076-1308-PM 1/16
XTANDI, Astellas, and the flying star logo are trademarks of Astellas Pharma Inc.
Effect of XTANDI on Other Drugs Avoid CYP3A4, CYP2C9, and
CYP2C19 substrates with a narrow therapeutic index, as XTANDI
may decrease the plasma exposures of these drugs. If XTANDI
is co-administered with warfarin (CYP2C9 substrate), conduct
additional INR monitoring.
Please see adjacent pages for Brief Summary of
Full Prescribing Information.
†As seen in the PREVAIL trial (Study 2): a multinational, double-blind, randomized,
phase 3 trial that enrolled 1717 patients with metastatic CRPC that progressed
on GnRH therapy or after bilateral orchiectomy, and who had not received prior
cytotoxic chemotherapy. All patients continued on GnRH therapy.1,2
§Results from this analysis were consistent with those from the prespecified
interim analysis.
|| In
the PREVAIL trial, 27% of patients in the XTANDI arm and 30% of patients
in the placebo arm received glucocorticoids for varying reasons. In the AFFIRM
trial (Study 1), 48% of patients in the XTANDI arm and 46% of patients in
the placebo arm received glucocorticoids. AFFIRM was a phase 3, multicenter,
placebo‑controlled, randomized trial that enrolled 1199 patients with metastatic
CRPC who had previously received docetaxel.1
References: 1. XTANDI [package insert]. Northbrook, IL: Astellas Pharma US, Inc.
2. Beer TM, Armstrong AJ, Rathkopf DE, et al, for the PREVAIL Investigators.
Enzalutamide in metastatic prostate cancer before chemotherapy. N Engl J Med.
2014;371(5):424-433. 3. Data on file, Medivation, Inc.
XTANDI® (enzalutamide) capsules for oral use
Initial U.S. Approval: 2012
BRIEF SUMMARY OF PRESCRIBING INFORMATION
The following is a brief summary. Please see the package
insert for full prescribing information.
INDICATIONS AND USAGE
XTANDI is indicated for the treatment of patients with
metastatic castration-resistant prostate cancer (CRPC).
CONTRAINDICATIONS
Pregnancy
XTANDI can cause fetal harm when administered
to a pregnant woman based on its mechanism of
action and findings in animals. XTANDI is not indicated
for use in women. XTANDI is contraindicated in women
who are or may become pregnant. If this drug is
used during pregnancy, or if the patient becomes
pregnant while taking this drug, apprise the patient of
the potential hazard to the fetus and the potential risk for
pregnancy loss.
WARNINGS AND PRECAUTIONS
Seizure
In Study 1, which enrolled patients who previously
received docetaxel, 7 of 800 (0.9%) patients treated with
XTANDI experienced a seizure and no patients treated
with placebo experienced a seizure. Seizure occurred
from 31 to 603 days after initiation of XTANDI. In Study
2, 1 of 871 (0.1%) chemotherapy-naive patients treated
with XTANDI and 1 of 844 (0.1%) patients treated with
placebo experienced a seizure. Patients experiencing
seizure were permanently discontinued from therapy
and all seizure events resolved. There is no clinical trial
experience re-administering XTANDI to patients who
experienced seizure.
Limited safety data are available in patients with
predisposing factors for seizure because these patients
were generally excluded from the trials. These exclusion
criteria included a history of seizure, underlying brain
injury with loss of consciousness, transient ischemic
attack within the past 12 months, cerebral vascular
accident, brain metastases, and brain arteriovenous
malformation. Study 1 excluded the use of concomitant
medications that may lower the seizure threshold,
whereas Study 2 permitted the use of these medications.
Because of the risk of seizure associated with XTANDI
use, patients should be advised of the risk of engaging
in any activity where sudden loss of consciousness could
cause serious harm to themselves or others. Permanently
discontinue XTANDI in patients who develop a seizure
during treatment.
Posterior Reversible Encephalopathy Syndrome (PRES)
There have been reports of posterior reversible
encephalopathy syndrome (PRES) in patients receiving
XTANDI. PRES is a neurological disorder which can present
with rapidly evolving symptoms including seizure,
headache, lethargy, confusion, blindness, and other
visual and neurological disturbances, with or without
associated hypertension. A diagnosis of PRES requires
confirmation by brain imaging, preferably magnetic
resonance imaging (MRI). Discontinue XTANDI in
patients who develop PRES.
ADVERSE REACTIONS
Clinical Trial Experience
Because clinical trials are conducted under widely varying
conditions, adverse reaction rates observed in the clinical
trials of a drug cannot be directly compared to rates in the
clinical trials of another drug and may not reflect the rates
observed in practice.
Two randomized clinical trials enrolled patients with
metastatic prostate cancer that has progressed on
androgen deprivation therapy (GnRH therapy or bilateral
orchiectomy), a disease setting that is also defined as
metastatic CRPC. In both studies, patients received
XTANDI 160 mg orally once daily in the active treatment
arm or placebo in the control arm. All patients continued
androgen deprivation therapy. Patients were allowed, but
not required, to take glucocorticoids.
The most common adverse reactions (≥ 10%) that
occurred more commonly (≥ 2% over placebo) in the
XTANDI-treated patients from the two randomized
clinical trials were asthenia/fatigue, back pain, decreased
appetite, constipation, arthralgia, diarrhea, hot flush,
upper respiratory tract infection, peripheral edema,
dyspnea, musculoskeletal pain, weight decreased,
headache, hypertension, and dizziness/vertigo.
Study 1: Metastatic Castration-Resistant Prostate
Cancer Following Chemotherapy
Study 1 enrolled 1199 patients with metastatic CRPC
who had previously received docetaxel. The median
duration of treatment was 8.3 months with XTANDI and
3.0 months with placebo. During the trial, 48% of patients
on the XTANDI arm and 46% of patients on the placebo
arm received glucocorticoids.
Grade 3 and higher adverse reactions were reported
among 47% of XTANDI-treated patients and 53% of
placebo-treated patients. Discontinuations due to adverse
events were reported for 16% of XTANDI-treated patients
and 18% of placebo-treated patients. The most common
adverse reaction leading to treatment discontinuation was
seizure, which occurred in 0.9% of the XTANDI-treated
patients compared to none (0%) of the placebo-treated
patients. Table 1 shows adverse reactions reported in
Study 1 that occurred at a ≥ 2% higher frequency in the
XTANDI arm compared to the placebo arm.
Table 1. Adverse Reactions in Study 1
XTANDI
Placebo
N = 800
N = 399
Grade Grade Grade Grade
a
3-4
1-4
3-4
1-4
(%)
(%)
(%)
(%)
General Disorders
Asthenic
50.6
9.0
44.4
9.3
Conditionsb
Peripheral
15.4
1.0
13.3
0.8
Edema
Musculoskeletal And Connective Tissue Disorders
Back Pain
26.4
5.3
24.3
4.0
Arthralgia
20.5
2.5
17.3
1.8
Musculoskeletal 15.0
1.3
11.5
0.3
Pain
Muscular
9.8
1.5
6.8
1.8
Weakness
Musculoskeletal
2.6
0.3
0.3
0.0
Stiffness
Gastrointestinal Disorders
Diarrhea
21.8
1.1
17.5
0.3
Vascular Disorders
Hot Flush
20.3
0.0
10.3
0.0
Hypertension
6.4
2.1
2.8
1.3
Nervous System Disorders
Headache
12.1
0.9
5.5
0.0
9.5
0.5
7.5
0.5
Dizzinessc
Spinal Cord
Compression
and Cauda
7.4
6.6
4.5
3.8
Equina
Syndrome
Paresthesia
6.6
0.0
4.5
0.0
Mental
Impairment
4.3
0.3
1.8
0.0
Disordersd
Hypoesthesia
4.0
0.3
1.8
0.0
Infections And Infestations
Upper
Respiratory
10.9
0.0
6.5
0.3
Tract Infectione
Lower
Respiratory
8.5
2.4
4.8
1.3
Tract And Lung
Infectionf
Psychiatric Disorders
Insomnia
8.8
0.0
6.0
0.5
Anxiety
6.5
0.3
4.0
0.0
Renal And Urinary Disorders
Hematuria
6.9
1.8
4.5
1.0
Pollakiuria
4.8
0.0
2.5
0.0
Injury, Poisoning And Procedural Complications
Fall
4.6
0.3
1.3
0.0
Non-pathologic
4.0
1.4
0.8
0.3
Fractures
Skin And Subcutaneous Tissue Disorders
Pruritus
3.8
0.0
1.3
0.0
Dry Skin
3.5
0.0
1.3
0.0
Table 1. Adverse Reactions in Study 1 (cont.)
Respiratory Disorders
Epistaxis
3.3
0.1
1.3
0.3
a
b
c
d
CTCAE v4
Includes asthenia and fatigue.
Includes dizziness and vertigo.
Includes amnesia, memory impairment, cognitive disorder,
and disturbance in attention.
e Includes nasopharyngitis, upper respiratory tract infection,
sinusitis, rhinitis, pharyngitis, and laryngitis.
f Includes pneumonia, lower respiratory tract infection,
bronchitis, and lung infection.
Study 2: Chemotherapy-naive Metastatic CastrationResistant Prostate Cancer
Study 2 enrolled 1717 patients with metastatic CRPC who
had not received prior cytotoxic chemotherapy, of whom
1715 received at least one dose of study drug. The median
duration of treatment was 17.5 months with XTANDI and
4.6 months with placebo. Grade 3-4 adverse reactions
were reported in 44% of XTANDI-treated patients and
37% of placebo-treated patients. Discontinuations due to
adverse events were reported for 6% of XTANDI-treated
patients and 6% of placebo-treated patients. The
most common adverse reaction leading to treatment
discontinuation was fatigue/asthenia, which occurred in
1% of patients on each treatment arm. Table 2 includes
adverse reactions reported in Study 2 that occurred at a
≥ 2% higher frequency in the XTANDI arm compared to
the placebo arm.
Table 2. Adverse Reactions in Study 2
Placebo
XTANDI
N = 844
N = 871
Grade Grade Grade Grade
a
1-4
3-4
3-4
1-4
(%)
(%)
(%)
(%)
General Disorders
Asthenic
46.9
3.4
33.0
2.8
Conditionsb
Peripheral
11.5
0.2
8.2
0.4
Edema
Musculoskeletal And Connective Tissue Disorders
Back Pain
28.6
2.5
22.4
3.0
Arthralgia
21.4
1.6
16.1
1.1
Gastrointestinal Disorders
Constipation
23.2
0.7
17.3
0.4
Diarrhea
16.8
0.3
14.3
0.4
Vascular Disorders
Hot Flush
18.0
0.1
7.8
0.0
Hypertension
14.2
7.2
4.1
2.3
Nervous System Disorders
11.3
0.3
7.1
0.0
Dizzinessc
Headache
11.0
0.2
7.0
0.4
Dysgeusia
7.6
0.1
3.7
0.0
Mental
5.7
0.0
1.3
0.1
Impairment
Disordersd
Restless Legs
2.1
0.1
0.4
0.0
Syndrome
Respiratory Disorders
11.0
0.6
8.5
0.6
Dyspneae
Infections And Infestations
Upper
16.4
0.0
10.5
0.0
Respiratory
Tract Infectionf
Lower
Respiratory
7.9
1.5
4.7
1.1
Tract And Lung
Infectiong
Psychiatric Disorders
Insomnia
8.2
0.1
5.7
0.0
Renal And Urinary Disorders
Hematuria
8.8
1.3
5.8
1.3
Injury, Poisoning And Procedural Complications
Fall
12.7
1.6
5.3
0.7
Non-Pathological
8.8
2.1
3.0
1.1
Fracture
Metabolism and Nutrition Disorders
Decreased
18.9
0.3
16.4
0.7
Appetite
Investigations
Weight
12.4
0.8
8.5
0.2
Decreased
Reproductive System and Breast Disorders
1.4
3.4
0.0
0.0
Gynecomastia
Table 2. Adverse Reactions in Study 2 (cont.)
a
b
c
d
CTCAE v4
Includes asthenia and fatigue.
Includes dizziness and vertigo.
Includes amnesia, memory impairment, cognitive disorder,
and disturbance in attention.
e Includes dyspnea, exertional dyspnea, and dyspnea at rest.
f Includes nasopharyngitis, upper respiratory tract infection,
sinusitis, rhinitis, pharyngitis, and laryngitis.
g Includes pneumonia, lower respiratory tract infection,
bronchitis, and lung infection.
Laboratory Abnormalities
In the two randomized clinical trials, Grade 1-4
neutropenia occurred in 15% of patients treated with
XTANDI (1% Grade 3-4) and in 6% of patients treated
with placebo (0.5% Grade 3-4). The incidence of Grade
1-4 thrombocytopenia was 6% of patients treated with
XTANDI (0.3% Grade 3-4) and 5% of patients treated
with placebo (0.5% Grade 3-4). Grade 1-4 elevations in
ALT occurred in 10% of patients treated with XTANDI
(0.2% Grade 3-4) and 16% of patients treated with
placebo (0.2% Grade 3-4). Grade 1-4 elevations in
bilirubin occurred in 3% of patients treated with XTANDI
(0.1% Grade 3-4) and 2% of patients treated with placebo
(no Grade 3-4).
Infections
In Study 1, 1% of patients treated with XTANDI compared
to 0.3% of patients treated with placebo died from
infections or sepsis. In Study 2, 1 patient in each treatment
group (0.1%) had an infection resulting in death.
Falls and Fall-related Injuries
In the two randomized clinical trials, falls including fallrelated injuries, occurred in 9% of patients treated with
XTANDI compared to 4% of patients treated with placebo.
Falls were not associated with loss of consciousness or
seizure. Fall-related injuries were more severe in patients
treated with XTANDI and included non-pathologic
fractures, joint injuries, and hematomas.
Hypertension
In the two randomized trials, hypertension was reported
in 11% of patients receiving XTANDI and 4% of patients
receiving placebo. No patients experienced hypertensive
crisis. Medical history of hypertension was balanced
between arms. Hypertension led to study discontinuation
in < 1% of patients in each arm.
Post-Marketing Experience
The following additional adverse reactions have been
identified during post approval use of XTANDI. Because
these reactions were reported voluntarily from a
population of uncertain size, it is not always possible
to reliably estimate the frequency or establish a causal
relationship to drug exposure.
Neurological Disorders: posterior reversible encephalopathy
syndrome (PRES)
DRUG INTERACTIONS
Drugs that Inhibit CYP2C8
Co-administration of a strong CYP2C8 inhibitor
(gemfibrozil) increased the composite area under the
plasma concentration-time curve (AUC) of enzalutamide
plus N-desmethyl enzalutamide by 2.2-fold. Coadministration of XTANDI with strong CYP2C8 inhibitors
should be avoided if possible. If co-administration
of XTANDI with a strong CYP2C8 inhibitor cannot be
avoided, reduce the dose of XTANDI.
Drugs that Induce CYP3A4
Co-administration of rifampin (strong CYP3A4 inducer
and moderate CYP2C8 inducer) decreased the composite
AUC of enzalutamide plus N-desmethyl enzalutamide
by 37%. Co-administration of strong CYP3A4 inducers
(e.g., carbamazepine, phenobarbital, phenytoin, rifabutin,
rifampin, rifapentine) with XTANDI should be avoided
if possible. St John’s wort may decrease enzalutamide
exposure and should be avoided. If co-administration of a
strong CYP3A4 inducer with XTANDI cannot be avoided,
increase the dose of XTANDI.
Effect of XTANDI on Drug Metabolizing Enzymes
Enzalutamide is a strong CYP3A4 inducer and a moderate
CYP2C9 and CYP2C19 inducer in humans. At steady
state, XTANDI reduced the plasma exposure to midazolam
(CYP3A4 substrate), warfarin (CYP2C9 substrate), and
omeprazole (CYP2C19 substrate). Concomitant use of
XTANDI with narrow therapeutic index drugs that are
metabolized by CYP3A4 (e.g., alfentanil, cyclosporine,
dihydroergotamine, ergotamine, fentanyl, pimozide,
quinidine, sirolimus and tacrolimus), CYP2C9 (e.g.,
phenytoin, warfarin) and CYP2C19 (e.g., S-mephenytoin)
should be avoided, as enzalutamide may decrease their
exposure. If co-administration with warfarin cannot be
avoided, conduct additional INR monitoring.
USE IN SPECIFIC POPULATIONS
Pregnancy– Pregnancy Category X.
Risk Summary
XTANDI can cause fetal harm when administered to a
pregnant woman based on its mechanism of action and
findings in animals. While there are no human data on the
use of XTANDI in pregnancy and XTANDI is not indicated
for use in women, it is important to know that maternal
use of an androgen receptor inhibitor could affect
development of the fetus. Enzalutamide caused embryofetal toxicity in mice at exposures that were lower than
in patients receiving the recommended dose. XTANDI
is contraindicated in women who are or may become
pregnant while receiving the drug. If this drug is used
during pregnancy, or if the patient becomes pregnant
while taking this drug, apprise the patient of the potential
hazard to the fetus and the potential risk for pregnancy
loss. Advise females of reproductive potential to avoid
becoming pregnant during treatment with XTANDI.
Animal Data
In an embryo-fetal developmental toxicity study in
mice, enzalutamide caused developmental toxicity
when administered at oral doses of 10 or 30 mg/kg/day
throughout the period of organogenesis (gestational days
6-15). Findings included embryo-fetal lethality (increased
post-implantation loss and resorptions) and decreased
anogenital distance at ≥ 10 mg/kg/day, and cleft palate
and absent palatine bone at 30 mg/kg/day. Doses of
30 mg/kg/day caused maternal toxicity. The doses tested
in mice (1, 10 and 30 mg/kg/day) resulted in systemic
exposures (AUC) approximately 0.04, 0.4 and 1.1 times,
respectively, the exposures in patients. Enzalutamide
did not cause developmental toxicity in rabbits when
administered throughout the period of organogenesis
(gestational days 6-18) at dose levels up to 10 mg/kg/day
(approximately 0.4 times the exposures in patients based
on AUC).
Nursing Mothers
XTANDI is not indicated for use in women. It is not known
if enzalutamide is excreted in human milk. Because
many drugs are excreted in human milk, and because
of the potential for serious adverse reactions in nursing
infants from XTANDI, a decision should be made to either
discontinue nursing, or discontinue the drug taking into
account the importance of the drug to the mother.
Pediatric Use
Safety and effectiveness of XTANDI in pediatric patients
have not been established.
Geriatric Use
Of 1671 patients who received XTANDI in the two
randomized clinical trials, 75% were 65 and over, while
31% were 75 and over. No overall differences in safety
or effectiveness were observed between these patients
and younger patients. Other reported clinical experience
has not identified differences in responses between the
elderly and younger patients, but greater sensitivity of
some older individuals cannot be ruled out.
Patients with Renal Impairment
A dedicated renal impairment trial for XTANDI has not
been conducted. Based on the population pharmacokinetic
analysis using data from clinical trials in patients with
metastatic CRPC and healthy volunteers, no significant
difference in enzalutamide clearance was observed
in patients with pre-existing mild to moderate renal
impairment (30 mL/min ≤ creatinine clearance [CrCL]
≤ 89 mL/min) compared to patients and volunteers with
baseline normal renal function (CrCL ≥ 90 mL/min).
No initial dosage adjustment is necessary for patients
with mild to moderate renal impairment. Severe renal
impairment (CrCL < 30 mL/min) and end-stage renal
disease have not been assessed.
Patients with Hepatic Impairment
Dedicated hepatic impairment trials compared the
composite systemic exposure of enzalutamide plus
N-desmethyl enzalutamide in volunteers with baseline
mild, moderate, or severe hepatic impairment (ChildPugh Class A, B, or C, respectively) versus healthy
controls with normal hepatic function. The composite
AUC of enzalutamide plus N-desmethyl enzalutamide
was similar in volunteers with mild, moderate, or severe
baseline hepatic impairment compared to volunteers with
normal hepatic function. No initial dosage adjustment is
necessary for patients with baseline mild, moderate, or
severe hepatic impairment.
OVERDOSAGE
In the event of an overdose, stop treatment with XTANDI
and initiate general supportive measures taking into
consideration the half-life of 5.8 days. In a dose escalation
study, no seizures were reported at ≤ 240 mg daily,
whereas 3 seizures were reported, 1 each at 360 mg,
480 mg, and 600 mg daily. Patients may be at increased
risk of seizure following an overdose.
NONCLINICAL TOXICOLOGY
Carcinogenesis, Mutagenesis, Impairment of Fertility
Long-term animal studies have not been conducted to
evaluate the carcinogenic potential of enzalutamide.
Enzalutamide did not induce mutations in the bacterial
reverse mutation (Ames) assay and was not genotoxic
in either the in vitro mouse lymphoma thymidine
kinase (Tk) gene mutation assay or the in vivo mouse
micronucleus assay.
Based on nonclinical findings in repeat-dose toxicology
studies, which were consistent with the pharmacological
activity of enzalutamide, male fertility may be impaired
by treatment with XTANDI. In a 26-week study in rats,
atrophy of the prostate and seminal vesicles was observed
at ≥ 30 mg/kg/day (equal to the human exposure based
on AUC). In 4-, 13-, and 39-week studies in dogs,
hypospermatogenesis and atrophy of the prostate and
epididymides were observed at ≥ 4 mg/kg/day (0.3 times
the human exposure based on AUC).
Manufactured by: Catalent Pharma Solutions, LLC,
St. Petersburg, FL 33716
Manufactured for and Distributed by: Astellas Pharma
US, Inc., Northbrook, IL 60062
Marketed by:
Astellas Pharma US, Inc., Northbrook, IL 60062
Medivation, Inc., San Francisco, CA 94105
Revised: October 2015
15C018-XTA
Rx Only
© 2015 Astellas Pharma US, Inc.
XTANDI® is a registered trademark of Astellas Pharma Inc.
076-1200-PM
For your patients with overactive bladder (OAB)
Rethin
OAB
Treatment
Myrbetriq is a ß3-adrenergic agonist indicated for patients with OAB symptoms
of urge urinary incontinence, urgency, and urinary frequency1
It may be time to take another look at OAB treatment with Myrbetriq
INDICATIONS AND USAGE
Myrbetriq® (mirabegron) is a beta-3 adrenergic agonist indicated for the treatment of overactive bladder
(OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency.
IMPORTANT SAFETY INFORMATION
Myrbetriq is contraindicated in patients who have known hypersensitivity reactions to mirabegron or any
component of the tablet.
Myrbetriq can increase blood pressure. Periodic blood pressure determinations are recommended, especially
in hypertensive patients. Myrbetriq is not recommended for use in severe uncontrolled hypertensive
patients (defined as systolic blood pressure ≥ 180 mm Hg and/or diastolic blood pressure ≥ 110 mm Hg).
Urinary retention in patients with bladder outlet obstruction (BOO) and in patients taking antimuscarinic
medications for the treatment of OAB has been reported in postmarketing experience in patients taking
mirabegron. A controlled clinical safety study in patients with BOO did not demonstrate increased urinary
retention in Myrbetriq patients; however, Myrbetriq should be administered with caution to patients with
clinically significant BOO. Myrbetriq should also be administered with caution to patients taking
antimuscarinic medications for the treatment of OAB.
Angioedema of the face, lips, tongue and/or larynx has been reported with Myrbetriq. In some cases
angioedema occurred after the first dose. Cases of angioedema have been reported to occur hours after
IMPORTANT SAFETY INFORMATION (cont’d)
the first dose or after multiple doses. Angioedema associated with upper airway swelling may be life
threatening. If involvement of the tongue, hypopharynx, or larynx occurs, promptly discontinue Myrbetriq
and initiate appropriate therapy and/or measures necessary to ensure a patent airway.
Since Myrbetriq is a moderate CYP2D6 inhibitor, the systemic exposure to CYP2D6 substrates such as
metoprolol and desipramine is increased when co-administered with Myrbetriq. Therefore, appropriate
monitoring and dose adjustment may be necessary, especially with narrow therapeutic index drugs
metabolized by CYP2D6, such as thioridazine, flecainide, and propafenone.
Most commonly reported adverse reactions (> 2% and > placebo) for Myrbetriq 25 mg and 50 mg versus
placebo, respectively, were hypertension (11.3%, 7.5% vs 7.6%), nasopharyngitis (3.5%, 3.9% vs 2.5%),
urinary tract infection (4.2%, 2.9% vs 1.8%), and headache (2.1%, 3.2% vs 3.0%).
Please see Brief Summary of Prescribing Information for Myrbetriq on following pages.
Reference: 1. Myrbetriq [Prescribing Information]. Northbrook, IL:
Astellas Pharma US, Inc.
Myrbetriq is a registered trademark of Astellas Pharma Inc.
©2016 Astellas Pharma US, Inc.
All rights reserved.
Printed in USA
057-1078-PM
March 2016
Table 1 Continued
BRIEF SUMMARY OF PRESCRIBING INFORMATION
Myrbetriq 25 mg
(%)
Myrbetriq 50 mg
(%)
1380
432
1375
Constipation
1.4
1.6
1.6
Upper Respiratory
Tract Infection
1.7
2.1
1.5
Arthralgia
1.1
1.6
1.3
Diarrhea
1.3
1.2
1.5
Myrbetriq is contraindicated in patients who have known hypersensitivity reactions to mirabegron or any
component of the tablet [see Adverse Reactions (6.1, 6.2)].
Tachycardia
0.6
1.6
1.2
Abdominal Pain
0.7
1.4
0.6
---------------------------------------------WARNINGS AND PRECAUTIONS----------------------------------------------
Fatigue
1.0
1.4
1.2
The following information is a brief summary only. See full prescribing information for Myrbetriq.
Myrbetriq (mirabegron) extended-release tablets
®
-------------------------------------------------INDICATIONS AND USAGE-------------------------------------------------Myrbetriq® is a beta-3 adrenergic agonist indicated for the treatment of overactive bladder (OAB) with symptoms
of urge urinary incontinence, urgency, and urinary frequency.
----------------------------------------------------CONTRAINDICATIONS---------------------------------------------------
Increases in Blood Pressure
Myrbetriq can increase blood pressure. Periodic blood pressure determinations are recommended, especially in
hypertensive patients. Myrbetriq is not recommended for use in patients with severe uncontrolled hypertension
(defined as systolic blood pressure greater than or equal to 180 mmHg and/or diastolic blood pressure greater
than or equal to 110 mmHg) [see Clinical Pharmacology (12.2)].
In two, randomized, placebo-controlled, healthy volunteer studies, Myrbetriq was associated with dose-related
increases in supine blood pressure. In these studies, at the maximum recommended dose of 50 mg, the mean
maximum increase in systolic/diastolic blood pressure was approximately 3.5/1.5 mmHg greater than placebo.
Number of Patients
Placebo
(%)
*Includes reports of blood pressure above the normal range, and BP increased from baseline, occurring
predominantly in subjects with baseline hypertension.
Other adverse reactions reported by less than 1% of patients treated with Myrbetriq in Studies 1, 2, or 3
included:
Cardiac disorders: palpitations, blood pressure increased [see Clinical Pharmacology (12.2)]
Eye disorders: glaucoma [see Clinical Pharmacology (12.2)]
Gastrointestinal disorders: dyspepsia, gastritis, abdominal distension
In contrast, in OAB patients in clinical trials, the mean increase in systolic and diastolic blood pressure at the
maximum recommended dose of 50 mg was approximately 0.5 - 1 mmHg greater than placebo. Worsening of
pre-existing hypertension was reported infrequently in Myrbetriq patients.
Infections and Infestations: sinusitis, rhinitis
Urinary Retention in Patients with Bladder Outlet Obstruction and in Patients Taking Antimuscarinic
Medications for OAB
Reproductive system and breast disorders: vulvovaginal pruritus, vaginal infection
Urinary retention in patients with bladder outlet obstruction (BOO) and in patients taking antimuscarinic
medications for the treatment of OAB has been reported in postmarketing experience in patients taking
mirabegron. A controlled clinical safety study in patients with BOO did not demonstrate increased urinary
retention in Myrbetriq patients; however, Myrbetriq should be administered with caution to patients with
clinically significant BOO. Myrbetriq should also be administered with caution to patients taking antimuscarinic
medications for the treatment of OAB [see Clinical Pharmacology (12.2)].
Investigations: GGT increased, AST increased, ALT increased, LDH increased
Renal and urinary disorders: nephrolithiasis, bladder pain
Skin and subcutaneous tissue disorders: urticaria, leukocytoclastic vasculitis, rash, pruritus, purpura, lip edema
Table 2 lists the rates of the most commonly reported adverse reactions, derived from all adverse events in
patients treated with Myrbetriq 50 mg for up to 52 weeks in Study 4. The most commonly reported adverse
reactions (>3% of Myrbetriq patients) were hypertension, urinary tract infection, headache, and nasopharyngitis.
Table 2: Percentages of Patients with Adverse Reactions, Derived from all Adverse Events, Reported by
Greater Than 2% of Patients Treated With Myrbetriq 50 mg Once Daily in Study 4
Myrbetriq 50 mg
(%)
Active Control
(%)
Number of Patients
812
812
Hypertension
9.2
9.6
Urinary Tract Infection
5.9
6.4
Patients Taking Drugs Metabolized by CYP2D6
Headache
4.1
2.5
Since mirabegron is a moderate CYP2D6 inhibitor, the systemic exposure to CYP2D6 substrates such as
metoprolol and desipramine is increased when co-administered with mirabegron. Therefore, appropriate
monitoring and dose adjustment may be necessary, especially with narrow therapeutic index drugs metabolized
by CYP2D6, such as thioridazine, flecainide, and propafenone [see Drug Interactions (7.1) and Clinical
Pharmacology (12.3)].
Nasopharyngitis
3.9
3.1
Back Pain
2.8
1.6
Constipation
2.8
2.7
Dry Mouth
2.8
8.6
----------------------------------------------------ADVERSE REACTIONS----------------------------------------------------
Dizziness
2.7
2.6
Clinical Trials Experience
Sinusitis
2.7
1.5
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the
clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not
reflect the rates observed in clinical practice.
Influenza
2.6
3.4
Arthralgia
2.1
2.0
Cystitis
2.1
2.3
Angioedema
Angioedema of the face, lips, tongue, and/or larynx has been reported with Myrbetriq. In some cases angioedema
occurred after the first dose. Cases of angioedema have been reported to occur hours after the first dose or
after multiple doses. Angioedema associated with upper airway swelling may be life threatening. If involvement
of the tongue, hypopharynx, or larynx occurs, promptly discontinue Myrbetriq and initiate appropriate therapy
and/or measures necessary to ensure a patent airway [see Adverse Reactions (6.2)].
In three, 12 week, double-blind, placebo-controlled, safety and efficacy studies in patients with overactive
bladder (Studies 1, 2, and 3), Myrbetriq was evaluated for safety in 2736 patients, [see Clinical Studies (14)].
Study 1 also included an active control. For the combined Studies 1, 2, and 3, 432 patients received Myrbetriq
25 mg, 1375 received Myrbetriq 50 mg, and 929 received Myrbetriq 100 mg once daily. In these studies, the
majority of the patients were Caucasian (94%), and female (72%) with a mean age of 59 years (range 18 to
95 years).
Myrbetriq was also evaluated for safety in 1632 patients who received Myrbetriq 50 mg once daily
(n=812 patients) or Myrbetriq 100 mg (n=820 patients) in a 1 year, randomized, fixed dose, double-blind, active
controlled, safety study in patients with overactive bladder (Study 4). Of these patients, 731 received Myrbetriq
in a previous 12 week study. In Study 4, 1385 patients received Myrbetriq continuously for at least 6 months,
1311 patients received Myrbetriq for at least 9 months, and 564 patients received Myrbetriq for at least 1 year.
In Study 4, in patients treated with Myrbetriq 50 mg once daily, adverse reactions leading to discontinuation
reported by more than 2 patients and at a rate greater than active control included: constipation (0.9%), headache
(0.6%), dizziness (0.5%), hypertension (0.5%), dry eyes (0.4%), nausea (0.4%), vision blurred (0.4%), and
urinary tract infection (0.4%). Serious adverse events reported by at least 2 patients and exceeding active
control included cerebrovascular accident (0.4%) and osteoarthritis (0.2%). Serum ALT/AST increased from
baseline by greater than 10-fold in 2 patients (0.3%) taking Myrbetriq 50 mg, and these markers subsequently
returned to baseline while both patients continued Myrbetriq.
In Study 4, serious adverse events of neoplasm were reported by 0.1%, 1.3%, and 0.5% of patients treated
with Myrbetriq 50 mg, Myrbetriq 100 mg and active control once daily, respectively. Neoplasms reported by
2 patients treated with Myrbetriq 100 mg included breast cancer, lung neoplasm malignant and prostate cancer.
The most frequent adverse events (0.2%) leading to discontinuation in Studies 1, 2 and 3 for the 25 mg or
50 mg dose were nausea, headache, hypertension, diarrhea, constipation, dizziness and tachycardia.
In a separate clinical study in Japan, a single case was reported as Stevens-Johnson syndrome with increased
serum ALT, AST and bilirubin in a patient taking Myrbetriq 100 mg as well as an herbal medication (Kyufu Gold).
Atrial fibrillation (0.2%) and prostate cancer (0.1%) were reported as serious adverse events by more than
1 patient and at a rate greater than placebo.
Postmarketing Experience
Table 1 lists adverse reactions, derived from all adverse events, that were reported in Studies 1, 2 and 3 at an
incidence greater than placebo and in 1% or more of patients treated with Myrbetriq 25 mg or 50 mg once daily
for up to 12 weeks. The most commonly reported adverse reactions (greater than 2% of Myrbetriq patients and
greater than placebo) were hypertension, nasopharyngitis, urinary tract infection and headache.
Table 1: Percentages of Patients with Adverse Reactions, Derived from All Adverse Events, Exceeding
Placebo Rate and Reported by 1% or More Patients Treated With Myrbetriq 25 mg or 50 mg Once Daily in
Studies 1, 2, and 3
Placebo
(%)
Myrbetriq 25 mg
(%)
Myrbetriq 50 mg
(%)
1380
432
1375
Hypertension*
7.6
11.3
7.5
Nasopharyngitis
2.5
3.5
3.9
Urinary Tract Infection
1.8
4.2
2.9
Headache
3.0
2.1
3.2
Number of Patients
Because these spontaneously reported events are from the worldwide postmarketing experience, from a
population of uncertain size, the frequency of events and the role of mirabegron in their causation cannot be
reliably determined.
The following events have been reported in association with mirabegron use in worldwide postmarketing
experience:
Gastrointestinal disorders: nausea
Skin and subcutaneous tissue: angioedema of the face, lips, tongue, and larynx, with or without respiratory
symptoms [see Warnings and Precautions (5.3)]; pruritus
Urologic: urinary retention [see Warnings and Precautions (5.2)]
----------------------------------------------------DRUG INTERACTIONS--------------------------------------------------Drug interaction studies were conducted to investigate the effect of co-administered drugs on the
pharmacokinetics of mirabegron and the effect of mirabegron on the pharmacokinetics of co-administered
drugs (e.g., ketoconazole, rifampin, solifenacin, tamsulosin, and oral contraceptives) [see Clinical Pharmacology
(12.3)]. No dose adjustment is recommended when these drugs are co-administered with mirabegron.
Although no dose adjustment is recommended with solifenacin or tamsulosin based on the lack of
pharmacokinetic interaction, Myrbetriq should be administered with caution to patients taking antimuscarinic
medications for the treatment of OAB and in patients with clinically significant BOO because of the risk of
urinary retention [see Warnings and Precautions (5.2)].
The following are drug interactions for which monitoring is recommended:
Cardiac Electrophysiology
Drugs Metabolized by CYP2D6
The effect of multiple doses of Myrbetriq 50 mg, 100 mg and 200 mg once daily on QTc interval was evaluated
in a randomized, placebo- and active- controlled (moxifloxacin 400 mg) four-treatment-arm parallel crossover
study in 352 healthy subjects. In a study with demonstrated ability to detect small effects, the upper bound
of the one-sided 95% confidence interval for the largest placebo adjusted, baseline-corrected QTc based on
individual correction method (QTcI) was below 10 msec. For the 50 mg Myrbetriq dose group (the maximum
approved dosage), the mean difference from placebo on QTcI interval at 4-5 hours post-dose was 3.7 msec
(upper bound of the 95% CI 5.1 msec).
Since mirabegron is a moderate CYP2D6 inhibitor, the systemic exposure of drugs metabolized by CYP2D6
enzyme such as metoprolol and desipramine is increased when co-administered with mirabegron. Therefore,
appropriate monitoring and dose adjustment may be necessary when Myrbetriq is co-administered with these
drugs, especially with narrow therapeutic index CYP2D6 substrates, such as thioridazine, flecainide, and
propafenone [see Warnings and Precautions (5.4) and Clinical Pharmacology (12.3)].
Digoxin
When given in combination, mirabegron increased mean digoxin Cmax from 1.01 to 1.3 ng/mL (29%) and AUC
from 16.7 to 19.3 ng.h/mL (27%). Therefore, for patients who are initiating a combination of mirabegron
and digoxin, the lowest dose for digoxin should initially be considered. Serum digoxin concentrations should
be monitored and used for titration of the digoxin dose to obtain the desired clinical effect [see Clinical
Pharmacology (12.3)].
Warfarin
The mean Cmax of S- and R-warfarin was increased by approximately 4% and AUC by approximately 9% when
administered as a single dose of 25 mg after multiple doses of 100 mg mirabegron. Following a single dose
administration of 25 mg warfarin, mirabegron had no effect on the warfarin pharmacodynamic endpoints
such as International Normalized Ratio (INR) and prothrombin time. However, the effect of mirabegron on
multiple doses of warfarin and on warfarin pharmacodynamic end points such as INR and prothrombin time
has not been fully investigated [see Clinical Pharmacology (12.3)].
----------------------------------------------USE IN SPECIFIC POPULATIONS--------------------------------------------Pregnancy
Pregnancy Category C
There are no adequate and well-controlled studies using Myrbetriq in pregnant women. Myrbetriq should be
used during pregnancy only if the potential benefit to the patient outweighs the risk to the patient and fetus.
Women who become pregnant during Myrbetriq treatment are encouraged to contact their physician.
Risk Summary
Based on animal data, mirabegron is predicted to have a low probability of increasing the risk of adverse
developmental outcomes above background risk. Reversible adverse developmental findings consisting of
delayed ossification and wavy ribs in rats and decreased fetal body weights in rabbits occurred at exposures
greater than or equal to 22 and 14 times, respectively, the maximum recommended human dose (MRHD). At
maternally toxic exposures decreased fetal weights were observed in rats and rabbits, and fetal death, dilated
aorta, and cardiomegaly were reported in rabbits.
Nursing Mothers
For the Myrbetriq 100 mg and 200 mg doses groups (dosages greater than the maximum approved dose and
resulting in substantial multiples of the anticipated maximum blood levels at 50 mg), the mean differences
from placebo in QTcI interval at 4-5 hours post-dose were 6.1 msec (upper bound of the 95% CI 7.6 msec) and
8.1 msec (upper bound of the 95% CI 9.8 msec), respectively. At the Myrbetriq 200 mg dose, in females, the
mean effect was 10.4 msec (upper bound of the 95% CI 13.4 msec).
In this thorough QT study, Myrbetriq increased heart rate on ECG in a dose dependent manner. Maximum mean
increases from baseline in heart rate for the 50 mg, 100 mg, and 200 mg dose groups compared to placebo
were 6.7 beats per minutes (bpm), 11 bpm, and 17 bpm, respectively. In the clinical efficacy and safety studies,
the change from baseline in mean pulse rate for Myrbetriq 50 mg was approximately 1 bpm. In this thorough QT
study, Myrbetriq also increased blood pressure in a dose dependent manner (see Effects on Blood Pressure).
Effects on Blood Pressure
In a study of 352 healthy subjects assessing the effect of multiple daily doses of 50 mg, 100 mg, and 200 mg
of Myrbetriq for 10 days on the QTc interval, the maximum mean increase in supine SBP/DBP at the maximum
recommended dose of 50 mg was approximately 4.0/1.6 mmHg greater than placebo. The 24-hour average
increases in SBP compared to placebo were 3.0, 5.5, and 9.7 mmHg at Myrbetriq doses of 50 mg, 100 mg and
200 mg, respectively. Increases in DBP were also dose-dependent, but were smaller than SBP.
In another study in 96 healthy subjects to assess the impact of age on pharmacokinetics of multiple daily doses
of 50 mg, 100 mg, 200 mg, and 300 mg of Myrbetriq for 10 days, SBP also increased in a dose-dependent
manner. The mean maximum increases in SBP were approximately 2.5, 4.5, 5.5 and 6.5 mmHg for Myrbetriq
exposures associated with doses of 50 mg, 100 mg, 200 mg and 300 mg, respectively.
In three, 12-week, double-blind, placebo-controlled, safety and efficacy studies (Studies 1, 2 and 3) in OAB
patients receiving Myrbetriq 25 mg, 50 mg, or 100 mg once daily, mean increases in SBP/DBP compared to
placebo of approximately 0.5 - 1 mmHg were observed. Morning SBP increased by at least 15 mmHg from
baseline in 5.3%, 5.1%, and 6.7% of placebo, Myrbetriq 25 mg and Myrbetriq 50 mg patients, respectively.
Morning DBP increased by at least 10 mmHg in 4.6%, 4.1% and 6.6% of placebo, Myrbetriq 25 mg, and
Myrbetriq 50 mg patients, respectively. Both SBP and DBP increases were reversible upon discontinuation of
treatment.
------------------------------------------------NONCLINICAL TOXICOLOGY------------------------------------------------
It is not known whether Myrbetriq is excreted in human milk. Mirabegron was found in the milk of rats at
concentrations twice the maternal plasma level. Mirabegron was found in the lungs, liver, and kidneys of nursing
pups. No studies have been conducted to assess the impact of Myrbetriq on milk production in humans, its
presence in human breast milk, or its effects on the breast-fed child. Because Myrbetriq is predicted to be
excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision
should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance
of the drug to the mother.
Long-term carcinogenicity studies were conducted in rats and mice dosed orally with mirabegron for two years.
Male rats were dosed at 0, 12.5, 25, or 50 mg/kg/day and female rats and both sexes of mice were dosed at
0, 25, 50, or 100 mg/kg/day. Mirabegron showed no carcinogenic potential at systemic exposures (AUC) 38 to
45-fold higher in rats and 21 to 38-fold higher in mice than the human systemic exposure at the 50 mg dose.
Pediatric Use
Mutagenesis
The safety and effectiveness of Myrbetriq in pediatric patients have not been established.
Mirabegron was not mutagenic in the Ames bacterial reverse mutation assay, did not induce chromosomal
aberrations in human peripheral blood lymphocytes at concentrations that were not cytotoxic, and was not
clastogenic in the rat micronucleus assay.
Geriatric Use
No dose adjustment is necessary for the elderly. The pharmacokinetics of Myrbetriq is not significantly
influenced by age [see Clinical Pharmacology (12.3)]. Of 5648 patients who received Myrbetriq in the phase 2
and 3 studies, 2029 (35.9%) were 65 years of age or older, and 557 (9.9%) were 75 years of age or older. No
overall differences in safety or effectiveness were observed between patients younger than 65 years of age and
those 65 years of age or older in these studies.
Carcinogenesis, Mutagenesis, Impairment of Fertility
Carcinogenicity
Impairment of Fertility
Fertility studies in rats showed that mirabegron had no effect on either male or female fertility at non-lethal
doses up to 100 mg/kg/day. Systemic exposures (AUC) at 100 mg/kg in female rats was estimated to be
22 times the MRHD in women and 93 times the MRHD in men.
Renal Impairment
------------------------------------------PATIENT COUNSELING INFORMATION------------------------------------------
Myrbetriq has not been studied in patients with end stage renal disease (CLcr <15 mL/min or eGFR <15 mL/
min/1.73 m2 or patients requiring hemodialysis), and, therefore is not recommended for use in these patient
populations.
Inform patients that Myrbetriq may increase blood pressure. Periodic blood pressure determinations are
recommended, especially in patients with hypertension. Myrbetriq has also been associated with infrequent
urinary tract infections, rapid heartbeat, rash, and pruritus. Inform patients that urinary retention has been
reported when taking mirabegron in combination with antimuscarinic drugs used in the treatment of overactive
bladder. Instruct patients to contact their physician if they experience these effects while taking Myrbetriq.
In patients with severe renal impairment (CLcr 15 to 29 mL/min or eGFR 15 to 29 mL/min/1.73 m2), the daily
dose of Myrbetriq should not exceed 25 mg. No dose adjustment is necessary in patients with mild or moderate
renal impairment (CLcr 30 to 89 mL/min or eGFR 30 to 89 mL/min/1.73 m2) [see Clinical Pharmacology (12.3)].
Patients should read the patient leaflet entitled “Patient Information” before starting therapy with Myrbetriq.
Hepatic Impairment
Rx Only
Myrbetriq has not been studied in patients with severe hepatic impairment (Child-Pugh Class C), and therefore
is not recommended for use in this patient population.
PRODUCT OF JAPAN OR IRELAND – See bottle label or blister package for origin
In patients with moderate hepatic impairment (Child-Pugh Class B), the daily dose of Myrbetriq should not
exceed 25 mg. No dose adjustment is necessary in patients with mild hepatic impairment (Child-Pugh Class A)
[see Clinical Pharmacology (12.3)].
Marketed and Distributed by:
Astellas Pharma US, Inc.
Northbrook, Illinois 60062
Gender
Myrbetriq® is a registered trademark of Astellas Pharma Inc. All other trademarks or registered trademarks are
the property of their respective owners.
No dose adjustment is necessary based on gender. When corrected for differences in body weight, the Myrbetriq
systemic exposure is 20% to 30% higher in females compared to males.
---------------------------------------------------------OVERDOSAGE-------------------------------------------------------Mirabegron has been administered to healthy volunteers at single doses up to 400 mg. At this dose, adverse
events reported included palpitations (1 of 6 subjects) and increased pulse rate exceeding 100 bpm (3 of
6 subjects). Multiple doses of mirabegron up to 300 mg daily for 10 days showed increases in pulse rate
and systolic blood pressure when administered to healthy volunteers. Treatment for overdosage should be
symptomatic and supportive. In the event of overdosage, pulse rate, blood pressure and ECG monitoring is
recommended.
------------------------------------------------CLINICAL PHARMACOLOGY------------------------------------------------Pharmacodynamics
Urodynamics
The effects of Myrbetriq on maximum urinary flow rate and detrusor pressure at maximum flow rate were
assessed in a urodynamic study consisting of 200 male patients with lower urinary tract symptoms (LUTS)
and BOO. Administration of Myrbetriq once daily for 12 weeks did not adversely affect the mean maximum
flow rate or mean detrusor pressure at maximum flow rate in this study. Nonetheless, Myrbetriq should be
administered with caution to patients with clinically significant BOO [see Warnings and Precautions (5.2)].
© 2015 Astellas Pharma US, Inc.
Revised: December 2015
15L110-MIR-BRFS
057-0908-PM
NOTES
COURSES
Table of Contents
Board of Directors .................................................................................................................................................................. 4
Committees ............................................................................................................................................................................. 5
Specialty Programs ............................................................................................................................................................ 10
Office of Education Courses ............................................................................................................................................ 13
THURSDAY
CME Information .................................................................................................................................................................... 8
1
SATURDAY
SUNDAY
MONDAY
TUESDAY
EXHIBITORS
Saturday
Plenary Sessions I and II ................................................................................................................................................. 79
Sexual Medicine Society of North America .......................................................................................................... 80
Engineering and Urology Society ............................................................................................................................... 82
Residents Forum ............................................................................................................................................................... 83
Arab Association of Urology ........................................................................................................................................ 83
Society for Pediatric Urology ....................................................................................................................................... 84
Poster and Podium Sessions ......................................................................................................................................... 85
Society for Basic Urologic Research/Society of Urologic Oncology Joint Session ..................................... 98
Indian American Urological Association ................................................................................................................ 98
World Chinese Urological Society ............................................................................................................................. 99
AUA/American College of Osteopathic Surgeons Urology Program ......................................................... 100
Science & Technology Poster Session .................................................................................................................... 101
Poster and Podium Sessions ....................................................................................................................................... 106
Surgical Techniques: Radical Prostatectomy ....................................................................................................... 117
Society of Urologic Oncology .................................................................................................................................. 117
Setbacks and Operative Solutions (SOS): Benign ............................................................................................... 118
Poster, Podium and Video Sessions ......................................................................................................................... 118
Bangladesh Association of Urological Surgeons ................................................................................................. 130
Society for Basic Urologic Research ...................................................................................................................... 130
Urologic Care for the Allied Health Professional ................................................................................................. 131
INDEXES
Friday
Society for Pediatric Urology ....................................................................................................................................... 23
AQUA Registry Forum ..................................................................................................................................................... 35
AUA/Confederación Americana de Urología ...................................................................................................... 36
Basic Sciences Symposium ........................................................................................................................................... 36
Urologic Oncology Research Symposium .............................................................................................................. 37
Live Surgery I ..................................................................................................................................................................... 38
Video Session 1 ................................................................................................................................................................ 39
Society of Genitourinary Reconstructive Surgeons ............................................................................................... 40
Late-Breaking Session: Prostate Biopsy ..................................................................................................................... 51
American Society for Men’s Health ......................................................................................................................... 51
Late-Breaking Session: High-Intensity Focused Ultrasound: Hope or Hype? ................................................. 52
Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction ................................... 52
Setbacks and Operative Solutions (SOS): Malignant ......................................................................................... 53
Poster, Podium and Video Sessions ........................................................................................................................... 54
Crossfire: Controversies in Urology: Malignant ....................................................................................................... 66
FRIDAY
Thursday
Society of University Urologists/Society of Urology Chairpersons and Program Directors ....................... 21
Society for Fetal Urology ............................................................................................................................................... 21
Second Opinion Cases: Benign ................................................................................................................................ 131
Hungarian Urological Association & Polish Urological Association .............................................................. 132
AUA-Eurasian Urology Platform ................................................................................................................................. 132
Society of Women in Urology: Women Leaders in Urology Forum ............................................................... 143
Sunday
Plenary Sessions I and II ............................................................................................................................................. 145
Society of Women in Urology Annual Breakfast Meeting ................................................................................ 146
Urologic Care for the Allied Health Professional ................................................................................................. 159
Challenges for Urologic Research: Diabesity ....................................................................................................... 159
International Prostate Forum ..................................................................................................................................... 160
Surgical Techniques: Partial Nephrectomy ........................................................................................................... 173
Society for the Study of Male Reproduction ........................................................................................................ 173
Crossfire: Controversies in Urology: Benign ........................................................................................................... 174
AUA/AACU Health Policy Forum .............................................................................................................................. 174
Funding Opportunities and Grantwriting Guidance for Early Career Investigators ................................. 174
Society for Infection and Inflammation in Urology ............................................................................................. 189
Society of Urologic Robotic Surgery ....................................................................................................................... 189
Korean World Urologic Congress ............................................................................................................................ 189
History Forums I and II .................................................................................................................................................. 190
Geriatric Urological Society ....................................................................................................................................... 192
Japanese Urological Association ............................................................................................................................. 193
British Association of Urological Surgeons/Urological Society of Australia and New Zealand ............. 193
Sociedad Argentina de Urología ............................................................................................................................. 194
Urological Congenitalism Forum .............................................................................................................................. 194
R. Frank Jones Urological Society ............................................................................................................................ 195
Second Opinion Cases: Malignant ......................................................................................................................... 196
Research Forum: Early Career Investigators Showcase .................................................................................... 196
Association Française d’Urologie ............................................................................................................................. 197
Monday
Plenary Session I ........................................................................................................................................................... 209
Live Surgery II .................................................................................................................................................................. 227
Surgical Techniques: Percutaneous Nephrolithotomy ....................................................................................... 244
Young Urologists Forum ............................................................................................................................................... 244
Research on Calculus Kinetics (ROCK) Society ................................................................................................... 244
Urologic Society for Transplantation and Renal Surgery ................................................................................. 245
AUA/Brazilian/Portuguese Urology Program ....................................................................................................... 246
International Russian-Speaking Urological Society ............................................................................................ 246
Court is in Session .......................................................................................................................................................... 258
Egyptian Urological Society ....................................................................................................................................... 258
Pan African Urological Surgeons Association/Caribbean Urological Association .................................. 259
Philippine Urological Association ............................................................................................................................. 259
Società Italiana di Urologia/AUA Joint Meeting ................................................................................................. 259
Town Hall: Optimizing Quality of Life in Patients with Advanced Cancer .................................................. 260
2
Clinical Controversies in Men’s Health ................................................................................................................... 260
Tuesday
Plenary Session I ........................................................................................................................................................... 275
Poster and Podium Sessions ....................................................................................................................................... 277
Exhibitor Listing ............................................................................................................................................................... 301
Author Index ................................................................................................................................................................... 303
3
2015-2016 Board of Directors
Officers of the Board of Directors
President ..............................................................................................................................................William F. Gee
President-Elect...........................................................................................................................Richard K. Babayan
Immediate Past President ..........................................................................................................William W. Bohnert
Secretary ..............................................................................................................................................Manoj Monga
Treasurer .................................................................................................................................Steven M. Schlossberg
Section Representatives to the Board of Directors
Mid-Atlantic ........................................................................................................................................Craig A. Peters
New England ..................................................................................................................................Kevin R. Loughlin
New York ........................................................................................................................Muhammad S. Choudhury
North Central.........................................................................................................................Chandru P. Sundaram
Northeastern...................................................................................................................................John D. Denstedt
South Central ..........................................................................................................................Randall B. Meacham
Southeastern .................................................................................................................................Thomas F. Stringer
Western............................................................................................................................................Scott K. Swanson
AUA Headquarters
American Urological Association, Inc.
1000 Corporate Boulevard
Linthicum, Maryland 21090
Telephone: 410-689-3700
FAX: 410-689-3800
E-mail: [email protected]
Website: www.auanet.org
Annual Business Meeting
San Diego Convention Center
Room 2
Tuesday, May 10, 2016 @ 12:15 pm
4
2015-2016 Committees
Program Planning Committee
Deborah J. Lightner
Armando J. Lorenzo
Jill Macoska
Tom McBride
Kurt A. McCammon
Arturo Mendoza-Valdés
Stephen Y. Nakada
Joel B. Nelson
Victor W. Nitti
R. Corey O’Connor
Aria F. Olumi
Priya Padmanabhan
Lane S. Palmer
C. Lowell Parsons
Margaret S. Pearle
David F. Penson
Michel A. Pontari
Christopher R. Porter
James R. Porter
Glenn M. Preminger
Gail S. Prins
Daniel I. Rosenstein
Andrew D. Rule
Edmund S. Sabanegh
Hossein Sadeghi-Nejad
Eila C. Skinner
J. Brantley Thrasher
Evan M. Vapnek
Run Wang
J. Stuart Wolf, Jr.
Elaine M. Worcester
Elizabeth B. Yerkes
Manoj Monga, Chair
Gregory T. Bales
John M. Barry
Douglas A. Canning
Gaetano Ciancio
Peter E. Clark
J. Quentin Clemens
Hillary L. Copp
Ross M. Decter
Ananias C. Diokno
Todd Doran
Sean P. Elliott
Christopher P. Evans
Robert J. Evans
Peggy Francis
Pat F. Fulgham
David A. Ginsberg
David S. Goldfarb
Leonard G. Gomella
Chris M. Gonzalez
Angelo E. Gousse
Tomas L. Griebling
Frederick A. Gulmi
Lawrence S. Hakim
Jeffrey M. Holzbeierlein
David F. Jarrard
Byron D. Joyner
Anil K. Kapoor
Edward D. Kim
Barry A. Kogan
Peter N. Kolettis
Badrinath R. Konety
Urologic Video Education Committee
Misop Han, Chair
Jay Raman, Vice Chair
Joseph Alukal
Duane Baldwin
Sara Best
Toby C. Chai
Karim Chamie
David Chen
Carley Davis
Scott Delacroix
Una Lee
Jeremy Myers
Phillip Pierorazio
James Porter
Lee Richstone
Craig Rogers
Jaspreet Sandhu
Richard Schlussel
Aseem Shukla
Alana Desai
Daniel Dugi
Sherburne Figenshau
Reza Ghavamian
Mohan Gundeti
Jim Hu
Altan Ilkay
Melissa Kaufman
Isaac Kim
Richard Lee
Rob Stein
Kelly Stratton
Alex Te
Ramakrishna Venkatesh
Bryan Voelzke
Steven K. Wilson
Guan Wu
Jennifer Yang
Lee Zhao
Program Abstract Review Committee
Rosalyn M. Adam
Kourosh Afshar
Peter C. Albertsen
Zaki Almallah
Christopher L. Amling
Karl-Erik Andersson
Kenneth W. Angermeier
Monish Aron
William J. Aronson
Dean G. Assimos
Anthony Atala
Paul F. Austin
Timothy D. Averch
Michael Bailey
K. C. Balaji
D. Duane Baldwin
James F. Borin
Luis H. Braga
Steven B. Brandes
Robert Brannigan
William O. Brant
Peter N. Bretan
Benjamin Breyer
Gregory A. Broderick
Benjamin Brucker
Fiona C. Burkhard
Frank N. Burks
Arthur L. Burnett
Nicol C. Bush
Wade Bushman
Ralph Buttyan
Jeffrey A. Cadeddu
Chris Bangma
Daniel A. Barocas
Julia S. Barthold
Arie S. Belldegrun
Carol J. Bennett
Nelson Bennett
Mitchell C. Benson
Ryan K. Berglund
Sam B. Bhayani
John Bischof
Jay T. Bishoff
Trinity Bivalacqua
Jerry G. Blaivas
Jeremy M. Blumberg
Michael L. Blute
Stephen A. Boorjian
5
Mark P. Cain
Anne P. Cameron
Jeffrey B. Campbell
Steven C. Campbell
Benjamin K. Canales
Serge Carrier
Rafael Carrion
Peter R. Carroll
Ballantine Carter
William J. Catalona
Marc Cendron
Toby Chai
Karim Chamie
David Chan
Michael Chancellor
Sam S. Chang
Brian Chapin
Justin Chee
Earl Y. Cheng
Ben Chew
Joseph Chin
George H. Chow
George J. Christ
Brian S. Christine
Kristin Chrouser
Peter E. Clark
J. Quentin Clemens
Michael Coburn
Craig V. Comiter
Michael Cookson
Christopher S. Cooper
Matthew R. Cooperberg
Hillary L. Copp
Nicholas G. Cost
Raymond A. Costabile
Daniel J. Culkin
Anthony D’Amico
Rajvir Dahiya
Philipp Dahm
Guido Dalbagni
Marc A. Dall’Era
Margot S. Damaser
Sakti Das
Brian J. Davis
John W. Davis
Rodney Davis
Elise J. B. De
Jean J. de la Rosette
William R. DeFoor
Donna Deng
Louis J. Denis
John D. Denstedt
Ithaar H. Derweesh
Mihir M. Desai
Jordan Dimitrakov
Martin Dineen
Colin P. N. Dinney
Michael DiSandro
Michael E. DiSanto
Roger Dmochowski
S. Machele Donat
Bryan Donnelly
Tracy M. Downs
James M. Dupree
James A. Eastham
Scott E. Eggener
Karyn Eilber
Brian H. Eisner
Mostafa M. Elhilali
Christopher S. Elliott
Daniel S. Elliott
Sean P. Elliott
Bradley A. Erickson
Christopher P. Evans
Gary J. Faerber
Walid A. Farhat
Amr F. Fergany
Fernando Ferrer
Robert C. Flanigan
Brian J. Flynn
Richard S. Foster
Stephen J. Freedland
Gerhard J. Fuchs
Pat F. Fulgham
Arvind Ganpule
Michael J. Kennelly
Saeed R. Khan
Mohit Khera
Adam S. Kibel
Edward D. Kim
Fernando J. Kim
Eric A. Klein
Laurence Klotz
Bodo E. Knudson
Dicken Ko
Kathleen Kobashi
Michael Koch
Tobias S. Kohler
Peter N. Kolettis
Thomas F. Kolon
Badrinath R. Konety
Amy E. Krambeck
John N. Krieger
Sanjay B. Kulkarni
Rajeev Kumar
Eric A. Kurzrock
Natasha Kyprianou
Eric Laborde
M. Pilar Laguna
Henry Lai
Delores Lamb
Paul H. Lange
Jerilyn M. Latini
John P. Lavelle
Cheryl T. Lee
Eugene K. Lee
Bradley C. Leibovich
Gary E. Lemack
Thomas S. Lendvay
Lori Lerner
Seth Lerner
Raymond J. Leveillee
Ronald W. Lewis
John A. Libertino
John C. Lieske
Deborah J. Lightner
Daniel W. Lin
Guiting Lin
W. Marston Linehan
Michael E. Lipkin
Larry I. Lipshultz
Mark S. Litwin
Vinata Lokeshwar
Armando J. Lorenzo
Yair Lotan
Kevin Loughlin
Franklin C. Lowe
William T. Lowrance
Alvaro Lucioni
Tom F. Lue
Antonio Macedo
Danil V. Makarov
Stanley B. Malkowicz
Jodi K. Maranchie
Joel L. Marmar
Viraj Master
Surena F. Matin
Brian R. Matlaga
Tadashi Matsuda
Kurt McCammon
R. Dale McClure
Kevin T. McVary
Mani M. Menon
Megan Merrill
Mark Garzotto
John M. Gatti
Matthew Gettman
Robert H. Getzenberg
Gamal M. Ghoniem
Peter J. Gilling
Jeffrey R. Gingrich
David A. Ginsberg
Jordan Gitlin
Martin E. Gleave
David A. Goldfarb
David S. Goldfarb
Howard B. Goldman
Marc Goldstein
Leonard G. Gomella
Alex Gomelsky
Cristiano M. Gomes
Christopher M. Gonzalez
Ricardo R. Gonzalez
Mark L. Gonzalgo
John L. Gore
E. Ann Gormley
Angela E. Gousse
Michael Grasso
Kristen L. Greene
Tomas L. Griebling
Andreas Gross
Mantu Gupta
Khurshid A. Guru
Jorge Gutierrez Aceves
George P. Haber
Lawrence S. Hakim
Joanna Hannan
Philip M. Hanno
Richard E. Hautmann
Jason Hedges
Joel J. Heidelbaugh
Brian T. Helfand
Wayne J. G. Hellstrom
Gerard D. Henry
S. Duke Herrell
Adonis K. Hijaz
John M. Hollingsworth
Jeffrey M. Holzbeierlein
Katherine C. Hubert
Stephen J. Hudak
Mitchell R. Humphreys
Robert E. Hurst
Micah Jacobs
David F. Jarrard
Keith Jarvi
Rama Jayanthi
Emilie K. Johnson
Ted Johnson
J. Stephen Jones
Steven Joniau
Mark L. Jordan
Jean Joseph
Ashish M. Kamat
Christopher J. Kane
Jihad H. Kaouk
Steven A. Kaplan
Jose A. Karam
Aaron Katz
Mark Katz
Ronald Kaufman
Louis R. Kavoussi
Melise A. Keays
Francis X. Keeley
6
Edward Messing
Peter D. Metcalfe
Jeff M. Michalski
David C. Miller
Nicole L. Miller
Jesse N. Mills
Martin Miner
Moben Mirza
Robert Moldwin
Drogo K. Montague
Courtenay K. Moore
Michael Moran
Allen F. Morey
Judd Moul
Arthur P. Mourtzinos
John P. Mulhall
Stephen Y. Nakada
Nissrine Nakib
Caleb P. Nelson
Christian Nelson
Joel B. Nelson
Casey Ng
J. Curtis Nickel
Alan M. Nieder
Craig S. Niederberger
Robert Oates
Takehiko Ogawa
Kenneth Pace
Lance Pagliaro
Vermon M. Pais, Jr.
Blake W. Palmer
Lane S. Palmer
Allan J. Pantuck
Gyan Pareek
Dipen J. Parekh
John M. Park
C. Lowell Parsons
J. Kellogg Parsons
Alan W. Partin
Anup Patel
Sutchin Patel
John G. Pattaras
Margaret Pearle
Kristina Penniston
David F. Penson
Daniel P. Petrylak
Michael Phelan
John L. Phillips
Peter A. Pinto
Joao L. Pippi Salle
Louis Pisters
Carol Podlasek
Kamal Pohar
Hans G. Pohl
Michel Pontari
Christopher R. Porter
Glenn M. Preminger
Joseph C. Presti
Gail S. Prins
Raj S. Pruthi
Marcus L. Quek
Ronald Rabinowitz
Ganesh V. Raj
Ranjith Ramasamy
Abhay M. Rane
Ardeshir Rastinehad
Leonardo O. Reis
William S. Reynolds
Mack Roach, III
William W. Roberts
Larissa V. Rodriguez
Claus G. Roehrborn
Keith Rourke
Jonathan C. Routh
Eric S. Rovner
Michael Ruggieri
Daniel B. Rukstalis
Paul Russo
Fred Saad
Arthur Sagalowsky
Christopher Saigal
Mary K. Samplaski
Martin G. Sanda
Jaspreet S. Sandhu
Jay Sandlow
Richard Santucci
Michael Sarosdy
Oliver Sartor
Stephen J. Savage
Charles D. Scales
Harriette M. Scarpero
Anthony J. Schaeffer
Douglas S. Scherr
Philippe E. Spiess
Arnulf Stenzl
Andrew J. Stephenson
Michael D. Stifelman
Marshall L. Stoller
M. Lynn Stothers
Seth A. Strope
Urs E. Studer
Jun-Kyu Suh
Chandru P. Sundaram
Roger L. Sur
Suzette Sutherland
Robert S. Svatek
Robert M. Sweet
Scott Tagawa
Stacy T. Tanaka
Samir S. Taneja
Simon Tanguay
Gregory E. Tasian
Alexis E. Te
Serdar Tekgul
Martha K. Terris
Christopher D. Tessier
John C. Thomas
Ian M. Thompson
Peter N. Schlegel
Mark P. Schoenberg
Bradley F. Schwartz
Allen D. Seftel
Jay Shah
Ojas Shah
Ira D. Sharlip
David Sharp
Joel Sheinfeld
Patrick J. Shenot
Alan W. Shindel
Margarett Shnorhavorian
Neal Shore
Daniel A. Shoskes
Steven S. Siegel
Karl-Dietrich Sievert
Mark Sigman
Matthew N. Simmons
Eila C. Skinner
Marc C. Smaldone
Angela B. Smith
Joseph A. Smith, Jr.
Norm Smith
Mark S. Soloway
R. Ernest Sosa
7
R. Houston Thompson
Edouard J. Trabulsi
Landon Trost
Thomas M. T. Turk
James C. Ulchaker
Robert Uzzo
Johan Vande Walle
Sandip P. Vasavada
Vijaya Vemulankonda
Run Wang
John T. Wei
Wolfgang Weidner
Alan J. Wein
Dana A. Weiss
Robert M. Weiss
James C. Williams, Jr.
J. Stuart Wolf, Jr.
Christopher G. Wood
Hadley M. Wood
Guan Wu
Stanley Yap
Elizabeth B. Yerkes
James Yoo
Pei Zhong
Kevin Zorn
CME Information
ment of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to
provide learners with information so they can make
their own judgments.
Statement of Need
Urologists need a thorough knowledge of the most
recent developments and techniques as well as established guidelines in urology to ensure the highest standards of patient care and safety.
Resolution of Conflict of Interest
Learning Objectives
All disclosures will be reviewed by the program/course
directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors
and/or editors, will document the mechanism(s) for
management and resolution of the conflict of interest
and final approval of the activity will be documented
prior to implementation. Any of the mechanisms below
can/will be used to resolve conflict of interest:
● Peer review for valid, evidence-based content of all
materials associated with an educational activity by
the course/program director and/or Education
Content Review Committee or its subgroup
● Limit content to evidence with no recommendations
● Introduction of a debate format with an unbiased
moderator (point-counterpoint)
● Inclusion of moderated panel discussion
● Publication of a parallel or rebuttal article for an
article that is felt to be biased
● Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
● Divestiture of the relationship by faculty
At the conclusion of the 2016 Annual Meeting, participants should be able to:
● describe recent developments in the medical and
surgical management of urology patients
● identify new technologies for the treatment of urologic problems
● analyze the potential threats to urologic practice
and specify possible solutions
● integrate the latest guidelines on the management
of urological diseases into their practice
Accreditation Statement
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical
education for physicians.
Credit Designation
The American Urological Association designates this live
activity for a maximum of 64.5 AMA PRA Category 1
Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the
activity.
Off-label or Unapproved Use of Drugs or
Devices
It is the policy of the AUA to require the disclosure of all
references to off-label or unapproved uses of drugs or
devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to
off-label or unapproved uses of drugs or devices.
Please consult the prescribing information for full disclosure of approved uses.
Other Learners
The AUA is not accredited to offer credit to participants
who are not MDs or DOs. However, the AUA will issue
documentation of participation that states that the
activity was certified for AMA PRA Category 1 CreditTM.
Evidence-Based Content
Disclaimer
It is the policy of the AUA to ensure that the content
contained in this CME activity is valid, fair, balanced,
scientifically rigorous and free of commercial bias.
AUA Disclosure Policy
The opinions and recommendations expressed by faculty, authors, and other experts whose input is included
in this program are their own and do not necessarily
represent the viewpoint of the AUA.
All persons in a position to control the content of an
educational activity (i.e., activity planners, presenters,
authors) are required to disclose to the provider any
relevant financial relationships with any commercial
interest. The AUA must determine if the individual’s relationships may influence the educational content and
resolve any conflicts of interest prior to the commence-
Consent to Use of Photographic Images: Attendance at
or participation in AUA meetings and other activities
constitutes an agreement by the registrant to AUA’s use
and distribution (both now and in the future) of the
registrant or attendee’s image or voice in photographs,
videotapes, electronic reproductions, and audiotapes
of such events and activities.
8
CME Information
●
Onsite: Sails Pavilion, CME Booth in Registration
Saturday, 7:30 a.m. – 6 p.m. Sunday & Monday,
6:30 a.m. – 4 p.m. Tuesday, 6:30 a.m. – 5 p.m.
● Online
● Mobile App (iPhone, iPad, Android phones and tablets)
Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by
attendees is prohibited inside AUA meeting rooms.
Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and
the American Urological Association.
Note: All 2016 Annual Meeting CME credits/participation must be claimed by December 31, 2016. Credits/
participation for the 2016 Annual Meeting cannot be
claimed after this date. You must scan your badge
upon entrance into courses and sessions (except for
Plenary) offered for credit to have your credits automatically entered onto your transcript. All Plenary
Session credits must be self-claimed with a valid
badge log-in at the CME booth, online, or via the
Annual Meeting Mobile App. Credits will be awarded
only to the person whose name is associated with the
badge.
Special Assistance: The American Urological Association
(AUA), an organization accredited for continuing medical
education (CME), complies with the Americans with Disabilities Act §12112(a). If any participant is in need of
special assistance or has any dietary restrictions, a written
request should be submitted at least one month in advance. For additional assistance with your request please
call 1-800-908-9414.
Getting Your CME Credits or Certificate of
Attendance
You can claim your CME/Certificate of Attendance
several ways:
Questions? Email [email protected].
9
Specialty Programs
Page
American Society for Men’s Health .............................................................................................................................. 51
Arab Association of Urology ............................................................................................................................................ 83
Association Française d’Urologie ................................................................................................................................. 197
AUA/American College of Osteopathic Surgeons ................................................................................................ 100
AUA/Brazilian/Portuguese Urology Program ............................................................................................................. 246
AUA/Confederación Americana de Urologı́a ........................................................................................................... 36
AUA-Eurasian Urology Platform ..................................................................................................................................... 132
Bangladesh Association of Urological Surgeons ..................................................................................................... 130
British Association of Urological Surgeons/Urological Society of Australia and New Zealand ................. 193
Egyptian Urological Society ........................................................................................................................................... 258
Engineering and Urology Society ................................................................................................................................... 82
Geriatric Urological Society ........................................................................................................................................... 192
Hungarian Urological Association & Polish Urological Association ................................................................... 132
Indian American Urological Association ...................................................................................................................... 98
International Russian-Speaking Urological Society ................................................................................................. 246
Japanese Urological Association ................................................................................................................................. 193
Korean World Urologic Congress ................................................................................................................................. 189
Pan African Urological Surgeons Association/Caribbean Urological Association ....................................... 259
Philippine Urological Association ................................................................................................................................. 259
R. Frank Jones Urological Society ................................................................................................................................ 195
Research on Calculus Kinetics (ROCK) Society ....................................................................................................... 244
Sexual Medicine Society of North America ................................................................................................................ 80
Sociedad Argentina de Urologı́a ................................................................................................................................. 194
Società Italiana di Urologia ........................................................................................................................................... 259
Society for Basic Urologic Research ............................................................................................................................ 130
Society for Basic Urologic Research/Society of Urologic Oncology ................................................................... 98
Society for Fetal Urology ................................................................................................................................................... 21
Society for Infection and Inflammation in Urology ................................................................................................. 189
Society for Pediatric Urology .................................................................................................................................... 23, 84
Society for the Study of Male Reproduction ............................................................................................................ 173
Society of Genitourinary Reconstructive Surgeons ................................................................................................... 40
Society of University Urologists/Society of Urology Chairpersons and Program Directors ............................ 21
Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction ....................................... 52
Society of Urologic Oncology ....................................................................................................................................... 117
Society of Urologic Robotic Surgery ........................................................................................................................... 189
Society of Women in Urology ............................................................................................................................... 143, 146
Urologic Society for Transplantation and Renal Surgery ...................................................................................... 245
World Chinese Urological Society .................................................................................................................................. 99
10
NOTES
NOTES
OFFICE OF EDUCATION COURSES
ALL COURSES ARE APPROVED FOR AMA PRA CATEGORY 1 CREDITTM
8:30 am - 6:30 pm
8:30 am - 11:30 am
01 PG
MANAGEMENT OF URETERAL STRICTURE
DISEASE
Louis Kavoussi, Director
Sammy Elsamra, Thomas Jarrett, Richard Link
Room 3
02 PG
REAL MEN GET REAL PELVIC PAIN
Jeannette Potts, Director
Stanley Antolak, Rhonda Kotarinos, Christopher
Payne, Dean Tripp
Room 4
03 PG
MANAGEMENT OF PROSTATE CANCER: A
CASE BASED APPROACH WITH EMPHASIS ON
INTEGRATING NEW MOLECULAR
DIAGNOSTICS INTO CLINICAL PRACTICE
Eric Klein, Director
Andrew Stephenson
Room 8
04 PG
05 PG
06 PG
11 IC
HOW TO PREPARE AND GIVE MORE
EFFECTIVE MEDICAL PRESENTATIONS:
IMPROVING YOUR SLIDES AND TIPS ON
BETTER PUBLIC SPEAKING
Stephen Leslie, Director
Room 10
12 IC
UROLITHIASIS: SURGICAL MANAGEMENT,
PERCUTANEOUS, SHOCK WAVE
LITHOTRIPSY AND URETEROSCOPY - HOW
WE DO IT
Stephen Nakada, Director
Bodo Knudsen, Margaret Pearle
Room 11
94 IC
LASER PHYSICS AND SAFETY FOR THE
PRACTICING UROLOGIST
Lori Lerner, Director
Clinton Collins
Room 6C
3:30 pm - 5:30 pm
RISK-STRATIFICATION OF LOCALIZED RENAL
MASSES
Mohamad Allaf, Director
Steven Campbell, Phillip Pierorazio, Robert Uzzo
Room 9
VASECTOMY REVERSAL AND MALE
INFERTILITY TREATMENT IN THE ICSI ERA
Peter Schlegel, Director
Sheldon Marks, Robert Oates
Room 10
DISORDERS OF THE PENIS: PEYRONIE’S
DISEASE, PRIAPISM, CONGENITAL
CURVATURE, ADULT ACQUIRED BURIED
PENIS AND CORPORAL FRACTURE
Laurence Levine, Director
Gregory Broderick, David Ralph
Room 11
13 IC
TESTICULAR CANCER: CURRENT CONCEPTS
AND CONTROVERSIES
Joel Sheinfeld, Director
George Bosl, Brett Carver
Room 3
14 IC
PHOTOSELECTIVE VAPORIZATION OF THE
PROSTATE (PVP) AND GREEN LASER
ENUCLEATION OF THE PROSTATE
(GREENLEP) USING THE 532NM LITHIUM
TRIBORATE LASER
Henry Woo, Director
Oliver Reich, Fernando Sancha
Room 4
15 IC
OPTIMIZING PROSTATE CANCER
DIAGNOSTICS: TRANSPERINEAL,
TRANSRECTAL AND MRI-ULTRASOUND
FUSION TARGETED BIOPSIES
Richard Popert, Director
Ben Challacombe, Janette Kinsella, Stephen
Williams
Room 6C
16 IC
AUA GUIDELINES 2016: SURGICAL
MANAGEMENT OF RENAL AND URETERAL
STONES
Dean Assimos, Director
Brian Matlaga, Ojas Shah
Room 11
17 IC
DEVELOPING A PERI-OPERATIVE SURGICAL
HOME PROGRAM
Mitchell Sokoloff, Director
Jennifer Yates, Shubjeet Kaur
Room 9
18 IC
LAPAROSCOPIC DONOR NEPHRECTOMY:
STEP-BY-STEP APPROACH
Arvind Ganpule, Director
Pradeep Rao
Room 10
1:00 pm - 3:00 pm
07 IC
08 IC
09 IC
10 IC
ROBOTIC RADICAL CYSTECTOMY: GETTING
STARTED AND TIPS AND TRICKS FROM THE
EXPERTS
Michael Woods, Director
Erik Castle, Angela Smith
Room 3
CONTEMPORARY TREATMENT STRATEGIES
IN THE MANAGEMENT OF PENILE CANCER
Philippe Spiess, Director
Sukhbinder Minhas, Chris Protzel
Room 4
AUA GUIDELINE: CASTRATION-RESISTANT
PROSTATE CANCER UPDATE
Michael Cookson, Director
William Lowrance, Adam Kibel
Room 8
EVALUATION AND MANAGEMENT OF
UROGENITAL PAIN
Michael Sabia, Director
Hossein Sadeghi-Nejad, Allen Seftel, Karolynn
Echols
Room 9
13
COURSES
Friday, May 6, 2016
3:30 pm - 6:30 pm
19 PG
MANAGEMENT OF CHALLENGING RENAL
MASSES: CASE BASED APPROACH WITH
ADVANCED TECHNIQUES IN ROBOTIC
PARTIAL NEPHRECTOMY
Chandru Sundaram, Director
Jihad Kaouk, Mihir Desai, Arieh Shalhav
Room 8
Saturday, May 7, 2016
8:00 am - 6:30 pm
8:00 am - 11:00 am
101 HO
21 PG
22 PG
24 PG
CONTEMPORARY PHARMACOTHERAPY FOR
OAB
Eric Rovner, Director
Alan Wein, Christopher Chapple
Room 8
29 IC
SUCCESSFUL INTEGRATION OF ADVANCED
PRACTICE NURSES AND PHYSICIAN
ASSISTANTS INTO UROLOGY PRACTICES
Claus Roehrborn, Director
Brad Hornberger
Room 9
30 IC
GERIATRIC UROLOGY: BASIC PRINCIPLES
FOR UROLOGIC PRACTICE
Tomas Griebling, Director
Theodore Johnson, E. Camille Vaughan
Room 10
31 IC
VAGINAL MESH SURGERY, MALPRACTICE &
LITIGATION PREVENTION, AND CASE REVIEW
Matthew Karlovsky, Director
Gopal Badlani, J. Bounds
Room 11
MR FUSION GUIDED PROSTATE BIOPSY 1:
INTRODUCTION TO BASIC TECHNIQUES
Peter Pinto, Art Rastinehad, Co-Directors
Room 27
8:30 am - 11:30 am
20 PG
28 IC
ROBOTIC UPPER URINARY TRACT
RECONSTRUCTION: A TOP TO BOTTOM
APPROACH
Michael Stifelman, Director
Lee Zhao, Daniel Eun, Raju Thomas
Room 3
SURGEONS AS EDUCATORS: A PRIMER FOR
ACADEMIC DEVELOPMENT AND TEACHING
EXCELLENCE
Tobias Kohler, Director
Kurt McCammon, Patrick McKenna, Bradley
Schwartz
Room 4
INFERTILITY UPDATE 2016: A
COMPREHENSIVE APPROACH TO THE
CLINICAL DIAGNOSIS AND TREATMENT OF
THE INFERTILE MALE
Larry Lipshultz, Director
Michael Eisenberg, Craig Niederberger, Edmund
Sabanegh
Room 8
2:00 pm - 5:00 pm
102 HO
REOPERATIVE PELVIC FLOOR MEDICINE: FOR
THE UROLOGIST AND GYNECOLOGIST
Roger Dmochowski, Director
Mickey Karram, Alexander Gomelsky
Room 10
3:30 pm - 6:30 pm
32 PG
COMPLICATIONS OF ROBOTIC UROLOGICAL
SURGERY: PREVENTION, RECOGNITION AND
MANAGEMENT
Rene Sotelo, Director
Monish Aron, Reza Ghavamian, Joseph Smith
Room 8
33 PG
FOUNDATIONS OF FEMALE UROLOGY
J. Christian Winters, Director
Stephen Kraus, Nirit Rosenblum
Room 9
34 PG
UTIS: ANTIBIOTICS, RESISTANCE AND
TREATMENT STRATEGIES
John Krieger, Director
Kurt Naber, Richard Grady, Florian Wagenlehner
Room 10
35 PG
UROLOGICAL TRAUMA AND
RECONSTRUCTION
Allen Morey, Director
Noel Armenakas, Michael Coburn
Room 11
1:00 pm - 3:00 pm
25 IC
PHYSICIAN CONTRACT NEGOTIATION:
EMPLOYMENT AND OWNERSHIP IN THE
CURRENT ECONOMIC CLIMATE
Thomas Stringer, Director
Thomas Crawford, Michael Igel
Room 3
26 IC
PRACTICAL CONSIDERATIONS IN
GENITOURINARY PROSTHETIC SURGERY
Drogo Montague, Director
Room 4
27 IC
UROLOGY 911: HANDLING INTRAOPERATIVE
CONSULTS
Michael Schwartz, Director
Brian Duty, Jessica Kreshover
Room 6C
REFINING TECHNIQUES FOR THE ADVANCED
USER
Samir Taneja, Director
Leonard Marks, Peter Pinto, Osamu Ukimura
Room 27
14
6:00 am - 6:30 pm
6:00 am - 8:00 am
36 IC
PRACTICAL MEDICAL MANAGEMENT OF
NEPHROLITHIASIS - A GUIDELINES AND
CASE-BASED APPROACH
Glenn Preminger, Director
Roger Sur
Room 8
37 IC
MANAGEMENT OF LOCALLY ADVANCED AND
METASTATIC RENAL CELL CARCINOMA: A
CASE BASED APPROACH
Christopher Wood, Director
Edwin Jason Abel, Vitaly Margulis, Jose Karam
Room 4
38 IC
MANAGEMENT OF THE URETERAL
STRICTURE; SELECTING THE RIGHT
APPROACH FOR DURABLE OUTCOMES
Stuart Flechner, Director
Marshall Stoller, Robert Stein
Room 6C
40 IC
AUA GUIDELINES 2016: NON-MUSCLE
INVASIVE BLADDER CANCER
Sam Chang, Director
Chad Ritch, James McKiernan
Room 9
42 IC
PROSTATE CANCER DIAGNOSTICS:
BIOMARKERS, MRI, AND BIOPSY
TECHNIQUES
Daniel Barocas, Director
John Wei, Scott Eggener
Room 11
43 PG
47 PG
CATASTROPHIES, COMPLICATIONS AND
CORRECTIONS IN PERCUTANEOUS RENAL
SURGERY
Arthur Smith, Director
Ralph Clayman, Jean de la Rosette, Mahesh Desai
Room 9
48 PG
PRACTICAL URORADIOLOGY: THE OFFICE
BASED INTERPRETATION OF UROLOGIC
RADIOGRAPHIC STUDIES
Jay Bishoff, Director
Shane Anderson, Sero Andonian, Srinivas Vourganti
Room 10
39 IC
TESTOSTERONE THERAPY: NEW CONCEPTS
FOR A RAPIDLY CHANGING FIELD
Abraham Morgentaler, Director
Abdul Traish
Room 6C
49 IC
NEW TECHNIQUES IN BPH SURGERY:
ENDOSCOPIC ENUCLEATION
Peter Gilling, Director
Andreas Gross, Lori Lerner
Room 3
50 IC
PELVIC FLOOR ULTRASOUND IN
ASSESSMENT OF COMPLEX VOIDING
DYSFUNCTION, PELVIC ORGAN PROLAPSE
AND MESH COMPLICATIONS
Lewis Chan, Director
Pat Fulgham, Vincent Tse
Room 4
51 IC
DIFFICULT CASES IN HIGH RISK BLADDER
CANCER: AN EVIDENCE BASED APPROACH
Michael Cookson, Director
Jeffrey Holzbeierlein, Timothy Masterson
Room 8
52 IC
AUA GUIDELINES 2016: URETHRAL
STRICTURE DISEASE
Richard Santucci, Director
Sean Elliott, Hunter Wessells
Room 9
53 IC
COMMON PROBLEMS IN PEDIATRIC
UROLOGY: WHAT EVERY UROLOGIST
SHOULD KNOW
Richard Rink, Director
Mark Cain
Room 10
REFINING TECHNIQUES FOR THE ADVANCED
USER
Samir Taneja, Director
Leonard Marks, Peter Pinto, Osamu Ukimura
Room 27
8:30 am - 11:30 am
41 PG
URODYNAMIC EVALUATION AND ADVANCES
IN MANAGEMENT OF ADULT NEUROGENIC
LOWER URINARY TRACT DYSFUNCTION IN
ADULTS: A CASE BASED APPROACH
Hari Tunuguntla, Director
Angelo Gousse, Stephen Kraus
Room 8
1:00 pm - 3:00 pm
8:00 am - 11:00 am
103 HO
46 PG
FLAPS IN PELVIC RECONSTRUCTIVE
SURGERY
Shlomo Raz, Director
Ja-Hong Kim
Room 11
URINARY DIVERSION AFTER ROBOTASSISTED RADICAL CYSTECTOMY
Hani Rashid, Director
Ahmed Ghazi, Khurshid Guru, Guan Wu
Room 3
44 PG
MEDICAL MALPRACTICE IN UROLOGY: HOW
TO PREVENT AND DEFEND
Christopher Coogan, Director
Elizabeth Kavaler, David Sobel, Darlene King
Room 4
45 PG
VASECTOMY: A VERY PRACTICAL COURSE
ON PREOPERATIVE, INTRAOPERATIVE AND
POSTOPERATIVE MANAGEMENT
Ira Sharlip, Director
Stanton Honig, Joel Marmar, Jay Sandlow
Room 6C
1:30 pm - 4:30 pm
54 PG
15
PROSTATE CANCER UPDATE 2016
(TRADUCIDO EN ESPAÑOL)
William Catalona, Director
Douglas Dahl, Stanley Liauw, Stacy Loeb, Robert
Nadler, Russell Szmulewitz
Room 11
COURSES
Sunday, May 8, 2016
2:00 pm - 5:00 pm
104 HO
57 PG
RENAL CELL CARCINOMA: A
COMPREHENSIVE COURSE OF SURGICAL &
MEDICAL MANAGEMENT FOR HIGH RISK
DISEASE. FROM ROBOTIC PARTIAL
NEPHRECTOMY, COMPLICATION
MANAGEMENT TO TARGETED THERAPY –
NEW PARADIGMS FOR TREATMENT
Benjamin Lee, Director
James Porter, Hans Hammers, Maxwell Meng
Room 8
58 PG
UROLITHIASIS: METABOLIC EVALUATION
AND MEDICAL TREATMENT
Michael Lipkin, Director
Sara Best, Jodi Antonelli, Brian Eisner
Room 9
59 PG
ADVANCED PERCUTANEOUS
NEPHROLITHOTOMY
Evangelos Liatsikos, Director
John Denstedt, Thomas Knoll
Room 10
PRACTICAL PCNL: FROM ACCESS TO EXIT– A
HANDS-ON COURSE
David Hoenig, Director
David Leavitt, Zeph Okeke, Art Rastinehad, Robert
Sweet
Room 27
3:30 pm - 6:30 pm
55 PG
MALE HEALTH: STRATEGIES FOR MANAGING
LIFELONG WELLNESS
Richard Pelman, Director
S. Larry Goldenberg, Kevin Loughlin, Martin Miner,
Mark Moyad, Michael Lutz
Room 3
56 PG
CHALLENGES IN THE EVALUATION AND
MANAGEMENT OF POST-PROSTATECTOMY
INCONTINENCE
Craig Comiter, Director
Ajay Singla, Zaki Almallah, Gregory Bales, Michael
Kennelly
Room 4
Monday, May 9, 2016
6:00 am - 6:30 pm
6:00 am - 8:00 am
8:30 am - 11:30 am
60 IC
ABLATIVE TECHNOLOGIES FOR PROSTATE
CANCER: WHOLE GLAND AND FOCAL
THERAPY
Joseph Chin, Director
Jonathan Coleman, Hashim Ahmed
Room 3
65 PG
PRIMARY AND REOPERATIVE HYPOSPADIAS
REPAIR: EVIDENCE-BASED DECISION
MAKING
Warren Snodgrass, Director
Nicol Bush
Room 3
61 IC
TRANSURETHRAL RESECTION OF BLADDER
CANCER - A DECEPTIVELY DIFFICULT
COMMON OPERATION - HOW TO IMPROVE
Mark Soloway, Director
Arthur Sagalowsky, Alexandre Zlotta
Room 4
66 PG
ROBOT-ASSISTED RADICAL
PROSTATECTOMY: BEYOND THE LEARNING
CURVE
John Davis, Director
Kevin Zorn, Fatih Atug, Declan Murphy, Koon Rha
Room 4
62 IC
BOTULINUM TOXIN: WHY USE IT, HOW TO DO
IT, WHAT ARE THE RESULTS?
Michael Chancellor, Director
Room 8
67 PG
63 IC
THE USE OF ROBOTIC TECHNOLOGY IN
FEMALE PELVIC FLOOR RECONSTRUCTION
Jennifer Anger, Director
Karyn Eilber, Kimberly Kenton
Room 9
MANAGEMENT OF WOMEN WITH SEXUAL
DYSFUNCTION USING FDA-APPROVED AND
OFF LABEL TREATMENTS
Irwin Goldstein, Director
Susan Kellogg-Spadt, Noel Kim, Kenneth Peters
Room 8
68 PG
THE ROLE OF SACRAL NEUROMODULATION
IN UROLOGICAL PRACTICE
Steven Siegel, Director
Norbert Kaula
Room 10
ADVANCED URETEROSCOPY: OVERCOMING
CHALLENGING PROBLEMS
Michael Grasso, Director
Demetrius Bagley, Scott Hubosky, Olivier Traxer
Room 9
69 PG
ENDOUROLOGÍA AVANZADA - MANEJO DE
CIRUGIA RENAL PERCUTEA Y CIRUGIA
INTRARRENAL RETROGRADA COMPLEJA
(ESTE CURSO SE PRESENTA SÓLO EN
ESPAÑOL)
Jorge Gutierrez-Aceves, Director
Francisco Daels, Jose Sesmero
Room 10
64 IC
76 IC
NUTRITION COUNSELING FOR THE
PREVENTION OF UROLITHIASIS
Patrick Lowry, Director
Kristina Penniston
Room 6C
16
ADVANCED ROBOTIC UROLOGIC ONCOLOGY:
EXTREME UNFORGETTABLE CASES AND
THEIR MANAGEMENT
Vipul Patel, Director
David Albala, Sam Bhayani, Rafael Coelho,
Alexandre Mottrie, Bernardo Maria Rocco
Room 11
3:30 pm - 6:30 pm
23 PG
CODING AND REIMBURSEMENT UPDATE 2016
Ronald Kaufman, Director
Jonathan Rubenstein, Stephanie Stinchcomb
Room 6C
78 PG
GLOBAL PERSPECTIVES IN URETHRAL
RECONSTRUCTION
Hunter Wessells, Director
Guido Barbagli, Sanjay Kulkarni
Room 3
79 PG
PEDIATRIC BLADDER AND BOWEL
DYSFUNCTION
Lane Palmer, Director
Paul Austin, Christopher Cooper, Mark Horowitz
Room 4
80 PG
MANAGEMENT OF NONMUSCLE INVASIVE
BLADDER CANCER: PRACTICAL SOLUTIONS
FOR COMMON PROBLEMS
Cheryl Lee, Director
Ashish Kamat, Theresa Koppie, J. Alfred Witjes
Room 8
1:00 pm - 3:00 pm
71 IC
MANAGEMENT OF SMALL RENAL MASSES,
TECHNICAL ADVANCES IN NEPHRON
SPARING SURGERY, AND MANAGEMENT OF
LOCALLY ADVANCED RCC: A CASE BASED
APPROACH
Steven Campbell, Director
Brian Lane, Robert Uzzo
Room 3
72 IC
GUIDELINES BASED EVALUATION AND
TREATMENT OF MLUTS AND BPH
Steven Kaplan, Director
Alexis Te, Kevin McVary
Room 4
73 IC
ACTIVE SURVEILLANCE FOR PROSTATE
CANCER
Laurence Klotz, Ian Thompson, Co-Directors
Mark Emberton
Room 6C
81 PG
TESTOSTERONE: DIAGNOSIS AND
MANAGEMENT OF THE HYPOGONADAL MALE
Wayne Hellstrom, Director
Mohit Khera, Martin Miner
Room 8
HOW GENERAL UROLOGISTS CAN EVALUATE
AND TREAT MALE INFERTILITY
Marc Goldstein, Director
Peter Chan, Mark Sigman
Room 9
82 PG
COMPREHENSIVE MANAGEMENT OF T1A
RENAL CELL CARCINOMA: A PRACTICAL
REVIEW TO OPTIMIZE PATIENT TREATMENT
AND OUTCOMES
Jaime Landman, Director
Anthony Chang, Laura Findeiss, James McKiernan,
Jeffrey Cadeddu
Room 10
83 PG
MANAGEMENT OF COMMON PSA DILEMMAS
Gerald Andriole, Director
Anthony D’Amico, Adam Kibel, A. Oliver Sartor
Room 11
74 IC
75 IC
VAGINAL SURGERY FOR THE UROLOGIST
Victor Nitti, Director
Benjamin Brucker
Room 9
77 IC
URINARY TRACT BLEEDING: FROM
ASYMPTOMATIC MICROHEMATURIA TO
INTRACTABLE HEMORRHAGIC CYSTITIS
Stephen Boorjian, Director
Daniel Barocas, Jay Raman
Room 11
Tuesday, May 10, 2016
6:00 am - 11:30 am
6:00 am - 8:00 am
84 IC
85 IC
CONTEMPORARY CONCEPTS AND
CONTROVERSIES IN THE DIAGNOSIS AND
MANAGEMENT OF UPPER TRACT
UROTHELIAL CARCINOMA (UTUC)
Shahrokh Shariat, Director
Wes Kassouf, Surena Matin, Douglas Scherr
Room 3
URINARY DIVERSION: CURRENT
INDICATIONS, TECHNIQUES AND
MANAGEMENT OF COMPLICATIONS
Siamak Daneshmand, Director
Eila Skinner
Room 4
17
86 IC
NOCTURIA: ADVANCES IN DIAGNOSIS AND
MANAGEMENT
Jeffrey Weiss, Director
Room 6C
87 IC
BEYOND PSA: UTILIZATION OF NOVEL
PROSTATE CANCER GENOMIC BIOMARKERS
FOR THE PRACTICING UROLOGIST
Jeffrey Tomaszewski, Director
Marc Smaldone, Allen Seftel
Room 8
88 IC
RENAL BIOPSY UPDATE: INDICATIONS,
TECHNIQUES, PITFALLS AND RECENT
PATHOLOGICAL MODIFICATIONS TO
OPTIMIZE RESULTS
Raymond Leveillee, Director
Merce Jorda, J. Stuart Wolf
Room 9
COURSES
70 PG
89 IC
THE ROLE OF SURGICAL MANAGEMENT IN
CHRONIC ORCHIALGIA
Ryan Smith, Director
Raymond Costabile, Parviz Kavoussi
Room 10
8:30 am - 11:30 am
90 PG
URETHRAL RECONSTRUCTION
Kenneth Angermeier, Director
Kenneth Carney, Kennon Miller, Daniel Rosenstein
Room 4
91 PG
NOVEL AGENTS AND CONCEPTS IN THE
MANAGEMENT OF HORMONE NAÏVE AND
CASTRATION RESISTANT PROSTATE
CANCER
Judd Moul, Director
Lawrence Karsh, Christopher Sweeney
Room 8
18
92 PG
INTERSTITIAL CYSTITIS/BLADDER PAIN
SYNDROME: A PRIMER AND A WORLD VIEW
Philip Hanno, Director
Jorgen Nordling, Arndt Van Ophoven
Room 10
93 PG
TREATMENT OF COMPLEX UROLITHIASIS
AND ENDOUROLOGIC COMPLICATIONS
Amy Krambeck, Director
John Lieske, Nicole Miller, Vernon Pais
Room 6C
NOTES
NOTES
1:00 pm - 5:00 pm
SOCIETY OF UNIVERSITY UROLOGISTS / SOCIETY OF UROLOGY CHAIRPERSONS AND PROGRAM DIRECTORS (SUU/SUCPD)
Room 11 @ San Diego Convention Center
SOCIETY OF UNIVERSITY UROLOGISTS
Society Chair: Stephen Nakada
2:35
RESIDENT QUALITY IMPROVEMENT PROJECT
Christopher Tessier
1:00
WELCOME
2:50
1:05
PATIENT SAFETY IN YOUR DEPARTMENT
Timothy Averch
GRANT RECIPIENT REPORTS
David Johnson, Jaime Landman, Charles Scales
3:05
GAINING AND SUSTAINING GRANT FUNDING
David Jarrard
AUA OFFICE OF EDUCATION
Victor Nitti
3:15
BREAK
3:30
SUU/SUCPD COMBINED BUSINESS MEETING
5:00
ADJOURN
1:25
1:45
MOC UPDATE
Gerald Jordan
SOCIETY OF UROLOGY CHAIRPERSONS AND
PROGRAM DIRECTORS
Society Chair: J. Brantley Thrasher
2:00
RRC REPORT
Mary Joyce Turner
2:15
AUA OFFICE OF RESEARCH – EDUCATION
AND GRANT INITIATIVES
Aria Olumi
APPROVED FOR AMA PRA CATEGORY 1
CREDITTM
Thursday, May 5, 2016
6:00 pm - 8:00 pm
SOCIETY FOR FETAL UROLOGY (SFU)
Room 23 AB @ San Diego Convention Center
6:00
SFU CLINICAL CASE PRESENTATION
SESSION: RESIDENTS AND FELLOWS WILL
PRESENT THEIR MOST INTERESTING OR
UNIQUE CLINICAL CASE THAT FOCUS ON
AREAS WITHIN FETAL UROLOGY
*Presenting author
8:00
ADJOURN
CREDITTM
21
THURSDAY
Thursday, May 5, 2016
NOTES
MP ⫽ Moderated Poster Session, PD ⫽ Podium Session
Friday, May 6, 2016
7:30 am – 5:30 pm
6:30
REGISTRATION/BREAKFAST
7:30
SESSION 1: PRIZE ABSTRACTS
Jonathan Routh
Michael Hsieh
8:30
SESSION 2: DSD
Margarett Shnorhavorian
Mike Disandro
9:30
DSD PANEL: EVOLVING ROLE OF PATIENT
ADVOCACY
Moderator: Jeff Campbell
Panelists: Noi Liang, Arlene Baratz, Emily Quinn,
Ilene Wong Gregorio
10:25
BREAK/EXHIBITS
10:45
SESSION 3: DYSFUNCTIONAL VOIDING AND
ENURESIS POSTER SESSION
Dana Weiss
Paul Austin
11:40
MEREDITH CAMPBELL LECTURE:
MENTORING
Larry Baskin
12:15
1:45
SFU PANEL: PRENATAL IMAGING
Moderator: Sean Corbett
Panelists: BAPU Endorsement of Consensus
Statement on Hydronephrosis
Alan Baile
Prenatal Imaging and Management
Andrew Hull
2:45
SESSION 4: HYDRONEPHROSIS/PUVS
PODIUM SESSION
George Chiang
Micah Jacobs
3:45
BREAK/EXHIBITS
4:10
SFU LECTURE: MANAGEMENT OF PUV
Curtis Sheldon
4:40
SESSION 5: HYDRONEPHROSIS/PUVS
John Gatti
Adam Hittleman
5:30
ADJOURN
CREDITTM
LUNCH (NOT PROVIDED)
12:15-12:30 SFU BUSINESS MEETING (SFU MEMBERS
ONLY)
Friday, May 6, 2016
8:00 am - 10:00 am
Moderated Poster Session 1
BLADDER CANCER: EPIDEMIOLOGY & EVALUATION I
Room 30 ABC @ San Diego Convention Center
Moderators: Karim Chamie and Robert Grubb
ABSTRACT
NUMBER TITLE
MP01-01 COMBINED HEAT SHOCK PROTEIN 90
AND KINASE INHIBITOR THERAPY:
INSIGHTS FROM THE CANCER GENOME
ATLAS FOR MUSCLE INVASIVE BLADDER
CANCER
Heinric Williams, Danville, PA, Thomas
Prince*, Bethesda, MD
ABSTRACT
NUMBER TITLE
MP01-04 ONCOLOGIC AND PERIOPERATIVE
OUTCOMES OF “CYTOREDUCTIVE”
RADICAL CYSTECTOMY FOR PATIENTS
WITH METASTATIC BLADDER CANCER IN
THE UNITED STATES
Francisco Gelpi-Hammerschmidt*, Jeffrey
Leow, Dayron Rodriguez, Ilker Tinay,
Christopher Allard, Nawar Hanna, Ross
Krasnow, Christian Meyer, Michael Zavaski,
Adam Kibel, Mark Preston, Quoc-Dien Trinh,
Steven Chang, Boston, MA
MP01-02 EFFICACY OF INTRAOPERATIVE
TRANEXAMIC ACID INFUSION FOR
REDUCING BLOOD TRANSFUSION
DURING RADICAL CYSTECTOMY
Harras Zaid*, David Yang, Matthew Tollefson,
Igor Frank, Prabin Thapa, William Parker, R.
Jeffrey Karnes, R. Houston Thompson,
Stephen Boorjian, Rochester, MN
MP01-05
MP01-03 PREVALENCE OF PREOPERATIVE DEEP
VEIN THROMBOSIS AND PREDICTIVE
VALUE OF D-DIMER ASSAY IN PATIENTS
UNDERGOING RADICAL CYSTECTOMY
FOR UROTHELIAL CARCINOMA
Tanner Miest*, R. Jeffrey Karnes, Stephen
Boorjian, R. Houston Thompson, Igor Frank,
Matthew Tollefson, Rochester, MN
*Presenting author
23
GENDER-RELATED DIFFERENCES IN
UROTHELIAL CARCINOMA OF THE
BLADDER: A POPULATION-BASED STUDY
FROM THE SWEDISH NATIONAL REGISTRY
OF URINARY BLADDER CANCER
Andreas Thorstenson*, Stockholm, Sweden,
Oskar Hagberg, Lund, Sweden, Börje
Ljungberg, Umeå, Sweden, Fredrik Liedberg,
Lund, Sweden, Georg Jancke, Linköping,
Sweden, Sten Holmäng, Gothenburg, Sweden,
Per-Uno Malmström, Uppsala, Sweden,
Abolfazl Hosseini, Stockholm, Sweden, Staffan
Jahnson, Linköping, Sweden
FRIDAY
SOCIETY FOR PEDIATRIC UROLOGY
Seaport A-E @ Hyatt
MP01-06 DRAMATIC RACIAL DISPARITIES IN
DIETARY MICRONUTRIENT INTAKE
AMONG BLADDER CANCER SURVIVORS
Ajay Gopalakrishna*, Thomas Longo, Joseph
Fantony, Brant Inman, Durham, NC
MP01-13 ANTI-PPP1CA AUTOANTIBODY
DETECTED BY PROTEOMICS ANALYSES
IS ASSOCIATED WITH BIOLOGICAL
AGGRESSIVENESS AND POOR
PROGNOSIS IN PATIENTS WITH
BLADDER CANCER
Shuhei Hirano*, Kazumasa Matsumoto, Sho
Minami, Morihiro Nishi, Ken ichi Tabata,
Tetsuo Fujita, Yuichi Sato, Masatsugu
Iwamura, Sagamihara, Japan
MP01-07 ASSESSING THE RELATIVE
CONTRIBUTION OF HOSPITAL AND
SURGEON VOLUME ON SHORT TERM
MORTALITY OUTCOMES FOLLOWING
RADICAL CYSTECTOMY
Nikhil Waingankar*, Philadelphia, PA,
Katherine Mallin, Chicago, IL, Brian Egleston,
Robert Uzzo, Marc Smaldone, Philadelphia,
PA, David Winchester, Chicago, IL,
Alexander Kutikov, Philadelphia, PA
MP01-14 USING DATA-ENABLED PROCESS MAP
ANALYSIS TO IDENTIFY DELAYS IN
TREATMENT AMONG PATIENTS WITH
BLADDER CANCER UNDERGOING
RADICAL CYSTECTOMY
Nima Almassi*, Eric Klein, Andrew
Stephenson, Venkatesh Krishnamurthi,
Cleveland, OH
MP01-08 NO DIFFERENCE IN PHYSICAL ACTIVITY
IN BLADDER CANCER SURVIVORS
TREATED WITH TRANSURETHRAL
RESECTION OR RADICAL CYSTECTOMY
Joseph Fantony*, Ajay Gopalakrishna,
Thomas Longo, Brant Inman, Durham, NC
MP01-15
MP01-09 CAN A GENE METHYLATION ASSAY
IMPROVE THE PERFORMANCE OF
CYTOLOGY?
Thomas Longo*, Ajay Gopalakrishna, Joseph
Fantony, Durham, NC, Richmond Owusu,
San Diego, CA, Raymond Lance, Virginia
Beach, VA, Wen-Chi Foo, Brant Inman,
Durham, NC, Michael Abern, Chicago, IL
PREOPERATIVE ASYMPTOMATIC
LEUKOCYTOSIS AND RADICAL
CYSTECTOMY: ANALYSIS OF THE
NATIONAL SURGICAL QUALITY
IMPROVEMENT PROGRAM DATABASE
Ifeanyi Onyeji*, Wilson Sui, Justin T. Matulay,
Maxwell B. James, Marissa C. Velez, Sven
Wenske, G. Joel DeCastro, New York, NY
MP01-16 IMPACT OF TRAINEE INVOLVEMENT ON
POST-OPERATIVE OUTCOMES AFTER
RADICAL CYSTECTOMY: AN ANALYSIS
UTILIZING THE NATIONAL SURGICAL
QUALITY IMPROVEMENT PROGRAM
Seth Olcese*, Raffaella DeRosa, Sean Kern,
Alexander Ernest, Michael Lustik, Leah
McMann, Joseph Sterbis, Tripler AMC, HI
MP01-10 POTENTIAL UTILITY OF APPARENT
DIFFUSION COEFFICIENT (ADC) VALUE
AS A BIOMARKER TO PREDICT THE
DIFFERENCE BETWEEN T1G3 NONMUSCLE INVASIVE BLADDER CANCER
(NMIBC) AND MUSCLE INVASIVE
BLADDER CANCER (MIBC)
Masaaki Fujimura*, Narashino, Japan,
Shinichi Sakamoto, Chiba, Japan, Nobuyuki
Sekita, Hiroaki Sato, Hiroyoshi Kono,
Narashino, Japan, Nobuyoshi Takeuchi, Rika
Nishikawa, Chiba, Japan, Masashi Yano,
Sakura, Japan, Naoki Nihei, Chiba, Japan,
Hiroyoshi Suzuki, Sakura, Japan, Kazuo
Mikami, Narashino, Japan, Tomohiko
Ichikawa, Chiba, Japan
MP01-17 ASSOCIATION OF DISTANCE TO
TREATMENT FACILITY WITH SURVIVAL
AND QUALITY OUTCOMES FOLLOWING
RADICAL CYSTECTOMY: A MULTIINSTITUTIONAL STUDY
Ahmed Haddad*, Ryan Hutchinson, Nirmish
Singla, Dallas, TX, Erika Wood, Houston, TX,
Gus Miranda, Los Angeles, CA, Boris
Gershman, Rochester, MN, Vitaly Margulis,
Arthur Sagalowsky, Ganesh Raj, Dallas, TX,
Robert Svatek, San Antonio, TX, Peter Black,
Vancouver, Canada, Stephen Boorjian,
Rochester, MN, Jay Shah, Houston, TX, Sia
Daneshmand, Los Angeles, CA, Yair Lotan,
Dallas, TX
MP01-11 DETECTION OF MALIGNANCY BY
HEMATURIA SCREENING IN PATIENTS
ON ANTICOAGULATION
William Daly, Jefferson Berryman, Millard
Henry, Aaron Benham, Shannon Smith*,
Zoona Sarwar, Julie Stoner, Jonathan
Heinlen, Oklahoma City, OK
MP01-18 THE POTENTIAL IMPACT OF
NEOADJUVANT CHEMOTHERAPY ON
PATIENTS UNDERGOING RADICAL
CYSTECTOMY FOR NON-UROTHELIAL
MUSCLE INVASIVE BLADDER CANCER
Francisco Gelpi-Hammerschmidt*, Dayron
Rodriguez, Ilker Tinay, Christopher Allard,
Nawar Hanna, Steven Chang, Quoc-Dien
Trinh, Mark Preston, Boston, MA
MP01-12 PREDICTORS OF GENITOURINARY
MALIGNANCY AMONG PATIENTS WITH
PRIMARY MICROSCOPIC HEMATURIA
Paras Shah, Patrick Samson*, New Hyde
Park, NY, Derek Friedman, Binghamton, NY,
Karly Stoltman, Hempstead, NY, Vinay Patel,
New Hyde Park, NY, Simpa Salami, Ann
Arbor, MI, Andrew Ng, Hempstead, NY,
Manaf Alom, Jessica Kreshover, Joph
Steckel, Manish Vira, Lee Richstone, Louis
Kavoussi, Justin Han, New Hyde Park, NY
24
MP01-19 UTILIZATION PATTERNS OF
INTRAVESICAL BACILLUS CALMETTEGUERIN THERAPY FOR PATIENTS WITH
HIGH-GRADE, NON-MUSCLE INVASIVE
BLADDER CANCER
Andrew Lenis*, Mark Litwin, Christopher
Saigal, Nicholas Donin, Los Angeles, CA,
Julie Lai, Jan Hanley, Santa Monica, CA,
Badrinath Konety, Minneapolis, MN, Karim
Chamie, Los Angeles, CA
MP01-20 ALL CAUSE MORTALITY AFTER
NEPHROURETERECTOMY WITH
BLADDER CUFF EXCISION
Matt Heavner, Manish Patel*, Marc Colaco,
Ashok Hemal, Winston-Salem, NC
FRIDAY
CREDITTM
Friday, May 6, 2016
8:00 am - 10:00 am
PROSTATE CANCER: MARKERS I
Moderators: Eric Klein, Mark Frydenberg, and Ganesh Palapattu
ABSTRACT
NUMBER TITLE
MP02-01 CLINICAL UTILITY OF PHI (PROSTATE
HEALTH INDEX) IN MEN WITH TPSA > 10
NG/ML. RESULTS FROM A MULTICENTRIC
EUROPEAN STUDY
Giovanni Lughezzani*, Massimo Lazzeri,
Rodolfo Hurle, NicolòMaria Buffi, Paolo
Casale, Girolamo Fiorini, Roberto
Peschechera, Luisa Pasini, Silvia
Zandegiacomo, Milan, Italy, Vittorio Bini,
Perugia, Italy, Alessio Benetti, Milan, Italy,
Alexander Haese, Hamburg, Germany, Joan
Palou Redorta, Barcelona, Spain, Thomas
McNicholas, Stevenage, United Kingdom,
Alexandre de la Taille, Créteil, France,
Giorgio Guazzoni, Milan, Italy
ABSTRACT
NUMBER TITLE
MP02-04 IDENTIFICATION OF RACE-SPECIFIC
BIOMARKERS FOR PROSTATE CANCER
PROGRESSION FROM FORMALIN-FIXED
BIOPSY TISSUE.
John Petros*, Rebecca Arnold, Atlanta, GA,
Jianpeng Xu, Berkeley, CA, Qi Long, Soma
Sannigrahi, Atlanta, GA, Jong Park, Tampa,
FL, Adeboye Osunkoya, Carlos Moreno,
Atlanta, GA
MP02-05
MP02-02 MULTICENTER VALIDATION STUDY OF A
MOLECULAR URINE TEST TO PREDICT
HIGH-GRADE PROSTATE CANCER
Rianne Hendriks*, Siebren Dijkstra,
Nijmegen, Netherlands, Erik Cornel, Hengelo,
Netherlands, Sander Jannink, Hans de Jong,
Daphne Hessels, Frank Smit, Willem
Melchers, Gisele Leyten, Nijmegen,
Netherlands, Theo De Reijke, Amsterdam,
Netherlands, Henk Vergunst, Nijmegen,
Netherlands, Paul Kil, Tilburg, Netherlands,
Ben Knipscheer, Emmen, Netherlands,
Christina Hulsbergen-van de Kaa, Peter
Mulders, Inge Van Oort, Jack Schalken,
Nijmegen, Netherlands
MP02-06 EVALUATION OF A GENOMIC CLASSIFIER
IN RADICAL PROSTATECTOMY PATIENTS
WITH LYMPH NODE METASTASIS
Hak J. Lee, San Diego, CA, Kasra Yousefi,
Zaid Haddad, Vancouver, Canada, Firas
Abdollah, Detroit, MI, Lucia Lam, Heesun
Shin, Mohammed Alshalalfa, Vancouver,
Canada, Elana Godebu, Song Wang, Ahmed
Shabaik, San Diego, CA, Elai Davicioni,
Vancouver, Canada, Christopher Kane*, La
Jolla, CA
MP02-03 NEXT-GENERATION SEQUENCING
REVEALS TRANSCRIPT CLUSTERS WITH
PROGNOSTIC POTENTIAL FOR
PROSTATE CANCER
Friedemann Horn*, Sabina Christ-Breulmann,
Sven-Holger Puppel, Tilo Buschmann, Kristin
Reiche, Michael Specht, Catharina Bertram,
Maik Friedrich, Stefanie Binder, Conny
Blumert, Jörg Hackermüller, Markus Kreuz,
Markus Löffler, Leipzig, Germany, Marieta I.
Toma, Michael Muders, Gustavo B. Baretton,
Michael Fröhner, Susanne Füssel, Manfred
Wirth, Dresden, Germany
*Presenting author
AUTOANTIBODIES AGAINST ERG,
AMACR, C-MYC AND HERV GAG IN THE
SERA OF PROSTATE CANCER PATIENTS:
POTENTIAL USE IN
DIAGNOSIS/PROGNOSIS
Anshu Rastogi*, Amina Ali, Sreedatta
Banerjee, Lakshmi Ravindranath, Gyorgy
Petrovics, Shyh-Han Tan, Jennifer Cullen,
Yongmei Chen, Denise Young, Isabell
Sesterhenn, Jacob Kagan, Sudhir Srivastava,
David McLeod, Shiv Srivastava, Alagarsamy
Srinivasan, Rockville, MD
MP02-07 NOVEL URINE MARKERS FOR
DIAGNOSING AND MONITORING NONINDOLENT PROSTATE CANCER
Daniella B. Frias, Ilsa L. Coleman, John S.
Banerji*, Khanh Pham, Claudio Jeldres,
Roman Gulati, Jing Xia, Seattle, WA, Scott
Tomlins, AnnArbor, MI, Christopher Porter,
Peter S. Nelson, Seattle, WA
25
MP02-08 VPAC1 IN SHED URINARY CELLS – A
POTENTIAL GENITOURINARY CANCER
BIOMARKER
Edouard Trabulsi*, Sushil Tripathi, Anne
Calvaresi, Charalambos Solomides, Leonard
Gomella, Mathew Thakur, Philadelphia, PA
MP02-15
MP02-09 TARGETED SEQUENCING OF PROSTATE
CANCER-ASSOCIATED RNAS IN
EXTRACELLULAR VESICLES FROM POSTDRE URINE
Kathryn Pellegrini, Dattatraya Patil*, Kristen
Douglas, Kathryn Wehrmeyer, Anna Bausum,
Mersiha Torlak, Martin Sanda, Carlos
Moreno, Atlanta, GA
SERUM LACDINAC-PSA DETERMINED BY
SURFACE PLASMON FIELD-ENHANCED
FLUORESCENCE SPECTROSCOPY
(SPFS)-BASED ASSAY SYSTEM HAS
IMPROVED DIAGNOSTIC ACCURACY
THAN PSA
Yuki Tobisawa*, Tohru Yoneyama, Shingo
Hatakeyama, Yasuhiro Hashimoto, Takuya
Koie, Chikara Ohyama, Hirosaki, Japan
MP02-16 LOW APPARENT DIFFUSION
COEFFICIENT (ADC) VALUE IS
ASSOCIATED WITH BIOCHEMICAL
RECURRENCE IN HIGH RISK PROSTATE
CANCER PATIENTS
Gyoohwan Jung, Min Young Yoon, Seoul,
Korea, Republic of, Juhyun Park, Jung Kwon
Kim, Chang Wook Jeong, Ja Hyeon Ku,
Hyeon Hoe Kim, Jae-Seung Paick, Cheol
Kwak, Seoul, Korea, Republic of, Hoyoung
Ryu*, Seoul, Korea, Republic of
MP02-10 HIGHLY-TRAINED DOGS’ OLFACTORY
SYSTEM FOR DETECTING BIOCHEMICAL
RECURRENCE FOLLOWING RADICAL
PROSTATECTOMY
Gianluigi Taverna*, Castellanza VA, Italy,
Lorenzo Tidu, Grosseto, Italy, Fabio Grizzi,
Rozzano, Italy, Giorgio Bozzini, Mauro
Seveso, Castellanza VA, Italy, Marco
Provenzano, NicoloMaria Buffi, Giorgio
Guazzoni, Rozzano MI, Italy, Alberto
Mandressi, Castellanza VA, Italy
MP02-17 COMPUTER EXTRACTED NUCLEAR
FEATURES FROM FEULGEN AND H&E
IMAGES PREDICT BIOCHEMICAL
RECURRENCE IN PROSTATE CANCER
PATIENTS FOLLOWING RADICAL
PROSTATECTOMY
Anna Gawlik*, George Lee, Jon Whitney,
Cleveland, OH, Jonathan Epstein, Robert
Veltri, Baltimore, MD, Anant Madabhushi,
Cleveland, OH
MP02-11 A NANOSTRING PLATFORM BASED
ASSAY DEFINES ABSENCE OF ERG
FUSION OR ATTENUATED ANDROGEN
RECEPTOR FUNCTION INDEX (ARFI) AS
EARLY INDICATORS OF BIOCHEMICAL
RECURRENCE IN A SUBSET OF LOW
GRADE PROSTATE CANCER
Wusheng Yan, Denise Young, Yingjie Song,
Yongmei Chen, Shilpa Katta, Kai Ying, Jacob
Kagan, Sudhir Srivastava, Albert Dobi,
Rockville, MD, David McLeod, Bethesda, MD,
Isabell Sesterhenn, Silver Spring, MD, Shiv
Srivastava, Gyorgy Petrovics*, Rockville, MD
MP02-18 THE RELATIVE CONTRIBUTION OF MRI
FUSION TARGETED BIOPSY AND
SYSTEMATIC BIOPSY VARY WITH
INCREASING SERUM PSA LEVEL
Xiaosong Meng*, Neil Mendhiratta, Andrew B.
Rosenkrantz, Pauline Guiffart, Richard
Huang, Fang-Ming Deng, Ming Zhou,
Jonathan Melamed, William C. Huang,
Herbert Lepor, Samir S. Taneja, New York,
NY
MP02-12 PROSTATE-SPECIFIC EXTRACELLULAR
VESICLES AS A NOVEL BIOMARKER IN
HUMAN PROSTATE CANCER
Yong Hyun Park*, Seoul, Korea, Republic of,
Hyun Woo Shin, Pohang, Korea, Republic of,
Ae Ryang Jung, Oh Sung Kwon, Seoul,
Korea, Republic of, Jaesung Park, Pohang,
Korea, Republic of, Ji Youl Lee,
Seoul, Korea, Republic of
MP02-19 BIOMARKERS OF BIOCHEMICAL (BCR)
AND CLINICAL RECURRENCE (CR) IN
PROSTATE CANCER (PCA) FOLLOWING
RADICAL PROSTATECTOMY (RP) –
PERFORMANCE OF A 17-GENE GENOMIC
PROSTATE SCORE (GPS) AND TESTS
FOR PTEN LOSS
Cristina Magi-Galluzzi*, Cleveland, OH,
Michael Bonham, Athanasios Tsiatis,
Redwood City, CA, Sara Falzarano,
Cleveland, OH, Anne Dee, Tara Maddala,
Dejan Knezevic, Phillip Febbo, H. Jeffrey
Lawrence, Redwood City, CA, Eric Klein,
Cleveland, OH
MP02-13 MICRORNA EXPRESSION PROFILING OF
PROSTATE TISSUE SUGGESTS MIR-5093P AS A DIAGNOSTIC MARKER FOR
PROSTATIC ADENOCARCINOMA
Jennifer Reifsnyder*, Ashley Winter, Anna
Mielnik, Sameer Mittal, Brian Robinson, Peter
Schlegel, Darius Paduch, New York, NY
MP02-20 THE CCP SCORE PROVIDES SIGNIFICANT
PROGNOSTIC INFORMATION IN
GLEASON SCORE < 7 PATIENTS
Jay Bishoff*, Salt Lake City, UT, Stephen
Freedland, Durham, NC, Thorsten Schlomm,
Hamburg, Germany, Julia Reid, Michael
Brawer, Steven Stone, Salt Lake City, UT,
Jack Cuzick, London, United Kingdom
MP02-14 VOXEL LEVEL RADIOLOGIC-PATHOLOGIC
VALIDATION OF RESTRICTION
SPECTRUM IMAGING WITH GLEASON
GRADE IN PROSTATE CANCER
Natalie Schenker-Ahmed*, Ghiam Yamin,
Ahmed Shabaik, Dennis Adams, Hauke
Bartsch, Joshua Kuperman, Nathan White,
Rebecca Rakow-Penner, Kevin McCammack,
J Kellogg Parsons, Christopher Kane, Anders
Dale, David Karow, La Jolla, CA
CREDITTM
26
Friday, May 6, 2016
8:00 am - 10:00 am
ABSTRACT
NUMBER TITLE
MP03-01 CLINICAL, PATHOLOGIC AND GENOMIC
PROFILES OF EXCEPTIONAL
RESPONDERS TO ANTIⴚPD1 THERAPY IN
RENAL CELL CARCINOMA
Mark Ball*, Michael Johnson, Michael Gorin,
Maria Rodriguez, Ming Zhang, Nick
Papadopoulos, Michael Haffner, Hans
Hammers, Luigi Marchionni, George Netto,
Charles Drake, Mohamad Allaf, Baltimore,
MD
ABSTRACT
NUMBER TITLE
MP03-06 PRELIMINARY ANALYSIS THE EFFICACY
AND SAFETY OF EVEROLIMUS FOR
RENAL ANGIOMYOLIPOMA ASSOCIATED
TUBEROUS SCLEROSIS IN CHINESE
PATIENTS: A SINGLE-CENTRE, SINGLEARM, PHASE II STUDY
Yi Cai, Hanzhong Li, Yushi Zhang*, Beijing,
China, People’s Republic of
MP03-07 RADIOFREQUENCY ABLATION OF
PRIMARY TUMORS COMBINED WITH
ANTI-PROGRAMMED DEATH-1 (PD-1)
ANTIBODY RESULTS IN AN ENHANCED
ANTITUMOR EFFECT AGAINST
ADVANCED RENAL CELL CARCINOMA
Xiaofeng Chang*, Nanjing, China, People’s
Republic of
MP03-02 A COMPARATIVE STUDY OBSERVING
SURGICAL OBSTACLES AND
EXPERIENCES INVOLVING
CYTOREDUCTIVE NEPHRECTOMY USING
DIFFERENT NEO-ADJUVANT TKI’S
(PANZOPANIB AND SUNITINIB) VERSUS
OPEN RADICAL NEPHRECTOMY
Sami Hamid*, Paula Pal, John Peters, Greg
Shaw, Tom Powles, London, United Kingdom
MP03-08 COMPREHENSIVE ANALYSIS AND
VALIDATION OF CONTEMPORARY
SURVIVAL PROGNOSTICATORS IN
PATIENTS WITH METASTATIC RENAL
CELL CARCINOMA TREATED WITH
TARGETED THERAPY
Kyo Chul Koo, Kwang Suk Lee*, Kang Su
Cho, Koon Ho Rha, Sung Joon Hong, Byung
Ha Chung, Dong Hyeon Lee, Seoul, Korea,
Republic of
MP03-03 METASTATIC RENAL CELL CARCINOMA
TO THE BLADDER: SYSTEMATIC REVIEW
OF 113 REPORTED CASES
Kazuhiro Matsumoto*, Nozomi Hayakawa,
Ryuichi Mizuno, Eiji Kikuchi, Akira Miyajima,
Mototsugu Oya, Tokyo, Japan
MP03-04 ROBOTIC RADICAL NEPHRECTOMY WITH
INFERIOR VENA CAVA TUMOR
THROMBECTOMY: INITIAL SERIES
Giuseppe Simone, Francesco Minisola*,
Rome, Italy, Andre Luis De Castro Abreu,
Los Angeles, CA, Mariaconsiglia Ferriero,
Salvatore Guaglianone, Gabriele Tuderti,
Leonardo Misuraca, Vincenzo Pompeo,
Riccardo Mastroianni, Manuela Costantini,
Rome, Italy, Monish Aron, Mihir Desai,
Inderbir Singh Gill, Los Angeles, CA, Michele
Gallucci, Rome, Italy
MP03-05
*Presenting author
MP03-09 CIRCULATING TUMOR DNA AS A
BIOMARKER IN ADVANCED RENAL CELL
CARCINOMA
Mark Ball*, Michael Gorin, Gunes Gunters,
Phillip Pierorazio, George Netto, Channing
Paller, Hans Hammers, Luis Diaz, Mohamad
Allaf, Baltimore, MD
MP03-10 PILOT STUDY EVALUATING PSMATARGETED 18F-DCFPYL PET/CT IN
PATIENTS WITH METASTATIC CLEAR
CELL RENAL CELL CARCINOMA
Michael A. Gorin*, Steven P. Rowe, Jody E.
Hooper, Hans-Joerg Hammers, Max Kates,
Mehrbod S. Javadi, Hazem Hawasli, Zsolt
Szabo, Martin G. Pomper, Mohamad E. Allaf,
Baltimore, MD
RADIOGRAPHIC SIZE OF
RETROPERITONEAL LYMPH NODES
PREDICTS PATHOLOGIC NODAL
INVOLVEMENT FOR PATIENTS
UNDERGOING RADICAL NEPHRECTOMY
FOR RENAL CELL CARCINOMA:
DEVELOPMENT OF A RISK PREDICTION
MODEL
Boris Gershman*, Naoki Takahashi, Daniel
Moreira, R. Houston Thompson, Stephen
Boorjian, Christine Lohse, Brian Costello,
John Cheville, Bradley Leibovich, Rochester,
MN
MP03-11 RETROPERITONEAL LYMPH NODE
DISSECTION IS NOT ASSOCIATED WITH
IMPROVED SURVIVAL AMONG PATIENTS
UNDERGOING CYTOREDUCTIVE
NEPHRECTOMY FOR METASTATIC
RENAL CELL CARCINOMA: A
PROPENSITY-SCORE BASED ANALYSIS
Boris Gershman*, Daniel Moreira, R. Houston
Thompson, Stephen Boorjian, Christine
Lohse, Brian Costello, John Cheville, Bradley
Leibovich, Rochester, MN
27
FRIDAY
KIDNEY CANCER: ADVANCED (INCLUDING DRUG THERAPY) I
Room 28 DE @ San Diego Convention Center
Moderators: Viraj Master and Shin Egawa
MP03-12 STAGING ADVANCED AND METASTATIC
CLEAR CELL RENAL CELL CARCINOMA
WITH 68 GALLIUM PSMA PET FOR
TREATMENT PLANNING
Handoo Rhee*, Chui Ming Tham, Paul
Thomas, John Blazak, Hema Samaratunga,
Keng Lim Ng, Glenda Gobe, Ian Vela, Simon
Wood, Brisbane, Australia
MP03-16 RENAL CANCER WITH VENOUS
THROMBUS - HOW DIFFERENT RENAL
VEIN AND INFERIOR VENA CAVA
INVOLVEMENT REALLY ARE?
Rodrigo Freddi, Rubens Park, Mauricio
Cordeiro*, Luiz Oliveira, Giuliano Guglielmetti,
Rafael Coelho, Wellington Andraus, William
Nahas, Sao Paulo, Brazil
MP03-13 CLINICAL OUTCOMES IN PATIENTS WITH
METASTATIC PAPILLARY RENAL CELL
CARCINOMA: A JAPANESE MULTIINSTITUTIONAL STUDY
Keiichi Ito*, Saitama, Japan, Shuji Mikami,
Tokyo, Japan, Katsunori Tatsugami, Fukuoka,
Japan, Naoya Masumori, Nobuo Shinohara,
Sapporo, Japan, Tsunenori Kondo, Tokyo,
Japan, Shotaro Nakanishi, Okinawa, Japan,
Yoji Nagashima, Tokyo, Japan, Masatoshi
Eto, Fukuoka, Japan, Tomomi Kamba, Kyoto,
Japan, Naoto Kuroda, Kochi, Japan,
Yoshihiko Tomita, Niigata, Japan, Hideyasu
Matsuyama, Yamaguchi, Japan, Tetsuro
Onishi, Chiba, Japan, Tomoyasu Tsushima,
Okayama, Japan, Hayakazu Nakazawa,
Mototsugu Oya, Tokyo, Japan, Seiichiro
Ozono, Shizuoka, Japan, Seiji Naito,
Fukuoka, Japan, Tomohiko Asano, Saitama,
Japan, Members of Japanese Society of
Renal Cancer, Tokyo, Japan
MP03-17 SYSTEMATIC EVALUATION OF
LABORATORY VALUES ASSOCIATED
WITH SURVIVAL IN METASTATIC RENAL
CELL CARCINOMA
John Leppert*, Abhinav Golla, I-Chun
Thomas, Remy Lamberts, Benjamin Chung,
Geoff Sonn, Sandy Srinivas, Alice Fan, Todd
Wagner, Stanford, CA, Viraj Master, Atlanta,
GA, James Brooks, Glenn Chertow, Stanford,
CA, Chirag Patel, Boston, MA
MP03-18 MULTIMODALITY APPROACH FOR
METASTATIC RENAL CELL CARCINOMA
IN A MODERN COHORT
Scott Pate*, Margaret Higgins, William
Parker, Jeffrey Holzbeierlein, Moben Mirza,
Peter Van Veldhuizen, Eugene Lee, Kansas
City, KS
MP03-19 THE ROLE OF CONCURRENT
LYMPHADENECTOMY WITH PARTIAL
NEPHRECTOMY IN HEREDITARY
LIEYOMYOMA AND RENAL CELL CANCER
PATIENTS: A 25 YEAR EXPERIENCE OF
THE UROLOGIC ONCOLOGY BRANCH OF
THE NATIONAL CANCER INSTITUTE
Louis Spencer Krane*, Bethesda, MA,
Abhinav Sidana, Kai Hammerich, James
Peterson, Daniel Su, Maria Merino,
Ramaprasad Srinivasan, W Marston Linehan,
Adam Metwalli, Bethesda, MD
MP03-14 TRENDS IN UTILIZATION OF
NEOADJUVANT CHEMOTHERAPY FOR
UPPER TRACT UROTHELIAL CARCINOMA
IN THE NATIONAL CANCER DATABASE
Clinton Bahler*, Francesca Monn, Chandru
Sundaram, Indianapolis, IN
MP03-15
TRENDS IN TREATMENT STRATEGIES
FOR METASTATIC RENAL CELL
CARCINOMA
Nawar Hanna*, Christian Meyer, Malte
Vetterlein, Alexander Cole, Thomas Seisen,
Jeffrey Leow, Philip Cheng, Francisco GelpiHammerschmidt, Michael Zavaski, Steven
Chang, Toni Choueiri, Maxine Sun, QuocDien Trinh, Boston, MA
MP03-20 ONCOLOGIC OUTCOME AFTER PARTIAL
NEPHRECTOMY COMPARED WITH
RADICAL NEPHRECTOMY FOR PRIMARY
RENAL TUMORS IN STAGE T3A
Asaf Shvero*, Dorit Zilberman, Yoram Mor,
Issac Kaver, Edi Fridman, Orith Portnoy,
Menahem Laufer, Raanan Berger, Jacob
Ramon, Zohar Dotan, Tel Hashomer, Israel
CREDITTM
28
Friday, May 6, 2016
8:00 am - 10:00 am
ABSTRACT
NUMBER TITLE
MP04-01 METFORMIN USE AND RISK OF
PROSTATE CANCER: RESULTS FROM
THE REDUCE STUDY
Tom Feng*, Los Angeles, CA, Xizi Sun,
Lauren Howard, Durham, NC, Adriana Vidal,
Los Angeles, CA, Daniel Moreira, Rochester,
MN, Ramiro Castro-Santamaria, King of
Prussia, PA, Gerald Andriole, St. Louis, MO,
Stephen Freedland, Los Angeles, CA
ABSTRACT
NUMBER TITLE
MP04-06 A PROSPECTIVE RANDOMIZED TRIAL OF
DIETARY CARBOHYDRATE RESTRICTION
FOR MEN INITIATING ANDROGEN
DEPRIVATION THERAPY:
CARBOHYDRATE AND PROSTATE STUDY
I (CAPS1)
Stephen Freedland*, William Aronson, Los
Angeles, CA, Lauren Howard, Jordan Smith,
Durham, NC, Matthew Smith, Boston, MA,
Jennifer Stout, Jenifer Allen, Daniel George,
Andrew Armstrong, Brant Inman, Pao-Hwa
Lin, Durham, NC
MP04-02 5-ALPHA REDUCTASE INHIBITORS AND
THE RISK OF PROSTATE CANCER
MORTALITY IN MEN TREATED FOR
BENIGN PROSTATIC HYPERPLASIA
Lauren Wallner*, Ann Arbor, MI, Julia DiBello,
Collegeville, PA, Bonnie Li, Pasadena, CA,
Stephen Van Den Eeden, Oakland, CA,
Sheila Weinmann, Portland, OR, Debra
Ritzwoller, Denver, CO, Jill Abell, Horsham,
PA, Ralph D’Agostino Jr, Winston-Salem, NC,
Ronald Loo, Pasadena, CA, David Aaronson,
Oakland, CA, Kathryn Richert-Boe, Portland,
OR, Ralph Horwitz, New Haven, CT, Steven
Jacobsen, Pasadena, CA
MP04-07 POVERTY IS ASSOCIATED WITH
ADVERSE PROSTATE CANCER
PATHOLOGY AMONG AFRICANAMERICAN MEN UNDERGOING RADICAL
PROSTATECTOMY
Samuel Weprin*, Philadelphia, PA, Joshua
Jones, Joshua Kaplan, Andrew Harbin,
Anastasiya Kamenko, Laura Giusto, Daniel
Parker, Jack Mydlo, Sylvia Yu, Daniel Eun,
Adam Reese, Philadelphia, PA
MP04-03 ROLE OF ADIPONECTIN IN PROSTATE
CANCER RISK AND THE PROLIFERATION
OF PROSTATE CANCER
Takashi Nitta*, Hidekazu Koike, Hiroshi
Mastui, Takeshi Miyao, Sota Kurihara,
Yoshiyuki Miyazawa, Haruo Kato, Yoshitaka
Sekine, Yasuhiro Shibata, Kazuto Ito,
Kazuhiro Suzuki, Maebashi, Japan
MP04-08 ABILITY OF THE GENERAL PUBLIC TO
ACCURATELY ESTIMATE SURVIVAL
RATES FOR PROSTATE CANCERS USING
UNRESTRICTED INTERNET SEARCHES
AND ONLINE NOMOGRAMS
Lucas P Labine*, Minneapolis, MN, Lee
Baumgarten, Philadelphia, PA, Isaac Palma,
Colby Dixon, Minneapolis, MN, Christopher J
Weight, Eagan, MN
MP04-04 RELATIONSHIP OF TESTOSTERONE
TREATMENT AND INCIDENT PROSTATE
CANCER RISK AMONG U.S. VETERANS
WITH LOW SERUM TESTOSTERONE
Thomas Walsh*, Molly Shores, Nicholas
Smith, Mary Lou Thompson, Alexandra Fox,
Kathryn Moore, Chloe Krakauer, Christopher
Forsberg, Susan Heckbert, Alvin Matsumoto,
Seattle, WA
MP04-09 DOES A CLEAR UNDERSTANDING OF
LIFE EXPECTANCY INCREASE
DECISIONAL CONFLICT AND ANXIETY
FOR MEN WITH NEWLY DIAGNOSED
PROSTATE CANCER?
Mazen Alsinnawi*, April E. Slee, John S.
Banerji, Kathryn L. Dahl, Sydney Akapame,
John D Massman III, Erika M. Wolff, John M.
Corman, Seattle, WA
MP04-05
MP04-10 TRENDS AND REGIONAL VARIATION IN
PROSTATE CANCER TREATMENT
Tudor Borza*, Samuel Kaufman, Vahakn B
Shahinian, Phyllis Yan, David C Miller, Ted A
Skolarus, Brent K Hollenbeck, Ann Arbor, MI
*Presenting author
THE IMPACT OF ACCESS-TO-CARE,
PATIENT CHARACTERISTICS, AND
DISEASE-SPECIFIC FACTORS ON
PROSTATE CANCER MORTALITY
Erik N. Mayer*, Heidi Hanson, William T.
Lowrance, Salt Lake City, UT
MP04-11 COMPARING QUALITY OF LIFE
OUTCOMES IN MEN RECEIVING EARLY
VERSUS LATE POST-PROSTATECTOMY
RADIATION THERAPY
Greg Murphy*, Peter Haddock, Ilene Staff,
Joseph Tortora, Alison Champagne, Joseph
Cusano, Joseph Wagner, Hartford, CT
29
FRIDAY
PROSTATE CANCER: EPIDEMIOLOGY & NATURAL HISTORY I
Moderators: Mitchell Benson and James Mohler
MP04-12 COMORBIDITY STATUS AS A PREDICTOR
OF HIGH-GRADE DISEASE IN MEN WITH
PROSTATE CANCER
Timothy Daskivich*, Los Angeles, CA,
Douglas Skarecky, Thomas Ahlering, Irvine,
CA, Stephen Freedland, Los Angeles, CA
MP04-17 DIFFERENTIAL GENE EXPRESSION IN
PROSTATE TISSUE ACCORDING TO
SEXUAL BEHAVIORS
Jennifer Rider*, Kathryn Wilson, Boston, MA,
Travis Gerke, Gainesville, FL, Ericka Ebot,
Boston, MA, Jennifer Sinnott, Columbus, OH,
Lorelei Mucci, Boston, MA
MP04-13 VALIDATION OF THE PROSTATE CANCER
PREVENTION TRIAL RISK CALCULATOR
2.0 IN MULTIPARAMETRIC MRI ERA
Michele Fascelli*, Philadelphia, PA, John
DiBianco, Christopher Bayne, Washington,
DC, Arvin George, Bethesda, MD, M. Minhaj
Siddiqui, College Park, MD, Thomas Frye,
Amichai Kilchevsky, Bethesda, MD, Alice
Semerjian, Washington, DC, Maria Merino,
Baris Turkbey, Bradford Wood, Peter Pinto,
Bethesda, MD
MP04-18 LONGITUDINAL REGRET AND HEALTHRELATED QUALITY OF LIFE FOLLOWING
TREATMENT FOR LOW- AND
INTERMEDIATE-RISK PROSTATE CANCER
Lauren Hurwitz*, Jennifer Cullen, Rockville,
MD, Daniel Kim, Bethesda, MD, Sally
Elsamanoudi, Rockville, MD, Jane Hudak,
Maryellen Colston, Judith Travis, Bethesda,
MD, Huai-Ching Kuo, Rockville, MD, David
McLeod, Inger Rosner, Bethesda, MD
MP04-14 PHASE IIA, RANDOMIZED PLACEBOCONTROLLED TRIAL OF SINGLE HIGH
DOSE CHOLECALCIFEROL (VITAMIN D3)
AND DAILY GENISTEIN (G-2535) VERSUS
PLACEBO IN MEN WITH EARLY STAGE
PROSTATE CANCER UNDERGOING
PROSTATECTOMY
David F. Jarrard*, Madison, WI, Badrinath R.
Konety, Minneapolis, MN, Joel Slaton,
Oklahoma City, OK, Wei Huang, Tracy
Downs, Jill Kolesar, KyungMann Kim, Tom
Havighurst, Madison, WI, Margaret G. House,
Howard L. Parnes, Bethesda, MD, Howard H.
Bailey, Madison, WI
MP04-19 A PROSPECTIVE STUDY OF HEALTH
RELATED QUALITY OF LIFE OUTCOMES
FOR HIGH RISK PROSTATE CANCER
PATIENTS MANAGED BY RADICAL
PROSTATECTOMY OR RADIATION
THERAPY WITH ANDROGEN
DEPRIVATION THERAPY
Mazen Alsinnawi*, Seattle, WA, Jennifer
Cullen, Rockville, MD, Erika M. Wolff, Seattle,
WA, Lauren M. Hurwitz, Rockville, MD,
Katherine Levie, Seattle, WA, Inger L.
Rosner, James L’Esperance, Timothy C.
Brand, Joseph R. Sterbis, Rockville, MD,
April Slee, Christopher R. Porter, seattle, WA
MP04-15
MP04-20 THE IMPACT OF SUBSEQUENT
METASTASES ON SURVIVAL AND
MEDICAL COSTS IN PROSTATE CANCER
PATIENTS
Neal Shore*, Myrtle Beach, SC, Tracy Li,
Maneesha Mehra, Mary Todd, Ryan Saadi,
Gaetan Leblay, Raritan, NJ, Robert Griffiths,
Waltham, MA
VASECTOMY AND THE RISK OF
PROSTATE CANCER IN A PROSPECTIVE
US COHORT: ANALYSIS IN THE
PRESENCE OF SELECTION BIAS
Michael Davenport*, Shufeng Li, James
Brooks, Mark Cullen, Michael Eisenberg,
Stanford, CA
MP04-16 CLINICAL ASSOCIATIONS WITH
PROSTATE CANCER MOLECULAR
FEATURES IN THE CANCER GENOME
ATLAS (TCGA) DATA
Daniel Lee*, David Golombos, Padraic
O’Malley, Deli Liu, Andrea Sboner, Ramy
Goueli, Neal Patel, Soo Kim, Khushabu
Kasabwala, Doug Scherr, Christopher
Barbieri, New York, NY
CREDITTM
30
Friday, May 6, 2016
8:00 am - 10:00 am
ABSTRACT
NUMBER TITLE
MP05-01 THE IMPACT OF CONTRALATERAL
KIDNEY VOLUME ON RENAL FUNCTION
AFTER RADICAL
NEPHROURETERECTOMY: IMPLICATIONS
FOR ELIGIBILITY FOR NEOADJUVANT
CHEMOTHERAPY FOR UPPER TRACT
UROTHELIAL CANCER
Wan Song, Hyun Hwan Sung, Deok Hyun
Han, Byong Chang Jeong, Seong Il Seo,
Seong Soo Jeon, Hyun Moo Lee, Han Yong
Choi, Hwang Gyun Jeon, Jae Ho Yoo*, Chi I
Hun Kwon, Heung Jae Park, Seoul, Korea,
Republic of, Kwang Ho Ryu, Gwangmyeong,
Korea, Republic of
MP05-02
MP05-03
MP05-04
*Presenting author
ABSTRACT
NUMBER TITLE
MP05-05 DIGITAL TOMOSYNTHESIS: A VIABLE
ALTERNATIVE TO NON-CONTRASTED
COMPUTED TOMOGRAPHY FOR THE
FOLLOW UP OF NEPHROLITHIASIS?
Adam Kaplan, Fernando Cabrera*, Durham,
NC, Ramy Youssef, Orange, CA, Matvey
Tsivian, Richard Shin, Charles Scales, Jr.,
Glenn Preminger, Michael Lipkin, Durham,
NC
VALIDATION OF 3-D VOLUMETRIC BASED
RENAL FUNCTION PREDICTION
CALCULATOR FOR NEPHRON SPARING
SURGERY
Aashish Kabra*, San Antonio, TX, Renato
Corradi, Stephanie Nougaret, New York, NY,
Melissa Suarez, Orange, CA, Jacob
Oppenheimer, San Antonio, TX, Zhamshid
Okhunov, Orange, CA, Hugh White, San
Antonio, TX, Hebert Vargas, New York, NY,
Jamie Landman, Orange, CA, Jonathan
Coleman, New York, NY, Michael Liss, San
Antonio, TX
ROLE OF PENILE DOPPLER US IN THE
PREOPERATIVE ASSESSMENT OF PENILE
SQUAMOUS CELL CARCINOMA
PATIENTS: RESULTS FROM A LARGE
PROSPECTIVE MULTICENTER EUROPEAN
STUDY
Giorgio Bozzini*, Mauro Seveso, Castellanza
VA, Italy, NicoloMaria Buffi, Giorgio
Guazzoni, Rozzano MI, Italy, Marco
Provenzano, Rozzano, Italy, Javier Romero
Otero, Madrid, Spain, Markus Margreiter,
Wien, Australia, Eduardo Garcia Cruz,
Barcelona, Spain, Boris Osmolorskji,
Moscow, Russian Federation, Paolo Verze,
Naples, Italy, Nicola Pavan, Trieste, Italy,
Francesco Sanguedolce, London, United
Kingdom, Gianluigi Taverna, Castellanza VA,
Italy
CONTRAST-ENHANCED ULTRASOUND
(CEUS) AND ELASTOGRAPHY
TECHNIQUES IN THE EVALUATION OF
UNCLEAR SCROTAL MASSES
Julian Marcon*, Matthias Trottmann, Melvin
D’Anastasi, Vera Mai, Johannes Rübenthaler,
Wael Khoder, Christian G. Stief, Maximilian
Reiser, Dirk-Andre Clevert, Munich, Germany
31
MP05-06
UTILITY OF RETROGRADE PYELOGRAM
IN THE SETTING OF NON DIAGNOSTIC
VISUALIZATION ON CT UROGRAM
Abdo Kabarriti*, Robert Kovell, Shailen
Sehgal, Christopher Miller, Thomas Guzzo,
Phillip Mucksavage, Philadelphia, PA
MP05-07
RADIOGRAPHIC MISDIAGNOSES AFTER
PERIURETHRAL BULKING AGENTS
Natalie Gaines*, Priyanka Gupta, Iyad S.
Khourdaji, Royal Oak, MI, Keval Parikh,
Rochester, MI, Kim A. Killinger, Royal Oak,
MI, Michael Ehlert, Minneapolis, MN, Larry T.
Sirls, Royal Oak, MI
MP05-08
ACUTE ANAPHYLAXIS RISK IN PATIENTS
WITH REPORTED CONTRAST ALLERGIES
UNDERGOING UROGRAPHY: FACT OR
FICTION?
Rachel Moses*, Annah Vollstedt, Vernon
Pais, Lebanon, NH
MP05-09
OPTIMIZATION OF FLUOROSCOPIC
IMAGING TO REDUCE RADIATION
EXPOSURE IN CHILDREN UNDERGOING
ENDOUROLOGICAL INTERVENTION
Ahmed fahmy*, Mohamed Youssif, Hazem
Rhashad, Waleed Dawoud, Ibrahim
Mokhless, Alexandria, Egypt
MP05-10
AUTOMATED STONE VOLUME
MEASUREMENT USING REDUCED-DOSE
(RD) CT IS COMPARABLE STANDARDDOSE (SD) CT
John Roger Bell*, Amy Lim, Perry Pickhardt,
Stephen Y Nakada, Madison, WI
MP05-11
PREVALENCE OF PROTECTIVE
SHIELDING UTILIZATION FOR RADIATION
DOSE REDUCTION IN ADULT PATIENTS
UNDERGOING COMPUTED TOMOGRAPHY
Brittany Uribe*, Rahul Dutta, Kyle Spradling,
Jaime Landman, Orange, CA
MP05-12
INCREASED UTILIZATION OF
MULTIPARAMETRIC MAGNETIC
RESONANCE IMAGING FOR DETECTION
AND MANAGEMENT OF PROSTATE
CANCER
Daniel Oberlin*, Frank Miller, David Casalino,
Joshua Meeks, Chicago, IL
FRIDAY
IMAGING/RADIOLOGY: URORADIOLOGY I
Moderators: Daniel Rukstalis and Christopher Porter
MP05-13
MP05-14
MP05-15
MP05-16
PROSTATE MRI BEFORE RADICAL
PROSTATECTOMY DOES NOT AFFECT
MARGINS AND FUNCTIONAL OUTCOMES
Vidit Sharma*, Boyd R Viers, Alessandro
Morlacco, Adam T Froemming, Matthew K
Tollefson, R. Houston Thompson, Stephen A
Boorjian, Igor Frank, Matthew T Gettman, R.
Jeffrey Karnes, Rochester, MN
CAN MAGNETIC RESONANCE IMAGING
REDUCE POSITIVE SURGICAL MARGINS
IN RADICAL PROSTATECTOMY?
Guilherme Padovani*, Gabriel Anjos, Giuliano
Guglielmetti, Regis Franca, Publio Viana,
Maurı́cio Cordeiro, Rafael Coelho, William
Nahas, Sao Paulo, Brazil
PROSTATE CANCER YIELD IN MRI
LESIONS VARIES ACROSS
RADIOLOGISTS
Geoffrey Sonn*, Richard Fan, Shufeng Li,
Pejman Ghanouni, Andreas Loening, Bruce
Daniel, Katherine To’o, Harcharan Gill,
Benjamin Chung, James Brooks, Stanford,
CA
MP05-17
USE OF ULTRASOUND IN UROLOGY
PRACTICE
Alexandra Rehfuss*, Paul Feustel, Barry
Kogan, Albany, NY
MP05-18
CENTRAL ZONE LESION ON MRI,
SHOULD WE BE CONCERNED?
Wei Phin Tan*, Patrick Whelan, Charles
McKiel, Shahid Ekbal, Narendra Khare,
Dennis Pessis, Leslie Deane, Chicago, IL
MP05-19
PRIOR NEGATIVE FUSION-GUIDED
PROSTATE BIOPSY: WHEN IS A REPEAT
BIOPSY NECESSARY?
Meet Kadakia*, Arvin George, Abhinav
Sidana, Michael Kongnyuy, Akhil Muthigi,
Amichai Kilchevsky, Thomas Frye, Francesca
Mertan, Daniel Su, Maria Merino, Peter
Choyke, Baris Turkbey, Bradford Wood, Peter
Pinto, Bethesda, MD
MP05-20
HISTOPATHOLOGIC CORRELATION OF
PIRADS VERSION 2 LESIONS ON 3T
MULTIPARAMETRIC PROSTATE MRI
Corinne C. Liu, Kaitlin E. Kosinski, Jeffrey T.
Schiff, Aaron E. Katz*, Mineola, NY
COMPUTATIONAL FLUID DYNAMICS
SIMULATION OF MALE VOIDING: A
NOVEL METHOD USING REAL-TIME
MAGNETIC RESONANCE IMAGE
Shigehiro Soh*, Toshiyuki Iwahata, Keisuke
Suzuki, Tomohiro Kobayashi, Shin Takeshi,
Yoshitomo Kobori, Hiroshi Okada, Koshigaya,
Japan
CREDITTM
Friday, May 6, 2016
8:00 am - 10:00 am
Podium Session 1
URODYNAMICS/LOWER URINARY TRACT DYSFUNCTION/FEMALE PELVIC MEDICINE: INCONTINENCE: EVALUATION
(URODYNAMIC TESTING)
Moderators: Jerry Blaivas, Courtenay Moore and Cristiano Gomes
TIME
8:00
8:10
ABSTRACT
NUMBER TITLE
PD01-01 SIMILARITY ANALYSIS BETWEEN
CATHETERLESS URODYNAMIC STUDY
USING PENILE CUFF AND
CONVENTIONAL URODYNAMIC STUDY
FOR EVALUATION OF MALE LOWER
URINARY TRACT SYMPTOM
Sangrak Bae*, Joonse Jung, Bonghee Park,
Changhee Han, Sunghak Kang, Yongseok
Lee, Uijeonbu-si, Korea, Republic of
PD01-02
ABSTRACT
TIME NUMBER TITLE
8:20 PD01-03 VIDEOURODYNAMIC CHANGES AND THE
PREDICTORS OF EARLY RECOVERY ON
URINARY CONTINENCE AFTER
LAPAROSCOPIC RADICAL
PROSTATECTOMY
Hsu-Che Huang*, New Taipei City, Taiwan,
Yuan-Hong Jiang, Hann-Chorng Kuo,
Hualien, Taiwan
THE CORRELATION BETWEEN
RETROGRADE LEAK POINT PRESSURE
AND 24-HOUR PAD WEIGHT FOR MEN
WITH POST PROSTATECTOMY
INCONTINENCE
Eskinder Solomon*, Sachin Malde, Mahreen
Pakzad, Rizwan Hamid, Julian Shah, Tamsin
Greenwell, Jeremy Ockrim, London, United
Kingdom
32
8:30
PD01-04
CAN FILLING PHASE URODYNAMIC
PARAMETERS PREDICT THE SUCCESS
OF THE BULBAR ARTIFICIAL URINARY
SPHINCTER IN TREATING POSTPROSTATECTOMY INCONTINENCE?
Eskinder Solomon*, London, United Kingdom,
Rajan Veeratterapillay, Christopher Harding,
Newcastle Upon Tyne, United Kingdom,
Tamsin Greenwell, London, United Kingdom
8:40
PD01-05
EFFECT OF PARITY AND TYPE OF
DELIVERY ON PATIENT-REPORTED
URINARY OUTCOMES: RESULTS FROM A
NATIONWIDE SAMPLE
Michael Daugherty*, Timothy Byler, Natasha
Ginzburg, Syracuse, NY
PD01-06
THE RELATIONSHIP BETWEEN
PSYCHIATRIC DISORDERS &
OVERACTIVE BLADDER
Nicole A. Negbenebor*, Jonathan Shaw,
Christine Raker, Vivian Sung, Providence, RI
9:00
PD01-07
CHANGES IN THE Q-TIP ANGLE IN
RELATION TO THE PATIENT POSITION
AND BLADDER FILLING
Jong-hyun Yun, Gumi, Korea, Republic of,
Jae Heon Kim, Seoul, Korea, Republic
of, Kyuhyung Cho, Gumi, Korea, Republic of,
Hee Jo Yang, Cheonan, Korea, Republic of,
Jaeho Kim, Gumi, Korea, Republic of, Doo
Sang Kim, Yun Soo Jeon, Changho Lee*,
Cheonan, Korea, Republic of
9:10
9:20
PD01-08
PD01-09
A RANDOMIZED COMPARATIVE STUDY
CORRELATING COUGH STRESS TEST
WITH URODYNAMICS AND 24 HOUR PAD
TEST IN THE EVALUATION OF STRESS
URINARY INCONTINENCE
Joseph Welles Henderson*, Cleveland, OH,
Sarah Kane, Louisville, KY, Jeffrey Mangel, Elias
Kikano, Jorge Garibay, Robert Pollard, Sangeeta
Mahajan, Adonis Hijaz, Cleveland, OH
9:30
PD01-10
THE ROLE OF DELAYED INTERVENTION
IN WOMEN UNDERGOING SLING
REVISION
Ekene Enemchukwu*, Palo Alto, CA, Nihar
Shah, Alice Drain, Raveen Syan, Victor Nitti,
Benjamin Brucker, New York, NY
9:40
PD01-11
OUR 10-YEAR EXPERIENCE WITH
FEMALE URETHROLYSIS: URETHRAL
PRESSURE PROFILOMETRY
CORRELATES WITH DEGREE OF
OBSTRUCTION IN CLINICALLY
OBSTRUCTED WOMEN AFTER ANTIINCONTINENCE PROCEDURE
Amy D. Dobberfuhl*, Craig V. Comiter,
Stanford, CA
9:50
PD01-12
A FLUID-STRUCTURE INTERACTION
SIMULATION OF FECAL INCONTINENCE
Yun Peng, Leila Neshatian, Rose Khavari,
Timothy Boone, Yingchun Zhang*, Houston,
TX
CREDITTM
UNDERSTANDING DETRUSOR
CONTRACTION DURATION: WHAT ARE
NORMAL PARAMETERS? AND WHAT ARE
DETERMINING FACTORS?
Marissa Velez*, Justin T. Matulay, Arindam
RoyChoudhury, Wilson Sui, Kimberly L.
Cooper, Doreen E. Chung, New York, NY
Friday, May 6, 2016
8:00 am - 10:00 am
Podium Session 2
GENERAL & EPIDEMIOLOGICAL TRENDS & SOCIOECONOMICS: QUALITY IMPROVEMENT & PATIENT SAFETY I
Moderators: Timothy Averch and Fernando Kim
TIME
8:00
ABSTRACT
NUMBER TITLE
PD02-01 THE IMPACT OF FRAILTY ON
COMPLICATIONS IN PATIENTS
UNDERGOING COMMON UROLOGIC
PROCEDURES; A STUDY FROM THE
AMERICAN COLLEGE OF SURGEONS
IMPROVEMENT DATABASE
Anne M Suskind*, Louise C Walter, Chengshi
Jin, John Boscardin, Saunak Sen, Matthew R
Cooperberg, Emily Finlayson, San Francisco,
CA
8:10
PD02-02
ENHANCED RECOVERY AFTER SURGERY
AND CARE COORDINATION PATHWAY AT
CITY OF HOPE: DECREASED LENGTH OF
STAY, READMISSIONS, AND
COMPLICATIONS
Steven V. Kardos*, Kevin G. Chan, Bertram Yuh,
Jonathan Yamzon, Nora H. Ruel, Finly Zachariah,
Clayton S. Lau, Laura Crocitto, Duarte, CA
8:20
PD02-03
UNDERLYING REASONS ASSOCIATED WITH
HOSPITAL READMISSION FOLLOWING
UROLOGIC SURGERY IN THE U.S.
Mark Tyson*, Sam Chang, Nashville, TN
*Presenting author
ABSTRACT
TIME NUMBER TITLE
8:30 PD02-04 HOSPITAL BUT NOT SURGICAL VOLUME
PREDICTS 30- AND 90-DAY
COMPLICATIONS IN RADICAL
CYSTECTOMY (RC) – RESULTS FROM
THE PROSPECTIVE MULTICENTER
RADICAL CYSTECTOMY SERIES
(PROMETRICS 2011) STUDY GROUP
Christian Meyer*, Sami-Ramzi Ley-Bannurah,
Malte Vetterlein, Hamburg, Germany, Roman
Mayr, Michael Gierth, Hans-Martin Fritsche,
Maximilian Burger, Regensburg, Germany,
Bastian Keck, Bernd Wullich, Erlangen,
Germany, Thomas Martini, Christian Bolenz,
Ulm, Germany, Armin Pycha, Bolzano, Italy,
Julian Hanske, Florian Roghman, Joachim
Noldus, Herne, Germany, Christian Gilfrich,
Matthias May, Straubing, Germany, Patrick
Bastian, Düsseldorf, Germany, Michael Rink,
Felix Chun, Roland Dahlem, Margit Fisch,
Atiqullah Aziz, Hamburg, Germany
33
FRIDAY
8:50
8:40
PD02-05
SURVIVAL AMONG PATIENTS WITH
UROLOGIC MALIGNANCIES TREATED AT
SAFETY NET CANCER CENTERS
Lindsey Herrel*, Sandra Wong, David Miller,
Ann Arbor, MI
8:50
PD02-06
HEALTHCARE-ASSOCIATED INFECTIONS
BY MULTIDRUG-RESISTANT BACTERIA IN
A TERTIARY UROLOGY DEPARTMENT
Vera Marques*, Francisco Rolo, Edgar
Tavares Silva, Alexandra Torres, Arnaldo
Figueiredo, Alfredo Mota, Coimbra, Portugal
9:00
9:10
PD02-07
PD02-08
NEEDLE DISINFECTANT TECHNIQUE
DURING PROSTATE BIOPSY IS
ASSOCIATED WITH LESS INFECTIONRELATED HOSPITALIZATION: RESULTS
FROM A STATEWIDE QUALITY
IMPROVEMENT COLLABORATIVE
Gregory Auffenberg*, Yuqing Gao, David
Miller, Zaojun Ye, Andrew Brachulis, Susan
Linsell, Ann Arbor, MI, David Kraklau, St.
Joesph, MI, Nitin Ambani, Jackson, MI,
Edward Barton, Novi, MI, Khurshid Ghani,
Ann Arbor, MI
9:20
PD02-09
COST-EFFECTIVENESS OF EXTENDED
VENOUS THROMBOEMBOLISM
PROPHYLAXIS AFTER ROBOTIC RADICAL
PROSTATECTOMY
Michael Rydberg*, Andrew Cohen, Chicago,
IL, Sangtae Park, Evanston, IL
9:30
PD02-10
CHALLENGING THE MICROHEMATURIA
GUIDELINES: BACK TO THE FUTURE?
Richard Matulewicz*, Oana Popescu, Donald
Lloyd-Jones, Joshua Meeks, Chicago, IL
9:40
PD02-11
PROCEDURES FOR PELVIC ORGAN
PROLAPSE AND STRESS URINARY
INCONTINENCE: A NATIONAL
COMPARISON OF POST-OPERATIVE
COMPLICATIONS BETWEEN UROLOGISTS
AND GYNECOLOGISTS
Marissa Velez*, Ifeanyi Onyeji, Justin T.
Matulay, Wilson Sui, Maxwell James, Doreen
E. Chung, Kimberly L. Cooper, Matthew
Rutman, Gina M. Badalato, New York, NY
9:50
PD02-12
EVALUATION OF UNPLANNED HOSPITAL
READMISSIONS AFTER MAJOR
UROLOGIC INPATIENT SURGERY IN THE
ERA OF ACCOUNTABLE CARE
Matthew Cohn*, Benjamin Stone, New York,
NY, Nicholas Donin, Los Angeles, CA,
Michael Schulster, James Wysock, New York,
NY, Marc Bjurlin, Brooklyn, NY
INCREASING PREVALENCE OF
CIPROFLOXACIN RESISTANT
ORGANISMS AND THE RISE OF MULTIDRUG RESISTANT ORGANISMS ON
RECTAL SWAB
Nicholas O’Block, Dimitri Papagiannopoulos*,
Waseem Ahmad, Wei Phin Tan, Lester Raff,
Christopher Coogan, Kalyan Latchamsetty,
Chicago, IL
CREDITTM
Friday, May 6, 2016
8:00 am - 10:00 am
Podium Session 3
PROSTATE CANCER: LOCALIZED: ACTIVE SURVEILLANCE I
Moderators: Peter Carroll and David Sharp
TIME
8:00
8:10
ABSTRACT
NUMBER TITLE
PD03-01 YOUNGER AGE IS ASSOCIATED WITH
DECREASED RISK OF BIOPSY
PROGRESSION DURING ACTIVE
SURVEILLANCE FOR LOW AND
INTERMEDIATE RISK PROSTATE CANCER
Michael Leapman*, Hao Nguyen, Janet
Cowan, Nanette Perez, Katsuto Shinohara,
San Francisco, CA, William Catalona,
Chicago, IL, Matthew Cooperberg, Peter
Carroll, San Francisco, CA
PD03-02
ABSTRACT
TIME NUMBER TITLE
8:20 PD03-03 COMPARISON OF PATHOLOGIC
OUTCOMES AT PROSTATECTOMY FOR
MEN WITH LOW-RISK PROSTATE
CANCER CHOOSING INITIAL ACTIVE
SURVEILLANCE VERSUS
PROSTATECTOMY
Gregory Auffenberg*, Susan Linsell, Ann
Arbor, MI, Bradley Rosenberg, Royal Oak,
MI, David Miller, Ann Arbor, MI
8:30
COMPARATIVE ANALYSIS OF IMMEDIATE
VERSUS DELAYED PROSTATECTOMY IN
PROSTATE CANCER PATIENTS ELIGIBLE
FOR ACTIVE SURVEILLANCE
Ashwin Mallya*, Vilvapathy Senguttuvan
Karthikeyan, Bangalore, India, Arjun
Sivaraman, Rafael Sanchez-Salas, Marc
Galiano, François Rozet, Eric Barret, Xavier
Cathelineau, Paris, France
34
PD03-04
LONG-TERM ONCOLOGIC OUTCOMES OF
RADICAL PROSTATECTOMY IN A LARGE
COHORT OF PATIENTS ON ACTIVE
SURVEILLANCE
Ardalan E. Ahmad*, Maria Komisarenko,
Ruby Grewal, Narhari Timilshina, Robert
Hamilton, Girish Kulkarni, Alexandre Zlotta,
Neil Fleshner, Antonio Finelli, Toronto,
Canada
PD03-05
UPSTAGING IN RADICAL
PROSTATECTOMY IN THE POST-PSA
ERA: AN EFFECT OF DELAYED
DIAGNOSIS OR BETTER PATIENT
SELECTION?
Katherine Rotker*, Joseph Brito, Liz Edmund,
Andres Matoso, Joseph Renzulli, Providence,
RI
8:50
PD03-06
RADICAL PROSTATECTOMY FOLLOWING
ACTIVE SURVEILLANCE IS ASSOCIATED
WITH INCREASED RATES OF
UNFAVOURABLE PATHOLOGY
Richard Savdie*, Robert Bell, Jonathan
Anning, Alan So, Martin Gleave, Peter Black,
Larry Goldenberg, Vancouver, Canada
9:00
PD03-07
IMPROVED RECOVERY OF ERECTILE
FUNCTION IN YOUNGER MEN AFTER
RADICAL PROSTATECTOMY: DOES IT
JUSTIFY IMMEDIATE INTERVENTION IN
LOW-RISK PROSTATE CANCER
PATIENTS?
Justin Lee*, Daniel Sjoberg, Mariam Imnadze,
John Mulhall, Andrew Vickers, Behfar Ehdaie,
New York, NY
9:10
9:20
PD03-08
PD03-09
9:30
PD03-10
APPLICABILITY OF EPSTEIN’S CRITERIA
FOR ACTIVE SURVEILLANCE IN A
CONTEMPORARY US COHORT
UNDERGOING ROBOTIC
PROSTATECTOMY
Naveen Kachroo*, Mireya Diaz, Mani Menon,
Ali Dabaja, Detroit, MI
9:40
PD03-11
PATHOLOGIC OUTCOMES AMONG MEN
WITH EARLY VERSUS DELAYED
PROGRESSION TO RADICAL
PROSTATECTOMY AFTER INITIAL ACTIVE
SURVEILLANCE
Nima Almassi*, Yaw Nyame, Daniel Greene,
Vishnu Ganesan, Charles Dai, Joseph Zabell,
Samuel Haywood, Chad Reichard, Anna
Zampini, Hans Arora, Alice Crane, Daniel
Hettel, Ahmed El-Shafei, Robert Stein,
Khaled Fareed, Michael Gong, J. Stephen
Jones, Andrew Stephenson, Eric Klein,
Cleveland, OH
9:50
PD03-12
APPLYING SEVEN CONTEMPORARY
ACTIVE SURVEILLANCE PROTOCOLS TO
PROSTATECTOMY: SIGNIFICANT
DIFFERENCES IN MIDTERM
ONCOLOGICAL OUTCOMES
Sami-Ramzi Leyh-Bannurah*, Montreal,
Canada, Petra Strölin, Pierre Tennstedt,
Thomas Steuber, Hans Heinzer, Markus
Graefen, Lars Budäus, Hamburg, Germany
PATHOLOGICAL OUTCOME FOLLOWING
RADICAL PROSTATECTOMY IN MEN WITH
PSA GREATER THAN 10 AND
HISTOLOGICALLY FAVORABLE-RISK
PROSTATE CANCER
Young Suk Kwon*, Jiwoong Yu, Sinae Kim,
Christopher Han, Nicholas Farber,
Jongmyung Kim, New Brunswick, NJ, Seok
Soo Byun, Seoul, Korea, Republic of, WunJae Kim, Cheongju, Korea, Republic of,
Seong Soo Jeon, Seoul, Korea, Republic of,
Isaac Kim, New Brunswick, NJ
CREDITTM
PATHOLOGICAL FEATURES AND
ONCOLOGICAL OUTCOMES OF KOREAN
PROSTATE CANCER PATIENTS ELIGIBLE
FOR ACTIVE SURVEILLANCE: ANALYSIS
FROM K-CAP REGISTRY
Kyo Chul Koo, Kwang Suk Lee*, In Young
Choi, Ji Youl Lee, Jun Hyuk Hong, ChoungSoo Kim, Sung Kyu Hong, Seok-Soo Byun,
Hyun Moo Lee, Seung Hwan Lee, Koon Ho
Rha, Byung Ha Chung, Seoul, Korea,
Republic of
Friday, May 6, 2016
8:00 am - 10:00 am
AQUA REGISTRY FORUM
Room 6 F @ San Diego Convention Center
PART I: WHAT DOES THE AQUA REGISTRY DO
AND HOW DOES IT WORK?
8:00
8:15
OVERVIEW: VALUE OF THE AQUA REGISTRY
AND PQRS REPORTING, MEANINGFUL USE
(MU) OF DATA AND FUTURE CMS PAYMENT
MODELS
J. Quentin Clemens
TECHNICAL ASPECTS OF DATA EXTRACTION,
SECURITY, ANALYSIS AND REPORTING
Tim Parr
8:45
LEGAL ASPECTS: PRIVACY AND HIPAA
COMPLIANCE
Diane Bieri
PART II: AQUA REGISTRY VALUE
DEMONSTRATION AND DISCUSSION
THE AQUA REGISTRY HELPS IMPROVE
UROLOGIC CARE QUALITY AND PATIENT
OUTCOMES
Matthew Cooperberg
*Presenting author
8:30
35
FRIDAY
8:40
9:00
AQUA VALUE DEMONSTRATION
Moderator: J. Quentin Clemens
Panelists: Ronald Suh, Jeremy Shelton
9:30
PANEL Q&A SESSION
Panelists: Matthew Cooperberg, Ronald Suh,
Diane Bieri, Jeremy Shelton
9:50
CLOSING REMARKS
J. Stuart Wolf
10:00
ADJOURN
CREDITTM
Friday, May 6, 2016
8:00 am - 5:00 pm
AUA/CONFEDERACION AMERICANA DE UROLOGIA (CAU)
Hall A @ San Diego Convention Center
MORNING SESSION
Moderator: Shlomo Raz
2:00
URETERAL ACCESS: SIMPLE TO COMPLEX
Glenn M. Preminger
8:00
TREATMENT OF URETHRAL STRICTURE
Leonard N. Zinman
2:30
8:30
ROBOTIC PROSTATECTOMY
Mani Menon
CHALLENGING ACCESS IN LAPAROSCOPY/
ROBOTIC SURGERY
Louis R. Kavoussi
2:45
TREATMENT OF TESTICULAR CANCER
Mark S. Litwin
PREOPERATIVE EVALUATION
Peter G. Schulam
3:05
TREATMENT OF KIDNEY CANCER
W. Marston Linehan
APPROACH TO SMALL MASSES
Jeffrey A. Cadeddu
3:25
APPROACH TO LARGE MASSES
Lee Richstone
3:45
DECISION ANALYSIS
Claus G. Roehrborn
4:05
ENDOSCOPIC MANAGEMENT (TURP,
GREENLIGHT, BUTTON, BIPOLAR, RF)
Steven A. Kaplan
9:00
9:30
10:00
BREAK
10:30
TREATMENT OF PENILE CANCER
Antonio Pompeo
11:00
RENAL STONES
James E. Lingeman
11:30
CARCINOMA OF THE PROSTATE
Ian M. Thompson, Jr.
4:30
11:55
AUA/CAU REMARKS
Secretary General, CAU: Hugo Davila
AUA Secretary: Manoj Monga
ENUCLEATION TECHNIQUES (ENDOSCOPIC
AND ROBOTIC)
Zeph Okeke
4:55
CONCLUSION
5:00
ADJOURN
12:05
TREATMENT OF INFERTILITY
Peter N. Schlegel
12:30
BREAK
CREDITTM
AFTERNOON SESSION: SEMINAR ON
MINIMALLY INVASIVE SURGERY
Moderator: Louis R. Kavoussi
1:30
PERCUTANEOUS RENAL ACCESS – WHERE
AND HOW (FLUOROSCOPIC,
ULTRASONOGRAPHIC AND ENDOSCOPIC
GUIDANCE)
Jaime Landman
Friday, May 6, 2016
8:00 am - 5:30 pm
BASIC SCIENCES SYMPOSIUM
8:00
8:10
OPENING REMARKS
Moderator: Carolyn Best
Program Chair: Jill Macoska
KEYNOTE I: THE MICROBIOME OF THE
URINARY TRACT—A ROLE BEYOND
INFECTION
Jeremy Burton
36
8:45
Q&A
9:00
SESSION I: ADVANCING UROLOGY THROUGH
MICROBIOME RESEARCH
Moderator: Jeremy Burton
9:05
MICROBIOME OF THE MALE UROLGENITAL
TRACT
David Nelson
SPECIAL PRESENTATION: INFLAMMATORY
RESPONSES AND THE MICROBIOME IN OAB
A. Lenore Ackerman
2:25
MICROBIAL COMMUNITIES: STRENGTH IN
NUMBERS
Scott Hultgren
9:55
Q&A
2:50
10:10
SESSION II: THE MICROBIOME IN CHRONIC
PELVIC PAIN (CPP) AND WHAT WE CAN
LEARN FROM THE GUT MICROBIOME
Moderator: Daniel Shoskes
FOSTERING PROTECTION AGAINST UTIS
Ann Stapleton
3:15
Q&A
3:30
SESSION IV: THE MICROBIOME IN URINARY
STONE DISEASE
Moderator: John Lieske
3:35
GUT MICROBIOTA AND OXALATE
HOMEOSTASIS
Marguerite Hatch
4:00
PROBIOTICS FOR PREVENTION OF KIDNEY
STONES
Moderator: John Lieske
4:25
SHEDDING NEW LIGHT ON KIDNEY STONE
MICROBIOME MINERALIZATION DYNAMICS
Bruce Fouke
10:15
FIGHTING FIRE WITH FIRE: PROBIOTIC
PROTECTION AGAINST CPP
David Klumpp
10:40
THE GUT MICROBIOME AND CPP
Daniel Shoskes
11:05
GUT MICROBIOTA INFLUENCE BEHAVIOR:
THE MICROBIOTA-GUT-BRAIN AXIS
Mark Lyte
11:30
HOST-SPECIFIC DEFENSE MECHANISMS
AGAINST INTRACELLULAR INFECTION
Soman Abraham
4:50
11:55
THE URINARY MICROBIOTA AND UROLOGIC
CHRONIC PELVIC PAIN: INSIGHTS FROM THE
NIH MAPP MICROBIOME PROJECT
J. Curtis Nickel
THE ASSOCIATION BETWEEN BACTERIA AND
URINARY STONES
Andrew Schwaderer
5:15
Q&A
12:20
Q&A
5:25
12:30
LUNCH BREAK (LUNCH NOT PROVIDED)
CONCLUSIONS, NEXT STEPS, AND CLOSING
REMARKS
Jill Macoska, Carolyn Best
1:30
KEYNOTE II: THE BLADDER MICROBIOME IN
Linda Brubaker
5:30
ADJOURN
2:05
Q&A
2:20
SESSION III: THE MICROBIOME IN
UNDERSTANDING, PREVENTING, AND
TREATING UTIS
Moderator: Scott Hultgren
CREDITTM
Friday, May 6, 2016
8:00 am - 5:30 pm
UROLOGIC ONCOLOGY RESEARCH SYMPOSIUM
8:00
WELCOME
Aria Olumi, Carolyn Best
8:10
THE NATIONAL CANCER INSTITUTE
TRANSLATIONAL RESEARCH PROGRAM
Andrew Hruszkewycz
8:40
SESSION I: IMMUNOTHERAPY
Moderator: Robert Reiter
8:45
MOLECULAR PROFILING OF KIDNEY CANCER
Allan Pantuck
9:05
GU CANCER IMMUNOTHERAPY – WHAT WE
STILL NEED TO KNOW
Padmanee Sharma
9:25
ADJUVANT/NEOADJUVANT APPROACHES TO
RCC PERIOPERATIVE IMMUNOTHERAPY
Lauren Harshman
*Presenting author
37
9:45
ANTI-PDL AND ANTI PDL-1 TRIALS IN
BLADDER CANCER
Nicholas Vogelzang
10:05
Q&A
10:20
HIGHLIGHTS FROM THE SPORE CAREER
DEVELOPMENT PROGRAMS
Kenneth Pienta
10:40
SPECIAL PRESENTATION: SPORE CAREER
DEVELOPMENT AWARDEE
Neema Navai
11:00
SESSION II: PANEL DISCUSSION: THE ROLE
OF CLINICAL TRIALS RESEARCH IN
UROLOGY
Moderator: Robert Reiter
Panelists: Raoul Concepcion
Seth Lerner
Colin Dinney
FRIDAY
9:30
12:00
Q&A
12:15
LUNCH (NOT PROVIDED)
1:15
SESSION III: GENETICS/EPIGENETICS
Moderator: Scott Tomlins
1:40
NOVEL GENOMIC SIGNATURES TO PREDICT
TREATMENT RESPONSE IN PROSTATE
CANCER
Robert Bristow
2:00
THE REALITY OF GU CANCER GEONOMICS
VS. THE PROMISE OF PERSONALIZED
MEDICINE
Scott Tomlins
1:20
2:20
OVERCOMING EPIGENETIC SILENCING IN
PROSTATE CANCER
William Nelson
TARGETING DNA REPAIR-HORMONE
CROSSTALK IN ADVANCED PROSTATE
CANCER
Karen Knudsen
2:40
Q&A
3:00
SESSION IV: TARGETED THERAPIES FOR
PERSONALIZED MEDICINE
Moderator: Peter Nelson
3:05
EMERGING MOLECULAR BIOMARKERS IN
ADVANCED PROSTATE CANCER
Himisha Beltran
3:25
PRIMARY AND METASTATIC TUMOR
HETEROGENEITY: IMPLICATIONS FOR
PERSONALIZED TREATMENT SELECTION
Peter Nelson
3:45
Q&A
4:05
PERSONALIZED MEDICINE FOR RENAL CELL
CARCINOMA
James Brugarolas
4:25
TARGETED APPROACHES IN ADVANCED
BLADDER CANCER
Jonathan Rosenberg
4:45
EMERGING THERAPIES FOR NON-MUSCLE
Colin Dinney
5:05
Q&A
5:20
FINAL THOUGHTS & ACKNOWLEDGEMENTS
Aria Olumi
5:30
ADJOURN
CREDITTM
Friday, May 6, 2016
8:30 am - 11:30 am
LIVE SURGERY I
Room 6 A @ San Diego Convention Center
Moderator: Manoj Monga
WELCOME & ANNOUNCEMENTS
8:30
9:30
SINGLE-USE DIGITAL FLEXIBLE
URETEROSCOPY FOR INTRARENAL LASER
LITHOTRIPSY
Surgeon: Roger Sur
Moderators: Wilson Molina, Michael Lipkin
10:30
DIGITAL URS AND MINI PCNL WITH
ULTRASONIC LITHOTRIPTER
Surgeon: Jorge Gutierrez-Aceves
Moderators: D. Duane Baldwin, Khurshid Ghani
11:30
ADJOURN
CREDITTM
INFLATABLE PENILE PROSTHESIS:
SUBMUSCULAR PLACEMENT OF RESERVOIR
Surgeons: Allen Morey, Jordan Siegel
Moderators: Kurt McCammon, Drogo Montague
38
Friday, May 6, 2016
10:00 am - 12:00 pm
Video Session 1
Room 29 CD @ San Diego Convention Center
Moderators: Richard Lee and Scott Delacroix, Jr.
ABSTRACT
NUMBER TITLE
V1-01
ROBOTIC INTRACORPOREAL INDIANA
POUCH: REPLICATING OPEN SURGERY
Andre Luis de Castro Abreu*, Los Angeles,
CA, Giuseppe Simone, Roma, Italy, Sameer
Chopra, Los Angeles, CA, Mariaconsiglia
Ferriero, Rocco Papalia, Roma, Italy,
Nariman Ahmadi, Los Angeles, CA, Riccardo
Mastroianni, Roma, Italy, Daniel Park, Andre
Berger, Los Angeles, CA, Salvatore
Guaglianone, Roma, Italy, Rene Sotelo, Los
Angeles, CA, Michelle Gallucci, Roma, Italy,
Monish Aron, Inderbir Gill, Mihir Desai, Los
Angeles, CA
V1-02
NOVEL TECHNIQUE FOR THE
RECONSTRUCTION OF REFRACTORY
PROSTATIC URETHRAL STENOSIS
ASSOCIATED WITH MEDIAL THIGH
FISTULA FOLLOWING BRACHYTHERAPY
Temitope Rude*, Kiranpreet Khurana, Jamie
Levine, Lee Zhao, New York, NY
V1-03
ROBOTIC ASSISTED LAPAROSCOPIC
VESICOURETHRAL STRICTURE EXCISION
AND ANASTOMOSIS
Travis Allemang*, John Malcolm, Oscar
Suarez, Douglas Kelly, Kurt McCammon,
Norfolk, VA
V1-04
ROBOTIC ASSISTED INGUINAL
LYMPHADENECTOMY FOR PENILE
CANCER: THE MD ANDERSON CANCER
CENTER TECHNIQUE
Isuru Jayaratna*, Surena Matin, Curtis
Pettaway, Houston, TX
V1-05
V1-06
*Presenting author
ABSTRACT
NUMBER TITLE
V1-07
ROBOTIC-ASSISTED EXTRAVESICAL
VESICOVAGINAL FISTULA REPAIR WITH
OMENTAL FLAP
Kara Watts*, Richard Ho, Reza Ghavamian,
Nitya Abraham, Bronx, NY
INTRAPERITONEAL ROBOTIC ASSISTED
LAPAROSCOPIC EXCISION OF AN UPPER
POLE URETEROCELE AND COHEN
CROSS-TRIGONAL URETERAL
REIMPLANTATION OF A DUPLICATED
SYSTEM
Patricia Lewandoski*, Amar Raval, Andrew
Pridjian, T. Erneseto Figueroa, Ilia Zeltser,
Philadelphia, PA
V1-08
PRIMARY ROBOTIC URETEROENTERIC
ANASTOMOTIC REVISION IN STUDER
NEOBLADDER: OPERATIVE TECHNIQUE
AND CASE SERIES
Jaspreet Parihar*, Greg Gin, Clayton Lau,
Kevin Chan, Jonathan Yamzon, Duarte, CA
V1-09
ROBOTIC RADICAL CYSTECTOMY WITH
INTRA-CORPOREAL NEOBLADDER
URINARY DIVERSION
Mehrdad Alemozaffar*, Atlanta, GA
V1-10
ROBOT ASSISTED TRANSPLANT
URETERONEOCYSTOSTOMY
Haidar Abdul-Muhsin*, Kelli Gross, Karen
Stern, Nitin Katariya, Erik Castle, Phoenix, AZ
V1-11
SIMULTANEOUS ROBOTIC-ASSISTED
MITROFANOFF PROCEDURE AND
URETHRECTOMY FOR URETHRAL
CARCINOMA
David Crawley*, Farmington, CT, James
Bienvenu, Richard Kershen, Joseph Wagner,
Hartford, CT
V1-12
ROBOTIC-ASSISTED RADICAL
PROSTATECTOMY AND CONTINENT
URINARY STOMA (MITROFANOFF) IN A 7
YEAR CHILD.
Wenceslao Villamil*, Carlos Fernando Andrade,
Alberto Jurado, Juan Moldes, Francisco De
badiola, Oscar Damia, Pablo Martinez, Carlos
roberto Giudice, Buenos Aires, Argentina
CREDITTM
ROBOTIC-ASSISTED LAPAROSCOPIC
STUMP URETERECTOMY WITH PARTIAL
CYSTECTOMY
Wai Lee*, Abram D’Amato, Felix Cheung,
Justina Tam, Stony Brook, NY, Steven
Sobey, Southhampton, NY, Wayne Waltzer,
Stony Brook, NY, Anthony Corcoran, Garden
City, NY
39
FRIDAY
ROBOTICS-BLADDER/RECONSTRUCTION
The videos in this session as well as the video libraries from the 2011-2016 Annual Meetings may be viewed in the Surgical Video Library and
purchased in the Products Store during the Annual Meeting. Both are located in the Sails Pavilion. AUA members receive free online access to the
Surgical Video Library throughout the year through AUAUniversity. Visit www.AUAnet.org/University to access.
Friday, May 6, 2016
10:00 am - 4:20 pm
SOCIETY OF GENITOURINARY RECONSTRUCTIVE SURGEONS (GURS)
10:00
OPENING REMARKS
Society President: Daniela Andrich
10:05
INTRODUCTION OF BRANTLEY SCOTT
LECTURER
10:10
BRANTLEY SCOTT LECTURE: OVERVIEW OF
MEDICAL DEVICE CONCEPTS OF ARTIFICIAL
URINARY SPHINCTERS – NEW & OLD
Sean Elliott
10:40
INTRODUCTION OF DEVINE LECTURER
10:45
DEVINE LECTURE: OVERVIEW OF PENILE
URETHRAL RECONSTRUCTION – OLD & NEW
Margit Fisch
11:15
INDUSTRY SPONSORED LUNCH (NON-CME)
(CME PROGRAM RESUMES)
12:15
STATE-OF-THE-ART LECTURE: THE NEED
12:20
WHAT WE’VE GOT AND WHAT WE REALLY
NEED IN GENITOURINARY RECONSTRUCTIVE
SURGERY
Anthony Mundy
12:50
12:55
STATE-OF-THE-ART TISSUE ENGINEERING
AND PRINTABLE ORGANS
Anthony Atala
1:30
DEVELOPMENT OF GENITOURINARY ORGANS
USING 3D SCAFFOLD MADE FROM
NANOTECHNOLOGY BASED MATERIALS
FUNCTIONALIZED WITH BIOACTIVE
MOLECULES AND STEM CELLS
Alexander Seifalian
2:05
NEW STRATEGIES FOR INFECTION CONTROL:
INSIGHTS FROM EVOLUTIONARY ECOLOGY
Adin Ross-Gillespie
2:40
FROM BENCH TO BEDSIDE: DEVELOPMENT
OF A SUBLINGUAL BACTERIAL VACCINE FOR
IMMUNOSTIMULATION AND PREVENTION OF
RECURRENT URINARY TRACT INFECTIONS
Enrique Fernandez-Caldes
3:10
MODERATED ROUND TABLE DISCUSSION
Moderator: Daniela Andrich
Panelists: Anthony Mundy, Anthony Atala
4:10
GURS MINUTES
4:20
ADJOURN
CREDITTM
STATE-OF-THE-ART LECTURE: INNOVATION
AND STRATEGIES FOR SOLUTIONS
Friday, May 6, 2016
10:30 am - 12:30 pm
BLADDER CANCER: EPIDEMIOLOGY & EVALUATION II
Moderators: Arthur Sagalowsky and Rodney Davis
ABSTRACT
NUMBER TITLE
MP06-01 INCIDENCE AND IMPACT OF VENOUS
THROMBOEMBOLISM IN RADICAL
CYSTECTOMY PATIENTS UNDERGOING
PRE-OPERATIVE CHEMOTHERAPY FOR
MUSCLE-INVASIVE BLADDER CANCER
Aditya Bagrodia*, Ranjit Sukhu, Andrew
Winer, Michael Vacchio, Eric Levy, Byron
Lee, Timothy Donahue, Eugene Cha, Melissa
Assel, Daniel Sjoberg, Andrew Vickers,
Jonathan Rosenberg, Dean Bajorin, Guido
Dalbagni, Bernard Bochner, New York, NY
ABSTRACT
NUMBER TITLE
MP06-03 VARIATION IN READMISSION
PARAMETERS BETWEEN OPEN AND
ROBOTIC ASSISTED RADICAL
CYSTECTOMY: A CONTEMPORARY
POPULATION LEVEL ANALYSIS
Tudor Borza*, Ann Arbor, MI, Bruce L
Jacobs, Pittsburgh, PA, Jeffrey S.
Montgomery, Todd M. Morgan, Alon Z.
Weizer, Khaled S. Hafez, Cheryl T. Lee,
Benjamin Y Li, Chang He, Ann Arbor, MI,
Jonathan E Helm, Bloomington, IN, Mariel S
Lavieri, Brent K Hollenbeck, Ted A Skolarus,
Ann Arbor, MI
MP06-02 SAFETY AND EFFICACY OF EXTENDEDDURATION THROMBOEMBOLIC
PROPHYLAXIS FOLLOWING RADICAL
CYSTECTOMY
Harras Zaid*, David Yang, Matthew Tollefson,
Igor Frank, William Parker, R. Houston
Thompson, R. Jeffrey Karnes, Stephen
Boorjian, Rochester, MN
MP06-04 IMPACT OF ANESTHESIOLOGY VOLUMES
ON EARLY AND LATE OUTCOMES AFTER
CYSTECTOMY: A POPULATION-BASED
STUDY
D. Robert Siemens*, Melanie Jaeger, Xuejiao
Wei, Christopher Booth, Kingston, Canada
40
PRECYSTECTOMY EPITHELIAL TUMOR
MARKER RESPONSE TO NEOADJUVANT
CHEMOTHERAPY AND ITS EFFECT ON
ONCOLOGICAL OUTCOMES IN
UROTHELIAL BLADDER CANCER
Soroush T Bazargani*, Thomas G. Clifford,
Hooman Djaladat, Anne Schuckman, Sarmad
Sadeghi, Tanya Dorff, David Quinn, Siamak
Daneshmand, Los Angeles, CA
MP06-11 SMALL CELL BLADDER CANCER:
CONTEMPORARY TREATMENT OUTCOMES
INCLUDING PROPHYLACTIC CRANIAL
IRRADIATION IN SELECT PATIENTS
Tara Nikonow*, Timothy Lyon, Robert Turner,
Jodi Maranchie, Ronald Hrebinko, Benjamin
Davies, Jeffrey Gingrich, Bruce Jacobs,
Pittsburgh, PA
MP06-12 FRAIL PATIENTS ARE LESS LIKELY TO
BE DISCHARGED TO HOME AFTER
CYSTECTOMY
Jeffrey Pearl*, Dattatraya Patil, Shipra Arya,
Mehrdad Alemozaffar, Viraj Master, Kenneth
Ogan, Atlanta, GA
MP06-06 PROSPECTIVE PREOPERATIVE
EVALUATION OF PATIENTS
UNDERGOING RADICAL CYSTECTOMY:
THE SCHONBERG MORTALITY INDEX
OUTPERFORMS OTHER FRAILTY AND
MALNUTRITION ASSESSMENTS FOR THE
PREDICTION OF 30-DAY READMISSION
AND COMPLICATIONS
Nathan Brooks*, Lewis Thomas, Michael
O’Donnell, Brad Erickson, Kenneth Nepple,
Iowa City, IA
MP06-13 UROLOGISTS’ COMPLIANCE WITH THE
2012 AUA ASYMPTOMATIC
MICROHEMATURIA GUIDELINES
Arnon Lavi*, Micky Gross, Michael Cohen,
Afula, Israel
MP06-07 INCIDENCE OF BLADDER CANCER AFTER
RADIATION FOR PROSTATE CANCER AS
A FUNCTION OF TIME AND RADIATION
MODALITY
Aryeh Keehn, Ethan Fram, Bronx, NY,
Farhang Rabbani*, Newnan, GA
MP06-14 ADENOCARCINOMA OF THE BLADDER:
PATHOLOGIC CHARACTERISTICS, TRENDS
IN MANAGEMENT, AND SURVIVAL
Andrew Cohen*, Vignesh Packiam, Charles
Nottingham, Norm Smith, Gary Steinberg,
Chicago, IL, Sanjay Patel, Oklahoma City, OK
MP06-08 TUMOR GRADE HETEROGENEITY IN
BLADDER UROTHELIAL CARCINOMA VALIDATION OF A SYSTEM USING
COMBINED NUMBERS
Gustavo Mendonça, Bruno Carneiro, Adriano
Cintra, Amilcar Castro, Athanase Billis,
Leonardo Reis*, Campinas, Brazil
MP06-15
MP06-16 EQUIVALENT SHORT-TERM OUTCOMES
OF ROBOTIC VERSUS OPEN RADICAL
CYSTECTOMY FOR BLADDER CANCER
Jamie S Pak*, Khawaja Bilal, Mark
Finkelstein, Michael A Palese, New York, NY
MP06-09 ASSESSMENT OF PATIENT CENTERED,
CANCER SPECIFIC QUALITY METRICS IN
CYSTECTOMY: HOW DID WE PERFORM?
Ahmed Hussein*, Buffalo, NY, James
Peabody, Detroit, MI, Seyedeh Dibaj, Gregory
Wilding, Buffalo, NY, Alex Mottrie, Asse,
Belgium, Ashok Hemal, Winston-Salem, NC,
Douglas Scherr, New York, NY, Francis
Schanne, Wilmington, DE, Koon-Ho Rha,
Sinchon-dong, Korea, Republic of, Mani
Menon, Detroit, MI, Peter Wiklund,
Stockholm, Sweden, Prokar Dasgupta,
Shamim Kahn, London, United Kingdom,
Alon Weizer, Ann Arbor, MI, Joan Palou
Redorta, Barcelona, Spain, Lee Richstone,
New Hyde Park, NY, M. Derya Balbay,
Okmeydan, Turkey, Adam Kibel, Bostom,
MA, Jihad Kaouk, Cleveland, OH, Michael
Stockle, Homburg, Germany, Michael Woods,
Chapel Hill, NC, AK Hosseini, Solna,
Sweden, Timothy Wilson, Duarte, CA, Carl
Wijburg, Arnhem, Netherlands, Ali Canda,
Okmeydan, Turkey, khurshid Guru, Buffalo,
NY
MP06-17 GEMCITABINE PLUS PACLITAXEL AS
THIRD LINE CHEMOTHERAPY: A
FEASIBLE OPTION FOR METASTATIC
UROTHELIAL CARCINOMA PATIENTS
Taku Naiki*, Keitaro Iida, Ryosuke Ando,
Toshiki Etani, Noriyasu Kawai, Takashi
Nagai, Yosuke Sugiyama, Masahiro Kondo,
Nagoya, Japan, Takehiko Okamura, Anjo,
Japan, Takahiro Yasui, Nagoya, Japan
MP06-18 PREVALENCE OF CLOSTRIDIUM
DIFFICILE INFECTION IN PATIENTS
AFTER RADICAL CYSTECTOMY AND
NEOADJUVANT CHEMOTHERAPY
Katherine Cotter*, Owen Aftreth, John
Schomburg, Yunhua Fan, Badrinath Konety,
Minneapolis, MN
MP06-19 A MULTI-CENTER INTERNATIONAL STUDY
ASSESSING THE IMPACT OF DIFFERENCES
IN BASELINE CHARACTERISTICS AND
PERIOPERATIVE CARE FOLLOWING
RADICAL CYSTECTOMY
Takahiro Osawa*, Sapporo, Japan, Cheryl T.
Lee, Ann Arbor, MI, Takashige Abe, Norikata
Takada, Sapporo, Japan, Khaled S. Hafez,
Jeffrey S. Montgomery, Alon Z. Weizer, Brent
K. Hollenbeck, Ted A. Skolarus, Ann Arbor, MI,
Sachiyo Murai, Nobuo Shinohara, Sapporo,
Japan, Todd M. Morgan, Ann Arbor, MI
MP06-10 TRAJECTORIES OF READMISSION RISK
REDEFINE THE PERIOD OF HEIGHTENED
VULNERABILITY FOLLOWING UROLOGIC
ONCOLOGIC PROCEDURES
Matthew Zapf*, Robert Blackwell, Jessica
Hannick, Anai Kothari, Paul Kuo, Gopal
Gupta, Maywood, IL
*Presenting author
TIME TO INCIDENT OF POSTOPERATIVE
COMPLICATIONS AFTER RADICAL
CYSTECTOMY
Richard Matulewicz, Brian Jordan*, Yousef
Al-Shraideh, Jennifer Tse, Joshua Meeks,
Shilajit Kundu, Chicago, IL
41
FRIDAY
MP06-05
MP06-20 THE FEASIBILITY AND SAFETY
EVALUATION OF THE PRESSURE
MONITORED AIR CYSTOSCOPY DURING
ACTIVE HEMATURIA
Yu Fan*, Yu Wang, Lin Yao, Wei Yu, Qian
Zhang, Jie Jin, Yu Fan, Beijing, China,
People’s Republic of
CREDITTM
Friday, May 6, 2016
10:30 am - 12:30 pm
PROSTATE CANCER: MARKERS II
Moderators: J. Brantley Thrasher and Neil Fleshner
ABSTRACT
NUMBER TITLE
MP07-01 VALIDATION OF A GENOMIC RISK
CLASSIFIER TO PREDICT PROSTATE
CANCER DEATH IN HIGH RISK PATIENTS
R. Jeffrey Karnes, Rochester, MN, Ashley
Ross, Edward Schaeffer, Baltimore, MD, Eric
Klein, Cleveland, OH, Nicholas Erho, Kasra
Yousefi, Mandeep Takhar, Elai Davicioni,
Vancouver, Canada, Bruce Trock*, Baltimore,
MD
ABSTRACT
NUMBER TITLE
MP07-06 VERY-SMALL-NUCLEAR CIRCULATING
TUMOR CELL (VSNCTC) AS A PUTATIVE
BIOMARKER FOR VISCERAL
METASTASIS IN METASTATIC
CASTRATION-RESISTANT PROSTATE
CANCER (MCRPC)
Jie-Fu Chen, Hao Ho, Elisabeth Hodara,
Alexandar Ureno, Ann Go, Elizabeth
Kaufman, Margarit Sievert, Daniel Luthringer,
Jiaoti Huang, Ker-Chau Li, Zunfu Ke, Leland
Chung, Hsian-Rong Tseng, Edwin Posadas*,
Los Angeles, CA
MP07-02 THE IMPACT OF QUANTITY AND TYPE OF
GLEASON PATTERN 4 ON BIOCHEMICAL
PROSTATECTOMY FOR PROSTATE
CANCER
Blake Anderson*, Shane Pearce, Bonnie
Choy, Gregory Zagaja, Gladell Paner, Scott
Eggener, Chicago, IL
MP07-07 PREDICTING ADVERSE PATHOLOGICAL
OUTCOMES IN PROSTATE CANCER (PCA)
PROSTATECTOMY (RP): THE ROLE OF
GENOMIC SIGNATURE.
Firas Abdollah*, Detroit, MI, Jason Alter, Zaid
Haddad, Maria Santiago, Kasra Yousefi,
Lucia Lam, Voleak Choeurng, Mark
Schleikelman, Christine Buerki, Elai Davicioni,
Vancouver, Canada, Vipul Patel, Celebration,
FL, Nikhil L. Shah, Atlanta, GA
MP07-03 PRIMARY TUMOR ANDROGEN RECEPTOR
SIGNALING AS A PREDICTOR OF
CASTRATE RESISTANCE
Ashley Ross*, Brian Shinder, Jeffrey Tosoian,
Baltimore, MD, Nicholas Erho, Mohammed
Alshalalfa, Kasra Yousefi, Vancouver,
Canada, Paula Hurley, Baltimore, MD, Elai
Davicioni, Vancouver, Canada, Felix Feng,
Ann Arbor, MI, Phuoc Tran, Baltimore, MD,
Edward Schaeffer, Chicago, IL
MP07-08 THE PLATEAU EFFECT OF NUMBER OF
PROSTATE CANCER RISK-ASSOCIATED
SINGLE NUCLEOTIDE POLYMORPHISMS
USED TO ASSESS GENETIC RISK
Haitao Chen, Shanghai, China, People’s
Republic of, Vignesh T. Packiam*, Chicago,
IL, Brian T. Helfand, Carly A. Conran, S. Lilly
Zheng, Evanston, IL, William B. Isaacs,
Baltimore, MD, Charles B. Brendler, Jianfeng
Xu, Evanston, IL
MP07-04 HSD3B1 AND RESISTANCE TO CYP17A1
INHIBITION IN PROSTATE CANCER
Chad Reichard*, Nima Almassi, Cleveland,
OH, Carly Russell, San Francisco, CA,
Jianbo Li, Cleveland, OH, Terence
Friedlander, San Francisco, CA, Nima Sharifi,
Cleveland, OH
MP07-05
MP07-09 ALDO-KETO-REDUCTASE 1C3
EXPRESSION IS AN INDEPENDENT RISK
FACTOR FOR OCCURRENCE OF
CANCER IN HIGH RISK PROSTATE
CANCER TREATED WITH NEOADJUVANT
THERAPY AND PROSTATECTOMY
Yasuhiro Hashimoto*, Hiromichi Iwamura,
Atsushi Imai, Shingo Hatakeyama, Takahiro
Yoneyama, Takuya Koie, Chikara Ohyama,
Hirosaki, Japan
SERUM TESTOSTERONE AS A
BIOMARKER FOR PROSTATE CANCER
DIAGNOSIS IN THE IMPACT POPULATION
Alexander Dias*, Sibel Saya, Elizabeth
Bancroft, Elizabeth Page, Christos
Mikropoulus, Natalie Taylor, Kathryn Myhill,
Anthony Chamberlain, Sarah Thomas, Zsofia
Kote-Jarai, Ros Eeles, London, United
Kingdom
42
MP07-10 THE FREQUENCY OF DRUGGABLE
TARGETS IN LOCALIZED PROSTATE
CANCER: INITIAL ANALYSIS FROM THE
DECIPHER GRID
Elai Davicioni*, San Diego, Ca, Nicholas
Erho, Lucia Lam, Mandeep Takhar, Hussam
Al-Deen Ashab, Anders Olson, Michael
Dillon, Kasra Yousefi, Zaid Haddad, Penelope
Wood, Mohammed Alshalalfa, Vancouver,
Canada
MP07-17 CLINICAL VALIDATION OF A LIVE-CELL
PHENOTYPIC BIOMARKER - BASED
DIAGNOSTIC ASSAY FOR THE
PREDICTION OF ADVERSE PATHOLOGY
IN PROSTATE CANCER
David Albala*, Syracuse, NY, Vladimir
Mouraviev, Orlando, FL, Kimberly RiegerChrist, Travis Sullivan, Burlington, MA,
Naveen Kella, San Antonio, TX, Kevin Knopf,
San Francisco, CA, Hani Rashid, Rochester,
NY, Michael Manak, Brad Hogan, Gauri Dixit,
Delaney Berger, Wendell Su, Matthew
Whitfield, Jonathan Varsanik, Mani Foroohar,
Beverly, MA, Stephen Zappala, Andover, MA,
Ashok Chander, Beverly, MA, Grannum Sant,
Medford, MA
MP07-11 INTRADUCTAL CARCINOMA OF THE
PROSTATE IS AN INDEPENDENT FACTOR
FOR DISTANT METASTASES AT INITIAL
RECURRENCE: AN INSIGHT TO
TREATMENT PLANNING.
Jennifer Sirois, Vincent Q. Trinh*, Babak K.
Mansoori, Andrée-Anne Grosset, Roula
Albadine, Mathieu Latour, Fred Saad,
Dominique Trudel, Montreal, Canada
MP07-12 ABDOMINAL OBESITY, ALTERED
ADIPOKYNES AND ELEVATED C-PEPTIDE
LEVELS ARE ASSOCIATED WITH HIGH
GLEASON SCORE IN PATIENTS
UNDERGOING DIAGNOSTIC PROSTATE
BIOPSY: DATA FROM PROSPECTIVE
REGISTRY
Jehonathan H Pinthus*, Hamilton, Canada,
Katie M. Di Sebastiano, Waterloo, Canada,
Wilhelmina C.M. Duivenvoorden, Hamilton,
Canada, Joel A. Dubin, Waterloo, Canada,
Marina Mourtzakis, Waterloo, Canada
MP07-18 PERSISTENCE OF CIRCULATING
TUMOUR CELLS (CTCS) IN MEN TREATED
WITH ANDROGEN DEPRIVATION
THERAPY CAN BE USED TO ENRICH AND
PROPAGATE TEMPORARY
PERSONALIZED CELL LINES
Handoo Rhee*, Jennifer Gunter, Lidja
Jovanovic, Elizabeth Williams, Brett Hollier,
Colleen Nelson, Ian Vela, Brisbane, Australia
MP07-13 BASELINE SERUM
DEHYDROEPIANDROSTERONE SULFATE
(DHEAS) CAN PREDICT
RESPONSIVENESS TO PRIMARY
ANDROGEN DEPRIVATION THERAPY IN
PATIENTS WITH HORMONE NAÏVE
METASTATIC PROSTATE CANCER
Akihiro Yano*, Hironori Sugiyama, Eiken Cho,
Hideki Takeshita, Yohei Okada, Makoto
Morozumi, Satoru Kawakami, Takumi
Yamada, Kawagoe, Japan
MP07-19 NEW MOUSE XENOGRAFT MODELS FOR
HUMAN PROSTATE CANCER BONE AND
BRAIN METASTASES
Qinlong Li, Lijuan Yin, Michael Lewis, Peng
Duan, Lawrence W. Jones, Quanlin Li,
Leland W. K. Chung, Isla Garraway, Haiyen
E. Zhau*, Los Angeles, CA
MP07-20 DEVELOPMENT AND VALIDATION OF
GENOMIC SIGNATURE THAT PREDICTS
ADT TREATMENT FAILURE
R. Jeffrey Karnes*, Rochester, MN, Hussam
Al-Deen Ashab, Vancouver, Canada, Bruce J.
Trock, Ashley E. Ross, Harrison Tsai, Jeffrey
J. Tosoian, Baltimore, MD, Nicholas Erho,
Mohammed Alshalafa, Voleak Choeurng,
Kasra Yousefi, Mandeep Takhar, Zaid
Haddad, Vancouver, Canada, Firas Abdollah,
Detroit, MI, Eric A. Klein, Cleveland, OH, Paul
L. Nguyen, Boston, MA, Felix Y. Feng, Ann
Arbor, MI, Adam Dicker, Robert Benjamin
Den, Philadelphia, PA, Elai Davicioni,
Vancouver, Canada, Robert B. Jenkins,
Rochester, MD, Tamara L. Lotan, Edward M.
Schaeffer, Baltimore, MD
MP07-14 TUMOR MARKER DETECTION AS THE
COMPLEMENT TO CIRCULATING TUMOR
CELL ENUMERATION IN PREDICTING
PROGNOSIS AND TREATMENT EFFECT IN
METASTATIC CASTRATION-RESISTANT
PROSTATE CANCER
Kun Chang*, Bo Dai, Ding-wei Ye, Shanghai,
MP07-15
*Presenting author
UTILITY OF PTEN/ERG STATUS IN A
CONTEMPORARY COHORT OF MEN WITH
FAVORABLE-RISK PROSTATE CANCERS
Jeffrey Tosoian*, Carlos Morais, Liana
Guedes, Abdelrazak Meliti, Stephanie
Glavaris, Ridwan Alam, Meera Chappidi,
Patrick Mullane, Baltimore, MD, Edward
Schaeffer, Chicago, IL, H. Ballentine Carter,
Angelo DeMarzo, Ashley Ross, Tamara
Lotan, Baltimore, MD
CREDITTM
43
FRIDAY
MP07-16 DEVELOPMENT OF PROSTATE CANCER
GENE SIGNATURES AND GENE SCORES
OF AGGRESSIVENESS FOR AFRICAN
AMERICANS AND EUROPEANS
AMERICANS
Isaac Powell*, Greg Dyson, Aliccia BolligFischer, Detroit, MI
Friday, May 6, 2016
10:30 am - 12:30 pm
GENERAL & EPIDEMIOLOGICAL TRENDS & SOCIOECONOMICS: QUALITY IMPROVEMENT & PATIENT SAFETY II
Moderator: Roger Dmochowski
ABSTRACT
NUMBER TITLE
MP08-01 PERIOPERATIVE BLOOD TRANSFUSION
AND RADICAL PROSTATECTOMY:
ANALYSIS OF THE NATIONAL SURGICAL
DATABASE
Justin T. Matulay*, Wilson Sui, Ifeanyi Onyeji,
Maxwell B. James, Marissa C. Velez, G. Joel
DeCastro, New York, NY
ABSTRACT
NUMBER TITLE
MP08-08 CAN A COMPUTERIZED ORDERING
SYSTEM REDUCE FOLEY CATHETER
TRAUMA?
Ted Lee*, Heiko Yang, David Hanauer, Julian
Wan, Ann Arbor, MI
MP08-09 NUTRITIONAL STATUS AND MAJOR
ABDOMINAL SURGERIES: 30ⴚDAY
POSTOPERATIVE COMPLICATIONS
Nicola Pavan*, Trieste, Italy, Carmen Mir,
Chad R. Ritch, Samarpit Ray, Nachiketh
Soodana⫺Prakash, Raymond R. Balise,
Miami, FL, Carlo Trombetta, Trieste, Italy,
Dipen J. Parekh, Mark L. Gonzalgo, Miami,
FL
MP08-02 THE IMPACT OF A SURGICAL SAFETY
CHECKLIST ON OPERATING ROOM TIME
AND COST IN ROBOTIC ASSISTED
PROSTATECTOMY
Tillman Hudson*, Jordan Grant, Lawrence
Tsai, Kristofer Wagner, Harry
Papaconstantinou, Jessica Pruszynski,
Patrick Lowry, Temple, TX
MP08-10 TRENDS IN REGIONALIZATION OF CARE
AND MORTALITY FOR PATIENTS
TREATED WITH RADICAL CYSTECTOMY
Nikhil Waingankar*, Philadelphia, PA,
Katherine Mallin, Chicago, IL, Brian Egleston,
Robert Uzzo, Alexander Kutikov,
Philadelphia, PA, David Winchester, Chicago,
IL, Marc Smaldone, Philadelphia, PA
MP08-03 RESIDENT FATIGUE: HOME CALL’S
EFFECT ON SLEEP AND FATIGUE ON
UROLOGY RESIDENTS
Stephen Ryan*, Wendy Craig, Moritz Hansen,
Rebecca White, Portland, ME
MP08-04 INCIDENTS RELATED TO FOLEY
CATHETER INSERTION AND
MAINTENANCE AND THE EFFICACY OF A
MEDICAL STAFF EDUCATIONAL
PROGRAM FOR SAFETY MANAGEMENT
Akira Komiya*, Sanae Antaku, Junko
Matsushima, Hiroshi Okudera, Toyama-shi,
Japan
MP08-05
MP08-11 PREOPERATIVE ANTIBIOTICS PRIOR TO
BLADDER BIOPSY: ARE THEY
NECESSARY?
Christopher I. Sayegh*, Marissa C. Velez,
Justin T. Matulay, Gina M. Badalato, Mitchell
C. Benson, Kimberly L. Cooper, New York,
NY
MP08-12 IS TRANSFER OF ADOLESCENTS FOR
TESTICULAR TORSION APPROPRIATE?
Amul Bhalodi*, Mark Ferretti, Michael
Goltzman, Ivan Miller, Israel Franco, Valhalla,
NY
REDUCED LENGTH OF STAY AND
READMISSION RATES USING A
STANDARDIZED CLINICAL CARE
PATHWAY FOLLOWING ROBOTIC
PROSTATECTOMY
George Turini, III*, Melissa Clark, Christopher
Tucci, Jason Machan, Dragan Golijanin,
Gyan Pareek, Joseph Renzulli, II,
Providence, RI
MP08-13 LATER CAREER UROLOGISTS ARE LESS
LIKELY TO UTILIZE AUA GUIDELINES
Lael Reinstatler*, Florian Schroeck, Elias
Hyams, Lebanon, NH
MP08-14 STENTRACKER: A SMARTPHONE
APPLICATION FOR THE PREVENTION OF
“FORGOTTEN” RETAINED URETERAL
STENTS (RUS).
Wilson R. Molina*, Rodrigo Donalisio da
Silva, McCabe C. Kenny, Diedra Gustafson,
Rodrigo Pessoa, Leticia Nogueira, Denver,
CO, Mark E. Leo, Las Vegas, NV, Michael K.
Yu, Dayton, OH, Fernando J. Kim, Denver,
CO
MP08-06 DISTRACTIONS IN THE OPERATING
THEATRE. ARE WE TOO LOUD?
Rafal Turo*, Chester, United Kingdom, Michal
Smolski, Preston, United Kingdom, Dev
Gulur, Sanjay Das, Ninaad Awsare, Bo
Pettersson, Chester, United Kingdom
MP08-07 IMPROVED PAIN CONTROL WITH LOCAL
ANESTHETIC AFTER PERCUTANEOUS
NEPHROSTOLITHOTOMY: A RESIDENT
DRIVEN QUALITY IMPROVEMENT STUDY
James Mason*, Rishi Modh, Akira
Yamamoto, Vincent Bird, Gainesville, FL
MP08-15
44
ONLINE NEWS MEDIA REPORTING OF
PSA TESTING IS OF POOR QUALITY AND
HAS NEGATIVE BIAS
Belinda Li*, Alissa Hart, Gopal Gupta,
Maywood, IL
MP08-19 IMPROVING RADICAL CYSTECTOMY
CARE: OUTCOMES, COMPLIANCE, AND
BARRIERS TO ADOPTION FOR A NEW
PROTOCOL
Jacob Groenendyk*, Joel Vetter, Vicky Peck,
Seth Strope, Saint Louis, MO
MP08-20 IMPROVING SURGICAL TRAINING:
SHIFTING THE CULTURE FROM
“APPRENTICESHIP” TO “PATIENTCENTERED” LEARNING
Ming-Hsien Wang*, Timothy Baumgartner,
Baltimore, MD
MP08-17 UROLOGIC ROBOTIC OPERATING ROOM
TURNOVER TIME PROJECT
Heather J. Chalfin*, Mary Grace Hensell, A.
Scott Dunbar Pritzker, Misop Han, Baltimore,
MD
CREDITTM
MP08-18 RELATIONSHIP BETWEEN PHYSICIAN
SOCIAL NETWORK STRUCTURE AND
HOSPITAL TEAMWORK CLIMATE
John Hollingsworth*, Parth Shah, Samuel
Kaufman, Jordan Everson, Ann Arbor, MI
Friday, May 6, 2016
10:30 am - 12:30 pm
PROSTATE CANCER: EPIDEMIOLOGY & NATURAL HISTORY II
Moderators: William Lowrance and Steven Joniau
ABSTRACT
NUMBER TITLE
MP09-01 RACIAL VARIATION IN PATIENTREPORTED OUTCOMES FOLLOWING
TREATMENT FOR LOCALIZED PROSTATE
CANCER: RESULTS FROM THE CEASAR
STUDY
Mark Tyson*, JoAnn Alvarez, Tatsuki
Koyama, Matthew Resnick, Nashville, TN,
Karen Hoffman, Houston, TX, David Penson,
Daniel Barocas, Nashville, TN
ABSTRACT
NUMBER TITLE
MP09-04 RACIAL DISPARITIES IN SURVIVAL
OUTCOMES FOR VETERANS WITH
PROSTATE CANCER
Eric Kim*, Suhong Luo, Katiuscia O’Brian,
Niraj Badhiwala, Bettina Drake, Kenneth
Carson, M’Liss Hudson, Robert Grubb, St.
Louis, MO
MP09-05
MP09-02 THE SIGNIFICANCE OF ANTERIOR
PROSTATE LESIONS ON
MULTIPARAMETRIC MRI IN AFRICAN
AMERICAN MEN
Michael Kongnyuy*, Abhinav Sidana, Arvin
George, Akhil Muthigi, Meet Kadakia, Amogh
Iyer, Thomas Frye, Michele Fascelli, Richard
Ho, Francesca Mertan, Bethesda, MD, Minhaj
Siddiqui, Baltimore, MD, Daniel Su, Maria
Merino, Baris Turkbey, Peter Choyke,
Bradford Wood, Peter Pintoi, Bethesda, MD
MP09-06 THE CHANGE IN PROSTATE CANCER
PRESENTATION AND DIAGNOSIS
COINCIDING WITH SCREENING
RECOMMENDATIONS.
Franklin Gaylis*, San Diego, CA, Jenny Choi,
San Diego, FL, Paul Dato, Hilary Prime,
Renee Calabrese, Edward Cohen, A. Karim
Kader, San Diego, CA
MP09-03 MULTIPARAMETRIC MRI AND FUSION
BIOPSY DECREASES DETECTION OF
INDOLENT CANCER IN AFRICAN
AMERICAN MEN
Michael Kongnyuy*, Arvin George, Minhaj
Siddiqui, Akhil Muthigi, Meet Kadakia,
Abhinav Sidana, Amichai Kilchevsky, Thomas
Frye, Michele Fascelli, Francesca Mertan,
Daniel Su, Maria Merino, Baris Turkbey,
Peter Choyke, Bradford Wood, Peter Pinto,
Bethesda, MD
*Presenting author
DOES THE NEW PROSTATE CANCER
GRADING SYSTEM IMPROVE PREDICTION
OF CLINICAL RECURRENCE?
Paolo Dell’Oglio*, Milan, Italy, Stephen A.
Boorjian, Rochester, MN, Nicola Fossati,
Giorgio Gandaglia, Andrea Gallina, Emanuele
Zaffuto, Marco Bianchi, Massimo Freschi,
Claudio Doglioni, Milan, Italy, Pierre
Karakiewicz, Montreal, Canada, Francesco
Montorsi, Milan, Italy, Jeffrey R. Karnes,
Rochester, MN, Alberto Briganti, Milan, Italy
MP09-07 RISK OF LYMPH NODE METASTASES IN
PATHOLOGICAL GLEASON SCORE <6
PROSTATE ADENOCARCINOMA:
ANALYSIS OF INSTITUTIONAL AND
POPULATION-BASED DATABASES
Hannah Wenger, Aria Razmaria, Gladell
Paner, Adam Weiner*, Scott Eggener,
Chicago, IL
45
FRIDAY
MP08-16 LOSS OF RENAL FUNCTION AND SLOW
GAIT SPEED ARE RISK FACTORS FOR
POSTOPERATIVE DELIRIUM AFTER
UROLOGICAL SURGERY
Shingo Hatakeyama*, Tendo Sato, Teppei
Okamoto, Hayato Yamamoto, Atsushi Imai,
Takahiro Yoneyama, Yasuhiro Hashimoto,
Takuya Koie, Chikara Ohyama, Hirosaki,
Japan
MP09-08 HIGH RATES OF METASTATIC DISEASE
IN PROSTATE CANCER AMONG BRCA2
MUTATION CARRIERS: IMPLICATIONS
FOR SCREENING
Stephanie Gleicher*, Syracuse, NY, Eric
Kauffman, Buffalo, NY, Gennady Bratslavsky,
Srinivas Vourganti, Syracuse, NY
MP09-13 OUTCOMES OF MEN WITH LOCALLY
ADVANCED (LAPCA) OR REGIONALLY
ADVANCED PROSTATE CANCER (RAPCA)
FOLLOWING CONSERVATIVE
MANAGEMENT (CM)
Parth Modi*, Izak Faiena, Neal Patel, New
Brunswick, NJ, Shunhua Shen, Bryn Mawr,
PA, Eric A. Singer, Dirk Moore, Robert
DiPaola, Grace Lu-Yao, Isaac Y. Kim,
Thomas L. Jang, New Brunswick, NJ
MP09-09 HISTORICAL TRENDS IN HIGH-RISK
PROSTATE CANCER PATIENTS
CHARACTERISTICS: A 27 YEARS OLD
OBSERVATIONAL STUDY FROM A
MULTICENTER PROSTATE CANCER
CLINICAL AND TRANSLATIONAL
RESEARCH GROUP
Marco Bianchi*, Alberto Briganti, Milan, Italy,
Jeffrey R. Karnes, Rochester, MN, Giorgio
Gandaglia, Nicola Fossati, Milan, Italy, Martin
Spahn, Bern, Switzerland, Paolo Gontero,
Turin, Italy, Lorenzo Tosco, Leuven, Belgium,
Burkhard Kneitz, Wurzburg, Germany, Felix
Chun, Hamburg, Germany, Emanuele
Zaffuto, Milan, Italy, Dirk De Ridder, Leuven,
Belgium, Maxine Sun, Montreal, Canada,
Markus Graefen, Hamburg, Germany,
Giansilvio Marchioro, Novara, Italy, Detlef
Frohneberg, Karlsruhe, Germany, Bertrand
Guilloneau, New York, NY, Simone Giona,
Turin, Italy, Rafael Sanchez-Salas, Xavier
Cathelineau, Paris, France, Pierre
Karakiewicz, Montreal, Canada, Hein Van
Poppel, Leuven, Belgium, Francesco
Montorsi, Milan, Italy, Steven Joniau, Leuven,
Belgium
MP09-14 EXTERNAL VALIDATION OF A MODEL
PREDICTING SURVIVAL OF MEN WITH
RECURRENT PROSTATE CANCER AFTER
RADICAL PROSTATECTOMY
Paolo Dell’Oglio*, Nazareno Suardi, Milan,
Italy, Stephen A. Boorjian, Rochester, MN,
Nicola Fossati, Giorgio Gandaglia, Milan,
Italy, Zhe Tian, Montreal, Canada, Marco
Moschini, Umberto Capitanio, Milan, Italy,
Pierre Karakiewicz, Montreal, Canada,
Francesco Montorsi, Milan, Italy, Jeffrey R.
Karnes, Rochester, MN, Alberto Briganti,
Milan, Italy
MP09-15
MP09-10 SURGERY VERSUS RADIOTHERAPY FOR
CLINICALLY-LOCALIZED PROSTATE
CANCER: A SYSTEMATIC REVIEW AND
META-ANALYSIS
Christopher Wallis*, Refik Saskin, Toronto,
Canada, Richard Choo, Rochester, MN,
Sender Herschorn, Ronald Kodama, Raj
Satkunasivam, Prakesh Shah, Cyril Danjoux,
Robert Nam, Toronto, Canada
IMPROVED SURVIVAL WITH PROSTATE
DIRECTED TREATMENT FOR MEN WITH
ADVANCED BUT NON-METASTATIC
PROSTATE CANCER– A CENTERS FOR
DISEASE CONTROL BREAST AND
PROSTATE CANCER QUALITY AND
PATTERNS OF CARE (CDC POC-BP)
STUDY
Jaclyn Chen*, Sacramento, CA, Ann
Hamilton, Mary Lo, Los Angeles, CA,
Rosemary Cress, Davis, CA, Marc Dall’Era,
Sacramento, CA
MP09-16 CONTEMPORARY MAPPING OF POSTPROSTATECTOMY PROSTATE CANCER
RELAPSE WITH C-11 CHOLINE PET AND
MULTIPARAMETRIC MRI
Ilya Sobol*, Rimki Haloi, Sean Park, Boyd
Viers, Brian Davis, Lance Mynderse, Stephen
Boorjian, Houston Thompson, Matthew
Tollefson, Matthew Gettman, Adam
Froemming, Val Lowe, Fernando Quevedo,
Igor Frank, Jeffrey Karnes, Eugene Kwon,
Rochester, MN
MP09-11 TRENDS IN SURGICAL MANAGEMENT OF
HIGH-RISK PROSTATE CANCER:
EVIDENCE OF AN EVOLVING TREATMENT
PARADIGM
Jeffrey Tosoian*, Baltimore, MD, Debasish
Sundi, Brian Chapin, Houston, TX, R. Jeffrey
Karnes, Rochester, MN, Emmanuel
Antonarakis, Meera Chappidi, Ridwan Alam,
Stephanie Glavaris, Kamyar Ghabili,
Mohamad Allaf, Trinity Bivalacqua, Kenneth
Pienta, Phuoc Tran, Baltimore, MD, Edward
Schaeffer, Chicago, IL, Ashley Ross,
Baltimore, MD
MP09-17 THE NATURAL HISTORY OF METASTASIS
AS A FUNCTION OF PSADT IN A
SURGICALLY-TREATED PATIENT
COHORT EXPERIENCING BIOCHEMICAL
RELAPSE
Jennifer Cullen*, Rockville, MD, Bruce Trock,
Baltimore, MD, Yongmei Chen, Inger Rosner,
Rockville, MD, Daniel Suzman, Zhaoyong
Feng, Baltimore, MD, Lauren Hurwitz, Claire
Huai-Ching Kuo, David McLeod, Rockville,
MD, Mario Eisenberger, Baltimore, MD
MP09-12 FREEDOM FROM BIOCHEMICAL
RECURRENCE AND METASTASIS IN MEN
WITH VERY HIGH RISK PROSTATE
CANCER TREATED AT A TERTIARY
CENTER: VALIDATION OF A NEW RISK
STRATUM
Debasish Sundi*, Houston, TX, Jeffrey
Tosoian, Baltimore, MD, Mary Achim, John
Davis, Curtis Pettaway, John Ward, Surena
Matin, Louis Pisters, Houston, TX, Edward
Baltimore, MD, Brian Chapin, Houston, TX
46
MP09-20 THE COMBINATION OF HISTOLOGICAL
PROSTATE ATROPHY AND
INFLAMMATION IS ASSOCIATED WITH
LOWER RISK OF PROSTATE CANCER
Daniel Moreira*, Rochester, MN, J. Curtis
Nickel, Kingston, Canada, Gerald Andriole,
St. Louis, MO, Ramiro Castro-Santamaria,
King of Prussia, PA, Stephen Freedland, Los
Angeles, CA
CREDITTM
MP09-19 CLINICAL FINDINGS AND TREATMENT
OUTCOMES IN PATIENTS WITH
EXTRAPROSTATIC EXTENSION
IDENTIFIED ON PROSTATE BIOPSY
Katherine Fleshner*, Montreal, Canada,
Melissa Assel, Nicole Benfante, Justin Lee,
Andrew Vickers, Samson Fine, Sigrid
Carlsson, James Eastham, New York, NY
Friday, May 6, 2016
10:30 am - 12:30 pm
URODYNAMICS/LOWER URINARY TRACT DYSFUNCTION/FEMALE PELVIC MEDICINE: PELVIC PROLAPSE
Moderators: Alexander Gomelsky and J. Christian Winters
ABSTRACT
NUMBER TITLE
MP10-01 ASSOCIATION BETWEEN VAGINAL
PRESSURE AND TRANSVERSUS
ABDOMINIS MUSCLE THICKNESS IN
PATIENTS WITH PELVIC ORGAN
PROLAPSE
Tomohiro Matsuo*, Akihiro Asai, Kojiro Ohba,
Yasuyoshi Miyata, Hideki Sakai, Nagasaki,
Japan
ABSTRACT
NUMBER TITLE
MP10-05 SACROCOLPOPEXY FOR POSTHYSTERECTOMY VAGINAL VAULT
PROLAPSE: LONG TERM FOLLOW-UP
Manuel Di Biase*, Ester Illiano, Perugia, Italy,
Konstantinos Giannitsas, Patras, Greece,
Alessandro Zucchi, Perugia, Italy, Massimo
Lazzeri, Milano, Italy, Raffaele Balsamo,
Napoli, Italy, Elisabetta Costantini, Perugia,
Italy
MP10-02 STRAINING TO VOID AND IPSS-QOL
SCORE ARE INDEPENDENTLY
ASSOCIATED WITH DYSPAREUNIA
Yoshitaka Aoki*, Manami Tsutsumiuchi, Akiko
Itoga, Masahiro Okada, Satoshi Yokoi,
Tetsuyuki Kurokawa, Yosuke Matsuta,
Hideaki Ito, Chieko Matsumoto, Yukinori
Kusaka, Osamu Yokoyaka, Fukui, Japan
MP10-06 OBESITY AND OUTCOMES OF ROBOTIC
ASSISTED SACROCOLPOPEXY
Lindsay Martin*, Rose Calixte, Bogdan
Grigorescu, Mineola, NY, Peter Finamore,
Bayshore, NY
MP10-07 OUTCOMES OF MINIMALLY INVASIVE
ABDOMINAL SACROCOLPOPEXY WITH
RESIDENT OPERATIVE INVOLVEMENT
Emily Slopnick*, Adonis Hijaz, Robert
Abouassaly, Carvell Nguyen, Simon Kim,
Cleveland, OH
MP10-03 SEXUAL FUNCTION IN PATIENTS
UNDERGOING POSTERIOR
COMPARTMENT REPAIR COMPARED TO
THOSE UNDERGOING ANTERIOR OR
APICAL REPAIRS
Priyanka Gupta*, Natalie Gaines, Kim A.
Killinger, Judith A. Boura, Larry T. Sirls,
Royal Oak, MI
MP10-08 ROLE OF UTERINE PRESERVING
SURGERY IN MESH BASED PELVIC
ORGAN PROLAPSE REPAIR.
James Forde*, Bilal Chughtai, Benjamin
Stone, Wei-Chun Hsu, Jialin Mao, Alexis Te,
Art Sedrakyan, New York, NY
MP10-04 LONG-TERM OUTCOMES OF ABDOMINAL
VS. VAGINAL APICAL PROLAPSE REPAIR
AMONG FEMALE MEDICAIRE
BENEFICIARIES
Aqsa Khan*, Phoenix, AZ, Karyn Eilber, Los
Angeles, CA, Ning Wu, Bethesda, MD, Chris
Pashos, Lexington, MA, Jennifer Anger, Los
Angeles, CA
*Presenting author
MP10-09 PATHOPHYSIOLOGICAL RELATIONSHIP
BETWEEN PELVIC ORGAN PROLAPSE
AND OVERACTIVE BLADDER
Steven Weissbart*, Ariana Smith, Uduak
Andy, Lily Arya, Philadelphia, PA
47
FRIDAY
MP09-18 BIOPSY-DETECTED GLEASON PATTERN 5
IS A PARTICULARLY STRONG
PREOPERATIVE PREDICTOR OF
RECURRENCE, METASTASIS, AND
MORTALITY IN MEN WITH HIGH-RISK
PROSTATE CANCER
Sean Stroup*, San Diego, CA, Daniel
Moreira, Rochester, MN, Zinan Chen, Lauren
Howard, Durham, NC, Martha Terris,
Augusta, GA, William Aronson, West Los
Angeles, CA, Matthew Cooperberg, San
Francisco, CA, Christopher Amling, Portland,
OR, Christopher Kane, San Diego, CA,
MP10-10 DOES THE DEGREE OF CYSTOCELE
PREDICT DE-NOVO STRESS URINARY
INCONTINENCE AFTER PROLAPSE
REPAIR? FURTHER ANALYSIS OF THE
CARE TRIAL
Michael Davenport*, Eric Sokol, Stanford, CA,
Christopher Elliott, San Jose, CA
MP10-16 LONG-TERM EFFICACY AND PATIENT
SATISFACTION OF PELVIC ORGAN
PROLAPSE REDUCTION USING
TRANSVAGINAL MESH
Melanie Aube-Peterkin*, Sherbrooke,
Canada, Marilyne Guerin, Quebec City,
Canada, Tina McVeigh, Sherbrooke, Canada,
Caroline Rheaume, Quebec City, Canada, Le
Mai Tu, Sherbrooke, Canada
MP10-11 WHAT IS THE ROLE OF PREOPERATIVE
URODYNAMICS FOR WOMEN
UNDERGOING PROLAPSE SURGERY?
Dianne Glass*, New York, NY, Aqsa Khan,
Scottsdale, AZ, Lauren Seo, Benjamin
Brucker, Victor Nitti, New York, NY
MP10-17 SURGEON EXPERIENCE AND
TRANSVAGINAL PROLAPSE MESH
COMPLICATIONS
Blayne Welk*, Erin Kelly, Jennifer Winick-Ng,
London, Canada
MP10-12 SOCIAL IMPACT AND HEALTHCARE
SEEKING BEHAVIOR OF SYMPTOMS OF
GENITAL PROLAPSE AMONG WOMEN IN
A DEVELOPING GULF COUNTRY
Hasan Elbiss, Nawal Osman, Fayez
Hammad*, Al Ain, United Arab Emirates
MP10-18 GOOGLE TRENDS©: A MEASURE OF THE
SOCIETAL IMPACT OF THE FDA
TRANSVAGINAL MESH SAFETY
COMMUNICATIONS
Juzar Jamnagerwalla*, Los Angeles, CA,
Brent Medoff, Scranton, PA, Karyn S. Eilber,
Jennifer T. Anger, Los Angeles, CA
MP10-13 SAFETY OF MESH USE IN VAGINAL
CYSTOCELE REPAIR: ANALYSIS OF
NATIONAL PATIENT CHARACTERISTICS
AND COMPLICATIONS
Ifeanyi Onyeji, Marissa Velez*, Wilson Sui,
Maxwell James, Justin T. Matulay, Doreen E.
Chung, New York, NY
MP10-19 TRENDS AND FAILURE RATES IN THE
MEDICAL TREATMENT OF PELVIC ORGAN
PROLAPSE FOR MEDICARE PATIENTS
Bashir Al Hussein Al Awamlh*, Lily Wang,
Benjamin Stone, Dina Bedretdinova, James
Forde, Philip Li, Bilal Chugtai, Richard Lee,
New York, NY
MP10-14 LONG-TERM RESULTS OF CYSTOCELE
REPAIR WITH SOLVENT-DEHYDRATED
CADAVERIC FASCIA OR DERMAL
ALLOGRAFT: 559 PATIENTS WITH 4-YEAR
FOLLOW-UP
Saad Juma*, Encinitas, CA, Sharon Mee,
Gary Leach, Los Angeles, CA
MP10-15
MP10-20 THE TRUTH BEHIND TRANSVAGINAL
MESH LITIGATION: DEVICES, TIMELINES,
AND PROVIDER CHARACTERISTICS
Lauren N. Wood*, Colby P. Souders, Karyn
S. Eilber, Lynn McClelland, Alex R. Souders,
Vicki Steiner, Jennifer T. Anger, Los Angeles,
CA
HIGH MIDLINE LEVATOR MYORRHAPHY
FOR VAGINAL VAULT PROLAPSE: LONGTERM RESULTS
Yuefeng Wu*, Alana Christie, Feras Alhalabi,
Philippe Zimmern, Dallas, TX
CREDITTM
Friday, May 6, 2016
10:30 am - 12:30 pm
SURGICAL TECHNOLOGY & SIMULATION: TRAINING & SKILLS ASSESSMENT I
Moderator: James Borin
ABSTRACT
NUMBER TITLE
MP11-01 ANALYSIS OF RESIDENT IMPACT ON
FLOW DISRUPTIONS DURING ROBOTIC
SURGERY
Tom Feng*, Christopher Dru, Nicole Tarui,
Ken Catchpole, Karyn Eilber, Jennifer Anger,
Los Angeles, CA
ABSTRACT
NUMBER TITLE
MP11-03 MODULAR TRAINING FOR RARP: WHERE
TO BEGIN?
Catherine Lovegrove*, London, United
Kingdom, Giacomo Novara, Padua, Italy,
Khurshid Guru, Buffalo, NY, Alex Mottrie,
Aalst, Belgium, Ben Challacombe, London,
United Kingdom, Johar Raza, Buffalo, NY,
Henk Van der Poel, Amsterdam, Netherlands,
James Peabody, Detroit, MI, Rick Popert,
Prokar Dasgupta, Kamran Ahmed, London,
United Kingdom
MP11-02 IMPACT OF RESIDENT TRAINEE
INVOLVEMENT ON ROBOT ASSISTED
RADICAL PROSTATECTOMY (RARP)
OUTCOMES.
Eric Schommer*, Kolbi Tonkovich, Zhou Li,
David Thiel, Jacksonville, FL
48
MP11-05
MP11-12 LIVE STREAMING OF ROBOTIC SURGERY
FROM LEADING EDUCATIONAL CENTRES
ENABLES A GLOBAL APPROACH TO
SURGICAL TEACHING.
Justin Collins*, Stockholm, Sweden,
Alexander Mottrie, Aalst, Belgium, Abolfazl
Hosseini, Stockholm, Sweden, Benjamin
Challacombe, London, United Kingdom,
Christofer Adding, Stockholm, Sweden,
Prokar Dasgupta, London, United Kingdom,
Walter Artibani, Verona, Italy, Richard
Gaston, Thierry Piechaud, Bordeaux, France,
Prasanna Sooriakumaran, Oxford, United
Kingdom, Giovannalberto Pini, Milan, Italy,
Andreas Nilsson, Evangelos Fragkiadis,
Stockholm, Sweden, Ashutosh Tewari, Ketan
Badani, New York, NY, Inderbir Gill, Mihir
Desai, Los Angeles, CA, Vipul Patel,
Celebration, FL, Rajesh Ahlawat, New Delhi,
India, Declan Murphy, Melbourne, Australia,
Rafael Coelho, Sao Paulo, Brazil, Koon Rha,
Soeul, Korea, Republic of, Giorgio Gandaglia,
Aalst, Belgium, Harko Verhagen, Stockholm,
Sweden, Peter Wiklund, Stockholm, Sweden
IS SEEING BELIEVING? TECHNICAL
MENTORSHIP DURING ROBOT-ASSISTED
SURGERY
Ahmed Hussein*, Somayeh Shafiei,
Mohamed Sharif, Basel Ahmad, Ehsan
Esfahani, Khurshid Guru, Buffalo, NY
MP11-06 A GESTURE IS WORTH A THOUSAND
WORDS: VERBAL AND NONVERBAL
COMMUNICATION DURING ROBOTASSISTED SURGERY
Judith Tiferes*, Ann Bisantz, O’Hara Ryan,
Nicole Wawrzyniak, Basel Ahmad, Justen
Kozlowski, Ahmed Hussein, Khurshid Guru,
Buffalo, NY
MP11-07 INSIGHT INTO RESIDENT SURGICAL
INVOLVEMENT USING ROBOLOG
Kristin G. Baldea*, Ryan Thorwarth, Marcus
L. Quek, Gopal N. Gupta, Chicago, IL
MP11-08 CROWDSOURCING ASSESSMENT OF
SURGEON DISSECTION OF RENAL
ARTERY AND VEIN DURING ROBOTIC
PARTIAL NEPHRECTOMY: A NOVEL
APPROACH FOR QUANTITATIVE
ASSESSMENT OF SURGICAL
PERFORMANCE
Mary Powers*, New Orleans, LA, Thomas
Lendvay, Seattle, WA, Aaron Boonjindasup,
Michael Pinsky, Philip Dorsey, Michael
Maddox, New Orleans, LA, Bryan Comstock,
Seattle, WA, Li-Ming Su, Gainesville, LA,
Matthew Gettman, Rochester, MN, Chandra
Sundaram, Indianapolis, IN, Erik Castle,
Rochester, MN, Jason Lee, Toronto, Canada,
Benjamin Lee, New Orleans, LA
MP11-13 EVALUATING ROBOTIC OPERATIVE
EXPERIENCE: HOW SUTURE INTEGRITY
CAN ASSESS A SURGEON’S
PROFICIENCY
Tim Large*, Indianapolis, IN, Alison Keenan,
Madison, WI, William Bennett Jr, Mark Cain,
Richard Rink, Benjamin Whittam,
Indianapolis, IN
MP11-14 MULTI-INSTITUTIONAL VALIDATION AND
ASSESSMENT OF TRAINING MODALITIES
IN ROBOTIC SURGERY (THE MARS
PROJECT)
Nicholas Raison*, Kamran Ahmed, Abdullatif
Aydin, London, United Kingdom, Alexandre
Mottrie, Aalst, Belgium, Henk Van Der Poel,
Amsterdam, Netherlands, Prokar Dasgupta,
London, United Kingdom
MP11-09 PRIOR EXPERIENCE IN ATHLETICS IS
SIGNIFICANTLY ASSOCIATED WITH
INCREASED ROBOTIC SURGICAL SKILL
IN ROBOT-NAIVE MEDICAL STUDENTS
Kevin Shee*, Fady Ghali, Hanover, NH, Elias
S Hyams, Lebanon, NH
MP11-15
MP11-10 DEVELOPING BENCHMARK SCORES FOR
THE EAU HANDS-ON-TRAINING (HOT)
COURSE IN ROBOTIC SURGERY
Nicholas Raison*, Kamran Ahmed, London,
United Kingdom, Willem Brinkman,
Rotterdam, Netherlands, Nicola Fossati,
Milan, Italy, Henk Van Der Poel, Amsterdam,
Netherlands
*Presenting author
ROBOT-ASSISTED LAPAROSCOPIC
PARTIAL NEPHRECTOMY WITH ALF–X
ROBOT ON PIG MODEL
Giorgio Bozzini*, Mauro Seveso, Pietro Bono,
Oliviero De Francesco, Alberto Mandressi,
Gianluigi Taverna, Castellanza VA, Italy
MP11-16 IS IT NECESSARY TO USE REDUCED SIZE
TRAINING BOXES FOR PEDIATRIC
ROBOTIC SURGERY?- A PRELIMINARY
COMPARATIVE STUDY
Engin Yilmaz, Saynur Yilmaz, Ankara,
Turkey, Minki Baek*, Houston, TX, Josue
Ortiz Romero, Monterrey, Mexico, Chester
Koh, Houston, TX
49
FRIDAY
MP11-11 ANALYSIS OF GLOBAL EVALUATIVE
ASSESSMENT OF ROBOTIC SURGERY
(GEARS) AS AN IMMEDIATE
ASSESSMENT TOOL IN ROBOTIC
SURGERY CURRICULUM
Jamal Nabhani*, Thomas Bottyan, Thomas
Clifford, Sarfaraz Serang, Andrew Hung, Los
Angeles, CA
MP11-04 LEARNING CURVE IN ROBOT-ASSISTED
RADICAL PROSTATECTOMY: PRACTICE
MAKES PERFECT, BUT WHAT PRACTICE?
Catherine Lovegrove*, London, United
Kingdom, Giacomo Novara, Padua, Italy,
Khurshid Guru, Buffalo, NY, Alex Mottrie,
Aalst, Belgium, Ben Challacombe, London,
United Kingdom, Johar Raza, Buffalo, NY,
Henk Van der Poel, Amsterdam, Netherlands,
James Peabody, Detroit, MI, Rick Popert,
Prokar Dasgupta, Kamran Ahmed, London,
United Kingdom
MP11-17 USE OF AN EDUCATION TOOL TO
FACILITATE IMMEDIATE AND DIRECTED
SURGICAL SKILLS FEEDBACK IN
UROLOGY
Jason R. Lomboy*, Matthew R. Macey, Troy
A. Sukhu, AnnaMarie Connolly, Eric M.
Wallen, Davis P. Viprakasit, Chapel Hill, NC
MP11-20 ACADEMIC SKILLS OF JUNIOR
SCIENTISTS IN UROLOGY ARE
PREDOMINANTLY ACQUIRED BY SELFSTUDY
Hendrik Borgmann*, Frankfurt, Germany,
Johannes Salem, Dortmund, Germany
CREDITTM
MP11-18 UNPROFESSIONAL CONTENT ON SOCIAL
MEDIA AMONG U.S. UROLOGY
RESIDENCY GRADUATES
Kevin Koo*, Zita Ficko, E. Ann Gormley,
Lebanon, NH
MP11-19 INFLUENCE OF SOCIAL MEDIA ON
UROLOGIC KNOWLEDGE ACQUISITION
AMONG YOUNG UROLOGISTS
Juan Gomez Rivas, Madrid, Spain, Pieter
Uvin, Leuven, Belgium, Moises Rodriguez
Socarras, Vigo, Spain, Giulio Patruno,
Francesco Esperto, Rome, Italy, Paulo Jorge
Dinis, Coimbra, Portugal, Hendrik Borgmann*,
Frankfurt, Germany
Friday, May 6, 2016
10:30 am - 12:30 pm
Podium Session 4
KIDNEY CANCER: ADVANCED (INCLUDING DRUG THERAPY) II
Moderators: Megan Merrill and R. Houston Thompson
ABSTRACT
TIME NUMBER TITLE
10:30 PD04-01 RENAL CELL CARCINOMA WITH
ISOLATED LYMPH NODE INVOLVEMENT:
NATURAL HISTORY AND PREDICTORS OF
ONCOLOGIC OUTCOMES
10:40 PD04-02
ABSTRACT
TIME NUMBER TITLE
10:50 PD04-03 EVEROLIMUS FOR RENAL
ANGIOMYOLIPOMA ASSOCIATED WITH
TSC OR SLAM: FINAL LONG-TERM
RESULTS FROM EXIST-2
John Bissler*, Memphis, TN, Elzbieta
Radzikowska, Warsaw, Poland, Bernard
Zonnenberg, Utrecht, Netherlands, Elena
Belousova, moscow, Russian Federation,
Michael D Frost, St. Paul, MN, Matthias
Sauter, Munich, Germany, Chris kinngswood,
Brighton, United Kingdom, Susanne
Brakemeier, Berlin, Germany, Petrus de
Vries, Cape Town, South Africa, Noah
Berkowitz, Maurizio Voi, East Hanover, NJ,
Severine Peyrard, Rueil-Malmaison, France,
Klemens Budde, Berlin, Germany, David Neal
Franz, Cincinnati, OH
RENAL FUNCTION BEFORE AND AFTER
CYTOREDUCTIVE NEPHRECTOMY IN A
PHASE 3 RANDOMIZED CLINICAL TRIAL
Erik N. Mayer*, William T. Lowrance, Salt
Lake City, UT, Robert Uzzo, Philadelphia,
PA, Christopher Wood, Houston, TX,
Alexander Kutikov, Marc Smaldone,
Philadelphia, PA, Jason Gee, Burlington, MA,
William Huang, New York, NY, Thomas
Gardner, Indianapolis, IN, Gennady
Bratslavsky, Syracuse, NY, Jeff Holzbeierlein,
Kansas City, MO, Lawrence Karsh, Denver,
CO, Viraj Master, Atlanta, GA, Neal Shore,
Myrtle Beach, SC, Brian Lane, Grand Rapids,
MI
11:00 PD04-04
50
OPTIMIZING PATIENT SELECTION FOR
CYTOREDUCTIVE NEPHRECTOMY IN THE
TARGETED THERAPY ERA
11:20 PD04-06
TRENDS OF METASTASECTOMY FOR
AND THEIR IMPACT ON OVERALL
SURVIVAL
Christian Meyer*, Quoc-Dien Trinh, Malte
Vetterlein, Björn Löppenberg, Boston, MA,
Firas Adollah, Detroit, MI, Thomas Seisen,
Julian Hanske, Jeffrey Leow, Boston, MA,
Jesse Sammon, Mani Menon, Detroit, MI,
Adam Kibel, Steven Chang, Toni Choueiri,
Maxine Sun, Boston, MA
CYTOREDUCTIVE NEPHRECTOMY IN THE
TARGETED THERAPY ERA: AN ANALYSIS
OF THE NATIONAL CANCER DATA BASE
Nawar Hanna*, Christian Meyer, Malte
Vetterlein, Alexander Cole, Thomas Seisen,
Jeffrey Leow, Philip Cheng, Francisco GelpiHammerschmidt, Michael Zavaski, Steven
Chang, Toni Choueiri, Maxine Sun, QuocDien Trinh, Boston, MA
11:30 PD04-07
FACTORS INFLUENCING THE USE OF
THE NEPHRECTOMY IN PATIENTS AFTER
AN INITIAL DIAGNOSIS OF METASTATIC
RENAL CANCER
Joel Slaton, Winston-Salem, NC, Sean Elliott,
Oluwakayode Adejoro*, Minneapolis, MN
11:40 PD04-08
PROGNOSTIC SIGNIFICANCE OF TUMOR
EXTENT INTO THE VENOUS SYSTEM IN
PATIENTS UNDERGOING SURGICAL
TREATMENT FOR RENAL CELL
CARCINOMA WITH VENOUS TUMOR
THROMBUS
Takuto Hara, Kobe, Japan, Hideaki Miyake*,
Hamamatsu, Japan, Masato Fujisawa, Kobe,
Japan
11:50 PD04-09
PROGNOSTIC FACTORS OF RENAL CELL
CARCINOMA WITH VENOUS TUMOR
EXTENSION
Regis Bezerra*, Mauricio Cordeiro, Giovanna
Caserta, George Lins, Julia Fukushima,
William Nahas, Sao Paulo, Brazil
12:00 PD04-10
IDENTIFYING MRCC PATIENTS WITH
VENOUS THROMBUS WHO ARE LIKELY
TO BENEFIT FROM CYTOREDUCTIVE
SURGERY
E. Jason Abel*, Madison, WI, Kamran Zargar,
Tampa, FL, Vitaly Margulis, Dallas, TX, Michael
A. Mann, Madison, WI, Philippe E. Spiess, Kenan
Ashouri, Tampa, FL, Leonardo Borregales,
Houston, TX, Ahmed Haddad, Charles Rew,
Gong Chen, Dallas, TX, Fangfang Shi, Madison,
WI, Surena Matin, Christopher G. Wood, Jose A.
Karam, Houston, TX
12:10 PD04-11
EXPRESSION LEVELS OF PD-L1 AND PDL2 EXPRESSION IN RADICAL
NEPHRECTOMY SPECIMENS AS
PROGNOSTIC PREDICTORS IN PATIENTS
WITH METASTATIC RENAL CELL
CARCINOMA TREATED WITH TYROSINE
KINASE INHIBITORS
Takuto Hara*, Kobe, Japan, Hideaki Miyake,
Japan
12:20 PD04-12
CYTOREDUCTIVE NEPHRECTOMY:
INEQUITIES IN ACCESS
Kieran Beattie*, Albert Bang, David Smith,
Manish Patel, Sydney, Australia
CREDITTM
Friday, May 6, 2016
11:30 am - 11:50 am
LATE-BREAKING SESSION: PROSTATE BIOPSY
Room 6A @ San Diego Convention Center
11:30
11:40
AUA WHITE PAPER ON THE PREVENTION
AND TREATMENT OF THE MORE COMMON
COMPLICATIONS RELATED TO PROSTATE
BIOPSY UPDATE
Michael Liss
11:50
ADJOURN
CREDITTM
MRI-TARGETED PROSTATE BIOPSY AFTER
PRIOR NEGATIVE BIOPSY: AN SAR-AUA
CONSENSUS STATEMENT
Peter Choyke
Friday, May 6, 2016
11:45 am - 5:30 pm
AMERICAN SOCIETY FOR MEN’S HEALTH (ASMH)
Room 20 BC @ San Diego Convention Center
11:45
INDUSTRY SPONSORED SYMPOSIUM (NONCME)
1:00
INTRODUCTION
Program Chairs: Culley Carson, Martin Miner
1:15
GENOMIC TESTING FOR PROSTATE CANCER:
WHAT IS THE BEST CLINICAL TOOL
Gerald Andriole
1:45
PROSTATE CANCER UPDATE
Moderator: Gerald Andriole
*Presenting author
51
MANAGEMENT OF CASTRATE RESISTANT
PROSTATE CANCER: WHAT IS THE PLACE OF
THE UROLOGIST
E. David Crawford
FRIDAY
11:10 PD04-05
2:15
PANEL DISCUSSION
2:30
MANAGEMENT OF HYPOGONADISM IN THE
AGING MALE
Moderator: Martin Miner
4:15
ESTABLISHMENT AND FRANCHISING OF
MEN’S HEALTH CLINICS IN THE USA
Steven Kaplan
ERECTILE DYSFUNCTION AND TRT
Allen Seftel
4:30
ESTABLISHMENT OF A US MEN’S HEALTH
PROGRAM, CURRICULUM AND FELLOWSHIP
Joel Heidelbaugh
4:45
ESTABLISHMENT AND FRANCHISING OF
MEN’S HEALTH CLINICS IN THE EU
Frans Debruyne
PEYRONIE’S DISEASE: A MEN’S HEALTH
DILEMMA
Moderator: Culley Carson
5:00
USE OF SOCIAL MEDIA AND COMMUNITY
OUTREACH FOR MEN’S HEALTH
Michael Lutz
NEW PARADIGM FOR MEDICAL
MANAGEMENT OF PEYRONIE’S DISEASE
Martin Gelbard
5:15
PANEL DISCUSSION
5:30
ADJOURN
2:45
TRT AND CVD: CONTROVERSY AND SAFETY
Martin Miner
3:00
PANEL DISCUSSION
3:15
BREAK WITH EXHIBITORS
3:30
3:45
4:00
ESTABLISHMENT OF MEN’S HEALTH CLINIC
AND MEDICAL PRACTICE
Moderator: Steven Kaplan
SURGICAL MANAGEMENT OF REFRACTORY
PEYRONIE’S DISEASE
Culley Carson
CREDITTM
PANEL DISCUSSION
Friday, May 6, 2016
11:50 am – 1:00 pm
LATE-BREAKING SESSION: HIGH-INTENSITY FOCUSED ULTRASOUND - HOPE OR HYPE?
Room 6A @ San Diego Convention Center
Moderator: Michael O. Koch
11:50
HIFU: THE FDA PATH TO APPROVAL
Charles Viviano
12:00
HIFU: THE CANADIAN EXPERIENCE
Nathan Lawrentschuk
12:10
HIFU: THE EUROPEAN EXPERIENCE
Christian Chaussy
12:20
HIFU: OVERVIEW OF INSTRUMENTATION AND
TECHNIQUE
Mark Emberton
12:30
CASE PANEL DISCUSSION: TARGETING THE
RIGHT PATIENT AND LESION FOR FOCAL VS
HEMI-ABLATION VS. WHOLE GLAND
ABLATION
Moderator: Samir Taneja
Panelists: Joseph Chin
Thomas Polascik
Sebastien Crouzet
1:00
ADJOURN
CREDITTM
Friday, May 6, 2016
12:30 pm - 4:30 pm
THE SOCIETY OF URODYNAMICS, FEMALE PELVIC MEDICINE AND UROGENITAL RECONSTRUCTION (SUFU)
Room 20 D @ San Diego Convention Center
12:30
WELCOME AND INTRODUCTION
Program Chair: Michael Kennelly
12:35
STATE-OF-THE-ART: TRANSITIONAL
UROLOGIC CARE: EFFECTIVE TRANSITION
FROM PEDIATRIC TO ADULT UROLOGY
Hadley Wood
12:50
UPDATED NEURO-UROLOGY TERMINOLOGY
& CLASSIFICATION OF NEUROGENIC LOWER
URINARY TRACT DYSFUNCTION
Jerzy Gajewski
DETRUSOR UNDERACTIVITY
Moderator: Alan Wein
52
STATE-OF-THE-ART: PATHOPHYSIOLOGY OF
Christopher Chapple
1:10
PANEL DISCUSSION & DIFFICULT CASE
PRESENTATION: MODERN TREATMENT OF
NEUROGENIC DETRUSOR UNDERACTIVITY
(CONSERVATIVE AND MEDICAL THERAPY;
ELECTRICAL STIMULATION/LATTISIMUS
DORSI TRANSPLANT; LUMBAR TO SACRAL
NERVE REROUTING)
Panelists: Michael Chancellor, Karl-Dietrich Sievert,
Kenneth Peters
1:40
2:50
URETHRAL OVERACTIVITY/NEUROGENIC
DETRUSOR SPHINCTER DYSSYNERGIA
Moderator: John Lavelle
3:00
PANEL DISCUSSION WITH DIFFICULT CASE
PRESENTATION: OPTIMAL TREATMENT OF
DSE IN THE MALE PATIENT (SPHINCTER
STENTS; NEUROTOXINS;
NEUROSTIMULATION/NEUROMODULATION;
SUPRAPUBIC TUBE)
Panelists: Patrick Shenot, Christopher Smith, Jerry
Blaivas, Graham Creasey
3:30
TETRAPLEGIC MALE WITH DESD
CHALLENGING CASE: DIABETIC MALE WITH
LUTS AND HYPOCONTRACTILE BLADDER
DETRUSOR OVERACTIVITY
Moderator: Stephen Kraus
1:50
2:00
2:30
STATE-OF-THE-ART: PATHOPHYSIOLOGY OF
NEUROGENIC DETRUSOR OVERACTIVITY
Toby Chai
SPECIAL CONSIDERATIONS IN NEUROLOGIC
DISORDERS
Moderator: Benjamin Brucker
PANEL DISCUSSION WITH DIFFICULT CASE
PRESENTATION: CONTEMPORARY
TREATMENT OF NEUROGENIC DETRUSOR
OVERACTIVITY (NEW AND FUTURE
PHARMACOLOGIC STRATEGIES;
NEUROTOXIN THERAPY – ADVANTAGES AND
DISADVANTAGES; BLADDER
RECONSTRUCTION – TISSUE REENGINEERING)
Panelists: Karl-Erik Andersson, David Ginsberg,
Sender Herschorn
CHALLENGING CASE: PARKINSON’S MALE
WITH NDO & BPO/BPH
URETHRAL UNDERACTIVITY/ NEUROGENIC
STRESS INCONTINENCE
Moderator: Angelo Gousse
2:40
POINT-COUNTERPOINT: MANAGEMENT OF
TETRAPLEGIC FEMALE WITH NONFUNCTIONAL URETHRA (SUPRAVESICAL
URINARY DIVERSION VS BLADDER NECK
CLURE ⴝ URINARY DIVERSION)
Debaters: Una Lee, John Hairston
POINT-COUNTERPOINT: MANAGEMENT OF
T11 SCI MALE ON CIC WITH SUI (SLING VS.
ARTIFICIAL URINARY SPHINCTER)
Debaters: Craig Comiter, Timothy Boone
3:40
SEXUAL DYSFUNCTION IN NEUROLOGIC
DISORDERS: TREATMENT OF NEUROLOGIC
ERECTILE AND FEMALE SEXUAL
DYSFUNCTION
Stacy Elliott
4:00
AUTONOMIC DYSREFLEXIA –
PATHOPHYSIOLOGY AND MANAGEMENT
Kristy Borawski
4:10
COMPARATIVE EFFECTIVENESS OF BLADDER
MANAGEMENT STRATEGIES
John Stoffel
4:20
NEUROGENIC BLADDER SURVEILLANCE
Emmanuel Chartier-Kastler
4:30
ADJOURN
CREDITTM
Friday, May 6, 2016
1:00 pm - 2:00 pm
SETBACKS AND OPERATIVE SOLUTIONS (SOS): MALIGNANT
Moderator: Rene Sotelo
1:00
1:30
UPPER TRACT COMPLICATIONS: RADICAL
AND PARTIAL NEPHRECTOMY, RPLND,
ADRENALECTOMY
Panelists: Jeffrey Cadeddu, Craig Rogers,
Sam Bhayani, Lee Ponsky
2:00
CREDITTM
LOWER TRACT COMPLICATIONS:
PROSTATECTOMY, CYSTECTOMY, PELVIC
LYMPH NODE DISSECTION
Panelists: Ronney Abaza, Thomas Ahlering,
Vipul Patel, Georges Pascal Haber
*Presenting author
ADJOURN
53
FRIDAY
1:00
Friday, May 6, 2016
1:00 pm - 3:00 pm
ADRENAL
Moderators: Rajeev Kumar and John Phillips
ABSTRACT
NUMBER TITLE
MP12-01 SYSTEMATIC GENETIC SCREENING IN A
PROSPECTIVE GROUP OF DANISH
PATIENTS WITH PHEOCHROMOCYTOMA
Morten Steen Svarer Hansen*, Niels
Jacobsen, Anja L Frederiksen, Lars Lund,
Marianne S Andersen, Dorte Glintborg,
Odense C, Denmark
ABSTRACT
NUMBER TITLE
MP12-07 THE IMPLICATION OF AORTIC
CALCIFICATION ON PERSISTENT
HYPERTENSION AFTER LAPAROSCOPIC
ADRENALECTOMY IN PATIENTS WITH
PRIMARY ALDOSTERONISM
Hayato Yamamoto*, Naoki Fujita, Shingo
Hatakeyama, Atsushi Imai, Takahiro
Yoneyama, Yasuhiro Hashimoto, Takuya
Koie, Chikara Ohyama, Hirosaki, Japan
MP12-02 INCIDENTAL ADRENAL MASS: DO OUR
RESULTS SUPPORT THE GUIDELINES?
Paulo Dinis*, Pedro Nunes, Arnaldo
Figueiredo, Maria José Freire, Mario
Lourenço, Belmiro Parada, Alfredo Mota,
Coimbra, Portugal
MP12-08 SURGICAL AND HEMODYNAMIC
OUTCOMES IN PATIENTS UNDERGOING
PHEOCHROMOCYTOMA AND
PARAGANGLIOMA SURGERY: A
PROSPECTIVE COHORT STUDY
Niren Rao, Rashmi Ramachandran, Nikhil
Tandon, Prabhjot Singh, Rajeev Kumar*, New
Delhi, India
MP12-03 SUBCLINICAL CUSHING’S SYNDROME
IDENTIFIED ON LAPAROSCOPIC
ADRENALECTOMY PERFORMED FOR
PREOPERATIVE DIAGNOSIS OF NONFUNCTIONING CORTICAL ADENOMA
Kazuyuki Numakura*, Norihiko Tsuchiya,
Hiroshi Tsuruta, Mitsuru Saito, Takamitsu
Inoue, Shintaro Nariata, Mingguo Huang,
Shigeru Satoh, Tomonori Habuchi, Akita,
Japan
MP12-09 COMPARATIVE STUDY OF
LAPAROSCOPIC (216 CASES) AND
ROBOTIC (40 CASES) POSTERIOR
RETROPERITONEAL ANATOMICAL
ADRENALECTOMY
Gongxian Wang*, Bin Fu, Weipeng Liu,
Cheng Zhang, xiaochen zhou, Nanchang,
MP12-04 MASKED RENAL DYSFUNCTION IN
PATIENTS WITH ADRENAL CUSHING’S
SYNDROME MANIFESTED BY
ADRENALECTOMY
Yuki Nakamura*, Soichiro Yoshida, Isao
Minami, Yusuke Uchida, Minato Yokoyama,
Junichiro Ishioka, Yoh Matsuoka, Noboru
Numao, Kazutaka Saito, Takanobu
Yoshimoto, Yasuhisa Fujii, Yoshihiro Ogawa,
Kazunori Kihara, Tokyo, Japan
MP12-05
MP12-10 THE LEARNING CURVE OF
RETROPERITONEAL LAPAROSCOPIC
ADRENALECTOMY
Shinichi Sakamoto*, Hiroto Kato, Masayasu
Sugiyama, Kei Yoneda, Haruki Baba,
Tomokazu Sazuka, Koji Kawamura, Takashi
Imamoto, Naoki Nihei, Tomohiko Ichikawa,
Chiba, Japan
IMPACT OF ELEVATED URINARY
METANEPHRINE/NORMETANEPHRINE
AND IMPAIRED GLUCOSE TOLERANCE
TEST ON THE DEVELOPMENT OF
HYPOGLYCEMIA FOLLOWING REMOVAL
OF PHEOCHROMOCYTOMA
Yuma Waseda*, Shingo Moriyama, Takayuki
Nakayama, Hajime Tanaka, Masaharu Inoue,
Masaya Ito, Tokyo, Japan, Yoshinobu Komai,
Chiba, Japan, Soichiro Yoshida, Naoko
Kawamura, Minato Yokoyama, Junichiro
Ishioka, Yoh Matsuoka, Noboru Numao,
Kazutaka Saito, Yasuhisa Fujii, Kazunori
Kihara, Tokyo, Japan
MP12-11 A NOVEL PATHOLOGY RELATED TO
SUBCAPSULAR ALDOSTERONEPRODUCING CELL CLUSTERS CAUSES
HYPERALDOSTERONISM
Koshiro Nishimoto*, Tachikawa, Japan,
Tsugio Seki, Colton, CA, Isao Kurihara,
Kenichi Yokota, Shinjuku, Japan, Masao
Omura, Tetsuo Nishikawa, Yokohama, Japan,
Hirotaka Shibata, Oita, Japan, Takeo Kosaka,
Mototsugu Oya, Makoto Suematsu, Kuniaki
Mukai, Tokyo, Japan
MP12-12 DIFFERENCES BETWEEN EXTRAADRENAL PARAGANGLIOMAS AND
PHEOCHROMOCYTOMAS IN MALIGNANT
POTENTIAL
Shinako Takeda*, Yoshihide Kawasaki,
Fumitoshi Satoh, Ryo Morimoto, Koji
Mitsuzuka, Yasuhiro Kaiho, Akihiro Ito,
Shigeto Ishidoya, Sendai, Japan, Kenji
Numahata, Yamagata, Japan, Yoichi Arai,
Sendai, Japan
MP12-06 MEDIUM-TERM OUTCOMES AFTER
LAPAROSCOPIC ADRENALECTOMY FOR
PRIMARY ALDOSTERONISM
Yoshihide Kawasaki*, Yasuhiro Kaiho, Akihiro
Ito, Koji Mitsuzuka, Fumitoshi Satoh, Ryo
Morimoto, Yoshikiyo Ono, Shigeto Ishidoya,
Tomonori Matsuura, Hideki Ota, Kei Takase,
Yoichi Arai, Sendai, Japan
54
MP12-17 ADRENALECTOMY FOR BENIGN AND
MALIGNANT DISEASE: A POPULATIONBASED STUDY ON UTILIZATION AND
OUTCOMES FROM 2003-2013
Izak Faiena*, Alexandra Tabakin, New
Brunswick, NJ, Jeffrey Leow, Boston, MA,
Neal Patel, Parth Modi, Amirali Salmasi, New
Brunswick, NJ, Benjamin Chung, Stanford,
CA, Steven Chang, Boston, MA, Eric Singer,
New Brunswick, NJ
MP12-14 A META-ANALYSIS OF THE ROLE OF
ADJUVANT RADIOTHERAPY AFTER
SURGERY FOR ADRENOCORTICAL
CARCINOMA
Victor Srougi*, Sao Paulo, Brazil, Jose
Bessa, Feira de Santana, Brazil, Fabio
Tanno, Amanda Ferreira, Lia Lousada,
Madson Almeida, Cristiane Almeda, Miguel
Srougi, Berenice Mendonça, Ana Hoff, Jose
Chambo, Maria Fragoso, Sao Paulo, Brazil
MP12-15
MP12-18 SURGICAL MANAGEMENT OF PATIENTS
WITH ADRENAL MASSES AND THE ROLE
OF THE MODERN UROLOGIST
Ryan Levey*, Marshall Oelsen, Hagop
Sarkissian, Kent Armeson, Stephen Savage,
Charleston, SC
PATIENT SELECTION FOR
LAPAROSCOPIC EXCISION OF ADRENAL
METASTASES: A MULTICENTER COHORT
STUDY
Benoit Peyronnet*, Rennes, France,
Alexandre Gryn, Chu Toulouse, France,
Jean-Baptiste Beauval, Toulouse, France,
Karim Bensalah, Rennes, France, Michel
Soulié, Mathieu Thoulouzan, Toulouse,
France, Gregory Verhoest, Rennes, France,
Eric Huyghe, Toulouse, France, Andrea
Manunta, Rennes, France
MP12-19 NATIONAL TRENDS AND PREDICTORS IN
30-DAY POSTOPERATIVE
COMPLICATIONS AND READMISSION
RATES FOLLOWING MINIMALLY
INVASIVE ADRENALECTOMY
Ruben M. Pinkhasov, Mark Cogburn*,
Brooklyn, NY, Alexandr Pinkhasov, Michall
Abaev, Buffalo, NY, Zuhair Alhussaini,
Buddima Ranasinghe, Antonio Montgomery,
Ervin Teper, Ciril Godec, David Silver,
Brooklyn, NY
MP12-20 PREDICTORS OF 30-DAY
COMPLICATIONS AND HOSPITAL
READMISSIONS FOLLOWING
ADRENALECTOMY.
Ariel Schulman*, Westchester, NY, Mark
Cogburn, Ervin Teper, Peter Homel,
Brooklyn, NY, John Phillips, Majid Eshghi,
Westchester, NY
MP12-16 ELECTIVE ADRENALECTOMIES: DO
OBESITY AND DIABETES AFFECT
SURGICAL OUTCOMES?
Pamela Lu*, Valary Raup, Malte Vetterlein,
Christian Meyer, Bjoern Loeppenberg, QuocDien Trinh, Jairam Eswara, Boston, MA
CREDITTM
Friday, May 6, 2016
1:00 pm - 3:00 pm
BLADDER CANCER: NON-INVASIVE I
Moderators: Kamal Pohar and Eugene Lee
ABSTRACT
NUMBER TITLE
MP13-01 PREOPERATIVE NEUTROPHIL-TOLYMPHOCYTE RATIO IS A USEFUL
BIOMARKER FOR PREDICTING WORSE
CLINICAL OUTCOME IN NON-MUSCLE
INVASIVE BLADDER CANCER PATIENTS
WITH A PREVIOUS HISTORY OF
SMOKING.
Koichiro Ogihara*, Eiji Kikuchi, Kazuyuki
Yuge, Kazuhiro Matsumoto, Akira Miyajima,
Tokyo, Japan, Hirotaka Asakura, Saitama,
Japan, Mototsugu Oya, Tokyo, Japan
*Presenting author
ABSTRACT
NUMBER TITLE
MP13-02 IS RE-RESECTION NECESSARY? RERESECTION OF NON-MUSCLE INVASIVE
BLADDER CANCER AT A TERTIARY CARE
CENTER
Rano Matta*, Ashraf Al Matar, Bimal Bhindi,
Alexander Zlotta, Neil Fleshner, Michael
Jewett, Robert Hamilton, Antonio Finelli,
Girish Kulkarni, Toronto, Canada
MP13-03 HRQOL IN PATIENTS UNDERWENT
INTRAVESICAL INSTILLATION OF BCG
OR MMC FOR NON-MUSCLE INVASIVE
BLADDER CANCER
Salvatore Siracusano, Tommaso Silvestri*,
Stefano Ciciliato, Laura Toffoli, Trieste, Italy,
Francesco Visalli, Pordenone, Italy, Giacomo
Di Cosmo, Renato Talamini, Trieste, Italy
55
FRIDAY
MP12-13 SURVIVAL OUTCOME FOLLOWING
SURGERY FOR MALIGNANT
PHEOCHROMOCYTOMA OF ADRENAL
ORIGIN.
Andrew Franklin*, Naveen Pokala, Columbia,
MO
MP13-04 CONCENTRATION OF MITOMYCIN-C IN
URINE ACCORDING TO URINE PH AFTER
INTRAVESICAL INSTILLATION OF
MITOMYCIN-C IN NON-MUSCLE INVASIVE
BLADDER CANCER PATIENTS
Sung Han Kim, Jae Young Joung, Jinsoo
Chung, Kang Hyun Lee, Ho Kyung Seo*,
Goyang, Korea, Republic of, Whi-An Kwon,
Gunpo, Korea, Republic of, Sohee Kim,
Kyung-Ohk Ahn, Kyung-Chae Jeong, SangJin Lee, Sooin Yun, Jungnam Joo, SangHyun Hwang, Do-Hoon Lee, goyang, Korea,
Republic of, Dong Wan Sohn, Seoul, Korea,
Republic of
MP13-05
MP13-08 THE COMPARISON ONE IMMEDIATE
POSTOPERATIVE INTRAVESICAL
CHEMOTHERAPY WITH SHORT-TERM
ADJUVANT INTRAVESICAL
CHEMOTHERAPY AFTER TURBT IN LOWAND INTERMEDIATE RECURRENT RISK
OF NON-MUSCLE-INVASIVE BLADDER
CANCER- A RANDOMIZED PROSPECTIVE
STUDY IN JAPAN.
Yoshio Naya*, Takumi Shiraishi, Masakatsu
Oishi, Takashi Ueda, Hiroyuki Nakanshi,
Yasuyuki Naitoh, Terukazu Nakamura,
Fumiya Hongo, Kazumi Kamoi, Koji Okihara,
Kazuya Mikami, Kyoto, Japan, Tsuyoshi
Iwata, Nantan, Japan, Osamu Ukimura,
Kyoto, Japan
A RANDOMIZED TRIAL COMPARING TWO
DIFFERENT RETENTION PERIODS OF
INTRAVESICAL PIRARUBICIN
INSTILLATION FOR INTERMEDIATE RISK
NON-MUSCLE INVASIVE BLADDER
CANCER (NMIBC) AFTER
TRANSURETHRAL RESECTION.
Ryoma Kurahashi*, Yutaka Kasejima,
Yoshiaki Kawano, Wataru Takahashi,
Takahiro Yamaguchi, Ken-ichiro Tanoue,
Hiroshi Sakakida, Junji Yatsuda, Youji
Murakami, Yutaka Sugiyama, Kumamoto,
Japan, Masatoshi Eto, Fukuoka, Japan
MP13-09 NARROW BAND IMAGING CYSTOSCOPY
IN NON-MUSCLE INVASIVE BLADDER
CANCER - A PROSPECTIVE RANDOMIZED
COMPARISON TO THE STANDARD WHITE
LIGHT CYSTOSCOPY
Prem Nath Dogra*, New Delhi, India,
Pragnesh Desai, Delhi, India, Prabhjot singh,
New Delhi, India
MP13-10 THE INCIDENCE OF LATE BLADDER
TUMOR RECURRENCE OF UPPER TRACT
UROTHELIAL CARCINOMA AND OPTIMAL
CYSTOSCOPIC FOLLOW-UP: A
MULTICENTER STUDY
Junichiro Ishioka*, Kazutaka Saito, Masaharu
Inoue, Masaya Itoh, Soichiro Yoshida, Minato
Yokoyama, Yoh Matsuoka, Noboru Numao,
Yasuhisa Fujii, Tokyo, Japan, Yasuyuki
Sakai, Chiba, Japan, Tetsuo Okuno, Ibaraki,
Japan, Chizuru Arisawa, Tokyo, Japan,
Shigeyoshi Kamata, Saitama, Japan,
Katsushi Nagahama, Chiba, Japan, Junji
Yonese, Tokyo, Japan, Akira Noro, Saitama,
Japan, Toshihiko Tsujii, Tokyo, Japan, Shinji
Morimoto, Ibaraki, Japan, Yukio Kageyama,
Saitama, Japan, Kazunori Kihara, Tokyo,
Japan
MP13-06 CAN INTRAVESICAL ADMINISTRATION
OF ANTIFIBRINOLYTIC AGENT
POTENTIATE THE ACTION OF BACILLUS
CALMETTE- GUERIN AFTER
TRANSURETHRAL RESECTION OF NON–
MUSCLE INVASIVE BLADDER CANCER? :
MULTICENTER PROSPECTIVE
RANDOMIZED CONTROLLED STUDY.
Mohamed Soliman, Tanta, Egypt, Hussein
Aldaqadossi*, Fayoum, Egypt, Ahmed El-Abd,
Ahmed Abou- Ramadan, Mohamed ElGharabawy, Abd-Elhamid El-Bahnasy, Tanta,
Egypt, Mohamed Abd-Eltawab, Aswan, Egypt
MP13-07 IMPROVED EFFICACY OF ADJUVANT,
SINGLE DOSE INTRAVESICAL
APAZIQUONE BY TIMING POSTRESECTION IN TWO DOUBLE-BLIND,
RANDOMIZED, PLACEBO-CONTROLLED
PHASE 3 STUDIES IN NON-MUSCLE
Fred Witjes*, Nijmegen, Netherlands,
Lawrence Karsh, Denver, CO, Mark Soloway,
Aventura, FL, Gajanan Bhat, Guru Reddy,
Allen Yang, Lee F. Allen, Irvine, CA, Neal
Shore, Myrtle Beach, SC
MP13-11 HIGH SPECIFICITY OF DIFFUSIONWEIGHTED MRI IN DIFFERENTIATING
RESIDUAL BLADDER CANCER FROM
POSTOPERATIVE CHANGES
Yuki Nakamura*, Soichiro Yoshida, Hiroshi
Tanaka, Masaharu Inoue, Masaya Ito, Minato
Yokoyama, Junichiro Ishioka, Yoh Matsuoka,
Noboru Numao, Kazutaka Saito, Yasuhisa
Fujii, Kazunori Kihara, Tokyo, Japan
MP13-12 MODERATE CHRONIC KIDNEY DISEASE
(EGFR <60 ML/MIN) PREDICTS
RECURRENCE AND PROGRESSION IN
BLADDER CANCER PATIENTS TREATED
WITH TRANSURETHRAL RESECTION
Michael L. Blute, Jr*, Madison, WI, Victor
Kucherov, Rochester, NY, Daniel D. Shapiro,
Timothy J. Rushmer, Fangfang Shi, Benjamin
Fuller, Kyle A. Richards, E. Jason Abel,
David F. Jarrard, Madison, WI, Edward M.
Messing, Rochester, NY, Tracy M. Downs,
Madison, WI
56
MP13-18 THE COMPARISON BETWEEN EAU 2014
RISK CLASSIFICATION AND EORTC RISK
CLASSIFICATION IN RECURRENCE-, AND
PROGRESSION-FREE SURVIVAL IN
JAPANESE MULTI-CENTER COHORT
WITH 1,084 PATIENTS
Satoru Muto*, Takeshi Ieda, Shigeto Yanada,
Fumitaka Shimizu, Shin-ichi Hisasue, Tatsuya
Ogishima, Hisamitsu Ide, Raizo Yamaguchi,
Shigeo Horie, Tokyo, Japan
MP13-14 WHAT BENCHMARKS CAN WE EXPECT IN
DETERMINING MARKERS OF QUALITY IN
THE TREATMENT OF NON-MUSCLE
INVASIVE BLADDER CANCER?
Stanley Yap, Francisco Chavez, Neil
Pugashetti*, Marc Dall’Era, Christopher
Evans, Ralph deVereWhite, Sacramento, CA
MP13-15
MP13-19 A PHASE II/III TRIAL OF CG0070, AN
ONCOLYTIC ADENOVIRUS, FOR BCGREFRACTORY NON-MUSCLE-INVASIVE
BLADDER CANCER (NMIBC)
Vignesh T. Packiam*, Alexa N. Campanile,
Chicago, IL, Daniel A. Barocas, Nashville,
TN, Karim Chamie, Los Angeles, CA, Ronald
L. Davis III, Winston-Salem, NC, A. Karim
Kader, San Diego, CA, Donald L. Lamm,
Pheonix, AZ, Alex W. Yeung, Santa Ana, CA,
Gary D. Steinberg, Chicago, IL
MOLECULAR URINE CYTOLOGY –
BLADDER EPICHECK IS A NOVEL
MOLECULAR DIAGNOSTIC TOOL FOR
MONITORING OF BLADDER CANCER
PATIENTS
Adam Wasserstrom, Danny Frumkin,
Rehovot, Israel, Zohar Dotan, Tel-Aviv, Israel,
Elena Bukin, Tal Gadish, Shiri Hanuka,
Revital Knirsh, Rehovot, Israel, Abd Elhalim
Darawsha, Ilan Leibovitch*, Tel-Aviv, Israel
MP13-20 SECOND-GENERATION ANTISENSE
OLIGONUCLEOTIDE - HSP27 A NEW
INTRAVESICAL TREATMENT FOR
BLADDER CANCER: PHASE 1CLINICAL
TRIAL.
Sebastian Frees*, Eliana Beraldi, Kim Chi,
Ladan Fazli, Peter Black, Martin Gleave, Alan
So, Vancouver, Canada
MP13-16 DECREASE IN RATE OF TX HISTOLOGY
AFTER TRANSURETHRAL RESECTION OF
BLADDER TUMOURS FOLLOWING
IMPLEMENTATION OF AN INSTITUTIONAL
QUALITY IMPROVEMENT PROGRAMME
Gianluca Giannarini*, Alessandro Crestani,
Vito Palumbo, Mattia Calandriello, Maria
Abbinante, Vincenzo Ficarra, Udine, Italy
CREDITTM
MP13-17 CHARACTERIZING INTERMEDIATE-RISK
CANCER: IMPLICATIONS FOR THE
DEFINITION OF INTERMEDIATE RISK AND
TREATMENT STRATEGY
Kazuhiro Matsumoto*, Eiji Kikuchi, Yoshinori
Yanai, Nozomi Hayakawa, Yujiro Ito,
Takahiro Maeda, Hirohiko Nagata, Akira
Miyajima, Mototsugu Oya, Tokyo, Japan
*Presenting author
57
FRIDAY
MP13-13 SURVEILLANCE FOR BLADDER CANCER
PATIENTS – DO PATHOLOGY REPORTS
TELL US WHAT WE NEED TO KNOW?
Florian Schroeck*, White River Junction, VT,
Erik Pattison, Lebanon, NH, Daniel Denhalter,
Olga Patterson, Scott DuVall, Salt Lake City,
UT, John Seigne, Lebanon, NH, Brenda
Sirovich, Philip Goodney, White River
Junction, VT
Friday, May 6, 2016
1:00 pm - 3:00 pm
PROSTATE CANCER: LOCALIZED: RADIATION THERAPY
Moderators: Martha Terris and John Davis
ABSTRACT
NUMBER TITLE
MP14-01 HYPOFRACTIONATED VERSUS
CONVENTIONALLY FRACTIONATED
RADIOTHERAPY FOR PROSTATE
CANCER: 5-YEAR ONCOLOGIC
OUTCOMES OF THE DUTCH
RANDOMIZED PHASE 3 HYPRO TRIAL
Ruud Wortel*, Luca Incrocci, Shafak Aluwini,
Rotterdam, Netherlands, Erik Schimmel,
Arnhem, Netherlands, Stijn Krol, Leiden,
Netherlands, Peter-Paul van der Toorn,
Eindhoven, Netherlands, Hanja de Jager, The
Hague, Netherlands, Maarten Dirkx, Wendim
Ghidey, Ben Heijmen, Rotterdam,
Netherlands, Floris Pos, Amsterdam,
Netherlands
ABSTRACT
NUMBER TITLE
MP14-06 THE IMPACT OF ADJUVANT
RADIOTHERAPY ON CANCER-SPECIFIC
MORTALITY IN PROSTATE CANCER
PATIENTS WITH SEMINAL VESICLE
INVOLVEMENT: A COMPETING-RISKS
REGRESSION ANALYSIS
Giorgio Gandaglia, Nicola Fossati, Marco
Bianchi*, Paolo Dell’Oglio, Marta Picozzi,
Elena Farina, Renzo Colombo, Umberto
Capitanio, Emanuele Zaffuto, Walter
Cazzaniga, Stefano Luzzago, Cesare
Cozzarini, Francesco Montorsi, Alberto
Briganti, Milan, Italy
MP14-07 PATTERNS AND PREDICTORS OF
CLINICAL RECURRENCE FOLLOWING
EARLY SALVAGE RADIATION THERAPY
IN PATIENTS WITH PSA RISE AFTER
RADICAL PROSTATECTOMY: A LONG
TERM MULTI-INSTITUTIONAL ANALYSIS
Nicola Fossati*, Milan, Italy, Jeffrey R.
Karnes, Rochester, MN, Alessandro
Morlacco, Villejuif, France, Marco Moschini,
Milan, Italy, Stephen A. Boorjian, Rochester,
MN, Thomas Seisen, Alberto Bossi, Villejuif,
France, Cesare Cozzarini, Claudio Fiorino,
Barbara Noris Chiorda, Giorgio Gandaglia,
Milan, Italy, Lorenzo Tosco, Dirk De Ridder,
Steven Joniau, Leuven, Belgium, Gregor
Goldner, Wien, Austria, Shahrokh François
Shariat, Vienna, Austria, Wolfgang
Hinkelbein, Berlin, Germany, Karin
Haustermans, Leuven, Belgium, Bertrand
Tombal, Brussels, Belgium, Francesco
Montorsi, Milan, Italy, Hein Van Poppel,
Leuven, Belgium, Thomas Wiegel, Ulm,
Germany, Alberto Briganti, Milan, Italy
MP14-02 ONCOLOGICAL OUTCOMES IN PATIENTS
WITH LOCALLY ADVANCED PROSTATE
CANCER TREATED WITH NEOADJUVANT
ENDOCRINE AND EXTERNAL BEAM
RADIATION THERAPY FOLLOWED BY
ADJUVANT CONTINUOUS/INTERMITTENT
ENDOCRINE THERAPY IN AN OPENLABEL, RANDOMIZED, PHASE III TRIAL
Kazuto Ito*, Kazuhiro Suzuki, Maebashi,
Japan, Hidetoshi Yamanaka, Takasaki, Japan
MP14-03 LONG-TERM OUTCOMES OF PROSTATE
BRACHYTHERAPY
Nelson Stone*, Vail, CO, Richard Stock, New
York, NY
MP14-04 OUTCOMES OF RADIATION FOLLOWING
EXPECTANT MANAGEMENT FOR LOW
RISK, LOCALIZED PROSTATE CANCER
Maria Komisarenko*, Ardalan E Ahmad,
Melvin Chua, Jure Murgic, Antonio Finelli,
Toronto, Canada
MP14-05
POST-SALVAGE THERAPY,
PARTICULARLY WITH NADIR PSA<1,
DELAYS THE TIME TO SUBSEQUENT
ANDROGEN DEPRIVATION THERAPY
Anuj Desai*, Mohammed Haseebuddin,
Daniel Parker, Karthik Devarajan, Nikhil
Waingankar, Benjamin Ristau, Michael
Haifler, Eric Horwitz, Colleen Turrisi,
Alexander Kutikov, Marc Smaldone, Richard
Greenberg, Robert Uzzo, Rosalia Viterbo,
David Chen, Philadelphia, PA
58
MP14-11 WHEN IS THE OPTIMAL TIMING FOR
SALVAGE RADIATION THERAPY IN
PATIENTS WITH INCREASING PSA AFTER
RADICAL PROSTATECTOMY? A PATIENT
RISK STRATIFICATION MODEL BASED ON
PROSTATE CANCER AGGRESSIVENESS
MP14-12 EFFICACY OF EARLY AND DELAYED
RADIATION IN A PROSTATECTOMY
COHORT ADJUSTED FOR GENOMIC AND
CLINICAL RISK
Ashley Ross*, Baltimore, MD, Robert Den,
Philadelphia, PA, Kasra Yousefi, Vancouver,
Canada, Bruce Trock, Baltimore, MD, Elai
Davicioni, Vancouver, Canada, Jeffrey
Tosoian, Baltimore, MD, Darby Thompson,
Burnaby, Canada, Voleak Choeurng, Zaid
Haddad, Vancouver, Canada, Phuoc Tran,
Baltimore, MD, Edouard Trabulsi, Leonard
Gomella, Costas Lallas, Philadelphia, PA,
Firas Abdollah, Detroit, MI, Felix Feng, Ann
Arbor, MI, Adam Dicker, Philadelphia, PA,
Stephen Freedland, Los Angeles, CA, Jeffrey
Karnes, Rochester, MN, Edward Schaeffer,
Baltimore, MD
MP14-09 SURVIVAL AFTER CONSERVATIVE
MANAGEMENT VERSUS EXTERNAL BEAM
RADIOTHERAPY IN VERY ELDERLY
PATIENTS WITH LOCALIZED PROSTATE
CANCER
Paolo Dell’Oglio, Katharina Boehm, Vincent
Trudeau, Zhe Tian, Montreal, Canada,
Alessandro Larcher, Milan, Italy, Sami-Ramzi
Leyh-Bannurah, Montreal, Canada, Marco
Moschini, Umberto Capitanio, Milan, Italy,
Shahrokh Shariat, Vienna, Austria, Alberto
Briganti, Francesco Montorsi, Milan, Italy,
Fred Saad, Pierre Karakiewicz*, Montreal,
Canada
MP14-10 DETRIMENTAL ROLE OF PREPROSTATECTOMY NEOADJUVANT
ANDROGEN DEPRIVATION IN NODENEGATIVE PATIENTS TREATED WITH
ADJUVANT RT
Cesare Cozzarini*, Barbara Noris Chiorda,
Chiara Lucrezia Deantoni, Alberto Briganti,
Claudio Fiorino, Giorgio Gandaglia, Nicola
Fossati, Massimo Freschi, Carla Sini, Milan,
Italy, Rodolfo Montironi, Ancona, Italy,
Francesco Montorsi, Nadia Di Muzio, Milan,
Italy
MP14-13 COST-EFFECTIVENESS ANALYSIS OF
ADJUVANT VERSUS SALVAGE
RADIOTHERAPY AFTER RADICAL
PROSTATECTOMY FOR HIGH-RISK
DISEASE
Ellen Daily*, Chicago, IL, Sangtae Park,
Evanston, IL
MP14-14 MANAGEMENT OF RADIATION THERAPY
ONCOLOGY GROUP (RTOG) GRADE 4
UROLOGIC COMPLICATIONS OF
CANCER
Erik N. Mayer*, Jonathan D. Tward, Sara
Lenherr, James M. Hotaling, William O.
Brant, Jeremy B. Myers, Salt Lake City, UT
MP14-15
*Presenting author
59
CLINICO-DOSIMETRIC FACTORS
PREDICTING LONG-TERM SEVERE
URINARY INCONTINENCE AFTER POSTPROSTATECTOMY RT. RESULTS OF A
LONGITUDINAL OBSERVATIONAL STUDY.
Barbara Noris Chiorda, Carla Sini, Claudio
Fiorino, Alberto Briganti, Anna Chiara, Chiara
Lucrezia Deantoni, Nicola Fossati, Giorgio
Gandaglia, Nazareno Suardi, Francesco
Montorsi, Nadia Di Muzio, Cesare Cozzarini*,
Milan, Italy
FRIDAY
MP14-08 LONG-TERM IMPACT OF ADJUVANT
VERSUS EARLY SALVAGE RADIATION
THERAPY ON CLINICAL RECURRENCE IN
PT3N0 PROSTATE CANCER PATIENTS
TREATED WITH RADICAL
PROSTATECTOMY: RESULTS OF A
MULTI-INSTITUTIONAL ANALYSIS
MP14-16 INCREASED PROSTATE SIZE AND
HISTORY OF PREOPERATIVE VOIDING
DYSFUNCTION ASSOCIATED WITH
GREATER URINARY TOXICITY AFTER
POSTⴚPROSTATECTOMY ADJUVANT OR
SALVAGE RADIATION
Juan Guzman*, Ricardo Sanchez-Ortiz, San
Juan, Puerto Rico
MP14-19 THE TIME ELAPSED BETWEEN RADICAL
PROSTATECTOMY AND POSTOPERATIVE RADIOTHERAPY HAS A
SIGNIFICANT IMPACT ON THE
SUBSEQUENT ERECTILE FUNCTION
RECOVERY RATES
Giorgio Gandaglia*, Nicola Fossati, Marco
Bianchi, Paolo Dell’Oglio, Marta Picozzi,
Elena Farina, Vito Cucchiara, Alessandro
Larcher, Milan, Italy, Pierre Karakiewicz,
Montreal, Canada, Vincenzo Mirone, Naples,
Italy, Cesare Cozzarini, Francesco Montorsi,
Alberto Briganti, Milan, Italy
MP14-17 PREDICTING ERECTILE FUNCTION
FOLLOWING RADIATION THERAPY FOR
PROSTATE CANCER AT THE POINT OF
CARE
Stephen Mihalcik*, Boston, MA, Jonathan
Chipman, Nashville, TN, Martin Sanda,
Atlanta, GA, Irving Kaplan, Catrina Crociani,
Peter Chang, PROST-QA Consortium,
Boston, MA
MP14-20 PROSTATE IMAGING REPORTING AND
DATA SYSTEM SCORE BEFORE
PROSTATE BIOPSY CAN PREDICT
BIOCHEMICAL FAILURE IN PROSTATE
CANCER PATIENTS TREATED WITH
HIGH-DOSE-RATE BRACHYTHERAPY
Keisuke Hata*, Junpei Iizuka, Yasunobu
Hashimoto, Tsunenori Kondo, Toshio Takagi,
Hirohito Kobayashi, Kazunari Tanabe, Tokyo,
Japan
MP14-18 NEGLECTED SEXUAL SIDE EFFECTS TO
RADIATION THERAPY FOR PROSTATE
CANCER
Anders Frey*, Herlev, Denmark, Christian
Korsgård Pedersen, Roskilde, Denmark,
Henriette Lindberg, Jens Sønksen, Rasmus
Bisbjerg, Mikkel Fode, Herlev, Denmark
CREDITTM
Friday, May 6, 2016
1:00 pm - 3:00 pm
PROSTATE CANCER: LOCALIZED: ACTIVE SURVEILLANCE II
Moderators: Martin Gleave and Ian Thompson, Jr.
ABSTRACT
NUMBER TITLE
MP15-01 CONTEMPORARY ANALYSIS OF
MEDICARE REIMBURSEMENTS RELATED
TO TREATMENT OF LOCALIZED
PROSTATE CANCER
Paolo Dell’Oglio, Anne Sophie Valiquette,
Sami-Ramzi Leyh-Bannurah, Zhe Tian,
Vincent Trudeau, Montreal, Canada,
Alessandro Larcher, Ettore Di Trapani, Milan,
Italy, Shahrokh Shariat, Vienna, Austria,
Umberto Capitanio, Alberto Briganti,
Francesco Montorsi, Milan, Italy, Markus
Graefen, Hamburg, Germany, Fred Saad,
Pierre Karakiewicz*, Montreal, Canada
MP15-02
ABSTRACT
NUMBER TITLE
MP15-03 APPROPRIATENESS CRITERIA FOR
CANCER FROM THE MICHIGAN
UROLOGIC SURGERY IMPROVEMENT
COLLABORATIVE
Michael Cher*, Detroit, MI, Apoorv Dhir,
Susan Linsell, Ann Arbor, MI, Bradley
Rosenberg, Mohammad Jafri, Royal Oak, MI,
David Miller, Khurshid Ghani, Steven
Bernstein, James Montie, Ann Arbor, MI,
Brian Lane, Grand Rapids, MI
THE EFFECT OF RADICAL
PROSTATECTOMY, EXTERNAL BEAM
RADIATION THERAPY, AND ACTIVE
SURVEILLANCE ON LIFE INSURANCE
PREMIUMS IN PATIENTS WITH
PROSTATE CANCER
Mark Biebel*, Michael Piecuch, Jeffrey Stock,
Newark, NJ, Hank George, Greendale, WI,
Christopher Wright, Maywood, NJ
60
MP15-04
VARIATION IN ACTIVE SURVEILLANCE
FOLLOW-UP OVER TWO YEARS IN
DIVERSE UROLOGY PRACTICES
Amy Luckenbaugh*, Gregory Auffenberg,
Scott Hawken, Apoorv Dhir, Susan Linsell,
Ann Arbor, MI, Sanjeev Kaul, Royal Oak, MI,
David Miller, Ann Arbor, MI
MP15-05
COST-EFFECTIVENESS ANALYSIS OF
INITIAL MANAGEMENT STRATEGIES FOR
LOW-RISK PROSTATE CANCER
Alan Thong*, Justin Lee, Sigrid Carlsson,
Behfar Ehdaie, New York, NY
MP15-06
AFRICAN-AMERICAN MEN WITH LOWRISK PROSTATE CANCER ARE
CANDIDATES FOR ACTIVE
SURVEILLANCE: THE WILL-ROGERS
EFFECT?
Robert Qi*, Judd Moul, Durham, NC
SERIAL ANATOMIC PROSTATE
ULTRASOUND IMAGING DURING
PROSTATE CANCER ACTIVE
SURVEILLANCE
Mohamed Eltemamy*, Michael Leapman,
Janet Cowan, Katsuto Shinohara, Antonio
Westphalen, Peter Carroll, San Francisco, CA
MP15-08
IS PSA DENSITY OR PSA (OR NEITHER)
USEFUL TO PREDICT BIOPSY
RECLASSIFICATION IN ACTIVE
SURVEILLANCE PATIENTS?
Roghayeh Fazeli*, Mufaddal Mamawala,
Patricia Landis, Sacha Wolf, H. Ballentine
Carter, Bruce J Trock, Baltimore, MD
MP15-09
BASELINE AND LONGITUDINAL PCA3
PREDICT MORE EXTENSIVE CANCER IN
AN ACTIVE SURVEILLANCE POPULATION
Jeffrey Tosoian*, Mufaddal Mamawala,
Patricia Landis, Sacha Wolf, Jonathan
Epstein, Lori Sokoll, Christian Pavlovich,
Baltimore, MD
MP15-10
THE PROGNOSTIC SIGNIFICANCE OF A
NEGATIVE CONFIRMATORY PROSTATE
BIOPSY ON PROGRESSION FOR
PATIENTS ON ACTIVE SURVEILLANCE
Vishnu Ganesan*, Charles Dai, Yaw Nyame,
Daniel Greene, Nima Almassi, Joseph Zabell,
Hans Arora, Sam Haywood, Alice Crane,
Chad Reichard, Daniel Hettel, Anna Zampini,
Ahmed El-Shafei, Robert Stein, Khaled
Fareed, Michael Gong, J Stephen Jones,
Andrew Stephenson, Eric Klein, Cleveland,
OH
MP15-11
MP15-12
MP15-13
RISK FACTORS FOR UPSTAGING IN
PATIENTS WITH LOW RISK PROSTATE
CANCER USING K-CAP REGISTRY
Se Young Choi*, Sangjun Yoo, Sang Hoon
Song, Dalsan You, In Gab Jeong, Seok-Soo
Byun, Ji Youl Lee, Byung Ha Chung,
Choung-Soo Kim, Seoul, Korea, Republic of
DOES PERINEURAL INVASION ON INITIAL
PROSTATE BIOPSY PREDICT HIGHER
RISK OF PROGRESSION IN PATIENTS ON
CANCER?
Ardalan E. Ahmad*, Maria Komisarenko,
Ruby Grewal, Narhari Timilshina, Robert
Hamilton, Girish Kulkarni, Alexandre Zlotta,
Neil Fleshner, Antonio Finelli, Toronto,
Canada
PATHOLOGICAL FINDINGS IN PATIENTS
FULFILLING THE EPSTEIN CRITERIA FOR
INSIGNIFICANT PROSTATE CANCER AND
HAVING A NEGATIVE MPMRI
Nicolas Branger, Thomas Maubon, Miriam
Traumann, Jeanne Thomassin-Piana, Maria
Paciencia, Serge Brunelle, Naji Salem,
Gwenaelle Gravis, Jochen Walz*, Marseille,
France - Metropolitan
MP15-14
PATIENTS NOT SUITABLE FOR ACTIVE
SURVEILLANCE BUT IN WHOM GLEASON
UPGRADING COULD BE EXCLUDED HAVE
BIOCHEMICAL RECURRENCE RATES
SIMILARLY FAVORABLE TO PATIENTS
WHO ARE SUITABLE FOR ACTIVE
SURVEILLANCE
Roderick van den Bergh*, Declan Murphy,
Declan Murphy, Melbourne, Australia, Henk
van der Poel, Amsterdam, Netherlands
MP15-15
A RETROSPECTIVE REVIEW OF A LARGE
ACTIVE SURVEILLANCE COHORT IN
PATIENTS WITH PROSTATE CANCER AT
THE CLEVELAND CLINIC
Yaw A. Nyame*, Nima Almassi, Daniel
Greene, Vishnu Ganesan, Charles Dai,
Joseph Zabell, Samuel Haywood, Chad
Reichard, Hans Arora, Daniel Hettel, Anna
Zampini, Alice Crane, Ahmed El-Shafei,
Robert Stein, Khaled Fareed, Michael Gong,
J. Stephen Jones, Andrew J. Stephenson,
Eric A. Klein, Cleveland, OH
MP15-16
OUTCOMES AND FACTORS CHANGING
TO INTERVENTION IN ACTIVE
SURVEILLANCE FOR LOCALIZED
PROSTATE CANCER: SYSTEMATIC
REVIEW AND META-ANALYSIS OF
CONTEMPORARY SERIES
Ahmed Aboumohamed*, Ilir Agalliu, Reza
Ghavamian, Bronx, NY
MP15-17
MP-MRI UPGRADES MEN WHO HAVE HAD
A BIOPSY SHOWING PRIOR CANCER
Cayce Nawaf*, James Rosoff, Jeffrey
Weinreb, Peter Humphrey, Angelique Levi,
Steffen Huber, Preston Sprenkle, New
Haven, CT
MP15-18
MULTIPARAMETRIC MRI OUTPERFORMS
PSA VELOCITY FOR PATHOLOGIC
PROGRESSION IN MEN ON ACTIVE
SURVEILLANCE FOR PROSTATE CANCER
Michael Kongnyuy*, Arvin George, Bethesda,
MD, Minhaj Siddiqui, Baltimore, MD, Akhil
Muthigi, Meet Kadakia, Thomas Frye,
Abhinav Sidana, Amichai Kilchevsky, Hui
Han, Francesca Mertan, Daniel Su, Maria
Bradford Wood, Peter Pinto, Bethesda, MD
MP15-19
FUSION MRI-ULTRASOUND BIOPSY
DURING PROSTATE CANCER ACTIVE
SURVEILLANCE
Michael Leapman, Geraldine Tran*, Hao
Nguyen, Janet Cowan, Antonio Westphalen,
Katsuto Shinohara, Peter Carroll, San
Francisco, CA
MP15-20
10 YEARS LATER: IMPACT OF THE 2005
INTERNATIONAL SOCIETY OF
UROLOGICAL PATHOLOGY GLEASON
GRADING CONSENSUS ON THE SAFETY
OF ACTIVE SURVEILLANCE.
Lukas Hefermehl*, Kurt Lehmann, Baden,
Switzerland
CREDITTM
*Presenting author
61
FRIDAY
MP15-07
Friday, May 6, 2016
1:00 pm - 3:00 pm
PROSTATE CANCER: DETECTION & SCREENING I
Moderators: Martin Sanda and Ahmed Shabsigh
ABSTRACT
NUMBER TITLE
MP16-01 HIGH-RESOLUTION MAGNETIC
RESONANCE IMAGING DIFFERENTIATES
BETWEEN NORMAL
HISTOMORPHOLOGICAL SIGNATURES
AND PROSTATE CANCER IN THE
RESECTED PROSTATE GLAND
Matthieu Durand*, Nice, France, Manu Jain,
Brian Robinson, Eric Aronowitz, Youssef El
Douahy, Robert Leung, Douglas S Scherr,
Amelia Ng, New-York, Ny, Dominique
Donzeau, Jean Amiel, Nice, France, Pascal
Spincemaille, New-York, Ny, Arnauld Villers,
Lille, France, Douglas Ballon, New-York, Ny
ABSTRACT
NUMBER TITLE
MP16-07 SHOULD WE CONTINUE TO BIOPSY MEN
WITH PI-RADS III AFTER PREVIOUS
NEGATIVE BIOPSY?
Massimo Lazzeri*, Giovanni Lughezzani,
NicolòMaria Buffi, Paolo Casale, Rodolfo
Hurle, Girolamo Fiorini, Roberto
Peschechera, Luisa Pasini, Silvia
Zandegiacomo, Luca Balzarini, Federica
Mrakic, Milan, Italy, Vittorio Bini, Perugia,
Italy, Giorgio Guazzoni, Milan, Italy
MP16-08 MRI-US FUSION IS SUPERIOR TO BOTH
COGNITIVE AND RANDOM PROSTATE
NEEDLE BIOPSY OF THE PROSTATE
Daniel Oberlin*, Richard Matulewicz, Joshua
Meeks, Chicago, IL
MP16-02 ROLE OF SIMULTANEOUS TRUS GUIDED
RANDOM BIOPSY IN MEN WITH
UNILATERAL CANCER SUSPICIOUS
REGIONS UNDERGOING MRI-US FUSION
TARGETED PROSTATE BIOPSY
Darren J Bryk*, Elton Llukani, Andrew B
Rosenkrantz, Samir S Taneja, William C
Huang, Herbert Lepor, New York, NY
MP16-09 COMPARISON OF MRI/ULTRASOUNDFUSION-BIOPSY TO SYSTEMATIC
PROSTATE BIOPSY IN PREDICTION OF
FINAL HISTOPATHOLOGY IN
PROSTATECTOMY SPECIMEN
Angelika Borkowetz*, Stefan Zastrow, Ivan
Platzek, Marieta Toma, Teresa Renner,
Michael Froehner, Manfred Wirth, Dresden,
Germany
MP16-03 THE IMPACT OF A LEARNING CURVE IN
THE PERFORMANCE OF MRI-US FUSIONTARGETED PROSTATE BIOPSY:
IMPROVEMENTS IN CANCER DETECTION
OVER TIME
Neil Mendhiratta*, Andrew Rosenkrantz,
Xiaosong Meng, Richard Huang, Samir
Taneja, New York, NY
MP16-10 DIAGNOSTIC ACCURACY AND
EFFICIENCY OF COGNITIVE FUSIONTRANSRECTAL ULTRASOUND GUIDED
BIOPSY COMPARED TO TRADITIONAL 12CORE TRANSRECTAL ULTRASOUND
GUIDED BIOPSY IN MEN SCHEDULED
FOR REPEAT PROSTATE BIOPSY
Ricardo Lopez del Campo*, Ana Celma
Domenech, Lucas Regis Placido, Pol Servian
Vives, Carlos Gasanz Serrano, Jacques
Planas Morin, Ines de Torres Ramirez, Sarai
Roche Valles, Juan Morote Robles,
Barcelona, Spain
MP16-04 A COMPARISON OF PROSTATE CANCER
DETECTION AT 3T MRI WITH AND
WITHOUT AN ENDORECTAL COIL: A
PROSPECTIVE, PAIRED-PATIENT STUDY
Daniel Costa*, Qing Yuan, Yin Xi, Claus
Roehrborn, Neil Rofsky, Yair Lotan, Franto
Francis, Robert Lenkinski, Debbie Travalini,
Ivan Pedrosa, Dallas, TX
MP16-05
COMPARISON OF PROSTATE HEALTH
INDEX (PHI) AND MULTIPARAMETRIC
MAGNETIC RESONANCE IMAGING (MRI)
IN DETECTION OF CLINICALLYSIGNIFICANT PROSTATE CANCER
Alexander Glaser*, Phillip Cooper, Kimberly
Roehl, William Catalona, Chicago, IL
MP16-11 ROUTINE USE OF MAGNETIC
RESONANCE IMAGING IN PROSTATE
CANCER FACILITATES BETTER
CANDIDATE SELECTION FOR ACTIVE
SURVEILLANCE
Arjun Sivaraman*, Youness Ahallal, Rafael
Sanchez-Salas, Estefania Linares Espinos,
Jose I. Perez-Reggeti, Paris, France, Andrea
Russo, Milan, Italy, Gustavo Armando
Hernandez Palacios, Eric Barret, Marc
Galiano, François Rozet, Xavier Cathelineau,
Paris, France
MP16-06 DIAGNOSTIC ACCURACY OF MAGNETIC
RESONANCE IMAGING (MRI) 5-POINT
LIKERT SCORING SYSTEM EVALUATED
BY THE RESULT OF
MRI/ULTRASONOGRAPHY FUSION
TARGETED BIOPSY OF THE PROSTATE
Toshitaka Shin*, Los Angeles, CA, Thomas
B. Smyth, Owings Mills, MD, Osamu
Ukimura, Jie Cai, Nariman Ahmadi, Andre
Luis de Castro Abreu, Los Angeles, CA,
Hiromitsu Mimata, Oita, Japan, Inderbir S.
Gill, Los Angeles, CA
MP16-12 COMPARISON OF IMAGE QUALITY AND
PATIENT DISCOMFORT IN PROSTATE
MRI: ENDORECTAL COIL VS. PELVIC
PHASED ARRAY COIL
Borna K. Barth, Zürich, Switzerland,
Alexander Cornelius, Aarau, Switzerland,
Daniel Nanz, Daniel Eberli*, Olivio F. Donati,
Zürich, Switzerland
62
MP16-18 OPTIMAL COMBINATION OF MRITARGETED BIOPSY AND SYSTEMATIC
BIOPSY FOR MEN WITH SUSPICION OF
PROSTATE CANCER
Noboru Numao*, Masaya Ito, Yoh Matsuoka,
Soichiro Yoshida, Motohiro Fujiwara, Yuki
Nakamura, Yuma Waseda, Shingo Moriyama,
Takayuki Nakayama, Hajime Tanaka,
Masaharu Inoue, Naoko Kawamura, Minato
Yokoyama, Junichiro Ishioka, Kazutaka Saito,
Yasuhisa Fujii, Kazunori Kihara, Tokyo,
Japan
MP16-14 DETECTION OF PROSTATE CANCER
USING MAGNETIC RESONANCE IMAGING/
ULTRASONOGRAPHY FUSION TARGETED
BIOPSY IN AFRICAN-AMERICAN MEN
Toshitaka Shin*, Los Angeles, CA, Thomas
B. Smyth, Owings Mills, MD, Osamu
Ukimura, Jie Cai, Nariman Ahmadi, Andre
Luis de Castro Abreu, Los Angeles, CA,
Hiromitsu Mimata, Oita, Japan, Inderbir S.
Gill, Los Angeles, CA
MP16-15
MP16-19 BXCHIP™ CLINICAL TISSUE ARRAY
INCREASES CANCER DETECTION RATE &
AMOUNT OF TISSUE AVAILABLE FOR
PATHOLOGIST REVIEW
Kirk Wojno*, Royal Oak, MI, Rima Al-Jundi,
St. Clair Shores, MI, Ann Mazurco, Royal
Oak, MI, Hayder Al Hamzawy, Salt Lake, UT
THE DIAGNOSTIC ROLE OF
RESONANCE IMAGING BEFORE INITIAL
PROSTATE BIOPSY: THE DEVELOPMENT
OF NOMOGRAMS PREDICTING THE
OUTCOMES OF PROSTATE BIOPSY
Dong Fang*, Chenglin Zhao, Da Ren, Wei
Yu, Rui Wang, Huihui Wang, Xuesong Li,
Xiaoying Wang, Zhongcheng Xin, Liqun
Zhou, Beijing, China, People’s Republic of
MP16-20 METABOLIC SYNDROME IS ASSOCIATED
WITH INCREASED RISK OF PROSTATE
CANCER: A SYSTEMATIC REVIEW AND
META-ANALYSIS
Giorgio Ivan Russo*, Sebastiano Cimino,
Catania, Italy, Arcangelo Sebastianelli,
Matteo Salvi, Florence, Italy, Cosimo De
Nunzio, Rome, Italy, Marco Carini, Sergio
Serni, Florence, Italy, Giuseppe Morgia,
Catania, Italy, Mauro Gacci, Florence, Italy
MP16-16 GLEASON SCORING OF PROSTATE
BIOPSIES IN ACTIVE SURVEILLANCE
PATIENTS OBTAINED BY STANDARD
TRUS AND MRI: AN UPDATE
James Bienvenu*, Peter Haddock, Joseph
Cusano, Joseph Wagner, Hartford, CT
CREDITTM
MP16-17 CAN SYSTEMATIC BIOPSY BE SAFELY
OMITTED IN THE ERA OF MRI/TRUSFUSION TARGETED PROSTATE BIOPSY?
Yasukazu Nakanishi*, Hiroshi Fukushima,
Minato Yokoyama, Madoka Kataoka, Ken-ichi
Tobisu, Fumitaka Koga, Tokyo, Japan
Friday, May 6, 2016
1:00 pm - 3:00 pm
Podium Session 5
INFERTILITY: THERAPY I
Moderators: Mary Samplaski and Vincenzo Mirone
TIME
1:00
1:10
ABSTRACT
NUMBER TITLE
PD05-01 MICRODISSECTION TESTICULAR SPERM
EXTRACTION IN PATIENTS WITH
AZOOSPERMIA DUE TO CHEMOTHERAPY
Takeshi Shin*, Yukihito Shimomura,
Tomohiro Kobayashi, Akane Miyata,
Japan
PD05-02
*Presenting author
ABSTRACT
TIME NUMBER TITLE
1:20 PD05-03 MICRODISSECTION ONCO-TESE IN
AZOOSPERMIC CANCER PATIENTS
Chris Poullis, Saad Abumelha, Fahad
AlMashat, Tet Yap*, Elizabeth Williamson,
David Ralph, Suks Minhas, London, United
Kingdom
1:30
PREDICTORS OF SPERMATOGENESIS IN
RADICAL ORCHIECTOMY SPECIMEN AND
THE POTENTIAL IMPLICATIONS FOR THE
AZOOSPERMIC TESTIS CANCER PATIENT
Ohad Shoshany, Yariv Shtabholtz, Petach
Tikva, Israel, Eran Schreter, Haifa, Israel,
Maxim Yakimov, Haim Pinkas, Jack Baniel,
Shay Golan*, Petach Tikva, Israel
63
PD05-04
THE OUTCOME OF MICRODISSECTION
TESTICULAR SPERM EXTRACTION
(MTESE) IN MEN WITH MATURATION
ARREST
Tet Yap*, Chris Poullis, Saad Abumelha,
Fahad Al Mashat, Elizabeth Williamson,
David Ralph, Suks Minhas, London, United
Kingdom
FRIDAY
MP16-13 MINIMIZING THE GLEASON SCORE
UPGRADE FROM BIOPSY TO
PROSTATECTOMY SPECIMEN THROUGH
MPMRI AND TEMPLATE MAPPING FUSION
BIOPSY
Oliver Gross*, Ashkan Mortezavi, Lilian
Neuhaus, Tullio Sulser, Daniel Eberli, Zürich,
Switzerland
1:40
PD05-05
CHROMOSOMAL ANOMALIES AND
SPERM RETRIEVAL RATE OF PATIENTS
WITH NONOBSTRUCTIVE AZOOSPERMIA
Tomoki Takeda*, Shoichiro Iwatsuki, Takashi
Hamakawa, Hiroyuki Kamiya, Yukihiro
Umemoto, Hiroki Kubota, Yasue Kubota,
Shoichi Sasaki, Takahiro Yasui, Nagoya,
Japan
1:50
PD05-06
PREVALENCE OF BIOCHEMICAL
HYPOGONADISM IN MEN WITH NONOBSTRUCTIVE AZOOSPERMIA (NOA)
BEFORE AND AFTER TESTICULAR
SPERM EXTRACTION (M-TESE)
Chris Poullis, Fahad AlMashat*, Mark
Johnson, Christina Fontaine, Saad Abumelha,
Tet Yap, Suks Minhas, London, United
Kingdom
2:00
2:10
PD05-07
PD05-08
TESTICULAR SPERM EXTRACTION FOR
TREATMENT OF NON-OBSTRUCTIVE
AZOOSPERMIA IN MEN WITH HISTORY
OF CRYPTORCHIDISM
Phil Bach*, Bobby Najari, Filipe Tenorio Lira
Neto, Gianpiero Palermo, Nikica Zaninovic,
Zev Rosenwaks, Peter Schlegel, New York,
NY
LIVE BIRTH RATES IN MEN WITH NONOBSTRUCTIVE AZOOSPERMIA (NOA)
UNDERGOING MICRODISSECTION
TESTICULAR SPERM EXTRACTION
(MTESE)
Chris Poullis, Saad Abumelha*, Fahad Al
Mashat, Nagla Rushwan, Tet Yap, Meen Yau
Thum, Hossam Abdalla, Suks Minhas,
2:20
PD05-09
EFFECTIVENESS OF INDIVIDUAL AND
SMALL NUMBER OF HUMAN
SPERMATOZOA CRYOPRESERVATION
FOR FERTILITY PRESERVATION IN
PATIENTS WITH SEVERE MALE FACTOR
OF INFERTILITY
Jianlin Hu*, Jian Sun, Yuan Xu, Zijue Zhu,
Xiaofeng Wan, Yuehua Gong, Yan Hong,
Huixing Chen, Peng Li, Xiaohong Gao,
Zhenbo Zhang, Zheng Li, Yu Wu, Shanghai,
2:30
PD05-10
ICSI OUTCOME IN PATIENTS WITH HIGH
DNA FRAGMENTATION: TESTICULAR VS
EJACULATED SPERM: QATAR
EXPERIENCE
Ahmad Hassan AlMalki*, Haitham T
ElBardisi, Sami S AlSaid, Hassan Burjaq,
Moza AlBadr, Mohamad M Arafa, Doha,
Qatar
2:40
PD05-11
IMPROVED FERTILITY OUTCOMES
FOLLOWING TESTICULAR SPERM
ASPIRATION IN MEN WITH ELEVATED
SPERM DNA FRAGMENTATION INDICES
Nishant Patel*, Mike, T.C. Hsieh, San Diego,
CA
2:50
PD05-12
USE OF TESTICULAR VERSUS
EJACULATED SPERM FOR
INTRACYTOPLASMIC SPERM INJECTION
AMONG MEN WITH
CRYPTOZOOSPERMIA: A METAANALYSIS
Nikita Abhyankar*, Martin Kathrins, Craig
Niederberger, Chicago, IL
CREDITTM
Friday, May 6, 2016
1:00 pm - 3:00 pm
Podium Session 6
IMAGING/RADIOLOGY: URORADIOLOGY II
Moderators: David Hoenig and Joseph Presti, Jr.
TIME
1:00
1:10
ABSTRACT
NUMBER TITLE
PD06-01 SAMPLING OF HYPOECHOIC LESIONS
IMPROVES THE PERFORMANCE OF MRITARGETED PROSTATE BIOPSY
Nabeel Shakir*, Minhaj Siddiqui, Arvin
George, Michael Kongnyuy, Michele Fascelli,
Maria Merino, Baris Turkbey, Peter Choyke,
PD06-02
ABSTRACT
TIME NUMBER TITLE
1:20 PD06-03 IMAGING OVERUSE PERSISTS IN POSTPROSTATECTOMY PATIENTS
Tudor Borza*, Megan Caram, Ryan M Blake,
Jennifer Davis, Ann Arbor, MI, Danil V
Makarov, New York, NY, Jeremy B Shelton,
Los Angeles, CA, John T Leppert, Stanford,
CA, Brent K Hollenbeck, Ted A Skolarus, Ann
Arbor, MI
MANUALLY CONTROLLED TRANSPERINEAL TARGETED BIOPSY WITH
REAL-TIME FUSION IMAGE OF MULTIPARAMETRIC MAGNETIC RESONANCE
IMAGE AND TRANS-RECTAL
ULTRASOUND IMAGE FOR THE
DIAGNOSIS OF PROSTATE SIGNIFICANT
CANCER BASED ON PROSTATE IMAGEREPORTING AND DATA SYSTE
Sunao Shoji*, Taro Higure, Masayoshi
Kawakami, Mayura Nakano, Hachioji, Japan,
Toshiro Terachi, Shimokasuya, Japan,
Toyoaki Uchida, Hachioji, Japan
1:30
64
PD06-04
MIDLINE PROSTATE LESIONS: FUSION
BIOPSY IMPROVES DETECTION OF
CLINICALLY SIGNIFICANT CANCER
Akhil Muthigi*, Arvin George, Michael
Kongnyuy, Abhinav Sidana, Nabeel Shakir,
Meet Kadakia, Amichai Kilchevsky, Thomas
Frye, Daniel Su, Maria Merino, Baris Turkbey,
Bethesda, MD
PD06-05
THE MRI-INVISIBLE PROSTATE CANCER:
INCIDENCE AND SIGNIFICANCE
Jason Wu*, Daniel Margolis, Shyam
Natarajan, Alan Priester, Jiaoti Huang, Maria
Luz Macairan, Patricia Lieu, Devi Sharma,
Frederick Dorey, Leonard Marks, Los
Angeles, CA
1:50
PD06-06
THE EFFECT OF NEUROVASCULAR
BUNDLE PRESERVATION ON CHANGES
IN PENIS LENGTHS AND ELASTICITY
SCORES FOLLOWING RADICAL
PROSTATECTOMY
Nurullah Hamidi*, Evren Suer, Ilker Gokce,
Namik Altýnbas, Cemil Yagci, Sumer Baltaci,
Kadir Turkolmez, Ankara, Turkey
2:00
PD06-07
GLEASON SCORE WITHIN PROSTATE
ABNORMAL AREAS DEFINED BY
RESONANCE IMAGING DID NOT VARIED
ACCORDING TO THE PIRADS SCORE.
Hakim Slaoui, Yann Neuzillet*, Mathieu
Rouanne, Abdelali Abdou, Pierre Marie
Lugagne Delpon, Antoine Scherrer, Camelia
Radulescu, Suresnes, France, Vincent
Molinié, Fort-de-France, France, Thierry
Lebret, Suresnes, France
2:10
PD06-08
PROSPECTIVE TRIAL TO EVALUATE A
HIGH RESOLUTION DIFFUSIONWEIGHTED MRI IN PROSTATE CANCER
PATIENTS
Ali Reza Sharif-Afshar*, Christopher Nguyen,
Tom Feng, Lucas Payor, Zhaoyang Fan, Rola
Saouaf, Debiao Li, Hyung Kim, Los Angeles,
CA
2:20
PD06-09
TEN-YEAR ACTIVE MONITORING IN
PATIENTS WITH HIGH RISK OF
PROSTATE CANCER BY ANNA/C-TRUS
IMAGING
Theodoros Tokas*, Björn Grabski, Annemie
Loch, Kristin Korte, Azizbek Ramankulov,
Patrik Berg, Leif Baeurle, Udo Paul, Tillmann
Loch, Flensburg, Germany
2:30
PD06-10
MULTI-PARAMETRIC MAGNETIC
RESONANCE IMAGING TO EVALUATE
AND MONITOR PROSTATE CANCER
AFTER HIGH-INTENSITY FOCUSED
ULTRASOUND: IMPLICATION FOR
TARGETED FOCAL THERAPY
Sunao Shoji*, Taro Higure, Masayoshi
Kawakami, Mayura Nakano, Hachioji, Japan,
Toshiro Terachi, Kanagawa, Japan, Toyoaki
Uchida, Hachioji, Japan
2:40
PD06-11
REPRODUCIBILITY OF SUPRASPINAL
RESPONSES TO AUTOMATED,
REPETITIVE BLADDER FILLING - AN FMRI
STUDY
Matthias Walter*, Lorenz Leitner, Lars
Michels, Spyros Kollias, Patrick Freund,
Martina Liechti, Thomas M. Kessler, Ulrich
Mehnert, Zürich, Switzerland
2:50
PD06-12
ADDITION OF ULTRASOUND BLADDER
IMAGING DURING URODYNAMICS TO
CALCULATE DETRUSOR WALL TENSION
AND STRESS
Anna Nagle*, Adam Klausner, Andrew
Colhoun, Paul Ratz, Wayne Barbee, Laura
Carucci, John Speich, Richmond, VA
CREDITTM
Friday, May 6, 2016
1:00 pm - 3:00 pm
Video Session 2
FEMALE VOIDING DYSFUNCTION
ABSTRACT
NUMBER TITLE
V2-01
TRANSVAGINAL SLING EXCISION: TIPS
AND TRICKS
Marisa Clifton*, Howard Goldman, Cleveland,
OH
V2-02
*Presenting author
ABSTRACT
NUMBER TITLE
V2-03
REMOVAL OF OBSTRUCTING SYNTHETIC
SLING FROM URETHRA
Javier Pizarro-Berdichevsky*, Michelle P
Goldman, Howard B Goldman, Cleveland,
OH
FEMALE URETHRAL DISEASE
Paholo Barboglio Romo*, Anne P. Cameron,
Ann Arbor, MI
V2-04
65
ALLOGRAFT DERMIS FOR FEMALE
PELVIC FLOOR REPAIR
Kelly McAlvany*, Javier Piraino, Emma
Bendana, Charles Secrest, Longview, TX
FRIDAY
1:40
V2-05
HOLMIUM LASER EXCISON OF
GENITOURINARY MESH EROSION
Christina Godwin*, Brian Linder, Daniel Elliott,
Rochester, MN
V2-09
ELECTROVAPORIZATION OF LARGE
BLADDER DIVERTICULUM
Ryan Chandhoke*, Bilal Farhan, Gamal
Ghoniem, Orange, CA
V2-06
CONSTRUCTION OF A VAGINAL VAULT
MODEL TO EDUCATE RESIDENTS IN THE
PELVIC ORGAN PROLAPSE
QUANTIFICATION SYSTEM
Priyanka Kadam-Halani, Melissa Laudano*,
Bronx, NY, Nuan Cui, Jamaica, NY, Jessica
Harroche, Daniela Carlos, Nicole
Fleischmann, Tal Fligelman, Ava Leegant,
Keith Downing, Bronx, NY
V2-10
VAGINAL APPROACH TO
VESICOUTERINE FISTULA
Eder Brazão Jr*, Lucas Gon, Raphael Pioli,
Cassio Riccetto, Paulo Palma, Campinas,
Brazil
V2-11
UTILIZING TRANSLABIAL ULTRASOUND
FOR IDENTIFICATION AND ASSESSMENT
OF SYNTHETIC VAGINAL MESH
Jim Shen*, Kevin Kim, Salim Cheriyan,
Mohamed Keheila, Josianne Bailey, Glenn
Rouse, Loma Linda, CA
V2-12
A NOVEL TECHNIQUE FOR THE
REMOVAL OF TRANSOBTURATOR MIDURETHRAL SLING EXCISION
Temitope Rude*, Daniel Hoffman, Victor Nitti,
New York, NY
V2-07
V2-08
CYSTOSCOPIC FINDINGS OF PLACENTA
PERCRETA WITH BLADDER
INVOLVEMENT
Ahmed Alghrouz*, Stephanie Tran, Satyan
Shah, Albuquerque, NM
TRANSVAGINAL BLADDER NECK
CLOSURE FOR THE DEVASTATED
FEMALE URETHRA
Gregory Murphy*, Farmington, CT, Richard
Kershen, Hartford, CT
CREDITTM
Friday, May 6, 2016
2:00 pm - 5:00 pm
CROSSFIRE: CONTROVERSIES IN UROLOGY: MALIGNANT
Moderator: Mark Soloway
2:00
HIGH GRADE TRANSITIONAL CELL CANCER
IN A SOLITARY KIDNEY: BEST TREATED
ENDOSCOPICALLY
Moderator: Andrew Stephenson
Debaters - Pro: David Chen
Surena Matin
Debaters - Con: Christopher Evans
R. Houston Thompson
2:30
MRI FUSION PROSTATE BIOPSY: THE NEW
GOLD STANDARD FOR DIAGNOSIS AND
STAGING
Moderator: Jay Bishoff
Debaters - Pro: Peter Pinto
Leonard Marks
Debaters - Con: Antonio Finelli
J. Stephen Jones
3:00
CYTOREDUCTIVE NEPHRECTOMY IS STILL
IMPORTANT FOR ADVANCED/METASTATIC
RENAL CELL CANCER
Moderator: Arthur Sagalowsky
Debaters - Pro: Jose Karam
Peter Clark
Debaters - Con: Allan Pantuck
Sumanta Pal
3:30
4:00
RENAL CELL CANCER: NO ROOM FOR
MARGINS: BETTER TO ENUCLEATE
Moderator: Gennady Bratslavsky
Debaters - Pro: Thomas Guzzo
J. Stuart Wolf
Debaters - Con: Scott Eggener
Stephen Boorjian
4:30
RADICAL PROSTATECTOMY IS BETTER THAN
RADIOTHERAPY FOR HIGH RISK PROSTATE
CANCER
Moderator: Leonard Gomella
Debaters - Pro: James Eastham
Joel Nelson
Debaters - Con: Mack Roach
Joseph Kang
5:00
ADJOURN
CREDITTM
BLADDER PRESERVATION FOR MUSCLE
INVASIVE CANCER
Moderator: Adam Kibel
Debaters - Pro: Douglas Dahl
Jason Efstathiou
Debaters - Con: Jay Shah
Piyush Agarwal
66
Friday, May 6, 2016
3:30 pm - 5:30 pm
ABSTRACT
NUMBER TITLE
MP17-01 PREDICTORS OF LONG-TERM BLADDER
MANAGEMENT IN SPINAL CORD INJURY
PATIENTS - UPPER EXTREMITY
FUNCTION MATTERS MOST
Dimitar V. Zlatev*, Stanford, CA, Kazuko
Shem, Christopher S. Elliott, San Jose, CA
ABSTRACT
NUMBER TITLE
MP17-09 TRENDS IN SUPRASPINAL VARIATION IN
PATIENTS WITH MULTIPLE SCLEROSIS
AND DETRUSOR SPHINCTER
DYSSENERGIA
Rose Khavari*, Christof Karmonik, Thomas
Potter, Michael Shy, Houston, TX, Sophie
Fletcher, Santa Rosa, CA, Timothy Boone,
Houston, TX
MP17-02 UROLOGIC MORBIDITY IN A
CONTEMPORARY COHORT OF SCI
PATIENTS
Blayne Welk*, Kuan Liu, Jennifer Winick-Ng,
Salimah Shariff, London, Canada
MP17-10 SACRAL NEUROMODULATION THERAPY
IN PATIENTS WITH NEUROLOGIC LOWER
URINARY TRACT DYSFUNCTION –
SHOULD IT REMAIN AN OFF LABEL
INDICATION? ANALYSIS OF 80
CONSECUTIVE CASES
Henry Okafor*, Bradley Gill, Javier
Pizarro⫺Berdichevsky, Marisa Clifton, Elodi
Dielubanza, Anna Faris, Adrienne Quirouet,
Howad Goldman, Raymond Rackley, Sandip
Vasavada, Courtenay Moore, Cleveland, OH
MP17-03 THE MAXIMUM DETRUSOR PRESSURE AS
A PREDICTIVE FACTOR AFTER
INCONTINENTATION PROCEDURES FOR
SURGICAL MANAGEMENT OF
DETRUSOR-SPHINCTER DYSSYNERGIA
Alexandre Hourié*, François-Xavier Nouhaud,
Maximilien Baron, John-David Rebibo, JeanNicolas Cornu, Philippe Grise, Rouen, France
MP17-11 INTRADETRUSOR INJECTIONS OF
BOTULINUM TOXIN A IN ADULT
PATIENTS WITH SPINA BIFIDA : A
MULTICENTER STUDY
Benoit Peyronnet*, Juliette Hascoet, Rennes,
France, Mathieu Roumiguié, Evelyne CastelLacanal, Toulouse, France, Mireille
Damphousse, Nelly Senal, Rennes, France,
Philippe Marque, Toulouse, France, Andrea
Manunta, Rennes, France, Xavier Gamé,
Toulouse, France
MP17-04 URODYNAMIC FINDINGS IN ADULTS
WITH MODERATE TO SEVERE CEREBRAL
PALSY
Mya Levy*, Katherine Cotter, Robert
Goldfarb, Minneapolis, MN, Jenna Katorski,
St. Paul, MN, Daniel Liberman, Sean P.
Elliott, Minneapolis, MN
MP17-05
URODYNAMIC PARAMETERS AND
UROLOGICAL PRESENTATION DIFFER
DEPENDING ON SYMPTOM ONSET IN
ADULT PRIMARY TETHERED CORD
SYNDROME
Hee Seo Son*, Irela Soto Troya, Yu Jeong
Jeon, Myung Joo Kim, Sang Woon Kim, Jang
Hwan Kim, Seoul, Korea, Republic of
MP17-12 SERIAL BOTULINUM TOXIN INJECTIONS
OFFER DURABLE RESULTS FOR
NEUROGENIC BLADDER: 4 YEAR
URODYNAMIC OUTCOMES
Alexandra Rehfuss*, Gabriel Leinwand, Paul
Feustel, Elise De, Albany, NY
MP17-06 LOWER URINARY TRACT DYSFUNCTION
IN PATIENTS WITH STROKE: A
PROSPECTIVE STUDY
Pawan Vasudeva*, Delhi, India, Harbinder
Singh, Delhi, India, Gaurav Kumar, Delhi,
India, Neeraj Kumar, Delhi, India
MP17-13 INTRADETRUSOR
ONABOTULINUMTOXINA INJECTIONS
FOR REFRACTORY NEUROGENIC
DETRUSOR OVERACTIVITY
INCONTINENCE: DO WE NEED
URODYNAMIC INVESTIGATION FOR
OUTCOME ASSESSMENT?
Jure Tornic*, Zürich, Switzerland, Lorenz
Leitner, Zürich and Basel, Switzerland,
Miriam Koschorke, Matthias Walter,
Stephanie Knüpfer, Marc P. Schneider, Ulrich
Mehnert, Thomas M. Kessler, Zürich,
Switzerland
MP17-07 CLINICAL EFFICACY OF ADENOSINE A2A
RECEPTOR ANTAGONIST ON LOWER
URINARY TRACT SYMPTOMS IN
PARKINSON’S DISEASE: A PROSPECTIVE
STUDY
Takeya Kitta*, Ichiro Yabe, Yukiko Kanno,
Hiroki Chiba, Kimihiko Moriya, Ikuko
Takahashi, Masaaki Matsushima, Hidenao
Sasaki, Nobuo Shinohara, Sapporo, Japan
MP17-08 EFFICACY AND TOLERABILITY OF
MIRABEGRON IN MULTIPLE SCLEROSIS:
A PROSPECTIVE ANALYSIS
Temitope Rude, Ekene Enemchukwu*, Carrie
Lyn Sammarco, Victor Nitti, Benajmin M
Brucker, New York, NY
*Presenting author
67
FRIDAY
URODYNAMICS/LOWER URINARY TRACT DYSFUNCTION/FEMALE PELVIC MEDICINE: NEUROGENIC VOIDING DYSFUNCTION
Moderators: David Ginsberg and Suzette Sutherland
MP17-14 MORE THAN 15 YEARS EXPERIENCE
WITH INTRADETRUSOR
FOR TREATING REFRACTORY
NEUROGENIC DETRUSOR
OVERACTIVITY: LESSONS TO BE
LEARNED
Sharmistha Guggenbühl-Roy*, Zürich,
Switzerland, Lorenz Leitner, Zürich and
Basel, Switzerland, Jure Tornic, Matthias
Walter, Stephanie Knüpfer, Marc P.
Schneider, Ulrich Mehnert, Thomas M.
Kessler, Zürich, Switzerland
MP17-15
MP17-17 VALIDITY OF THE NERVE GROWTH
FACTOR AS A BIOMARKER FOR
NEUROGENIC LOWER URINARY TRACT
DYSFUNCTION
Jens Wöllner*, David Pavlicek, Jivko
Stoyanov, Jürgen Pannek, Joerg Krebs,
Nottwil, Switzerland
MP17-18 ROLE OF BRAIN-DERIVED
NEUROTROPHIC FACTOR (BDNF) IN
LOWER URINARY TRACT DYSFUNCTION
OF MICE WITH SPINAL CORD INJURY
(SCI)
Naoki Wada*, Takahiro Shimizu, Shun Takai,
Nobutaka Shimizu, Pradeep Tyagi, William de
Groat, Anthony Kanai, Pittsburgh, PA,
Hidehiro Kakizaki, Asahikawa, Japan, Naoki
Yoshimura, Pittsburgh, PA
BACTERIURIA IN PATIENTS
UNDERGOING INTRADETRUSOR
FOR REFRACTORY NEUROGENIC
DETRUSOR OVERACTIVITY: DO WE NEED
ANTIBIOTIC PROPHYLAXIS?
Lorenz Leitner*, Zürich and Basel,
Switzerland, Ulla Sammer, Matthias Walter,
Stephanie Knüpfer, Marc P. Schneider,
Burkhardt Seifert, Ulrich Mehnert, Thomas M.
Kessler, Zürich, Switzerland
MP17-19 CELL THERAPY FOR NEUROGENIC
DETRUSOR OVERATIVITY RESULTING
FROM CHRONIC SPINAL CORD INJURY
(SCI) IN RATS
Jillene M. Brooks, Danielle J. Degoski,
Durham, NC, Paul C. Dolber, Galveston, TX,
Matthew O. Fraser*, Apex, NC
MP17-16 CHARACTERIZATION OF TONIC ACTIVITY
OF EXTERNAL URETHRAL SPHINCTER
DURING VOIDING UNDERLYING
INEFFICIENT VOIDING AFTER SPINAL
CORD INJURY IN RATS
Katsumi Kadekawa*, Pittsburgh, PA,
Mitsuharu Yoshiyama, Chuo, Japan, Tsuyoshi
Majima, Pradeep Tyagi, Pittsburgh, PA, Kimio
Sugaya, Okinawa, Japan, Naoki Yoshimura,
Pittsburgh, PA
MP17-20 PREVENTION OF DETRUSOR
OVERACTIVITY WITH EARLY
MUSCARINIC BLOCKADE AFTER SPINAL
CORD TRANSECTION IN RATS
Xavier Biardeau*, Sachar Aharony, Oleg
Loutochin, Lysanne Campeau, Jacques
Corcos, Montreal, Canada
CREDITTM
Friday, May 6, 2016
3:30 pm - 5:30 pm
PROSTATE CANCER: LOCALIZED: ABLATIVE THERAPY
Moderators: Kevin Zorn and Thomas Polascik
ABSTRACT
NUMBER TITLE
MP18-01 WHOLE GLAND SALVAGE HIGH
INTENSITY FOCUSED ULTRASOUND OF
PROSTATE: INTERMEDIATE TERM
RESULTS OF PROSPECTIVE PHASE II
CLINICAL TRIAL
Khurram Siddiqui*, Michele Billia, London,
Canada, Philippe Violette, Woodstock,
Canada, Andrew Arifin, KimChi Tran, Joseph
Chin, London, Canada
ABSTRACT
NUMBER TITLE
MP18-02 DEVELOPMENT AND INTERNAL
VALIDATION OF A MULTIVARIABLE
PREDICTION MODEL FOR BIOCHEMICAL
FAILURE AFTER FOCAL SALVAGE HIGH
INTENSITY FOCUSED ULTRASOUND FOR
LOCALLY RECURRENT PROSTATE
CANCER: PRESENTATION OF A RISK
SCORE FOR INDIVIDUAL PATIENT
PROGNOSIS
Max Peters*, Utrecht, Netherlands, Taimur
Shah, Abi Kanthabalan, Neil McCartan,
London, United Kingdom, Jochem van der
Voort van Zyp, Marinus Moerland, Marco van
Vulpen, Utrecht, Netherlands, Richard
Hindley, Basingstoke, United Kingdom, Mark
Emberton, Hashim Ahmed, London, United
Kingdom
68
MP18-09 WHEN IS TUMOUR VOLUME AN
EXCLUSION CRITERIA FOR FOCAL
THERAPY? RESULTS FROM A RADICAL
PROSTATECTOMY SERIES
Nicola Fossati, Giorgio Gandaglia, Nazareno
Suardi*, Umberto Capitanio, Paolo Dell’Oglio,
Emanuele Zaffuto, Vito Cucchiara,
Alessandro Larcher, Armando Stabile, Elena
Farina, Andrea Salonia, Francesco Montorsi,
MP18-04 WHOLE GLAND SALVAGE
CRYOABLATION OF PROSTATE: LONGTERM ONCOLOGICAL OUTCOMES
Khurram Siddiqui*, Michele Billia, London,
Canada, Philippe Violette, Woodstock,
Canada, Andrew Arifin, KimChi Tran,
Jonathan Izawa, Joseph Chin, London,
Canada
MP18-05
MP18-10 ONCOLOGIC OUTCOMES AFTER
HEMIABLATION THERAPY FOR
LOCALIZED PROSTATE CANCER
Estefania Linares Espinos*, Jose I. PerezReggeti, Eric Barret, Arjun Sivaraman, Rafael
Sanchez-Salas, Marc Galiano, François
Rozet, Dominique Prapotnich, Nathalie
Cathala, Annick Mombet, Xavier Cathelineau,
Paris, France
IS SALVAGE FOCAL CRYOTHERAPY
CURATIVE TREATMENT FOR PATIENTS
WITH LOCALIZED RECURRENT
PROSTATE CANCER?
Courtney J. Berg*, Kaitlin E. Kosinski, Aaron
E. Katz, Mineola, NY
MP18-11 MR-GUIDED FOCAL LASER ABLATION OF
INTERMEDIATE RISK PROSTATE
CANCER: PHASE I TRIAL
Shyam Natarajan, Steven Raman*, Alan
Priester, James Garritano, Daniel Margolis,
Patricia Lieu, Maria Macairan, Jiaoti Huang,
Warren Grundfest, Leonard Marks, Los
Angeles, CA
MP18-06 SALVAGE EXTERNAL BEAM RADIATION
THERAPY (EBRT) FOR LOCAL
RECURRENCE AFTER HIGH INTENSITY
FOCUSED ULTRASOUND (HIFU) FAILURE
VERSUS SALVAGE HIFU FOR LOCAL
RECURRENCE AFTER EBRT FAILURE: A
MATCHED PAIR COMPARISON
Ji-Wann Lee, Albert Gelet, Lyon, France,
Jeremy Soria, Clermont Ferrand, France,
Marc Colombel, Pascal Pommier, Lyon,
France, Christelle Melodelima, Grenoble,
France, Olivier Rouviere, Lionel Badet,
Sebastien Crouzet*, Lyon, France
MP18-12 EVALUATION OF URINARY FUNCTION
AFTER CRYOABLATION OF THE
PROSTATE
Alexander Govorov*, Alexander Vasilyev,
Dmitry Pushkar, Moscow, Russian Federation
MP18-13 PRIMARY FOCAL CRYOTHERAPY IN THE
TREATMENT OF PREDOMINANTLY
ANTERIOR AND HIGH VOLUME
INTERMEDIATE AND HIGH-RISK
LOCALIZED PROSTATE CANCER IN THE
UK
Taimur Shah*, Benjamin Thomas, London,
United Kingdom, Massimo Valerio, Lausanne,
Switzerland, Ahmed Hashim, Manit Arya,
MP18-07 APPLICABILITY ANALYSIS OF FOCAL
THERAPY TO INTERMEDIATE- AND HIGHRISK PROSTATE CANCER
Yoh Matsuoka*, Noboru Numao, Kazutaka
Saito, Hiroshi Tanaka, Masaharu Inoue,
Masaya Ito, Soichiro Yoshida, Minato
Yokoyama, Junichiro Ishioka, Yasuhisa Fujii,
MP18-14 CAN SMALL LESIONS OF GLEASON 3ⴙ4
BE LEFT UNTREATED IN FOCAL
THERAPY? ANALYSIS OF RADICAL
PROSTATECTOMY SPECIMENS.
Kent Kanao*, Keishi Kajikawa, Ikuo
Kobayashi, Hiroyuki Muramatsu, Shingo
Morinaga, Genya Nishikawa, Takahiko
Yoshizawa, Yoshiharu Kato, Masahito
Watanabe, Kogenta Nakamura, Makoto
Sumitomo, Nagakute, Japan
MP18-08 FOCAL HIFU FOR TREATMENT OF
LOCALISED PROSTATE CANCER: A
MULTI-CENTRE REGISTRY EXPERIENCE
Stephanie Guillaumier*, Sami Hamid, Susan
Charman, Susan Charman, Jan van der
Meulen, Neil McCartan, Karishma Shah,
London, United Kingdom, Richard Hindley,
Basingstoke, United Kingdom, Raj Nigam,
Surrey, United Kingdom, Tim Dudderidge,
Southampton, United Kingdom, N Afzal, A
Cornaby, Dorset, United Kingdom, H Lewi,
Chelmsford, United Kingdom, Raj Persad,
Bristol, United Kingdom, J Virdi, Harlow,
United Kingdom, Caroline Moore, London,
United Kingdom, Manit Arya, Harlow, United
Kingdom, Mark Emberton, Hashim Uddin
Ahmed, London, United Kingdom
*Presenting author
69
FRIDAY
MP18-03 PREDICTORS OF LOCAL DISEASE
CONTROL AFTER SALVAGE WHOLE
GLAND PROSTATE CRYOABLATION
Yaw Nyame, Ahmed Elshafei*, Hans Aurora,
Cleveland, OH, Robert W. Given, Virginia
Beach, VA, Thomas J. Polascik, Durham,
NC, Ashley E. Ross, Baltimore, MD, Vladimir
B. Mouraviev, Celebration, FL, J.Stephen
Jones, Cleveland, OH
MP18-15
EFFICACY OF HIGH INTENSITY FOCUSED
ULTRASOUND (HIFU) AS A PRIMARY
MONOTHERAPY FOR LOW RISK
LOCALIZED PROSTATE CANCER:
OUTCOMES FROM THE ENLIGHT TRIAL
Cary Robertson*, Durham, NC, Anthony
Sliwinski, Richmond, VA, Eric Wallen, Chapel
Hill, NC, John Ward, Houston, TX, William
Orovan, Hamilton, Canada, Donald Locke,
Ocala, FL, E David Crawford, Paul Maroni,
Aurora, CO, Robert Donnell, Milwaukee, WI,
Ivan Grunberger, Ivan Colon, Brooklyn, NY,
Richard Bevan-Thomas, Arlington, TX, Ravi
Munver, Ihor Sawczuk, Hackensack, NJ, Sam
Chang, Nashville, TN, Inderbir Gill, Los
Angeles, CA
MP18-18 MAGNETIC RESONANCE IMAGINGGUIDED TRANSURETHRAL ULTRASOUND
PROSTATE ABLATION IN PATIENTS WITH
LOCALIZED PROSTATE CANCER: 18MONTH OUTCOMES OF A PROSPECTIVE
PHASE I STUDY
Joseph Chin, London, Canada, James Relle,
Jason Hafron, Royal Oak, MI, Lonel
Popeneciu, Timur Kuru, Heidelburg,
Germany, Michele Billia, Khurram Siddiqui*,
London, Canada, Matthias Roethke,
Heidelburg, Germany, Cesare Romagnoli,
London, Canada, Mathieu Burtnyk, Toronto,
Canada, Heinz-Peter Schlemmer, Sascha
Pahernik, Heidelburg, Germany
MP18-19 LOCAL RADICAL TUMOR ABLATION
THROUGH COMBINED TRANSURETHRAL
RESECTION AND TRANSRECTAL HIGH
INTENSITY FOCUSED ULTRASOUND: A
VALID THERAPY TO TREAT HIGH RISK
PROSTATE CANCER ?
Christian Chaussy*, Regensburg, Germany,
Stefan Thueroff, Munich, Germany
MP18-16 PROPENSITY SCORE MATCHED
COMPARISON OF PARTIAL TO WHOLE
GLAND CRYOTHERAPY FOR
INTERMEDIATE-RISK PROSTATE
CANCER: AN ANALYSIS OF THE COLD
REGISTRY DATA
Kae Jack Tay*, Thomas Polascik, Durham,
NC, Ahmed Elshafei, Cleveland, OH, Efrat
Tsivian, Durham, NC, J. Stephen Jones,
Cleveland, OH
MP18-20 THE NANOKNIFE ELECTROPORATION
ABLATION TRIAL (NEAT): A
PROSPECTIVE DEVELOPMENT STUDY
Massimo Valerio*, Louise Dickinson, Afia Ali,
Navin Ramachadran, Ian Donaldson, Neil
Mccartan, Alex Freeman, Hashim Uddin
Ahmed, Mark Emberton, London, United
Kingdom
MP18-17 COMPARISONS OF ONCOLOGICAL AND
FUNCTIONAL OUTCOMES AMONG
RADICAL RETROPUBIC
PROSTATECTOMY, HIGH DOSE RATE
BRACHYTHERAPY, CRYOABLATION AND
HIGH-INTENSITY FOCUSED
ULTRASOUND FOR LOCALIZED
PROSTATE CANCER: A PROSPECTIVE,
CONTROLLED, NONRANDOMIZED TRIAL
Po Hui Chiang*, Yi Yang Liu, Kaohsiung,
Taiwan
CREDITTM
Friday, May 6, 2016
3:30 pm - 5:30 pm
IMAGING/RADIOLOGY: URORADIOLOGY III
Moderators: Edouard Trabulsi and J. Kyle Anderson
ABSTRACT
NUMBER TITLE
MP19-01 MULTISPECTRAL PHOTOACOUSTIC
IMAGING DIFFERENTIATES RENAL CELL
CARCINOMA FROM ONCOCYTOMA
Lorraine Liang*, Bhargava Chinni, Jerome
Jean-Gilles, Edward Messing, Guan Wu,
Navalgund Rao, Vikram Dogra, Rochester,
NY
ABSTRACT
NUMBER TITLE
MP19-03 THE SHAPELY RENAL MASS: CONTOUR
EVALUATION OF RENAL CELL
CARCINOMA
Felix Yap, Darryl Hwang, Steven Cen, Xuejun
Zhang, Andre Luis de Castro Abreu, Mihir
Desai, Monish Aron, Inderbir Gill, Vinay
Duddalwar*, Los Angeles, CA
MP19-02 EXTERNAL VALIDATION OF FOUR
NEPHROMETRY SCORES FOR TRANSPERITONEAL ROBOTIC PARTIAL
NEPHRECTOMY-DO WE HAVE A WINNER?
Bhavan Rai*, Amit Patel, Ahmed Abroaf,
Nikhil Vasdev, Jim Adshead, Stevenage,
United Kingdom
MP19-04 CT-BASED VOLUMETRIC
CHARACTERIZATION OF RENAL CLEAR
CELL CARCINOMA IN VON HIPPELLINDAU (VHL) USING NOVEL HISTOGRAM
ANALYSIS.
Ashkan Malayeri*, Amir Pourmorteza, Nikeith
Shah, Rabindra Gautam, Alireza Yazdi, Jana
Lovell, Shawna Boyle, Ishan Asokan,
Ramaprasad Srinivasan, Adam Metwalli, W.
Marston Linehan, Bethesda, MD
70
MP19-12 CORRELATION BETWEEN
SEMIQUANTITATIVE
SONOELASTOGRAPHY AND
IMMUNOHISTOCHEMISTRY IN THE
EVALUATION OF TESTICULAR FOCAL (<
10 MM) LESIONS
Antonio Luigi Pastore*, Giovanni Palleschi,
Domenico Autieri, Antonino Leto, Andrea
Ripoli, Andrea Fuschi, Yazan Al Salhi, Samer
Al Rawashdah, Vincenzo Petrozza, Antonio
Carbone, Latina, Italy
COMPARISON OF CONTRAST-ENHANCED
ULTRASOUND SCAN (CEUS) AND MRI IN
THE FOLLOW-UP OF CRYOABLATION
FOR SMALL RENAL TUMORS.
EXPERIENCE WITH 80 CASES.
Guglielmo Zeccolini*, Bernardino De Concilio,
Antonio Celia, Bassano Del Grappa, Italy
MP19-06 PREOPERATIVE RADIOLOGIC
ASSESSMENT FOR PERINEPHRIC FAT
INVASION (T3A): COMPARISON WITH
PATHOLOGICAL STAGING
Zhamshid Okhunov*, Jae Young Park,
Chenhui Zhao, Molly Baker, Mohammad
Helmy, Chandana Lall, Mari Bozoghlanian,
MP19-13 WIDE VARIATION IN RADIATION DOSE
DURING COMPUTERIZED TOMOGRAPHY
Andrew Cohen*, Chicago, IL, Katie Hughes,
Natalie Fahey, Brandon Caldwell, Chi-Hsiung
Wang, Sangtae Park, Evanston, IL
MP19-07 THREE-DIMENSIONAL EVALUATION OF
PERIRENAL ADIPOSE TISSUE VOLUME
PREDICTS RENAL CORTICAL NEOPLASM
HISTOPATHOLOGY
Austin Drysch*, Zhamshid Okhunov, Albert
Yang, Cyrus Khoyliar, Mary Bozoghlanian,
Helen Kim, Mohammad Helmy, Ralph
Clayman, Jaime Landman, Orange, CA
MP19-14 A QUALITATIVE STUDY TO UNDERSTAND
GUIDELINE-DISCORDANT USE OF
IMAGING TO STAGE INCIDENT
PROSTATE CANCER
Danil V. Makarov*, Erica Sedlander, Caitlin
Curnyn, R. Scott Braithwaite, Heather T.
Gold, Scott E. Sherman, New York, NY,
Steven Zeliadt, Seattle, WA, Michele Shedlin,
New York, NY
MP19-08 MAGNETIC RESONANCE (MR)
RENOGRAPHY: A MORE RELIABLE
MEASURE OF CHANGE IN SINGLE
KIDNEY FUNCTION AFTER PARTIAL
NEPHRECTOMY
Dmitry Volkin*, Stella Kang, William C Huang,
New York, NY
MP19-15
MP19-09 REPORTING STANDARDS OF
INDETERMINATE RENAL MASSES ON CT
AND MRI: A NATIONAL SURVEY OF
UROLOGISTS AND RADIOLOGISTS BY
THE SOCIETY OF ABDOMINAL
RADIOLOGY RCC DISEASE-FOCUSED
PANEL
Eric Hu*, Ann Arbor, MI, Stuart Silverman,
Boston, MA, Andrew Smith, Jackson, MS,
Hersh Chandarana, New York, NY, Khaled
Hafez, Ganesh Palapattu, Matt Davenport,
Ann Arbor, MI
MP19-16 REDUCING FLUOROSCOPY TIMES AND
DOSAGE IN THE CYSTOSCOPY SUITE: A
SIMPLE, COST EFFECTIVE
INTERVENTION
Cameron Ghaffary*, Rafay Soleja, Nancy
Brownlee, Joseph Sonstein, Galveston, TX
MP19-17 SPATIAL DISTRIBUTION AND
CONCENTRATION OF ELEMENTS WITHIN
LIESEGANG-LIKE RINGS IN APATITEBASED KIDNEY STONES
Sunita Ho*, Ryan Hsi, Sabra Djomehri, San
Francisco, CA, Samuel Webb, Menlo Park,
CA, Marshall Stoller, San Francisco, CA
MP19-10 CAN MAGNETIC
RESONANCE/ULTRASOUND FUSION
IMAGING TECHNOLOGY BE USED FOR
REAL TIME IMAGE GUIDANCE DURING
FOCAL SURGICAL THERAPY FOR
PROSTATE CANCER? A FEASIBILITY
STUDY.
Haidar Abdul-Muhsin*, Akira Kawashima,
Alvin Silva, Melissa Stanton, Gianni Moshero,
Erik Castle, Paul Andrews, Mitchell
Humphreys, Phoenix, AZ
MP19-18 BLADDER PROLAPSE CONFIGURATION
ON STANDING CYSTOGRAM CAN
PREDICT ANTERIOR VAGINAL WALL
SUSPENSION PROCEDURE OUTCOMES
Yuefeng Wu*, Alana Christie, Rebecca
Lavelle, Feras Alhalabi, Gaurav Khatri,
MP19-11 MRI PELVIC FLOOR FINDINGS IN
FEMALES WITH URGENCY URINARY
INCONTINENCE
Ahmed Mohamed Fathy*, Hussein Aly
Hussein, Samer Morsy, Raina Farouk El
Sayed, Mohamed Salah Abdel-Azim, Cairo,
Egypt
*Presenting author
RADIATION EXPOSURE OF THE
SURGEON: BENEFIT AND
PRACTICABILITY OF A LEAD-ACRYL
SHIELD FOR URETEROSCOPY
Thomas Knoll*, Jan Peter Jessen, Heiko
Kohns, Roland Steiner, Roland Umbach,
Gunnar Wendt-Nordahl, Sindelfingen,
Germany
MP19-19 AN ANALYSIS OF THE EFFECT OF 3D
PRINTED RENAL CANCER MODELS ON
SURGICAL PLANNING
Temitope Rude*, Nicole Wake, Daniel K.
Sodickson, James Borin, Michael Stifelman,
Hersh Chandarana, William C. Huang, New
York, NY
71
FRIDAY
MP19-05
MP19-20 RECURRENCE RATES OF RADIOLOGICAL
EMBOLIZATION FOR THE TREATMENT OF
VARICOCELE ARE COMPARABLE TO
SURGICAL INTERVENTION: A DECADE
LONG STUDY
Munad Khan*, Nathan Papa, Matthew Lukies,
Silverton Buraundi, Dinesh Ranatunga,
Damien Bolton, Nathan Lawrentschuk,
Melbourne, Australia
CREDITTM
Friday, May 6, 2016
3:30 pm - 5:30 pm
SURGICAL TECHNOLOGY & SIMULATION: TRAINING & SKILLS ASSESSMENT II
Moderators: Thomas Lendvay and Bradley Schwartz
ABSTRACT
NUMBER TITLE
MP20-01 REALISING A NEW MODEL TO TRAIN
RESIDENTS IN NEPHROSTOMY TUBE
PALCEMENT AND PCNL
Giorgio Bozzini*, Castellanza VA, Italy, Marco
Provenzano, Rozzano MI, Italy, Mauro
Seveso, Alberto Mandressi, Castellanza VA,
Italy, NicoloMaria Buffi, Giorgio Guazzoni,
Rozzano MI, Italy, Gianluigi Taverna,
Castellanza VA, Italy
ABSTRACT
NUMBER TITLE
MP20-05 DEVELOPMENT OF THE SIMULATE
URETERORENOSCOPY TRAINING
CURRICULUM
Abdullatif Aydin*, Ahmed Shafi, London, United
Kingdom, James Brewin, Salisbury, United
Kingdom, Craig McIlhenny, Larbert, United
Kingdom, John McCabe, Liverpool, United
Kingdom, Matthew Bultitude, Jonathan Glass,
London, United Kingdom, Nicholas Rukin,
Wolverhampton, United Kingdom, Jake
Patterson, Sheffield, United Kingdom,
Muhammad Shamim Khan, Prokar Dasgupta,
Kamran Ahmed, London, United Kingdom
MP20-02 THREE-DIMENSIONAL PRINTED KIDNEY
MODELS WITH EXTENSIVE
UROLITHIASIS: A NOVEL RESIDENT
EDUCATIONAL TOOL FOR PLANNING
PERCUTANEOUS NEPHROLITHOTOMY
Simone L Vernez*, Kyle Spradling, Orange,
CA, Benjamin Dolan, Irvine, CA, Rahul Dutta,
Zhamshid Okhunov, Ramy F Youssef,
Kamaljot Kaler, Jaime Landman, Ralph V
Clayman, Orange, CA
MP20-06 VALIDATION OF THE SIMULATE
URETERORENOSCOPY TRAINING
CURRICULUM
Abdullatif Aydin*, Ahmed Al-Jabir, Mohammed
Husnain Iqbal, Haleema Aya, Pranav Osuri,
Nicholas Raison, London, United Kingdom,
James Brewin, Salisbury, United Kingdom,
Craig McIlhenny, Larbert, United Kingdom,
Nicholas Rukin, Wolverhampton, United
Kingdom, Jake Patterson, Sheffield, United
Kingdom, Howard Marsh, Gillingham, United
Kingdom, Ranan Dasgupta, Azhar Khan,
London, United Kingdom, Shahid Khan, Surrey,
United Kingdom, Stephen Brown, Manchester,
United Kingdom, Azi Samsuddin, John
McCabe, Liverpool, United Kingdom,
MP20-03 PERCUTANEOUS ACCESS SKILL
IMPROVEMENT AFTER THE AUA PCNL
TRAINING COURSE USING THE
SIMPORTAL FLUORO-LESS C-ARM
TRAINER
Kristin Chrouser, Benjamin Marsh*, Robert
Sweet, Minneapolis, MN
MP20-04 DEVELOPMENT AND VALIDATION OF A
URETERORENOSCOPY NON-TECHNICAL
SKILLS CURRICULUM
Abdullatif Aydin*, Oliver Brunckhorst,
Haleema Aya, David Eldred-Evans, Ahmed
Al-Jabir, London, United Kingdom, James
Brewin, Salisbury, United Kingdom, Craig
McIlhenny, Larbert, United Kingdom,
MP20-07 LAPAROSCOPIC SKILLS ASSESSMENT
STUDY – DEVELOPING NATIONAL
TECHNICAL SKILLS MILESTONES FOR
CANADIAN UROLOGY TRAINEES
Jason Lee*, Toronto, Canada, Sero
Andonian, Montreal, Canada, Trevor Shuler,
Edmonton, Canada, Kenneth Pace, Ethan
Grober, Toronto, Canada
MP20-08 COMPUTER-GENERATED ASSESSMENT
OF TECHNICAL SURGICAL SKILLS (CATS)
Thomas Osinsk, Devansh Arpit, Safwan
Wshah, Ahmed Ghazi*, Rochester, NY
72
MP20-16 TRAINING AND SKILLS ASSESSMENT
FOR FUSION-GUIDED PROSTATE BIOPSY:
DEFINING THE LEARNING CURVE
Akhil Muthigi*, Arvin George, Daniel Su,
Bethesda, MD, Pingkun Yan, Jochen
Kruecker, Cambridge, MA, Harish Narayanan,
Janice Thai, Bethesda, MD, Meet Kadakia,
Michael Kongnyuy, Amogh Iyer, Abhinav
Sidana, Amichai Kilchevsky, Thomas Frye,
Baris Turkbey, Peter Choyke, Bethesda, MD,
Bradford Wood, Bethesda, MD, Peter Pinto,
Bethesda, MD
MP20-10 STRUCTURED LEARNING FOR ROBOTIC
SURGERY UTILIZING A GENERIC
PROFICIENCY SCORE
Andrew J. Hung*, Thomas Bottyan, Sarfaraz
Serang, Thomas G. Clifford, Swar H. Shah,
Hana Yokoi, Monish Aron, Inderbir S. Gill,
Los Angeles, CA
MP20-17 ACCELEROMETER MEASUREMENT OF
HEAD MOVEMENT DURING
LAPAROSCOPIC SURGERY: WILL IT HELP
OPTIMIZE ERGONOMICS OF SURGERY?
Sarayuth Viriyasiripong, Asis Lopez, Weil
Lai*, Gregory Mitchell, Sree Harsha
Mandava, Aaron Boonjindasup, Mary Powers,
Jonathan Silberstein, Benjamin Lee, New
Orleans, LA
MP20-11 DEVELOPMENT OF A SMARTPHONEFRIENDLY WEB APP FOR LIVE
EVALUATION OF ROBOTIC SURGERY
Thomas Bottyan*, Thomas G. Clifford, Zein
K. Nakhoda, Sarfaraz Serang, Andrew J.
Hung, Los Angeles, CA
MP20-18 CONCURRENT VALIDITY OF A
SIMULATED INANIMATE MODEL FOR
PHYSICAL LEARNING EXPERIENCE IN
PARTIAL NEPHRECTOMY (SIMPLE-PN)
Braden Candela*, Jonathan Stone, Jennifer
Park, Guan Wu, Hani Rashid, Jean Joseph,
Ahmed Ghazi, Rochester, NY
MP20-12 DOES ROBOTIC SIMULATOR
PERFORMANCE CORRELATE WITH
SURGICAL SKILL?
James Mills*, Helen Hougen, Daniel Bitner,
Tracey Krupski, Noah Schenkman,
Charlottesville, VA
MP20-19 SHARED DISCUSSION OR SELFPROMOTION? USE OF TWITTER BY U.S.
UROLOGY RESIDENCY PROGRAMS
Kevin Koo*, E. Ann Gormley, Lebanon, NH
MP20-13 DEVELOPMENT AND CONTENT
VALIDATION OF THE ASSESSMENT TOOL
FOR ROBOT-ASSISTED PARTIAL
NEPHRECTOMY
Eilidh Bruce*, Catherine Lovegrove, Nicholas
Raison, Benjamin Challacombe, London,
United Kingdom, Giacomo Novara, Alex
Mottrie, Aalst, Belgium, Jacques Hubert,
Nancy, France, Declan Murphy, Melbourne,
Australia, Prokar Dasgupta, Kamran Ahmed,
MP20-20 EVALUATION OF GLOBAL CONTINENTAL
UROLOGY RESIDENCY TRAINING
PROGRAMS: DISCREPANCIES AND
PERCEIVED RESIDENT COMPETENCIES
Zhamshid Okhunov*, Orange, CA, Thomas
Tailly, Ghent, Belgium, Giulio Patruno, Rome,
Italy, Simone L. Vernez, Rahul Dutta,
Stephanie Fukawa, Harwood Garland,
Samuel Juncal, Renai Yoon, Kamaljot Kaler,
Ramy Youssef, Orange, CA, Elspeth
McDougal, Vancouver, Canada, Mark L.
Jordan, Jaime Landman, Ralph Clayman,
Orange, CA
MP20-14 VARIATION IN THE TECHNICAL SKILL OF
SURGEONS PERFORMING ROBOTASSISTED RADICAL PROSTATECTOMY
Khurshid Ghani*, Ann Arbor, MI, Khurshid
Guru, Ahmed Aly, Buffalo, NY, Brian Lane,
Grand Rapids, MI, Richard Sarle, Dearborn,
MI, Susan Linsell, Andrew Brachulis, David
Miller, Ann Arbor, MI, Bryan Comstock,
Thomas Lendvay, seattle, WA, James
Peabody, Detroit, MI
MP20-15
*Presenting author
CREDITTM
ASSESSING INTRA-OPERATIVE
ERGONOMICS AND WORKLOAD IN
ROBOTIC SURGERY USING INERTIA
MEASURING UNIT SENSORS AND
VALIDATED QUESTIONNAIRES.
Justin Collins*, Stockholm, Sweden, Denny
Yu, Susan Hallbeck, Melissa Morrow,
Rochester, MN, Cem Dural, Peter Wiklund,
Magnus Kjellman, Mikael Forsman,
Stockholm, Sweden
73
FRIDAY
MP20-09 ROBOTIC SURGICAL SKILL ACQUISITION
IN TRAINEES: A RANDOMIZED
COMPARISON OF THE TWO ROBOTIC
TRAINERS AND TRAINEES’ SKILLS
TRANSFER TO A 3-D PRINTED
SIMULATED SURGICAL TASK IN THE
OPERATING ROOM
Nathan C. Wong*, Jen Hoogenes, Badr
Alharbi, Saahil Vij, Kevin Kim, Elisa
Bolognone, Bobby Shayegan, Edward D.
Matsumoto, Hamilton, Canada
Friday, May 6, 2016
3:30 pm - 5:30 pm
Podium Session 7
INFERTILITY: THERAPY II
Moderators: Jay Sandlow and Mark Sigman
TIME
3:30
3:40
3:50
4:00
4:10
4:20
4:30
ABSTRACT
NUMBER TITLE
PD07-01 ASSESSMENT OF TIME-DEPENDENT
CHANGES IN SEMEN PARAMETERS IN
INFERTILE MEN FOLLOWING
MICROSURGICAL VARICOCELECTOMY
Teruo Fukuda*, Hideaki Miyake, Noritoshi
Enatsu, Kei Matsushita, Masato Fujisawa,
Kobe, Japan
PD07-02
PD07-03
PD07-04
PD07-05
PD07-06
PD07-07
ABSTRACT
TIME NUMBER TITLE
4:40 PD07-08 CHANGES IN TESTICULAR VOLUME AND
FUNCTION AFTER TESTOSTERONE
REPLACEMENT VS. RESTORATION:
ANALYSIS OF A RANDOMIZED, DOUBLE
BLIND, PLACEBO-CONTROLLED TRIAL OF
ENCLOMIPHENE CITRATE VS.
ANDROGEL™ 1.62% IN MEN WITH
SECONDARY HYPOGONADISM
Igor Sorokin*, Charles Welliver, Paul Feustel,
Adam Parker, Albany, NY, Jaye Thompson,
Greg Fontenot, Ronald Wiehle, The
Woodlands, TX, Andrew McCullough, Albany,
NY
COMPARISON OF PATERNITY RATES
AND TIME TO CONCEPTION BETWEEN
ADOLESCENTS WITH VARICOCELE WHO
UNDERWENT MICROSURGICAL
VARICOCELE REPAIR OR HAD
OBSERVATION ONLY: A SINGLE
INSTITUTE EXPERIENCE WITH 408
CASES
Selahittin Éayan*, Sedat Şahin, Erdem
Akbay, Mersin, Turkey
COMPARING VASOEPIDIDYMOSTOMY
TECHNIQUE OUTCOMES: LONGITUDINAL
INTUSSUSCEPTION
VASOEPIDIDYMOSTOMY (LIVE) VERSUS
OTHER TECHNIQUES
Filipe Neto*, Abimbola Ayangbesan, Bobby
Najari, Phil Bach, Andrew Gottesdiener, Philip
Li, Marc Goldstein, New York, NY
MEN UNDERGOING
VASOEPIDIDYMOSTOMY FOR
VASECTOMY REVERSAL HAVE WORSE
OUTCOMES THAN MEN WITH PRIMARY
EPIDIDYMAL OBSTRUCTION
Bobby Najari*, Abimbola Ayangbesan,
Andrew Gottesdiener, Phil Bach, Filipe
Tenorio Lira Neto, Philip Li, Marc Goldstein,
New York, NY
THE UTILITY OF PSEUDOEPHEDRINE IN
DIABETES ASSOCIATED
ANEJACULATION
coskun kacagan*, sýrnak, Turkey, Christian
Nelson, nelson bennett, john mulhall, new
york, NY
ELECTROEJACULATION PERFORMED IN
PATIENTS WITH SPINAL CORD LESION –
A SINGLE CENTER 21 YEARS
EXPERIENCE
Tycho Lock*, Timo Soeterik, Ralph Oude
Ophuis, Paul Veenboer, Utrecht, Netherlands
4:50
PD07-09
EFFECT OF ANASTROZOLE ON
PROSTATE SPECIFIC ANTIGEN VALUES
IN HYPOGONADAL, SUBFERTILE MEN
Lorenzo DiGiorgio*, Robert Paul Bonitz,
Newark, NJ, David Shin, Hackensack, NJ
5:00
PD07-10
EFFECT OF BARIATRIC SURGERY ON
SEMEN PARAMETERS AND HORMONE
PROFILE; A PROSPECTIVE
OBSERVATIONAL STUDY.
Ahmad Majzoub*, Cleveland, OH, Mohamed
Arafa, Sami Al Said, Gaby Jabbour, Moataz
Basha, Doha, Qatar, Edmund Sabanegh,
Cleveland, OH, Haitham El Bardisi, Doha,
Qatar
5:10
PD07-11
DURATION OF TESTOSTERONE THERAPY
AND MALE AGE PREDICT TIME TO
RETURN OF NORMAL TOTAL MOTILE
SPERM COUNT AFTER HUMAN
CHORIONIC GONADOTROPIN THERAPY
Taylor P. Kohn*, Matthew R. Louis, Stephen
M. Pickett, Mark C. Lindgren, Alexander W.
Pastuszak, Larry I. Lipshultz, Houston, TX
5:20
PD07-12
POST-THAW OUTCOMES OF RARE OR
VERY LOW CONCENTRATIONS OF
CRYOPRESERVED SPERM
Nikita Abhyankar*, Chicago, IL, Martin
Kathrins, Boston, MA, Juergen Liebermann,
Meike Uhler, Yoshitomo Kobori, Gail Prins,
Craig Niederberger, Chicago, IL
CREDITTM
IS SPERM MORPHOLOGY ASSESSMENT
OF PATIENTS UTLIZING IN VITRO
FERTILIZATION USEFUL IN PREDICTING
ANEUPLOIDY?
Jorge Rodriguez-Purata*, Joseph Lee,
Michael Whitehouse, Lucky Sekhon, Kaitlyn
Costigan, Tanmoy Mukherjee, Benjamin
Sandler, Alan Copperman, Natan Bar-Chama,
New York City, NY
74
Friday, May 6, 2016
3:30 pm - 5:30 pm
Podium Session 8
TIME
3:30
3:40
3:50
ABSTRACT
NUMBER TITLE
PD08-01 PREDICTION OF THE CANCER STATE TO
INFORM A PERSONALIZED
MANAGEMENT PROGRAM FOR
PROSTATE CANCER
Rebecca Coley*, Aaron Fisher, Mufaddal
Mamawala, Kenneth Pienta, Scott Zeger, H.
Ballentine Carter, Baltimore, MD
PD08-02
PD08-03
EVALUATING THE FOUR KALLIKREIN
PANEL OF THE 4KSCORE FOR
PREDICTION OF HIGH-GRADE PROSTATE
CANCER IN MEN IN THE CANARY
PROSTATE ACTIVE SURVEILLANCE
STUDY (PASS)
Daniel Lin*, Marshall Brown, Lisa Newcomb,
Seattle, WA, Daniel Sjoberg, New York, NY,
James Brooks, Stanford, CA, Peter Carroll,
San Francisco, CA, Atreya Dash, Seattle,
WA, Michael Fabrizio, Norfolk, VA, Martin
Gleave, Vancouver, Canada, Todd Morgan,
Ann Arbor, MI, Peter Nelson, Seattle, WA,
Ian Thompson, San Antonio, TX, Yingye
Zheng, Seattle, WA
5-ALPHA-REDUCTASE INHIBITORS IN
MEN ON ACTIVE SURVEILLANCE FOR
PROSTATE CANCER
Charles Dai, Vishnu Ganesan, Joseph
Zabell*, Yaw Nyame, Daniel Hettel, Nima
Almassi, Daniel Greene, Samuel Haywood,
Chad Reichard, Anna Zampini, Alice Crane,
Hans Arora, Ahmed El-Shafei, Robert Stein,
Khaled Fareed, Michael Gong, J. Stephen
Jones, Andrew Stephenson, Eric Klein,
Cleveland, OH
4:00
PD08-04
VALIDATION OF A RISK CALCULATOR
PREDICTING BIOPSY OUTCOME IN
PROSTATE CANCER TREATED WITH
ACTIVE SURVEILLANCE
Daan Nieboer, Monique J. Roobol, Ewout W.
Steyerberg, Chris H. Bangma*, Rotterdam,
Netherlands
4:10
PD08-05
MEN WITH LOW-RISK PROSTATE
CANCER: NATIONWIDE, POPULATIONBASED STUDY IN SWEDEN
Stacy Loeb*, New York, NY, Yasin
Folkvaljon, Uppsala, Sweden, Caitlin Curnyn,
New York, NY, David Robinson, Umeå,
Sweden, Ola Bratt, Cambridge, United
Kingdom, Pär Stattin, Umeå, Sweden
4:20
PD08-06
*Presenting author
ABSTRACT
TIME NUMBER TITLE
4:30 PD08-07 MOLECULAR PROGRESSION OF
GLEASON 6 PROSTATE CANCER:
TRACKING OF SPECIFIC CLONES BY
IMAGE-GUIDED BIOPSY
Ganesh Palapattu*, Andi Cani, Daniel
Hovelson, Rohit Mehra, Jeffery Montgomery,
Todd Morgan, Simpa Salami, Scott Tomlins,
Ann Arbor, MI, Shyam Natarajan, Leonard
Marks, Los Angeles, CA
RISK PREDICTION TOOL FOR GRADE
RECLASSIFICATION IN FAVORABLE-RISK
MEN ON ACTIVE SURVEILLANCE
Mufaddal Mamawala*, Karthik Rao, Patricia
Landis, Jonathan Epstein, Bruce Trock,
Jeffrey Tosoian, Kenneth Pienta, H.
Ballentine Carter, Baltimore, MD
75
4:40
PD08-08
RACIAL DISPARITIES IN THE
FREQUENCY AND INTENSITY OF ACTIVE
SURVEILLANCE FOR LOW RISK
PROSTATE CANCER
Cindy Jean-Baptiste*, Yunhua Fan, Stephanie
Jarosek, Badrinath Konety, Minneapolis, MN
4:50
PD08-09
PREDIAGNOSTIC PROSTATEⴚSPECIFIC
ANTIGEN KINETICS ARE NOT
ASSOCIATED WITH THE RISK OF
PROGRESSION IN PROSTATE CANCER
PATIENTS MANAGED WITH ACTIVE
SURVEILLANCE
Viacheslav Iremashvili*, Shane Barney,
Murugesan Manoharan, Bruce Kava, Dipen J
Parekh, Sanoj Punnen, Miami, FL
5:00
PD08-10
FURTHER REDUCTION OF
DISQUALIFICATION RATES BY
ADDITIONAL MRI-TARGETED BIOPSY
WITH TRANSPERINEAL SATURATION
BIOPSY COMPARED TO STANDARD 12CORE SYSTEMATIC BIOPSIES FOR
SELECTION OF PROSTATE CANCER
PATIENTS FOR ACTIVE SURVEILLANCE.
Jan Philipp Radtke*, Heidelberg, Germany,
Timur Hasan Kuru, Cologne, Germany, David
Bonekamp, Martin Freitag, Claudia Verena
Kesch, Maya Wolf, Heidelberg, Germany,
Celine Alt, Duesseldorf, Germany, Gencay
Hatiboglu, Heidelberg, Germany, Silvan
Boxler, Berne, Switzerland, Sascha Pahernik,
Wilfried Roth, Matthias Claudius Roethke,
Heinz-Peter Schlemmer, Markus
Hohenfellner, Boris Hadaschik, Heidelberg,
Germany
5:10
PD08-11
COMBINING MRI-US FUSION TARGETED
BIOPSY WITH SYSTEMATIC BIOPSY
IMPROVES RISK STRATIFICATION OF
ACTIVE SURVEILLANCE CANDIDATES
Xiaosong Meng*, Andrew B. Rosenkrantz,
Neil Mendhiratta, Pauline Guiffart, Richard
Huang, Fang-Ming Deng, Ming Zhou,
Jonathan Melamed, William C. Huang,
Herbert Lepor, Samir S. Taneja, New York,
NY
FRIDAY
PROSTATE CANCER: LOCALIZED: ACTIVE SURVEILLANCE III
Moderator: Neal Shore
5:20
PD08-12
PROGNOSTIC VALUE OF PERCENT
GLEASON GRADE 4 IN PROSTATE
BIOPSY SPECIMENS AFTER RADICAL
PROSTATECTOMY
Adam Cole*, Rohit Mehra, Daniel Spratt,
Ganesh Palapattu, Chang He, Scott Tomlins,
Alon Weizer, Angela Wu, Felix Fang, Jeffrey
Montgomery, Lakshmi Kunju, David Miller,
Brent Hollenbeck, John Wei, Todd Morgan,
Ann Arbor, MI
CREDITTM
Friday, May 6, 2016
3:30 pm - 5:30 pm
Podium Session 9
PROSTATE CANCER: DETECTION & SCREENING II
Moderators: Fred Saad and J. Kellogg Parsons
TIME
3:30
3:40
3:50
ABSTRACT
NUMBER TITLE
PD09-01 CORRELATION BETWEEN STAGE SHIFT
AND DIFFERENCES IN MORTALITY
BETWEEN THE TWO STUDY ARMS OF
THE ERSPC.
Monique J. Roobol*, Rotterdam, Netherlands,
Anssi Auvinen, Tampere, Finland, Sigrid V.
Calsson, Goteborg, Sweden, Maciej
Kwiatkowski, Aarau, Switzerland, Louis J.
Denis, Antwerp, Belgium, Marco Zappa,
Florence, Italy, Alvaro Paez, Madrid, Spain,
Jonas Hugosson, Goteborg, Sweden, Sue M.
Moss, London, United Kingdom, Leonard P.
Bokhorst, Rotterdam, Netherlands
PD09-02
PD09-03
ABSTRACT
TIME NUMBER TITLE
4:00 PD09-04 ESTIMATING THE HARMS AND BENEFITS
OF PROSTATE CANCER SCREENING:
COMPARING COMMON CLINICAL
PRACTICE TO RECOMMENDED GOOD
PRACTICE
Sigrid Carlsson*, New York, NY, Tiago de
Carvalho, Monique Roobol, Rotterdam,
Netherlands, Jonas Hugosson, Gothenburg,
Sweden, Anssi Auvinen, Tampere, Finland,
Maciej Kwiatkowski, Aarau, Switzerland,
Arnauld Villers, Lille, France, Marco Zappa,
Florence, Italy, Vera Nelen, Antwerp,
Belgium, Alvaro Paez, Madrid, Spain, James
Eastham, Hans Lilja, New York, NY, Harry de
Koning, Rotterdam, Netherlands, Andrew
Vickers, New York, NY, Eveline Heijnsdijk,
Rotterdam, Netherlands
PROSTATE CANCER SCREENING AND
REFERRAL PATTERNS IN THE YEARS
SURROUNDING THE UNITED STATES
PREVENTATIVE SERVICES TASK FORCE
RECOMMENDATION AGAINST PSA
SCREENING IN ALL MEN
Ryan Hutchinson, Abdulhadi Akhtar*, Justin
Haridas, Deepa Bhat, Claus Roehrborn, Yair
Lotan, Dallas, TX
USPSTF PSA SCREENING GUIDELINES
RESULT IN HIGHER GLEASON SCORE
DIAGNOSES
Glen Gejerman*, Patrick Ciccone, Martin
Goldstein, Vincent Lanteri, Burton Schlecker,
John Sanzone, Michael Esposito, Sergey
Rome, Michael Ciccone, Eric Margolis,
Robert Simon, Yijun Guo, Bloomfield, NJ, Sri
Ram Pentakota, Newark, NJ, Hossein
Sadeghi-Nejad, Bloomfield, NJ
76
4:10
PD09-05
PROSTATE CANCER SCREENING
DECISION MAKING IN THREE STATES:
2013 BEHAVIORAL RISK FACTOR
SURVEILLANCE SYSTEM ANALYSIS
Jun Li*, Ingrid Hall, Guixiang Zhao, Atlanta,
GA
4:20
PD09-06
PROSTATE CANCER IS LESS FREQUENT
AND SEVERE IN HYPOGONADAL MEN
TREATED ADEQUATELY WITH
TESTOSTERONE UNDECANOATE
INJECTIONS (TU) FOR UP TO 8 YEARS
COMPARED TO UNTREATED
HYPOGONADAL CONTROLS
Ahmad Haider*, Karim Sultan Haider,
Bremerhaven, Germany, Gheorghe Doros,
Abdulmaged Traish, Boston, MA
4:30
PD09-07
THE ROLE OF PATIENT RACE AND
ETHNICITY IN PREDICTING PHYSICIAN
RECOMMENDATION OF PROSTATESPECIFIC ANTIGEN (PSA) TESTING
George Turini, III*, Annie Gjelsvik, Dragan
Golijanin, Gyan Pareek, Joseph Renzulli, II,
Providence, RI
4:40
PD09-08
SHOULD A MAN WITH A HISTORY OF
BREAST CANCER BE SCREENED FOR
PROSTATE CANCER?
Nikita Abhyankar*, Kent Hoskins, Michael
Abern, Gregory Calip, Chicago, IL
PD09-09
PROSTATE DISEASE CORRELATION ON
DEMOGRAPHICS AND CLINICAL
FINDINGS AMONG NATIONAL ANNUAL
PROSTATIC DIGITAL RECTAL EXAM
CAMPAIGN PARTICIPANTS
Paul Nimrod Firaza*, Rufino Agudera, Noel
Espallardo, Ulysses Quanico, Manila,
Philippines
5:00
PD09-10
EFFECT OF SHORT MESSAGE SERVICE
REMINDERS ON ADHERENCE TO
FOLLOW-UP OF NATIONAL PROSTATIC
DIGITAL RECTAL EXAM CAMPAIGN
PARTICIPANTS: A RANDOMIZED
CONTROLLED PILOT STUDY
Paul Nimrod Firaza*, Enrique Ian Lorenzo,
Ulysses Quanico, Manila, Philippines
5:10
PD09-11
5:20
PD09-12
SIGNIFICANCE OF PREOPERATIVE
BUTYRYLCHOLINESTERASE AS AN
INDEPENDENT PREDICTOR OF
BIOCHEMICAL RECURRENCE-FREE
SURVIVAL IN PATIENTS WITH PROSTATE
CANCER TREATED WITH RADICAL
PROSTATECTOMY
Takuya Koie*, Chikara Ohyama, Atsushi Imai,
Shingo Hatakeyama, Takahiro Yoneyama,
Yasuhiro Hashimoto, Tohru Yoneyama, Yuki
Tobisawa, Hirosaki, Japan
CREDITTM
DIAGNOSIS OF PROSTATE CANCER IN
ARAB MEN
Waleed Hassen*, Abu Dhabi, United Arab
Emirates
Friday, May 6, 2016
3:30 pm - 5:30 pm
Podium Session 10
GENERAL & EPIDEMIOLOGICAL TRENDS & SOCIOECONOMICS: QUALITY IMPROVEMENT & PATIENT SAFETY III
Moderator: Howard Goldman
TIME
3:30
ABSTRACT
NUMBER TITLE
PD10-01 THE USE OF PORTABLE VIDEO MEDIA
VERSUS STANDARD VERBAL
COMMUNICATION IN THE UROLOGICAL
CONSENT PROCESS: A RANDOMISED
CONTROLLED CLINICAL TRIAL
Matthew Winter*, Jon Kam, Ellen Hardy,
Sunny Nalavenkata, Marcus Handmer,
Hannah Ainsworth, Don Lee, Mark LouieJohnsun, Sydney, Australia
3:40
PD10-02
FOLEY CONSULTS: AN OPPORTUNITY
FOR QUALITY IMPROVEMENT BY
UROLOGICAL HOUSESTAFF
Lisa Parrillo*, Mark Upton, Philadelphia, PA,
Justin Ziemba, Baltimore, MD
3:50
PD10-03
SIMPLE OPERATING ROOM BUNDLE
REDUCES SUPERFICIAL SURGICAL SITE
INFECTIONS AFTER MAJOR UROLOGIC
SURGERY
Sarah Vij*, Ganesh Kartha, Venkatesh
Krishnamurthi, Howard B Goldman, Michelle
Ponziano, Cleveland, OH
4:00
PD10-04
*Presenting author
ABSTRACT
TIME NUMBER TITLE
4:10 PD10-05 COMPARISON OF PUBLICLY REPORTED
SURGICAL OUTCOMES WITH QUALITY
MEASURES FROM A STATEWIDE
SURGICAL IMPROVEMENT
COLLABORATIVE
Gregory Auffenberg*, Khurshid Ghani, Zaojun
Ye, Apoorv Dhir, Yuqing Gao, Ann Arbor, MI,
Brian Stork, Muskegon, MI, David Miller, Ann
Arbor, MI
COMPLIANCE WITH AUA ANTIBIOTIC
GUIDELINES – HOW ARE WE DOING WITH
URETEROSCOPY?
Daniel Greene*, Bradley Gill, Bryan Hinck,
Nima Almassi, Yaw Nyame, Venkatesh
Krishnamurthi, Sriharan Sivalingam, Manoj
Monga, Cleveland, OH
77
4:20
PD10-06
PATIENT FRAILTY PREDICTS FOR
SERIOUS COMPLICATIONS AFTER RENAL
CANCER SURGERY– ANALYSIS FROM
NSQIP
Jessica Hoffen*, Natalie Fahey, ChiHsiung
4:30
PD10-07
FASTER CARE FOR LESS? COST MODEL
OF HEMATURIA CARE REDESIGN
Tony T. Chen*, Wendy Webster, Mohammad
Shahsahebi, Michael E. Lipkin, Glenn M.
Preminger, Sharon K. Hull, Charles D.
Scales, Jr., Durham, NC
4:40
PD10-08
COMPLIANCE AND METABOLIC STONE
DISEASE. DOES DISTANCE TO CARE
MATTER?
Maxx Gallegos*, Julie Riley, Albuquerque,
NM
FRIDAY
4:50
4:50
PD10-09
HEALTH CARE DISPARITIES AND POST
DISCHARGE COMPLICATIONS IN
CYSTECTOMY
David M. Golombos*, Padraic O’Malley,
Patrick Lewicki, Bashir Al Hussein Al
Awamlh, New York, NY, Daniel P. Nguyen,
Bern, Switzerland, Igor Inoyatov, Brooklyn,
NY, Douglas S. Scherr, New York, NY
5:00
PD10-10
AFRICAN AMERICAN RACE IS NOT
ASSOCIATED WITH POST-OPERATIVE
COMPLICATIONS FOLLOWING UROLOGIC
ONCOLOGY PROCEDURES IN THE
AMERICAN COLLEGE OF SURGEONS
IMPROVEMENT PROGRAM
Daniel Parker*, Elizabeth Handorf, Marc
Smaldone, Robert G. Uzzo, Adam Reese,
Philadelphia, PA
5:10
PD10-11
COMPARISON OF SURVIVAL OUTCOMES
FOR AFRICANⴚAMERICAN AND
CAUCASIAN MEN WITH ADVANCED
PENILE CANCER IN FLORIDA
Chad R. Ritch*, Miami, FL, Nicola Pavan,
Trieste, Italy, Samarpit Ray, Nachiketh
Soodana⫺Prakash, Raymond R. Balise,
Dipen J. Parekh, Mark L. Gonzalgo, Miami,
FL
5:20
PD10-12
IMPLEMENTATION OF THE THREE E’S
(EFFICIENCY, EDUCATION, AND ECONSULTS) TO IMPROVE UROLOGY
ACCESS WITHIN THE VETERANS HEALTH
ADMINISTRATION
Matthew Uhlman*, Savanah Lakose, Dena
Dietzler, Joseph Cullen, Bradley Erickson,
Iowa City, IA
CREDITTM
78
Plenary Session
7:30 am - 12:00 pm
7:30
WELCOME AND ANNOUNCEMENTS
7:35
POINT-COUNTERPOINT: MITOMYCIN C FOR REFRACTORY BLADDER NECK CONTRACTURE
Moderator:
Kenneth Angermeier
Debater - Pro: Jill Buckley
Debater - Con: Anthony Mundy
7:55
STATE-OF-THE-ART LECTURE: LICHEN SCLEROSUS
Bradley Erickson
8:10
CRITICAL DISCUSSION: URETHROPLASTY: TRANSECTING VS. NON-TRANSECTING APPROACHES
Critical Discussant:
Gerald Jordan
Presenters:
Daniela Andrich
Keith Rourke
8:30
STATE-OF-THE-ART LECTURE: UROLOGY AND GLOBAL HEALTH: GLOBAL CIRCUMCISION: WHO CARES
Philip Li
8:35
STATE-OF-THE-ART LECTURE: UROLOGY AND GLOBAL HEALTH: WORLD VASECTOMY DAY
Ira Sharlip
8:40
CRITICAL DISCUSSION: STRATIFYING THE CARE OF BPH: FROM BENCH TO BEDSIDE AND BACK
John Hollingsworth
Presenters:
William Ricke
Wade Bushman
JOURNAL OF UROLOGY 2015: HIGH IMPACT ARTICLES
9:00
JOURNAL OF UROLOGY 2015: YEAR IN REVIEW
Joseph Smith
9:05
JOURNAL OF UROLOGY 2015: TOP PAPERS: FEMALE UROLOGY AND STONES
Toby Chai
9:15
JOURNAL OF UROLOGY 2015: TOP PAPERS: BPH AND ERECTILE DYSFUNCTION
Kevin McVary
9:25
JOURNAL OF UROLOGY 2015: TOP PAPERS: PROSTATE AND TESTIS CANCER
Laurence Klotz
9:35
JOURNAL OF UROLOGY 2015: TOP PAPERS: BLADDER AND RENAL CANCER
Badrinath Konety
9:45
JOURNAL OF UROLOGY 2015: TOP PAPERS: INVESTIGATIVE UROLOGY
Karl-Erik Andersson
10:00
PANEL DISCUSSION: ROBOTS ON THE HORIZON
Moderator:
Prokar Dasgupta
Panelists:
Michael Stark
Tadashi Matsuda
Koon Rha
10:25
CRITICAL DISCUSSION: STRATIFYING THE CARE OF BLADDER CANCER: FROM BENCH TO BEDSIDE AND
BACK
Alon Weizer
Panelists:
Anthony Costello
Bernard Bochner
Michael Shen
10:45
PANEL DISCUSSION: MANAGEMENT OF REFRACTORY OAB IN THE GERIATRIC PATIENT
Moderator:
David Ginsberg
Panelists:
Kenneth Peters
Michael Albo
Ragi Doggweiler
*Presenting author
79
SATURDAY
PLENARY I - SATURDAY
BEST ABSTRACTS
11:10
BEST ABSTRACT: PI-01: PROGRESSION FROM NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) TO
MUSCLE INVASION IS ASSOCIATED WITH LOWER RESPONSE RATES TO NEOADJUVANT CHEMOTHERAPY
Eugene Pietzak*, Eugene Cha, Emily Zabor, Qiang Li, David Solit, Jonathan Rosenberg, Dean Bajorin, Bernard
Bochner, Harry Herr, Gopa Iyer, New York, NY
11:18
BEST ABSTRACT: PI-02: A SYSTEMATIC APPROACH TO DISCUSSING ACTIVE SURVEILLANCE TO PATIENTS
WITH LOW-RISK PROSTATE CANCER
Behfar Ehdaie*, Melissa Assel, Nicole Benfante, New York, NY, Deepak Malhotra, Boston, MA, Andrew Vickers, New
York, NY
11:26
BEST ABSTRACT: PI-03: A RANDOMIZED STUDY OF INTRA-OPERATIVE AUTOLOGOUS RETROPUBIC
URETHRAL SLING ON URINARY CONTROL AFTER ROBOT ASSISTED RADICAL PROSTATECTOMY
Hao Nguyen*, Michael Leapman, San Francisco, CA, Sanoj Punnen, Miami, FL, Janet Cowan, San Francisco, CA,
Clint Cary, Indianapolis, IN, Christopher Welty, Matthew Cooperberg, Maxwell Meng, Kirsten Greene, Sima Porten,
Maurice Garcia, Peter Carroll, San Francisco, CA
11:34
BEST ABSTRACT: PI-04: SURGEON AND HOSPITAL VARIATION IN THE COSTS OF ROBOT-ASSISTED RADICAL
PROSTATECTOMY IN THE UNITED STATES
Alexander Cole*, Jeffrey Leow, Steven Chang, Christian Meyer, Nawar Hanna, Adam Kibel, Boston, MA, Mani Menon,
Jesse Sammon, Firas Abdollah, Detroit, MI, Benjamin Chung, Palo Alto, CA, Maxine Sun, Quoc-Dien Trinh, Boston,
MA
11:42
BEST ABSTRACT: PI-05: ULTRA-SHORT, SHORT, MEDIUM AND LONG-PULSE LASER LITHOTRIPSY
PERFORMANCE
Peter Kronenberg*, Amadora, Portugal, Olivier Traxer, Paris, France
11:50
BEST ABSTRACT: PI-06: LONG-TERM PUDENDAL NERVE ELECTRICAL STIMULATION ACCELERATES
RECOVERY FROM STRESS INCONTINENCE VIA INCREASED NEUROTROPHIN EXPRESSION AND NERVE
REGENERATION IN AN ANIMAL MODEL
Hai-Hong Jiang*, Qixiang Song, Bradley Gill, Yolanda Cruz, Cleveland, OH, Zhiliang Weng, Wenzhou, China, People’s
Republic of, Margot Damaser, Cleveland, OH
12:00
SESSION CONCLUDES
APPROVED FOR AMA PRA CATEGORY 1 CREDITTM
Plenary Session
10:00 am - 11:00 am
PLENARY II - SATURDAY
10:00
POINT-COUNTERPOINT: RENAL AUTOTRANSPLANT IS BETTER THAN ILEAL URETER FOR SEVERE
RADIATION-INDUCED URETERAL STRICTURES
Moderator:
Paul Kozlowski
Debater - Pro: Frank Darras
Debater - Con: Robert Stein
10:20
STATE-OF-THE-ART LECTURE: LIFE EXPECTANCY CALCULATIONS CAN IMPACT PATIENT SELECTION IN ALL
AREAS OF UROLOGY
John Barry
10:35
POINT-COUNTERPOINT: RADICAL PROSTATECTOMY SHOULD BE ENCOURAGED TO MEN AT ANY AGE
Moderator:
Edward Messing
Debater - Pro: John Davis
Debater - Con: Peter Albertsen
11:00
SESSION CONCLUDES
7:00 am - 6:30 pm
SEXUAL MEDICINE SOCIETY OF NORTH AMERICA (SMSNA)
Ballroom 20 D @ San Diego Convention Center
7:00
NON-CME PORTION OF PROGRAM
PRESIDENTIAL WELCOME
Moderator: Lawrence Hakim
BREAKFAST SYMPOSIUM: BREAKFAST
INCLUDED (HOSTED IN ROOM 20BC)
8:00
8:05
CME PORTION OF PROGRAM COMMENCES
80
CME ACTIVITY ANNOUNCEMENTS
Moderator: Run Wang
SESSION 1 – ICSM/ISSM
Moderators: Lawrence Hakim, Luca Incrocci
11:40
MALE SEXUAL FUNCTION: KEY
RECOMMENDATIONS FROM THE 4TH
INTERNATIONAL CONSULTATION FOR
SEXUAL MEDICINE
Gerald Brock
8:25
MEDICARE COVERAGE IN THE BEDROOM:
THE LIGHTS ARE ON
Eugene Rhee
FEMALE SEXUAL FUNCTION: KEY
RECOMMENDATIONS FROM THE 4TH
INTERNATIONAL CONSULTATION FOR
SEXUAL MEDICINE
Sharon Parish
8:40
ISSM WORLD MEETING IN BEIJING: A
MESSAGE FROM ISSM PRESIDENT
Wayne Hellstrom
8:55
ISSM WORLD MEETING IN BEIJING: CHINESE
SEXUAL MEDICINE AND WELCOME MESSAGE
- LOC
Hui Jiang
9:10
Q&A
9:20
SESSION 2 – SEXUAL FUNCTION AND
URINARY CONTINENCE AFTER RADICAL
PROSTATECTOMY
Moderators: Nelson Bennett, O. Lenaine Westney
9:40
11:55
Q&A
12:00
LUNCH SYMPOSIUM: LUNCH INCLUDED HOSTED IN ROOM 20D (CME NOT PROVIDED)
1:00
CME PORTION OF PROGRAM RESUMES
SESSION 6 – WOUNDED WARRIOR AND GU
INJURIES
Moderators: Hossein Sadeghi-Nejad, Gregory
Broderick
1:05
GU BATTLEFIELD INJURIES
Robert Dean
1:20
VIDEO AND LIVE DISCUSSION – PERSONAL
EXPERIENCE OF A WOUNDED WARRIOR
Aaron Causey, Kathleen Causey
1:45
Q&A
2:00
SESSION 7 – SEX AND PAIN
Moderators: Serge Carrier, Zhong Cheng Xin
DECIPHERING CHRONIC GENITAL PAIN
Melissa Farmer
POSTPROSTATECTOMY INCONTINENCE:
WHAT ARE THE ACTUAL RATES?
William Brant
9:30
SESSION 5 – 3RD ANNUAL IRA D. SHARLIP
LECTURE
Moderators: Ira Sharlip, Ronald Lewis
INCIDENCE OF SEXUAL DYSFUNCTION
AFTER RADICAL PROSTATECTOMY
Brian Christine
PSYCHOLOGICAL IMPACT AND
THERAPEUTIC APPROACHES FOR POST
PROSTATECTOMY SEXUAL DYSFUNCTION
AND URINARY INCONTINENCE
Christian Nelson
2:10
POST ORGASMIC ILLNESS SYNDROME
Chris McMahon
2:20
WHAT WE CAN DO FOR CHRONIC SCROTAL
CONTENT PAIN
Laurence Levine
2:30
Q&A
2:40
SESSION 8 – PANEL DISCUSSION: CHOOSING
IMPLANTS FOR ED WITH PD
Moderators: LeRoy Jones, Gerard Henry
9:50
Q&A
10:00
BREAK
10:15
SESSION 3 – POINT COUNTERPOINT DEBATE:
PENILE REHABILITATION
Moderators: Run Wang, Ricardo Munarriz
2:50
INFLATABLE WITH PARYLENE COATED
CYLINDERS
John Mulcahy
10:20
PENILE REHABILITATION IS BENEFICIAL
AFTER PELVIC ONCOLOGY SURGERY
Debater - Pro: Trinity Bivalacqua
Debater - Con: Landon Trost
3:00
NON INFLATABLE
David Ralph
3:10
Q&A
3:20
BREAK
3:35
SESSION 9 – ANDROGENS
Moderators: Andrew McCullough, Irwin Goldstein
10:50
Q&A
11:00
SESSION 4 – PEYRONIE’S DISEASE
Moderators: Allen Morey, Rafael Carrion
INFLATABLE WITH BIOFLEX CYLINDERS
Steven Wilson
SMSNA HYPOGONADISM COLLOQUIUM:
UPDATE
Arthur Burnett
PENILE CURVATURE IS NOT A PURELY
SEXUAL DYSFUNCTION: NON-SEXUAL
CONSEQUENCES OF PD
John Mulhall
11:15
TREATMENT OF ATYPICAL PD
Wayne Hellstrom
11:30
Q&A
*Presenting author
81
3:50
ANDROGENS AND BPH/LUTS/PROSTATE
CANCER: NEW KNOWLEDGE
Tobias Kohler
4:05
FACT OR FICTION: POST FINASTERIDE
SYNDROME
Mohit Khera
4:20
Q&A
SATURDAY
8:10
4:30
SESSION 10 – TRANSGENDER: PANEL
DISCUSSION
Moderators: Run Wang, Hossein Sadeghi-Nejad
5:25
SETTING UP PENILE TRANSPLANT PROGRAM
– A MULTIDISCIPLINARY JOURNEY
Arthur Burnett
FROM MALE TO FEMALE: PREPARATION AND
SURGICAL TIPS
Dana Ohl
5:40
Q&A
5:50
SMSNA BUSINESS MEETING (MEMBERS
ONLY)
6:30
ADJOURN
4:45
FROM FEMALE TO MALE: SURGICAL TIPS
AND MANAGEMENT OF COMPLICATIONS
Curtis Crane
5:00
Q&A
5:10
SESSION 11 – PENILE TRANSPLANT
CREDITTM
LESSON LEARNT FROM WORLD FIRST
SUCCESSFUL PENILE TRANSPLANTATION
Andre Van Der Merwe
7:15 am - 4:30 pm
ENGINEERING AND UROLOGY SOCIETY (EUS) - SECTION OF THE ENDOUROLOGICAL SOCIETY
Marina DE @ Marriott
7:15
REGISTRATION
9:20
7:25
WELCOME
Society Chair: William Roberts
NEW TECHNOLOGY IN URETERAL STENTS
Evangelos Liatsikos
9:30
SESSION 3: IDEA TO CLINICAL IMPACT
WORKSHOP: THE MEDICAL DEVICE
DEVELOPMENT PROCESS AT THE
UNIVERSITY OF MICHIGAN
7:30
SESSION 1: EMERGING HIGH-IMPACT
TECHNOLOGIES
Moderator: Sara Best
INTRODUCTION TO THE MEDICAL DEVICE
PROCESS: THE STORY OF HISTOTRIPSY
William Roberts
SECOND-HARMONIC GENERATION IMAGING
FOR CANCER: UROLOGIC APPLICATIONS
Sara Best, Kevin Eliceiri
7:42
BOILING-POINT HISTOTRIPSY FOR RCC:
PRECLINICAL DEVELOPMENT
George Schade
7:54
3D PRINTING SURGICAL TOOLS
Jeffrey Cadeddu
8:06
ENHANCED LITHOTRIPSY THROUGH
SUPPRESSION OF CAVITATION BUBBLES
Tim Hall
8:18
BURST WAVE LITHOTRIPSY: NONINVASIVE
STONE DISINTEGRATION BY FOCUSED
ULTRASOUND WITHOUT SHOCK WAVES
Adam Maxwell
8:30
SESSION 2: EAU SECTION OF UROTECHNOLOGY
Moderators: Evangelos Liatsikos, Jens Rassweiler
NEW TRAINING MODELS IN ENDOUROLOGY
Domenico Veneziano
8:40
ROBOTIC LIVING DONOR-EUROPEAN
EXPERIENCE
Michael Stoeckle
8:50
EXISTING SYSTEMS FOR NAVIGATION OF
PROSTATE BIOPSY
M. Fiedier
9:00
NEW LAPAROSCOPIC SUTURING DEVICE
Jens Rassweiler
9:10
LASER INDUCED STONE DISINTEGRATION
Thomas Knoll
9:50
TOOLS FOR INSIGHT: BUSINESS MODEL AND
VALUE PROPOSITION CANVASES
Bradley Martin
10:20
VALUE PROPOSITION DESIGN
Jon Servoss
10:40
CUSTOMER DISCOVERY: VERIFYING THE
UNMET NEED
Bradley Martin
11:05
CREATING YOUR INNOVATION PITCH
Connie Chang
11:20
WRAP UP: RESOURCES AND SUPPORT FROM
THE UNIVERSITY OF MICHIGAN
Connie Chang
11:30
AWARDS PRESENTATIONS
Dan Stoianovici
12:00
LUNCH BREAK
1:00
SESSION 4: STENT WORKING GROUP / FDA
PANEL DISCUSSION
Moderator: Ravindra Kulkarni
DRUG-ELUTING STENTS – AN UPDATE
John Denstedt
1:15
82
RADIANCE URETERAL STENT: CHALLENGES
AND ISSUES WITH REGULATORY
CLEARANCE
Walter Ryan
1:30
DELIVERING INNOVATOIN IN DRUG ELUTING
URETERAL STENTS: AN INDUSTRY
PERSPECTIVE
Tim Harrah
1:45
THE DO’S AND DON’T’S FOR AN APPROVAL
OF NEW DEVICES
John Baxley
2:00
SESSION 5: IMAGED GUIDED WORKING
GROUP
Moderator: James Borin
THE EVOLVING ROLE OF RENAL ENDOSCOPY
AS A DIAGNOSIS TOLL FOR PATIENTS WITH
NEPHROLITHIASIS
Michael Borofsky
2:10
#3-D PRINTING IN UROLOGY
Jonathan Silberstein
2:20
FIBER-OPTIC CONFOCAL LASER
ENDOMICROSCOPY: OPTICAL TISSUE
CHARACTERIZATION OF RENAL TUMORS
Li-Ming Su
2:30
TRANSPERINEAL MRI/US FUSION PROSTATE
BIOPSY
Ben Challacombe
2:40
NEAR-INFRARED FLUORESCENCE IMAGING
TO FACILITATE ROBOTIC RECONSTRUCTIVE
SURGERY
Lee Zhao
2:50
IRREVERSIBLE ELECTROPORATION IN
UROLOGY: TREATMENT AND FOLLOW-UP
Pilar Laguna Pes
POSTER SESSIONS 1 & 2 (TO RUN
CONCURRENT WITH EUS SESSION)
1:00 - 2:30 PM AND 3:00 - 4:30 PM
4:30
ADJOURN
CREDITTM
7:30 am – 11:45 am
RESIDENTS FORUM
7:30
REGISTRATION
10:10
BREAK
7:45
WELCOME AND INTRODUCTORY REMARKS
Committee Chair: Benjamin Ristau
10:20
CORE CURRICULUM SERIES
Yair Lotan
7:50
PRESENTATION SPONSORED BY BOSTON
SCIENTIFIC
10:30
TEACHING AWARD PRESENTATION
Daniel Parker
FINDING YOUR FIRST JOB: WHAT I WISH I
KNEW
Moderator: Hans Arora
10:40
RAFFLE DRAWING/CLOSING REMARKS
10:45
FELLOWS INTRODUCTION
8:10
POLICY PANEL OF EXPERTS ROUNDTABLE
Mark Litwin
James Ulchaker
C.J. Stimson
11:00
LUNCH WITH A FELLOW (PEDIATRICS,
RECONSTRUCTION, ONCOLOGY,
ENDOUROLOGY, MINIMALLY INVASIVE &
ROBOTIC SURGERY, INFERTILITY, FEMALE
PELVIC & RECONSTRUCTIVE MEDICINE)
8:40
PRACTICE PANEL OF EXPERTS
Gerald Jordan,
Richard Santucci
Sameer Siddiqui
Sanford Siegel
11:45
ADJOURN
9:10
GETTING TO “WIN” IN YOUR CONTRACT
NEGOTIATION
Roger Bonds
7:30 am - 12:00 pm
ARAB ASSOCIATION OF UROLOGY
1AB @ San Diego Convention Center
7:30
BREAKFAST AND COFFEE
8:00
WELCOME
Ibrahim Bani-Hani, Hassan Abol-Enein
SESSION I: URO-ONCOLOGY
Moderators: Ibrahim Bani Hani, Adel Alhunaian, Raja
Khauli
*Presenting author
83
8:05
BLADDER SPARING TREATMENT IN INVASIVE
BLADDER CANCER: LIMITATIONS AND
OUTCOME
Kemat Ashish
8:20
RENAL MASS: PREOPERATIVE NEEDLE
BIOPSY, VALUE AND LIMITATIONS
Ismail Khalaf
8:35
HIGH RISK AND LOCALLY ADVANCED
PROSTATE CANCER: MULTIDICIPLINARY
TREATMENT
Peter T. Scardino
8:50
HORMONE REFRACTORY PROSTATE
CANCER: THERAPEUTIC ALTERNATIVES
Fred Saad
9:05
OPTIMIZATION OF TURBT OF NON MUSCLE
INVASIVE DISEASE
Mark S. Soloway
9:20
DISCUSSION
9:40
9:55
10:10
10:25
BPH: TURP, OPEN PROSTATECTOMY IN THE
ERA OF LASER
Hassan Abol-Enein
10:40
DISCUSSION
SESSION III: FUNCTIONAL UROLOGY
Moderators: Nibbrass Al-Hamdani, Muhamed Bulbul,
Abdul Naser Al Shunaigat
11:00
SUI IN FEMALES: THE BEST, THE EASIEST
AND COST EFFECTIVE TREATMENT
Gamal M. Ghoniem
11:15
SESSION II: ENDOUROLOGY AND STONES
Moderators: Nasr Ramadan, Mohamed Eissa, Yasser
Farahat
LONG-TERM TESTOSTERONE THERAPY
Ridwan Shabsigh
11:30
RECENT ADVANCES IN URS: EXPANDED
INDICATIONS
Wahib E.F. Isac
MEDICAL TREATMENT OF MALE INFERTILITY:
WHAT IS NEW?
Keith A. Jarvi
11:45
DISCUSSION
11:55
CLOSING REMARKS
12:00
ADJOURN
MEDICAL TREATMENT OF URINARY STONES:
THE PLACE IN MODERN UROLOGY
Ibrahim Bani Hani
LIMITATION OF PCNL: ENDOSCOPIC
SOLUTIONS
Michael Grasso, III
CREDITTM
7:30 am – 5:30 pm
SOCIETY FOR PEDIATRIC UROLOGY
Seaport A-E @ Hyatt
6:30
REGISTRATION/BREAKFAST
12:15 – 1:30 FELLOWS LUNCHEON
7:30
SESSION 6: HYPOSPADIAS POSTER SESSION
Melise Keays
Elizabeth Yerkes
1:45
SESSION 8: NEUROPATHIC BLADDER
Konrad Szymanski
Eric Kurzock
8:35
SPU LECTURE: THE 8 PRACTICES OF HIGHLY
SUCCESSFUL SURGEONS
Jeffrey Smith
2:50
9:20
BREAK/EXHIBITS
POINT COUNTERPOINT: TRAUMA: KIDS ARE
LITTLE ADULTS
Moderator: Chad Wallis
Panelists: Yes: Ben Breyer
No: Doug Husmann
9:40
SESSION 7: NEUROPATHIC BLADDER/RECON
Dominic Frimberger
Tony Herndon
3:45
BREAK/EXHIBITS
4:10
SESSION 9: TUMOR/TRAUMA/TRANSPLANT
Blake Palmer
Fernanado Ferrer
5:20
PEDIATRIC UROLOGIC ONCOLOGY WORKING
GROUP (PUOWG) SURVEY OF SPU MEMBERS
ON THE CURRENT STATE OF ONCOLOGY
AMONG PEDIATRIC UROLOGISTS
Nicholas Cost
on behalf of the PUOWG Executive Committee
5:30
ADJOURN
10:15
PANEL DISCUSSION: UROLOGIC
CONGENITALISM: SUCCESSFUL TRANSITION
FROM CHILDHOOD TO ADULTHOOD
Moderator: Rosalia Misseri
Panelists: Elizabeth Yerkes, Hadley Wood, Joseph
Smith
11:15
SPU PRESIDENTIAL ADDRESS
11:30
SPU PRIZE AWARDS, GRADUATING FELLOWS
AND SPU RESEARCH GRANT PRESENTATION
11:45
SPU ANNUAL BUSINESS MEETING (SPU
MEMBERS ONLY)
12:15
LUNCH (ON OWN)
CREDITTM
84
8:00 am - 10:00 am
PROSTATE CANCER: DETECTION & SCREENING III
Moderators: Ryan Berglund and Ben Challacombe
ABSTRACT
NUMBER TITLE
MP21-01 THE WEIGHTED GLEASON SCORE OF
PROSTATE BIOPSY SPECIMENS
IMPROVES THE PREDICTION OF
PATHOLOGIC GLEASON SCORE
Eric Cho*, Joshua Kaplan, Andrew Harbin,
Anastasiya Kamenko, Frederick Ramsey,
Jack Mydlo, Daniel Eun, Adam Reese,
Philadelphia, PA
ABSTRACT
NUMBER TITLE
MP21-07 THE AFFORDABLE CARE ACT AND PSA
SCREENING PRACTICES: ANALYSIS OF
RACIAL SUBGROUPS
Alexander Cole*, Christian Meyer, Malte
Vetterlein, Björn Löppenberg, Adam Kibel,
Boston, MA, Firas Abdollah, Detroit, MI,
Jeffrey Leow, Thomas Seisen, Michael
Zavaski, Maxine Sun, Boston, MA, Jesse
Sammon, Detroit, MI, Quoc-Dien Trinh,
Boston, MA
MP21-02 NOVEL QUANTITATIVE IMAGING
ALGORITHMS DISTINGUISH LOCALIZED
AND METASTATIC HIGH-GRADE PRIMARY
PROSTATE CANCERS
Eric Miller*, Arkadiusz Gertych, Zhaoxuan
Ma, Nathan Ing, Michael Lewis, Beatrice
Knudsen, Isla Garraway, Los Angeles, CA
MP21-08 DETERMINANTS OF PROSTATE SPECIFIC
ANTIGEN SCREENING AMONG BLACK
MEN IN THE UNITED STATES IN THE
CONTEMPORARY ERA
Jesse Sammon*, Deepansh Dalela, Detroit,
MI, Firas Abdollah, Royal Oak, MI, Toni
Choueiri, Boston, MA, Paul Han, Moritz
Hansen, Portland, ME, Paul Nguyen, Boston,
MA, Akshay Sood, Mani Menon, Detroit, MI,
Quoc-Dien Trinh, Boston, MA
MP21-03 HOW ACCURATE IS THE PSA TEST? A
PREVALENCE STUDY OF DISTURBED
PSA VALUES IN A TERTIARY REFERRAL
HOSPITAL
Cedric Poyet*, Karim Saba, Noemie
Lautenbach, Lanja Saleh, Martin Umbehr,
Tullio Sulser, Michael Müntener, Arnold von
Eckardstein, Zurich, Switzerland
MP21-09 INFORMED DECISION MAKING PRIOR TO
PSA SCREENING: INITIAL RESULTS
USING THE AMERICAN CANCER SOCIETY
(ACS) DECSION AID (DA) AMONG A
MEDICALLY UNDERSERVED COHORT
Mehmet Gokce*, Jacqueline Frost, Pamela
Roberson, Robert Volk, Curtis Pettaway,
Houston, TX
MP21-04 SCREENING FOR FLUOROQUINOLONE
RESISTANT E. COLI PRIOR TO TRUS
GUIDED PROSTATE BIOPSY IS COST
EFFECTIVE AND SIGNIFICANTLY
REDUCES THE RISK OF SEPSIS.
Michael Holmes*, Chunhuan Lao, Ross
Lawrenson, Chris Mansell, Hamilton, New
Zealand
MP21-05
MP21-10 THE IMPACT OF MEDICARE ELIGIBILITY
ON PROSTATE CANCER SCREENING
BEHAVIORS
Christian Meyer*, Boston, MA, Jesse
Sammon, Detroit, MI, Björn Löppenberg,
Jeffrey Leow, Nawar Hanna, Julian Hanske,
Alexander Cole, Boston, MA, Firas Abdollah,
Mani Menon, Detroit, MI, Maxine Sun, QuocDien Trinh, Boston, MA
TEMPORAL TRENDS IN PROSTATE
CANCER RISK GROUP STRATIFICATION
FOLLOWING THE 2008 UNITED STATES
PREVENTIVE SERVICES TASK FORCE
RECOMMENDATIONS
Firas Abdollah*, Royal Oak, MI, Deepansh
Dalela, Akshay Sood, Jesse Sammon, Patrick
Karabon, Detroit, MI, Christian Meyer, Maxine
Sun, Toni Choueiri, Boston, MA, Mani
Menon, Detroit, MI, Quoc-Dien Trinh, Boston,
MA
MP21-11 AGE DEPENDENT VARIATION IN THE
EFFECT OF PHYSICIAN
RECOMMENDATIONS TO UNDERGO
PROSTATE SPECIFIC ANTIGEN (PSA)
SCREENING FOLLOWING THE UNITED
STATES PREVENTIVE SERVICES TASK
FORCE 2012 STATEMENT AGAINST PSA
SCREENING.
Jesse Sammon*, Deepansh Dalela, Detroit,
MI, Firas Abdollah, Royal Oak, MI, Akshay
Sood, Detroit, MI, Paul Han, Moritz Hansen,
Portland, ME, Björn Löppenberg, Patrick
Karabon, Mani Menon, Detroit, MI, Quoc-Dien
Trinh, Boston, MA
MP21-06 STATE-BY-STATE RACIAL VARIATIONS IN
PROSTATE SPECIFIC ANTIGEN
SCREENING PATTERNS: A NATIONWIDE
ANALYSIS.
Deepansh Dalela*, Björn Löppenberg, Akshay
Sood, Jesse Sammon, Detroit, MI, Maxine
Sun, Quoc-Dien Trinh, Boston, MA, Wooju
Jeong, Craig Rogers, James Peabody, Mani
Menon, Detroit, MI, Firas Abdollah, Royal
Oak, MI
*Presenting author
85
MP21-12 PCA3 AND T2:ERG ADD FURTHER
PREDICTIVE AND CLINICAL BENEFIT TO
THE DETECTION OF PROSTATE CANCER
IN MEN OF VARIOUS AGES IN THE EARLY
DETECTION RESEARCH NETWORK
(EDRN)
Padraic O’Malley*, David M. Golombos,
Patrick Lewicki, Bashir Al Hussein Al
Awamlh, Paul J. Christos, New York, NY, Ian
M. Thompson, San Antonio, TX, Martin G.
Sanda, Atlanta, GA, John T. Wei, Livonia, MI,
Mark A. Rubin, Christopher E. Barbieri,
Douglas S. Scherr, New York, NY
MP21-17 STANDARD PROSTATE BIOPSY VS NEW
DIAGNOSTIC PATH WITH MRI AND
FUSION BIOPSY: PRELIMINARY RESULTS
OF A PROSPECTIVE RANDOMIZED
STUDY.
Francesco Porpiglia*, Fabrizio Mele, Matteo
Manfredi, Riccardo Bertolo, Daniele
Amparore, Enrico Checcucci, Roberta Aimar,
Marco Cossu, Enrico Bollito, Orbassano,
Torino, Italy, Filippo Russo, candiolo, torino,
Italy, Dario Gned, Agostino De Pascale,
Orbassano, Torino, Italy, Stefano Cirillo,
candiolo, torino, Italy, Cristian Fiori,
Orbassano, Torino, Italy
MP21-13 DEVELOPMENT OF A NEW NOMOGRAM
TO PREDICT INSIGNIFICANT PROSTATE
CANCER IN PATIENTS UNDERGOING
Jae Ho Yoo*, Tae Heon Kim, Seoul, Korea,
Republic of, Seung Hee Yum, Gunpo, Korea,
Republic of, Byong Chang Jeong, Seong Il
Seo, Seong Soo Jeon, Han Yong Choi, Hyun
Moo Lee, Seoul, Korea, Republic of
MP21-18 PROSTATE CANCER DETECTION
BETWEEN PERIPHERAL ZONE AND
TRANSITIONAL ZONE TARGETED
BIOPSIES: PRELIMINARY RESULTS FROM
A PROSPECTIVE COHORT OF MEN
UNDERGOING MRI-US FUSION BIOPSY
Bruno Nahar*, Nachiketh Soodana Prakash,
Raymond Balise, Tara Abboud, Nicola Pavan,
Samarpit Rai, Felipe Munera, Vasanti
Jhaveri, Rosa Castillo, Murugesan
Manoharan, Bruce Kava, Ramgopal
Satyanarayana, Mark Gonzalgo, Chad Ritch,
Dipen Parekh, Sanoj Punnen, Miami, FL
MP21-14 IS THERE ANY OBJECTIVE
CORRELATION BETWEEN PROSTATE
IMAGING-REPORTING AND DATA
SYSTEM SCORE ON PRE-BIOPSY
MULTIPARAMETRIC MRI OF THE
PROSTATE AND GLEASON SCORE ON
TARGETED TRUS AND TEMPLATE
PROSTATE BIOPSY?
Yih Chyn Phan*, Panagiotis Papikinos,
Shahid Khan, Naomi Sellars, Ajay Pankhania,
James Henderson, Mushtaq Shuja, Michael
Swinn, Abhay Rane, Redhill, United Kingdom
MP21-15
MP21-19 PREVALENCE OF MRI USE IN PATIENTS
RECEIVING TREATMENT FOR PROSTATE
CANCER
Katherine Cotter*, Yunhua Fan, Badrinath
Konety, Minneapolis, MN
MP21-20 ENDORECTAL MULTIPARAMETRIC 3TESLA MAGNETIC RESONANCE IMAGING
ASSOCIATED TO SYSTEMATIC
COGNITIVE BIOPSIES DO NOT INCREASE
PROSTATE CANCER DETECTION RATE: A
RANDOMIZED PROSPECTIVE TRIAL
Gianluigi Taverna*, Giorgio Bozzini, Mauro
Seveso, Oliviero de Francesco, Pietro Bono,
Castellanza VA, Italy, Marco Provenzano,
NicoloMaria Buffi, Giorgio Guazzoni, Rozzano
MI, Italy, Alberto Mandressi, Castellanza VA,
Italy
RESONANCE IMAGING AND MRI/TRUSFUSION-BIOPSY FOR INDEX TUMOR
DETECTION: CORRELATION WITH
RADICAL PROSTATECTOMY SPECIMEN
Jan Philipp Radtke*, Constantin Schwab,
Maya Wolf, Martin Freitag, Heidelberg,
Germany, Celine Alt, Duesseldorf, Germany,
Claudia Verena Kesch, Sascha Pahernik,
David Bonekamp, Wilfried Roth, Svenja
Schüler, Christian Stock, Heinz-Peter
Schlemmer, Matthias Claudius Roethke,
Markus Hohenfellner, Boris Hadaschik,
Heidelberg, Germany
CREDITTM
MP21-16 3T MULTI-PARAMETRIC MRI
PERFORMANCE IN PROSTATE CANCER
DETECTION: PERIPHERAL ZONE TUMORS
VS. TRANSITIONAL ZONE
Nazanin Asvadi*, Pooria Khoshnoodi, Hector
Alcala, Amin Moshksar, Daniel Margolis, Los
Angeles, CA, Anthony Sisk, Los Angels, CA,
Jiaoti Huang, Robert Reiter, Steven Raman,
Los Angeles, CA
86
8:00 am - 10:00 am
STONE DISEASE: SURGICAL THERAPY I
Moderators: David Duchene, Brian Eisner and Ali Kural
ABSTRACT
NUMBER TITLE
MP22-01 REARRANGEMENT OF THE GUY’S STONE
SCORE IMPROVES PREDICTION OF
STONE FREE RATE AFTER
PERCUTANEOUS NEPHROLITHOTOMY.
Jorge Moreno-Palacios*, Efraı́n MaldonadoAlcaraz, Enrique Garcia-Peña, Juan Ramon
Torres-Anguiano, Eduardo Serrano-Brambila,
Leon Octavio Torres-Mercado, Virgilio
Augusto López-Sámano, Mexico City, Mexico
ABSTRACT
NUMBER TITLE
MP22-08 THE USE OF AN OCCLUSION BALLOON
DEVICE AND PCNL OUTCOMES: SINGLE
CENTER EXPERIENCE
Ilan Z. Kafka, Marc J. Rogers*, Omar Ayyash,
Sarah Sprauer, Timothy D. Averch,
Pittsburgh, PA
MP22-09 ENDOLITHOTRIPSY FOR UROLITHIASIS
IN A GAS (CO2) MEDIUM.
P.V. Glibochko, Y.G. Alyaev, L.M. Rapoport,
D.G. Tsarichenko, E.G. Arzumanyan*,
Moscow, Russian Federation
MP22-02 COMPARISON OF SCORING SYSTEMS
USED TO PREDICT STONE FREE STATUS
AFTER PERCUTANEOUS
NEPHROLITHOTOMY: A SINGLE CENTRE
STUDY WITH 208 CASES
Benjamin Lim*, Wai Loon Yam, Sey Kiat Lim,
Jin Kiat Teo, Darren Goh, Foo Cheong Ng,
Singapore, Singapore
MP22-10 INCREASED THE RISK OF POSITIVE
INTRAOPERATIVE URINE CULTURE
AFTER URETEROSCOPIC LITHOTRIPSY
FOR PATIENTS WITH MILD PYURIA
Kuan-Jung Lin*, Yi-Hsiu Huang, Taipei,
Taiwan
MP22-03 RIRS: DUSTING VS FRAGMENTAION FOR
RENAL STONE < 2 CM
Wael Gamal*, Ahmed Mmdouh, Sohag, Egypt
MP22-11 SAFETY AND SURGICAL OUTCOMES OF
PERCUTANEOUS NEPHROLITOTOMY IN
PATIENTS WITH POOR RENAL
FUNCTION.
Alexander Heinze*, Miguel Villalobos,
Eduardo Cruz-Nuricumbo, Lizzette Gomez de
Regil, Rodrigo Suarez-Ibarrola, Carlos Otilio
Garcı́a-Jiménez, Marı́a Teresa del Carmen
Moreno y Suarez, Eddie Noj-Moreno, Merida,
Mexico, Maria Dolores Alsina, Joey Piccolo,
Kassandra Oliva, Mérida, Mexico
MP22-04 URETEROSCOPY FOR URETERAL
STONES: A MULTIVARIATE ANALYSIS OF
ADVERSE EVENTS
Carrie Yeast*, Woodson Smelser, Jack
Campbell, Derek Benham, Chelsea Deroche,
James Cummings, Columbia, MO
MP22-05
MICROPERC VERSUS MINIPERC FOR THE
MANAGEMENT OF MEDIUM-SIZED RENAL
STONES: A COMPARATIVE
MULTICENTER CLINICAL STUDY.
Amr Gaber, Dortmund, Germany, Riccardo
Galli, Marco Rosa, Salvatore Micali, Modena,
Italy, Mohamed Keheila*, New York, NY,
Mohamed Abdelhafez, Medhat Abdalla,
Assiut, Egypt, David Leavitt, New York, NY,
Giampaolo Bianchi, Modena, Italy, Michael
Truss, Dortmund, Germany
MP22-12 THE RELATIONSHIP BETWEEN
OPERATIVE TIMES AND COMPLICATION
RATES IN PERCUTANEOUS
NEPHROSTOLITHOTOMY PROCEDURES
Julie Stein*, Kaitlan Cobb, John Michael
DiBianco, Patrick Mufarrij, Washington, DC
MP22-13 BURST LASER LITHOTRIPSY – A NOVEL
LITHOTRIPSY MODE
Peter Kronenberg*, Amadora, Portugal,
Olivier Traxer, Paris, France
MP22-06 PELVIC URETERAL STONES IN WOMEN:
MICROURETEROSCOPY REDUCES THE
NEED FOR URETERAL STENTING
COMPARED TO CONVENTIONAL
URETEROSCOPY.
Juan-Pablo Caballero-Romeu*, Alicante,
Spain, Juan-Antonio Galán-Llopis, Helena
Pérez-Seoane, Alejandro-Jose Garcia-Segui,
Aleixandre Verges-Prosper, Araceli AmorósTorres, Elche, Spain
MP22-14 THE IMPACT OF LASER FIBER STRIPPING
ON STONE FRAGMENTATION & POWER
OUTPUT
Cayde Ritchie*, Patrick Yang, Brandon
Peplinski, Salim Cheriyan, Samuel Abourbih,
Duane Baldwin, Loma Linda, CA
MP22-15
MP22-07 SPONTANEOUS PASSAGE OF URETERAL
STONES FOLLOWING STENT PLACEMENT
Lee Baumgarten*, Anuj Desai, Michel Pontari,
Daniel Eun, Jack Mydlo, Adam Reese,
Philadelphia, PA
*Presenting author
87
STONE RETROPULSION WITH THE USE
OF A RECENTLY INTRODUCED HOLMIUM
LASER SYSTEM.
Panagiotis Kallidonis*, Lefteris Amanatides,
Nikolaos Spiliopoulos, Vasileios
Panagopoulos, Marinos Vasilas, Iason
Kyriazis, Wissam Kemal, Evangelos Liatsikos,
Patra, Greece
MP22-16 A RANDOMIZED CONTROLLED STUDY OF
MULTI-PERSON TAKE TURNS
OPERATION AND SINGLE-PERSON
OPERATION IN FLEXIBLE
URETEROSCOPY FOR >1.5CM RENAL
CALCULI
Gonghui Li*, Hangzhou, China, People’s
Republic of
MP22-19 PERI-OPERATIVE OUTCOMES OF
PERCUTANEOUS STONE SURGERY IN
PATIENTS WITH URINARY DIVERSIONS.
Marco Bolgeri*, Giorgio Mazzon, Vimoshan
Arumuham, Rebecca Dale, Clare Allen, Alex
Kirkham, Navin Ramachandran, Sian Allen,
Daron Smith, Tim Philp, Simon Choong,
MP22-17 COMBINED ROBOTIC FLEXIBLE
URETERORENOSCOPY AND MINI
PERCUTANEOUS LITHOTRIPSY IN
SUPINE POSITION
Kemal Sarica*, Istanbul, Turkey, Nida Zafer
Tokatli, Remzi Saglam, H. Gurdal Inal,
Yildirim Yilmaz, Ankara, Turkey, Anup Patel,
MP22-20 CLINICAL OUTCOMES OF
PERCUTANEOUS NEPHROLITOTOMY IN
PATIENTS WITH INCIDENTAL PURULENT
URINE
Miguel Villalobos-Gollas*, Alexander Heinze,
Lizzette Gomez-de-Regil, Merida, Mexico
CREDITTM
MP22-18 THE VOLUMETRIC EVALUATION OF
MULTI CENTRIC RESULTS OF ROBOT
ASSISTED FLEXIBLE URETEROSCOPY
Petrisor Geavlete*, Bucharest, Romania, Jens
Rassweiler, Heilbronn, Germany, Jan Klein,
Ulm, Germany, Nida Zafer Tokatli, Ankara,
Turkey, Olivier Traxer, Paris, France,
AbdulQadir Al Zarooni, Yasser Farahat, Umm
Al Quwain, United Arab Emirates, Remzi
Saglam, Ankara, Turkey
8:00 am - 10:00 am
SURGICAL TECHNOLOGY & SIMULATION: INSTRUMENTATION & TECHNOLOGY I
Moderators: Jean de la Rosette, Gerhard Fuchs and Georges Haber
ABSTRACT
NUMBER TITLE
MP23-01 FLOW DISRUPTIONS IN ROBOTICASSISTED LAPAROSCOPIC RADICAL
PROSTATECTOMY: THE IMPACT OF
RESIDENT EDUCATION
Christopher Dru*, Tom Feng, Los Angeles,
CA, Jennifer Anger, Beverly Hills, CA, Ken
Catchpole, Los Angeles, CA
ABSTRACT
NUMBER TITLE
MP23-05 EVALUATION OF TMAX, THERMAL
SPREAD, AND HEAT DISSIPATION OF
MONOPOLAR “SHORT BURST” CAUTERY
MIITIGATED BY ICE COLD IRRIGATION IN
A PORCINE MODEL
Adam Gordon, Douglas Skarecky*, Zhamshid
Okhunov, Christina Hwang, Renai Yoon,
Thomas Ahlering, Orange, CA
MP23-02 OVERNIGHT STAY IS ADEQUATE FOR
ALL TYPES OF ROBOTIC RENAL
SURGERY
Sean Henderson, Janice Rosenthal, Ronney
Abaza*, Dublin, OH
MP23-06 TRANSVAGINAL NATURAL ORIFICE
TRANSLUMINAL ENDOSCOPIC SURGERY
(NOTES) IN UROLOGY: REPORT OF 261
CASES IN A SINGLE CENTER
Zou Xiaofeng*, Zhang Guoxi, Xiao Rihai,
Yuan Yuanhu, Wu Gengqing, Wang Xiaoning,
Xue Yijun, Ganzhou, Jiangxi, China, People’s
Republic of
MP23-03 CONTINENCE RECOVER AFTER
VESICOURETHRAL ANASTOMOSIS WITH
BIDIRECTIONAL SUTURE (V-LOC 180)
VERSUS POLYGLECAPRONE
(MONOCRYL) IN ROBOTIC-ASSISTED
Emad Rajih*, Blatimore, MD, Malek Meskawi,
Abdullah Alenizi, Kevin C Zorn, Assaad
Elhakim, Montreal, Canada
MP23-07 BIODEGRADABLE DRUG-ELUTING
STENTS: TARGETING UROTHELIAL
TUMORS OF UPPER URINARY TRACT
Alexandre Barros*, Gmr, Portugal, Shane
Browne, Berkeley, CA, Carlos Oliveira,
Braga, Portugal, Rui L. Reis, Ana Rita
Duarte, Gmr, Portugal, Kevin Healy,
Berkeley, CA, Estevão Lima, Braga, Portugal
MP23-04 IMPACT OF OBESITY ON WOUND
COMPLICATIONS FOLLOWING RADICAL
PROSTATECTOMY IS MITIGATED BY
ROBOTIC TECHNIQUE
M Francesca Monn*, Kaitlin R. Jaqua, Adam
C. Calaway, Matthew J. Mellon, Michael O.
Koch, Ronald S. Boris, Indianapolis, IN
88
MP23-08 HYBRID TRANSVAGINAL NOTES
NEPHRECTOMY VERSUS CONVENTIONAL
LAPAROSCOPIC NEPHRECTOMY: A
PROSPECTIVE, NONRANDOMISED TRIAL
AT A SINGLE CENTER
Zou Xiaofeng*, Zhang Guoxi, Xue Yijun,
Yuan Yuanhu, Xiao Rihai, Wu Gengqing,
Ganzhou, Jiangxi, China, People’s Republic
of
MP23-14 INITIAL CLINICAL EXPERIENCE WITH A
NOVEL ELECTROMAGNETICALLY
TRACKED TRANSPERINEAL FUSIONGUIDED PROSTATE BIOPSY SYSTEM
Arvin George*, Daniel Su, Bethesda, MD,
Paavo Immonen, Cambridge, MA, Janice
Thai, Harish Narayanan, Bethesda, MD,
Bachir Taouli, Sarah Lewis, New York, NY,
Scott Thompson, Samuel Coons III,
Cambridge, MA, Baris Turkbey, Peter
Choyke, Peter Pinto, Bradford Wood,
Bethesda, MD, Ardeshir Rastinehad, New
York, NY
MP23-09 ROBOT-ASSISTED LAPAROSCOPIC
RETROPERITONEAL LYMPH NODE
DISSECTION FOR NON-SEMINOMATOUS
TESTICULAR CANCER IN THE PRIMARY
SETTING: A RETROSPECTIVE MULTIINSTITUTIONAL ANALYSIS
Michael Marshall*, San Diego, CA, Haidar
Abdul-Muhsin, Phoenix, AZ, Sean Stroup,
San Diego, CA, Ithaar Derweesh, La Jolla,
CA, Michael Woods, Chapel Hill, NC, James
Porter, Seattle, WA, Erik Castle, Phoenix, AZ,
James L’Esperance, San Diego, CA
MP23-15
MP23-10 MULTICENTER EVALUATION OF
PRIMARY ROBOT-ASSISTED
LAPAROSCOPIC RPLND IN LOW-STAGE
NON-SEMINOMATOUS TESTICULAR
CANCER
Shane Pearce*, Chicago, IL, Michael Gorin,
Baltimore, MD, Amy Luckenbaugh, Ann
Arbor, MI, Stephen Williams, John Ward,
Houston, TX, Jeffrey Montgomery, Khaled
Hafez, Alon Weizer, Ann Arbor, MI, Phillip
Pierorazio, Mohamad Allaf, Baltimore, MD,
James Porter, Seattle, WA, Scott Eggener,
Chicago, IL
MP23-16 EVALUATION OF THE ROLE OF
LAPAROENDOSCOPIC SINGLE-SITE
SURGERY VERSUS MINILAPAROSCOPY
FOR TREATMENT OF DIFFERENT UPPER
URINARY TRACT PATHOLOGIES:
PROSPECTIVE RANDOMIZED
COMPARATIVE STUDY
Aly Abdel-Karim*, Elsaid Yahia, Mohamed
Hassouna, Salah Elsalmy, Alexandria, Egypt
MP23-17 IMPROVED OUTCOMES DURING ROBOTIC
PROSTATECTOMY UTILIZING AIRSEAL
TECHNOLOGY
Mona Yezdani*, Sue-Jean Yu, Alexandra
Lee, Benjamin Taylor, Alice McGill, Kelly
Monahan, David Lee, Philadelphia, PA
MP23-11 MARGIN ASSESSMENT IN RENAL
SURGERY USING A HANDHELD OPTICAL
COHERENCE TOMOGRAPHY PROBE
Wesley W Ludwig*, Sara E Wobker, Michael
A Gorin, Mark W Ball, Baltimore, MD, Adam
M Zysk, Chicago, IL, Philip M Pierorazio,
Mohamad E Allaf, Baltimore, MD
MP23-18 INTER-HOSPITAL TELEMENTORING FOR
ROBOTIC SURGERY
Thomas G. Clifford*, Daoud Dajani, Peter
Khooshabeh, Eric Hwang, Mihir M. Desai,
Inderbir S. Gill, Andrew J. Hung, Los
Angeles, CA
MP23-12 INTRAOPERATIVE RADIATION THERAPY
DURING GENITOURINARY SURGERY: THE
IMPORTANCE OF SPECIMEN MARGIN
STATUS IN IMPROVING SURVIVAL
Meera Chappidi*, Max Kates, Zeyad Schwen,
Nikolai Sopko, Phuoc Tran, Nita Ahuja,
Stephanie Terezakis, Phillip Pierorazio, Trinity
Bivalacqua, Baltimore, MD
MP23-19 SUTURELESS PARTIAL NEPHRECTOMY
USING LASER TISSUE WELDING
Gilad Amiel*, Haifa, Israel, Tung Shu, Yasmin
Wadia, Houston, TX
MP23-20 BLUE LIGHT CYSTOSCOPY FOR
DIAGNOSIS OF UROTHELIAL BLADDER
CANCER: RESULTS FROM A
PROSPECTIVE MULTICENTER REGISTRY
Soroush T Bazargani*, Thomas G. Clifford,
Hooman Djaladat, Anne Schuckman, Los
Angeles, CA, Brian Willard, West Columbia,
SC, Badrinath Konety, Minneapolis, MN,
Siamak Daneshmand, Los Angeles, CA
MP23-13 SAFETY AND EFFECTIVENESS OF SAF-R,
AN ADVANCED PATIENT POSITIONING
SYSTEM, FOR ROBOT-ASSISTED PELVIC
SURGERY IN TRENDELENBURG
POSITION
Saman S. Talab*, Azadeh Elmi, Glen W.
Barrisford, Jaydev Sarma, Shahin
Tabatabaei, Boston, MA
*Presenting author
ALEXIS WOUND
PROTECTOR/RETRACTOR REDUCES
WOUND INFECTION DURING RADICAL
CYSTECTOMY AND URINARY DIVERSION
Ajaydeep S. Sidhu*, Elizabeth T. Nagoda,
Rafael E. Yanes, Joan C. Delto, Akshay
Bhandari, Jorge R. Caso, Alan M. Nieder,
Miami Beach, FL
CREDITTM
89
8:00 am - 10:00 am
INFECTIONS/INFLAMMATION/CYSTIC DISEASE OF THE GENITOURINARY TRACT: KIDNEY & BLADDER I
Moderators: Tomas Griebling and Philip Hanno
ABSTRACT
NUMBER TITLE
MP24-01 A MICROFILTRATION DEVICE FOR
UROGENITAL SCHISTOSOMIASIS
DIAGNOSTICS
Yuan Xiao, University Park, PA, Yi Lu,
Tucson, AZ, Michael Hsieh*, Washington,
DC, Joseph Liao, Stanford, CA, Pak Wong,
University Park, PA
ABSTRACT
NUMBER TITLE
MP24-09 REG3␥ STRATIFIES THE BLADDER
UROTHELIUM WITH SUBVERSION OF
THIS PATHWAY BY UPEC DURING
CHRONIC CYSTITIS
Christina Ching*, Ashley Jackson, Birong Li,
Columbus, OH, Keith Pierce, David Hains,
Memphis, TN, Kirk McHugh, Brian Becknell,
Columbus, OH
MP24-02 PCR IN GENITO URINARY
TUBERCULOSIS
Maniyur Raghavendran, Sr.*, A. Venugopal,
Mysore, India
MP24-10 DIABETIC CONDITIONS IMPAIR
NEUTROPHIL RECRUITMENT INTO THE
UROTHELIUM AND MARKEDLY DELAY
THE CLEARANCE OF INTRACELLULAR
BACTERIAL COMMUNITY OF
UROPATHOGENIC E. COLI
Yan Liu, Feng He, Ellen Shapiro, Herbert
Lepor, Xue-Ru Wu*, New York, NY
MP24-03 DIRECT DETECTION OF URINARY TRACT
INFECTION FROM URINE SAMPLES
USING MATRIX-ASSISTED LASER
DESORPTION IONIZATION-TIME OF
FLIGHT MASS SPECTROMETRY
Katsumi Shigemura*, Kayo Osawa, Kazushi
Tanaka, Yuzo Nakano, Soichi Arakawa,
Masato Fujisawa, Kobe, Japan
MP24-11 THE INCREASED EXPRESSION OF
TRANSIENT RECEPTOR POTENTIAL
VANILLOID-4 (TRPV4) IN
CYCLOPHOSPHAMIDE-INDUCED
INFLAMMATORY CYSTITIS
Ho Song Yu*, Seong Woong Na, Yang Hyun
Cho, Je Guk Ryu, Bo Sung Shin, Deokhyeon
Nam, Ho Seok Chung, Eu Chang Hwang,
Sun-ouck Kim, Seung Il Jung, Taek Won
Kang, Dongdeuk Kwon, Kwangsung Park,
Gwangju, Korea, Republic of
MP24-04 THE UROPATHOGENIC ESCHERICHIA
COLI PILUS USHER CONTROLS PROTEIN
INTERACTIONS VIA DOMAIN MASKING
AND IS FUNCTIONAL AS AN OLIGOMER
Glenn Werneburg*, Hemil Chauhan, Nadine
Henderson, David Thanassi, Stony Brook, NY
MP24-05
TOLL-LIKE RECEPTOR 5 MEDIATED
SENSING OF BACTERIAL FLAGELLIN
DRIVES ANTIMICROBIAL PEPTIDE
EXPRESSION IN NORMAL HUMAN
UROTHELIUM
Carwyn Edwards*, Claire Varley, Jennifer
Southgate, York, United Kingdom
MP24-12 MOLECULAR CHARACTERISTICS OF
EXTENDED-SPECTRUM ␤-LACTAMASEPRODUCING ESCHERICHIA COLI
ISOLATED URINARY TRACT INFECTION
IN A UNIVERSITY TEACHING HOSPITAL
Katsumi Shigemura*, Kayo Osawa, Kazushi
Tanaka, Yuzo Nakano, Toshiro Shirakawa,
Soichi Arakawa, Masato Fujisawa, Kobe,
Japan
MP24-06 IN VIVO ROLE OF NLRP3
INFLAMMASOME IN INNATE UROTHELIAL
DEFENSES AGAINST UROPATHOGENIC
E. COLI
MP24-13 EVALUATION OF PROTEIN
PHOSPHATASE PPM1A AS A NOVEL
TARGET IN RENAL FIBROSIS
Alexandra Rehfuss*, Paul Higgins, Rohan
Samarakoon, Albany, NY
MP24-07 MULTINUCLEATED UROTHELIAL
UMBRELLA CELLS AS INITIATORS OF
INNATE HOST DEFENSES AGAINST
UROPATHOGENIC E. COLI
MP24-14 RADIATION THERAPY ATTENUATES
REGENERATION OF THE UROTHELIUM IN
NOVEL CELL CULTURE RADIATION
MODEL
Bernadette Zwaans*, Sarah Bartolone, Royal
Oak, MI, Peter Levanovich, Detroit, MI,
Monica Liebert, Ann Arbor, MI, Michael
Chancellor, Laura Lamb, Royal Oak, MI
MP24-08 EPIGENETIC REGULATION OF DNA
DAMAGE REPAIR GENE 8-OXOGUANINE
DNA GLYCOSYLASE (OGG1) IN THE
PYROPTOSIS PATHWAYS OF
HEMORRHAGIC CYSTITIS
Christopher Dru*, Subhash Haldar, Neil
Bhowmick, Los Angeles, CA
MP24-15
90
CLINICALLY DIVERSE LPS ISOLATES
DIRECTLY STIMULATE DRG NEURONS:
RELEVANCE FOR BLADDER PAIN
Abdel Belmadani, Richard Miller, Rachel
Miller, Anne-Marie Malfait, Ryan Yaggie,
Anthony Schaeffer, David Klumpp*, Chicago,
IL
MP24-16 PLASMA AND URINARY
PHARMACOKINETICS OF A NOVEL, ORAL
SHIP1 ACTIVATOR AQX-1125 IN FEMALE
PATIENTS WITH INTERSTITIAL CYSTITIS
J. Curtis Nickel*, Kingston, Canada, Robert
Evans, Winston Salem, NC, Patrick Tam,
Judy Toews, Lloyd Mackenzie, Heidi Biagi,
Stephen Shrewsbury, Vancouver, Canada
MP24-19 NOVEL DUAL-BALLOON URINARY
CATHETERS REDUCE CATHETERASSOCIATED URINARY TRACT
INFECTIONS
Jonathan Beilan*, Tracy Lund, Kristen Beane,
Tampa, FL, Raul Ordorica, Riverside, CA,
David Hernandez, Tampa, FL
MP24-20 COMPARISON OF URINARY TRACT
INFECTION RATES ASSOCIATED WITH
TRANSURETHRAL CATHETERIZATION,
SUPRAPUBIC TUBE AND CLEAN
INTERMITTENT CATHETERIZATION IN
THE POSTOPERATIVE SETTING: A
NETWORK META-ANALYSIS.
Christopher Han*, New Brunswick, NJ, Sinae
Kim, New Burnswick, NJ, Kushan Radadia,
New Brunswick, NJ, Philip Zhao, New Hyde
Park, NY, Sammy Elsamra, Ephrem Olweny,
Robert Weiss, New Brunswick, NJ
MP24-17 PERVASIVE BIOFILM COVERAGE: AN
ANALYSIS OF BIOFILM FORMATION IN
INDWELLING URINARY CATHETERS
Mohamed Ibrahim, Vrad Levering*, Eileen
Lanham, James Parra, Harold Leraas,
Gabriel Lopez, Bruce Klitzman, Andrew
Peterson, Howard Levinson, Durham, NC
MP24-18 FEASIBILITY OF NON-USE OF
ANTIMICROBIAL PROPHYLAXIS IN
MINIMALLY INVASIVE CLEAN SURGERY
FOR RENAL OR ADRENAL TUMORS: A
PROSPECTIVE STUDY OF 668 CASES
Motohiro Fujiwara*, Masaharu Inoue, Minato
Yokoyama, Toshiki Kijima, Takayuki
Nakayama, Masaya Ito, Soichiro Yoshida,
Junichiro Ishioka, Yoh Matsuoka, Noboru
Numao, Kazutaka Saito, Yasuhisa Fujii,
CREDITTM
8:00 am - 10:00 am
GENERAL & EPIDEMIOLOGICAL TRENDS & SOCIOECONOMICS: PRACTICE PATTERNS, QUALITY OF LIFE AND SHARED
DECISION MAKING I
Moderator: Norm Smith
ABSTRACT
NUMBER TITLE
MP25-01 DECISIONAL QUALITY IN PATIENTS WITH
BENIGN PROSTATIC HYPERPLASIA (BPH)
Joseph Shirk*, Sylvia Lambrechts, Lorna
Kwan, Meghana Munnangi, Amit Sumal,
Christopher Saigal, Los Angeles, CA
MP25-02
MP25-03
MP25-04
*Presenting author
ABSTRACT
NUMBER TITLE
MP25-05 UTILIZATION OF RADIOTHERAPY FOR
PROSTATE CANCER ACCORDING TO
UROLOGISTS’ PRACTICE PATTERNS
Stephen Williams*, Jinhai Huo, Benjamin
Smith, Brian Chapin, Karen Hoffman,
Houston, TX
DECISIONAL QUALITY IN PATIENTS WITH
SMALL RENAL MASSES
Joseph Shirk*, Aaron Laviana, Sylvia
Lambrechts, Lorna Kwan, Amit Sumal,
Christopher Saigal, Los Angeles, CA
RENAL CELL CARCINOMA: ADHERENCE
TO SURVEILLANCE GUIDELINES
Luriel Smith-Harrison*, Jennifer Lobo,
Charlottesville, VA, Andrew Dick, Claude
Setodji, Rachana Seelam, Janet Hanley,
Santa Monica, CA, Christopher Saigal, Los
Angeles, CA, Tracey Krupski, Charlottesville,
VA, Urologic Diseases in America, Santa
Monica, CA
IMPACT OF A NOVEL METHOD OF
PATIENT PREFERENCE ELICITATION ON
DECISION QUALITY IN MEN WITH
PROSTATE CANCER
Joseph Shirk*, Alan Kaplan, Josemanuel
Saucedo, Sylvia Lambrechts, Ely Dahan,
Kate Crespi, Christopher Saigal, Los Angeles,
CA
91
MP25-06
UTILIZATION OF RADIOTHERAPY FOR
PROSTATE CANCER ACCORDING TO
UROLOGISTS’ PRACTICE PATTERNS
Stephen Williams*, Jinhai Huo, Benjamin
Smith, Karen Hoffman, Houston, TX
MP25-07
PATTERNS OF PSA SCREENING AMONG
LOW INCOME AFRICAN AMERICAN AND
WHITE MEN: DATA FROM THE
SOUTHERN COMMUNITY COHORT STUDY
Kelvin Moses*, Zhiguo Zhao, Yuqi Bi, Joseph
Acquaye, Arturo Holmes, Jay Fowke, William
Blot, Nashville, TN
MP25-08
DETERMINANTS OF PROSTATE CANCER
SCREENING IN ASIAN AMERICANS
Hanhan Li*, Detroit, MI, Julian Hanske,
Christian Meyer, Boston, MA, Firas Abdollah,
Detroit, MI, Toni Choueiri, Adam Kibel,
Boston, MA, Paul Han, Scarborough, ME,
Mani Menon, Jesse Sammon, Detroit, MI,
MP25-09
THE IMPACT OF UNITES STATES
(USPTSTF) RECOMMENDATION ON PSA
TESTING IN AUSTRALIA
Homayoun Zargar*, Rodrick van den Bergh,
Siska Van Bruwaene, Daniel Moon, Nathan
Lawrentschuk, Declan Murphy, Anthony
Costello, Melbourne, Australia
MP25-15
INITIAL PHARMACOTHERAPY FOR
OVERACTIVE BLADDER SYMPTOMS
AMONG MEDICARE BENEFICIARIES
Charles Scales, Jr.*, Melissa Greiner, Lesley
Curtis, Brad Hammill, Andrew Peterson,
Cindy Amundsen, Viviana Martinez-Bianchi,
Mitchell Heflin, Kenneth Schmader, Durham,
NC
MP25-10
DECLINE IN PROSTATE SPECIFIC
ANTIGEN SCREENING AMONG PRIMARY
CARE PHYSICIANS IN RESPONSE TO
UNITED STATES PREVENTATIVE
SERVICES TASK FORCE
RECOMMENDATIONS
Jonathan Shoag, Khushabu Kasabwala*,
Sameer Mittal, Joshua Halpern, Daniel Lee,
Jim Hu, Christopher Barbieri, New York, NY
MP25-16
MEDICATION SWITCHING AFTER INITIAL
PHARMACOTHERAPY FOR OVERACTIVE
BLADDER
Charles Scales, Jr.*, Melissa Greiner, Lesley
Curtis, Brad Hammill, Andrew Peterson,
Cindy Amundsen, Viviana Martinez-Bianchi,
Mitchell Heflin, Kenneth Schmader, Durham,
NC
MP25-17
MP25-11
PHYSICIAN-LEVEL VARIATION IN THE
USE OF OBSERVATION FOR LOCALIZED
PROSTATE CANCER
Mark Tyson*, Amy Graves, Daniel Barocas,
Sam Chang, David Penson, Matthew
Resnick, Nashville, TN
MP25-12
ANALYSIS OF ACTIVE SURVEILLANCE
FOLLOW-UP: HOW CLOSELY ARE
PATIENTS MONITORED OVER TIME?
Gregory Auffenberg*, Amy Luckenbaugh,
Scott Hawken, Apoorv Dhir, Susan Linsell,
Ann Arbor, MI, Sanjeev Kaul, Royal Oak, MI,
CONTEMPORARY UTILIZATION TRENDS
OF SYSTEMIC CHEMOTHERAPY FOR
(UTUC)
Mohammed Haseebuddin*, Elizabeth
Handorf, Joshua Jones, Alexander Kutikov,
Nikhil Waingankar, Benjamin Ristau, Michael
Haifler, Yu-Ning Wong, Rosalia Viterbo,
Richard Greenberg, Robert Uzzo, David
Chen, Marc Smaldone, Philadelphia, PA
MP25-18
CHARACTERISTICS OF PATIENTS WHO
VISITED THE EMERGENCY ROOM AFTER
PROSTATE BIOPSY: SINGLE CENTER
RETROSPECTIVE STUDY
Jae Min Chung*, Seung Chan Jeong, Sang
Don Lee, Yangsan, Korea, Republic of
MP25-19
INCIDENCE OF BLADDER CANCER AFTER
RADIATION FOR PROSTATE CANCER AS
A FUNCTION OF TIME AND RADIATION
MODALITY
Aryeh Keehn*, Jacob Taylor, Mark
Schoenberg, Farhang Rabbani, Bronx, NY
MP25-20
ASSOCIATION BETWEEN
GENITOURINARY DISEASES AND
DEPRESSIVE SYMPTOMS IN THE 20052012 NATIONAL HEALTH AND NUTRITION
EXAMINATION SURVEY
Lakshay Jain*, Houston, TX, Michelle Kim
Douglas Mata, Boston, MA
MP25-13
MP25-14
THE NORTH AMERICAN QUALITY OF LIFE
STONE CONSORTIUM: FOLLOW-UP
RESULTS FROM A PROSPECTIVE,
LONGITUDINAL, MULTI-CENTER
VALIDATION STUDY OF THE HEALTHRELATED QUALITY OF LIFE OF PATIENTS
WITH KIDNEY STONES
Kristina L Penniston, Madison, WI, Lauren E
Tennyson*, Timothy D Averch, Pittsburgh,
PA, Davis P Viprakasit, Chapel Hill, NC, Jodi
A Antonelli, Dallas, TX, Sriharan Sivalingam,
Cleveland, OH, Roger L Sur, San Diego, CA,
Ben H Chew, Vancouver, Canada, Vernon M
Pais Jr, Hanover, NH, Vincent G Bird,
Gainesville, FL, Stephen Y Nakada, Madison,
WI
CREDITTM
TRENDS IN THE DIAGNOSIS AND
MANAGEMENT OF URINARY
INCONTINENCE IN THE UNITED STATES
James Forde*, Bilal Chughtai, Benjamin
Stone, Meagan Cea, Alexis Te, Tara Bishop,
New York, NY
92
8:00 am - 10:00 am
Podium Session 11
BLADDER CANCER: NON-INVASIVE II
Moderators: Ashish Kamat and Stanley Yap
TIME
8:00
ABSTRACT
NUMBER TITLE
PD11-01 RANDOMIZED CONTROLLED STUDY OF
THE EFFICACY AND SAFETY OF
CONTINUOUS SALINE BLADDER
IRRIGATION AFTER TRANSURETHRAL
RESECTION FOR THE TREATMENT OF
CANCER
Takehisa Onishi*, Takuji Shibahara, Satoru
Masui, Yusuke Sugino, Ise, Japan, Takeshi
Sasaki, Tsu, Japan
8:10
PD11-02
EN BLOC RESECTION OF BLADDER
TUMOURS (ERBT): MULTIVARIABLE
ANALYSIS FOR PREDICTION OF
RECURRENCE AT MID-TERM FOLLOW-UP
Rodolfo Hurle*, Massimo Lazzeri, NicolòMaria
Buffi, Giovanni Lughezzani, Paolo Casale,
Girolamo Fiorini, Roberto Peschechera, Luisa
Pasini, Silvia Zandegiacomo, Piergiuseppe
Colombo, Emanuela Morenghi, Giorgio
Guazzoni, Milan, Italy
8:20
PD11-03
EN BLOC THULIUM LASER RESECTION
OF BLADDER TUMORS: 3-YR SINGLE
CENTRE EXPERIENCE.
Giuseppe Simone, Rome, Italy, Alessandro
Giacobbe, Turin, Italy, Rocco Papalia, Rome,
Italy, Devis Collura, Leonardo D’ Urso,
Emanuele Castelli, Gianluca Muto, Turin,
Italy, Riccardo Mastroianni, Mariaconsiglia
Ferriero, Francesco Minisola, Leonardo
Misuraca, Gabriele Tuderti*, Michele Gallucci,
Giovanni Muto, Rome, Italy
8:30
8:40
PD11-04
PD11-05
*Presenting author
ABSTRACT
TIME NUMBER TITLE
8:50 PD11-06 THE ROLE OF SINGLE INSTILLATION
CHEMOTHERAPY IN PATIENTS WHO
RECEIVE SUBSEQUENT BACILLUS
CALMETTE-GUERIN FOR NON-MUSCLE
Kazuhiro Matsumoto*, Yoshinori Yanai,
Nozomi Hayakawa, Yujiro Ito, Takahiro
Maeda, Hirohiko Nagata, Mototsugu Oya,
Tokyo, Japan
TRANSURETHRAL ENDOSCOPIC
SUBMUCOSAL EN BLOT DISSECTION
FOR NON-MUSCLE INVASIVE BLADDER
TUMOR: A PROSPECTIVE COMPARISON
STUDY OF HYBRIDKNIFE ASSISTED
VERSUS CONVENTIONAL DISSECTION
TECHNIQUE
Yongyi Cheng*, Wexing Qu, Yi Sun, Jing Li,
Liang Liang, Xi’an, China, People’s Republic
of
THE CHEMOABLATIVE EFFECT OF
VESIGEL INSTILLATION IN PATIENTS
WITH NMIBC – PRELIMINARY RESULTS
Boris Friedman*, Yoram Dekel, Haifa, Israel,
Andrea Tubaro, Rome, Italy, Ami Sidi,
Benjamin Shalva, Holon, Israel, Jack Baniel,
Daniel Kedar, Petach Tikvah, Israel, Lorenzo
Colombo, Milan, Italy, Dov Engelshtein,
Naharya, Israel, Edi Fridman, Tel Aviv, Israel,
Ifat Klein, Michal Jeshurun, Baruch Nerotski,
Dima Zolotrayov, Nadav Malchi, Raanana,
Israel, Joan Palou Redorta, Barcelona, Spain,
Gregory Wirth, Geneva, Switzerland, Ilan
Leibovitch, Kfar Saba, Israel, Fred Witjes,
Nijmegen, Netherlands
93
9:00
PD11-07
INTEGRATED RESULTS OF TWO
MULTICENTER, RANDOMIZED, PLACEBO
CONTROLLED, DOUBLE BLIND, PHASE 3
TRIALS (SPI-611/612) OF SINGLE-DOSE
INTRAVESICAL APAZIQUONE
IMMEDIATELY FOLLOWING RESECTION
IN PATIENTS WITH NON-MUSCLE
Lawrence Karsh*, Denver, CO, Neal Shore,
Myrtle Beach, SC, Daniel Saltzstein, San
Antonio, TX, Gajanan Bhat, Guru Reddy, Lee
F. Allen, Irvine, CA, Mark Soloway, Aventura,
FL
9:10
PD11-08
COLOR AND MORPHOLOGY
COMBINATION FOR DETECTION OF LOWGRADE UROTHELIAL CANCER CELLS:
MULTI-CENTER VALIDATION STUDY
Ofer Yossepowitch*, Pethah Tikva, Israel, Ilan
Leibovitch, Kfar Saba, Israel, Ofer Nativ,
Haifa, Israel, Yoram Mor, Tel Aviv, Israel,
Michael Cohen, Afula, Israel, Uri Lindner,
Rehovot, Israel, Ami Sidi, Holon, Israel, Ofer
Gofrit, Jerusalem, Israel, Haim Matzkin, Tel
Aviv, Israel, Ronny Rona, Kfar-Saba, Israel,
Alexander Shtabsky, Tel Aviv, Israel, Sylvia
Lew, Ness Ziona, Israel
9:20
PD11-09
MOLECULAR TUMOR GRADING OF NON
MUSCLE INVASIVE BLADDER CANCER
BASED ON WHOLE TRANSCRIPTOME
ANALYSIS
Jess Shen, Toronto, Canada, Aidan P Noon,
Sheffield, United Kingdom, Eduardo Aguiar
Cabeza, Cynthia Kuk, Christine Ilczynski,
Ruoyu Ni, Balram Sukhu, Kim Chan, Adrian
Gunaratne, Annette Erlich, Chris Cremer,
Quaid Morris, Nuno L Barbosa-Morais, Neil
Fleshner, Girish Kulkarni, Benjamin J
Blencowe, Azar Azad, Theodorus H. van der
Kwast, Alexandre R. Zlotta*, Jeffrey Wrana,
Toronto, Canada
9:30
9:40
PD11-10
PD11-11
A 10-ITEM CHECKLIST CHECKLIST
IMPROVES REPORTING OF CRITICAL
PROCEDURAL ELEMENTS DURING
TRANSURETHRAL RESECTION OF
BLADDER TUMOR
Christopher Anderson*, Ryan Weber, New
York, NY, Darshan Patel, William Lowrance,
Salt Lake City, UT, Adam Mellis, Michael
Cookson, Oklahoma City, OK, Maximilian
Lang, Daniel Barocas, Sam Chang, Nashville,
TN, Elizabeth Newberger, Jeffrey
Montgomery, Alon Weizer, Ann Arbor, MI,
Bruce Kava, Miami, FL, Max Jackson,
Anooop Meraney, Hartford, CT, Daniel
Sjoberg, Bernard Bochner, Guido Dalbagni,
Machele Donat, Harry Herr, New York, NY
9:50
PD11-12
COMPARISON OF OUTCOMES BETWEEN
ULTRASONOGRAPHY AND CYSTOSCOPY
IN THE SURVEILLANCE OF PATIENTS
WITH LOW- OR INTERMEDIATE-RISK
CANCER
Naoya Niwa*, Kazuhiro Matsumoto, Tokyo,
Japan, Nobuyuki Tanaka, Saitama, Japan,
Nozomi Hayakawa, Yujiro Ito, Takahiro
Maeda, Tokyo, Japan, Seiya Akatsuka,
Takeshi Masuda, Saitama, Japan, So
Nakamura, Mototsugu Oya, Tokyo, Japan
CREDITTM
BLADDER ULTRASONOGRAPHY,
CYTOLOGY AND URINE ANALYSIS AS
ALTERNATIVES TO CYSTOSCOPY
DURING SCREENING FOR NON-MUSCLE
Mohamed Elkenawi, Ahmed Harraz*, Hashim
Farg, Mohamed Abou El-Ghar, Ahmed ElHefnawy, Yasser Osman, Mansoura, Egypt
8:00 am - 10:00 am
Podium Session 12
TRAUMA/RECONSTRUCTION/DIVERSION: URETER (INCLUDING PYELOPLASTY) AND BLADDER RECONSTRUCTION (INCLUDING
FISTULA), AUGMENTATION, SUBSTITUTION, DIVERSION I
Moderators: Robert Kovell and Kristin Chrouser
TIME
8:00
8:10
ABSTRACT
NUMBER TITLE
PD12-01 A NATIONAL ANALYSIS OF
PERIOPERATIVE OUTCOMES FOR
REVISION OF A URETEROENTERIC
ANASTOMOSIS
Joseph J. Pariser*, Shane M. Pearce,
Vignesh T. Packiam, Norm D. Smith, Gary D.
Steinberg, Gregory T. Bales, Chicago, IL
PD12-02
ABSTRACT
TIME NUMBER TITLE
8:40 PD12-05 PERIOPERATIVE OUTCOMES FOLLOWING
OPEN AND MINIMALLY INVASIVE
URETERAL REIMPLANTATION: AN
ANALYSIS OF 512 CASES FROM THE
IMPROVEMENT (NSQIP) DATABASE
Vignesh T. Packiam*, Joseph J. Pariser,
Andrew J. Cohen, Charles U. Nottingham,
Sarah F. Faris, Gregory T. Bales, Chicago, IL
SPECIFIC PREDISPOSING RISK FACTORS
FOR THE DEVELOPMENT OF
URETEROENTERIC STRICTURES AFTER
OPEN RADICAL CYSTECTOMY AND ILEAL
NEOBLADDER DIVERSION
Bjoern Volkmer*, Andreas Kahlmeyer,
Melanie Enders, Karen Czeloth, Regina
Stredele, Kassel, Germany, Richard
Hautmann, Ulm, Germany
8:20
PD12-03
PRIMARY URETEROENTERIC
ANASTOMOTIC REVISION AFTER
URINARY DIVERSION
Greg Gin*, Jaspreet Parihar, Bertram Yuh,
Jonathan Yamzon, Clayton Lau, Kevin Chan,
Duarte, CA
8:30
PD12-04
MALIGNANT URETEROINTESTINAL
ANASTOMOTIC STRICTURE FOLLOWING
RADICAL CYSTECTOMY: PATTERNS,
RISK FACTORS, AND OUTCOMES
Mary E. Westerman*, Boyd R. Viers, R.
Jeffrey Karnes, Robert Tarrell, Prabin Thapa,
R. Houston Thompson, Matthew K. Tollefson,
Stephen A. Boorjian, Rochester, MN
94
8:50
PD12-06
URINARY DIVERSION FOR
COMPLICATIONS OF RADIATION
THERAPY FOR THE TREATMENT OF
PROSTATE CANCER: UPDATED RESULTS
FROM THE TRAUMA AND UROLOGIC
RESEARCH NETWORK OF SURGEONS
Mitchell Bassett*, Salt Lake City, UT, Sean
Elliott, Minneapolis, MN, Joshua
Broghammer, Kansas City, KS, Benjamin
Breyer, San Francisco, CA, Bryan Voelske,
Seattle, WA, Bradley Erickson, Iowa City, IA,
Christopher Mcclung, Columbus, OH, Alex
Vanni, Burlington, MA, Robert Goldfarb,
Minneapolis, MN, Chong Zhang, Angela
Presson, Jonathan Tward, Jeremy Myers,
Salt Lake City, UT
9:00
PD12-07
NEOBLADDER-VAGINAL FISTULA
REPAIR: THE UNIVERSITY OF SOUTHERN
CALIFORNIA EXPERIENCE.
Shilo Rosenberg*, Larissa V Rodriguez, Gus
Miranda, David A Ginsberg, Los Angeles, CA
9:10
PD12-08
DURABILITY AND EFFICACY OF
URETERONEOCYSTOSTOMY IN
PATIENTS WITH MALIGNANT URETERAL
OBSTRUCTION
Gillian Stearns*, Burlington, VT, Amy Tin,
Nicole Benfante, Daniel Sjoberg, Jaspreet
Sandhu, New York, NY
9:20
PD12-09
CHARACTERIZATION OF INFECTION RISK
AFTER RADICAL CYSTECTOMY:
RESULTS FROM THE NATIONAL
SURGICAL QUALITY IMPROVEMENT
PROGRAM
William Parker*, Matthew Tollefson, Courtney
Heins, Kristine Hanson, Elizabeth
Habermann, Harras Zaid, Igor Frank, R.
Houston Thompson, Stephen Boorjian,
Rochester, MN
9:30
PD12-10
CASE DURATION AND PERIOPERATIVE
HYPOTENSION ARE ASSOCIATED WITH
GREATER INCIDENCE OF HIGH GRADE
COMPLICATIONS IN PATIENTS WHO
UNDERGO URINARY DIVERSION FOR
BENIGN INDICATIONS
Yahir Santiago-Lastra*, Michael R. Mathis,
Elizabeth Andraska, Aleda M.L. Thompson,
Bahaa S. Malaeb, Anne P. Cameron, J.
Quentin Clemens, John T. Stoffel, Ann Arbor,
MI
9:40
PD12-11
GASTROINTESTINAL RECOVERY IS
ACCELERATED AND ELECTROLYTE
DISTURBANCES ARE REDUCED AFTER
RADICAL CYSTECTOMY BY
PERIOPERATIVE USE OF A NEW
CRYSTALLOID SOLUTION: RESULTS OF A
RANDOMIZED CLINICAL TRIAL.
Lukas M. Löffel, Fiona C. Burkhard, Patrick
Y. Wuethrich*, Bern, Switzerland
9:50
PD12-12
COMPLICATION RATES AFTER RADICAL
CYSTECTOMY AFTER RADIOTHERAPY:
AN INTERNATIONAL, MULTICENTER
RETROSPECTIVE STUDY ON 609 CASES
Paolo Gontero*, Francesca Pisano, turin,
Italy, Steven Joniau, Maarten Albersen,
Leuven, Belgium, Antonino Battaglia, Paolo
Destefanis, turin, Italy, Renzo Colombo,
Alberto Briganti, Federico Pellucchi, Giusy
Burgio, Milan, Italy, Bas Van Rhijn, Elies E.
Fransen Van de Putte, Amsterdam,
Netherlands, Salvador Esquena, Juan Palou,
Barcelona, Spain, Marek Babjuk, Prague,
Czech Republic, Hans Martin Fritsche,
Roman Mayr, Regensburg, Germany, Peter
Albers, Guenter Niegisch, Düsseldorf,
Germany, Alexandre De la Taille, Alexandra
Masson-Lecomte, Morgan Roupret, Paris,
France, Tommaso Cai, Trento, Italy, J Alfred
Witjes, Max Bruins, Nijmegen, Netherlands,
Jack Baniel, Roy Mano, Tel Aviv, Israel,
Maurizio Brausi, Carpi, Italy, Alberto Lapini,
Francesco Sessa, Florence, Italy, Jaques
Irani, Poitiers, France, Arnulf Stenzl, Georgios
Gakis, Tuebingen, Germany, R. Jeffrey
Karnes, Fabio Zattoni, Rochester, MN,
Douglas Scherr, Padraic O’Malley, New York,
NY, Shahrokh F Shariat, Vienna, Austria,
Peter Black, Hamidreza Abdi, Vancouver,
Canada, Vsevolod B Matveev, Olga I
Samuseva, Maria V Peters, Moscow, Russian
Federation, Dipen J Parekh, Mark Gonzalgo,
Miami, FL, Aziz Atiquallah, Margit Fish,
Michael Rink, Hamburg, Germany
CREDITTM
8:00 am - 10:00 am
Podium Session 13
BLADDER CANCER: UPPER TRACT TRANSITIONAL CELL CARCINOMA I
Moderators: Matthew Kaag and Anne Schuckman
TIME
8:00
ABSTRACT
NUMBER TITLE
PD13-01 LOSS OF FOXA1 EXPRESSION IS
ASSOCIATED WITH ADVERSE
PATHOLOGIC FEATURES AND INFERIOR
ONCOLOGIC OUTCOMES FOLLOWING
RADICAL NEPHROURETERECTOMY
Lauren Shuman*, Joshua Warrick, David
DeGraff, Hershey, PA, Shahrokh Shariat,
Vienna, Austria, Jose Karam, Christopher
Wood, Houston, TX, Alon Weizer, Ann Arbor,
MI, Mesut Remzi, Andrea Haitel, Vienna,
Austria, Karim Bensalah, Nathalie RiouxCeclerq, Rennes, France, Christian Bolenz,
Mannheim, Germany, Marco Roscigno,
Bergamo, Italy, Laura-Maria Krabbe, Payal
Kapur, Yair Lotan, Vitaly Margulis, Dallas, TX,
Jay Raman, Hershey, PA
*Presenting author
ABSTRACT
TIME NUMBER TITLE
8:10 PD13-02 MICRO-RNA EXPRESSION PROFILES IN
DIFFERENTIATE GRADE AND STAGE:
IMPLICATIONS FOR CLINICAL DECISION
MAKING
Brendan Browne*, Chintan Patel, Travis
Sullivan, Eric Burks, Burlington, MA, Jay
Raman, Joshua Warrick, Hershey, PA, David
Canes, Kimberly Rieger-Christ, Burlington,
MA
95
8:20
8:30
8:40
PD13-03
PD13-04
PD13-05
A MULTI-INSTITUTIONAL EVALUATION
OF CLINICAL AND TUMOR
CHARACTERISTICS IN UPPER TRACT
UROTHELIAL CARCINOMA FROM CHINA
AND THE UNITED STATES
Nirmish Singla*, Ryan Hutchinson, Dallas,
TX, Dong Fang, Xiaohong Su, Zhengqing
Bao, Zhenpeng Cao, Beijing, China, People’s
Republic of, Syed Jafri, Hershey, PA,
Gengyan Xiong, Lei Zhang, Beijing, China,
People’s Republic of, Arthur Sagalowsky, Yair
Lotan, Dallas, TX, Xuesong Li, Liqun Zhou,
Beijing, China, People’s Republic of, Jay
Raman, Hershey, PA, Vitaly Margulis, Dallas,
TX
NATURAL HISTORY OF A NONDIAGNOSTIC UPPER TRACT EVALUATION
Mary E. Westerman*, Johann P. Ingimarsson,
Stephen A. Boorjian, Amy E. Krambeck,
Rochester, MN
FLUORESCENCE IN SITU HYBRIDIZATION
(FISH) IN THE DIAGNOSIS OF BLADDER
AND UPPER TRACT UROTHELIAL
CARCINOMA: A SINGLE-INSTITUTION
EXPERIENCE
Mark Mann*, Ryan Cleary, Leonard Gomella,
Scott Hubosky, Peter McCue, Demetrius
Bagley, Costas Lallas, Edouard Trabulsi,
Philadelphia, PA
8:50
PD13-06
LIKELIHOOD OF UNDERLYING LYNCH
SYNDROME IN JAPANESE UPPER TRACT
UROTHELIAL CARCINOMA PATIENTS
Masaya Ito*, Soichiro Yoshida, Masaharu
Inoue, Minato Yokoyama, Junichiro Ishioka,
Yoh Matsuoka, Noboru Numao, Kazutaka
Saito, Yasuhisa Fujii, Kazunori Kihara, Tokyo,
Japan
9:00
PD13-07
CHARACTERIZATION OF UPPER TRACT
UROTHELIAL CARCINOMA IN PATIENTS
WITH CLINICAL SUSPICION OF LYNCH
SYNDROME
Hong Truong*, Sarah Hegarty, Scott
Hubosky, Kelly Healy, Jeanne HoffmanCensits, Veda Giri, Philadelphia, PA
9:10
PD13-08
A 30-YEAR 250-CASE HISTORY OF
PERCUTANEOUS ENDOSCOPIC
RESECTION FOR UPPER TRACT
UROTHELIAL CARCINOMA AT A SINGLE
INSTITUTION
Philip Zhao*, New Hyde Park, NY, Piruz
Motamedinia, New Haven, CT, David Leavitt,
Detroit, MI, Mohamed Keheila, David Hoenig,
Zeph Okeke, Arthur Smith, New Hyde Park,
NY
9:20
PD13-09
EFFICACY AND TOLERABILITY OF
BACILLUS CALMETTE-GUÉRIN THERAPY
FOR CARCINOMA IN SITU OF THE UPPER
URINARY TRACT
Ikko Tomisaki*, Tatsuhiko Kubo, Ryoichi
Hamasuna, Naohiro Fujimoto, Kitakyushu
City, Japan
9:30
PD13-10
PRECLINICAL TRIAL OF SERIAL
MITOGEL® INSTILLATIONS INTO THE
PELVICALYCEAL SYSTEM OF THE
YORKSHIRE SWINE
Nicholas Donin*, Sandra Duarte, Los
Angeles, CA, Dalit Strauss-Ayali, Yael
Agmon-Gerstein, Nadav Malchi, Ra’anana,
Israel, Allan Pantuck, Arie Belldegrun, Karim
9:40
PD13-11
LONGER INTERVAL BETWEEN DISEASE
ONSET AND TREATMENT INITIATION IS
ASSOCIATED WITH UNFAVORABLE
PATHOLOGICAL AND ONCOLOGICAL
OUTCOMES OF NEPHROURETERECTOMY
FOR UPPER URINARY TRACT
UROTHELIAL CANCER
Kazuhide Hirayama*, Takashi Kobayashi,
Yoshiyuki Matsui, Takahiro Inoue, Tomomi
Kanba, Osamu Ogawa, Kyoto, Japan
9:50
PD13-12
EXTERNAL VALIDATION OF PROGNOSTIC
IMPACT OF PATIENT AGE AND GENDER
IN PATIENTS TREATED WITH RADICAL
NEPHROURETERECTOMY: PROPOSED
NEW PERSPECTIVE OF GENDERADJUSTED AGE IN UPPER TRACT
UROTHELIAL CARCINOMA
Hiroaki Kobayashi*, Eiji Kikuchi, Tokyo,
Japan, Nobuyuki Tanaka, Suguru Shirotake,
Saitama, Japan, Yasumasa Miyazaki, Hiroki
Ide, Tokyo, Japan, Jun Obata, Tochigi,
Japan, Katsura Hoshino, Kanagawa, Japan,
Kazuhiro Matsumoto, Gou Kaneko, Masayuki
Hagiwara, Tokyo, Japan, Takeo Kosaka,
Saitama, Japan, Satoshi Hara, Kanagawa,
Japan, Akira Miyajima, Tokyo, Japan, Tetsuo
Momma, Saitama, Japan, Ken Nakagawa,
Chiba, Japan, Mototsugu Oya, Tokyo, Japan
CREDITTM
96
8:00 am - 10:00 am
Podium Session 14
IMAGING/RADIOLOGY: URORADIOLOGY IV
Moderators: Phillip Mucksavage and Gary Faerber
TIME
8:00
8:10
8:20
8:30
8:40
8:50
ABSTRACT
NUMBER TITLE
PD14-01 CAN CONTRAST-ENHANCED
ULTRASOUND REPLACE FLUOROSCOPIC
NEPHROSTOGRAM?
Manint Usawachintachit*, John Mongan,
Matthew Truesdale, Stefanie Weinstein,
Thomas Chi, San Francisco, CA
PD14-02
PD14-03
PD14-04
PD14-05
PD14-06
*Presenting author
ABSTRACT
TIME NUMBER TITLE
9:00 PD14-07 DIFFERENTIATION BETWEEN CLEAR
CELL RENAL CELL CARCINOMAS AND
ONCOCYTOMAS USING TEXTURE
ANALYSIS OF CT IMAGES
Vinay Duddalwar*, Xuejun Zhang, Darryl
Hwang, Steven Cen, Felix Yap, Chidubem
Ugwueze, Andre Abreu, Monish Aron, Mihir
Desai, Inderbir Gill, Los Angeles, CA
ULTRASOUND GUIDED PERCUTANEOUS
SCLEROTHERPY OF SIMPLE RENAL
CYSTS WITH N-BUTYL CYANOACRYLATE
(NBCA) AND IODIZED OIL MIXTURE AS
AN OUTPATIENT PROCEDURE
Tamer Abou Elgreed*, Mohamed Abdelaal,
Ashraf Enite, Cairo, Egypt
PROGNOSTIC SIGNIFICANCE OF
POSTOPERATIVE SKELETAL MUSCLE
MASS RECOVERY IN METASTATIC RENAL
CELL CARCINOMA PATIENTS WHO
UNDERWENT CYTOREDUCTIVE
NEPHRECTOMY
Hiroshi Fukushima*, Yasukazu Nakanishi,
Madoka Kataoka, Ken-ichi Tobisu, Fumitaka
Koga, Tokyo, Japan
SPECTRUM OF RADIOLOGICAL FINDINGS
OF HEREDITARY LEIOMYOMATOSIS AND
RENAL CELL CANCER (HLRCC).
Jana Lovell*, Andrew Dwyer, Elizabeth
Jones, Nikeith Shah, Rabindra Gautam, Ishan
Asokan, Adam Metwalli, Ramaprasad
Srinivasan, W. Marston Linehan, Ashkan
Malayeri, Bethesda, MD
VIDEO-RATE STRUCTURED
ILLUMINATION MICROSCOPY TO
DIAGNOSE PRESENCE OF KIDNEY
CANCER ON 18-GAUGE CORE NEEDLE
RENAL BIOPSY
Weil Lai*, Mei Wang, David Tulman, Sree
Harsha Mandava, James Liu, Jonathan
Brown, Benjamin Lee, New Orleans, LA
DEVELOPMENT AND VALIDATION OF A
NOVEL STEPWISE ALGORITHM USING CT
AND MRI FOR DIAGNOSIS OF FAT-POOR
ANGIOMYOLIPOMA IN SMALL RENAL
MASSES
Hajime Tanaka*, Yasuhisa Fujii, Soichiro
Yoshida, Minato Yokoyama, Junichiro
Kazutaka Saito, Sho Uehara, Takeshi Yuasa,
Shinya Yamamoto, Hitoshi Masuda, Junji
Yonese, Kazunori Kihara, Tokyo, Japan
9:10
PD14-08
CORRELATION BETWEEN CONTRASTED
CT SCAN AND NUCLEAR MEDICINE
IMAGING TO DETERMINE DIFFERENTIAL
RENAL FUNCTION IN URETEROPELVIC
OBSTRUCTION
Jacob Ark*, Christopher Mitchell, Tracy
Marien, S. Duke Herrell, Nashville, TN
9:20
PD14-09
ANALYSIS OF TRACER CLEARANCE AT
40 MIN IN MAG 3 RENAL SCANS
IDENTIFIES PATIENTS WITH
SYMPTOMATIC UPJ OBSTRUCTION BUT
NORMAL T1/2
Friedrich-Carl von Rundstedt*, Jason Scovell,
Wesley A. Mayer, Richard E. Link, Houston,
TX
9:30
PD14-10
NOVEL USE OF AN IMAGE
ENHANCEMENT DEVICE TO REDUCE
FLUOROSCOPIC RADIATION EXPOSURE
DURING URETEROSCOPIC LITHOTRIPSY:
A RANDOMIZED, PROSPECTIVE CLINICAL
EVALUATION OF LESSRAYTM
Ashley Brandon, Michael Fabrizio, Virginia
Beach, VA, Arjun Poddar, Norfolk, VA, Shaun
Wason*, Virginia Beach, VA
9:40
PD14-11
APPLICATIONS OF THE TWINKLING SIGN
IN URETERAL CALCULUS, ITS ROLE IN
DIAGNOSIS AND CLINICAL
IMPLICATIONS: A SINGLE INSTITUTION
STUDY.
Arun Panackal*, Santhosh Kumar, Muscat,
Oman
9:50
PD14-12
IMPACT OF AUA RECOMMENDATIONS ON
IMAGING TRENDS IN THE FOLLOW-UP OF
URETERAL CALCULI
Anika Ackerman, New York, NY, Joanne
Dale*, Adam Kaplan, Tony Chen, Laura Ding,
Glenn Preminger, Charles Scales, Michael
Lipkin, Durham, NC
CREDITTM
97
8:00 am - 11:50 am
SOCIETY FOR BASIC UROLOGIC RESEARCH / THE SOCIETY OF UROLOGIC ONCOLOGY (SBUR / SUO) JOINT SESSION
Grand ABC @ Hyatt
8:00
WELCOME
9:45
PANEL DISCUSSION AND Q&A
8:05
IDENTIFICATION AND TARGETING
RESISTANCE IN CASTRATION-RESISTANT
PROSTATE CANCER
9:50
BREAK
10:00
MOVING PAST TKI’S IN RENAL CANCER
10:00
BIOMARKERS OF
ABIRATERONE/ENZALUTAMIDE RESISTANCE
AND THERAPEUTIC IMPLICATIONS
Emmanuel Antonarakis
MECHANISMS OF THERAPEUTIC
RESISTANCE IN RENAL CANCER: MOVING
PAST TKI’S IN RENAL CANCER
W. Marston Linehan
10:25
ROLE OF NON-CODING RNA IN RENAL
CANCER
Rajvir Dahiya
8:50
10:50
8:55
RESISTANCE AND OPTIONS IN
UROLOTHELIAL CARCINOMA
10:55
DONALD S. COFFEY LECTURE
Carlo Croce
WHAT’S SO DIFFICULT ABOUT A NEW
APPROACH POST-BCG?
Michael O’Donnell
11:50
ADJOURN
MECHANISMS OF CASTRATION-RESISTANCE
Timothy Thompson
8:25
9:20
CREDITTM
MICRODOSING FOR CHEMO-THERAPEUTIC
RESPONSE IN ADVANCED UROTHELIAL
CANCER
Chong-Xian Pan
8:00 am - 1:45 pm
INDIAN AMERICAN UROLOGICAL ASSOCIATION (IAUA)
7:00
BREAKFAST & EXHIBITS
8:00
INTRODUCTIONS
8:10
PROSTATE CANCER
Moderators: Chandru Sundaram, Desi Ramesh
10:40
CONTEMPORARY MANAGEMENT OF
SUPERFICIAL BLADDER CANCER AND CIS
Raj Pruthi
RISK STRATIFICATION FOR PROSTATE
CANCER TO DETERMINE TREATMENT –
INCLUDING USE OF BIOMARKERS AND
GENOMICS
Ketan Badani
8:30
HORMONE REFRACTORY PROSTATE CANCER
– ROLE OF CHEMOTHERAPY? ROLE OF THE
UROLOGIST?
Basir Tareen
8:50
HIGH RISK CANCER PROSTATE - INDIAN
PERSPECTIVE IN GLOBAL SCENARIO
Rajeev Sood
9:10
PANEL DEBATE: THE “DEATH” OF SWL –
SHOULD WE STILL BE USING IT?
Moderators: Ojas Shah, Percy Chibber
Debaters: Brian Matlaga, Vernon Pais
9:40
10:10
UROTHELIAL CARCINOMA AND
CONTROVERSIES IN THE MANAGEMENT OF
THE URINARY UPPER TRACT UROTHELIAL
CARCINOMA
Moderators: Khurshid Guru, Venkatesh Krishnamurthi
PANEL DEBATE: POST-PROSTATECTOMY
INCONTINENCE – SLINGS VS. AUS
Moderators: Ajay Singla, Rajeev Sood
Debaters: Allen Morey, Craig Comiter
COFFEE BREAK / VISIT POSTERS & EXHIBITS
11:10
ROLE OF NEOADJUVANT THERAPY
William Huang
11:25
ROLE OF LYMPHADENECTOMY AND USE OF
TEMPLATE
Monish Aron
11:40
ED MANAGEMENT AND NEW THERAPEUTIC
OPTIONS
Joseph Alukal
11:55
INDUSTRY SPONSORED LUNCH PROGRAM:
(NON-CME)
12:55
IAUA BUSINESS MEETING – MEMBERS ONLY
1:15
POSTER PRESENTATIONS AND DISCUSSION
Moderators: Chandru Sundaram, Puneet Sindhwani
1:45
ADJOURN
CREDITTM
98
8:00 am - 2:30 pm
WORLD CHINESE UROLOGICAL SOCIETY (WCUS)
Ballroom 20 A @ San Diego Convention Center
8:00
WELCOME
Tom Lue
10:15
SESSION 4: BASIC SCIENCE IN ONCOLOGY
Moderators: Tony Wu, Zhonging Yu
8:05
SCIENTIFIC PROGRAM
Richard Lo
10:15
8:10
SESSION 1: LO PING-WAN MEMORIAL
LECTURE
Moderators: Richard Lo, Zhangqun Ye
SMALL RNA-MEDIATED DPYSL3 GENE
EXPRESSION IN PROSTATE CANCER CELLS
Benyi Li
10:25
GENETIC VARIANTS OF THE AUTOPHAGY
PATHWAY AS PROGNOSTIC INDICATORS FOR
PROSTATE CANCER
Shu-Pin Huang
10:35
APPLICATION OF ARNA IN UROLOGY
Leng Cheng Li
10:45
DISCUSSION
10:50
WCUS AWARDS
Moderators: Tom Lue, Run Wang
11:00
SESSION 5: ADVANCE IN LOWER URINARY
TRACT SYMPTOMS
Moderators: Henry Lai, Jianye Wang
11:00
THE ROLE OF IMAGING IN DIAGNOSIS AND
MANAGEMENT OF VOIDING DYSFUNCTION
Lewis Chan
11:10
POST-PROSTATECTOMY INCONTINENCE AND
FEMALE UROLOGY
Vincent Tse
11:20
THE APPROACHES AND TIPS OF
URETHRORECTAL FISTULA
RECONSTRUCTION SURGERY
H. Li
11:30
DISCUSSION
11:35
LUNCH
12:00
SESSION 6: ENDOUROLOGY-1
Moderators: Guan Wu, Chia-Hsiang Lin
STATE OF ART OF PROSTATE CANCER
THERAPY
Peter Carroll
8:30
DISCUSSION
8:35
SESSION 2: ONCOLOGY-A
Moderators: Hong Li, Liyan Zhuang
MRI/USG FUSION TARGETED BIOPSY - NEW
STANDARD FOR PROSTATE CANCER
DIAGNOSIS?
Yiu MK, Ma WK
8:45
ULTRASOUND CT WITH ARTIFICIAL
INTELLIGENCE FOR EARLY DETECTION OF
PROSTATE CANCER
Li-Ping Xie
8:55
SURGICAL OUTCOMES OF ROBOTIC
ASSISTED LAPAROSCOPIC RADICAL
PROSTATECTOMY (RALRP) ON CHINESE
PROSTATE CANCER PATIENTS: SIX-YEAR
EXPERIENCE FROM A SINGLE TERTIARY
CENTRE IN HONG KONG
9:05
ANDROGEN DEPRIVATION THERAPY AND
THE RISK OF ACUTE MYOCARDIAL
INFARCTION IN CHINESE MEN WITH
PROSTATE CANCER
9:15
DISCUSSION
9:20
SESSION 3: ONCOLOGY-B
Moderators: George Chow, Tung Shu, Chu Sau
Kwan Peggy
FACTORS AFFECTING OPERATIVE
ERGONOMICS IN LESS ADRENALECTOMY
Yao-Chou Tsai
EXVIVO NEPHRON-SPARING BENCH
SURGERY AND ANTOTRANPLANTATION FOR
RENAL TUMORS
Ming Chen
9:30
9:40
12:10
RADICAL CYSTECTOMY AND
INTRACORPOREAL ILEAL NEOBLADDER
CONSTRUCTION
Nianzeng Xing
EXPERIENCE OF LAPAROSCOPIC AND
RADICAL CYSTECTOMY WITH URINARY
DIVERSION
Cheng-Kuang Yang
12:20
ARISTOLOCHIC ACID AND UROLOGICAL
CANCER: ITS IMPLICATION IN CLINICAL
MANAGEMENT
See-Tong Pang
A NOVEL APPROACH FOR ROBOTIC PARTIAL
NEPHRECTOMY: COMBINED TRANSRETROPERITONEAL 3-STEP APPROACH
Bo Yang
12:30
ENUCLEATION OF THE PROSTATE FOR THE
MANAGEMENT OF BENIGN PROSTATIC
HYPERPLASIA (BPH): A REAL GOLD
STANDARD
Zhong Wang
9:50
TUMOUR COMPLEXITY IS PREDICTIVE FOR
EARLY BUT NOT LONG-TERM RENAL
FUNCTION AFTER PARTIAL NEPHRECTOMY
12:40
DISCUSSION
10:00
DISCUSSION
12:45
10:05
BREAK
SESSION 7: ENDOUROLOGY-2
Moderators: Lee Zhao, Shaw Zhou, Yiu Ming Kwong
*Presenting author
99
THE TECHNIQUES OF URETERAL
RECONSTRUCTION: THE IUPU’S
EXPERIENCES
Xuesong Li
12:55
1:05
TRANSURETHRA HOLMIUM EN BLOC
RESECTION OF NON-MUSCLE INVASIVE
BLADDER TUMOR: PREMARY REPORT
C. Jiang
PERFECTING ZERO ISCHEMIA’ TECHNIQUE? APPLICATION OF NEAR-INFRARED
FLUORESCENCE IMAGING IN PARTIAL
NEPHRECTOMY
1:15
DISCUSSION
1:20
SESSION 8: UPDATE ON UROLOGY AND
ANDROLOGY
Moderators: Philip Li, Edmond Wong
1:20
1:30
TREATMENT OF RENAL PARTIAL STAGHORN
CALCULI IN CHILDREN WITH
EXTRACORPOREAL SHOCKWAVE
LITHOTRIPSY
Jianye Jia
1:40
USE OF HEMOSTATIC MATRIX TO REDUCE
LYMPHCOCELES REQUIRING INTERVENTION
IN RENAL TRANSPLANTATION: A TWO
CENTER TRIAL
1:50
KETAMINE INDUCED CYSTITIS: HOW FAR
ARE WE IN DECIPHERING ITS
PATHOPHYSIOLOGY?
Teng Ong
2:00
DISCUSSION
2:30
CLOSING REMARKS / ADJOURN
AGING IN ASIA – IMPLICATION ON MEN’S
HEALTH
Hui-Meng Tan
8:00 am - 5:00 pm
AUA / AMERICAN COLLEGE OF OSTEOPATHIC SURGEONS (ACOS) UROLOGY PROGRAM
8:00
MANAGEMENT OF NEPHROLITHIASIS
(HIGHLIGHTS FROM THE SEGURA
CONFERENCE)
Dawon Stephens
2:05
ERECTILE DYSFUNCTION
Tarek Pacha
2:45
BREAK
8:40
FEMALE SEXUAL DYSFUNCTION
Ashley Tapscott
3:00
PEYRONIE’S DISEASE MANAGEMENT
UPDATE
Michael Butcher
9:20
PEDIATRIC UROLOGY
Ariella Friedman
3:30
TRAUMA RECONSTRUCTION IN INDIA
Craig Hunter
10:00
BREAK
4:00
10:15
PROSTATE CANCER FOCAL THERAPY: AN
EMERGING TREATMENT PARADIGM
Marc Bjurlin
PHALLOPLASTY FOR GENDER DYSPHORIA
Mang Chen, Curtis Crane
4:30
BUSINESS IN UROLOGY
Frederick Berg
5:00
ADJOURN
10:45
CURRENT TOOLS FOR RISK STRATIFICATION
OF LOCALIZED PROSTATE CANCER
Nathan Hale
11:15
ROBOTIC TRICKS/TIPS DISCUSSION PANEL
Panelists: Pedro Maria, Fred Maggiolo
12:15
LUNCH
12:45
VESICOVAGINAL FISTULA REPAIR
Michael Ehlert
1:25
NEUROGENIC BLADDER
Gillian Sterns
CREDITTM
100
May 7-10, 2016
10:30 am
S&T Poster Session
SCIENCE & TECHNOLOGY POSTERS
Booth #1911 @ San Diego Convention Center
ABSTRACT
NUMBER TITLE
ST-01
CD4ⴙ CIRCULATING LYMPHOCYTES
COULD REFLECT BOTH THE
EXPRESSION PROFILE OF TISSUE
INFILTRATING LYMPHOCYTES AND
DISEASE PROGRESSION IN RENAL CELL
CARCINOMA PATIENTS
Atsunari Kawashima*, Takayuki Kanazawa,
Kayoko Maekawa, Mitsunobu Matsumoto,
Kumiko Goto, Akiko Morimoto, Kota Iwahori,
Takeshi Ujike, Akira Nagahara, Kazutoshi
Fujita, Motohide Uemura, Norio Nonomura,
Hisashi Wada, Suita, Japan
ST-02
ST-03
PERCENTAGE OF RENAL PARENCHYMAL
PRESERVATION AND RENAL TUMOR
MORPHOLOGY ARE DETERMINANTS OF
RENAL FUNCTIONAL OUTCOME
FOLLOWING PERCUTANEOUS
CRYOABLATION
Catherine Dufour*, Alp Beksac, Zachary
Hamilton, Unwanaobong Nseyo, Sean
Berquist, Abdel-rahman Hassan, Song Wang,
Jason Woo, Gerant Rivera-Sanfeliz, Michael
Liss, La Jolla, CA, Robert Wake, Memphis,
TN, Ithaar Derweesh, La Jolla, CA
MAXIMUM STANDARDIZED UPTAKE
VALUE OF 18F-FDG PET/CT PREDICTS
SURVIVAL OF PATIENTS WITH
ADVANCED UROTHELIAL CARCINOMA
Masaki Kobayashi*, Hajime Tanaka, Soichiro
Yoshida, Minato Yokoyama, Junichiro
Kazutaka Saito, Yasuhisa Fujii, Takeshi
Yuasa, Shinya Yamamoto, Hitoshi Masuda,
Junji Yonese, Kazunori Kihara, Tokyo, Japan
ST-04
PSYCHOMETRIC PROPERTIES OF THE
BLADDER CANCER- SUPPORTIVE CARE
NEEDS SURVEY QUESTIONNAIRE (SCNSBLC)
Nihal Mohamed*, New York, NY
ST-05
LONG-TERM FOLLOW-UP AFTER
NEOBLADDER WITH PROSTATIC
CAPSULE AND SEMINAL-SPARING
CYSTECTOMY (PCSSC) FOR BLADDER
CANCER
Salvatore Siracusano*, Trieste, Italy, Renzo
Colombo, Milan, Italy, Stefano Ciciliato, Laura
Toffoli, Tommaso Silvestri, Trieste, Italy,
Maurizio Brausi, Modena, Italy, Renato
Talamini, Trieste, Italy
ST-06
*Presenting author
ABSTRACT
NUMBER TITLE
ST-07
GENOMIC RISK STRATIFICATION OF
WITH SINGLE NUCLEOTIDE
POLYMORPHISM MICROARRAY AND
DISEASE RECURRENCE IN
LONGITUDINAL FOLLOW UP OF
RESECTED TUMORS
Austin Younger*, Charleston, SC, James S.
Rosoff, Greenwich, CT, Austin DeRosa,
Denver, CO, Hagop Sarkissian, Dayna Wolff,
Stephen J. Savage, Charleston, SC
HIGH ABSOLUTE MONOCYTE COUNT
PREDICTS POOR CLINICAL OUTCOME IN
PATIENTS WITH CASTRATIONRESISTANT PROSTATE CANCER
TREATED WITH DOCETAXEL
CHEMOTHERAPY
Keisuke Shigeta*, Takeo Kosaka, Toshiaki
Shinojima, Ryuichi Mizuno, Eiji Kikuchi, Akira
MIyajima, Mototsugu Oya, Tokyo, Japan
101
ST-08
OBSTRUCTIVE SLEEP APNEA
INCREASES THE RISK OF URINARY
INCONTINENCE
Shih-Yen Lu*, Yu-Hwa Fang, Hsiao-Jen
Chung, Eric Yi-Hsiu Huang, Chih-chieh Lin,
Alex T. L. Lin, Kuang-Kuo Chen, Taipei city,
Taiwan
ST-09
THE FERTILITY QUALITY OF LIFE AND
SEXUAL DYSFUNCTION IN MEN SEEKING
FERTILITY TREATMENT
Zhe Zhang*, Hui Jiang, Yuzhuo Yang,
Hongliang Zhang, Haocheng Lin, Lianming
Zhao, Wenhao Tang, Defeng Liu, Jiaming
Mao, Kai Hong, BeiJing, China, People’s
Republic of
ST-10
PROSTATE CANCER DIAGNOSIS BY
MULTIPLE SECRETED PROTEIN
BIOMARKERS IN VOIDED URINE
Tujin Shi, Yuqian Gao, Wei-jun Qian,
Richland, WA, Robin Leach, Ian Thompson,
San Antonio, TX, Sue-Ing Quek, William Ellis,
Elizabeth Vitello, Alvin Liu*, Seattle, WA
ST-11
SAFETY PROFILE ASSESSMENT OF
MANDATORY RESEARCH BIOPSIES OF
THE PROSTATE: A TEN YEAR MULTICENTER EXPERIENCE
Nicholas Tadros*, Paige Ferris, Jackilen
Shannon, Thomasz Beer, Mark Garzotto,
Portland, OR
ST-12
RACE DOES NOT PREDICT THE
DEVELOPMENT OF METASTASES IN MEN
WITH NON-METASTATIC CASTRATE
RESISTANT PROSTATE CANCER
Colette Whitney*, Lauren Howard, Durham,
NC, Christopher Amling, Portland, OR,
William Aronson, Los Angeles, CA, Matthew
Cooperberg, San Francisco, CA, Christopher
Kane, San Diego, CA, Martha Terris,
Augusta, GA, Stephen Freedland, Los
Angeles, CA
ST-13
INFORMING FOCAL THERAPY MARGINS
THROUGH MRI-PATHOLOGY
CORRELATION
Alan Priester*, Khoshnoodi Pooria, Shellee
Ogawa, Jesse Le, James Garritano, Bryan
Radosavcev, Daniel Margolis, Robert Reiter,
Jiaoti Huang, Warren Grundfest, Shyam
Natarajan, Leonard Marks, Los Angeles, CA
ST-14
URINARY AQUAPORIN-1 AND PERILIPIN-2
IN CONJUNCTION WITH RENAL MASS
BIOPSY: A NOVEL ALGORITHM IN THE
MANAGEMENT OF SMALL RENAL
MASSES
Joseph Song*, Anderson Barrett, Jeremiah
Morrissey, Jonathan Mobley, Karen
Figenshau, Joel Vetter, Sam Bhayani, Evan
Kharasch, Sherburn Figenshau, Saint Louis,
MO
ST-15
ST-16
ST-17
ST-18
QUALITY OF STUDIES REPORTING
SAFETY AND EFFICACY OF SYNTHETIC
MIDⴚURETHRAL SLINGS (SMUS)
Mubashir Billah*, New York, NY, Salma
Ahsanuddin, Brooklyn, NY, Jerry Blaivas,
New York, NY
OUTCOMES FOLLOWING PARTIAL
EXICISION COMPARED TO FORMAL
URETHROLYSIS FOR PATIENTS SEEKING
REVISION OF ANTIⴚINCONTINENCE
SLING
Alice Drain*, New York, NY, Ekene
Enemchukwu, Stanford, CA, Nihar Shah, Nirit
Rosenblum, Victor Nitti, Benjamin Brucker,
Raveen Syan, New York, NY
PROSPECTIVE RANDOMIZED TRIAL
COMPARING THE USE OF TITAN CLIPS
VERSUS BIPOLAR COAGULATION TO
SEAL LYMPHATIC VESSELS DURING
PROSTATECTOMY AND EXTENDED
PELVIC LYMPH NODE DISSECTION
Pietro Grande*, Giovanni Battista Di Pierro,
Livio Mordaini, Matteo Ferrari, Hansjörg
Danuser, Agostino Mattei, Lucerne,
Switzerland
PREOPERATIVE MEMBRANOUS
URETHRAL LENGTH BECOMES PREDICT
FACTOR FOR THE EARLY URINARY
INCONTINENCE AFTER ROBOT ASSISTED
PROSTATECTOMY
Daiki Ikarashi*, Yoichiro Kato, Mitsugu
Kanehira, Ryo Takata, Misato Takayama,
Akito Ito, Mitsutaka Onoda, Renpei Kato,
Tomohiko Matsura, Kazuhiro Iwasaki, Jun
Sugimura, So Ohmori, Takaya Abe, Wataru
Obara, Morioka-shi, Japan
102
ST-19
SAFETY AND EFFICACY OF REMEEX
SLING SYSTEM FOR FEMALE URINARY
INCONTINENCE AND FEASIBILITY OF READJUSTMENT
Jung Ki Jo*, Beyongdo Song, In Jae Lee, Ha
Rim Kook, Seongnam-si, Korea, Republic of,
Young Ik Lee, Busan-si, Korea, Republic of,
Sang Wook Lee, Jeong Hyun Kim,
Kanwondo, Korea, Republic of, Seong Jin
Jeong, Seongnam-si, Korea, Republic of
ST-20
VALIDATION OF TNM CLASSIFICATION
FOR METASTATIC PROSTATIC CANCER
TREATED USING PRIMARY ANDROGEN
DEPRIVATION THERAPY
Yoshifumi Kadono*, Takahiro Nohara, Satoru
Ueno, Kouji Izumi, Yasuhide Kitagawa,
Hiroyuki Konaka, Atsushi Mizokami,
Kanazawa, Japan, Mizuki Onozawa, Tokyo,
Japan, Shiro Hinotsu, Okayama, Japan,
Hideyuki Akaza, Tokyo, Japan, Mikio Namiki,
Kanazawa, Japan
ST-21
IMPACT OF ROBOT ASSISTED
LAPAROSCOPIC PROSTATECTOMY ON
VOIDING IMPROVEMENT IN PATIENTS
WITH LOWER URINARY TRACT
SYMPTOMS
Dong Soo Kim*, Seung-Kwon Choi, Sang
Hyub Lee, Koo Han Yoo, Dong-Gi Lee,
Gyeuong Eun Min, Hyung-Lae Lee, Sun-Ju
Lee, Choong Hyun Lee, Sung-Goo Chang,
Seung Hyun Jeon, Seoul, Korea, Republic of
ST-22
PROGNOSTIC SIGNIFICANCE OF
NEPHRECTOMY IN PATIENTS WITH
TREATED WITH FIRST-LINE SYSTEMIC
THERAPY: A 10-YEAR RETROSPECTIVE
ANALYSIS ACCORDING TO MSKCC AND
HENG RISK CRITERIA
Sung Han Kim, Jae Young Joung, Jinsoo
Chung, Kang Hyun Lee, Ho Kyung Seo,
Goyang, Korea, Republic of, Whi-An Kwon*,
Gunpo, Korea, Republic of
ST-23
INTRAVESICAL TACROLIMUS IN
TREATMENT OF BLADDER PAIN
SYNDROME/INTERSTITIAL CYSTITIS
Nagendra Nath Mishra*, Ahmedabad, India
ST-24
MIXED URINARY INCONTINENCE: WHICH
ROLE FOR TRANSOBTURATOR MIDURETHRAL SLINGS
Franca Natale*, Rome, Italy, Raffaele
Balsamo, Catanzaro, Italy, Chiara La Penna,
Rome, Italy, Ester Illiano, Naples, Italy,
Konstantinos Giannitsas, Patras, Greece,
Manuel Di Biase, Elisabetta Costantini,
Perugia, Italy
ST-25
ANDROGEN DEPRIVATION THERAPY IN
THE CONTEXT OF DOSE ESCALATING
RADIATION: COMMUNITY PRACTICE
PATTERNS AND OUTCOMES
Bogdana Schmidt*, Janet L Cowan, Kirsten L
Greene, Peter R Carroll, Matthew R
Cooperberg, San Francisco, CA
ST-26
COMBINED INGUINAL HERNIA REPAIR
WITH A SYNTHETIC MESH DURING
ROBOT ASSISTED LAPAROSCOPIC
Fabian Schoofs*, Daniel Benamran, Nadim
Douaihy, Jacques Klein, Julien Schwartz,
Christophe Iselin, Geneva, Switzerland
ST-27
STATINS AND BIOCHEMICAL
RECURRENCE AND MORTALITY AFTER
RADICAL PROSTATECTOMY OR
RADIOTHERAPY: A SYSTEMATIC REVIEW
AND META-ANALYSIS
Ping Tan*, Shiyou Wei, Lu Yang, Liang Gao,
Zhuang Tang, Qiang Wei, Chengdu, China,
ST-28
ST-29
ST-30
ST-31
COMPARISON OF SEXUAL FUNCTION IN
TRANSSEXUAL WOMEN WHO
UNDERWENT SEX REASSIGNMENT
SURGERY BY TWO DIFFERENT
TECHNIQUES
Francesca Vedovo*, Nicola Pavan, Gaetano
Chiapparrone, Giovanni Liguori, Stefano
Bucci, Fabio Barbone, Carlo Trombetta,
Trieste, Italy
EIGHT YEAR MEDIAN FOLLOW UP OF
MIDURETHRAL SLINGS, SINGLE CENTER
EXPERIENCE
Mohamed Elkhamesy, Tamer Helmy, Ahmed
El Hefnawy, Mohamed Gaballah, Bassem
Wadie*, Mansoura, Egypt
COMPARISON OF QUALITY OF LIFE IN
PATIENTS WITH LOCALLY ADVANCED
PROSTATE CANCER TREATED WITH
NEOADJUVANT ENDOCRINE, EXTERNAL
BEAM RADIATION AND ADJUVANT
CONTINUOUS/INTERMITTENT
ENDOCRINE THERAPY IN RANDOMIZED
PHASE III TRIAL
Akira Yokomizo*, Hirofumi Koga, Fukuoka,
Japan, Kazuto Ito, Kazuhiro Suzuki,
Maebashi, Japan, Hidetoshi Yamanaka,
Takasaki, Japan, Seiji Naito, Fukuoka, Japan
TRANSCRIPTIONAL REGULATION OF
CORTICOTROPIN RELEASING FACTOR
Lizath Aguiniga*, Anthony Schaeffer, David
Klumpp, Chicago, IL
ST-32
HEALTH-CARE SERVICES UTILIZATION
DURING THE LAST 6 MONTHS OF LIFE
AMONG BLADDER CANCER PATIENTS
WHO UNDERWENT RADICAL
CYSTECTOMY IN QUEBEC, CANADA
Ahmed S. Zakaria Ahmed*, Fabiano Santos,
Alice Dragomir, Wassim Kassouf, Simon
Tanguay, Armen Aprikian, Montreal, Canada
ST-33
COMPARISON OF THE ADVERSE EVENTS
OF ONABOTULINUMTOXINA TREATMENT
BETWEEN IC/BPS AND OAB IN WOMEN –
DOES DIFFERENT PATHOPHYSIOLOGY
RESULT IN DIFFERENT OUTCOME?
Yuh-Chen Kuo*, Taipei, Taiwan, Yu-Khun
Lee, Hann-Chorng Kuo, Hualien, Taiwan
*Presenting author
103
ST-34
AN INITIAL EXPERIMENTAL MODEL OF
CYSTOPLASTY USING ILEAL
SEROMUSCULAR LAYER AND FREE
GREATER OMENTUM
Jun Shen*, Shengwen Li, Zhiqiang Song,
Haishan Shen, Jianchen Wu, Chuyi Huang,
Linxi Zhang, Yingmao Ruan, Beijing, China,
ST-35
EXOSOMAL MIRNAS AND SERUM
CYTOKINES AS PREDICTORS FOR
TREATMENT OUTCOMES IN PATIENTS
WITH METASTATIC RENAL CELL
CARCINOMA TREATED WITH AXITINIB
Naoko Suzuki-Honma*, Akita, Japan, Norihiko
Tsuchiya, Yamagata, Japan, Takamitsu
Inoue, Shintaro Narita, Mitsuru Saito, Hiroshi
Tsuruta, Atsushi Maeno, Shigeru Satoh,
Tomonori Habuchi, Akita, Japan
ST-36
THE IMPACT OF INTRAVENOUS
ACETAMINOPHEN ON OUTCOMES FOR
PATIENTS UNDERGOING EXTIRPATIVE
KIDNEY SURGERY
Ilker Tinay*, Ye Wang, Francisco GelpiHammerschmidt, Boston, MA, Benjamin
Chung, Palo Alto, CA, Steven Chang, Boston,
MA
ST-37
IMAGE FUSION OF REAL-TIME US WITH
CONTRAST CT/MRI FOR RENAL MASS
BIOPSY IN AN OUTPATIENT SETTING: A
PILOT STUDY
Andre Luis de Castro Abreu*, Sameer
Chopra, Toshitaka Shin, Carlee Beckler,
Nariman Ahmadi, Andre Berger, Monish
Aron, Mihir M. Desai, Inderbir S. Gill, Osamu
Ukimura, Los Angeles, CA
ST-38
DIAGNOSIS PERFORMANCE OF
CONTRAST-ENHANCED
ULTRASONOGRAPHY AND MAGNETIC
RESONANCE IMAGING FOR THE
ASSESSMENT OF COMPLEX RENAL
CYSTS: A PROSPECTIVE STUDY
Guillaume Defortescu*, Jean-Nicolas Cornu,
Anthony Giwerc, Claire Werquin, Françoise
Gobet, Sofiane Bejar, Christian Pfister,
François-Xavier Nouhaud, Rouen, France
ST-39
CONCORDANCE OF URETEROSCOPIC
BIOPSY GRADE TO RADICAL
NEPHROURETERECTOMY GRADE AND
STAGE BASED ON THE 1973 AND 2004
WHO CLASSIFICATION SYSTEMS FOR
Ryuta Tanimoto*, Scott G Hubosky, Kelly A
Healy, Ruth Birbe, Marluce Bibbo, Demetrius
H Bagley, Philadelphia, PA
ST-40
LUTEINIZING HORMONE RELEASING
HORMONE AGONISTS LOWER
TESTOSTERONE LEVELS MORE THAN
SUBCAPSULAR ORCHIECTOMY:
RESULTS FROM A RANDOMIZED TRIAL
Peter Østergren*, Caroline Kistorp, Mikkel
Fode, Finn Bennedbæk, Jens Faber, Jens
Sonksen, Herlev, Denmark
ST-41
IS THERE A DIFFERENCE IN OUTCOME
BETWEEN EARLY VERSUS DELAYED
REMOVAL OF SUBURETHRAL MIDURETHRAL SLING?
Himanshu Aggarwal*, Jeannine Foster,
Nirmish Singla, Feras Alhalabi, Gary Lemack,
ST-42
DIFFERENT MANAGEMENT OPTIONS FOR
HORSESHOE KIDNEY STONES: SINGLE
CENTER EXPERIENCE.
ABDULHAKIM AL OTAY*, Osama Sarhan,
AHMED AL HELALY, KHALID ALBEDAIWI,
MUSTAFA AL GHANBAR, Ziad Nakshabandi,
Ali Obeid, Riyadh, Saudi Arabia
ST-43
ST-44
ST-45
ST-46
ST-47
SHUNTING FOR ISCHEMIC PRIAPISM: AN
IMPROVED STRATEGY
Amjad Alwaal*, Jeddah, Saudi Arabia,
Maurice Garcia, Tom Lue, San Francisco, CA
MULTIPLE USE OF PHOTODYNAMIC
DIAGNOSIS OF THE BLADDER IN THE
SAME PATIENT CAN BE PERFORMED
WITH NO MAJOR SIDE EFFECTS –
RESULTS OF A LARGE SINGLE-CENTER
STUDY
Maria Apfelbeck*, Tobias Grimm, Alexander
Buchner, Birte-Swantje Schneevoigt,
Alexander Kretschmer, Friedrich Jokisch,
Markus Grabbert, Gerald Schulz, Christian
Stief, Alexander Karl, Munich, Germany
ASSOCIATION BETWEEN PUBIC HAIR
GROOMING AND SEXUALLY
TRANSMITTED INFECTIONS: RESULTS
FROM A NATIONALLY REPRESENTATIVE
PROBABILITY SAMPLE
E. Charles Osterberg*, Thomas Gaither,
Mohannad Awad, Matthew Truesdale, San
Francisco, CA, Siobhan Sutcliffe, St. Louis,
MO, Isabel Allen, Benjamin Breyer, San
Francisco, CA
COMPARISON OF GLEASON SCORE
MISCLASSIFICATION BETWEEN
TRANSRECTAL ULTRASOUND –
MAGNETIC RESONANCE IMAGING
FUSION GUIDED PROSTATE BIOPSIES
AND SYSTEMATIC BIOPSIES. A
PROSPECTIVE ANALYSIS ACCORDING TO
FINAL HISTOPATHOLOGY AFTER
PROSTATECTOMY
Sebastian Berg*, Herne, Germany, Florian
Roghmann, Johannes Rüb, Robin Epplen,
Rein-Jüri Palisaar, Joachim Noldus, Marko
Brock, Herne, Germany
A NETWORK META-ANALYSIS OF
INTRAVESICAL BCG SUBSTRAIN
EFFICACY IN THE TREATMENT OF NONMUSCLE INVASIVE BLADDER CANCER
Brock Boehm*, John Cornell, Michael Liss,
Dharam Kaushik, Robert Svatek, San
Antonio, TX
104
ST-48
FEASIBILITY OF EGFR EVALUATION IN
BLADDER WASHINGS OF PATIENTS
AFFECTED BY NON MUSCLE-INVASIVE
BLADDER CANCER
Vincenzo Serretta, Fabrizio Di Maida*,
Cristina Scalici Gesolfo, Gabriele Tulone,
Antonina Graziella Cangemi, Alessandro
Perez, Antonio Russo, Palermo, Italy, Marco
Moschini, Renzo Colombo, Milan, Italy
ST-49
HOW TO DEFINE STRESS URINARY
INCONTINENCE SUCCESS AFTER AN
ANTI-INCONTINENCE PROCEDURE IN
REAL LIFE PRACTICE: DO YOU TRUST
THE PATIENT OR THE QUESTIONNAIRES/
PAD USAGE?
Philippe Zimmern, Carlos Finsterbusch*,
Feras Alhalabi, Alana Christie, Dallas, TX
ST-50
DOES TRANSPERINEAL PROSTATE
BIOPSY REDUCE COMPLICATIONS
COMPARED WITH TRANSRECTAL
BIOPSY? A SYSTEMATIC REVIEW AND
META-ANALYSIS OF RANDOMISED
CONTROLLED TRIALS
Cindy Garcia*, Matthew Winter, Philip
Bergersen, Henry Woo, Venu Chalasani,
Sydney, Australia
ST-51
EXTRACELLULAR MATRIX
CHARACTERISTICS OF TUNICA
ALBUGINEA IN MEN WITH AND WITHOUT
PEYRONIEⴕS DISEASE
Andre V. Oliveira, Marcelo S. Watanabe,
Maria Aparecida Pinhal, Monica Luzia Leonel,
Thérèse R. Theodoro, Sidney Glina*, Santo
André, Brazil
ST-52
EARLY CHANGES IN SKELETAL MUSCLE
AS A STRONG PROGNOSTIC BIOMARKER
IN PATIENTS WITH METASTATIC RENAL
CELL CARCINOMA
Weijie Gu*, Yao Zhu, Dingwei Ye, Shanghai,
ST-53
TEN-YEAR OUTCOMES OF TREATMENT
FOR LOCALIZED PROSTATE CANCER IN
A SINGLE INSTITUTION; COMPARISON
OF RADICAL PROSTATECTOMY VS
RADIATION THERAPY PROPENSITY
SCORE MATCHING ANALYSIS
Narihiko Hayashi*, Yumiko Yokomizo, Kimito
Osaka, Kazuhikde Makiyama, Noboru
Nakaigawa, Masahiro Yao, Masataka Taguri,
Yokohama, Japan
ST-54
NOVEL MOLECULAR TARGETS AKR1C2
IS ASSOCIATED WITH TESTOSTERONE
METABOLISM IN PROSTATE CANCER
AFTER TREATMENT OF CURCUMIN
Hisamitsu Ide*, Yan Lu, Satoru Muto, Raizo
Yamaguchi, Shigeo Horie, Tokyo, Japan
ST-55
SARCOPENIA AND THE MODIFIED
GLASGOW PROGNOSTIC SCORE ARE
SIGNIFICANT PREDICTORS OF PATIENT
SURVIVAL IN METASTATIC RENAL CELL
CARCINOMA PATIENTS RECEIVING
FIRST-LINE SUNITINIB TREATMENT
Hiroki Ishihara*, Tsunenori Kondo, Kenji
Omae, Toshio Takagi, Jumpei Iizuka, Hirohito
Kobayashi, Kazunari Tanabe, Tokyo, Japan
ST-56
ST-57
ST-58
PROSTATE CANCER-ASSOCIATED
ABERRANT GLYCOSYLATED S2,3PSA
TEST UTILIZING MICROCAPILLARY
ELECTROPHORESIS-BASED
IMMUNOASSAY ENABLED CLINICAL
APPLICATION FOR EARLY DIAGNOSIS OF
PROSTATE CANCER
Tomokazu Ishikawa*, Tohru Yoneyama, Yuki
Tobisawa, Shingo Hatakeyama, Hirosaki,
Japan, Tatsuo Kurosawa, Kenji Nakamura,
Amagasaki, Japan, Chikara Ohyama,
Hirosaki, Japan
NOVEL TRU-CUT NEEDLE WITH 25 MM
CUTTING LENGTH IMPROVES THE
DETECTION RATE OF PROSTATE
CANCER IN TRANSRECTAL PROSTATE
BIOPSY
Keishi Kajikawa*, Kent Kanao, Shingo
Morinaga, Hiroyuki Muramatsu, Ikuo
Kobayashi, Genya Nishikawa, Takahiko
Yoshizawa, Yoshiharu Kato, Masahito
Watanabe, Kogenta Nakamura, Makoto
Sumitomo, Nagakute-city Aichi-ken, Japan
WHY DO SOME PATIENTS MAKE
PRIMARILY CALCIUM OXALATE
MONOHYDRATE VERSUS DIHYDRATE
STONES?
Kathleen Kan*, Rohit Chugh, Vincent
Olorunnisomo, Rachel Shapiro, Lynn
Cochran, Mantu Gupta, New York, NY
ST-59
FACTORS AFFECTING THE RESPONSE
RATE OF FREQUENCY VOLUME CHART
Seong Cheol Kim*, Jae-Seung Chung, Sang
Hyun Park, Seok San Park, Cheol Kyu Oh,
Busan, Korea, Republic of
ST-60
THE INFLUENCE OF LENGTH, GRADE,
AND LOCATION OF POSITIVE SURGICAL
MARGIN (PSM) ON BIOCHEMICAL
RECURRENCE IN ORGAN CONFINED
PROSTATE CANCER
Chanwoo Lee*, Aram Kim, Myong Kim,
Myung-Chan Park, Jaeyoon Jung, Hyun-Jung
Go, Yang-Soon Park, Yong Mee Cho, In Gab
Jeong, Cheryn Song, Jun-Hyuk Hong,
Choung-Soo Kim, Hanjong Ahn, Seoul,
Korea, Republic of
ST-61
*Presenting author
ST-62
EFFECT OF PULSED MAGNETIC
STIMULATION ON SEXUAL FUNCTION IN
COUPLES WITH INCONTINENT
PARTNERS
Renly Lim*, Men Long Liong, Wing Seng
Leong, Nurzalina Abdul Karim Khan, Kah Hay
Yuen, Penang, Malaysia
ST-63
EFFECT OF PROSTATE BIOPSY ON
ERECTILE FUNCTION IN NON ERECTILE
DYSFUNCTION MEN A PROSPECTIVE
STUDY
Edgar Linden-Castro*, Marcela Pelayo-Nieto,
Daniel Espinosa-perezgrovas, Adolfo
Gonzalez-Serrano, Gabriel Catalan-Quinto,
Roberto Cortez-Betancourt, Mexico, Mexico
ST-64
CIGARETTE SMOKING AND PROSTATE
CANCER IN A PROSPECTIVE RADICAL
PROSTATECTOMY ITALIAN COHORT
STUDY
R. Lombardo*, C. De Nunzio, G. Simone, M.
Bellangino, R. Papalia, R. Mastroianni, Rome,
Italy, D. Collura, Turin, Italy, A. Brassetti,
Rome, Italy, G. Muto, Turin, Italy, M. Gallucci,
A. Tubaro, Rome, Italy
ST-65
PROSPECTIVE, BLINDED,
INTERNATIONAL AND MULTICENTER
VALIDATION OF A GENE EXPRESSION
TEST FOR THE NON-INVASIVE
DIAGNOSIS OF BLADDER CANCER
Lourdes Mengual*, Maria J. Ribal, Juan J.
Lozano, Mercedes Ingelmo-Torres,
Barcelona, Spain, Jill Liang, CT. Han,
Shanghai, China, People’s Republic of, Juan
Palou, Oscar Rodriguez-Faba, Barcelona,
Spain, Fred Witjes, Antoine G. Van der
Heijden, Nijmegen, Netherlands, Rafael
Medina, JM. Conde, Sevilla, Spain, Michael
Marberger, Joerg Schmidbauer, Vienna,
Austria, Dingwei Ye, Xun Ye, Xia Meng,
Shanghai, China, People’s Republic of,
Antonio Alcaraz, Barcelona, Spain
CREDITTM
NOVEL DNA METHYLATION APPROACH
IDENTIFIES THE AGGRESSIVENESS OF FOCI
IN MULTIFOCAL PROSTATE CANCER
Gangning Liang*, Kamilla Mundbjerg, Sameer
Chopra, Mehrdad Alemozaffar, Christopher
Duymich, Peter Nichols, Manju Aron, Kimberly
Siegmund, Osamu Ukimura, Los Angeles, CA,
Torben Ørntoft, Karina Sørensen, Aarhus,
Denmark, Daniel Weisenberger, Peter Jones,
Inderbir Gill, Los Angeles, CA
105
10:30 am - 12:30 pm
INFECTIONS/INFLAMMATION/CYSTIC DISEASE OF THE GENITOURINARY TRACT: KIDNEY & BLADDER II
Moderators: Daniel Shoskes and Robert Evans
ABSTRACT
NUMBER TITLE
MP26-01 INCONSISTENCY IN THE DEFINITION OF
URINARY TRACT INFECTION IN THE
SPINAL CORD INJURY POPULATION: A
SYSTEMATIC REVIEW
Laura L. Giusto*, Philadelphia, PA, Yahir
Santiago-Lastra, Ann Arbor, MI, Michael V.
Hughes, Philadelphia, PA, Mark MacEachern,
Anne P. Cameron, Ann Arbor, MI
ABSTRACT
NUMBER TITLE
MP26-08 FACTORS ASSOCIATED WITH SEVERE
SEPTIC EVENTS AFTER SURGICAL
DECOMPRESSION OF OBSTRUCTING
URETERAL STONES: A PROSPECTIVE
ANALYSIS
Giovanni Marchini*, Paulo Moscardi, Victor
Srougi, Fábio Vicentini, Fábio Torricelli, Artur
Brito, Cesar Camara, Miguel Srougi, Eduardo
Mazzucchi, Sao Paulo, Brazil
MP26-02 THE ROLE OF ROUTINE URINE
CULTURES IN CHILDREN WITH SPINA
BIFIDA USING CLEAN INTERMITTENT
CATHETERIZATION
Takashi Ikeda*, Sayaka Akiyama, Woojin
Kim, Yuichiro Yamazaki, Kanagawa Pref.
Yokohama City, Japan
MP26-09 FACTORS PREDICTING MORBIDITY
AFTER SEPSIS SECONDARY TO URINARY
STONES
Yaniv Larish*, Leon Telis, Dillon
Sedaghatpour, Leonard Glickman, Sarah
Fleszar, Michael Diefenbach, Boback
Berookhim, New York, NY
MP26-03 CAN WE EXTRAPOLATE THE
BACTERIOLOGICAL FINDINGS OF SIMPLE
CYSTITIS IN WOMEN TO TREAT SIMPLE
PYELONEPHRITIS?
Marcelo Hisano*, Homero Bruschini, Antonio
Carlos Nicodemo, Marcos Lucon, Cristiano
Mendes Gomes, Miguel Srougi, Sao Paulo,
Brazil
MP26-10 PREDICTORS OF URINARY TRACT
INFECTIONS AFTER ENDOUROLOGIC
STONE SURGERY
Abhinav Sidana, Bethesda, MD, Daniel Box*,
Lindsay Derus, James Donovan, Cincinnati,
OH
MP26-11 IS PRE-OPERATIVE URINE CULTURE
SUFFICIENT TO PREDICT SEPTIC
COMPLICATIONS OF PERCUTANEOUS
NEPHROLITHOTOMY?
Marouene Chakroun, Walid Kerkeni*,
Abderrazak Bouzouita, Haroun Ayed,
Mohamed Cherif, Amine Derouiche,
Mohamed Riadh Ben Slama, Mohamed
Chebil, Tunis, Tunisia
MP26-04 OVER THE COUNTER ANTIBIOTICS?
EFFECTS ON ESCHERICHIA COLI
INCIDENCE AND RESISTANCE IN
UNCOMPLICATED URINARY TRACT
INFECTIONS IN JORDAN
Zeid AbuGhosh*, Mohammad Alsadi, Fares
Ayoub, Montaser Alhakim, Tala Alnawaji,
Amman, Jordan
MP26-05
DOSE RESPONSE OF CRANBERRY IN THE
TREATMENT OF LOWER URINARY TRACT
INFECTIONS IN WOMEN
Lynn Stothers*, Vancouver, Canada, Paula
Brown, Burnaby, Canada, Howard Fenster,
Mark Levine, Jonathan Berkowitz, Vancouver,
Canada
MP26-12 IMPACT OF POSITIVE URINE AND STONE
CULTURE ON SEPTIC SHOCK
FOLLOWING PERCUTANEOUS
NEPHROLITHOTOMY
Shivanshu Singh, Shrawan Singh*, Santosh
Kumar, Neelam Taneja, Arup K Mandal,
Chandigarh, India
MP26-06 RECURRENT URINARY TRACT
INFECTIONS DUE TO BACTERIAL
PERSISTENCE OR REINFECTION IN
WOMEN: DOES THIS FACTOR IMPACT
UPPER TRACT IMAGING FINDINGS?
Yuefeng Wu*, Lauren Rego, Alana Christie,
Rebecca Lavelle, Feras Alhalabi, Philippe
Zimmern, Dallas, TX
MP26-13 URINALYSIS FINDINGS ARE NOT
PREDICTIVE OF POSITIVE URINE
CULTURE IN PATIENTS WITH
INDWELLING URETERAL STENTS
Aydin Pooli*, Gates Cook, Sudhir Isharwal,
Vikas Desai, Chad LaGrange, Omaha, NE
MP26-14 ARE ANTIBIOTICS NECESSARY DURING
ROUTINE CYSTOSCOPIC STENT
REMOVAL?
Joel E. Abbott*, Michelle McDonald, Allison
Han, Charlie Lakin, Roger L. Sur, San Diego,
CA
MP26-07 USE OF ANTIBIOTICS IN MANAGEMENT
OF UPPER URINARY TRACT STONES IN
THE EMERGENCY DEPARTMENT
Amanda C Chi*, Christopher D Morrison, Aziz
Khambati, Robert B Nadler, Chicago, IL
106
MP26-15
SYMPTOMATIC URINARY TRACT
INFECTIONS IN RENAL TRANSPLANT
PATIENTS AFTER CYSTOSCOPY FOR
URETERAL STENT REMOVAL
Justin Gregg*, Caroline Kang, Thomas
Talbot, S. Duke Herrell, Roger Dmochowski,
Daniel Barocas, Nashville, TN
MP26-19 A SINGLE INSTITUTION’S EXPERIENCE
WITH HEMORRHAGIC CYSTITIS AFTER
BONE MARROW TRANSPLANTATION
Jason Au*, Christopher Graziano, Rodolfo
Elizondo, Nicolette Janzen, Swati Naik,
Abhishek Seth, Houston, TX
MP26-20 INTRAVESICAL INSTILLATION OF
LIPOSOMAL-TACROLIMUS (LP-10) IS AN
EFFECTIVE TREATMENT FOR CHRONIC
RADIATION CYSTITIS
Bernadette Zwaans*, Sarah Bartolone,
Michael Chancellor, Royal Oak, MI, Peter
Levanovich, Detroit, MI, Sarah Krueger, Brain
Marples, Laura Lamb, Royal Oak, MI
MP26-16 ENDOUROLOGICAL MANAGEMENT OF
RENAL PAPILLARY NECROSIS
Amit Bhattu*, Manohar T., Nanda Kishor G.,
U.B. Joshi, Santosh Bethur, Bangalore, India
MP26-17 PROGNOSTIC FACTORS FOR ADVERSE
OUTCOME IN PATIENTS WITH
EMPHYSEMATOUS PYELONEPHRITIS
Jorge Moreno-Palacios, Leon TorresMercado, Eduardo Serrano-Brambila, Efraı́n
Maldonado-Alcaraz, Miguel Angel Garcia
Padilla*, Distrito Federal, Mexico
CREDITTM
MP26-18 PROGNOSTIC FEATURES AND
MICROBIAL DISTRIBUTION OF URINARY
TRACT INFECTION FOLLOWING RADICAL
CYSTECTOMY
William Parker*, Amir Toussi, Matthew
Tollefson, Igor Frank, R. Houston Thompson,
Harras Zaid, Prabin Thapa, Stephen Boorjian,
Rochester, MN
10:30 am - 12:30 pm
BLADDER CANCER: UPPER TRACT TRANSITIONAL CELL CARCINOMA II
Moderators: Mantu Gupta, Levent Turkeri and Majid Eshghi
ABSTRACT
NUMBER TITLE
MP27-01 UDP-GLUCURONOSYLTRANSFERASE 1A
(UGT1A) IMMUNOHISTOCHEMISTRY IN
UPPER URINARY TRACT AS A STRONG
PROGNOSTICATOR
Koji Izumi, Yokohama, Japan, Satoshi Inoue*,
Hiroki Ide, Baltimore, MD, Kazutoshi Fujita,
Suita, Japan, Seiji Yamaguchi, Hiroaki
Fushimi, Osaka, Japan, George Netto,
Baltimore, MD, Norio Nonomura, Suita,
Japan, Hiroshi Miyamoto, Baltimore, MD
ABSTRACT
NUMBER TITLE
MP27-03 HYPERMETHYLATION OF THE RASSF1A
GENE PROMOTER AT CYTOSINE
GUANINE DINUCLEOTIDE ISLANDS
PREDICTS HIGHER MALIGNANT
POTENTIAL BUT BETTER URINARY
TRACT RECURRENCE-FREE SURVIVAL IN
PATIENTS AFTER SURGERY
Jin Liu*, Gengyan Xiong, Qi Tang, Dong
Fang, Xuesong Li, Liqun Zhou, Beijing,
MP27-02 PROGNOSTIC ROLE OF PROGRAMMED
CELL DEATH PROTEIN 1 EXPRESSION IN
SURGICALLY TREATED PATIENTS WITH
UPPER TRACT UROTHELIAL
CARCINOMA.
Nozomi Hayakawa*, Eiji Kikuchi, Shuji
Mikami, Kazuhiro Matsumoto, Keishiro
Fukumoto, Takeo Kosaka, Ryuichi Mizuno,
Akira Miyajima, Mototsugu Oya, Tokyo,
Japan
*Presenting author
MP27-04 HOMOGENOUS OR HETEROGENOUS
BIOLOGICAL BEHAVIORS BETWEEN
URETERAL AND RENAL PELVIC
TUMORS? A COMPARISON OF CLINICAL
FEATURES, PATHOLOGICAL OUTCOMES,
EPIGENETIC BIOMARKERS AND
ONCOLOGIC PROGNOSIS
Dong Fang*, Gengyan Xiong, Yuze Zhu,
Guangzhi Zhao, Yunchao Xing, Lei Zhang,
Jin Liu, Qi Tang, Xuesong Li, Liqun Zhou,
Beijing, China, People’s Republic of
107
MP27-05
ARE CALCULATED FORMULAS FOR
ESTIMATING RENAL FUNCTION
ADEQUATE FOR ADMINISTERED
CISPLATIN-BASED CHEMOTHERAPY IN
SOLITARY RENAL PATIENTS AFTER
NEPHROURETERECTOMY FOR UPPER
TRACT UROTHELIAL CARCINOMA?
Naoya Niwa*, Eiji Kikuchi, Masashi
Matsushima, Nobuyuki Tanaka, Toru
Nishiyama, Akira Miyajima, Shiro Saito,
MP27-10 IMPACT OF DIAGNOSTIC
URETEROSCOPY ON THE ONCOLOGICAL
OUTCOMES FOLLOWING RADICAL
NEPHROURETERECTOMY
Quentin Alimi*, Benoit Peyronnet, Gregory
Verhoest, Romain Mathieu, Andrea Manunta,
Lauranne Tondut, Karim Bensalah, Rennes,
France
MP27-11 IS PREOPERATIVE CHRONIC KIDNEY
DISEASE STATUS ASSOCIATED WITH
ONCOLOGIC OUTCOMES IN UPPER
URINARY TRACT UROTHELIAL
CARCINOMA? : A MULTICENTER
PROPENSITY SCORE MATCHED
ANALYSIS
Ho Seok Chung*, Eu Chang Hwang, Seung Il
Jung, Taek Won Kang, Dongdeuk Kwon, Jun
Seok Kim, Joon Hwa Noh, Gwangju, Korea,
Republic of, Jae Hyung You, Myung Ki Kim,
Jeonju, Korea, Republic of, Tae Hoon Oh, Ill
Young Seo, Iksan, Korea, Republic of, Seung
Baik, Chul-Sung Kim, Gwangju, Korea,
Republic of, Sung Gu Kang, Seok Ho Kang,
Jun Cheon, Seoul, Korea, Republic of
MP27-06 DEVELOPMENT OF A NEW PROGNOSTIC
MODEL TO PREDICT SURVIVAL OF
PATIENTS WITH METASTATIC
UROTHELIAL CARCINOMA RECEIVING
FIRST-LINE GEMCITABINE PLUS
CISPLATIN CHEMOTHERAPY:
MULTICENTER RETROSPECTIVE STUDY
BY THE SAPPORO MEDICAL UNIVERSITY
UROLOGIC ONCOLOGY CO
Takeshi Maehana*, Toshiaki Tanaka, Tetsuya
Shindo, Sapporo, Japan, Atsushi Takahashi,
Hakodate, Japan, Naoki Ito, Sapporo, Japan,
Keisuke Taguchi, Tomakomai, Japan, Hiroshi
Hotta, Asahikawa, Japan, Naoya Masumori,
Sapporo, Japan
MP27-12 PROGNOSTIC VALUE OF LYMPH NODE
YIELD DURING NEPHROURETERECTOMY
FOR UPPER TRACT UROTHELIAL
CARCINOMA
Andrew Winer*, Emily Vertosick, Renato
Beluco, Sigrid Carlsson, Samuel
Kaffenberger, Aditya Bagrodia, Katie Murray,
Daniel Sjoberg, John Sfakianos, Eugene Cha,
Guido Dalbagni, Jonathan Coleman, New
York, NY
MP27-07 APPARENT DIFFUSION COEFFICIENT AS
A PROGNOSTIC BIOMARKER OF UPPER
URINARY TRACT CANCER
Soichiro Yoshida*, Yusuke Uchida, Shuichiro
Kobayashi, Fumitaka Kobayashiga, Hiroshi
Tanaka, Minato Yokoyama, Junichiro Ishioka,
Yoh Matsuoka, Noboru Numao, Kazutaka
Saito, Yasuhisa Fujii, Kazunori Kihara, Tokyo,
Japan
MP27-13 ARISTOLOCHIC ACID INDUCED UNIQUE
ONCOLOGICAL CHARACTERISTIC IN
CHINA: GENDER RELATED DIFFERENCES
IN UPPER TRACT UROTHELIAL
CARCINOMA
Gengyan Xiong*, Yunchao Xing, Qi Tang,
Xuesong Li, Liqun Zhou, Beijing, China,
MP27-08 RISK STRATIFICATION MODEL FOR
LYMPHOVASCULAR INVASION,
PATHOLOGICAL T STAGE, LYMPH NODE
INVOLVEMENT, AND C-REACTIVE
PROTEIN PREDICTS HIGH-RISK
PATIENTS -WHO ARE CANDIDATE FOR
ADJUVANT CHEMOTHERAPY IN UPPER
URINARY TRACT UROTHELIAL CANCERKazuhiro Nagao*, Hideyasu Matsuyama, Ube,
Japan, Kiyohide Fujimoto, Kashihara, Japan,
Haruhito Azuma, Takasuki, Japan, Hiroaki
Shiina, Izumo, Japan, Shigeru Sakano,
Kitakyushu, Japan, Yoshihiro Tatsumi,
Kashihara, Japan, Teruo Inamoto, Takasuki,
Japan, Hiroaki Yasumoto, Izumo, Japan
MP27-14 LOCATION OF THE TUMOR IN UPPER
TRACT UROTHELIAL CARCINOMA (UTUC)
IMPACTS ON THE PRESENCE OF
CONCOMITANT UROTHELIAL
CARCINOMA OF THE BLADDER: A MULTIINSTITUTIONAL DATABASE STUDY
Teruo Inamoto*, Kiyoshi Takahara, Osaka,
Japan, Hideyasu Matsuyama, Ube, Japan,
Kiyohide Fujimoto, Kashihara, Japan, Hiroaki
Shiina, Izumo, Japan, Shigeru Sakano,
Kazuhiro Nagao, Ube, Japan, Makito Miyake,
Yoshihiro Tatsumi, Kashihara, Japan, Hiroaki
Yasumoto, Izumo, Japan, Haruhito Azuma,
Osaka, Japan
MP27-09 EXTIRPATIVE TREATMENT FOR
PANUROTHELIAL DISEASE: OUTCOMES
OF RADICAL NEPHROURETERECTOMY
FOR METACHRONOUS UPPER TRACT
CYSTECTOMY
Qiang Li*, Melissa Assel, Eugene Pietzak,
Aditya Bagrodia, Eugene Cha, Jonathan
Coleman, New York, NY
MP27-15
108
TUMOR LOCATION AS A PREDICTOR OF
SURVIVAL FOLLOWING
TRACT UROTHELIAL CANCER: A U.S.
POPULATION BASED ANALYSIS (20042012)
Meera Chappidi*, Max Kates, Trinity
Bivalacqua, Phillip Pierorazio, Baltimore, MD
MP27-16 IMPACT OF PERI-OPERATIVE BLOOD
TRANSFUSION ON ONCOLOGIC
OUTCOMES OF PATIENTS UNDERGOING
TRACT UROTHELIAL CARCINOMA.
Wan Song, Jae Ho Yoo*, Jae Yong Jeong,
Hyun Hwan Sung, Hwang Gyun Jeon, Byong
Chang Jeong, Seong Il Seo, Seong Soo
Jeon, Han Yong Choi, Hyun Moo Lee, Chi I
Hun Kwon, Heung Jae Park, Seoul, Korea,
Republic of, Kwang Ho Ryu, Gwangmyeong,
Korea, Republic of
MP27-18 IMPACT OF MAXIMUM TUMOR DIAMETER
ADJUSTED BY PRIMARY TUMOR
LOCATION IN PATIENTS WITH UPPER
TRACT UROTHELIAL CARCINOMA
MANAGED BY RADICAL
NEPHROURETERECTOMY: THE MULTIINSTITUTIONAL STUDY
Yasumasa Miyazaki*, Eiji Kikuchi, Nobuyuki
Tanaka, Tokyo, Japan, Suguru Shirotake,
Saitama, Japan, Kazuhiro Matsumoto, Hiroaki
Kobayashi, Hiroki Ide, Jun Obata, Tokyo,
Japan, Katsura Ishioka, Kanagawa, Japan,
Takeo Kosaka, Tokyo, Japan, Kent Kanao,
Aichi, Japan, Masafumi Oyama, Saitama,
Japan, Akira Miyajima, Tokyo, Japan, Tetsuo
Momma, Saitama, Japan, Shintaro
Hasegawa, Tochigi, Japan, Yosuke Nakajima,
Kanagawa, Japan, Masahiro Jinzaki,
MP27-17 UPGRADING AND NEW DIAGNOSIS OF
CIS ON POST-NEPHROURETERECTOMY
FINAL PATHOLOGY FOR UTUC: A SINGLE
INSTITUTION EXPERIENCE
Justin T. Matulay*, Marissa C. Velez, Wilson
Sui, Maxwell B. James, Ifeanyi Onyeji, James
M. McKiernan, Ojas Shah, New York, NY
CREDITTM
10:30 am - 12:30 pm
BLADDER & URETHRA: ANATOMY, PHYSIOLOGY & PHARMACOLOGY I
Moderators: Nissrine Nakib and Karl-Erik Andersson
ABSTRACT
NUMBER TITLE
MP28-01 PROFOUND INFLUENCE OF ANDROGENS
ON HISTOLOGIC ARCHITECTURE OF THE
RAT URETHRA
Matthias D Hofer*, Billy H Cordon, Dallas,
TX, Matthew I Bury, Earl Y Cheng, Chicago,
IL, Chris M Gonzalez, Cleveland, OH, Arun S
Sharma, Chicago, IL, Allen F Morey, Dallas,
TX
ABSTRACT
NUMBER TITLE
MP28-04 THE EFFECT OF SELECTIVE ␣␣1AADRENOCEPTOR BLOCKER SILODOSIN
ON URINARY BLADDER FUNCTION IN
RAT MODEL OF CYCLOPHOSPHAMIDE
INDUCED INTERSTITIAL CYSTITIS
Shogo Shimizu*, Takahiro Shimizu,
Youichirou Higashi, Nankoku, Japan, Bunya
Kawamoto, Katsuya Hikita, Kuniyasu
Muraoka, Masashi Honda, Atsushi Takenaka,
Yonago, Japan, Motoaki Saito, Nankoku,
Japan
MP28-02 SUPRASPINAL AND SPINAL EFFECTS OF
DOPAMINE UPTAKE INHIBITOR ON THE
MICTURITION REFLEX IN URETHANEANESTHETIZED RATS
Masashi Honda*, Yonago, Japan, Naoki
Yoshimura, Pittsburgh, PA, Bunya Kawamoto,
Tsounapi Panagiota, Yonago, Japan, Shogo
Shimizu, Nankoku, Japan, Hikita Katsuya,
Kuniyasu Muraoka, Yonago, Japan, Takahiro
Shimizu, Nankoku, Japan, Takehiro Sejima,
Yonago, Japan, Motoaki Saito, Nankoku,
Japan, Michael Chancellor, Royal Oak, MI,
Atsushi Takenaka, Yonago, Japan
MP28-05
MP28-06 COLITIS INDUCES LONG-TERM BLADDER
AFFERENT HYPERACTIVITY, WHICH IS
ATTENUATED BY CHRONIC ORAL
ADMINISTRATION OF THE GUANYLATE
CYCLASE-C AGONIST LINACLOTIDE
Luke Grundy*, Sonia Garcia-Caraballo,
Jessica Maddern, Grigori Rychkov, Adelaide,
Australia, Gerhard Hannig, Caroline Kurtz,
Ada Silos-Santiago, Cambridge, MA, Stuart
M. Brierley, Adelaide, Australia
MP28-03 THREE-DIMENSIONAL RELATIONSHIP
BETWEEN THE BLADDER
INTRAMUSCULAR INTERSTITIAL CELL
AND THE AXON INNERVATED IN THE
DETRUSOR BUNDLE BY FIB/SEM
TOMOGRAPHY
Tokumasa Hayashi*, Shingo Hirashima,
Keisuke Ohta, Kei-ichiro Nakamura, Tsukasa
Igawa, Kurume Fukuoka, Japan
*Presenting author
INITIAL NEUTROPHIL-TO-LYMPHOCYTE
RATIO (NLR) IS A PROGNOSTIC MARKER
IN PENILE CANCER PATIENTS.
Takashi Kawahara*, Jun Kasuga, Yokohama,
Japan, Hiroshi Miyamoto, Baltimore, MD,
Masahiro Yao, Yasushi Yumura, Hiroji
Uemura, Yokohama, Japan
109
MP28-07 SENSATION OF BLADDER FULLNESS BY
A NEW NEURONAL PATHWAY
ESTABLISHED BY GENITOFEMORAL OR
FEMORAL NERVE TRANSFER TO AN
ANTERIOR VESICAL PELVIC NERVE
BRANCH IN A CANINE DECENTRALIZED
BLADDER MODEL.
Michael Ruggieri*, Sandra Gomez-Amaya,
Alan Braverman, Philadelphia, PA, Neil
Lamarre, Madison, WI, Mary Barbe,
Philadelphia, PA
MP28-15
EFFECT OF NAFTOPIDIL ON THE BRAIN
NORADRENALINE-INDUCED DECREASE
OF ARGININE-VASOPRESSIN SECRETION
IN RATS
Takahiro Shimizu*, Shogo Shimizu,
Youichirou Higashi, Masaki Yamamoto,
Kumiko Nakamura, Nankoku, Japan, Naoki
Yoshimura, Pittsburgh, PA, Motoaki Saito,
Nankoku, Japan
MP28-16 BRAIN SEROTONIN AND
CORTICOTROPIN-RELEASING FACTOR
ARE INVOLVED IN BOMBESIN-INDUCED
FREQUENT URINATION IN RATS
Takahiro Shimizu*, Pittsburgh, PA, Shogo
Shimizu, Nankoku, Japan, Naoki Wada, Shun
Takai, Nobutaka Shimizu, Katsumi
Kadekawa, Tsuyoshi Majima, Pittsburgh, PA,
Youichirou Higashi, Motoaki Saito, Nankoku,
Japan, Naoki Yoshimura, Pittsburgh, PA
MP28-08 OXIDATIVE STRESS ACCELERATES THE
TRANSITION FROM COMPENSATED TO
DECOMPENSATED BLADDER FUNCTION
IN STZ-INDUCED DIABETIC MICE
Rania Elrashidy, Zagazig, Egypt, Guiming
Liu*, Michael Kavran, Cleveland, OH, Mervat
Asker, Sousou Ali, Hoda Mohamed, Zagazig,
Egypt, Firouz Daneshgari, Cleveland, OH
MP28-09 A NOVEL MODEL OF PELVIC ORGAN
ISCHEMIA: PELVIC FLOOR CONTRACTILE
FUNCTION IS MORE RESISTANT TO
ISCHEMIA AND POST-ISCHEMIA
REPERFUSION THAN BLADDER
DETRUSOR MUSCLE
Amy D. Dobberfuhl*, Stanford, CA, Catherine
Schuler, Robert E. Leggett, Elise J.B. De,
Robert M. Levin, Albany, NY
MP28-17 SPATIAL AND FUNCTIONAL
INTERACTIONS OF THE TRANSIENT
RECEPTOR POTENTIAL MELASTATIN-4
CHANNELS AND INOSITOL
TRISPHOSPHATE RECEPTORS: NOVEL
REGULATORY MECHANISM IN HUMAN
DETRUSOR SMOOTH MUSCLE FUNCTION
Aaron Provence*, Kiril Hristov, Columbia, SC,
Eric Rovner, Charleston, SC, Georgi V.
Petkov, Columbia, SC
MP28-10 COMBINED EFFECTS OF MELATONIN
AND CLADRIBINE ON APOPTOSIS IN
ISCHEMIA/REPERFUSION INJURY IN RAT
BLADDER
Young Seop Chang*, Hong Wook Kim,
Daejeon, Korea, Republic of, Karl-Erik
Andersson, Winston-Salem, NC, ki hak Song,
Yong Gil Na, Jae Sung Lim, Seung Woo
Yang, Chung Lyul Lee, Daejeon, Korea,
Republic of
MP28-18 17␤-ESTRADIOL DIRECT ACTIVATION OF
LARGE CONDUCTANCE VOLTAGE- AND
CA2ⴙ-ACTIVATED Kⴙ CHANNELS: NOVEL
REGULATORY MECHANISM IN HUMAN
DETRUSOR SMOOTH MUSCLE
Kiril Hristov*, Shankar Parajuli, Aaron
Provence, Columbia, SC, Eric Rovner,
Charleston, SC, Georgi Petkov, Columbia,
SC
MP28-11 UROTHELIAL DYSFUNCTION AND
PROTEIN EXPRESSIONS IN PATIENTS
WITH DETRUSOR UNDERCTIVITY
Yuan-Hong Jiang*, Hueih-Ling Ong, HannChorng Kuo, Hualien, Taiwan
MP28-19 “SOMETIMES A SHAM IS JUST A SHAM” –
WHY THE RODENT MODEL OF PARTIAL
BLADDER OUTLET OBSTRUCTION NEEDS
ADJUSTMENT
Martin Sidler*, Karen Aitken, Janet Jiang,
Toronto, Canada, Dominika Bijos, Bristol,
United Kingdom, Darius Bagli, Toronto,
Canada
MP28-12 MECHANISMS OF STRESS-INDUCED
BLADDER DYSFUNCTION: A NOVEL ROLE
FOR ALTERATIONS IN URINARY
BLADDER PERMEABILITY
Ehsan Mohammadi*, Niran Hadad, Robert
Hurst, Beverley Greenwood-Van Meerveld,
Oklahoma City, Ok
MP28-20 MUCOSA AFFECTS THE BLADDER
DYSFUNCTION IN DIABETES WITH HIGH
FAT DIET
Zongwei Wang*, Vivian Cristofaro, Tongxiang
Liu, Rongbin Ge, Maryrose Sullivian, Aria
Olumi, Boston, MA
MP28-13 URETHRAL AND DETRUSOR
DYSFUNCTION ARE DETERMINED BY THE
SEVERITY OF A CONTUSION-SCI IN
FEMALE RATS
Timothy Boone, Carolina Rivera, Alvaro
Munoz*, Houston, TX
CREDITTM
MP28-14 PROTEASE-ACTIVATED RECEPTOR 4
INDUCES BLADDER PAIN THROUGH
DISULFIDE HIGH MOBILITY GROUP BOX-1
ACTING ON RECEPTORS FOR ADVANCED
GLYCATION ENDPRODUCTS
Dimitrios Kouzoukas, Maywood, IL, Fei Ma*,
Lexington, KY, Katherine Meyer-Siegler, St.
Petersburg, FL, Karin Westlund, David Hunt,
Pedro Vera, Lexington, KY
110
10:30 am - 12:30 pm
TRANSPLANTATION & VASCULAR SURGERY: RENAL TRANSPLANTATION & VASCULAR SURGERY I
Moderator: Peter Bretan
ABSTRACT
NUMBER TITLE
MP29-01 TREATMENT OPTIONS AND PREDICTIVE
FACTORS FOR RECURRENCE AND
CANCER SPECIFIC MORTALITY IN
BLADDER CANCER AFTER RENAL
TRANSPLANTATION: A
MULTIINSTITUTIONAL ANALYSIS
Oscar Rodrı́guez*, Joan Palou, Barcelona,
Spain, Ana Palazzetti, Paolo Gontero, Torino,
Italy, Jorge Garcı́a-Olaverri, Barakaldo,
Spain, Jesús Marı́a Fernández Gómez,
Oviedo, Spain, Jonaton Olsburg, London,
United Kingdom, Carlo Terrone, Novara, Italy,
Arnaldo Figueiredo, Coimbra, Italy, Francesc
Vigués, Barcelona, Spain, Javier Burgos,
Enrique Lledó, Madrid, Spain, Alberto Breda,
Barcelona, Spain
ABSTRACT
NUMBER TITLE
MP29-07 ROBOTIC KIDNEY TRANSPLANTATION
WITH REGIONAL HYPOTHERMIA:
RESULTS FROM A PROSPECTIVE TWOARM NON-RANDOMIZED CONTROLLED
TRIAL (IDEAL PHASE 2B)
Akshay Sood*, Detroit, MI, Prasun Ghosh,
Gurgaon, India, Wooju Jeong, Deepansh
Dalela, Mahendra Bhandari, Detroit, MI,
Rajesh Ahlawat, Gurgaon, India, Mani
Menon, Detroit, MI
MP29-08 PERCUTANEOUS RENAL HILAR
BLOCKADE TO PREDICT SUCCESS OF
AUTO KIDNEY TRANSPLANTATION FOR
LOIN PAIN HEMATURIA SYNDROME
Jeffrey Campsen, Mitchell Bassett*, Ryan
O’Hara, Heather Thiesset, Robin Kim, Rulon
Hardman, Blake Hamilton, Salt Lake City, UT
MP29-02 KEEPING RENAL TRANSPLANTATION
WITHIN UROLOGY: THE SUCCESS OF A
HYBRID PRACTICE MODEL IN CANADA
Andrea Kokorovic*, Halifax, Canada, Neal
Rowe, Ottawa, Canada
MP29-09 RENO-PROTECTIVE EFFECT OF LOCAL
SILDENAFIL ADMINISTRATION IN CANINE
MODEL OF RENAL ISCHEMIA
REPERFUSION INJURY
Mohamed Zahran*, Ahmed Mosbah, Adel
Nabeeh, Ahmed A Shokeir, Mansoura, Egypt
MP29-03 SUCCESSFUL LAPAROSCOPIC
ALLOTRANSPLANTATION OF
EMBRYONIC KIDNEYS ENHANCED BY
ADIPOSE-DERIVED STEM CELLS
SUSPENSION
César Vera-Donoso*, Ximo Garcı́aDomı́nguez, Victoria Moreno-Manzano, Luı́s
Garcı́a-Valero, José Salvador Vicente-Antón,
Francisco Marco-Jiménez, Valencia, Spain
MP29-10 PROTECTIVE EFFECTS OF REGULATORY
T CELLS IN RENAL
ISCHEMIA/REPERFUSION INJURY IN
MICE
Ryohei Yamamoto*, Mitsuru Saito, Hiroshi
Tsuruta, Atsushi Maeno, Takamitsu Inoue,
Shintaro Narita, Norihiko Tsuchiya, Shigeru
Satoh, Tomonori Habuchi, Akita, Japan
MP29-04 TRENDS IN BODY MASS INDEX AFTER
DONOR NEPHRECTOMY: AN INTERVAL
ASSESSMENT
Christopher Dru*, Gerhard Fuchs, Los
Angeles, CA
MP29-05
MP29-11 REPOPULATION OF PRIMARY RENAL
CELLS FOR WHOLE ORGAN
ENGINEERING: FUNCTIONAL
EVALUATIONS
Mehran Abolbashari, Mi-Kyung Lee, Sigrid
Agcaoili, Tamer Aboushwareb, In Kap Ko,
John Jackson*, Anthony Atala, James Yoo,
Winston Salem, NC
TRENDS IN RESIDENT EXPOSURE TO
RENAL TRANSPLANT: A COMPARATIVE
ANALYSIS OF NON-UROLOGY SURGICAL
TRAINEES
Jennifer Bjazevic*, Sebastian Launcelott,
Shannon Stogryn, Winnipeg, Canada, Jasmir
Nayak, Seattle, WA, Thomas McGregor,
Winnipeg, Canada
MP29-12 FLOSEAL HEMOSTATIC MATRIX
REDUCES SYMPTOMATIC LYMPHOCELES
AFTER RENAL TRANSPLANTATION
Wai-Kit MA*, Donald CH Ip, Charles KW
Wong, Thomas YC Lam, Tin-Yu Chu, Yi
Chiu, Franklin KL Ho, Jason KW Wong, Brian
SH Ho, Ada TL Ng, James HL Tsu, FuKeung Cheung, Ming-Kwong Yiu, Hong Kong,
Hong Kong
MP29-06 LONG TERM TRANSPLANTATION OF
BIOENGINEERED PORCINE KIDNEY
CONSTRUCTS SEEDED WITH
AUTOLOGOUS CELLS
Joao Paulo Zambon*, In Kap Ko, Ick-Hee
Kim, Charesa Smith, John Jackson, Anthony
Atala, James Yoo, Winston Salem, NC
*Presenting author
111
MP29-13 LIVING DONOR NEPHRECTOMY: A
MULTICENTRIC COMPARATIVE STUDY
BETWEEN STANDARD LAPAROSCOPIC
AND ROBOT-ASSISTED LAPAROSCOPIC
DONOR NEPHRECTOMY.
Benjamin Pradere*, Tours, France, Benoit
Peyronnet, Rennes, France, Thibaut Benoit,
Toulouse, France, Alexandre May, Tours,
France, Frederico Salusto, Michel Soulié,
Pascal Rischmann, Nicolas Doumerc, Xavier
Gamé, Toulouse, France, Franck Bruyère,
Tours, France
MP29-17 HYDROGEN SULFIDE TREATMENT
MITIGATES DONOR TISSUE NECROSIS
DURING PROLONGED COLD STORAGE
AND IMPROVES SURVIVAL FOLLOWING
ALLOGENEIC RENAL
TRANSPLANTATION.
Ian Lobb*, Weihua Liu, Jifu Jiang, Dameng
Lian, Alp Sener, London, Canada
MP29-18 ANALYSIS OF DE NOVO UROLOGIC
CANCER IN KIDNEY TRANSPLANT
RECIPIENTS: SINGLE CENTER STUDY OF
3,951 CASES
Jaeyoon Jung*, Sangjun Yoo, Se Young
Choi, Wonseok Choi, Jae Hyeon Han, Seoul,
Korea, Republic of, Sungwoo Hong, Hyung
Jee Kim, Cheonan, Korea, Republic of,
Taekmin Kwon, Kyung Hyun Moon, Ulsan,
Korea, Republic of, Sang Hoon Song, Dalsan
You, In Gab Jeong, Choung-Soo Kim, Seoul,
Korea, Republic of
MP29-14 SERUM N-GLYCAN PROFILING PREDICT
ANTIBODY MEDIATED REJECTION IN
PATIENTS UNDERGOING LIVING KIDNEY
TRANSPLANTATION
Daisuke Noro*, Tohru Yoneyama, Yuki
Tobisawa, Shingo Hatakeyama, Mitsuru
Saito, Yasuhiro Hashimoto, Takuya Koie,
Shigeru Sato, Chikara Ohyama, Hirosaki,
Japan
MP29-15
MP29-19 INCIDENCE OF SOLID RENAL MASSES IN
TRANSPLANTED ALLOGRAFT KIDNEYS
John Grifith*, Katherine Brewer, Michael
Palese, Susan Lerner, Veronica Delaney,
Scott Ames, John Sfakianos, Ketan Badani,
Reza Mehrazin, New York, NY
COMPUTER-ASSISTED ANATOMICAL
DISSECTION CAAD OF THE RENAL
PLEXUS TO REFINE RENAL
DENERVATION IN THE TREATMENT OF
REFRACTORY HYPERTENSION
Cedric Lebacle, Krystel Nyangoh Timoh, Le
Kremlin Bicetre, France, Jelena Martinovic,
Clamart, France, Djibril Diallo, Mazen
Zaitouna, Gerard Benoit, Thomas Bessede*,
Le Kremlin Bicetre, France
MP29-20 COMPARISON OF CT-MEASURED SPLIT
RENAL VOLUME AND SPLIT RENAL
FUNCTION BY DTPA CINTIGRAPHY FOR
THE PREDICTION OF 12 MONTHS KIDNEY
GRAFT FUNCTION
Diogo Gil-Sousa*, Porto, Portugal, Jorge
Dias, Gaia, Portugal, Daniel Oliveira-Reis,
Diogo Carneiro, Jorge Malheiro, Manuela
Almeida, Leonı́dio Dias, António CastroHenriques, José Soares, Avelino Fraga,
Miguel Silva Ramos, Porto, Portugal
MP29-16 HYDROGEN SULFIDE
SUPPLEMENTATION MITIGATES
EFFECTS OF ISCHEMIA REPERFUSION
INJURY IN A MURINE MODEL OF
DONATION AFTER CARDIAC DEATH
RENAL TRANSPLANTATION
Jaskirandeep Grewal*, Ian Lobb, Manujendra
Saha, Aaron Haig, Jifu Jiang, Alp Sener,
London, Canada
CREDITTM
10:30 am - 12:30 pm
Podium Session 15
PROSTATE CANCER: DETECTION & SCREENING IV
Moderators: John Lynch and Chris Bangma
ABSTRACT
TIME NUMBER TITLE
10:30 PD15-01 THE IMPACT OF 2011 UNITED STATES
PANEL UPDATE ON PSA SCREENING
PRACTICE: A NATIONWIDE, AND STATEBY-STATE LEVEL ANALYSES.
Dalela, Akshay Sood, Detroit, MI, Christian
Meyer, Boston, MA, Moritz Hansen, Paul
Han, Portland, ME, Maxine Sun, Quoc-Dien
Trinh, Boston, MA, Mani Menon, Jesse
Sammon, Detroit, MI
ABSTRACT
TIME NUMBER TITLE
10:40 PD15-02 PRACTICE TIME OF PRIMARY CARE
PHYSICIANS IS ASSOCIATED WITH
CHANGE IN PSA ORDERING HABITS IN
THE YEARS SURROUNDING THE UNITED
STATES PREVENTATIVE SERVICES TASK
FORCE RECOMMENDATION AGAINST
PSA SCREENING
Ryan Hutchinson*, Nirmish Singla, Abdulhadi
Akhtar, Justin Haridas, Deepa Bhat, Claus
Roehrborn, Yair Lotan, Dallas, TX
112
10:50 PD15-03
11:00 PD15-04
11:10 PD15-05
11:20 PD15-06
11:30 PD15-07
*Presenting author
DIFFERENCES IN PROSTATE SPECIFIC
ANTIGEN TESTING AMONG UROLOGISTS
AND PRIMARY CARE PROVIDERS IN THE
UNITED STATES FOLLOWING THE 2011
USPSTF RECOMMENDATIONS
Michael Zavaski*, Christian Meyer, Julian
Hanske, David Friedlander, Philip Cheng,
Boston, MA, Mani Menon, Detroit, MI, Adam
Kibel, Alexander Cole, Jeffrey Leow, Boston,
MA, Firas Abdollah, Detroit, MI, Maxine Sun,
Boston, MA, Jesse Sammon, Detroit, MI,
THE ASSOCIATION BETWEEN FAMILY
HISTORY AND PROSTATE-SPECIFIC
ANTIGEN FROM A LARGE GROUP OF 45YEAR OLD MEN EMBARKING ON
PROSTATE CANCER SCREENING:
RESULTS FROM THE PROBASE TRIAL
Kathleen Herkommer*, Natalie T. S. Laenger,
Tobiasz Klorek, Donna P. Ankerst, Sonja
Grill, Helga Schulwitz, Munich, Germany,
Peter Albers, Christian Arsov, Dusseldorf,
Germany, Boris A. Hadaschik, Markus
Hohenfellner, Heidelberg, Germany, Florian
Imkamp, Markus Kuczyk, Hannover,
Germany, Juergen E. Gschwend, Munich,
Germany
LETHAL PROSTATE CANCER IN THE
PLCO CANCER SCREENING TRIAL
Jonathan Shoag*, Sameer Mittal, Joshua
Halpern, Douglas Scherr, Jim Hu, Christopher
GENETIC RISK SCORE DIFFERENTIATES
INHERITED RISK AMONG RELATIVES OF
PATIENTS WITH HEREDITARY PROSTATE
CANCER
Brian T. Helfand, Evanston, IL, Vignesh T.
Packiam*, Chicago, IL, Haitao Chen,
Shanghai, China, People’s Republic of, S.
Lilly Zheng, Carly A. Conran, Charles B.
Brendler, Evanston, IL, William B. Isaacs,
Baltimore, MD, Jianfeng Xu, Evanston, IL
EVALUATION OF PI-RADS
CLASSIFICATION IN PREDICTION OF
TUMOR-AGGRESSIVENESS IN TARGETED
BIOPSY
Angelika Borkowetz*, Ivan Platzek, Marieta
Toma, Teresa Renner, Michael Froehner,
Rainer Koch, Stefan Zastrow, Manfred Wirth,
Dresden, Germany
11:40 PD15-08
WHEN FUSION FALLS SHORT: PROSTATE
CANCER UPGRADING BY SYSTEMATIC
BIOPSY OVER FUSION BIOPSY
Akhil Muthigi*, Arvin George, Abhinav Sidana,
Michael Kongnyuy, Amogh Iyer, Meet
Kadakia, Francesca Mertan, Amichai
Kilchevsky, Thomas Frye, Daniel Su, Maria
11:50 PD15-09
OUTCOMES AFTER IMPLEMENTATION OF
SOFTWARE FUSION MRI-TARGETED
BIOPSY: IS FUSION BETTER THAN
COGNITIVE TARGETING?
Eric Kim*, Joel Vetter, John Weaver, Niraj
Badhiwala, Michael Glamore, Robert Grubb,
Gerald Andriole, St. Louis, MO
12:00 PD15-10
COMBINED ERSPC RISK CALCULATOR
AND MULTIPARAMETRIC MRI FOR
ADVANCED RISK MODELING OF
PROSTATE CANCER
Jan Philipp Radtke*, David Bonekamp, Martin
Freitag, Claudia Verena Kesch, Heidelberg,
Germany, Celine Alt, Duesseldorf, Germany,
Kamil Celik, Florian Distler, Kathrin
Wieczorek, Matthias Claudius Roethke,
Heinz-Peter Schlemmer, Markus
Hohenfellner, Boris Hadaschik, Heidelberg,
Germany
12:10 PD15-11
SHOULD WE STILL BIOPSY NEGATIVE
MP-MRIS?
Amanda Lu, Cayce Nawaf, James Rosoff,
Jeffrey Weinreb, Peter Humphrey, Angelique
Levi, Steffen Huber, Preston Sprenkle*, New
Haven, CT
12:20 PD15-12
CORRELATION BETWEEN
MULTIPARAMETRIC MRI FINDINGS AND
RADICAL PROSTATECTOMY SPECIMENS
IN 162 PATIENTS
Sean Huang*, Sarah Mann, Richard
O’Sullivan, Andrew Ryan, Adam Landau,
Ross Snow, Uri Hanegbi, Daniel Moon, Mark
Frydenberg, Jeremy Grummet, Melbourne,
Australia
CREDITTM
113
10:30 am - 12:30 pm
Podium Session 16
TRAUMA/RECONSTRUCTION/DIVERSION: URETHRAL RECONSTRUCTION (INCLUDING STRICTURE, DIVERTICULUM) I
Moderators: Hunter Wessells and Kurt McCammon
ABSTRACT
TIME NUMBER TITLE
10:30 PD16-01 UNDERSTANDING PATIENT
PREFERENCES FOR SURGICAL
MANAGEMENT OF URETHRAL
STRICTURE DISEASE
Lindsay A. Hampson*, Seattle, WA, Tracy
Lin, San Francisco, CA, Leslie Wilson, San
Francisci, CA, Isabel Allen, Thomas Gaither,
Benjamin N. Breyer, San Francisco, CA
10:40 PD16-02
10:50 PD16-03
VARIABLE DEFINITIONS OF URETHRAL
STRICTURE RECURRENCE AFTER
VISUAL INTERNAL URETHROTOMY AND
URETHROPLASTY
Benjamin A Sherer, M. Ryan Farrell*, Fahad
Chaus, Laurence A Levine, Chicago, IL
PATIENT AND CLINICIAN
PRIORITIZATION OF OUTCOMES AMONG
MEN WITH ANTERIOR URETHRAL
STRICTURE DISEASE
Bryan B. Voelzke*, Todd C. Edwards, Donald
L. Patrick, Seattle, WA, Benjamin N. Breyer,
San Francisco, CA
11:00 PD16-04
FACTORS AFFECTING FEASIBILITY OF
SAME DAY ANTERIOR URETHROPLASTY
Jeremy Reese*, Katherine Theisen, Vladimir
Lamm, Mang Chen, Pittsburgh, PA
11:10 PD16-05
LONG TERM RESULTS OF FEMALE
URETHRAL RECONSTRUCTION USING
DORSAL ONLAY LINGUAL MUCOSAL
GRAFT
Sameer Trivedi*, Udai Shankar Dwivedi,
Sartaj Wali Khan, V S Rathee, Pushpendra
Shukla, Aditya Kumar Singh, Varanasi, India
11:20 PD16-06
11:30 PD16-07
ABSTRACT
TIME NUMBER TITLE
11:40 PD16-08 FOLEY OR FIX: COMPARATIVE ANALYSIS
OF FOLEY, ABBREVIATED
URETHROPLASTY, AND MOBILIZATION
WITH PRIMARY URETHRAL
ANASTOMOSIS AT THE TIME OF AUS
EXPLANTATION FOR CUFF EROSION
Nathan Chertack*, Hemant Chaparala,
Kenneth Angermeier, Drogo Montague,
Hadley Wood, Cleveland, OH
DORSAL BUCCAL GRAFT
URETHROPLASTY IN FEMALE URETHRAL
STRICTURE DISEASE: A MULTI-CENTER
EXPERIENCE
Lindsay A. Hampson*, Seattle, WA, Jeremy
B. Myers, Salt Lake City, UT, Alex J. Vanni,
Burlington, MA, Thomas G. Smith III,
Houston, TX, Jason Chandrapal, Salt Lake
City, UT, Bryan B. Voelzke, Seattle, WA
11:50 PD16-09
HYPOGONADISM IS A RISK FACTOR FOR
ARTIFICIAL URINARY SPHINCTER CUFF
EROSION
Matthias D Hofer*, Kunj R Sheth, Timothy J
Tausch, Jordan Siegel, Billy H Cordon,
Nicholas L Kavoussi, Alexandra Klein, Claus
G Roehrborn, Allen F Morey, Dallas, TX
12:00 PD16-10
URETHRAL STRICTURES AND FISTULAS
AFTER PHALLOPLASTY IN A SERIES OF
133 TRANSSEXUAL MEN
Mang Chen*, Curtis Crane, San Francisco,
CA
12:10 PD16-11
IS THE LASER MIGHTIER THAN THE
SWORD? A COMPARATIVE STUDY FOR
THE URETHROTOMY
Coen Holzhauer*, Arjen Kums, Anita Roelofs,
Philip Weijerman, Michael Van Balken,
Arnhem, Netherlands
12:20 PD16-12
TUBULARIZED BUCCAL MUCOSA FOR
LONG SEGMENT URETERAL
REPLACEMENT : AN EXPERIMENTAL
STUDY IN DOGS
Adel Elbakry*, Mansoura, Egypt, Mohsen
Zaghlol, Ismalia, Egypt, Izzak Samir, ismailia,
Egypt, khaled Zalata, Mansoura, Egypt,
Hashem Rashwan, Ismailia, Egypt
CREDITTM
EXCISION OF URETHRAL DIVERTICULA
IN WOMEN: RISK FACTORS FOR
RECURRENCE AND DE NOVO STRESS
Aida Beganovic, Laetitia de Kort, Ruud
Bosch*, Utrecht, Netherlands
114
10:30 am - 12:30 pm
Podium Session 17
DECISION MAKING II
Moderators: Mark Litwin and Christopher Saigal
ABSTRACT
TIME NUMBER TITLE
10:30 PD17-01 INTERPRETATION OF A SURGEON
SCORECARD BY THE GENERAL PUBLIC
AND ITS EFFECT ON SURGEON
SELECTION
Lucas Labine*, Colby Dixon, Issac Palma,
Gretchen Hoff, Christopher Weight,
Minneapolis, MN
10:40 PD17-02
THE USE OF CYTOLOGY DURING THE
WORKUP OF PATIENTS WITH PRIMARY
MICROSCOPIC HEMATURIA: GUIDELINE
COMPLIANCE PATTERNS AMONG A
COHORT OF ACADEMIC UROLOGISTS
Patrick Samson, Paras Shah*, New Hyde
Park, NY, Derek Friedman, Binghamton, NY,
Karly Stoltman, Hempstead, NY, Vinay Patel,
New Hyde Park, NY, Simpa Salami, Ann
Arbor, MI, Andrew Ng, Hempstead, NY,
Manaf Alom, Jessica Kreshover, Joph
Steckel, Manish Vira, Lee Richstone, Louis
Kavoussi, Justin Han, New Hyde Park, NY
10:50 PD17-03
IMPACT OF APOLOGY LAWS ON
LITIGATION LENGTH
Patrick H McKenna*, Thomas W Bentley,
Christina J Sauder, Madison, WI
11:00 PD17-04
THE IMPACT OF ANXIETY AND
DEPRESSIVE SYMPTOMS ON
OVERACTIVE BLADDER
Amar Rawal*, Baixin Shen, Joel Vetter, Henry
Lai, St Louis, MO
11:10 PD17-05
MANAGEMENT OF CLINICAL STAGE I
SEMINOMA: HEADED IN THE RIGHT
DIRECTION, BUT FAST ENOUGH?
Richard Matulewicz*, Daniel Oberlin,
Chicago, IL, Joel Sheinfeld, New York, NY,
Joshua Meeks, Chicago, IL
11:20 PD17-06
DOES EMPLOYING A DECISION AID
IMPROVE PATIENT EDUCATION AND
PERCEPTION OF QUALITY OF CARE
John S. Banerji*, Erika M. Wolff, April E.
Slee, Sydney Akapame, Kathryn Dahl, Evan
T. Auerbach, John D. Massman III, Michael
C. Soung, Kim R. Pittenger, John M. Corman,
Seattle, WA
11:30 PD17-07
PROJECTING THE UROLOGY
WORKFORCE OVER THE NEXT 20 YEARS
Maxim McKibben*, E Will Kirby, Chapel Hill,
NC, Joshua Langston, Norfolk, VA, Matthew
Nielsen, Mathew Raynor, Eric Wallen, Angela
Smith, Michael Woods, Raj Pruthi, Chapel
Hill, NC
*Presenting author
ABSTRACT
TIME NUMBER TITLE
11:40 PD17-08 THE ASSOCIATION OF TRAVEL
DISTANCE TO CYSTECTOMY ON
READMISSION AND SURVIVAL
Troy Sukhu*, Jason Lomboy, Matthew
Macey, Anne Marie Meyer, Ke Meng,
Matthew Nielsen, Raj Pruthi, Eric Wallen,
Michael Woods, Angela Smith, Chapel Hill,
NC
11:50 PD17-09
RISING RATES OF UROTHELIAL
CARCINOMA WITH UNDERUTILIZATION
OF SYSTEMIC CHEMOTHERAPY – A 25YEAR CANCER REGISTRY REVIEW
Brian Blair*, Fabian Camacho, Eugene
Lengerich, Jay Raman, Hershey, PA
12:00 PD17-10
ASSIGNING VALUE TO THE PERSONAL
PATIENT PROFILE-PROSTATE DECISION
AID: A WILLINGNESS TO PAY ANALYSIS
Donna Berry*, Traci Blonquist, Boston, MA,
Leslie Wilson, San Francisco, CA, Barbara
Halpenny, Fangxin Hong, Boston, MA
12:10 PD17-11
THE GLOBAL BURDEN OF
GENITOURINARY CANCER: GEOGRAPHIC
AND TEMPORAL TRENDS IN MORBIDITY
AND MORTALITY
Catherine Harris*, Jonathan Brajtbord,
Matthew Cooperberg, Maxwell Meng, Anobel
Odisho, San Francisco, CA
12:20 PD17-12
PRIMARY CARE PHYSICIAN DENSITY
AND INSURANCE STATUS ON STAGE OF
DIAGNOSIS FOR UROLOGIC
MALIGNANCIES
Kristy Nguyen*, Marshall Shaw, Oklahoma
City, OK, Sarah Maness, Norman, OK,
Sanjay Patel, Kelly Stratton, Oklahoma City,
OK
CREDITTM
115
10:30 am - 12:30 pm
Podium Session 18
STONE DISEASE: SURGICAL THERAPY II
Moderators: David Wang and Brian Matlaga
ABSTRACT
TIME NUMBER TITLE
10:30 PD18-01 NATURAL HISTORY OF RESIDUAL
FRAGMENTS AFTER PERCUTANEOUS
NEPHROLITHOTOMY (PCNL)
Daniel Olvera-Posada*, Sohrab Naushad Ali,
Husain Alenezi, Marie Dion, John D.
Denstedt, Hassan Razvi, London, Canada
10:40 PD18-02
10:50 PD18-03
11:00 PD18-04
SYNCHRONOUS REAL-TIME VIRTUAL
SONOGRAPHY WITH THREEDIMENSIONAL COMPUTED TOMOGRAPHY
SCAN NAVIGATION TO CREATE
PERCUTANEOUS RENAL ACCESS TO THE
TARGET CALIX DURING PERCUTANEOUS
NEPHROLITHOTOMY
Tatsuhiko Hoshii*, Tsutomu Nishiyama,
Minami-Uonuma, Japan
ADOPTING ULTRASOUND GUIDANCE FOR
PERCUTANEOUS NEPHROLITHOTOMY:
EVALUATING THE LEARNING CURVE
AND ASSOCIATED BENEFITS
Manint Usawachintachit*, Selma Masic, San
Francisco, CA, Jianxing Li, Beijing, China,
People’s Republic of, Thomas Chi, San
Francisco, CA
PCNL ACCESS BY UROLOGIST OR
RADIOLOGIST: AN ANALYSIS OF THE
BAUS PCNL REGISTRY
James Armitage*, Cambridge, United
Kingdom, Sarah Fowler, London, United
Kingdom, William Finch, Neil Burgess, Stuart
Irving, Norwich, United Kingdom, John
Withington, Jonathan Glass, London, United
Kingdom, Oliver Wiseman, Cambridge,
United Kingdom
11:10 PD18-05
COMPARATIVE OUTCOMES OF
CONVENTIONAL PCNL AND
MINIATURIZED PCNL IN THE TREATMENT
OF KIDNEY STONES
Jessica Lange*, Jorge Gutierrez-Aceves,
Winston Salem, NC
11:20 PD18-06
RANDOMISED CONTROLLED TRIAL OF
ULTRA MINI PERCUTANEOUS
NEPHROLITHOTOMY VERSUS
RETROGRADE INTRARENAL SURGERY IN
THE TREATMENT OF 10-30MM CALCULI
Soumendra Datta*, Ka-Wing Ng, Colchester,
United Kingdom, Ronak Solanki, Janak
Desai, Ahmedabad, India
11:30 PD18-07
ABSTRACT
TIME NUMBER TITLE
11:40 PD18-08 MULTICENTER PHASE II STUDY OF THE
CLINICAL USE OF THE AVICENNA
ROBOFLEX URS ROBOT IN ROBOTIC
RETROGRADE INTRARENAL STONE
SURGERY
Jan-Thorsten Klein*, Ulm, Germany, Marcel
Fiedler, Heilbronn, Germany, Ahmet Sinan
Kabakci, Remzi Saglam, Ankara, Turkey,
Jens Rassweiler, Heilbronn, Germany
GLOBAL COSTS OF MODERN FLEXIBLE
URETEROSCOPY AT A HIGH VOLUME
TEACHING HOSPITAL
Michael S Borofsky*, Casey A Dauw, Nadya
York, Christine Hoovler, James E Lingeman,
Indianapolis, IN
11:50 PD18-09
SHOULD STONE REMOVAL BE DONE
AFTER STONE FRAGMENTATION IN THE
MANAGEMENT OF UPPER URINARY
SYSTEM STONES?
Erdal Alkan, Mirac Turan, Ahmet Oguz
Ozkanli, Emre Arpali, Mehmet Murad Basar*,
Oguz Acar, Mevlana Derya Balbay, Istanbul,
Turkey
12:00 PD18-10
DUSTING VS BASKETING DURING
URETEROSCOPIC LITHOTRIPSY—WHAT
IS MORE EFFICACIOUS? FINAL RESULTS
FROM THE EDGE RESEARCH
CONSORTIUM
Ben Chew, Vancouver, Canada, Ojas Shah,
New York, NY, Roger Sur, San Diego, CA,
Bodo Knudsen, Columbus, OH, Brian
Matlaga, Baltimore, MD, Brian Eisner,
Boston, MA, Amy Krambeck, Rochester, MN,
Nicole Miller, Nashville, TN, Manoj Monga,
Cleveland, OH, Mitchell Humphreys*,
Phoenix, AZ
12:10 PD18-11
COMPARISON OF AN ELECTRIC PULSE
LITHOTRIPTER TO THE HOLMIUM LASER:
STONE FRAGMENTATION EFFICIENCY
AND IMPACT ON FLEXIBLE
URETEROSCOPE DEFLECTION AND
FLOW
Adam Kaplan*, Tony Chen, Richard Shin,
Joanne Dale, Fernando Cabrera, Daniela
Radvak, Anika Ackerman, Georgy Sankin,
Pei Zhong, Charles Scales, Jr., Michael
Ferrandino, Neal Simmons, Glenn Preminger,
Michael Lipkin, Durham, NC
12:20 PD18-12
MULTIMODALITY SURGICAL APPROACH
TO RETAINED URETERAL STENTS:
EVALUATION OF OUTCOMES AND
DESCRIPTION OF PATIENT POPULATION
Ahmad Azzawe*, Kevin Hebert, Merideth
Rosenzweig, Landon Erickstad, John Mata,
Alexander Gomelsky, Dennis Venable, Wahib
Isac, Shreveport, LA
CREDITTM
116
11:00 am - 12:00 pm
SURGICAL TECHNIQUES: RADICAL PROSTATECTOMY
11:00
SURGICAL TECHNIQUES: RADICAL
PROSTATECTOMY
Moderator: Edward Schaeffer
Panelists: Matthew Gettman, Mani Menon, Jean Joseph
12:00
ADJOURN
CREDITTM
12:30 pm - 5:00 pm
SOCIETY OF UROLOGIC ONCOLOGY (SUO)
Grand ABC @ Hyatt
12:30
WELCOME AND INTRODUCTIONS
Society Chairs: Stephen Boorjian, Alexandre Zlotta
12:35
INTRODUCTION TO THE WHITMORE LECTURE
Robert Donohue
12:45
WHITMORE LECTURE
Arie Belldegrun
1:05
PROSTATE CANCER: BE WARY OF THE
UNDERTREATED HIGH-RISK PATIENT
Moderator: Neil Fleshner
THE PROBLEM OF UNDERTREATMENT OF
MEN WITH HIGH-RISK PROSTATE CANCER
Matthew Cooperberg
1:15
1:25
1:35
1:45
1:55
2:05
UNDERESTIMATING THE RISK OF HIGH-RISK
DISEASE IN THE PATIENT BEING
CONSIDERED FOR ACTIVE SURVEILLANCE
PATIENT: THE IMPLICATIONS OF RACE
Edward Schaeffer
2:55
WHAT TO DO WITH BCG REFRACTORY NMIBC
WHEN CYSTECTOMY IS NOT AN OPTION
Michael Cookson
3:05
BLADDER CANCER: WHAT DEFINES AN
EXTENDED DISSECTION AND HOW DO WE
KNOW IT HELPS?
Eila Skinner
3:15
IS THERE ANY ROLE FOR ADJUVANT
CHEMOTHERAPY OR NOVEL TARGETED
AGENTS AFTER RADICAL CYSTECTOMY?
Matthew Milowsky
3:25
ISSUES SURROUNDING SURVEILLANCE
AFTER RADICAL CYSTECTOMY
George Thalmann, Bernard Bochner
3:40
QUESTIONS/ CASES
3:50
CONTROVERSIES IN KIDNEY CANCER FROM
EARLY TO LATE STAGE DISEASE
Moderator: Robert Uzzo
ACTIVE SURVEILLANCE IN MEN WITH
GLEASON PATTERN 4 DISEASE
Antonio Finelli
NOVEL IMAGING MODALITIES FOR THE SOLID
RENAL MASS: ARE WE READY FOR A
RADIOGRAPHIC BIOPSY?
Robert Uzzo
IDENTIFYING THE PATIENT WHO BENEFITS
OF LYMPHADENECTOMY AT THE TIME OF
PROSTATECTOMY
James Eastham
4:00
DEBATE: THE IMPORTANCE OF ISCHEMIA
VERSUS VOLUME OF PARENCHYMA DURING
PARTIAL NEPHRECTOMY
Debaters: Scott Eggener, Steven Campbell
4:15
RADICAL PROSTATECTOMY IN THE SETTING
OF M1 DISEASE: A NEW PARADIGM?
Brian Chapin
MODERATOR-PROMPTED QUESTIONS TO
DEBATERS
4:25
EVOLVING ROLE OF IMAGE-GUIDED
TREATMENT FOR PELVIC NODAL RELAPSE
AFTER DEFINITIVE LOCAL THERAPY
Alberto Briganti
OPTIMIZATION OF SURVEILLANCE
FOLLOWING NEPHRECTOMY FOR RCC?
Suzanne Merrill
4:35
KIDNEY CANCER: DEBATE: OPTIMAL
SEQUENCING OF TREATMENTS FOR
PATIENTS WITH NEWLY DIAGNOSED
METASTATIC KIDNEY CANCER (SURGERY
FIRST VS SYSTEMIC THERAPY FIRST)
Debaters: Christopher Wood, Bradley Leibovich
4:50
MODERATOR-PROMPTED QUESTIONS/
CHALLENGING CASES TO DEBATERS
5:00
ADJOURN
IS THERE A ROLE FOR DEFINITIVE LOCAL
THERAPY IN THE SETTING OF CNⴙ DISEASE?
Jason Efstathiou
2:15
CASE-BASED DISCUSSION OF HIGH-RISK/
ADVANCED DISEASE
Moderator: Neil Fleshner
Panelist: Freddie Hamdy
2:35
BREAK
2:45
MINIMIZING MORBIDITY WHILE MAXIMIZING
ONCOLOGIC EFFICACY IN BLADDER CANCER
Moderator: Robert Svatek
CREDITTM
SELECTION OF TI PATIENTS FOR INITIAL
CYSTECTOMY
Sam Chang
*Presenting author
117
1:00 pm - 2:00 pm
SETBACKS AND OPERATIVE SOLUTIONS (SOS): BENIGN
Moderator: Bodo Knudsen
1:00
URETERAL PERFORATION DURING
URETEROSCOPY
Panelists: Roger Low, Gyan Pareek, Ben Chew
1:20
LOST CONTROL OF A LUMBAR VEIN/HOLE IN
THE IVC DURING DONOR NEPHRECTOMY
Panelists: Dicken Ko, Peter Schulam, Ashok Hemal,
Fernando Kim
1:40
CORPORAL PERFORATION DURING IPP
PLACEMENT
Panelists: Gerald Brock, Steven Wilson, Rafael
Carrion, John Mulcahy
2:00
ADJOURN
CREDITTM
1:00 pm - 3:00 pm
BLADDER & URETHRA: ANATOMY, PHYSIOLOGY & PHARMACOLOGY II
Moderators: Gamal Ghoniem and Michael Ruggieri
ABSTRACT
NUMBER TITLE
MP30-01 IDENTIFYING A SENSITIVE AND SPECIFIC
PANEL OF DNA METHYLATION MARKERS
IN MODELS OF CYSTITIS
Alex Ridgeway, In-Seon Choi, Chester Koh,
Swati Naik, Abhishek Seth*, Houston, TX
ABSTRACT
NUMBER TITLE
MP30-05 SELECTIVE PHARMACOLOGICAL
ACTIVATION OF INDIVIDUAL KCNQ
CHANNEL SUBTYPES IN DETRUSOR
SMOOTH MUSCLE: PROMISING NOVEL
APPROACH FOR OVERACTIVE BLADDER
TREATMENT
Aaron Provence*, Kiril Hristov, Georgi V.
Petkov, Columbia, SC
MP30-02 EFFECTS OF OMEGA-3 FATTY ACIDS IN A
RAT MODEL OF ATHEROSCLEROSISINDUCED CHRONIC BLADDER ISCHEMIA
Ji Yun Chae*, Hyoung Kook Jeong, Jong Jin
Park, Jong Wook Kim, Mi Mi Oh, Jae Hyun
Bae, Seok Ho Kang, Hong Seok Park, Du
Geon Moon, Jun Cheon, Je Jong Kim, Jeong
Gu Lee, Seoul, Korea, Republic of
MP30-06 IDENTIFICATION OF A DIVERSE FUNGAL
COMMUNITY (“MYCOBIOME”) IN THE
NORMAL FEMALE HUMAN LOWER
URINARY TRACT
A. Lenore Ackerman*, Los Angeles, CA,
Jennifer T. Anger, Karyn S. Eilber, Vincent A.
Funari, Jie Tang, Jayoung Kim, Michael R.
Freeman, Beverly Hills, CA
MP30-03 SONIC HEDGEHOG SIGNALING IN
NORMAL HUMAN BLADDER
DEVELOPMENT
Guodong Zhu*, Xi’an, China, People’s
Republic of, Haiyen Zhau, Los Angeles, CA,
Dapeng Wu, Wenbin Song, Dalin He, Xi’an,
China, People’s Republic of, Leland Chung,
Los Angeles, CA
MP30-07 BDNF ENHANCES DETRUSOR
EXCITABILITY THROUGH TRKB.T1
MEDIATED ACTIVATION OF CALCIUM
CHANNELS
Mahendra Kashyap*, William C deGroat,
Naoki Yoshimura, Pradeep Tyagi, Pittsburgh,
PA
MP30-04 HERPES SIMPLEX VIRUS (HSV) VECTORMEDIATED GENE DELIVERY OF
PORELESS TRPV1 CHANNELS OR
PROTEIN PHOSPHATE 1␣ (PP1␣)
REDUCES BLADDER OVERACTIVITY AND
NOCICEPTION IN RAT MODEL OF
CYSTITIS INDUCED BY HYDROGEN
PEROXIDE
Shun Takai*, Pittsburgh, PA, Tsuyoshi
Majima, Nagoya, Japan, Nobutaka Shimizu,
Takahiro Shimizu, Naoki Wada, Pittsburgh,
PA, Momokazu Gotoh, Nagoya, Japan,
William Goins, Justus Cohen, Joseph
Glorioso, Naoki Yoshimura, Pittsburgh, PA
MP30-08 METABOLOMICS REVEALS
DIFFERENTIAL CHANGES IN THE
ENERGY GENERATING PATHWAYS OF
THE DETRUSOR AND UROTHELIUM
CAUSED BY DIABETES.
Yi Wang*, Bronx, NY, Gary Deng,
Indianapolis, IN, Kelvin Davies, Bronx, NY
MP30-09 BI-LAYER SILK FIBROIN GRAFTS
PROMOTE TISSUE REGENERATION IN A
FETAL OVINE MODEL OF BLADDER
EXSTROPHY
Saif Affas, Khalid Algarrahi*, Debra Franck,
Yeun Goo Chung, Dario Fauza, Boston, MA,
Maryrose Sullivan, Vivian Cristofaro, West
Roxbury, MA, Catherine Seager, Ashley
Wietsma, Ruth Strakosha, Kyle Costa, Carlos
Estrada, Joshua Mauney, Boston, MA
118
MP30-10 REDUCED AFFERENT SENSITIVITY IN
THE RAT BILATERAL PELVIC NERVE
CRUSH MODEL OF DETRUSOR
UNDERACTIVITY
Christopher Chermansky*, Katsumi
Kadekawa, Hiroki Okada, Pittsburgh, PA,
Matthew Fraser, Durham, NC, Pradeep
Tyagi, Naoki Yoshimura, Pittsburgh, PA
MP30-16 GENETICALLY MODIFIED HUMAN
MUSCLE PRECURSOR CELLS
OVEREXPRESSING PGC-1〈 SUPPORT
EARLY MYOFIBER FORMATION FOR
BIOENGINEERING OF SLOW TWITCH
SPHINCTER MUSCLE
Deana Haralampieva, Souzan Salemi, Zürich,
Switzerland, Ivana Dinulovic, Basel,
Switzerland, Tullio Sulser, Zürich, Switzerland,
Simon M. Ametamey, Zürich, Sweden,
Christoph Handschin, Basel, Switzerland,
Daniel Eberli*, Zürich, Switzerland
MP30-11 IDENTIFICATION OF NADPH OXIDASES:
IMPLICATION FOR UROTHELIAL AND
BLADDER FUNCTION
Lisa Adjei, Guildford, United Kingdom,
Guiping Sui, London, United Kingdom, Max
Roberts, Guildford, United Kingdom, Rui Wu,
Shrewsbury, United Kingdom, Michael
Ruggieri, Philadelphia, PA, Changhao Wu*,
Guildford, United Kingdom
MP30-17 DOWN REGULATION OF BLADDER
ENDOCANNABINOID SYSTEM
FOLLOWING BLADDER OUTLET
OBSTRUCTION IN THE RATS
Teng-Lung Lin*, Wei-Ming Cheng, Taipei,
Taiwan
MP30-12 SPONTANEOUS ACTIVITY OF THE
HUMAN DETRUSOR DEPENDS ON THE
RATIO BETWEEN CONTRACTILE
RESPONSES TO NERVE STIMULATION
AND ANTICHOLINERGIC EFFECTS OF
PROTEIN KINASE C ACTIVATION
Joseph Hypolite*, Randall Meecham, Anna
Malykhina, Aurora, CO
MP30-18 ENHANCED ATP RELEASE AND P2X1R
EXPRESSION CONTRIBUTE TO BLADDER
DYSFUNCTION IN TYPE 2 DIABETES
Zongwei Wang*, Vivian Cristofaro, Hongying
Cao, Rongbin Ge, Maryrose Sullivian, Aria
Olumi, Boston, MA
MP30-19 CORRELATION BETWEEN SPINAL CORD
INJURY FORCE AND
ELECTROMYOGRAPHIC
CHARACTERISTICS OF THE LOWER
URINARY TRACT IN FEMALE RATS
Betsy Salazar*, Chuan Zhang, Kristopher
Hoffman, Yingchun Zhang, Carolina Rivera,
Timothy Boone, Alvaro Munoz, Houston, TX
MP30-13 FORMATION OF DOUBLE-STRANDED RNA
IN HUMAN BLADDER SMOOTH MUSCLE
CELLS REGULATES STRESS KINASES
AND CELL STRUCTURE IN OXIDATIVE
STRESS
Jing-Hua Yang, Zuohui Zhao, Kazem
Azadzoi*, Boston, MA
MP30-14 UROTHELIAL HYPERPLASIA AND
REGENERATION AFTER SPINAL CORD
INJURY
F. Aura Kullmann*, Dennis Clayton, Gerard
Apodaca, Irina Zabbarova, Youko Ikeda,
Anthony Kanai, Lori Birder, Pittsburgh, PA
MP30-15
*Presenting author
MP30-20 SYNCHRONIZED ELECTROMYOGRAPHIC
CHARACTERIZATION OF THE LOWER
URINARY TRACT IN NORMAL RATS:
EFFECTS OF INTRAVESICAL P2X3R
INHIBITION
Betsy Salazar*, Chuan Zhang, Yingchun
Zhang, Houston, TX, Anthony Ford, San
Mateo, CA, Timothy Boone, Alvaro Munoz,
Houston, TX
PHARMACOLOGICAL PROFILE OF DA8010, A NOVEL BLADDER SELECTIVE
MUSCARINIC RECEPTOR 3 ANTAGONIST
FOR TREATMENT OF OVERACTIVE
BLADDER
Min Jung Lee*, Jun-Hwan Moon, Hyun-Min
Park, Hyung Keun Lee, Jong Hwan Cho,
Sung Hak Choi, Weonbin Im, Yongin-si,
Korea, Republic of
CREDITTM
119
1:00 pm - 3:00 pm
DECISION MAKING III
Moderators: David Miller and Christopher Gonzalez
ABSTRACT
NUMBER TITLE
MP31-01 UROLOGY PAYMENTS FROM INDUSTRY
IN THE SUNSHINE ACT
Jathin Bandari*, Robert Turner II, Bruce
Jacobs, Benjamin Davies, Pittsburgh, PA
ABSTRACT
NUMBER TITLE
MP31-09 COMORBIDITY, DISABILITY, AND
PARTIAL NEPHRECTOMY USE FOR
OLDER PATIENTS WITH STAGE I KIDNEY
CANCER
Hung-Jui Tan*, Timothy Daskivich, Joseph
Shirk, Los Angeles, CA, Christopher Filson,
Atlanta, CA, Mark Litwin, Los Angeles, CA,
Jim Hu, New York, NY
MP31-02 THE PHYSICIAN PAYMENT SUNSHINE
ACT: REPORTING OF UROLOGIC DATA
Daniel Mazur*, Mary Kate Keeter, Christopher
Morrison, Andrew Choi, Jared Moss,
Chicago, IL, Marah Hehemann, Maywood, IL,
James Kashanian, New York, NY, Robert
Brannigan, Chicago, IL
MP31-10 PATIENT DISABILITY AND TREATMENT
VARIATION AMONG OLDER ADULTS
WITH KIDNEY CANCER
Hung-Jui Tan*, Karim Chamie, Mark Litwin,
Los Angeles, CA, Jim Hu, New York, NY
MP31-03 CYSTINE STONE-FORMERS HAVE
IMPAIRED HEALTH RELATED QUALITY
OF LIFE COMPARED TO NON-CYSTINE
STONE-FORMERS
Necole M Streeper*, Hershey, PA, Margaret L
Wertheim, Kristina L Penniston, Stephen Y
Nakada, Madison, WI
MP31-11 OPERATIONALIZING THE NATIONAL
COMPREHENSIVE CANCER NETWORK
GUIDELINES FOR PREDICTING LIFE
EXPECTANCY IN MEN WITH PROSTATE
CANCER
Lauren N. Wood*, Los Angeles, CA, Douglas
Skarecky, Thomas Ahlering, Sheldon
Greenfield, Irvine, CA, Timothy J. Daskivich,
Los Angeles, CA
MP31-04 WIDE VARIATION IN SURGEON
PARTICIPATION IN EARLY MEDICARE
ACCOUNTABLE CARE ORGANIZATIONS
Lindsey Herrel*, Scott Hawken, Chandy
Ellimoottil, Zaojun Ye, James Dupree, Brent
Hollenbeck, David Miller, Ann Arbor, MI
MP31-05
MP31-12 UTILIZATION TRENDS OF ADVANCED
PRACTICE PROVIDERS FOR OFFICE
PROCEDURAL UROLOGIC CARE IN THE
UNITED STATES FROM 2003 TO 2014
Bradley Erickson*, Yu Han, Iowa City, IA,
William Meeks, Raymond Fang, Patricia
Rehring, Linthicum, MD, Kenneth Nepple,
Iowa City, IA
TRENDS IN INPATIENT UROLOGICAL
SURGERY PRACTICE PATTERNS
Scott Hawken*, Lindsey Herrel, Chandy
Ellimoottil, Zaojun Ye, J. Quentin Clemens,
MP31-06 PERIOPERATIVE BLOOD TRANSFUSION
PREDICTS SHORT-TERM MORBIDITY AND
MORTALITY IN RADICAL AND PARTIAL
NEPHRECTOMIES: EVIDENCE FROM
NSQIP
Wilson Sui*, Ifeanyi Onyeji, Justin T. Matulay,
Marissa C. Velez, Maxwell B. James, G. Joel
DeCastro, Sven Wenske, New York, NY
MP31-13 COMPARATIVE EFFECTIVENESS OF A
PATIENT CENTERED PATHOLOGY
REPORT FOR BLADDER CANCER CARE
Matthew Mossanen*, Liam Macleod, Alice
Chu, Jonathan L. Wright, Daniel W. Lin,
Bruce Dalkin, Lawrence True, John L. Gore,
Seattle, WA
MP31-14 LEVERAGING BLADDER CANCER
PATHOLOGY REPORTS FOR RESEARCH:
GLEANING MEANING DESPITE WIDELY
VARIABLE LANGUAGE
Erik Pattison*, Lebanon, NH, Daniel
Denhalter, Olga Patterson, Scott DuVall, Salt
Lake City, UT, John Seigne, Lebanon, NH,
Brenda Sirovich, Philip Goodney, Douglas
Robertson, Florian Schroeck, White River
Junction, VT
MP31-07 TELE-UROLOGY VERSUS FACE-TO-FACE
CLINICS: A SURVEY OF PATIENT
PREFERENCE
Jeffrey Pearl*, Ilan Safir, Robert Gerhard,
Irina Kirillova, James Baumgardner, Jennifer
Lindelow, Christopher Filson, Muta M. Issa,
Atlanta, GA
MP31-08 PREOPERATIVE FRAILTY IS ASSOCIATED
WITH DISCHARGE TO SKILLED OR
ASSISTED LIVING FACILITIES AFTER
UROLOGY PROCEDURES OF VARYING
COMPLEXITY
Anne M Suskind*, Chengshi Jin, Matthew R
Cooperberg, Emily Finlayson, John
Boscardin, Saunak Sen, Louise C Walter,
San Francisco, CA
120
MP31-15
IMPACT OF HEALTH LITERACY ON
DISCHARGE DISPOSITION FOLLOWING
RADICAL CYSTECTOMY
Stephen F. Kappa*, Kristen R. Scarpato,
Kathryn M. Goggins, Sam S. Chang, Joseph
A. Smith, Jr., Peter E. Clark, David F.
Penson, Matthew J. Resnick, Daniel A.
Barocas, Sunil Kripalani, Kelvin A. Moses,
Nashville, TN
MP31-18 UTILIZATION OF NIH PROMIS® TOOL FOR
EVALUATION OF PATIENT REPORTED
OUTCOMES IN UROLITHIASIS
Giulia Lane*, Minneapolis, MN, Suzanne
Neises, Andrew Portis, St. Paul, MN
MP31-19 THE IMPACT OF PARTNERSHIP STATUS
AND SOCIAL SUPPORT ON HEALTH
RELATED QUALITY OF LIFE OUTCOMES
IN MEN WITH PROSTATE CANCER
Avi Baskin*, Lorna Kwan, Mary Zavala, Karim
MP31-16 THE IMPACT OF HEALTH LITERACY ON
SURGICAL OUTCOMES FOLLOWING
RADICAL CYSTECTOMY
Kristen Scarpato*, Stephen Kappa, Kathryn
Goggins, Sam Chang, Michael Cookson,
Joseph Smith, Jr, Peter Clark, David Penson,
Matthew Resnick, Dan Barocas, Kamran
Idrees, Sunil Kripalani, Kelvin Moses,
Nashville, TN
MP31-20 QUALITY OF LIFE AFTER A
MITROFANOFF CONTINENT URINARY
DIVERSION
Mohamed Nabil Mhiri*, Mohamed Amine
Mseddi, Anis Masmoudi, Mohamed Fourati,
Mehdi Bouassida, Nouri Rebai, Mourad Hadj
Slimen, Sfax, Tunisia
MP31-17 VALIDATING THE BLADDER UTILITY
SYMPTOM SCALE (BUSS): A NOVEL
PATIENT REPORTED OUTCOME QUALITY
OF LIFE MEASURE FOR ALL PATIENTS
WITH BLADDER CANCER
Nathan Perlis*, Kirstin Boehme, Toronto,
Canada, Munir Jamal, Mississauga, Canada,
Karen Bremner, Shabbir Alibhai, Antonio
Finelli, Paul Ritvo, Murray Krahn, Rushi
Gandhi, Girish Kulkarni, Toronto, Canada
CREDITTM
1:00 pm - 3:00 pm
TRANSPLANTATION & VASCULAR SURGERY: RENAL TRANSPLANTATION & VASCULAR SURGERY II
Moderators: Ronald Moore and Mark Jordan
ABSTRACT
NUMBER TITLE
MP32-01 PERCUTANEOUS NEPHROSTOMY
PLACEMENT AFTER RENAL
TRANSPLANTATION: INDICATIONS AND
IMPLICATIONS FOR LONG-TERM GRAFT
SURVIVAL
Jeffrey Pearl*, Atlanta, GA, Joshua Finkle,
Mikin Patel, Thuong Van Ha, Jeffrey Leef,
Chicago, IL, Kenneth Ogan, Atlanta, GA,
Jonathan Lorenz, Chicago, IL
ABSTRACT
NUMBER TITLE
MP32-04 RENAL CELL CARCINOMA IN THE NATIVE
KIDNEY IN DIALYSIS AND KIDNEY
TRANSPLANT RECIPIENTS. COMPARISON
OF PATHOLOGICAL FEATURES AND
ACKD INFLUENCE
Kleiton Yamaçake*, William Nahas, Ioannis
Antonopoulos, Hideki Kanashiro, Raphael
Kato, Renato Falci, Affonso Piovesan, Sao
Paulo, Brazil
MP32-02 UTILITY OF CONTRAST ENHANCED
ULTRASOUND IN THE DIAGNOSIS OF
ACUTE COMPLICATIONS AFTER RENAL
TRANSPLANT.
Sara Alvarez Rodriguez, Enrique Sanz
Mayayo, Victoria Gómez Dos Santos, Vital
Hevia Palacios, Rafael Rodrı́guez-Patrón
Rodrı́guez, Vı́ctor Dı́ez Nicolas*, Javier
Fabuel Alcañiz, Madrid, Spain
MP32-05
MP32-06 A PROSPECTIVE RANDOMIZED STUDY
COMPARING INTRAOPERATIVE PLACING
OF DRAINS VERSUS NO DRAIN ON
INCIDENCE OF LYMPHOCELE
FORMATION AFTER RENAL
TRANSPLANTATION
Ahmed fahmy*, Mohamed Youssif, Tamer
Aboyoussif, Hazem Rhashad, Alexandria,
Egypt
MP32-03 RISK FACTORS FOR UROLOGICAL
COMPLICATIONS FOLLOWING LIVING
DONOR RENAL TRANSPLANTATION IN
CHILDREN
Mohammed ElSheemy, Ahmed Shouman,
Ahmed Shoukry*, Waseem Aboulela, Kareem
Daw, Mohamed El Ghoneimy, Hany Morsi,
Hesham Badawy, Cairo, Egypt
*Presenting author
3D LAPAROSCOPIC DONOR
NEPHRECTOMY AND TRANSVAGINAL
RETRIEVAL OF DONOR KIDNEY - OUR
INITIAL EXPERIENCE AND TECHNIQUE
Abhay Anand, Krishnamohan Ramaswamy*,
Harigovind Pothiyedath, Ashish Jindal,
Kozhikode, India
121
MP32-07 WARM PERFUSION OF CARBON
MONOXIDE RELEASING MOLECULE 401
REDUCES INFLAMMATION AND DAMAGE
IN PRECLINICAL DONATION AFTER
CARDIAC DEATH KIDNEY
TRANSPLANTATION MODEL
Rabindra Bhattacharjee, Mahms Richard
Mohamed, Manu Saha, Karen Pineda Solis,
Richard Mayer, Peter Barrett, Ibrahim
AlHasan, Ghaleb Aboalsamh, Gediminas
Cepinskas, Patrick Luke*, London, Canada
MP32-14 CYSTOSCOPY AND BLADDER WASHOUT
FOR RECURRENT URINARY TRACT
INFECTIONS IN RENAL TRANSPLANT
RECIPIENTS
Andre Thomas, Benjamin Sherer*,
Oyedolamu Olaitan, Chicago, IL
MP32-15
MP32-08 THE EFFECT OF HYPOXIA-INDUCIBLE
FACTOR-1〈 EXPRESSION IN BIOPSY
SPECIMEN AFTER REPERFUSION ON THE
EARLY RECOVERY OF GRAFT FUNCTION
AFTER CADAVERIC KIDNEY
TRANSPLANTATION
Teruyuki Oda*, Takeshi Ishimura, Masato
Fujisawa, Kobe, Japan
CALCULATION OF GLOMERULAR
FILTRATION RATE FROM RENAL VOLUME
IN KIDNEY DONORS BY USING HERTS
FORMULA
Vimal Dixit*, Dehradun, India
MP32-16 ANALYSIS OF FACTORS THAT
PRESCRIBES THE COMPENSATORY
HYPERTROPHY RATIO OF THE
TRANSPLANTED KIDNEY
Masasahi Kato*, Takashi Fujita, Yasuhito
Funahashi, Shohei Ishida, Fumitoshi
Sakamoto, Mokokazu Gotoh, Nagoya, Japan
MP32-17 CLINICAL SIGNIFICANCE OF ISOLATED
V1 ARTERITIS IN RENAL
TRANSPLANTATION
David Mikhail*, Derek Kleinsteuber, James
Wei, Manal Gabril, Alp Sener, Madeleine
Moussa, Patrick Luke, London, Canada
MP32-09 OPEN MINIMALLY INVASIVE RENAL
TRANSPLANT IN OBESE PATIENTS
THROUGH THE ANTERIOR RECTUS
SHEATH
Stephen Phillips, II*, Sharon Hill, Lorie
Lipscomb, Bashir Sankari, Shih-Chieh Chueh,
Joseph Africa, Charleston, WV
MP32-18 RENAL TRANSPLANTATION WITH
DONORS OLDER THAN 70 YEARS
Paulo Dinis*, Lorenzo Marconi, Pedro Nunes,
Arnaldo Figueiredo, Belmiro Parada, Pedro
Moreira, Carlos Bastos, António Roseiro,
Vı́tor Dias, Franscisco Rolo, Alfredo Mota,
Coimbra, Portugal
MP32-10 NONINVASIVE RENAL TRANSPLANT
GRAFT MONITORING IN A SINGLE
INSTITUTION USING CELL-FREE DONOR
NUCLEIC ACID IN RECIPIENT PLASMA
VIA INSERTION-DELETION ALLELE
POLYMORPHISM
Yen Seow Benjamin Goh*, Sze Yee Sherry
Ho, Yi Quan Tan, Lata Raman, Vathsala
Anantharaman, Ting Hui Angeline Goh, Siew
Chuan Evelyn Koay, Ho Yee Tiong,
Singapore, Singapore
MP32-19 INCIDENCE AND TREATMENT OF
MALIGNANT TUMORS OF THE
GENITOURINARY TRACT IN RENAL
TRANSPLANT RECIPIENTS
Juan Manuel Ochoa Lopez*, Bernardo
Gabilondo Pliego, Jaime O Herrera Caceres,
Francisco Rodriguez Covarrubias, Ricardo
Alonso Castillejos Molina, Mexico City,
Mexico
MP32-11 PERCUTANEOUS TRANSLUMINAL
ANGIOPLASTY FOR TREATMENT OF
TRANSPLANT RENAL ARTERY STENOSIS
Alexander Massmann, C. Marchal, Christina
Niklas, Sarah Seiler-Mußler, Urban Sester,
Gunnar Heine, G. K. Schneider, Arno Bücker,
Michael Stöckle, Martin Janssen*, Homburg/
S., Germany
MP32-20 KIDNEY TRANSPLANTATION FROM
LIVING DONORS WITH RENAL AND
VASCULAR PATHOLOGY
Mahmoud Alameddine*, Zhobin
Moghadamyeghaneh, Mohammed Osman,
Luay Alshara, Mahmoud Morsi, Vincent Chia,
Gaetano Ciancio, Miami, FL
MP32-12 INCIDENCE OF DE NOVO PROSTATE
CANCER IN RENAL TRANSPLANT
RECIPIENTS
Benjamin Sherer*, Karl Godlewski, Leslie
Deane, Chicago, IL
CREDITTM
MP32-13 URETERIC IMPLANTATION INTO BOWEL
PORTION OF AUGMENTED BLADDERS
DURING KIDNEY TRANSPLANTATION: A
REVIEW OF UROLOGICAL
COMPLICATIONS AND OUTCOMES
Lynnette Tan Rui Ling*, Melissa Tay,
Angeline Goh, Hersharan Kaur, Vathsala
Anantharaman, Tiong Ho Yee, Singapore,
Singapore
122
1:00 pm - 3:00 pm
STONE DISEASE: SURGICAL THERAPY III
Moderators: Sri Sivalingam, Arvind Ganpule and Ojas Shah
ABSTRACT
NUMBER TITLE
MP33-01 RISK FACTORS FOR FEBRILE URINARY
TRACT INFECTION AFTER
URETEROSCOPIC STONE REMOVAL
Yuji Kato*, Tatsuro Koseki, Ryo Mastsutani,
Takumi Sasao, Hideki Wada, Kiyohito
Yamazaki, Taketoshi Saka, Sapporo, Japan
ABSTRACT
NUMBER TITLE
MP33-08 PREDICTING FACTORS FOR
COMPLICATIONS AND STONE
CLEARANCE FOLLOWING PEDIATRIC
MINI-PERCUTANEOUS
NEPHROLITHOTOMY
Mohammed ElSheemy, Ahmed Shouman,
Kareem Daw, Ahmed Shoukry*, Waseem
Aboulela, Mohamed El Ghoneimy, Hany
Morsi, Hesham Badawy, Cairo, Egypt
MP33-02 CLINICAL CHARACTERISTICS OF
POSTOPERATIVE FEBRILE URINARY
TRACT INFECTION AFTER
URETEROSCOPIC LITHOTRIPSY
Jun Nyung Lee, Jae-Wook Chung*, Yun-Sok
Ha, Seock Hwan Choi, Jae Soo Kim, Daegu,
Korea, Republic of, Gunnam Kim, Gumi-si,
Korea, Republic of, Bum Soo Kim, Hyun Tae
Kim, Tae-Hwan Kim, Eun Sang Yoo, Tae
Gyun Kwon, Sung Kwang Chung, Bup Wan
Kim, Daegu, Korea, Republic of
MP33-09 CONTEMPORARY TRENDS IN
PERCUTANEOUS NEPHROLITHOTOMY IN
THE UNITED STATES: 1998-2011
Karen Stern*, Phoenix, AZ, Mark Tyson,
Nashville, TN, Haidar Abdul-Muhsin, Mitchell
MP33-10 PCNL IN THE UNITED KINGDOM: TRENDS
IN 5000 CASES FROM BAUS PCNL
REGISTRY
William Finch*, Norwich, United Kingdom,
Robert Calvert, Liverpool, United Kingdom,
Sarah Fowler, London, United Kingdom,
James Armitage, Cambridge, United
Kingdom, Jonathan Glass, John Withington,
London, United Kingdom, Oliver Wiseman,
Cambridge, United Kingdom, Stuart Irving,
Neil Burgess, Norwich, United Kingdom
MP33-03 COMPUTED TOMOGRAPHY CAN PREDICT
POSITIVE STONE CULTURES PRIOR TO
Yýloren Tanýdýr*, Asgar Garayev, Ahmet
Þahan, Tarýk Emre Þener, Ýlker Tinay,
Çaðrý Akýn Þekerci, Cem Akbal, Ferruh
Þim°ek, Istanbul, Turkey
MP33-04 STONE VOLUME IS BEST PREDICTOR OF
OPERATIVE TIME REQUIRED IN
RETROGRADE INTRARENAL SURGERY
FOR RENAL CALCULI: IMPLICATIONS
FOR SURGICAL PLANNING AND QUALITY
IMPROVEMENT
Igor Sorokin*, Diana Cardona-Grau,
Alexandra Rehfuss, Alan Birney, Costas
Stavrakis, Allen Herr, Gabriel Leinwand, Paul
Feustel, Mark White, Albany, NY
MP33-05
MP33-11 ANATOMICAL VARIATIONS BETWEEN
VERTICAL AND HORIZONTAL BOLSTER
PLACEMENT AND THE IMPLICATIONS
FOR PERCUTANEOUS
NEPHROLITHOTOMY (PCNL) ACCESS
Daniel Sagalovich*, Cecilia Besa Correa,
Haresh Thummar, Blake Le Grand, Bachir
Taouli, Mantu Gupta, New York, NY
MP33-12 PERCUTANEOUS NEPHROLITHOTOMY IN
THE SUPER OBESE: A COMPARISON OF
OUTCOMES BASED ON BODY MASS
INDEX
Casey A Dauw*, Michael S Borofsky, Nadya
York, James E Lingeman, Indianapolis, IN
INVESTIGATING THE LINK BETWEEN
URETERIC STENT ENCRUSTATION AND
HEALTH RELATED QUALITY OF LIFE
Aditya Raja*, Mohamed Sherif, Hrishi Joshi,
Cardiff, United Kingdom
MP33-06 URETEROSCOPIC STONE TREATMENT
OUTCOMES IN SPINAL CORD INJURED
PATIENTS
Duncan Morhardt*, Miriam Hadj-Moussa, J.
Stuart Wolf, Jr., He Chang, Gary Faerber,
William Roberts, John Stoffel, Ann PelletierCameron, Ann Arbor, MI
MP33-13 PERCUTANEOUS ANTEGERADE
URETEROSCOPY FOR TREATMENT OF
URETEROINTESTINAL ANASTAMOTIC
STRICTURES
Natalia Hernandez*, Bosotn, MA, Patrick
Gomella, Washington, DC, Brian Matlaga,
Baltimore, MD, Gyan Pareek, Providence, RI,
Vernon Pais, Lebanon, NH, Patrick Mufarrij,
Washington, DC, Brian Eisner, Boston, MA
MP33-07 A PHYSICAL MODEL OF PRESSURE
CHANGES DURING FLEXIBLE
URETEROSCOPY
Alexandros Oratis, John Subasic, Natalia
Hernandez, James Bird, Brian Eisner*,
Boston, MA
*Presenting author
123
MP33-14 SEMI-RIGID URETEROSCOPY FOR
PROXIMAL URETERAL STONES: DOES
ADJUNCTIVE TAMSULOSIN THERAPY
INCREASE THE CHANCE OF SUCCESS?
Abul-Fotouh Ahmed, Al-Kharj, Saudi Arabia,
Aref Maarouf*, Zagazig, Egypt, Saad
Alshahrani, Al-Kharj, Saudi Arabia, Essam
Shalaby, Ismailia, Egypt
MP33-19 COMPARISON OF STONE-FREE RATES
BETWEEN EXTRACORPOREAL SHOCK
WAVE LITHOTRIPSY (ESWL) AND
FLEXIBLE URETERORENOSCOPY (FURS)
FOR UNTREATED RENAL CALCULI
Christian Fankhauser*, Thomas Hermanns,
Olivia Diethelm, Laura Lieger, Tullio Sulser,
Cedric Poyet, Zurich, Switzerland
MP33-15
MP33-20 A PROSPECTIVE RANDOMIZED
COMPARISON AMONG SWL, PCNL AND
RIRS FOR LOWER CALYCEAL STONES
LESS THAN 2 CM: A MULTICENTER
EXPERIENCE
Giorgio Bozzini*, Castellanza VA, Italy, Paolo
Verze, Naples, Italy, Orietta Dal Piaz, Graz,
Austria, Nicola Macchione, Milan, Italy, Marco
Provenzano, Rozzano MI, Italy, Mauro
Seveso, Castellanza VA, Italy, NicoloMaria
Buffi, Rozzano MI, Italy, Boris Osmolorskji,
Moscow, Russian Federation, Francesco
Sanguedolce, London, United Kingdom,
Giorgio Guazzoni, Rozzano MI, Italy, Karl
Pummer, Graz, Austria, Emanuele Montanari,
Milan, Italy, Gianluigi Taverna, Castellanza
VA, Italy
OFFICE-BASED URETEROSCOPY FOR
RENAL AND URETERAL STONE
TREATMENT: A PIONEER EXPERIENCE
Ghalib Jibara*, Brooklyn, NY, Jon Marks,
Patti Sablesak, New York, NY, Frederick
Glumi, Brooklyn, NY
MP33-16 IS IT NECESSARY TO REMOVE STONE
ACTIVELY WHEN WE PERFORM
RETROGRADE INTRARENAL SURGERY?
Jun Nyung Lee, Jae-Wook Chung*, Yun-Sok
Ha, Seock Hwan Choi, Jae Soo Kim, Daegu,
Korea, Republic of, Gunnam Kim, Gumi-si,
Korea, Republic of, Bum Soo Kim, Hyun Tae
Kim, Tae-Hwan Kim, Eun Sang Yoo, Tae
Gyun Kwon, Sung Kwang Chung, Bup Wan
Kim, Daegu, Korea, Republic of
MP33-17 THE LEARNING CURVE FOR
RETROGRADE INTRA-RENAL
SURGERY(RIRS): HOW MANY CASES ARE
NECESSARY?
Jose Arnaldo Shiomi da Cruz*, Cesar Thiago,
Ugo de Queiros Barros, Ricardo Leo Felts de
la Roca, Joao Paulo Cunha Lima, Ricardo Di
Migueli, Sao Paulo, Brazil
CREDITTM
MP33-18 FOURTH GENERATION FLEXBILE
URETEROSCOPES: A COMPARISON OF
OPTICS, DEFLECTION AND FLOW
Adam Kaplan, Daniela Radvak, Richard Shin,
Annika Ackerman, Tony Chen, Fernando
Cabrera, Joanne Dale*, Michael Ferrandino,
Charles Scales, Neal Simmons, Glenn
Preminger, Michael Lipkin, Durham, NC
1:00 pm - 3:00 pm
Podium Session 19
SURGICAL TECHNOLOGY & SIMULATION: INSTRUMENTATION & TECHNOLOGY II
Moderators: Khurshid Ghani and Duane Baldwin
TIME
1:00
ABSTRACT
NUMBER TITLE
PD19-01 COMPARISON OF A NOVEL COMBINED
HOLMIUM LASER AND SUCTION DEVICE,
LITHASSIST, TO AN ULTRASONIC
LITHOTRIPTER FOR PERCUTANEOUS
NEPHROLITHOTOMY- A RANDOMIZED
CONTROLLED MULTICENTER CLINICAL
TRIAL
Necole M Streeper*, Hershey, PA, Zhamshid
Okhunov, Jaime Landman, Orange, CA, John
R Bell, Sara L Best, Stephen Y Nakada,
Madison, WI
ABSTRACT
TIME NUMBER TITLE
1:10 PD19-02 IMPROVING FLEXIBLE URETEROSCOPE
DURABILITY IN A TEACHING CENTER
James P. Tierney*, Nathan E. Hale, Rebecca
J. Harless, Charleston, WV, Ginger R.
Barrick, Charleston, WV, Jamie L. Olsen,
Charleston, WV
1:20
124
PD19-03
CONSTRUCTION AND ASSESSMENT OF
AN INNOVATIVE VIRTUAL (RADIATION
FREE) FLUOROSCOPY PCNL SIMULATOR:
AN INDIGENOUS APPROACH TO
TRAINING
Ashish Rawandale*, Lokesh Patni, Yasser
Dar, GAutam Ladumor, Dhule, India
1:30
PD19-04
A MOBILE POINT-OF-CARE APPLICATION
FOR URETERAL STENT TRACKING
Justin Ziemba*, Wesley Ludwig, Baltimore,
MD, Leticia Ruiz, Panama City, Panama,
Eduardo Carvalhal, Porto Alegre, Brazil, Brian
Matlaga, Baltimore, MD
1:40
PD19-05
THE OPTIMAL GUIDEWIRE TYPE AND
EFFECT OF PRIOR USE ON THE EASE OF
URETERAL STENT INSERTION
Nazih Khater*, Herbert Hodgson, Kristene
Myklak, Muhannad Alsyouf, Javier Arenas,
Patrick Yang, D. Duane Baldwin, Loma Linda,
CA
1:50
2:00
2:10
PD19-06
PD19-07
PD19-08
2:20
PD19-09
ULTRASOUND-GUIDED RENAL ACCESS
REDUCES RADIATION EXPOSURE
DURING PERCUTANEOUS
NEPHROLITHOTOMY COMPARED TO
FLUOROSCOPIC GUIDANCE
Christopher Margono*, Manint
Usawachintachit, Thomas Chi, San
Francisco, CA
2:30
PD19-10
THE DURABILITY OF DIGITAL FLEXIBLE
URETEROSCOPES IN AN ACADEMIC
SETTING WITH MULTIPLE SURGEONS
Christopher Martin*, Phoenix, AZ, Mark
Tyson, Pheonix, AZ, Mitchell Humphreys,
Phoenix, AZ
PATIENTS ARE WILLING TO USE
PHYSICAL ACTIVITY MONITORS TO
ENHANCE THEIR MEDICAL CARE: A
SURVEY OF PERCEPTIONS AND
ACCEPTANCE AMONG A UROLOGICAL
PATIENT POPULATION
Boyd Viers*, Avinash Nehra, Marcelino
Rivera, Daniel O’Neil, Sarah Jenkins,
Matthew Tollefson, Matthew Gettman,
Rochester, MN
2:40
PD19-11
FLEXIBLE URETEROSCOPY DURABILITY
IN THE HANDS OF UK SURGEONS: A
SNAPSHOT
William Finch*, Norwich, United Kingdom,
Nick Rukin, Wolverhampton, United Kingdom,
Jake Patterson, Sheffield, United Kingdom,
Sunil Kumar, Reading, United Kingdom,
Oliver Wiseman, Cambridge, United Kingdom
PILOT ASSESSMENT OF
TRANSCUTANEOUS BOILING
HISTOTRIPSY ABLATION OF THE KIDNEY
IN THE PORCINE MODEL
George R. Schade*, Tatiana D. Khokhlova,
Yak-Nam Wang, Frank Starr, Adam D.
Maxwell, Wayne Kreider, Michael R. Bailey,
Vera Khokhlova, Seattle, WA
2:50
PD19-12
EFFECT OF VARYING PARAMETERS ON
IRREVERSIBLE ELECTROPORATION IN A
PORCINE MODEL
Noah Canvasser, Aaron Lay*, Ersin
Koseoglu, Nicholas Kavoussi, Jeffrey Gahan,
Elena Lucas, Jeffrey Cadeddu, Dallas, TX
A NEW DUAL CONE THERMOEXPANDABLE METAL STENT FOR
MAMAGEMENT OF MALIGNANT
URETERAL OBSTRUCTION IN PROSTATE
CANCER
Palle Jörn Sloth Osther*, Fredericia,
Denmark, Gihan Sabbah Gameel Al-Gameel,
Frank Hansen, Copenhagen, Denmark,
Anders Holm Nielsen, Roskilde, Denmark,
Merete Bendorff Hansen, Fredericia,
Denmark, Mette Holm, Copenhagen,
Denmark, Kim Hovgaard Andreassen,
Fredericia, Denmark
CREDITTM
1:00 pm - 3:00 pm
Podium Session 20
INFECTIONS/INFLAMMATION/CYSTIC DISEASE OF THE GENITOURINARY TRACT: PROSTATE & GENITALIA I
Moderators: John Krieger and Giuseppe Morgia
TIME
1:00
1:10
ABSTRACT
NUMBER TITLE
PD20-01 TESTOSTERONE AND CHRONIC
PROSTATITIS/CHRONIC PELVIC PAIN
SYNDROME: A PROPENSITY SCORE
MATCHED ANALYSIS
Jun Ho Lee*, Sung Won Lee, Seoul, Korea,
Republic of
PD20-02
*Presenting author
ABSTRACT
TIME NUMBER TITLE
1:20 PD20-03 ANALYSIS OF GUT MICROBIOME
REVEALS SIGNIFICANT DIFFERENCES
BETWEEN MEN WITH CHRONIC
SYNDROME AND CONTROLS
Daniel Shoskes*, Jessica Altemus, Alan
Polackwich, Barbara Tucky, Hannah Wang,
Charis Eng, Cleveland, OH
CHRONIC PROSTATE INFLAMMATION
PREDICTS SYMPTOM PROGRESSION IN
CHRONIC PROSTATITIS/CHRONIC PELVIC
PAIN PATIENTS
J. Curtis Nickel*, Kington, Canada, Stephen
Freedland, Durham, NC, Ramiro CastroSantamaria, King of Prussia, PA, Daniel
Moreira, Rochester, MN
125
1:30
PD20-04
PAIN SYNDROME IS ASSOCIATED WITH
IRRITABLE BOWEL SYNDROME: A
POPULATION-BASED STUDY
Shyi-Chun Yii*, Chun-Hou Liao, New Taipei
City, Taiwan, Shiu-dong Chung, New-Taipei
City, Taiwan, Herng-Ching Lin, New Taipei City,
Taiwan
1:40
PD20-05
POSSIBLE LINK BETWEEN PERIODONTAL
DISEASE AND CHRONIC PROSTATITIS
John Estemalik, Nabil Bissada, Nishant Joshi,
Catherine Demko, Eswar Shankar, Donald
Bodner, Sanjay Gupta*, Cleveland, OH
1:50
PD20-06
PRESENCE OF SEROTYPE H EXHIBITS
MILDER SYMPTOMATIC
CHARACTERISTICS IN AGED MEN THAN
OTHER SEROTYPES
Yu Seo, Gil Lee*, Cheonan, Korea, Republic
of
2:00
PD20-07
THE PAINFUL PELVIC SYMPTOMS IN
AGING MEN. THE RESULTS OF
POPULATION-BASED SAMPLE OF MEN
Elcio Nakano*, Paulo Sajovic de Conti,
Eduardo Muracca Yoshinaga, William C
Nahas, Miguel Srougi, Alberto Antunes, Sao
Paulo, Brazil
2:10
PD20-08
2:20
PD20-09
THE ROLE OF INFLAMMATORY
CYTOKINES AND MAPK SIGNALING IN
PAIN SYNDROME WITH RELATED
MENTAL HEALTH DISORDERS
Chao Hu*, Hualan Yang, Yanfang Zhao,
Xiang Chen, Yinying Dong, Yehao Dong,
Jiefeng Cui, Tongyu Zhu, Ping Zheng,
Shanghai, China, People’s Republic of,
Ching-Shwun Lin, San Francisco, CA, Jican
Dai, Shanghai, China, People’s Republic of
2:30
PD20-10
CLINICAL AND MICROBIOLOGICAL
FEATURES AND FACTORS ASSOCIATED
WITH FLUOROQUINOLONE RESISTANCE
IN MEN WITH COMMUNITY-ACQUIRED
ACUTE BACTERIAL PROSTATITIS
Min Gu Park*, Dae Yeon Cho, Jeong Kyun
Yeo, Min Chul Cho, Sung Yong Cho, Seoul,
Korea, Republic of, Jeong Woo Lee, Ilsan,
Korea, Republic of
2:40
PD20-11
THE ROLE OF INDOLEAMINE 2,3DIOXYGENASE IN EPIDIDYMITIS
Ohira Shin*, Hara Ryoei, Tone Shigenobu,
Fujii Tomohiro, Miyaji Yoshiyuki, Kuribayashi
Futoshi, Nagai Atsushi, Kurashiki City, Japan
2:50
PD20-12
DEVELOPMENT OF A CLINICALLY
RELEVANT SYMPTOM INDEX TO ASSESS
PATIENTS WITH CHRONIC ORCHIALGIA
Alan Polackwich*, Hans Arora, Jianbo Li,
Cleveland, OH, Parekattil Sijo, Clermont, FL,
Daniel Shoskes, Cleveland, OH
PREDICTORS OF PAIN RESOLUTION
AFTER VARICOCELECTOMY FOR
PAINFUL VARICOCELE
Hyun Jun Park*, Busan, Korea, Republic of,
Du Geon Moon, Seoul, Korea, Republic of,
Nam Cheol Park, Busan, Korea, Republic of
CREDITTM
1:00 pm - 3:00 pm
Podium Session 21
BENIGN PROSTATIC HYPERPLASIA: SURGICAL THERAPY & NEW TECHNOLOGY I
Moderators: Mitchell Humphreys and Amy Krambeck
TIME
1:00
ABSTRACT
NUMBER TITLE
PD21-01 MULTI-NATIONAL, PROSPECTIVE,
RANDOMIZED STUDY OF THE PROSTATIC
URETHRAL LIFT (PUL) VS.
TRANSURETHRAL RESECTION OF THE
PROSTATE (TURP): TWO YEAR RESULTS
Jens Sonsken*, Herlev, Denmark, Neil
Barber, Camberley, United Kingdom, Mark
Speakman, Taunton, United Kingdom,
Richard Berges, Cologne, Germany, Ulrich
Wetterauer, Freiburg, Germany, Damian
Greene, Sunderland, United Kingdom, KarlDietrich Sievert, Tuebingen, Germany,
Christopher Chapple, Sheffield, United
Kingdom, Francesco Montorsi, Milan, Italy,
Lasse Fahrenkrug, Herlev, Denmark,
Christian Gratzke, Munich, Germany
ABSTRACT
TIME NUMBER TITLE
1:10 PD21-02 PROSPECTIVE, RANDOMIZED, BLINDED
STUDY OF PROSTATIC URETHRAL LIFT
(PUL): FOUR YEAR RESULTS
Claus Roehrborn*, Dallas, TX, Steven Gange,
Salt Lake City, UT, Neal Shore, Myrtle
Beach, SC, Jonathan Giddens, Brampton,
Canada, Damien Bolton, Heidelberg,
Australia, Barrett Cowan, Englewood, CO,
Anthony Cantwell, Daytona Beach, FL, Kevin
McVary, Springfield, IL, Peter Chin, Figtree,
Australia, Alexis Te, New York, NY, Shahram
Gholami, San Jose, CA, Prem Rashid, Port
Macquarie, Australia, William Moseley, San
Diego, CA, Ronald Tutrone, Baltimore, MD,
Sheldon Freedman, Las Vegas, NV, Peter
Incze, Oakville, Canada, K. Scott Coffield,
Temple, TX, Fernando Borges, St.
Petersburg, FL, Daniel Rukstalis, Winston
Salem, NC
126
1:20
1:30
PD21-03
PD21-04
CONVECTIVE WATER VAPOR ENERGY
(WAVE) ABLATION: TWO-YEAR RESULTS
FOLLOWING TREATMENT OF LOWER
URINARY TRACT SYMPTOMS
SECONDARY TO BENIGN PROSTATIC
HYPERPLASIA
Christopher Dixon*, New York, NY, Edwin
Rijo Cedano, La Romana, Dominican
Republic, Dalibor Pacik, Viteslav Vit, Gabriel
Varga, Brno, Czech Republic, Lennart
Wagrell, Stockholm, Sweden, Thayne Larson,
Scottsdale, AZ
TREATMENT OF LOWER URINARY TRACT
SYMPTOMS DUE TO BENIGN PROSTATIC
HYPERPLASIA WITH CONVECTIVE
WATER VAPOR ENERGY ABLATION:
PRESERVED ERECTILE AND
EJACULATORY FUNCTION
Kevin McVary*, Springfield, IL, Steven
Gange, Salt Lake City, UT, Marc Gittelman,
Aventura, FL, Kenneth Goldberg, Carrollton,
TX, Kalpesh Patel, Tucson, AZ, Neal Shore,
Myrtle Beach, SC, Richard Levin, Towson,
MD, Michael Rousseau, Cincinnati, OH, J.
Randolf Beahrs, Woodbury, MN, Jed
Kaminetsky, New York, NY, Barrett Cowan,
Englewood, CO, Christopher Cantrill, San
Antonio, TX, Lance Mynderse, Rochester,
MN, James Ulchaker, Cleveland, OH, Thayne
Larson, Scottsdale, AZ, Christopher Dixon,
New York, NY, Claus Roehrborn, Dallas, TX
1:40
PD21-05
SINGLE-CENTER EXPERIENCE UTILIZING
SECOND GENERATION AQUABEAM
SYSTEM FOR THE TARGETED, HEATFREE REMOVAL OF PROSTATE TISSUE,
DURING THE TREATMENT OF BPH
Mihir Desai*, Los Angeles, CA, Abhishek
Laddha, Shashikant Mishra, Mahesh Desai,
Ravindra Sabnis, Abhishek Singh, Nadiad,
India
1:50
PD21-06
MID-TERM RESULTS USING
AQUABLATION, AN IMAGE GUIDED
ROBOT-ASSISTED WATER JET ABLATION
OF THE PROSTATE, FOR THE
TREATMENT OF BENIGN PROSTATIC
HYPERPLASIA (BPH).
Peter Gilling*, Tauranga, New Zealand, Mihir
Desai, Los Angeles, CA, Paul Anderson,
Melbourne, Australia, Andrew Tan, Perth,
Australia, Mahesh Desai, Nadiad, India
2:00
PD21-07
TREATMENT OF BENIGN PROSTATE
ENLARGEMENT WITH MEMOKATHTM 028
INTRAPROSTATIC STENT IN FRAIL
ELDERLY PATIENTS - A 5-YEAR SINGLE
CENTER EXPERIENCE.
Ming Ho Wong*, CW Fan, Hong Kong, Hong
Kong
*Presenting author
2:10
PD21-08
MEDITATE® TEMPORARY IMPLANTABLE
NITINOL DEVICE (TIND) IN THE
TREATMENT OF BENIGN PROSTATIC
OBSTRUCTION: TWO YEARS OF FOLLWUP RESULTS.
Cristian Fiori*, Daniele Amparore, Enrico
Checcucci, Giulia Ottaviano, Sabrina De
Cillis, Andrea Di Stasio, Nicoletta Serra,
Riccardo Bertolo, Giovanni Cattaneo,
Francesco Porpiglia, Orbassano, Torino, Italy
2:20
PD21-09
MULTISCALE ENTROPY ANALYSIS OF
SURFACE ELECTROMYOGRAPHIC
SIGNALS IS A VALUABLE TOOL TO
EVALUATE EXTERNAL URETHRAL
SPHINCTER FUNCTION_ AN ANALYSIS OF
SURGICAL OUTCOMES OF
TRANSURETHRAL INCISION OF
PROSTATE
Yuan-Hong Jiang*, Hsien-Tsai Wu, HannChorng Kuo, Hualien, Taiwan
2:30
PD21-10
MORCELLATION EFFICIENCY IN
HOLMIUM LASER ENUCLEATION OF THE
PROSTATE: COMPARATIVE STUDY OF
TWO GENERATIONS OF MORCELLATORS
Haidar Abdul-Muhsin*, Karen Stern, Mitchell
2:40
PD21-11
PROSPECTIVE LOW URINARY TRACT
SYMPTOMS ANALYSIS USING “MENⴕS
SEXUAL MEDICINE APP®” USERS DATA
Eduard Garcı́a-Cruz*, Barcelona, Spain,
Paolo Verze, Naples, Italy, Nuno Tomada,
Porto, Portugal, Maarten Albersen, Leuven,
Belgium, Albert Carrión, Alfonso Florensa,
Barcelona, Spain, Giulio Garaffa, London,
United Kingdom, Markus Margreiter, Vienna,
Austria, Bárbara Romano, Barcelona, Spain,
Javier Romero Otero, Madrid, Spain, Ege
Can Serefoglu, Istambul, Turkey, Ines
Tomada, Porto, Portugal, Antonio Alcaraz,
Barcelona, Spain
2:50
PD21-12
YOUNG ACADEMIC UROLOGIST BENIGN
PROSTATIC OBSTRUCTION NOMOGRAM
PREDICTS CLINICAL OUTCOME IN
PATIENTS TREATED WITH
TRANSURETHRAL PROSTATIC
RESECTION
Cosimo De Nunzio*, R. Lombardo, M.
Bellangino, Rome, Italy, M. Gacci, Florence,
Italy, A. Brassetti, C. Pellegrino, G. Tema, A.
Tubaro, Rome, Italy
CREDITTM
127
1:00 pm - 3:00 pm
Podium Session 22
BENIGN PROSTATIC HYPERPLASIA: MEDICAL & NON-SURGICAL THERAPY
Moderator: Thomas Turk
TIME
1:00
ABSTRACT
NUMBER TITLE
PD22-01 VOIDING SYMPTOMS, AGE AND BMI ARE
DRIVING FACTORS IN AUASS
Ilija Aleksic*, Charles Welliver, Albany, NY,
Randy Sulaver, Springfield, IL, Adam
Whittington, Brian Helfand, Evanston, IL,
Ömer Onur çakýr, Istanbul, Turkey, James
Griffith, Chicago, IL, Kevin McVary,
Springfield, IL
1:10
PD22-02
THE EFFECT OF STATINS ON
DEVELOPMENT OF SIGNIFICANT LOWER
URINARY TRACT SYMPTOMS: RESULTS
FROM THE REDUCE STUDY
Tom Feng*, Los Angeles, CA, Lauren
Howard, Durham, NC, Adriana Vidal, Los
Angeles, CA, Daniel Moreira, Rochester, MN,
Ramiro Castro-Santamaria, King of Prussia,
PA, Gerald Andriole, St. Louis, MO, Stephen
Freedland, Los Angeles, CA
1:20
PD22-03
EARLY VERSUS LATE CATHETER
REMOVAL IN PATIENTS WITH ACUTE
URINARY RETENTION (AUR) SECONDARY
TO BENIGN PROSTATIC HYPERPLASIA
UNDER TAMSULOSIN TREATMENT
Hosni Salem*, Tamer Zakaria, Samer Samir,
Alaa Meshref, Cairo, Egypt
1:30
1:40
PD22-04
PD22-05
ABSTRACT
TIME NUMBER TITLE
1:50 PD22-06 EFFECTS OF TESTOSTERONE
REPLACEMENT THERAPY ON LOWER
URINARY TRACT SYMPTOMS: A
SYSTEMATIC REVIEW AND METAANALYSIS.
Taylor P. Kohn*, Houston, TX, Douglas A.
Mata, Boston, MA, Ranjith Ramasamy,
Miami, FL, Larry I. Lipshultz, Houston, TX
COMPARISON OF ERECTILE
DYSFUNCTION TREATMENT EFFICACY
OF MIRODENALFIL 50MG ONCE DAILY
AND 100MG ON-DEMAND IN PATIENTS
WITH BENIGN PROSTATIC HYPERPLASIA
AND ERECTILE DYSFUNCTION :
MULTICENTER, RANDOMIZED TRIAL
Kyu Shik Kim, Guri, Korea, Republic of, Jae Heon
Kim, Seoul, Korea, Republic of, Jae Hoon Chung,
Sok-cho, Korea, Republic of, Cheol Young Oh*,
Chuncheon, Korea, Republic of, Tae Hyo Kim,
Busan, Korea, Republic of, Jae Hyun Bae, Jun
Hyun Han, Seung Hwan Lee, U-Syn Ha, Jae
Duck Choi, Seoul, Korea, Republic of, Joon Hwa
Noh, Kwangju, Korea, Republic of, Sung Yong
Cho, Hee Ju Cho, Seoul, Korea, Republic of,
Seung Wook Lee, Guri, Korea, Republic of, Won
Jae Yang, Seoul, Korea, Republic of, Ki Soo Lee,
Busan, Korea, Republic of, Hwa Yeon Sun,
TADALAFIL FOR MALE LUTS IMPROVES
ENDOTHELIAL FUNCTION
Kazuhiko Fukumoto*, Ryoei Hara, Tomohiro
Fujii, Yoshiyuki Miyaji, Atsushi Nagai,
Kurashiki, Japan
128
2:00
PD22-07
A META-ANALYSIS OF LONG ACTING
VERSUS SHORT ACTING
PHOSPHODIESTERASE 5 INHIBITORS :
COMPARISION BETWEEN THE
COMBINATION USE WITH ALPHABLOCKERS AND ALPHA-BLOCKER
MONOTHERAPHY
Hoon Choi*, Ji Sung Shim, Seung Min Jeong,
Jae Young Park, Ansan, Korea, Republic Of,
Du Geon Moon, Jeong Gu Lee, Seoul, Korea,
Republic Of, Jae Hyun Bae, Ansan, Korea,
Republic Of
2:10
PD22-08
CLINICALLY MEANINGFUL
IMPROVEMENTS IN LUTS/BPH SEVERITY
IN MEN TREATED WITH SILODOSIN PLUS
SERENOA REPENS OR SILODOSIN
ALONE
Luca Boeri*, Paolo Capogrosso, Eugenio
Ventimiglia, Giovanni La Croce, Donatella
Moretti, Roberta Scano, Luca Villa, Federico
Dehò, Alberto Briganti, Milan, Italy, Vincenzo
Mirone, Naples, Italy, Francesco Montorsi,
Andrea Salonia, Milan, Italy
2:20
PD22-09
MANAGEMENT OF MALE LOWER
URINARY TRACT SYMPTOMS IN A
SIMULATED OVER-THE-COUNTER
SETTING: AN EXPLORATORY, ACTUALUSE STUDY OF AN ALPHA BLOCKER
Claus G. Roehrborn*, Dallas, TX, Franklin C.
Lowe, Bronx, NY, Marc Gittelman, Aventura,
FL, Jan M. Wruck, Anna E. Verbeek,
Ridgefield, CT
2:30
PD22-10
IMPACT OF COMBINATION THERAPY 5 ARI ⴙ ALPHA - BLOCKERS ON ERECTILE
DYSFUNCTION AND ALTERATION OF
LIBIDO IN PATIENTS WITH LUTS / BPH : A
SYSTEMATIC REVIEW WITH METAANALYSIS
Giorgio Ivan Russo*, Vincenzo Favilla,
Tommaso Castelli, Salvatore Privitera,
Sebastiano Cimino, Giuseppe Morgia,
Catania, Italy
2:40
PD22-11
LONG TERM EFFICACY OF A
COMBINATION THERAPY WITH AN
ANTICHOLINERGIC AGENT AND AN 〈1BLOCKER FOR PATIENTS WITH BENIGN
PROSTATIC ENLARGEMENT
COMPLICATED BY OVERACTIVE
BLADDER: A RANDOMIZED,
PROSPECTIVE, COMPARATIVE TRIAL
USING A URODYNAMIC STUDY
Yoshihisa Matsukawa*, Yasuhito Funahashi,
Kazuna Matsuo, Shohei Ishida, Masashi
Kato, Tokunori Yamamoto, Momokazu Gotoh,
Nagoya, Japan
2:50
PD22-12
EFFICACY OF DOSE ESCALATION OF
TAMSULOSIN FOR THE TREATMENT IN
SYMPTOMATIC BENIGN PROSTATIC
HYPERPLASIA OF LOWER URINARY
TRACT SYMPTOMS : A RANDOMISED,
DOUBLE-BLIND, PHASE 3 TRIAL IN
KOREAN MEN
Kyu Shik Kim, Guri, Korea, Republic of, Jae
Heon Kim, Seung Hwan Lee, U-Syn Ha,
Deok Hyun Han, In Ho Chang, Jae Hyun
Bae, Jun Hyun Han, Tag Keun Yoo, Se
Woong Kim, Jae Il Chung, Seoul, Korea,
Republic of, Tae Hyo Kim, Busan, Korea,
Republic of, Cheol Young Oh*, Seoul, Korea,
Republic of, Jae Hoon Chung, Sok-cho,
Korea, Republic of, Seung Wook Lee, Guri,
Korea, Republic of, Jina Jung, Yong-Il Kim,
CREDITTM
1:00 pm - 3:00 pm
Video Session 3
MALE VOIDING/SEXUAL DYSFUNCTION/BPH/ INCONTINENCE/INFECTION/INFERTILITY
Surgical Video Library throughout the year through AUAUniversity. Visit www.AUAnet.org/University to access
Moderators: Jaspreet Sandhu and Alexis Te
ABSTRACT
NUMBER TITLE
V3-01
INFLATABLE PENILE PROSTHESIS
INSERTION WITH SYNCHRONOUS PENILE
PLICATION FOR THE TREATMENT OF
ERECTILE DYSFUNCTION AND
Paul H. Chung*, Ryan J. Flemons, Allen F.
Morey, Dallas, TX
V3-02
FREEHAND TRANSPERINEAL PROSTATE
BIOPSY UNDER LOCAL ANESTHESIA
John Michael DiBianco, Washington, DC,
Matthew Allaway*, Cumberland, MD
V3-03
MALE STRESS INCONTINENCE GRADING
SCALE FOR EVALUATION OF MEN WITH
POST-PROSTATECTOMY INCONTINENCE:
A PILOT STUDY
Allen Morey, Nirmish Singla*, Paul Chung,
Alexandra Klein, Timothy Tausch, Jordan
Siegel, Isamu Tachibana, Jeremy Scott,
Maude Carmel, Dallas, TX
V3-04
*Presenting author
ABSTRACT
NUMBER TITLE
V3-05
SINGLE-PORT EXTRAPERITONEAL
LAPAROSCOPIC HARVEST OF INFERIOR
EPIGASTRIC ARTERY FOR PENILE
REVASCULARIZATION
Blake Wynia*, New York, NY, Kiranpreet
Khurana, Jamie Levine, Joseph Alukal, New
York, NY
SUBCORONAL APPROACH TO
PLACEMENT WITH A MODIFIED NO
TOUCH TECHNIQUE
Alexander C. Small*, Aaron C. Weinberg,
Matthew J. Pagano, New York, NY,
Christopher M. Deibert, Omaha, NE, Robert
J. Valenzuela, New York, NY
129
V3-06
EJACULATION-SPARING
PHOTOSELECTIVE VAPORIZATION OF
THE PROSTATE: EVALUATION OF THE
EJACULATORY FUNCTION AND THE
LOWER URINARY TRACT SYMPTOMS
Toshihide Miyauchi*, Hisashi Yusu, Masanori
Kanzaki, Oita, Japan
V3-07
NO-NEEDLE, NO-SCALPEL VASECTOMY:
SINGLE SURGEON EXPERIENCE
Filipe Tenorio Lira Neto*, Benjamin Stone,
Phil Bach, Bobby Najari, Richard Lee, Philip
Li, Marc Goldstein, New York, NY
V3-08
GREEN LASER ENUCLEATION OF THE
PROSTATE (GREENLEP) “EN-BLOC
TECHNIQUE”
Enrique Rijo*, Jose Antonio Lorente, Oscar
Bielsa, Barcelona, Spain, Fernando GomezSancha, Madrid, Spain
V3-09
BIPOVEP - BIPOLAR VAPOENUCLEATION
OF THE PROSTATE. STEP-BY-STEP
VIDEO AND EARLY OUTCOME
Thorsten Bach*, Nikolai Filippow, Anika
Juerss, Akhmat Shabayev, Hamburg,
Germany
V3-10
STEP-BY-STEP LAPAROSCOPIC
VESICULECTOMY FOR HEMOSPERMIA
Marcos F Mello*, Hiury S Andrade, Victor
Srougi, Marco A Arap, Anuar I Mitre, Ricardo
J Duarte, Miguel Srougi, Sao Paulo, Brazil
V3-11
SURGICAL MANAGEMENT OF
EJACULATORY DUCT OBSTRUCTION
DUE TO PROSTATIC UTRICULAR CYST
Phil Bach*, Filipe Tenorio Lira Neto, New
York, NY, Ryan Chuang, Los Angeles, CA,
Bobby Najari, Richard Lee, Philip Li, Marc
Goldstein, New York, NY
V3-12
REAL-TIME MRI ASSESSMENT OF AGERELATED VOIDING FUNCTION AND
URETHRAL FORM
Toshiyuki Iwahata*, Shigehiro Soh, Keisuke
Suzuki, Tomohiro Kobayashi, Shin Takeshi,
Japan
CREDITTM
1:00 pm - 3:00 pm
BANGLADESH ASSOCIATION OF UROLOGICAL SURGEONS (BAUS)
Harbor GH @ Hyatt
1:00
FLEXIBLE URETEROSCOPY: TECHNIQUE
Majid Eshghi
2:40
HOLEP: BANGLADESH PERSPECTIVE
Mohammed Bhuiyan
1:20
RIRS: BANGLADESH EXPERIENCE
M. Shahidul Khan
2:45
OPEN DONOR NEPHRECTOMY
Tohid M.S. Hossain
1:25
LOCALIZED PROSTATE CANCER:
MANAGEMENT OPTIONS
John L. Phillips
2:50
OVERACTIVE BLADDER
Abdul Rashid Choudhury
2:55
1:55
EXPANDING THE ROLE OF PARTIAL
NEPHRECTOMY IN RENAL CELL CANCER BANGLADESH PERSPECTIVE
H.R. Harun
CAPD CATHETER USE IN BANGLADESH
Waliul Islam
3:00
ADJOURN
2:00
LAPAROSCOPIC DONOR NEPHRECTOMY
Chandru P. Sundaram
2:20
PYELOPLASTY IN CHILDREN: BANGLADESH
PERSPECTIVE
Isteaq A. Shameem
2:25
LAPAROSCOPIC/ROBOTIC PARTIAL
NEPHRECTOMY
Mutahar Ahmed
CREDITTM
1:00 pm - 3:35 pm
SOCIETY FOR BASIC UROLOGIC RESEARCH (SBUR) - BREAKOUT SESSION I
Hillcrest ABC @ Hyatt
1:00
WELCOME AND INTRODUCTORY REMARKS
2:45
1:05
AR MODULATION OF METABOLISM IN
PROSTATE CANCER
Chawnshang Chang
ALTERATIONS OF INFLAMMATION IN BPH
Karen Sfanos
3:05
INFLAMMATION IN KIDNEY STONE DISEASE
Saeed Khan
3:25
3:35
ADJOURN
1:25
ENERGY CONSUMPTION AND BLADDER
CANCER
Eugene Lee
1:45
METABOLIC SYNDROME AND BPH
Hideaki Ito
2:05
DECIPHERING THE RENAL CELL CARCINOMA
METABOLOME
Abraham Hakimi
2:25
BREAK
2:35
IL-17 IN HUMAN PROSTATE CANCER
Zongbing You
CREDITTM
130
1:00 pm - 3:35 pm
SOCIETY FOR BASIC UROLOGIC RESEARCH (SBUR) - BREAKOUT SESSION II
Cortez Hill ABC @ Hyatt
1:00
WELCOME & INTRODUCTORY REMARKS
1:05
MICRORNA AS A THERAPEUTIC TARGET IN
PROSTATE CANCER
Ralph deVere White
1:30
MICRORNA IN RENAL CELL CARCINOMA: ITS
MEANING AND APPLICATION
Norio Nonomura
1:55
2:55
FUNCTIONAL SCREENS CHARACTERIZE
MIRNA PATHWAY REGULATION IN PROSTATE
CANCER
Shawn Lupold
3:20
OPEN DISCUSSION AND CONCLUDING
REMARKS
3:35
ADJOURN
MIRNAS IN PROSTATE CANCER GROWTH
AND METASTASIS: BIOLOGY AND CLINICAL
APPLICATION
Leland Chung
2:20
BREAK
2:30
A NUCLEAR ROLE OF MIRNAS IN PROSTATE
CANCER
Long-Cheng Li
CREDITTM
1:00 pm - 5:00 pm
UROLOGIC CARE FOR THE ALLIED HEALTH PROFESSIONAL
1:00
Director: Louis Koncz
1:10
UTILIZATION OF APN/PA’S: AUA CONSENSUS
STATEMENT ON ADVANCED PRACTICE
PROVIDERS
Christopher Gonzalez
1:30
2:15
PHYSICIAN & APN/PA UTILIZATION
PRESENTATIONS: SMALL COMMUNITY
PRACTICE, LARGE COMMUNITY PRACTICE,
UNVERSITY PRACTICE
Panelists: Susan Flick, Christopher Gonzalez, Louis
Koncz, Bradford Nelson
Terra Schmitt, Steven Siegel
2:45
BILLING FOR THE ADVANCED PRACTICE
PROVIDER
Mark Painter
3:15
STI SCREENING AND MANAGEMENT
Jody Purifoy
4:15
URODYNAMICS - TESTING AND
INTERPRETATION
Mikel Gray
4:55
CLOSING REMARKS
5:00
ADJOURN
QUESTION & ANSWERS ON UTILIZATION
(ABOVE PRESENTERS)
2:00 pm - 5:00 pm
SECOND OPINION CASES: BENIGN
Moderator: Gary Lemack
2:00
STONE PREVENTION IN THE RECURRENT
CALCIUM STONE FORMER
Moderator: Margaret Pearle
Panelists: David Goldfarb, James Lingeman
2:30
CHRONIC PELVIC PAIN IN A YOUNG WOMAN
Moderator: Robert Evans
Panelists: C. Lowell Parsons, Kristene Whitmore
3:00
RENAL COLIC IN PREGNANCY
Moderator: Vernon Pais
Panelists: Amy Krambeck, Nicole Miller
*Presenting author
131
3:30
THE MALE WITH NOCTURIA
Moderator: Alan Wein
Panelists: Philip Van Kerrebroeck, Jeffrey Weiss
4:00
ERECTILE DYSFUNCTION IN THE MAN WITH
LOW TESTOSTERONE
Moderator: Landon Trost
Panelists: Raymond Costabile, William Brant
4:30
MIXED URINARY INCONTINENCE
Moderator: Angelo Gousse
Panelists: William Reynolds, Jennifer Anger
5:00
ADJOURN
CREDITTM
3:00 pm – 5:30 pm
HUNGARIAN UROLOGICAL ASSOCIATION (HUA) & POLISH UROLOGICAL ASSOCIATION (PTU)
Harbor AB @ Hyatt
3:00
3:05
3:15
WELCOME AND INTRODUCTIONS BY PTU
PRESIDENT
Piotr L. Chlosta
4:15
HIFU AND MINIMALLY INVASIVE SURGERY
FOR THE PROSTATE AND KIDNEY
Cary N. Robertson
PTU SESSION
4:35
AFTERNOON BREAK
GENDER DISPARITIES IN BLADDER CANCER
PRESENTATION AND OUTCOME
Jakub Dobruch
4:45
RADICAL TREATMENT FOR INVASIVE
BLADDER CANCER IN ELDERLY
Tomasz Drewa
THE SECRET KILLER: INCREASING
ANTIBIOTIC RESISTANCE
Peter Tenke
4:55
CHANGES OF TISSUE AND SERUM LEVELS
OF SYNDECAN-1 DURING PCA-PROGRESSION
Peter Nyirady
5:05
INTRAOPERATIVE FROZEN SECTION – THE
THIRD EYE IN RADICAL PROSTATECTOMY
Vinodh Kumar Adithyaa Arthanareeswaran
5:15
TREATMENT AND OBESITY IN PROSTATE
CANCER PATIENTS ON HORMONAL
TREATMENT – PROTECT-Z –NON
INTERVENTIONAL STUDY
Istvan Buzogany
5:25
CLOSING REMARKS BY HUA PRESIDENT
Istvan Buzogany
5:30
ADJOURN
3:25
EVOLVING ROLE OF RENAL TUMOR BIOPSY
Lukasz Nyk
3:35
MRI-TARGETED PROSTATE BIOPSY:
EVOLUTION AND CURRENT STATUS
Anna K. Czech
3:45
LAPAROSCOPIC SIMPLE PROSTATECTOMY:
TECHNIQUE, LIMITATIONS AND RESULTS
Tomasz Borkowski
HUA SESSION
AUA SESSION
3:55
THE ROLE OF CHANGING PROSTATE CANCER
GUIDELINES AND THEIR IMPACT ON THE
FUTURE EPIDEMIOLOGY OF HIGH STAGE
Matthew R. Cooperberg
3:00 pm - 7:20 pm
AUA-EURASIAN UROLOGY PLATFORM (EUP) JOINT MEETING PROGRAM
2:55
3:00
OPENING REMARKS
Ates Kadioglu, Inderbir Gill
STATE OF THE ART: SURGERY FOR
COMPLICATIONS: WHAT IS THE STANDARD?
Roger Dmochowski
ENDOUROLOGY SESSION
Moderators: Turhan Caskurlu, Altug Tuncel
TOTAL INTRACORPOREAL ROBOTIC
CYSTECTOMY
Alvin Goh
3:15
3:30
ROBOT-ASSISTED LAPAROSCOPIC SURGERY
IN PEDIATRIC UROLOGY
Chester Koh
MANAGEMENT OF RENAL STONES SMALLER
THAN 2 CM
Berkan Resorlu
3:45
NEW STRATEGIES FOR RECURRENCE
PREVENTION OF URINARY STONE DISEASE
Brian Matlaga
4:00
NEUROUROLOGY SESSION
4:15
DIFFICULT URETHRAL RECONSTRUCTION IN
WOMEN (STRICTURE, MESH, DIVERTICULUM)
Panelists: Alexander Gomelsky, Eric Rovner, Burhan
Coskun
4:40
BREAK
4:50
URO-ONCOLOGY SESSION
Moderators: Benjamin Lee, M. Derya Balbay
CHALLENGING CASES FOR RENAL CELL
CARCINOMA: A CASE MANAGEMENT PANEL
DISCUSSION
Moderator: Benjamin Lee
Panelists: Robert Flanigan, Ugur Boylu
132
5:20
BLADDER CANCER / RADICAL CYSTECTOMY
Monish Aron
5:40
MANAGEMENT OF HIGH RISK PROSTATE
CANCER: 2016 UPDATE
Daniel Lin
6:00
UROLIFT, REZUM AND PROTOX: THE NEW
FACE OF MISTS FOR BPH
Kevin McVary
7:00
NOCTURIA, MALE LUTS AND SLEEP
HYGIENE: DIAGNOSTIC DILEMMAS IN BPH
Brian Helfand
LUTS/BPH SESSION
Moderators: Onder Yaman, Bulent Sermerci
POSTER SESSION – POSTER WALKS 3:00 –
7:20 PM
Moderator: Selhattin Cayan
UPDATE ON ALPHA-BLOCKERS, 5-ARIS,
COMBINATION THERAPY AND PROSTATE
CANCER RISK FOR LUTS: WHAT IS ON
HORIZON?
Claus Roehrborn
6:20
6:40
7:20
ADJOURN
CREDITTM
SYMPTOMATIC LUTS, ED, METABOLIC
SYNDROME: WHAT IS THE RELEVANCE?
Steven Kaplan
3:30 pm - 5:30 pm
SURGICAL TECHNOLOGY & SIMULATION: INSTRUMENTATION & TECHNOLOGY III
Moderators: William Roberts, III and Raju Thomas
ABSTRACT
NUMBER TITLE
MP34-01 DEVELOPMENT AND DISSEMINATION OF
A LOW COST THREE-DIMENSIONALLY
PRINTED LAPAROSCOPIC TRAINER
Renai Yoon*, Zhamshid Okhunov, Benjamin
Dolan, Orange, CA, Michael J. Schwartz,
Paras H. Shah, Hannah Bierwiler, Long
Island, NY, Kamaljot Kaler, Ralph Clayman,
ABSTRACT
NUMBER TITLE
MP34-05 THE EFFECT OF VARIABLE PULSE
DURATION ON STONE COMMINUTION,
FIBER TIP DEGRADATION, AND STONE
RETROPULSION IN A “DUSTING” MODEL
Anika Ackerman, New York, NY, Tony Chen,
Brian Young*, Adam Kaplan, Chen Yang,
Richard Shin, William Simmons, Charles
Scales, Glenn Preminger, Michael Lipkin,
Durham, NC
MP34-02 PRINTED THREE-DIMENSIONAL ELASTIC
ORGAN MODEL TO INCREASE ROBOTASSISTED LAPAROSCOPIC PARTIAL
NEPHRECTOMY PERFORMANCE
Atsushi Okada*, Keiichi Tozawa, Daichi
Kobayashi, Kentaro Mizuno, Yukihiro
Umemoto, Noriyasu Kawai, Shoichi Sasaki,
Yutaro Hayashi, Katsushi Kunimoto, Kenjiro
Kohri, Takahiro Yasui, Nagoya, Japan
MP34-06 EVALUATION OF A NOVEL SINGLE USE
FLEXIBLE URETEROSCOPE
Adam Kaplan, Daniela Radvak, Richard Shin,
Anika Ackerman, Tony Chen, Joanne Dale*,
Charles Scales, Michael Ferrandino, Neal
Simmons, Glenn Preminger, Michael Lipkin,
Durham, NC
MP34-07 PRELIMINARY IN VITRO COMPARISON OF
FIXED AND VARIABLE PULSE LASER:
EVIDENCE FOR DECREASED
RETROPULSION AND SHORTENED
FRAGMENTATION TIME
John Roger Bell*, Kristina L Penniston, Sara
L Best, Stephen Y Nakada, Madison, WI
MP34-03 THREE-DIMENSIONAL PRINTING OF
SURGICAL CLIPS: A PILOT STUDY AND
TRIAL OF EFFICACY
Noah Canvasser*, Shuvro De, Aaron Lay,
Dallas, TX, Raul Fernandez, Arlington, TX,
Jeffrey Cadeddu, Dallas, TX
MP34-04 UROLOGISTS’ VIEWS ON LIVE SURGICAL
BROADCASTS AND BETTER THAN LIVE
SURGERY
Yih Chyn Phan*, Redhil, United Kingdom,
Oliver Wiseman, Cambridge, United
Kingdom, Philip James, Redhil, United
Kingdom, Ralph Clayman, Orange, CA,
Arthur Smith, New Hyde Park, NY, Abhay
Rane, Redhil, United Kingdom
*Presenting author
MP34-08 LIMITATION OF NEEDLE DEVIATION
DURING TRIANGULATED
PERCUTANEOUS RENAL ACCESS:
INITIAL EXPERIENCE WITH A NOVEL
SIMPLE DEVICE
Ahmad Tawfik*, Usama El-ashry, Yasser
Farahat, Mohamed Abo El-enen, Tanta,
Egypt
133
MP34-09 MEMOKATH 051 – A SAVE ALTERNATIVE
FOR TREATMENT OF URETERIC
STRICTURES
Simone Bier*, Steffen Rausch, Stefan
Aufderklamm, Tilman Todenhöfer, Bastian
Amend, Eva Neumann, Jens Bedke, Christian
Schwentner, Arnulf Stenzl, Stephan Kruck,
Tuebingen, Germany
MP34-16 EVALUATION OF A LAPAROSCOPIC HIGH
INTENSITY FOCUSED ULTRASOUND
PROBE FOR THE ABLATION OF SMALL
RENAL MASSES
Steven V Kheyfets*, Clint D Bahler, Chandru
P Sundaram, Indianapolis, IN
MP34-17 COMPLICATIONS OF TRANSVAGINAL
NATURAL ORIFICE TRANSLUMINAL
ENDOSCOPIC SURGERY (NOTES) IN
UROLOGY
Zhang Guoxi, Liu Quanliang, Zou Xiaofeng*,
Xue Yijun, Yuan Yuanhu, Xiao Rihai, Liu
Folin, Ganzhou, Jiangxi, China, People’S
Republic Of
MP34-10 DOES 3D TECHNOLOGY AFFECT VISUAL
SYSTEM ?
Andrea Tasca*, Giuseppe Benedetto, Filippo
Nigro, Vicenza, Italy, Luigi Bartolomei, 36100,
Italy, Nadia Minicucci, Padova, Italy, Sabino
Pisani, Milano, Italy
MP34-11 RESECTOSCOPE WORKING ELEMENT
WITH ROTATING HANDLE FOR A MORE
ERGONOMIC SURGERY
Joseph M. Ciccone, Boston, MA, Kyle Blum*,
Newark, NJ, Courtney K. Rowe, Boston, MA,
Daniel J. Gonzalez, Adam Libert, Jiayin Ling,
Man-Chi Liu, Nicholas Sazdanoff, Justus
Herder, Nevan Hanumara, Alexander H.
Slocum, Cambridge, MA, Josh Kaplan,
Michael Kearney, Boston, MA
MP34-18 COMPARISON OF
ONABOTULINUMTOXINA
INTRADETRUSOR INJECTION NEEDLE
PERFORMANCE WITH MODERN FLEXIBLE
CYSTOSCOPES
Robert Williams*, Jesse Dove, Steven Petrou,
David Thiel, Jacksonville, FL
MP34-19 USE OF A MATRIX OF COLLAGEN AND
ELASTIN TO BLADDER AUGMENTATION
IN THE PORCINE MODEL
Carlos Gasanz Serrano*, Carles Xavier
Raventos Busquets, Jordi Temprana
Salvador, Lucas Regis Placido, Pol Servian
Vives, Ricardo Lopez del Campo, Ignacio
Arroyo Soto, Enric Miret Alomar, Merce
Cuadras Soler, Luis Castro Sader, Cristian
Konstantinidis Garay, Marielle Esteves
Coelho, Carla Fonseca, Ines de Torres, Juan
Morote Robles, Barcelona, Spain
MP34-12 THREE-DIMENSIONAL IMAGING AND
ROBOTIC SURGERY IN A
COMPREHENSIVE DEPARTMENT WITHIN
AN ACADEMIC INSTITUTIONAL
FRAMEWORK
Toshihiko Masago*, Tetsuya Yumioka, Noriya
Yamaguchi, Hideto Iwamoto, Shuichi
Morizane, Masashi Honda, Takehiro Sejima,
Atsushi Takenaka, Yonago, Japan
MP34-13 BEYOND THE LEARNING CURVE:
ROBOTIC PARTIAL NEPHRECTOMY
OUTCOMES CONTINUE TO IMPROVE
WITH SURGEON EXPERIENCE
David J. Paulucci, New York, NY, Louis S.
Krane, Ashok K. Hemal, Winston-Salem, NC,
Ketan K. Badani*, New York, NY
MP34-20 OPEN VS. MINIMALLY INVASIVE
SURGICAL APPROACHES: ASSOCIATED
POST-OPERATIVE COMPLICATIONS OF
PEDIATRIC UROLOGIC SURGERY IN THE
UNITED STATES
Rohit Tejwani*, Brian Young, Hsin-Hsiao
Wang, Steven Wolf, John Wiener, Jonathan
Routh, Durham, NC
MP34-14 INVESTIGATING THE FEASIBILITY OF
OPTICAL COHERENCE TOMOGRAPHY TO
IDENTIFY PROSTATE CANCER – AN EXVIVO STUDY
Amit Patel*, London, United Kingdom,
Christoph Otte, Alexander Schlaefer,
Hamburg, Germany, Dror Nir, Cambridge,
United Kingdom, Sebastian Otte, Hamburg,
Germany, Thane Ngo, Tim Loke, Mathias
Winkler, London, United Kingdom
MP34-15
CREDITTM
ZERO ISCHEMIA PERI-TUMORAL
RADIOFREQUENCY ABLATION-ASSISTED
ROBOTIC LAPAROSCOPIC PARTIAL
NEPHRECTOMY – AN UPDATE ON
INTERMEDIATE OUTCOMES IN 49
PATIENTS
Kalen Rimar*, Robert Nadler, Chicago, IL
134
3:30 pm - 5:30 pm
BENIGN PROSTATIC HYPERPLASIA: EPIDEMIOLOGY & EVALUATION
Moderators: Franklin Lowe and Lori Lerner
ABSTRACT
NUMBER TITLE
MP35-01 IMPACT OF PROSTATE INFLAMMATION
ON 4 YEAR INCIDENCE, SEVERITY, AUR
AND SYMPTOM PROGRESSION OF
J. Curtis Nickel*, Kingston, Canada, Stephen
Freedland, Durham, NC, Claus Roehrborn,
Dallas, TX, Ramiro Castro-Santamaria, King of
Prussia, PA, Daniel Morreira, Rochester, MN
MP35-02
MP35-03
BENIGN PROSTATIC HYPERPLASIA AND
AUTOIMMUNE INFLAMMATORY
DISEASES COINCIDENCE AND
CONSEQUENCES
Jaclyn Pruitt, Jacqueline Petkewicz, Brittany
Lapin, Omar E Franco, Brian T. Helfand,
Charles B. Brendler, Chi-Hsiung Wang,
Simon W Hayward*, Evanston, IL
LOWER URINARY TRACT SYMPTOMS AS
RISK FACTOR FOR CARDIOVASCULAR
EVENTS IN MEN: A SYSTEMATIC REVIEW
AND META-ANALYSIS OF FIVE
LONGITUDINAL TRIALS
M. Gacci*, A. Sebastianelli, Florence, Italy, C.
De Nunzio, Rome, Italy, S. Serni, M. Maggi,
L. Vignozzi, Florence, Italy, G. Corona,
Bologna, Italy, G. Novara, Padua, Italy, K.T.
McVary, Springfield, IL, S.A. Kaplan, New
York, NY, S. Gravas, Larissa, Greece, C.
Chapple, Sheffield, United Kingdom
MP35-04
THE FLOW QUESTIONNAIRE:
DEVELOPING A NOVEL INSTRUMENT TO
EVALUATE LOWER URINARY TRACT
SYMPTOMS IN MEN
Daniel Heslop*, Lisa Sherden, Consuelo
Wilkins, Ken Wallston, Kelvin Moses,
Nashville, TN
MP35-05
DIGITAL RECTAL EXAM AND PROSTATE
SIZE FOR THE EVALUATION OF BENIGN
PROSTATE PATHOLOGY: AN ANALYSIS
OF 30,500 MEN PRESENTING FOR
SCREENING EXAMS IN THE PLCO
CANCER SCREENING TRIAL
Benjamin Stone*, Jonathan Shoag, Dina
Bedretdinova, Sameer Mittal, Joshua
Halpern, Patrick Lewicki, James Forde,
Christopher Barbieri, Bilal Chughtai, Philip Li,
Richard Lee, New York, NY
*Presenting author
ABSTRACT
NUMBER TITLE
MP35-06 THE PREVALENCE OF URGENCY IN
PATIENTS WITH LOWER URINARY TRACT
SYMPTOMS DUE TO BENIGN PROSTATIC
ENLARGEMENT. ANALYSIS OF THE
EVOLUTION REGISTRY
Andrea Tubaro*, Rome, Italy, Richard
Berges, Cologne, Germany, Christien Caris,
Arnhem, Netherlands, Alexandre De la Taille,
Paris, France, Francesco Esperto, Rome,
Italy, Louis Martinez-Pineiro, Madrid, Spain,
Mark Speakman, Taunton, United Kingdom,
Wim Witjes, Arnhem, Netherlands
135
MP35-07
FACTORS THAT INFLUENCE ON LOWER
URINARY TRACT SYMPTOM (LUTS)
RELATED QUALITY OF LIFE (QOL)
Hwancheol Son*, Woo Suk Choi, Ja Hyeon
Ku, Jae-Seung Paick, Sung Hyun Paick,
Hyeong Gon Kim, Seoul, Korea, Republic of
MP35-08
RELATIONSHIP BETWEEN SERUM
TESTOSTERONE AND NOCTURIA IN MEN
WITHOUT BENIGN PROSTATE
ENLARGEMENT
Seong Uk Jeh*, Sol Yoon, Deok Ha Seo, See
Min Choi, Sung Chul Kam, Jeong Seok Hwa,
Ky Hyun Chung, Jae Seog Hyun, Jinju,
Korea, Republic of
MP35-09
PHYSICAL ACTIVITY AS A RISK FACTOR
FOR LOWER URINARY TRACT
SYMPTOMS DIAGNOSIS IN PATIENTS
WITH BENIGN PROSTATIC
ENLARGEMENT: A PROSPECTIVE
MULTICENTER COHORT ANALYSIS
Cosimo De Nunzio*, Rome, Italy, L. Cindolo,
Vasto, Italy, F. Cancrini, Rome, Italy, M.
Gacci, Florence, Italy, F. Pellegrini, P.
Castellan, Vasto, Italy, R. Lombardo, F.
Presicce, A. Brassetti, M. Bellangino, G.
Tema, Rome, Italy, L. Schips, Vasto, Italy, A.
Sica, A. Tubaro, Rome, Italy
MP35-10
IS THERE ROOM FOR BEHAVIORAL AND
MODIFIABLE HEALTH-RELATED
TARGETS IN THE LOWER URINARY
TRACT SYMPTOMS SCENARIO
Osamu Ikari, Walker Laranja, João Alonso,
Fabiano Simões, Ronald Rejowski, Brunno
Sanches, Leonardo Reis*, Campinas, Brazil
MP35-11
METABOLIC ABNORMALITIES LINKED TO
AN INCREASED CARDIOVASCULAR RISK
ARE ASSOCIATED WITH HIGHER
STORAGE LOWER URINARY TRACT
SYMPTOMS
Cosimo De Nunzio*, G. Truscelli, R.
Lombardo, Rome, Italy, M. Gacci, Florence,
Italy, F. Presicce, C. Leonardo, C. Gaudio,
A.L. Lopes Mendes, A. Tubaro, Rome, Italy
MP35-12
MP35-13
MP35-14
MP35-15
MP35-16
PSA PREDICTS DEVELOPMENT OF
INCIDENT LOWER URINARY TRACT
SYMPTOMS: RESULTS FROM THE
REDUCE STUDY
Tom Feng*, Los Angeles, CA, Ross Simon,
Tampa, FL, Lauren Howard, Durham, NC,
Adriana Vidal, Los Angeles, CA, Daniel
Moreira, Rochester, MN, Ramiro CastroSantamaria, King of Prussia, PA, Gerald
Andriole, St. Louis, MO, Claus Roehrborn,
Dallas, TX, Stephen Freedland, Los Angeles,
CA
SERUM CHOLESTEROL AND RISK OF
PROGRESSION: RESULTS FROM THE
REDUCE STUDY
Tom Feng*, Los Angeles, CA, Lauren
Howard, Durham, NC, Adriana Vidal, Los
Angeles, CA, Daniel Moreira, Rochester, MN,
Ramiro Castro-Santamaria, King of Prussia,
PA, Gerald Andriole, St. Louis, MO, Stephen
PREDICTIVE FACTORS FOR A FAILURE
SURGICAL TREATMENT WITH
TRANSURETHRAL INCISION OF
PROSTATE IN MEN WITH SMALL BPH
AND BLADDER NECK DYSFUNCTION
Yuan-Hong Jiang*, Jia-Fong Jhang, Yu-Khun
Lee, Hann-Chorng Kuo, Hualien, Taiwan
MP35-17
UNDERACTIVE BLADDER (UAB)
SYMPTOMS AND VOIDING PARAMETERS
IN ELDERLY COMMUNITY-DWELLING
MALES WITH 5 YEAR FOLLOWUP
Lewis Chan*, Vincent Tse, Amanda Chung,
Vasi Naganathan, Robert Cumming, Sydney,
Australia
MP35-18
NOT A VOLUME BUT A STRUCTURAL
VARIATION OF THE PROSTATIC
URETHRA WITHIN THE PROSTATE
PREDICT THE DEGREE OF OBSTRUCTIVE
SYMPTOM: A PROSPECTIVE
MULTICENTER OBSERVATIONAL STUDY
Young-Hwii Ko*, Phil Hyun Song, Tae-Hwan
Kim, Byung Hoon Kim, Bum Soo Kim, Daegu,
Korea, Republic of, Ki Ho Kim, Gyeongju,
Korea, Republic of
MP35-19
BASELINE FUNCTIONAL STATUS
PREDICTS POSTOPERATIVE TREATMENT
FAILURE IN NURSING HOME RESIDENTS
UNDERGOING TRANSURETHRAL
RESECTION OF THE PROSTATE (TURP)
Anne M Suskind*, Louise C Walter, Shoujun
Zhao, Emily Finlayson, San Francisco, CA
MP35-20
PREVALENCE OF INCIDENTAL PROSTATE
CANCER IN HISTOLOGICAL SPECIMEN
AFTER HOLMIUM LASER ENUCLEATION
VERSUS TRANSURETHRAL RESECTION
OF THE PROSTATE
Annika Herlemann*, Kerstin Wegner, Munich,
Germany, Alexander Roosen, Bochum,
Germany, Christian G. Stief, Christian
Gratzke, Giuseppe Magistro, Alexander
Buchner, Munich, Germany
CLINICAL FEATURES OF
HYDRONEPHROSIS IN PATIENTS WITH
BENIGN PROSTATE HYPERPLASIA AND
ACUTE URINARY RETENTION
Chin-Heng Lu*, Howard Hong-Hao Wu, YuHua Fan, Chih-Chieh Lin, Yi-Hsiu Huang,
Tzu-Ping Lin, Hsiao-Jen Chung, Junne-Yih
Kuo, William Jhih-Sian Huang, Yen-Hua
Chang, Alex Tong-Long Lin, Kuang-Kuo
Chen, Taipei City, Taiwan
CREDITTM
THE IMPACT OF AGE ON OUTCOMES
AFTER BLADDER OUTLET PROCEDURES
Marc Colaco*, Winston-Salem, NC, Marcus
Fluck, John Danella, Danville, PA, Daniel
Rukstalis, Winston-Salem, NC
3:30 pm - 5:30 pm
INFECTIONS/INFLAMMATION/CYSTIC DISEASE OF THE GENITOURINARY TRACT: PROSTATE & GENITALIA II
Moderators: J. Curtis Nickel and Michel Pontari
ABSTRACT
NUMBER TITLE
MP36-01 THE URINARY MICROBIOME DIFFERS
SIGNIFICANTLY BETWEEN PATIENTS
WITH CHRONIC PROSTATITIS/CHRONIC
PELVIC PAIN SYNDROME AND
CONTROLS AS WELL AS BETWEEN
PATIENTS WITH DIFFERENT CLINICAL
PHENOTYPES
Daniel Shoskes*, Jessica Altemus, Alan
Polackwich, Barbara Tucky, Hannah Wang,
Charis Eng, Cleveland, OH
ABSTRACT
NUMBER TITLE
MP36-02 MICROBIOLOGICAL PROFILE AND DRUG
SUSCEPTIBILITY PATTERNS OF PUBIC
SYMPHYSIS OSTEOMYELITIS IN THE
PROSTATE CANCER SURVIVOR
Garjae Lavien*, Uwais Zaid, Andrew
Peterson, Durham, NC
136
MP36-03 PRESENCE OF URINARY UREAPLASMA
UREALYTICUM OR UREAPLASMA
PARVUM IS NOT ASSOCIATED WITH THE
OCCURRENCE OF CHRONIC
SYNDROME
Yu Seo, Gil Lee*, Cheonan, Korea, Republic
of
MP36-11 MICROBIOLOGICAL EVALUATION OF
INFECTED PELVIC LYMPHOCELE AFTER
ROBOTIC PROSTATECTOMY; POTENTIAL
PREDICTORS FOR CULTURE POSITIVITY
AND SELECTION OF THE BEST
EMPIRICAL ANTIMICROBIAL THERAPY
Alaa Hamada*, Nanaan Thirumavalavan,
Jorge Fleisher, Ingolf Tuerk, Boston, Ma
MP36-04 DUTASTERIDE IS ASSOCIATED WITH
REDUCED RISK OF TRANSRECTAL
PROSTATE BIOPSY-ASSOCIATED
URINARY TRACT INFECTION AND
RELATED HOSPITALIZATIONS: RESULTS
FROM THE REDUCE STUDY
Daniel Moreira*, Rochester, MN, Gerald
Andriole, St. Louis, MO, Ramiro CastroSantamaria, King of Prussia, PA, Stephen
MP36-12 PREOPERATIVE PREDICTORS OF
PATIENTS WHO FAIL MICROSURGICAL
DENERVATION OF THE SPERMATIC
CORD FOR CHRONIC SCROTAL CONTENT
PAIN
John Richgels, Melissa Farmer, Laurence
Levine*, Chicago, IL
MP36-05
MP36-13 ASSOCIATION BETWEEN URINE LEVELS
OF PDGF-BB AND PROSTATE VOLUME OF
BPH/LUTS PATIENTS
Pradeep Tyagi*, Mahendra Kashyap, Naoki
Yoshimura, Jeffrey Gingrich, Pittsburgh, PA,
Saundra Motley, Jay Fowke, Nashville, TN
IS PRE-OPERATIVE URINE CULTURE
NECESSARY IN ASYMPTOMATIC MEN
PRIOR TO TRANSRECTAL PROSTATE
NEEDLE BIOPSY?
David Qi*, Kathleen Lehman, Hershey, PA,
Kalyan Dewan, Girish Kirimanjeswara, State
College, PA, Jay Raman, Hershey, PA
MP36-14 UPREGULATION OF PROSTATIC
CANNABINOID RECEPTOR TYPE 2
FOLLOWING CASTRATION AND
CAPSAICIN-INDUCED PROSTATITIS IN
THE RATS
Teng-Lung Lin*, Taipei, Taiwan
MP36-06 VALIDATION OF AUA BEST PRACTICE
GUIDELINES FOR PROSTATE BIOPSY
INFECTIOUS COMPLICATIONS AND
REDUCING VARIABILITY AND DURATION
OF ANTIMICROBIAL UTILIZATION:
QUALITY IMPROVEMENT INITIATIVE
Behfar Ehdaie*, Emily Vertosick, Pedro
Recabal, Michael Manasia, Mary Schoen,
James Eastham, Karim Touijer, Massimiliano
Spaliviero, New York, NY
MP36-15
MP36-07 TRANSRECTAL ULTRASOUND GUIDED
ASPIRATION VERSUS TRANSURETHRAL
DEROOFING OF PROSTATIC ABSCESS: A
PROSPECTIVE RANDOMIZED STUDY
Mohammed Seleem, Esam Desoky, Ahmed
Eliwa, Mostafa Youssef, Mohamed Omran,
Ehab Elkady, Ahmed Sakr, Amr Fawzi*,
Zagazig, Egypt
MP36-16 THE EXPRESSION OF BETA-DEFENSIN
131 PROMOTES INNATE IMMUNITY IN
HUMAN PROSTATE EPITHELIAL CELLS
Jung Hoon Kim*, Kyeoung-Hwa Kim, Hae
Jong Kim, Jaekhyouk Lee, Soon Chul Myung,
Jae Duck Choi, Seung Hyun Ahn, Seoul,
Korea, Republic of
MP36-17 URINARY POLYCYCLIC AROMATIC
HYDROCARBONS: EXPOSING A NOVEL
CULPRIT IN PROSTATITIS
Golnaz Naderkhani*, Norman Smith, Dariush
Mirsattari, London, Canada
MP36-08 HIGH INCIDENCE OF OCCULT POSITIVE
URINE CULTURES AT TIME OF TURP:
OUR EXPERIENCE IN 100 CONSECUTIVE
PATIENTS
Nitin Sharma*, Yaniv Larish, Leon Telis,
David Samadi, New York, NY
MP36-18 HIGH-RISK HPV SUBTYPES IN
SQUAMOUS CELL CARCINOMA OF THE
SCROTUM
Joseph Brito*, Katherine Rotker, Marcos
Lepe, M Rahul Quddus, Providence, RI,
Pradip Manna, Overland Park, KS, Jonathan
Epstein, Baltimore, MD, Andres Matoso,
Joseph Renzulli, Providence, RI
MP36-09 PREDICTING BACTERIURIA PRIOR TO
GREENLIGHT LASERVAPORISATION OF
THE PROSTATE - ACCURACY OF
DIPSTICK URINE ANALYSIS AND URINE
FLOW CYTOMETRY
Gernot Bonkat*, Helge Seifert, Armin Halla,
Georg Müller, Adrian Egli, Axel Regineter,
Thomas Gasser, Alexander Bachmann, Malte
Rieken, Basel, Switzerland
MP36-19 MALIGNANCY IN BIOPSY PROVEN
PENILE LICHEN SCLEROSUS
Uwais Zaid*, Garjae Lavien, Bradley Potts,
Andrew Peterson, Durham, NC
MP36-10 ARTIFICIAL URINARY SPHINCTER
REINTERVENTION: OUTCOMES FROM A
NATIONAL PROSPECTIVE DATABASE
Valary Raup*, Pamela Lu, Christian Meyer,
Bjoern Loeppenberg, Malte Vetterlein, QuocDien Trinh, Jairam Eswara, Boston, MA
*Presenting author
EFFECTS OF DUTASTERIDE ON
PROSTATIC INFLAMMATION MEDIATED
BY ESTROGEN RECEPTOR ␤ IN A RAT
MODEL OF NONBACTERIAL PROSTATITIS
Shinsuke Mizoguchi*, Kenichi Mori, Fuminori
Sato, yufu, Japan, Naoki yoshimura,
Pittsburgh, PA, Hiromitsu Mimata, Yufu,
Japan
137
MP36-20 ABSOLUTE NEUTROPHIL COUNT
KINETICS IN RESPONSE TO SURGERY
SEGREGATES BY GLEASON SUM
Yaniv Larish*, Maria Katsigeorgis, Guillaume
Stoffels, David Samadi, New York, NY
CREDITTM
3:30 pm - 5:30 pm
DECISION MAKING IV
Moderators: James Dupree, IV and John Hollingsworth
ABSTRACT
NUMBER TITLE
MP37-01 EXPANDED PROSTATE CANCER INDEX
COMPOSITE-26 (EPIC-26) ONLINE:
VALIDATION OF AN INTERNET-BASED
INSTRUMENT FOR ASSESSMENT OF
HEALTH-RELATED QUALITY OF LIFE
AFTER TREATMENT FOR LOCALIZED
PROSTATE CANCER
David Einstein*, Boston, MA, Kyle Davis,
Lansing, MI, Catrina Crociani, Boston, MA,
Dattatraya Patil, Atlanta, GA, Andrew
Wagner, Boston, MA, Martin Sanda, Atlanta,
GA, Peter Chang, Boston, MA, PROST-QA
Consortium, Atlanta, GA
ABSTRACT
NUMBER TITLE
MP37-06 DELAYED TREATMENT OF HIGH-RISK
PROSTATE CANCER PATIENTS: IMPACT
OF SOCIOECONOMIC BARRIERS AND
USE OF ADVANCED TECHNOLOGIES
R. Steven Gerhard*, Datta Patil, Yuan Liu,
Kenneth Ogan, Mehrdad Alemozaffar,
Ashesh Jani, Omer Kucuk, Viraj Master,
Theresa Gillespie, Christopher Filson, Atlanta,
GA
MP37-07 INDIVIDUAL PATIENT DATA ANALYSIS IN
RANDOMIZED CLINICAL TRIALS: IMPACT
OF RACE ON PROSTATE CANCER
OUTCOMES
Daniel Spratt*, Ann Arbor, MI, Yu-Wei Chen,
Brandon Mahal, Boston, MA, Joseph
Osborne, NYC, NY, Shuang Zhao, Todd
Morgan, Ganesh Palapattu, Felix Feng, Ann
Arbor, MI, Paul Nguyen, Boston, MA
MP37-02 INFORMED DECISION-MAKING FOR
PROSTATE-SPECIFIC ANTIGEN
SCREENING
Nawar Hanna*, Michael Zavaski, Francisco
Gelpi-Hammerschmidt, Christian Meyer,
Malte Vetterlein, Boston, MA, Jesse
Sammon, Detroit, MI, Adam Kibel, Boston,
MA, Mani Menon, Detroit, MI, Jeffrey Leow,
Maxine Sun, Boston, MA, Firas Abdollah,
Detroit, MI, Quoc-Dien Trinh, Boston, MA
MP37-08 MISATTRIBUTION ERRORS IN UROLOGIC
PROCEDURES FROM THE PROPUBLICA
SURGEON SCORECARD
Young Suk Kwon*, Seonghyun Kang, Wei
Wang, Nicholas Farber, Kushan Radadia,
Paul Lee, Jongmyung Kim, Jeong Hee Hong,
Isaac Kim, New Brunswick, NJ
MP37-03 QUALITY, CONTENT, AND VALIDITY OF
INFORMATION PRESENTED ONLINE
RELATED TO ROBOTIC PROSTATECTOMY
Kevin Wong, David Wang*, Boston, Ma
MP37-09 ABILITY OF THE GENERAL PUBLIC TO
ACCURATELY ESTIMATE SURVIVAL
RATES FOR GENITOURINARY CANCER
USING UNRESTRICTED INTERNET
SEARCHES AND ONLINE NOMOGRAMS.
Lee Baumgarten*, Philadelphia, PA, Lucas
Labine, Colby Dixon, Isaac Palma,
Christopher Weight, Minneapolis, MN
MP37-04 PILOT EVALUATION OF A PATIENTCENTERED PROSTATE BIOPSY
PATHOLOGY REPORT
Jasmir Nayak*, Geolani Dy, Liam Macleod,
Alice Chu, William Ellis, Daniel Lin, Lawrence
True, Funda Vakar-Lopez, John Gore,
Seattle, WA
MP37-05
MP37-10 ADHESIVE BOWEL OBSTRUCTION
FOLLOWING UROLOGIC SURGERY:
IMPROVED OUTCOMES WITH EARLY
INTERVENTION
Arpeet Shah*, Robert Blackwell, Anai Kothari,
Marcus Quek, Fred Luchette, Robert
Flanigan, Paul Kuo, Gopa Gupta, Maywood,
IL
UNITED STATES PREVENTIVE SERVICES
TASK FORCE PROSTATE CANCER
SCREENING GUIDELINES WERE
ASSOCIATED WITH AGE AND RACE
DEPENDENT CHANGES IN PRIMARY
CARE PROSTATE SPECIFIC ANTIGEN
BASED SCREENING AT A TERTIARY
CARE CENTER
Christopher Miller*, Abdo Kabarriti, Jose
Pulido, Philadelphia, PA, Justin Ziemba,
Baltimore, MD, Thomas Guzzo, Alan Wein, S.
Bruce Malkowicz, Philadelphia, PA
138
MP37-11 THE NEAR FUTURE IMPACT OF
RETIREMENT ON THE UROLOGIC
WORKFORCE: RESULTS FROM AUA
CENSUS DATA
Thomas Gaither*, Mohannad Awad, San
Francisco, CA, Ramond Fang, Patricia
Rehring, William Meeks, Washington, DC, J.
Quentin Clemens, Ann Arbor, MI, Scott Gulig,
Washington, DC, Bradley Erickson, Iowa City,
IA, E. Charles Osterberg, Benjamin Breyer,
San Francisco, CA
MP37-16 UROLOGIST USE OF CYSTOSCOPY FOR
PATIENTS PRESENTING WITH
HEMATURIA
Samuel David*, Datta Patil, Mehrdad
Alemozaffar, Muta Issa, Viraj Master,
Christopher Filson, Atlanta, GA
MP37-17 CLINICAL USE OF PATIENT DECISIONMAKING AIDS FOR MANAGEMENT
DECISIONS IN STONE PATIENTS: A
SHARED DECISION MAKING APPROACH
Amy H. Lim*, Necole M. Streeper, Sara L.
Best, Kristina L. Penniston, Stephen Y.
Nakada, Madison, WI
MP37-12 UROLOGY APPLICANTSⴕ CRITERIA FOR
EVALUATING AND MATCHING INTO
RESIDENCY
Amir H Lebastchi*, Ian D McLaren, Gary J
Faerber, Kate H Kraft, Khaled S Hafez,
Casey A Dauw, Ann Arbor, MI, Vincent G
Bird, Thomas F Stringer, Gainesville, FL, Ajay
Singla, Toledo, OH, Mathew D Sorensen,
Hunter Wessells, Seattle, WA, Sapan N
Ambani, Ann Arbor, MI
MP37-18 EVALUATING PATTERNS OF
TESTOSTERONE PRESCRIPTION AMONG
40,878 USERS IN BRITISH COLUMBIA
BETWEEN 1997-2013
Jennifer Locke*, Ryan Flannigan, Hao Luo,
Mahyar Etminan, Ted Hoyda, S. Larry
Goldenberg, Vancouver, Canada
MP37-19 DOES SEX MATTER? A MATCHED PAIRS
ANALYSIS OF NEUROMODULATION
OUTCOMES IN WOMEN AND MEN
Priyanka Gupta*, Natalie Gaines, Jason
Gilleran, Kim A. Killinger, Jamie Bartley,
Cheryl Wolfert, Judith A. Boura, Kenneth M.
Peters, Royal Oak, MI
MP37-13 UROLOGY IS A SENSITIVE AREA:
ASSESSING PATIENT PREFERENCES FOR
MALE OR FEMALE UROLOGISTS
Zita Ficko*, Zhongze Li, Elias Hyams,
Lebanon, NH
MP37-14 NOW TRENDING: TWITTER USE IN THE
UROLOGY COMMUNITY AT THE
AMERICAN UROLOGICAL ASSOCIATION
ANNUAL SCIENTIFIC MEETING
Siobhan Hartigan*, Robert Caleb Kovell,
Philadelphia, PA
MP37-15
MP37-20 POST VASECTOMY SEMEN ANALYSIS:
DOES PATIENT CONVENIENCE IMPROVE
COMPLIANCE?
Eugene Kramolowsky*, Joseph Ellen, Brigette
Booth, Blake Moore, Nada Wood, Richmond,
VA
SAFETY AND EFFICACY OF
LAPAROSCOPIC AND ROBOT-ASSISTED
RENAL SURGERY IN THE EXTREMELY
OBESE (BMI > 40 KG/M2) AND BEYOND
(BMI > 50 KG/M2)
Ganesh Sivarajan*, Amul Bhalodi, Michael
Degen, Ravi Munver, Hackensack, NJ
CREDITTM
3:30 pm - 5:30 pm
Podium Session 23
STONE DISEASE: SURGICAL THERAPY IV
Moderators: R. John Honey, Vincent Bird and Eduardo Mazzucchi
TIME
3:30
3:40
ABSTRACT
NUMBER TITLE
PD23-01 THE EFFECT OF CONTINUED ASPIRIN
THERAPY IN PATIENTS UNDERGOING
PCNL
Brandon Otto*, Forat Lutfi, Russell Terry,
Mohit Gupta, VincentG Bird, Gainesville, FL
PD23-02
*Presenting author
ABSTRACT
TIME NUMBER TITLE
3:50 PD23-03 A PROSPECTIVE AND RANDOMIZED
COMPARISON OF FLUOROSCOPIC,
SONOGRAPHIC OR COMBINED
APPROACH FOR RENAL ACCESS IN
MINIMALLY INVASIVE PERCUTANEOUS
NEPHROLITHOTOMY
Guohua Zeng*, Wei Zhu, Jian Yuan, Yongda
Liu, Guanzhao Liu, Wenzhong Chen, Wenqi
Wu, Wen Zhong, Guangzhou, China,
People’s Republic of, Jean J.M.C.H. dela
Rosette, Amsterdam, Netherlands
IS IT SAFE TO CONTINUE ANTI-PLATELET
AND ANTI-COAGULATION THERAPY IN
PATIENTS UNDERGOING
(PCNL)? A NESTED CASE CONTROL
STUDY
Annah Vollstedt*, Lebanon, NH, Natalia
Hernandez Bustos, Brian Eisner, Cambridge,
MA, Lawrence Dagrosa, Vernon Pais,
Lebanon, NH
139
4:00
PD23-04
EFFICACY OF REAL-TIME VIRTUAL
SONOGRAPHY-GUIDED RENAL ACCESS
FOR ENDOSCOPIC COMBINED
INTRARENAL SURGERY
Shuzo Hamamoto*, Rei Unno, Kazumi
Taguchi, Ryosuke Ando, Atsushi Okada,
Keiichi Tozawa, Kenjiro Kohri, Takahiro
Yasui, Nagoya, Japan
4:10
PD23-05
RADIOLOGIC RELATION OF THE COLON
TO THE TRAJECTORY OF
ACCESS IN PRONE VERSUS FLANK FREE
MODIFIED SUPINE POSITION : A
PROSPECTIVE STUDY OF INTRA AND
INTER-INDIVIDUAL INFLUENCING
FACTORS
Esam Desoky, Ahmed Eliwa, Aref Maarouf*,
Ashraf Shahin, Ahmed Sakr, Khalid
Abdelwahab, Hossam Abdelrahman, Fatma
Zaiton, Zagazig, Egypt
4:20
4:30
PD23-06
PD23-07
OUTCOME OF MINI-PCNL VERSUS
EXTRACORPOREAL SHOCK WAVE
LITHOTRIPSY IN TREATMENT OF SINGLE
LOWER CALYCEAL STONE 10-20MM WITH
FAVORABLE LOWER CALYCEAL
ANATOMY: A PROSPECTIVE
RANDOMIZED STUDY
Mohamed Naguib*, Ahmed Eliwa, Mohamed
Seleem, Khalid Abdulwahab, Ehab Elsayed,
Mahmoud Abdulmaksood, Mohammed
Mostafa, Lotfy Bendary, Ahmed Al Ayman,
Hussain Kamel, Zagazig, Egypt
4:40
PD23-08
URETERAL ACCESS SHEATHS AND
URETERAL WALL INJURY: A
RANDOMIZED DOUBLE-BLIND CLINICAL
TRIAL
Christopher J. Loftus*, Vishnuvardhan
Ganesan, Cleveland, OH, Olivier Traxer,
Paris, France, Jesse Schold, Mark Noble, Sri
Sivalingam, Nicolas Muruve, Manoj Monga,
Cleveland, OH
4:50
PD23-09
IS PROLONGED USE OF URETERAL
ACCESS SHEATH SAFE?
Husain Alenezi*, Christopher J Howlett,
Alexander O El-Warrak, Daniel OlveraPosada, Marie Dion, Hassan Razvi, John D
Denstedt, London, Canada
5:00
PD23-10
URETEROSCOPE REPROCESSING: A
TIME-IN-MOTION STUDY OF A LENGTHY
JOURNEY
Sasha Druskin*, Justin Ziemba, Siyuan Cao,
Jane Wang, Brian Matlaga, Baltimore, MD
5:10
PD23-11
STONE DUSTING: OUTCOMES OF
URETEROSCOPIC LITHOTRIPSY USING A
MULTI-CAVITY HIGH-POWER HOLMIUM
LASER
James Tracey*, Galina Gagin, Duncan
Morhardt, John Hollingsworth, Khurshid
Ghani, Ann Arbor, MI
5:20
PD23-12
THE STENT IS NOT WORSE THAN THE
STONE: OBJECTIVE PAIRED ANALYSIS
USING PROMIS® PAIN ASSESSMENT
Andrew Portis*, Suzanne Neises, St Paul,
MN
PROSPECTIVE, RANDOMIZED
CONTROLLED TRIAL COMPARING THREE
DIFFERENT MODALITIES OF
LITHOTRITES FOR INTRACORPOREAL
LITHOTRIPSY IN PCNL
Nadya York*, Michael S Borofsky, Casey A
Dauw, James E Lingeman, Indianapolis, IN
APPROVED FOR AMA PRA CATEGORY
1 CREDITTM
3:30 pm - 5:30 pm
Podium Session 24
BENIGN PROSTATIC HYPERPLASIA: SURGICAL THERAPY & NEW TECHNOLOGY II
Moderators: Ricardo Gonzalez, Peter Gilling and John Wei
TIME
3:30
3:40
ABSTRACT
NUMBER TITLE
PD24-01 HOLMIUM LASER ENUCLEATION OF THE
PROSTATE VERSUS OPEN
PROSTATECTOMY: A PROSPECTIVE
COST ANALYSIS
Jose Ramon Perez-Carral*, Carmen Pozo,
Silvia Del Riego, Carlos Capitán, Ignacio
Sola, Carlos Llorente, Madrid, Spain
PD24-02
ABSTRACT
TIME NUMBER TITLE
3:50 PD24-03 A PROSPECTIVE, RANDOMISED TRIAL
COMPARING HOLMIUM LASER
(HOLEP) TO STANDARD
PROSTATE FOR SYMPTOMATIC BENIGN
PROSTATIC HYPERPLASIA: TWO-YEAR
FOLLOW-UP RESULTS
Yuan Yuanhu, Zou Xiaofeng*, Xiao Rihai,
Zhang Guoxi, Liu Folin, Liao Yunfeng,
Ganzhou, Jiangxi, China, People’S Republic
Of
A COST ANALYSIS OF 180W
THE PROSTATE (PVP) VS
PROSTATE (TURP)
Ankur Shah*, Charles Welliver, Laura ChangKit, Albany, NY
140
4:00
4:10
4:20
4:30
PD24-04
PD24-05
PD24-06
PD24-07
THULIUM LASER ENUCLEATION
(THULEP) VERSUS TRANSURETHRAL
RESECTION OF THE PROSTATE IN
SALINE (TURIS): A RANDOMIZED
PROSPECTIVE TRIAL TO COMPARE
INTRA AND EARLY POSTOPERATIVE
OUTCOMES
Giorgio Bozzini*, Castellanza VA, Italy, Marco
Provenzano, Rozzano, Italy, Mauro Seveso,
Oliviero de Francesco, Castellanza VA, Italy,
NicoloMaria Buffi, Giorgio Guazzoni,
Rozzano, Italy, Alberto Madressi, Gianluigi
Taverna, Castellanza VA, Italy
HOLMIUM LASER (HOLEP) VERSUS
BIPOLAR ENUCLAETION (TUEB) OF THE
PROSTATE. AN OBJECTIVE EVALUATION
THROUGH A PROSPECTIVE RANDOMIZE
STUDY (PRT)
Ahmed Shoma, Mohammed Nageib*, Adel
Nabeeh, Mansoura, Egypt
THE PROSTATE BY 180-W GREENLIGHT
LASER VERSUS BIPOLAR
PROSTATE: A SUBSET ANALYSIS OF THE
GOLIATH TRIAL
James Andrew Thomas*, Bridgend, United
Kingdom, Paul Zantek, Minneapolis, MN,
Alexander Bachmann, Basel, Switzerland,
Neil Barber, Cambereley, United Kingdom,
Gordon Muir, London, United Kingdom, Joan
Benejam, Manacor, Spain, Jens-Uwe
Stolzenberg, Leipzig, Germany, Franck
Bruyere, Tours, France, Wolfgang Loidl, Linz,
Austria, Andrew Thorpe, Newcastle, United
Kingdom, Ronald Morton, Minneapolis, MN
COMPARISON OF LAPAROSCOPIC EXTRA
PERITONEAL TRANSVESICAL
PROSTATECTOMY AND OPEN
PROSTATECTOMY
Kadir Omur Gunseren, Burhan Coskun, Onur
Kaygýsýz, Berna Vuruþkan, Yakup Kordan*,
Hakan Vuruþkan, Ýsmet Yavaþcaoðlu, Bursa,
Turkey
4:40
PD24-08
12-MONTH EVALUATION OF VOIDING
AND STORAGE SYMPTOMS AFTER
SURGERY FOR BLADDER OUTLET
OBSTRUCTION (PVP XPS 180W, HOLEP,
TURP) BY VALIDATED QUESTIONNAIRES.
Maria del Mar Martinez Morales*, Carlos
Capitán, Borja López, José R. Pérez-Carral,
Enrique de la Peña, Carlos Llorente, Madrid,
Spain
4:50
PD24-09
OBJECTIVE STRUCTURED ASSESSMENT
OF TECHNICAL SKILLS FOR THE PHOTOSELECTIVE VAPORIZATION OF THE
PROSTATE PROCEDURE (PVP-OSATS): A
PILOT STUDY
Yasser Noureldin*, Mohamed Elkoushy,
Serge Carrier, Mostafa Elhilali, Sero
Andonian, Montreal, Canada
5:00
PD24-10
EVALUATION OF THE LEARNING CURVE
FOR THULIUM LASER TRANSURETHRAL
VAPORESECTION OF THE PROSTATE
(THUVARP)
Ala’a Sharaf*, Jo Worthington, Hashim
Hashim, Bristol, United Kingdom
5:10
PD24-11
MULTICENTER INTERNATIONAL
EXPERIENCE OF 180W LBO LASER
PHOTO-VAPORIZATION IN MEN WITH
LARGE PROSTATES (PROSTATE
VOLUME>100CC): LONG-TERM
OUTCOMES OF 434 PATIENTS
Pierre-Alain Hueber*, Malek Meskawi, Roger
Valdivieso, Tristan Martel, Mounsif Azizi,
Montreal, Canada, Franck Bruyère, Tours,
France, Vincent Misrai, Toulouse, France,
Georges Fournier, Brest, France, Ravi
Munver, Ganesh Sivarajan, New Jersey, NJ,
Matthew Rutman, Alexis Te, Bilal Chughtai,
New York, NY, Dean Elterman, Toronto,
Canada, Kevin Zorn, Montreal, Canada
5:20
PD24-12
PATIENT FRAILTY IS A PREDICTOR FOR
COMPLICATIONS AFTER BPH SURGERY–
ANALYSIS FROM NSQIP
Jessica Hoffen*, Natalie Fahey, ChiHsiung
APPROVED FOR AMA PRA CATEGORY
1 CREDITTM
*Presenting author
141
3:30 pm - 5:30 pm
Video Session 4
ROBOTICS – PROSTATE/NOVEL IMAGING
Moderators: Misop Han and Ramakrishna Venkatesh
ABSTRACT
NUMBER TITLE
V4-01
OUR SUCCESSFUL EXPERIENCE
UTILIZING POSTERIOR
RHABDOSPHINCTER RECONSTRUCTION
DURING ROBOTIC PROSTATECTOMY
Mona Yezdani*, Ben Katz, Sylvia Yu, daniel
maas, Alexa Lee, Alice McGill, Kelly
V4-02
V4-03
V4-04
V4-05
V4-06
ABSTRACT
NUMBER TITLE
V4-07
EARLY EXPERIENCE OF ROBOTIC
SALVAGE PELVIC LYMPH NODE
DISSECTION IN THE GA-68 PSMA PET
SCANNING ERA
Declan Murphy*, Homayoun Zargar, Roderick
Van Den Bergh, Siska Van Bruwaene,
Michael Hofman, Jeremy Goad, Melbourne,
Australia, Geoff Coughlin, Brisbane, Australia,
Laurence Hawrewood, Phil Dundee,
SALVAGE ROBOTIC-ASSISTED
LAPAROSCOPIC PROSTATECTOMY
(SRARP)
Jamil Syed*, Christopher Chew, Mouraviev
Vladimir, Srinivas Samavedi, Gabriel OgayaPinies, Hariharan Ganapathi, Anup Kumar,
Rafael F. Coelho, Bernardo Rocco, Vipul R.
Patel, Celebration, FL
CONCOMITANT URETHRAL SLING AT
THE TIME OF ROBOTIC
PROSTATECTOMY USING AN IN SITU
VASCULARIZED ROTATIONAL
PERITONEAL FLAP
Tom Feng*, Lauren Wood, Soroush Ramin,
Los Angeles, CA
ROBOTIC TOTAL PELVIC EXENTERATION
WITH INTRACORPOREAL SIGMOID
CONDUIT AND COLOSTOMY: FIRST
CLINICAL REPORT
Matthew J. Maurice*, Daniel Ramirez,
Catherine M. Seager, Georges-Pascal Haber,
Cleveland, OH
A NOVEL TECHNIQUE OF DYNAMIC
LATERAL SUSPENSION OF POSTERIOR
RECONSTRUCTION SUTURE (DLSPRS)
AFTER VESICO-URETHRAL
ANASTOMOSIS DURING ROBOTIC
RADICAL PROSTATECTOMY- IMPROVES
EARLY CONTINENCE
Yuvaraja Thyavihally*, Abhinav Pednekar,
Santosh Waigaonkar, Nikhil Gulavani, Nikhil
Dharmadhikari, Tirathram Kaushik, Mumbai,
India
TECHNIQUE AND OUTCOMES OF
MAXIMAL URINARY MUSCLE
PRESERVATION DURING ROBOTIC
ASSISTED RADICAL PROSTATECTOMY
Luciano Nunez Bragayrac*, Fadi Darwiche,
Tareq Altartir, Eric Kauffman, Buffalo, NY
V4-08
INDIA INK INJECTION (TATTOOING) OF
THE URETERIC-INTESTINAL
ANASTOMOSIS IN URINARY DIVERSIONS:
A SIMPLE AND EFFECTIVE TECHNIQUE
TO AID IN SUBSEQUENT RECOGNITION
IN RETROGRADE MANIPULATIONS
Barrett McCormick*, Jonathan Beilan, Adam
Baumgarten, Daniel Martinez, Raul Ordorica,
Trushar Patel, David Hernandez, Tampa, FL
V4-09
DESCRIPTIVE TECHNIQUE FOR ROBOTIC
RADICAL PERINEAL PROSTATECTOMY
COMBINED WITH EXTENDED PELVIC
LYMPH NODE DISSECTION
Oktay Akca*, Onder Kara, Hiury Andrade,
Homayoun Zargar, Peter Caputo, Daniel
Ramirez, Robert J Stein, Kenneth
Angermeier, Jihad H Kaouk, Cleveland, OH
V4-10
18 F-CHOLINE PET/CT GUIDED
SUPEREXTENDED PLND FOR VERY HIGH
RISK PCA. FEASIBILITY AND SURGICAL
TECHNIQUE
Giuseppe Simone, Riccardo Mastroianni,
Rocco Papalia, Mariaconsiglia Ferriero,
Francesco Minisola*, Leonardo Misuraca,
Gabriele Tuderti, Salvatore Guaglianone,
Giovanni Muto, Michele Gallucci, Rome, Italy
V4-11
A NOVEL TRANSVERSUS ABDOMINAL
PLANE BLOCK DURING ROBOTIC
ASSISTED RADICAL PROSTATECTOMY
Mona Yezdani*, Ben Katz, Sylvia Yu, Daniel
Maas, Alexa Lee, Alice McGill, Kelly
V4-12
ROBOTIC SUPRAPUBIC
PROSTATECTOMY- A NOVEL TECHNIQUE
Mona Yezdani*, Abdo Kabarriti, Sylvia Yu,
Alice McGill, Kelly Monahan, David Lee,
Philadelphia, PA
CREDITTM
142
4:30 pm - 5:30 pm
SOCIETY OF WOMEN IN UROLOGY (SWIU): WOMEN LEADERS IN UROLOGY FORUM
Rancho Santa Fe 3 @ Marriott
4:30
CONTEMPORARY CASES IN ENDOUROLOGY
Moderator: Nicole Miller
Panelists: Amy Krambeck, Jodi Antonelli, Sara Best
5:30
ADJOURN
*Presenting author
CREDITTM
143
NOTES
Plenary Session
Sunday, May 8, 2016
7:25 am - 12:00 pm
7:25
7:30
HIGHLIGHTS: UROLOGIC ONCOLOGY RESEARCH
Aria Olumi
7:40
HIGHLIGHTS: BENIGN UROLOGIC RESEARCH
Rosalyn Adam
7:50
STATE-OF-THE-ART LECTURE: ACTIVE SURVEILLANCE FOR PROSTATE CANCER
H. Ballentine Carter
8:05
PANEL DISCUSSION: EVALUATING ELEVATED PSA AFTER A NEGATIVE BIOPSY
Moderator:
James Brooks
Panelists:
David Jarrard
Herbert Lepor
Angelo De Marzo
8:25
PANEL DISCUSSION: SCREENING FOR PROSTATE CANCER: PAST, PRESENT AND FUTURE
Moderator:
Peter Scardino
Panelists:
William Catalona
Stacy Loeb
Freddie Hamdy
8:50
STATE-OF-THE-ART LECTURE: LIPID AND CHOLESTEROL PROMOTION OF PROSTATE CANCER PROGRESSION
Michael Freeman
9:05
JOHN K. LATTIMER LECTURE: ERECTILE DYSFUNCTION: FROM BARK TO PILL TO STEM CELL AND BEYOND
Tom Lue
9:25
STATE-OF-THE-ART LECTURE: SEXUAL HEALTH AFTER ANDROGEN DEPRIVATION THERAPY FOR PROSTATE
CANCER
John Mulhall
9:40
STATE-OF-THE-ART LECTURE: FEMALE SEXUAL DYSFUNCTION: FDA AND BEYOND
Sharon Parish
9:55
AUA GUIDELINE: URETHRAL STRICTURES
Richard Santucci
10:05
JOURNAL OF UROLOGY LECTURE: THE ADVANTAGES AND PITFALLS OF STUDIES BASED ON
ADMINISTRATIVE DATABASES
Introduction Presenter:
Joseph Smith
Presenter:
Mark Litwin
10:25
HIGHLIGHTS: SOCIETY FOR PEDIATRIC UROLOGY PROGRAM
Luis Braga
10:35
JOURNAL OF UROLOGY 2015: HIGH IMPACT PEDIATRIC ARTICLES
Julian Wan
10:45
JOHN DUCKETT MEMORIAL LECTURE: A TALE OF TWO TESTES: THE BILATERAL IMPACT OF A UNILATERAL
DISEASE
Faruk Hadziselimovic
11:05
PANEL DISCUSSION STAYING ON TOP OF YOUR GAME: HONING A WELL-ROUNDED SURGEON
Moderator:
Pramod Reddy
Panelists:
Joseph Borer
Jeffrey Smith
11:25
CRITICAL DISCUSSION: INJECTION OR INTESTINE: MANAGEMENT OF THE HOSTILE NEUROPATHIC BLADDER
John Wiener
Presenters:
Armando Lorenzo
Mark Cain
11:45
STATE-OF-THE-ART LECTURE: FERTILITY FOR PATIENTS WITH DISORDERS OF SEXUAL DEVELOPMENT
Thomas Kolon
12:00
SESSION CONCLUDES
*Presenting author
145
SUNDAY
PLENARY I - SUNDAY
Plenary Session
Sunday, May 8, 2016
10:00 am - 11:00 am
PLENARY II - SUNDAY
10:00
AMERICAN BOARD OF UROLOGY UPDATE
J. Christian Winters
10:10
STATE-OF-THE-ART LECTURE: PENILE TRANSPLANTATION: THE FUTURE IS TODAY
Andre Van Der Merwe
10:20
PANEL DISCUSSION: HEALTH POLICY: UTILIZATION OF ADVANCED PRACTICE PROVIDERS TO ADDRESS THE
WORKFORCE SHORTAGE IN UROLOGY
Moderator:
Christopher Gonzalez
Presenters:
Claus Roehrborn
Raoul Concepcion
Patrick McKenna
10:40
RISING STAR REPORT: THE EFFECT OF GASTRIC BYPASS SURGERY ON RENAL FUNCTION AND
METABOLISM
Introduction Presenter: Carolyn Best
Presenter:
Benjamin Canales
10:50
UTILIZATION OF ADVANCED PRACTICE PROVIDERS FOR IN-OFFICE AND IN-OPERATING ROOM PROCEDURES
Bradley Erickson
11:00
SESSION CONCLUDES
Sunday, May 8, 2016
6:30 am - 10:00 am
SOCIETY OF WOMEN IN UROLOGY (SWIU): ANNUAL BREAKFAST MEETING
Marina E @ Marriott
6:30
BREAKFAST BUFFET
8:00
SWIU AWARD PRESENTATIONS
6:45
PRESIDENT’S WELCOME
Elizabeth Williams
8:20
ANNUAL BUSINESS MEETING
8:45
NETWORKING
6:50
AUA UPDATE
TBD
10:00
ADJOURN
7:00
SHIFTING REIMBURSEMENT: ONE SIZE DOES
NOT FIT ALL
Judy Rosenbloom
Sunday, May 8, 2016
8:00 am - 10:00 am
BLADDER CANCER: INVASIVE I
Moderators: Igor Frank and Carl Olsson
ABSTRACT
NUMBER TITLE
MP38-01 THE ASSOCIATION OF VARIANT
HISTOLOGY AND EXTRA NODAL
EXTENSION IN NODE POSITIVE
BLADDER
Michael Rink*, Armin Soave, Sarah Minner,
Oliver Engel, Luis A. Kluth, Guido Sauter,
Atiqullah Aziz, Andreas Becker, Roland
Dahlem, Margit Fisch, Hamburg, Germany
ABSTRACT
NUMBER TITLE
MP38-02 THE AMOUNT OF INTRA- AND
POSTOPERATIVE BLOOD TRANSFUSION
IN BLADDER CANCER PATIENTS WITH
RADICAL CYSTECTOMY IS AN
INDEPENDENT PROGNOSTIC FACTOR
FOR POOR OUTCOME – RESULTS OF A
SINGLE-CENTER STUDY
Alexander Buchner*, Tobias Grimm, BirteSwantje Schneevoigt, Alexander Kretschmer,
Markus Grabbert, Maria Apfelbeck, Gerald
Schulz, Christian G. Stief, Alexander Karl,
Munich, Germany
146
MP38-03 AN EASILY APPLICABLE MORTALITY
INDEX FOR PATIENTS SELECTED FOR
RADICAL CYSTECTOMY OR RADICAL
PROSTATECTOMY
Michael Froehner*, Rainer Koch, Ulrike
Heberling, Vladimir Novotny, Matthias Hübler,
Manfred P. Wirth, Dresden, Germany
MP38-10 CYSTECTOMY ASSOCIATED WITH
IMPROVED OVERALL SURVIVAL IN VERY
ELDERLY PATIENTS WITH MUSCLE
INVASIVE BLADDER CANCER; RESULTS
FROM THE NATIONAL CANCER DATA
BASE
Bream Matthew*, Matthew Maurice, Simon
Kim, Hui Zhu, Robert Abouassaly, Cleveland,
OH
MP38-04 SURVIVAL, PERIOPERATIVE OUTCOMES,
AND COSTS AFTER ROBOTIC-ASSISTED
VERSUS OPEN RADICAL CYSTECTOMY: A
NATIONAL COMPARATIVE
EFFECTIVENESS STUDY
Joshua Halpern*, Padraic O’Malley, Bilal
Chughtai, Douglas Scherr, Art Sedrakyan,
Jialin Mao, Jim Hu, New York, NY
TUMOR DISSEMINATION DURING ROBOTASSISTED RADICAL CYSTECTOMY: DOES
THE EMPEROR HAVE NO CLOTHES?
Ahmed Hussein*, Yingyu Ma, Gissou
Azabdaftari, Buffalo, NY, Nobuyuki Hinata,
Kobe, Japan, Wei Luo, Victoria Cranwell,
Brittany Bunch, Justen Kozlowski, Sean
Glenn, Song Liu, Candace Johnson, Khurshid
Guru, Buffalo, NY
MP38-12 PROPHYLACTIC ANTIBIOTICS IN THE
FIRST 30 DAYS FOLLOWING RADICAL
CYSTECTOMY WITH URINARY
DIVERSION LEADS TO FEWER URINARY
TRACT INFECTIONS
Ryan Werntz*, Theresa Koppie, Brian Junio,
Christopher Amling, Portland, OR
MP38-06 COMPARING LONG-TERM ONCOLOGIC
OUTCOMES BETWEEN OPEN RADICAL
CYSTECTOMY AND ROBOT-ASSISTED
LAPAROSCOPIC RADICAL CYSTECTOMY:
A RANDOMIZED CLINICAL TRIAL
Justin Lee*, Bernard Bochner, Daniel
Sjoberg, Nick Liu, Guido Dalbagni, Jonathan
Silberstein, Gal Karen-Paz, S. Machele
Donat, Jonathan Coleman, Sheila Mathew,
Andrew Vickers, Raul Parra, Harry Herr,
Vincent Laudone, New York, NY
MP38-13 LONG-TERM 10-YEAR HEALTH-RELATED
QUALITY OF LIFE OUTCOMES
FOLLOWING RADICAL CYSTECTOMY
Paul Gellhaus*, K. Clint Cary, Cindy Johnson,
M. Francesca Monn, Hristos Kaimakliotis,
Michael Weiner, Michael Koch, Richard
Bihrle, Indianapolis, IN
MP38-14 IMPLEMENTING A MULTIMODAL
PREHABILITATION PROGRAM IN A HIGHVOLUME BLADDER CANCER CENTER
Bente Thoft Jensen, Aarhus, Denmark, Guido
Dalbagni, New York, NY, Jørgen Bjerggaard
Jensen, Aarhus, Denmark, Caitlyn Retinger,
Mallory Bowker, Nora Love*, New York, NY
MP38-07 MEASURING THE DEPTH OF TUMOR
INVASION MAY HAVE GREATER
PROGNOSTIC VALUE THAN AJCC/UICC
STAGING OF BLADDER CANCER.
Nishikimi Toshinori*, Nagoya,Aichi, Japan,
Tsuzuki Toyonori, Nagoya, Japan, Kashiwagi
Yuuta, Okazaki, Japan, Sassa Naoto, Kimura
Toru, Nagoya, Japan, Fukatsu Akitoshi,
Komaki, Japan, Tanaka Kuniaki, Kariya,
Japan, Hattori Ryohei, Gotoh Momokazu,
Nagoya, Japan
MP38-15
MP38-08 PROGNOSTICS FACTORS OF POSITIVES
URETERAL SECTION DURING
CYSTECTOMY FOR BLADDER CANCER.
Francois Thomas*, Alezra Eric, Forzini
Thomas, Saint Fabien, Amiens, France
MP38-09 DOES THE ILEAL LENGTH USED FOR
NEOBLADDER RECONSTRUCTION AFTER
RADICAL CYSTECTOMY IMPACT ON
POSTOPERATIVE BOWEL HABITS ? - A
COMPARISON BETWEEN THE STUDERAND THE I-POUCH
Johannes Mischinger*, Tuebingen, Germany,
Mohamed Abdelhafez, Assiut, Egypt, Tilman
Todenhöfer, Stefan Aufderklamm, Steffen
Rausch, Christian Schwentner, Arnulf Stenzl,
Georgios Gakis, Tuebingen, Germany
*Presenting author
147
EXTRACAPSULAR EXTENSION AND
LYMPH NODE DENSITY IN UROTHELIAL
CARCINOMA OF THE BLADDER
FOLLOWING RADICAL CYSTECTOMY IN
NODAL-POSITIVE PATIENTS
Atiqullah Aziz*, Hamburg, Germany, Philipp
Nuhn, Mannheim, Germany, Michael Gierth,
Regensburg, Germany, Vladimir Novotny,
Dresden, Germany, Florian Roghmann,
Herne, Germany, Matthias May, Straubing,
Germany, Derya Tilki, Michael Rink,
Hamburg, Germany, Roman Mayr, HansMartin Fritsche, Maximilian Burger,
Regensburg, Germany, Armin Pycha,
Bolzano, Italy, Michael Froehner, Manfred P.
Wirth, Dresden, Germany, Chris Protzel,
Oliver W. Hakenberg, Rostock, Germany,
Rein-Jüri Palisaar, Joachim Noldus, Herne,
Germany, Stefan Vallo, Georg Bartsch, Axel
Haferkamp, Frankfurt, Germany, Patrick J.
Bastian, Düsseldorf, Germany, Christian
Gilfrich, Straubing, Germany, Roland Dahlem,
Margit Fisch, Felix Chun, Hamburg, Germany
SUNDAY
MP38-05
MP38-11 ONCOLOGICAL TRIFECTA AND
PENTAFECTA CRITERIA IN A
CONTEMPORARY COHORT OF BLADDER
CANCER PATIENTS AFTER RADICAL
CYSTECTOMY
Julian Hanske*, Nicolas von Landenberg,
Sebastian Berg, Jana Schmidt, Marko Brock,
Christian von Bodman, Jüri Palisaar, Florian
Roghmann, Joachim Noldus, Herne,
Germany
MP38-16 OUTCOMES OF ROBOT-ASSISTED
REPAIR OF DIVERSION-RELATED
COMPLICATIONS AFTER ROBOTASSISTED RADICAL CYSTECTOMY
Ahmed Hussein*, Zishan Hashmi, Seyedeh
Dibaj, Tareq Altartir, Thomas Fiorica, Joseph
Wing, Mohammad Durrani, John Binkowski,
Lesley Boateng, Gregory Wilding, Khurshid
Guru, Buffalo, NY
MP38-19 READAPTATION OF THE PERITONEUM
FOLLOWING EXTENDED PELVIC LYMPH
NODE DISSECTION (PLND) AND
CYSTECTOMY HAS BENEFICIAL IMPACT
ON BOWEL FUNCTION IN THE LONG
TERM WITHOUT COMPROMISING
ONCOLOGICAL RADICALITY.
Bernhard Kiss*, Mihai Dorin Vartolomei,
Alvaro Vidal Faune, George N. Thalmann,
Beat Roth, Bern, Switzerland
MP38-17 ATTEMPTED NERVE SPARING HAS A
LONG TERM IMPACT ON URINARY
CONTINENCE IN PATIENTS WITH AN
ORTHOTOPIC BLADDER SUBSTITUTE
Marc Furrer*, Daniel P. Nguyen, Tobias
Gross, George N. Thalmann, Urs E. Studer,
Bern, Switzerland
MP38-20 SIMPLIFIED CLINICAL COMORBIDITY
INDEX FOR PATIENTS CANDIDATE TO
RADICAL CYSTECTOMY
Paolo Dell’Oglio, Zhe Tian*, Sami-Ramzi
Leyh-Bannurah, Vincent Trudeau, Montreal,
Canada, Alessandro Larcher, Marco
Moschini, Nazareno Suardi, Umberto
Capitanio, Alberto Briganti, Francesco
Montorsi, Milan, Italy, Pierre Karakiewicz,
Montreal, Canada
MP38-18 URETHRAL RECURRENCE AFTER
RADICAL CYSTECTOMY: REVISITING THE
INCIDENCE AND PREDICTORS IN A
LARGE CONTEMPORARY SERIES
Islam Fakhreldin, Ahmed Harraz*, Mahmoud
Laymon, Yasser Osman, Bedair Ali-Eldin,
Atallah Shaaban, Mansoura, Egypt
CREDITTM
Sunday, May 8, 2016
8:00 am - 10:00 am
PROSTATE CANCER: DETECTION & SCREENING V
Moderators: Kevin Loughlin and Marc Smaldone
ABSTRACT
NUMBER TITLE
MP39-01 USE OF PSA SCREENING GUIDELINES
AMONG PRIMARY CARE PHYSICIANS
Matt Rosenberg*, Jackson, MI, David
Crawford, Aurora, CO, Jay Newmark, Mitch
Steiner, Miami, FL
ABSTRACT
NUMBER TITLE
MP39-05 SWISS PROSTATE-CHECK - A
POPULATION BASED RISK-CALCULATOR
FOR NEXT GENERATION PROSTATE
CANCER SCREENING
Maciej Kwiatkowski, Lukas Prause, Stephen
F Wyler, Tilmann Moeltgen, Andreas Huber,
Rainer Grobholz, Aarau, Switzerland, Lukas
Manka, Braunschweig, Germany, Burkhard
Seifert, Marco Randazzo, Zürich, Switzerland,
Franz Recker*, Aarau, Switzerland
MP39-02 DEVELOPMENT AND VALIDATION OF A
RISK PREDICTION MODEL FOR
PROSTATE CANCER DIAGNOSIS WITHIN
A STATEWIDE QUALITY IMPROVEMENT
COLLABORATIVE
Gregory Auffenberg*, Seliln Merdan, David
Miller, Karandeep Singh, Ann Arbor, MI,
Benjamin Stockton, St. Joseph, MI, Brian
Denton, Khurshid Ghani, Ann Arbor, MI
MP39-06 IMPACT OF GUIDELINES ON PROSTATE
CANCER SCREENING IN A POPULATIONBASED SETTING, 2000-2014:
PRELIMINARY RESULTS FROM THE
FIRST AUA DATA GRANT
Daniel Frendl*, Mara Epstein, Hassan
Fouayzi, Worcester, MA, Richard Krajenta,
Benjamin Rybicki, Detroit, MI, Mitchell
Sokoloff, Worcester, MA
MP39-03 DECREASING SCREENING EFFICACY
WITH INCREASING AGE: RESULTS FROM
A POPULATION-BASED SCREENING
TRIAL - SWISS ERSPC (AARAU)
Maciej Kwiatkowski*, Lukas Prause, Stephen
Manka, Alexander Müller, Braunschweig,
Germany, Marco Randazzo, Zürich,
Switzerland, Franz Recker, Aarau,
Switzerland
MP39-07 THE 4KSCORE CAN POTENTIALLY
REDUCE UNNECESSARY PROSTATE
BIOPSIES IN MEN WITH SUSPICIOUS PSA
IN A SCREENING POPULATION
Michael Maccini, Nicholas Westfall*, Priya
Werahera, Adrie van Bokhoven, Paul Maroni,
Shandra Wilson, Michael Glode, Paul
Arangua, David Crawford, Aurora, CO
MP39-04 INITIAL PROSTATE CANCER DETECTION
BEFORE AND AFTER UNITED STATES
RECOMMENDATION ON PROSTATE
CANCER SCREENING
Carl Olsson*, New York, NY, Ann Anderson,
Deepak Kapoor, Melville, NY
148
MP39-13 BASELINE PROSTATE-SPECIFIC ANTIGEN
(PSA) LEVELS IN MIDLIFE PREDICT
TOTAL AND AGGRESSIVE PROSTATE
CANCER IN AFRICAN-AMERICAN MEN
Mark Preston*, Kathryn Wilson, Travis Gerke,
Boston, MA, Sigrid Carlsson, Daniel Sjoberg,
New York, NY, Adam Kibel, Quoc-Dien Trinh,
Boston, MA, Lisa Signorello, Bethesda, MD,
Mark Steinwandel, Rockville, MD, Andrew
Vickers, Hans Lilja, New York, NY, Lorelei
Mucci, Boston, MA
MP39-09 PROPERTIES OF THE FOUR KALLIKREIN
PANEL FOR PREDICTION OF PROSTATE
BIOPSY OUTCOME IN MEN WITH HIGH
PSA (10-25 NG /ML)
Andrew Vickers*, Daniel Sjoberg, Emily
Vertosick, New York, NY, Monique Roobol,
Rottderdam, Netherlands, Freddie Hamdy,
Oxford, United Kingdom, Anders Bjartell,
Lund, Sweden, David Neal, Oxford, United
Kingdom, Jenny Donovan, Bristol, United
Kingdom, Hans Lilja, New York, NY
MP39-14 IMPACT OF THE 2012 UNITED STATES
RECOMMENDATION AGAINST PROSTATE
SPECIFIC ANTIGEN SCREENING ON
PROSTATE CANCER RISK GROUP
STRATIFICATION
Deepansh Dalela*, Detroit, MI, Bjorn
Loeppenberg, Boston, MA, Akshay Sood,
Jesse Sammon, Patrick Karabon, Detroit, MI,
Maxine Sun, Quoc-Dien Trinh, Boston, MA,
Wooju Jeong, James Peabody, Mani Menon,
Detroit, MI, Firas Abdollah, Royal Oak, MI
MP39-10 SERUM INSULIN-LIKE GROWTH FACTOR1 (IGF-1) WAS A VALUABLE BIOMARKER
TO PREDICT THE HIGH GRADE
PROSTATE CANCER IN FINAL
PATHOLOGY IN PATIENTS WHO HAD
LOW TO INTERMEDIATE DISEASE ON
BIOPSY.
Myong Kim*, Myungchan Park, Jong Won
Kim, Donghyun Lee, Seoul, Korea, Republic
of, Won Hee Park, Incheon, Korea, Republic
of, In Gab Jeong, Cheryn Song, Jun Hyuk
Hong, Choung-Soo Kim, Tai Young Ahn,
Hanjong Ahn, Seoul, Korea, Republic of
MP39-15
MP39-16 DETECTING HIGH GRADE CANCER AND
REDUCING PROSTATE BIOPSY AMONG
PLCO PARTICIPANTS USING A PRESPECIFIED STATISTICAL MODEL BASED
ON LEVELS OF FOUR KALLIKREIN
MARKERS AND MICROSEMINOPROTEINBETA IN BLOOD
Gerald L. Andriole*, St. Louis, MO, Daniel
Sjoberg, Andrew Vickers, New York, NY,
David Crawford, Aurora, CO, Hans Lilja, New
York, NY
MP39-11 BASELINE PSA BEFORE AGE 60 AS A
PREDICTOR OF IMPORTANT PROSTATE
CANCER DIAGNOSIS AND PROSTATE
CANCER-SPECIFIC MORTALITY IN THE
INTERVENTION ARM OF THE PROSTATE,
LUNG, COLORECTAL AND OVARIAN
TRIAL
Evan Kovac*, Cleveland, OH, Sigrid
Carlsson, Hans G. Lilja, New York, NY,
Jonas Hugosson, Gothenburg, Sweden,
Michael Kattan, Cleveland, OH, Erik
Holmberg, Gothenburg, Sweden, Andrew J.
Stephenson, Cleveland, OH
MP39-17 POOR PERFORMANCE OF THE ZAYTOUN
PROSTATE BIOPSY NOMOGRAM IN
MULTIPLE EXTERNAL VALIDATION
COHORTS
Daniel Sjoberg, New York, NY, Anders
Bjartell, Lund, Sweden, David Okrongly,
Woburn, MA, Andrew Vickers*, New York, NY
MP39-12 GLEASON MISCLASSIFICATION IN
DIFFERENT ACTIVE SURVEILLANCE
PROTOCOLS: CORRELATION BETWEEN
FUSION BIOPSIES MRI-ULTRASOUND
FUSION GUIDED BIOPSY AND FINAL
Sami-Ramzi Leyh-Bannurah*, Montreal,
Canada, Paolo Dell’Oglio, Milano, Italy, Dirk
Beyersdorff, Georg Salomon, Markus
Graefen, Hamburg, Germany, Wolfgang
Picker, Oslo, Norway, Lars Budäus,
Hamburg, Germany
*Presenting author
SCREENING FOR PROSTATE CANCER:
RESULTS FROM THE SWISS SECTION OF
THE ERSPC (AARAU)
Maciej Kwiatkowski*, Lukas Prause, Stephen
Manka, Braunschweig, Germany, Franz
Recker, Aarau, Switzerland
MP39-18 HIGHER FREQUENCY OF GERMLINE
BRCA1 AND BRCA2 MUTATIONS IN
AFRICAN AMERICAN PROSTATE CANCER
Gyorgy Petrovics*, Lakshmi Ravindranath,
Yongmei Chen, Kai Ying, Rockville, MD,
Amina Ali, Bethesda, MD, Denise Young,
Rockville, MD, David McLeod, Bethesda, MD,
Isabell Sesterhenn, Silver Spring, MD, Inger
Rosner, William Dahut, Bethesda, MD, Shiv
Srivastava, Rockville, MD, Michael Dean,
Gaithersburg, MD
149
SUNDAY
MP39-08 CLINICAL UTILITY OF AN EPIGENETIC
ASSAY TO REDUCE UNNECESSARY
REPEAT PROSTATE BIOPSIES
Jason Hafron*, Thanh Huynh, Ayad S.
Khourdaji, Royal Oak, MI, Richard D. Sarle,
St. Clair Shores, MI, Wim Van Criekinge,
Ghent, Belgium, Leander Van Neste,
Maastricht, Netherlands
MP39-19 PROSTATE CANCER DETECTION WITH
DIGITAL RECTAL EXAM IN THE
PROSTATE LUNG COLORECTAL AND
OVARIAN (PLCO) CANCER SCREENING
TRIAL
Joshua Halpern, Jonathan Shoag, Sameer
Mittal*, New York, NY, Stuart Lipsitz, Boston,
MA, Karla Ballman, Jim Hu, New York, NY
MP39-20 ARE THERE ANY APPROPRIATE
CRITERIA FOR RECOMMENDING
PROSTATE BIOPSY IN PATIENTS OVER
75 YEARS OLD?
Yu Teranishi*, Moroyama-cho,Saitama,
Japan, Takeo Kosaka, Kazuhiro Matsumoto,
Shinya Morita, Kazunobu Shinoda, Ryuichi
Mizuno, Toshiaki Shinojima, Eiji Kikuchi,
Hiroshi Asanuma, Akira Miyajima, Mototsugu
Oya, Tokyo, Japan
CREDITTM
Sunday, May 8, 2016
8:00 am - 10:00 am
PROSTATE CANCER: LOCALIZED: SURGICAL THERAPY I
Moderator: Scott Eggener and Leonard Gomella
ABSTRACT
NUMBER TITLE
MP40-01 WHO BENEFITS FROM ROBOT-ASSISTED
RADICAL PROSTATECTOMY IN TERMS OF
FUNCTIONAL OUTCOME?
Masahiro Takahashi*, Koji Mitsuzuka,
Yasuhiro Kaiho, Akihiro Ito, Yoichi Arai,
Sendai, Miyagi, Japan
ABSTRACT
NUMBER TITLE
MP40-05 EVALUATION OF OUTCOMES OF
SALVAGE ROBOTIC PROSTATECTOMY:
SINGLE SURGEON EXPERIENCE
Jamil Syed*, Christopher Chew, Anup Kumar,
Srinivas Samavedi, Cathy Jenson, Gabriel
Ogaya, Hariharan Palayapalayam Ganapathi,
Janice Doss, Anthony Bates, Celebration, FL,
Rafael F. Coelho, Sao Paulo, Brazil,
Bernardo Rocco, Milan, Italy, Vladimir
Mouraviev, Vipul R. Patel, Celebration, FL
MP40-02 SHORT-TERM RESULTS OF EXTENDED
PELVIC LYMPHADENECTOMY DURING
PROSTATECTOMY IN 1,000
CONSECUTIVE PATIENTS.
Ricardo Soares*, Guildford, United Kingdom,
Simon Bott, Frimley, United Kingdom,
Richard Hindley, Basingstoke, United
Kingdom, Roy McGregor, Montego Bay,
Jamaica, Christopher Eden, Guildford, United
Kingdom
MP40-06 LONGITUDINAL INVESTIGATION ON
PREDICTORS OF CONTINENCE
PROSTATECTOMY
Yuta Yamada*, Tetsuya Fujimura, Hiroshi
Fukuhara, Toru Sugihara, Takamasa
Horiuchi, Tohru Nakagawa, Haruki Kume,
Yukio Homma, Tokyo, Japan
MP40-03 EXTENDED VS. LIMITED PELVIC LYMPH
NODE DISSECTION DURING BILATERAL
NERVE-SPARING RADICAL
PROSTATECTOMY AND ITS EFFECT ON
CONTINENCE AND ERECTILE FUNCTION
RECOVERY: LONG-TERM RESULTS AND
TRIFECTA RATES OF A COMPARATIVE
ANALYSIS
Georgios Hatzichristodoulou*, Munich,
Germany, Stefan Wagenpfeil, Gudrun
Wagenpfeil, Homburg, Germany, Jürgen
Gschwend, Hubert Kübler, Munich, Germany
MP40-07 LONG-TERM FOLLOW-UP DATA AFTER
RADICAL PROSTATECTOMY:
DETERMINING WHEN TO STOP PSA
MONITORING
Kazuhiro Matsumoto*, Akari Komatsuda,
Yoshinori Yanai, Takeo Kosaka, Eiji Kikuchi,
Japan
MP40-08 INFLUENCE OF PATHOLOGIST ON
POSITIVE SURGICAL MARGINS
FOLLOWING RADICAL PROSTATECTOMY:
ANALYSIS OF 3,557 CASES
Jacob E. Tallman*, Vignesh T. Packiam,
Gladell P. Paner, Scott E. Eggener, Chicago,
IL
MP40-04 MINIMALLY INVASIVE SALVAGE
PROSTATECTOMY AFTER PRIMARY
RADIATION OR ABLATION TREATMENT:
COMPLICATIONS, FUNCTIONAL AND
LONG-TERM ONCOLOGICAL OUTCOMES
Estefania Linares Espinos*, Arjun Sivaraman,
Rafael Sanchez-Salas, Jose I. Perez-Reggeti,
Adrien Pamela, Eric Barret, Marc Galiano,
François Rozet, Dominique Prapotnich,
Nathalie Cathala, Annick Mombet, Xavier
MP40-09 IMPACT OF NERVE SPARING ON
POSTOPERATIVE CONTINENCE
FOLLOWING ROBOT ASSISTED RADICAL
PROSTATECTOMY: A PROPENSITY
SCORE MATCHED STUDY
Anup Kumar*, New Delhi, India, Srinivas
Samavedi, Vladimir Mouraviev, Hariharan
PG, Bernardo Rocco, Rafael F Coelho, Vipul
R Patel, Celebration, FL
150
MP40-10 COMPARISON OF POSITIVE SURGICAL
MARGIN RATES IN PROSTATE CANCER:
OPEN VERSUS ROBOT ASSISTED
PROSTATECTOMY
Sang Heon Lee, Juhyun Park, Ja Hyeon Ku,
Cheol Kwak, Hyeon Hoe Kim, Jae-Seung
Paick, Chang Wook Jeong, Seoul, Korea,
Republic of, Byung Soo Kim*, Hyung Suk
Kim, Jungbum Bae, Seoul, Korea, Republic
of
MP40-16 RISK FACTORS OF BIOCHEMICAL
RECURRENCE IN LOCALLY ADVANCED
PROSTATE CANCER PATIENTS WITH
PREOPERATIVE GLEASON GRADE OF 4
OR 5 AFTER ROBOT-ASSISTED RADICAL
PROSTATECTOMY
Yong Jin Kang, Won Sik Jang, Jong Kyou
Kwon, Cheol Yong Yoon, Joo Yong Lee,
Kang Su Cho, Won Sik Ham, Seoul, Korea,
Republic of, Young Sig Kim, Goyang, Korea,
Republic of, Young Deuk Choi, Jang Hee
Han*, Myung Soo Kim, Seoul, Korea,
Republic of
MP40-11 THE ROLE OF ROBOT-ASSISTED
RADICAL PROSTATECTOMY AND
EXTENDED PELVIC LYMPH NODE
DISSECTION IN PATIENTS WITH
LOCALLY ADVANCED PROSTATE
CANCER: RESULTS FROM A MULTIINSTITUTIONAL SERIES
Giorgio Gandaglia*, Aalst, Belgium, Elisa De
Lorenzis, Milan, Italy, Giacomo Novara,
Ruben De Groote, Aalst, Belgium, Bernardo
Rocco, Milan, Italy, Alexandre Mottrie, Aalst,
Belgium
MP40-18 LONG-TERM ONCOLOGICAL OUTCOMES
FOLLOWING RADICAL PROSTATECTOMY
FOR CLINICAL T1A AND T1B PROSTATE
CANCER
Daniel Moreira*, Boris Gershman, Stephen
Boorjian, R. Houston Thompson, Igor Frank,
Matthew Tollefson, Matthew Gettman, Rachel
Carlson, R. Jeffrey Karnes, Rochester, MN
OF SALVAGE RADICAL PROSTATECTOMY
FOR RADIO-RECURRENT/PERSISTENT
PROSTATE CANCER AFTER RADIATION
THERAPY.
Antoni Vilaseca*, Amy Tin, Daniel Nguyen,
Renato Corradi, Alexandre MArtin-Malburet,
Jaspreet Sandhu, Laura Leddy, Daniel
Sjoberg, James Eastham, Peter Scardino,
Karim Touijer, New York, NY
MP40-19 A NEW SUBCLASSIFICATION SYSTEM
FOR DECISION MAKING WITH
INTERMEDIATE RISK PROSTATE CANCER
PATIENTS TREATED BY RADICAL
PROSTATECTOMY : A MULTICENTER
STUDY
Jean Baptiste Beauval Beauval*, Toulouse,
France, Adil Ouzzane, Lille, France,
Guillaume Ploussard, Pierre Marie Patard,
Toulouse, France, Annabelle Gougeon, Paris,
France, Gauthier Marcq, Lille, France,
Romain Mathieu, Sébastien Vincendeau,
Rennes, France, Christophe Hennequin,
Raphaele Renard Penna, Paris, France, Luc
Cormier, Dijon, France, David Azria,
Montpellier, France, Philippe Beuzeboc,
Pierre Mongiat Artus, Paris, France, Gaelle
Fromont, Tours, France, Alexandre De La
Taille, Créteil, France, Morgan Roupret,
Paris, France, Michel Soulié, Toulouse,
France, Laurent Salomon, Créteil, France,
Arnaud Méjean, François Rozet, Paris,
France
MP40-13 PROGNOSTIC FACTORS AND
ONCOLOGIC OUTCOMES AFTER ROBOTASSISTED RADICAL PROSTATECTOMY IN
PT3B PROSTATE CANCER
Dae Keun Kim, Atalla Alatawi, Abulhasan
Sheikh, Ibrahim Alabdulaali, Ali Abdel
Raheem*, Young Deuk Choi, Koon Ho Rha,
MP40-14 PREDICTORS OF EXTRAPROSTATIC
EXTENSION AFTER RADICAL
PROSTATECTOMY IN A CONTEMPORARY
COHORT OF MEN BIOPSIED WITH AN
EXTENDED BIOPSY SCHEME
Wilson Rovira*, Ricardo Sanchez-Ortiz,
Guaynabo, Puerto Rico
MP40-15
ONCOLOGIC OUTCOMES AFTER
ROBOTIC-ASSISTED LAPAROSCOPIC VS
RETROPUBIC RADICAL
PROSTATECTOMY FOR HIGH-RISK
PROSTATE CANCER IN KOREAN MEN
USING K-CAP REGISTRY
Se Young Choi*, Chunwoo Lee, Jaeyoon
Jung, Sangjun Yoo, Dalsan You, In Gab
Jeong, Seoul, Korea, Republic of, Seok-Soo
Byun, Ji Youl Lee, Byung Ha Chung, Seoul,
Korea, Republic of, Chung-Soo Kim, Seoul,
Korea, Republic of
MP40-20 RELATIONSHIP BETWEEN NON-TUMOR
PROSTATE VOLUME AND RISK OF
POSITIVE SURGICAL MARGIN IN ORGAN
CONFINED PROSTATE CANCER
Republic of, In Rae Cho, Busan, Korea,
Republic of, Young Deuk Choi, Myung Soo
Kim*, Seoul, Korea, Republic of, Won Tae
Kim, Cheongju, Korea, Republic of
CREDITTM
*Presenting author
151
SUNDAY
MP40-17 IMPACT OF REGIONAL HYPOTHERMIA ON
URINARY CONTINENCE DURING RARP:
RESULTS FROM A DOUBLE-BLIND
RANDOMIZED CONTROL TRIAL
Kamaljot Kaler*, Thomas Ahlering, Orange,
CA
Sunday, May 8, 2016
8:00 am - 10:00 am
KIDNEY CANCER: LOCALIZED: SURGICAL THERAPY I
Moderators: Michael Stifelman, Brian Lane and Abhay Rane
ABSTRACT
NUMBER TITLE
MP41-01 COMPARISON OF OVERALL SURVIVAL
RATE BETWEEN PARTIAL AND RADICAL
NEPHRECTOMY FOR RENAL CELL
CARCINOMA IN PATIENTS WITH PREEXISTING CHRONIC KIDNEY DISEASE: A
MULTICENTER STUDY
Jae Seung Chung*, Busan, Korea, Republic
of, Seok-Soo Byun, Sang Eun Lee, Sung Kyu
Hong, Sang Chul Lee, Seongnam, Korea,
Republic of, Cheol Kwak, Sung Hoo Hong,
Seoul, Korea, Republic of, Yong June Kim,
Cheongu, Korea, Republic of, Seok Ho Kang,
ABSTRACT
NUMBER TITLE
MP41-07 1:1 EXACT MATCHED COMPARISON OF
ROBOT-ASSOCIATED PARTIAL
NEPHRECTOMY AND OPEN PARTIAL
NEPHRECTOMY ON POSTOPERATIVE
RENAL FUNCTION
Se Young Choi*, Sangjun Yoo, Jaeyoon
Jung, Wook Nam, Junghyun Shin, Seoul,
Korea, Republic of, Sang Hoon Song, Dalsan
You, In Gab Jeong, Choung-Soo Kim, Seoul,
Korea, Republic of
MP41-02 COMPARING CHANGES IN RENAL
FUNCTION AFTER RADICAL SURGERY
FOR UPPER TRACT UROTHELIAL
CARCINOMA AND RENAL CELL
CARCINOMA
Nirmish Singla*, Ryan Hutchinson, Ahmed
Haddad, Arthur Sagalowsky, Yair Lotan,
Vitaly Margulis, Dallas, TX
MP41-08 COMPARISON OF PERIOPERATIVE
OUTCOMES WITH OR WITHOUT
RENORRHAPHY IN OPEN PARTIAL
NEPHRECTOMY: A PROPENSITY SCOREMATCHED STUDY
Hidekazu Tachibana*, Toshio Takagi, Junpei
Iizuka, Tsunenori Kondo, Kazunari Tanabe,
Tokyo, Japan
MP41-03 CHANGING UTILIZATION OF PARTIAL
NEPHRECTOMY: ARE AT RISK PATIENTS
BEING LEFT BEHIND?
Harsha Mittakanti*, I-Chun Thomas, Remy
Lamberts, Geoffrey Sonn, Benjamin Chung,
Stanford, CA, Todd Wagner, Palo Alto, CA,
Glenn Chertow, James Brooks, John Leppert,
Stanford, CA
MP41-09 ASSESSMENT OF SURGICAL OUTCOMES
OF THE NON-RENORRHAPHY
TECHNIQUE IN OPEN PARTIAL
NEPHRECTOMY FOR >T1B RENAL
TUMORS
Toshio Takagi*, Tsunenori Kondo, Kenji
Omae, Junpei Iizuka, Hirohito Kobayashi,
Yasunobu Hashimoto, Kazunari Tanabe,
Tokyo, Japan
MP41-04 PREOPERATIVE PROTEINURIA IS
ASSOCIATED WITH WORSE RENAL
ELECTIVE PARTIAL NEPHRECTOMY
Dmitry Volkin*, Varun Vijay, Michael
Stifelman, Samir S Taneja, William C Huang,
New York, NY
MP41-05
MP41-10 RENAL TUMOR ENUCLEATION
MAXIMALLY PRESERVES RENAL
PARENCHYMAL VOLUME COMPARED TO
STANDARD PARTIAL NEPHRECTOMY
Robert H. Blackwell, Belinda Li*, Zachary
Kozel, Maywood, IL, Zhiling Zhang, Juping
Zhao, Cleveland, OH, Sarah Capodice,
Gregory Barton, Arpeet Shah, Jessica
Wetterlin, Marcus L. Quek, Maywood, IL,
Steven C. Campbell, Cleveland, OH, Gopal
N. Gupta, Maywood, IL
ASSOCIATION OF PREOPERATIVE
PROTEINURIA WITH RENAL FUNCTIONAL
OUTCOMES AFTER OPEN PARTIAL
NEPHRECTOMY IN PATIENTS WITH AN
ANATOMICALLY OR FUNCTIONALLY
SOLITARY KIDNEY
Hidekazu Tachibana*, Toshio Takagi, Junpei
Iizuka, Tsunenori Kondo, Kazunari Tanabe,
Tokyo, Japan
MP41-06 ACUTE IPSILATERAL RENAL
DYSFUNCTION AFTER PARTIAL
NEPHRECTOMY: SPECTRUM SCORE TO
UNMASK ISCHEMIC INJURY IN THE
OPERATED KIDNEY
Zhiling Zhang*, Juping Zhao, Wen Dong,
Palacios D Aguilar, Erick Remer, Jianbo Li,
Sevag Demirjian, Joseph Zabell, Steven
Campbell, Cleveland, Oh
152
MP41-16 A NOVEL AND SIMPLE “3S”
NEPHROMETRY SCORE SYSTEM TO
EVALUATE THE TECHNICAL
COMPLEXITY OF NEPHRON-SPARING
SURGERY
Zhang Shudong*, Ma Lulin, Liu Ke, zhang
Hongxian, Tian Yu, Bi Hai, Beijing, China,
MP41-12 DISCRIMINATION ABILITY OF THE
SURFACE-INTERMEDIATE-BASE MARGIN
(SIB) SCORE: AN EXTERNAL
HISTOPATHOLOGICAL EVALUATION
Alessandro Antonelli*, Maria Furlan, Mario
Sodano, Regina Tardanico, Simona Fisogni,
Alberto Cozzoli, Tiziano Zanotelli, Claudio
Simeone, Brescia, Italy
MP41-18 PATHOGENESIS, FEATURES AND
PROGNOSIS OF RENAL RELAPSE AFTER
PARTIAL NEPHRECTOMY
Alessandro Antonelli*, Mario Sodano, Maria
Furlan, Regina Tardanico, Simona Fisogni,
Francesca Carobbio, Alberto Cozzoli, Tiziano
Zanotelli, Claudio Simeone, Brescia, Italy
MP41-17 A COMPARATIVE ANALYSIS OF
COMPLICATIONS IN PATIENTS WITH
RENAL CELL CARCINOMA UNDERGOING
PARTIAL NEPHRECTOMY: A
MULTICENTER TRIAL
Steven V Kheyfets*, Clint D Bahler,
Indianapolis, IN, Arieh Shalhav, Chicago, IL,
Steven Shichman, Hartford, CT, Benjamin
Lee, New Orleans, LA, Li-Ming Su,
Gainesville, FL, Ashok Hemal, WinstonSalem, NC, Michael D Weintrab, Kaitlin
Jaqua, Indianapolis, IN, Itay Sagy, Shane
Pearce, Chicago, IL, Peter Haddock, Max
Jackson, Hartford, CT, Michael Maddox, New
Orleans, LA, Russell Terry, Gainesville, FL,
Louis S Krane, Winston-Salem, NC, Chandru
P Sundaram, Indianapolis, IN
MP41-19 LOCAL RECURRENCE AFTER PARTIAL
NEPHRECTOMY FOR PRIMARY RENAL
TUMORS – INCIDENCE, RISK FACTORS
AND ONCOLOGIC FOLLOW-UP
Asaf Shvero*, Dorit Zilberman, Yoram Mor,
Issac Kaver, Edi Fridman, Orith Portnoy,
Menahem Laufer, Raanan Berger, Jacob
Ramon, Zohar Dotan, Tel Hashomer, Israel
MP41-13 COMPARISON OF THE PATHOLOGICAL
ANATOMY OF HEALTHY MARGIN AND
TUMOR ENUCLEATION PARTIAL
NEPHRECTOMY SPECIMENS
Adam C Calaway*, Dibson Gondim, Chandra
Flack, Muhammed Idress, Ronald S Boris,
Indianapolis, IN
MP41-20 RACE EFFECTS ON PATHOLOGICAL AND
FUNCTIONAL OUTCOMES AFTER
Onder Kara*, Hiury Andrade, Homayoun
Zargar, Oktay Akca, Matthew Maurice, Peter
Caputo, Daniel Ramirez, Ercan Malkoc,
Charles Modlin, Jihad Kaouk, Cleveland, OH
MP41-14 COMPARISON OF RENAL STEREOLOGY
AND FUNCTION AFTER HILAR, ARTERIAL
OR SELECTIVE ARTERIAL CLAMPING
FOR LAPAROSCOPIC PARTIAL
NEPHRECTOMY.
Gustavo Bechara, Diogo De Souza*, José
Ferreira Filho, Leonardo Abreu, Bianca
Gregório, Waldemar Costa, Francisco
Sampaio, Rio De Janeiro, Brazil
MP41-15
*Presenting author
CREDITTM
RENAL FUNCTION AND PERIOPERATIVE
OUTCOMES OF SELECTIVE VERSUS
COMPLETE RENAL ARTERIAL CLAMPING
DURING ROBOT-ASSISTED PARTIAL
NEPHRECTOMY USING CONSOLEINTEGRATED REAL-TIME THREEDIMENSIONAL IMAGE OVERLAY
NAVIGATION
Junya Furukawa*, Masatomo Nishikawa,
Tomoaki Terakawa, Koji Chiba, Katsumi
Shigemura, Ken-ichi Harada, Nobuyuki
Hinata, Takeshi Ishimura, Kei Matsushita,
Yuzo Nakano, Hideaki Miyake, Kazushi
Tanaka, Masato Fujisawa, Kobe, Japan
153
SUNDAY
MP41-11 RESECTION TECHNIQUES FOR NEPHRON
SPARING SURGERY (NSS) VARY:
INSIGHTS FROM A PROSPECTIVELY
COLLECTED MULTI-INSTITUTIONAL
COHORT HARNESSING THE SURFACE–
INTERMEDIATE–BASE (S.I.B.) MARGIN
SCORE (SIB INTERNATIONAL
CONSORTIUM)
Andrea Minervini, Riccardo Campi, Andrea
Mari, Florence, Italy, Ottavio DeCobelli, Milan,
Italy, Francesco Sanguedolce, Bristol, United
Kingdom, Georgios Hatzichristodoulou,
Munich, Germany, Alessandro Antonelli,
Brescia, Italy, Brian Lane, Grand Rapids, MI,
Bulent Akdogan, Munich, Germany, Umberto
Capitanio, Milan, Italy, Martin Marszalek,
Vienna, Austria, Alessandro Volpe, Novara,
Italy, Nihat Karakoyunlu, Ankara, Turkey,
Hans Langenhuijsen, Nijmegen, Netherlands,
Tobias Klatte, Vienna, Austria, Oscar
Rodriguez-Faba, Barcelona, Spain, Miki
Haifler, Philadelphia, PA, Sabine BrookmanMay, Munich, Germany, Marco Roscigno,
Bergamo, Italy, Robert Uzzo, Philadelphia,
PA, Marco Carini, Florence, Italy, Alexander
Kutikov*, Philadelphia, PA
Sunday, May 8, 2016
8:00 am - 10:00 am
BENIGN PROSTATIC HYPERPLASIA: SURGICAL THERAPY & NEW TECHNOLOGY III
Moderators: Kevin McVary and Andreas Gross
ABSTRACT
NUMBER TITLE
MP42-01 ANALYSIS OF PRESENT STATUS FOR
SURGERY OF BENIGN PROSTATIC
HYPERPLASIA IN KOREA, 2010 TO 2014
Ji Sung Shim*, Seung Min Jeong, Hoon Choi,
Jae Young Park, Ansan, Korea, Republic Of,
Mi Mi Oh, Jeong Gu Lee, Seoul, Korea,
Republic Of, Jae Hyun Bae, Ansan, Korea,
Republic Of
ABSTRACT
NUMBER TITLE
MP42-08 OUTCOMES OF HOLEP PERFORMED IN
THE RETREATMENT SETTING
Tracy Marien*, Mustafa Kadihasanoglu,
Teerayut Tangpaitoon, Nashville, TN, Nadya
York, Indianapolis, IN, Andrew T. Blackburne,
Rochester, NY, Haidar Abdul-Muhsin,
Scottsdale, AZ, Michael S. Borofsky,
Indianapolis, IN, Amy E. Krambeck,
Rochester, NY, Mitchell R. Humphreys,
Scottsdale, AZ, James E. Lingeman,
Indianapolis, IN, Nicole L. Miller, Nashville,
TN
MP42-02 LONG-TERM EFFICACY OF HOLMIUM
LASER ENUCLEATION OF THE PROSTATE
IN PATIENTS WITH DETRUSOR
UNDERACTIVITY OR ACONTRACTILITY
Derek Lomas*, Amy Krambeck, Rochester,
MN
MP42-09 DURABLE SYMPTOM IMPROVEMENT
AFTER HOLMIUM LASER ENUCLEATION
OF THE PROSTATE (HOLEP): ANALYZING
OUTCOMES AT TEN YEARS IN OVER 100
MEN
Tim Large*, Michael S Borofsky, Casey A
Dauw, Nadya York, James E Lingeman,
Indianapolis, IN
MP42-03 LASER TREATMENT SHORTENS
POSTOPERATIVE LENGTH OF STAY –
CONSECUTIVE ANALYSIS OF 2648
PATIENTS
Thorsten Bach*, Claus Brunken, Andreas
Gross, Christian Wuelfing, Felix Woelbling,
Hamburg, Germany
MP42-10 CAN THE USE OF PRE-OPERATIVE
TRANSRECTAL ULTRASOUND PROSTATE
VOLUME PREDICT THEATRE OPERATING
TIMES FOR HOLMIUM LASER
SURGERY?
Farooq Khan*, M Asad Saleemi, Sanjeev
Taneja, Asher Alam, Mohammed Al-Sheikh,
Ian Nunney, Luton, United Kingdom, Tevita
Aho, Cambridge, United Kingdom
MP42-04 AN EMERGING HOLMIUM LASER
ENUCEATION OF THE PROSTATE
REALITY: 50 WATT HOLMIUM LASER
SURGERY OUTCOMES FROM A SINGLE
UNIT IN THE UK
Farooq Khan*, M Asad Saleemi, Sanjeev
Taneja, Asher Alam, Mohammed Al-Sheikh,
Luton, United Kingdom, Ian Nunney, Norwich,
United Kingdom, Tevita Aho, Cambridge,
United Kingdom
MP42-05
MP42-11 OPERATIVE EFFICIENCY AND POSTOPERATIVE FUNCTIONAL
IMPROVEMENTS OF PATIENTS
UNDERGOING HOLEP STRATIFIED BY
GLAND SIZE
Gregory D Fritz*, Dayton, OH, Michael S
Borofsky, Casey A Dauw, Nadya York,
James E Lingeman, Indianapolis, IN
FLUID DYNAMICS AND METABOLIC
ABNORMALITIES DURING HOLEP
Philip Wanzek*, Mary Westerman, John
Knoedler, Amy Krambeck, Rochester, MN
MP42-06 THE EN BLOC HOLEP TECHNIQUE: OUR
EXPERIENCE
Alim Dymov*, Nikolay Sorokin, Andrey
Vinarov, Moscow, Russian Federation
MP42-12 DO WE ABLATE MORE TISSUE USING
THE 180W XPS GREENLIGHT LASER?
RESULTS FROM A PROSPECTIVE 120W
HPS VS. 180W XPS GREENLIGHT LASER
3D-VOLUMETRY STUDY
Oliver Gross*, Benedikt Kranzbühler, Marian
Severin Wettstein, Christian Daniel
Fankhauser, Nico Grossmann, Etienne Xavier
Keller, Daniel Eberli, Marko Kozomara,
Zürich, Switzerland, Hans Helge Seifert,
Basel, Switzerland, Tullio Sulser, Cedric
Poyet, Thomas Hermanns, Zürich,
Switzerland
MP42-07 POSTOPERATIVE COMPLICATIONS IN 400
PATIENTS UNDERGONE ENDOSCOPIC
PROSTATIC SURGERY WITH THULLIUM
LASER
Luca Carmignani*, Dario Ratti, Damiano
Vizziello, Carlo Marenghi, Stefano Picozzi,
Elisabetta Finkelberg, Sebastiano Nazzani,
Robert Stubinski, Stefano Casellato, Milano,
Italy
154
MP42-13 MULTI-CENTER INTERNATIONAL
EXPERIENCE OF 180W LBO LASER
PHOTO-VAPORIZATION IN MEN WITH
LARGE PROSTATES (TRUS>100CC):
SAFETY OUTCOMES AND PREDICTIVE
FACTORS OF COMPLICATIONS
Malek Meskawi, Pierre-Alain Hueber*, Roger
Valdivieso, Tristan Martel, Mounsif Azizi,
Montreal, Canada, Franck Bruyère, Tours,
France, Vincent Misrai, Toulouse, France,
Georges Fournier, Brest, France, Ravi
Munver, Ganesh Sivarajan, New Jersey, NJ,
New York, NY, Dean Elterman, Toronto,
Canada, Kevin Zorn, Montreal, Canada
MP42-17 TES (THULLIUM EJACULATION
SPARING): IMPACT OF THUVEP/THUVAP
ON SEXUAL OUTCOMES
Luca Carmignani*, Damiano Vizziello, Dario
Ratti, Carlo Marenghi, Claudia Signorini,
Elisabetta Finkelberg, Stefano Picozzi, Robert
Stubinski, Stefano Casellato, Milano, Italy
MP42-14 SAFETY AND EFFICACY OF 180W HIGH
POWER 532 NM LASER VAPORIZATIONENUCLEATION PROSTATECTOMY IN
PROSTATES MEASURING OVER 150CC.
James Forde*, Benjamin Stone, Andrew Tam,
Dominique Thomas, Bilal Chughtai, Alexis Te,
New York, NY
MP42-15
MP42-19 PROSTATE ABLATION AND
ENUCLEATION: COMPARISON OF
PATIENT CHARACTERISTICS AND 30-DAY
SURGICAL OUTCOMES USING A
NATIONAL DATABASE
Evgeniy Kreydin*, Janine Oliver, Los Angeles,
CA, Michelle Kim, Boston, MA, Seth Cohen,
Anne Ackerman, Shlomo Raz, Los Angeles,
CA, Lori Lerner, Plymouth, MA
TREATMENT OF SYMPTOMATIC BENIGN
PROSTATIC HYPERPLASIA IN PATIENTS
OVER 80 YEARS OLD USING 180W HIGH
POWER 532NM LASER VAPORIZATIONENUCLEATION TECHNIQUE
Benjamin Stone*, James Forde, Andrew Tam,
Dominique Thomas, Bilal Chughtai, Alexis Te,
New York, NY
MP42-20 INCIDENTAL PROSTATE CANCER
DIAGNOSED AT HOLMIUM LASER
ENUCLEATION OF PROSTATE - REVIEW
OF PATIENT OUTCOMES
Nadya York*, Timothy Large, Michael
Borofsky, Casey Dauw, James Lingeman,
Ronald Boris, Indianapolis, IN
MP42-16 ASSESSMENT OF ENERGY DENSITY
USAGE DURING 180W LITHIUM
TRIBORATE LASER PHOTO-SELECTIVE
VAPORIZATION OF THE PROSTATE FOR
BENIGN PROSTATIC HYPERPLASIA. IS
THERE AN OPTIMAL AMOUNT OF KILOJOULES PER GRAM OF PROSTATE?
Roger Valdivieso*, Montreal, Canada,
Christian Meyer, Boston, MA, Pierre-Alain
Hueber, Malek Meskawi, Abdullah Alenizi,
Montreal, Canada, Quoc-Dien Trinh, Boston,
MA, Vincent Misrai, Toulouse, France,
New York, NY, Neil Barber, Amr Emara,
Surrey, United Kingdom, Ravi Munver, New
Jersey, NJ, Kevin Zorn, Montreal, Canada
CREDITTM
Sunday, May 8, 2016
8:00 am - 10:00 am
PEDIATRICS: TESTIS, VARICOCELE & STONES
Moderators: Kate Kraft and Gregory Tasian
ABSTRACT
NUMBER TITLE
MP43-01 EXTRACTABLE FRAGMENT VERSUS
DUSTING DURING URETEROSCOPIC
LASER LITHOTRIPSY IN CHILDREN:
PROSPECTIVE RANDOMIZIED STUDY
Mohamed Youssif, Ahmed fahmy*, Ibrahim
Mokhles, Ahmed Moustafa, Alexandria, Egypt
*Presenting author
ABSTRACT
NUMBER TITLE
MP43-02 INSIGHTS INTO PEDIATRIC STONE
DISEASE FROM A COMPARATIVE
FUNCTIONAL ANALYSIS OF THE
URINARY PROTEOME IN CHILDREN AND
ADULTS
Joel Koenig*, Scott Manson, Qiusha Guo,
Katelynn Moore, Zev Leopold, Paul Austin,
Saint Louis, MO
155
SUNDAY
MP42-18 CAN WE PRESERVE EJACULATION
AFTER TRANSURETHRAL RESECTION OF
THE PROSTATE? COMPARATIVE STUDY
BETWEEN THE CONVENTIONAL
TECHNIQUE AND A NEW TECHNIQUE
ABOUT 70 CASES
Sami Ben Rhouma*, Mohamed Ali Ben
Chehida, Sallami Ahmed, Gargouri Mourad,
Nouira Yassine, Tunis, Tunisia
MP43-03 DIETARY ZINC IS INVERSELY
ASSOCIATED WITH RISK OF
NEPHROLITHIASIS IN ADOLESCENTS
Gregory Tasian*, Michelle Ross, Lihai Song,
Robert Grundmeier, James Massey,
Philadelphia, PA, Thomas Chi, San
Francisco, CA, David Killilea, Oakland, CA,
Marshall Stoller, San Francisco, CA, Susan
Furth, Philadelphia, PA
MP43-11 TESTICULAR TORSION PAIN IN THE
PREPUBERTAL PATIENT: VARIATIONS IN
PRESENTATION
Kunj R. Sheth*, Dallas, TX, Melies Keays,
Ottawa, Canada, Candace Granberg,
Rochester, MN, Gwen M. Grimsby, Phoenix,
CA, Vani S. Menon, Dallas, TX, Daniel
DaJusta, Columbus, OH, Lauren Ostrov,
Martinez Hill, Emma Sanchez, Ryan
Hutchinson, Clanton B. Harrison, Micah A.
Jacobs, Rong Huang, Dallas, TX, Berk
Bergu, Ankara, Turkey, Halim Hennes, Bruce
J. Schlomer, Linda A. Baker, Dallas, TX
MP43-04 24-HOUR URINE ANALYSES AND KIDNEY
STONE RECURRENCE IN CHILDREN AND
ADOLESCENTS
Gregory Tasian*, Abdo Kabarriti, Angela
Kalmus, Susan Furth, Philadelphia, PA
MP43-05
MP43-12 US STATE AND FEDERAL TESTICULAR
TORSION MALPRACTICE LITIGATION: A
LEGAL DATABASE REVIEW
Thomas Gaither*, Hillary Copp, San
Francisco, CA
VARIATION IN CONSECUTIVE 24-HOUR
URINE STUDIES IN PEDIATRIC PATIENTS
Jonathan Ellison*, Seattle, WA, John
Hollingsworth, Phyllis Yan, Ann Arbor, MI,
John Asplin, Chicago, IL, Maggie Bierlein,
Ann Arbor, MI, Mark Barraza, Jacksonville,
FL, William Defoor, Cincinnati, OH, T Ernesto
Figueroa, Wilmington, DE, Elizabeth Jackson,
Cincinnati, OH, Rama Jayanthi, Columbus,
OH, Emilie Johnson, Chicago, IL, David
Joseph, Birmingham, AL, Craig Langman,
Chicago, IL, Andrew Schwaderer, Columbus,
OH, Margarett Shnorhavorian, Seattle, WA
MP43-13 HETEROGENEITY ON TESTICULAR
ULTRASOUND DIFFERS BETWEEN
NORMAL AND TORSED TESTES IN
PEDIATRIC PATIENTS
Christopher Hartman*, Patrick Samson,
Ricardo Palmerola, New Hyde Park, NY, Zara
Rahman, Maurisa Morris, Hempstead, NY,
Michael Siev, New York, NY, Lane S. Palmer,
New Hyde Park, NY, Sleiman Ghorayeb,
Hempstead, NY
MP43-06 24 HOUR URINARY PARAMETERS IN
OVERWEIGHT AND OBESE PEDIATRIC
PATIENTS - A SINGLE INSTITUTION
COHORT
Jathin Bandari*, Pankaj Dangle, Timothy
Lyon, Francis Schneck, Glenn Cannon, Heidi
Stephany, Michael Ost, Pittsburgh, PA
MP43-14 DOES ATMOSPHERIC TEMPERATURE
AFFECT THE RATE OF TESTICULAR
TORSION?
Jessica T. Casey*, Benjamin M. Whittam,
Konrad M. Szymanski, Rosalia Misseri, Mark
P. Cain, William E. Bennett, Jr., Indianapolis,
IN
MP43-07 FACTORS ASSOCIATED WITH
RECURRENT PEDIATRIC UROLITHIASIS:
A MULTI-INSTITUTIONAL ANALYSIS
Theodore Saitz*, Solange MongoueTchokote, Portland, OR, Cynthia Sharadin,
Dana Giel, Memphis, TN, Sean Corbett,
Charlottesville, VA, Aaron Bayne, Portland,
OR
MP43-15
MP43-08 UTILIZATION OF MEDICAL EXPULSIVE
THERAPY IN CHILDREN: AN
ASSESSMENT OF NATIONWIDE
PRACTICE PATTERNS AND OUTCOMES
Jonathan Ellison*, Benjamin Fu, Sarah Holt,
Thomas Lendvay, John Gore, Margarett
Shnorhavorian, Seattle, WA
PROTECTIVE EFFECT OF PLATELET RICH
PLASMA ON EXPERIMENTAL ISCHEMIA/
REPERFUSION INJURY IN TORSION OF
RAT TESTIS
Cagri Akin Sekerci, Yiloren Tanidir*, Tarik
Emre Sener, Ahmet Sahan, Istanbul, Turkey,
Ozge Cevik, Sivas, Turkey, Aysen Yarat,
Burcin Alev Tuzuner, Sule Cetinel, Elif
Kervacioglu Demir, Göksel Sener, Cem
Akbal, Istanbul, Turkey
MP43-16 HOW MANY SEMEN ANALYSES ARE
NEEDED TO EVALUATE THE
ADOLESCENT WITH A VARICOCELE?
Samir Derisavifard*, Casey A Seideman,
Wayland Wu, Ronnie G Fine, Jordan Gitlin,
Lane S Palmer, New Hyde Park, NY
MP43-09 CHANGES IN IMAGING FOR
UROLITHIASIS FOLLOWING THE IMAGE
GENTLY® CAMPAIGN AT A LARGE
CHILDREN’S HOSPITAL
Michael Kurtz*, Erin McNamara, Jeanne
Chow, Caleb Nelson, Boston, MA
MP43-17 TO DO OR NOT TO DO TESTIS-DELIVERYPROCEDURE DURING MICROSURGICAL
SUBINGUINAL VARICOCELECTOMY
PERFORMED ON PEDIATRIC PATIENTS
Young Kwon Hong*, Chang Il Choi, Young
Dong Yu, Geon Woo Lim, Seung Ryul Lee,
Dong Soo Park, Kyonggi, Korea, Republic of
MP43-10 LACK OF PARENTAL AWARENESS IN
TESTICULAR TORSION
Ariella A. Friedman*, Haris Ahmed, Jordan
Gitlin, Lane S. Palmer, New Hyde Park, NY
MP43-18 DOES VARICOCELE REPAIR IMPROVE
TOTAL MOTILE SPERM COUNT (TMSC) IN
ADOLESCENTS? A PILOT STUDY
Mihir Shah*, Philadelphia, PA, Julia Barthold,
Li Xie, Ahmad Bani-Hani, Wilmington, DE
156
MP43-19 RELATIONSHIP BETWEEN SERTOLI CELL
FUNCTION AND DIFFERENTIATION
PROCESS OF SPERMATOGONIAL STEM
CELLS IN CRYPTORCHID TESTES
Takashi Nagai*, Kentaro Mizuno, Yutaro
Hayashi, Hideyuki Kamisawa, Yoshinobu
Moritoki, Hidenori Nishio, Satoshi Kurokawa,
Akihiro Nakane, Tetsuji Maruyama, Takahiro
MP43-20 TESTICULAR HYPOPLASIA IS DRIVEN BY
DEFECTIVE VASCULAR FORMATION
Pankaj Dangle*, Dr. Cláudia Salgado, Miguel
Reyes-Mugica, Rajeev Chaudhry, Francis
Schneck, Michael Ost, Sunder Sims-lucas,
Pittsburgh, PA
CREDITTM
Sunday, May 8, 2016
8:00 am - 10:00 am
Podium Session 25
TIME
8:00
ABSTRACT
NUMBER TITLE
PD25-01 LONG-TERM IMPACT OF MODE OF
DELIVERY ON STRESS URINARY
INCONTINENCE AND URGENCY URINARY
INCONTINENCE: A SYSTEMATIC REVIEW
AND META-ANALYSIS.
Riikka Tähtinen, Kuopio, Finland, Rufus
Cartwright, London, United Kingdom,
Johnson Tsui*, New York City, NY, Riikka
Aaltonen, Turku, Finland, Yoshitaka Aoki,
Fukui, Japan, Jovita Cárdenas, México,
Mexico, Regina El Dib, São Paulo, Brazil,
Kirsi Joronen, Turku, Finland, Sumayyah Al
Juaid, Jeddah, Saudi Arabia, Sabreen
Kalantan, Riyadh, Saudi Arabia, Michal
Kochana, Malgorzata Kopec, Krakow, Poland,
Luciane Lopes, São Paulo, Brazil, Enaya
Mirza, London, United Kingdom, Sanna
Oksjoki, Turku, Finland, Jori Pesonen, Lahti,
Finland, Antti Valpas, Lappeenranta, Finland,
Li Wang, Yuqing Zhang, Diane Heels-Ansdell,
Gordon Guyatt, Hamilton, Canada, Kari
Tikkinen, Helsinki, Finland
8:10
PD25-02
THE IMPACT OF BASELINE DISABILITY
ON SURGICAL RISK FOR OLDER ADULTS
TREATED FOR KIDNEY CANCER
Hung-Jui Tan*, Mark Litwin, Los Angeles, CA,
8:20
PD25-03
SERIES OF SYSTEMATIC REVIEWS AND
META-ANALYSES OF THE RISK OF
THROMBOSIS AND BLEEDING IN
UROLOGICAL CANCER SURGERY
(ROTBUS CANCER)
Kari Tikkinen*, Helsinki, Finland, Samantha
Craigie, Hamilton, Canada, Arnav Agarwal,
Toronto, Canada, Philippe Violette, London,
Canada, Giacomo Novara, Padua, Italy,
Rufus Cartwright, London, United Kingdom,
Richard Naspro, Bergamo, Italy, Reed
Siemieniuk, Toronto, Canada, Michael Gould,
Pasadena, CA, Per Morten Sandset, Oslo,
Norway, Gordon Guyatt, Hamilton, Canada
*Presenting author
ABSTRACT
TIME NUMBER TITLE
8:30 PD25-04 A COMPARISON OF EVALUATION
STRATEGIES IN PATIENTS WITH
ASYMPTOMATIC MICROSCOPIC
HEMATURIA
Matthew Nielsen*, Mihaela Georgieva, Daniel
Erim, Chapel Hill, NC, Rebecca SmithBindman, San Francisco, CA, Ronald Loo,
Casey Ng, Pasadena, CA, Tullika Garg,
Danville, PA, Mathew Raynor, Stephanie
Wheeler, Chapel Hill, NC
157
8:40
PD25-05
EVALUATING THE EFFECTIVENESS OF
UROLOGIC TELEMEDICINE IN MALE
PRISONERS
Brenton Sherwood*, Kenneth Nepple, Bradley
Erickson, Iowa City, IA
8:50
PD25-06
THE PATIENT EXPERIENCE AND THE
QUALITY OF UROLOGIC CANCER
SURGERY IN US HOSPITALS
Joseph Shirk*, Hung-Jui Tan, Los Angeles,
CA, Jim Hu, New York, NY, Christopher
Saigal, Mark Litwin, Los Angeles, CA
9:00
PD25-07
IDENTIFYING DRIVERS OF TOTAL
EPISODE COST VARIATION IN RADICAL
PROSTATECTOMY
Lindsey Herrel*, John Syrjamaki, Susan
Linsell, David Miller, James Dupree, Ann
Arbor, MI
9:10
PD25-08
UNDERSTANDING THE RELATIONSHIP
BETWEEN EPISODE COSTS AND
DEVIATIONS FROM AN UNCOMPLICATED
RADICAL PROSTATECTOMY RECOVERY
PATHWAY
James Dupree*, Stacie Myers, Ann Arbor, MI,
Craig Rogers, Detroit, MI, John Syrjamaki,
Susan Linsell, Yuqing Gao, Khurshid Ghani,
James Montie, David Miller, Ann Arbor, MI
9:20
PD25-09
CLINICAL INTEGRATION IS ASSOCIATED
WITH LOWER COSTS OF CARE AMONG
PATIENTS UNDERGOING
PROSTATECTOMY
John M. Hollingsworth*, Ann Arbor, MI,
Russell Funk, Minneapolis, MN, Amy
Luckenbaugh, Jason Owen-Smith, Samuel
Kaufman, Brahmajee Nallamothu, Ann Arbor,
MI
SUNDAY
GENERAL & EPIDEMIOLOGICAL TRENDS & SOCIOECONOMICS: VALUE OF CARE: COST AND OUTCOMES MEASURES I
Moderators: Danil Makarov and Christopher Tessier
9:30
9:40
PD25-10
PD25-11
A STATEWIDE INTERVENTION TO
REDUCE THE USE OF LOW VALUE
IMAGING AMONG MEN WITH NEWLYDIAGNOSED PROSTATE CANCER.
Patrick Hurley*, Novi, MI, James Montie,
Apoorv Dhir, Yuqing Gao, Ann Arbor, MI,
Brian Drabik, Cadillac, MI, Kenneth Lim, Novi,
MI, Jon Curry, Grand Rapids, MI, Susan
Linsell, Andrew Brachulis, Khurshid Ghani,
Brian Denton, David Miller, Ann Arbor, MI
9:50
PD25-12
UROLOGIST PARTICIPATION IN
MEDICARE SHARED SAVINGS PROGRAM
(ACOS)
Scott Hawken*, Lindsey Herrel, Chandy
Ellimoottil, Zaojun Ye, Brent Hollenbeck,
CREDITTM
EARLY IMPACT OF MEDICARE
ON UROLOGICAL CANCER OUTCOMES
Lindsey Herrel*, Scott Hawken, Zaojun Ye,
Edward Norton, David Miller, Ann Arbor, MI
Sunday, May 8, 2016
8:00 am - 10:00 am
Video Session 5
RENAL ONCOLOGY
Moderators: Guan Wu and Kelly Stratton
ABSTRACT
NUMBER TITLE
V5-01
ROBOTIC PARTIAL NEPHRECTOMY FOR
INCREASINGLY COMPLEX RENAL
MASSES IN SOLITARY KIDNEYS USING
OFF CLAMP AND EARLY UNCLAMPING
TECHNIQUES
Manish Patel*, Ashok Hemal, Winston-Salem, NC
V5-02
HIGHLY COMPLEX RENAL MASSES
V5-03
NOVEL TECHNIQUE FOR PRE-OPERATIVE
REMOVAL OF INTRACARDIAC
THROMBUS PRIOR TO RADICAL
NEPHRECTOMY AND IVC
THROMBECTOMY
John Humphrey*, Drew Palmer, Ariel
Fredrick, John Libertino, Burlington, MA
V5-04
V5-05
V5-06
ABSTRACT
NUMBER TITLE
V5-07
A NOVEL TECHNIQUE OF NON-TISSUE
SUTURING LAPAROSCOPIC PARTIAL
NEPHRECTOMY WITHOUT THE
RENORRHAPHY
Nobuyuki Fukuzawa*, Hiroshi Tanaka,
Madoka Higuchi, Hidetaka Suzuki, Ai
Kawaguchi, Shintaro Maru, Tomoshige Akino,
Yoshiki Wada, Hiroshi Harada, Toshimori
Seki, Sapporo, Japan
A NOVEL APPROACH TO INTRAURETERAL
RESECTION OF NEOPLASMS: EN BLOC
LASER FULGURATION OF METASTATIC
RENAL CARCINOMA
Daniel M. Tennenbaum*, Eugene Pietzak,
Aditya Bagrodia, Jonathan Coleman, New
York, NY
SALVAGE ROBOTIC PARTIAL
NEPHRECTOMY AFTER FAILED CRYOABLATION
Aryeh Keehn*, Jacob Taylor, Reza
Ghavamian, Bronx, NY
INITIAL EXPERIENCE DURING
DEVELOPMENT OF LAPAROSCOPIC
12MM HIFU PROBE
Tim Large*, Chandru Sundaram, Indianapolis, IN
158
V5-08
CONTEMPORARY OPEN SURGICAL
TECHNIQUES FOR INTRACARDIAC
RENAL TUMOURS
Muddassar Hussain*, Kay Thomas, Conal
Austin, Tim O’Brien, London, United Kingdom
V5-09
PARTIAL NEPHRECTOMY FOR A T2B
LESION: TECHNIQUE AND OUTCOMES
Samay Jain*, Toledo, OH
V5-10
RIGHT RADICAL NEPHRECTOMY WITH
DISSECTION OF THROMBUS IN THE
INFERIOR VENA CAVA LEVEL III
Ivan Pinto, Roberto Vilches, Jorge Diaz, Pablo
Marchetti, Jaime Altamirano, Camilo Sandoval,
Alvaro Vidal, Cristobal Roman*, Alfredo Velasco,
Manuel Diaz, Ruben Olivares, Jose Miguel
Cabello, Renato Cabello, JC De la Maza, E
Turner, Santiago, Chile
V5-11
INTRASINUSAL DISSECTION AND 3-MM
OFF-CLAMP RENAL TUMORECTOMY BY
RETROPERITONEOSCOPY
Juan Antonio Peña*, Enver Moncada, Ivan
Schwartzmann, Esteban Emiliani, Alberto
Breda, Joan Palou, Humberto Villavicencio,
Barcelona, Spain
V5-12
LAPAROSCOPIC RESECTION OF
RETROPERITONEAL RECURRENCE OF
RENAL CARCINOMA
Juan Antonio Peña*, Enver Moncada, Ivan
Schwartzmann, Nicolás Nervo, Oscar
Rodrı́guez, Aguinel José Bastian, Joan Palou,
Humberto Villavicencio, Barcelona, Spain
CREDITTM
Sunday, May 8, 2016
8:00 am - 5:00 pm
8:00
1:00
BLADDER CANCER
Kristen Scarpato
8:05
FEMALE SEXUAL DYSFUNCTION
Irwin Goldstein
2:00
HORMONE RESISTANT PROSTATE CANCER
Anne Calvaresi
9:00
TESTOSTERONE REPLACEMENT AND FDA
WARNINGS
Kenneth Mitchell
3:00
MRI- UTILIZATION IN PROSTATE IMAGING
Lee Ponsky
4:00
10:00
GUIDELINES FOR TREATMENT AND FOLLOWUP OF RENAL CANCER
Arnold Chin
PROSTATE CANCER-ACTIVE SURVEILLANCE
AND MOLECULAR TESTING
Daniel Park
4:50
11:00
GUIDELINES FOR STONE WORKUP AND
PREVENTION
Davis Viprakasit
CLOSING REMARKS
5:00
ADJOURN
12:00
LUNCH BREAK
Sunday, May 8, 2016
10:00 am - 2:00 pm
CHALLENGES FOR UROLOGIC RESEARCH: DIABESITY
10:00
Carolyn Best
12:15
KEYNOTE: DIABETES AND METABOLIC
SYNDROME
David Bernlohr
TYPE II DIABETES, OBESITY AND URINARY
INCONTINENCE IN WOMEN
Jeanette Brown
10:05
12:35
Q&A
12:45
THE EFFECTS OF CAFFEINE AND SUGARSWEETENED BEVERAGE INTAKE ON
ERECTILE DYSFUNCTION IN DIABETIC OR
OBESE MEN
David Lopez
DIABESITY AND MALE INFERTILITY
Michael Eisenberg
1:05
NEW INSIGHTS FOR UROLOGIC
COMPLICATIONS IN TYPE I DIABETES
Aruna Sarma
10:45
Q&A
1:25
10:55
OBESITY AND AGE PROMOTE EPIGENTIC
SUPPRESSION OF PROSTATIC 5-ALPHA
REDUCTASE 2 – OPPORTUNITIES FOR
PERSONALIZED CARE IN BPH
Aria Olumi
INCREASED RISK OF URINARY TRACT
INFECTION IN A MOUSE MODEL OF TYPE II
DIABETES
Sara Colopy
1:54
Q&A
2:00
ADJOURN
10:25
11:15
DIABESITY AND LUTS
Wade Bushman
11:35
DIABETES AND RISK OF URINARY TRACT
INFECTIONS
Edward Boyko
11:55
DIABETES, OBESITY AND STONE DISEASE
David Goldfarb
*Presenting author
CREDITTM
159
SUNDAY
UROLOGIC CARE FOR THE ALLIED HEALTH PROFESSIONAL
Sunday, May 8, 2016
10:15 am - 4:00 pm
13TH INTERNATIONAL PROSTATE FORUM
10:15
13TH IPF INTRODUCTIONS AND AUA PCA
PROGRAMS
John Davis, Neal Shore
1:30
PCA IN JAPAN: OVERVIEW OF THE 2ND
LARGEST HEALTH CARE SYSTEM
Hideyuki Akaza
10:30
SESSION I: BIOLOGY
Moderators: Prokar Dasgupta, Badar Mian
1:45
10:30
PROSTATE CANCER 2016: WORLDWIDE
EPIDEMIOLOGY TRENDS
Curtis Pettaway
PRIAS STUDY: DESIGN AND CURRENT
STATUS
Monique Roobol
2:00
EYE OF THE BEHOLDER: IS DELAYED
TREATMENT ON ACTIVE SURVEILLANCE A
SUCCESS OR FAILURE?
Laurence Klotz
2:15
DISCUSSION
Moderators: Brian Chapin, Kelly Stratton
2:25
ABLATION THERAPY: HOW TO DISTINGUISH
ONCOLOGIC EFFICACY FROM AN ACTIVE
SURVEILLANCE MIMIC
Jean de la Rosette
10:45
PROSTATE CANCER GENETICS: CAN WE RECLASSIFY HETEROGENEITY
Stephen Freedland
11:00
DISCUSSION
11:10
SESSION II: DETECTION AND DIAGNOSTICS
Moderators: Peter Albertsen, Rafael Sanchez Salas
11:10
PRIMARY SCREENING—TIME TO CHANGE?
Stacy Loeb
2:40
11:25
USPSTF—EARLY IMPACT ON SCREENING
AND STAGING
Matthew Cooperberg
WHAT’S NEXT FOR RADIATION THERAPY IN
LOW TO FAVORABLE/INTERMEDIATE RISK?
Mack Roach
2:55
11:35
PREVENTING PROSTATE BIOPSY INFECTION:
PRE-CULTURE TRUS OR TRANSPERINEAL
Declan Murphy
SURGICAL PATHOLOGY VERSUS QUALITY OF
LIFE—WHICH SHOULD TAKE PRIORITY?
Rafael Coelho
3:10
DISCUSSION
11:50
MRI BEFORE PRIMARY VERSUS
SUBSEQUENT BIOPSIES
Mark Emberton
3:25
12:05
REPEAT BIOPSY: STATE-OF-THE-ART
PATIENT SELECTION AND TECHNIQUE
E. David Crawford
CASE DISCUSSION PANEL: NON-METASTATIC
AND ASYMPTOMATIC METASTATIC
CASTRATE RESISTANT PROSTATE CANCER
Moderator: Judd Moul
Presenters: Charles Ryan, Michael Cookson
3:55
12:20
DISCUSSION
WELCOMING COMMENT: 14TH IPF IN TURKEY
Mevlana Derya Balbay
12:30
LUNCH
4:00
ADJOURN
1:30
SESSION III: ACTIVE SURVEILLANCE AND
TREATMENT
Moderator: Derya Tilki
CREDITTM
Sunday, May 8, 2016
10:30 am - 12:30 pm
BENIGN PROSTATIC HYPERPLASIA: BASIC RESEARCH & PATHOPHYSIOLOGY
Moderator: Robert Getzenberg
ABSTRACT
NUMBER TITLE
MP44-01 SUPPRESSION OF STEROID-5-ALPHAREDUCTASE 2 (SRD5A2) IN HUMAN
PROSTATE IS REGULATED BY
EPIGENETIC MODIFICATIONS
Rongbin Ge, Zongwei Wang*, Shulin Wu,
Chin-Lee Wu, Shahin Tabatabaei, Aria Olumi,
Boston, MA
ABSTRACT
NUMBER TITLE
MP44-02 EFFECTS OF ANTIANDROGEN AND 5ALPHA-REDUCTASE INHIBITOR ON
PROSTATE TISSUE ANDROGEN
CONTENT
Yasuhiro Shibata*, Seiji Arai, Takashi Nitta,
Yoshiyuki Miyazawa, Haruo Kato, Hidekazu
Koike, Kazuto Ito, Kazuhiro Suzuki,
Maebashi, Japan
160
MP44-03 THE ADDITIONAL EFFECTS OF ALPHA
BLOCKER IN BPH RAT; EFFECT ON CNS
AND PROSTATE VOLUME
Khae Hawn Kim*, Chang Hee Kim, Kwang
Taek Kim, Jin Kyu Oh, Tae Beom Kim, Han
Jung, Sang Jin Yoon, Kyung Jin Chung,
Incheon, Korea, Republic of
MP44-11 GROWTH HORMONE-RELEASING
HORMONE (GHRH) ANTAGONISTS
REDUCE INFLAMMATION- AND
TRANSFORMING GROWTH FACTOR
(TGF)-␤2-INDUCED PROLIFERATION OF
HUMAN BPH-1 PROSTATE EPITHELIAL
CELLS GROWN IN 3D CULTURE
Petra Popovics*, Andrew V. Schally, Roberto
Perez, Rhenzi Cai, Ferenc G. Rick, Miami, FL
MP44-04 THE ASSOCIATION OF ALPHA1AADRENOCEPTOR (ADRA1A) GENE
SINGLE NUCLEOTIDE POLYMORPHISMS
WITH ADVERSE EVENTS OF ALPHA
BLOCKERS IN KOREAN BPH
POPULATION.
Chung Lyul Lee*, Ki Hak Song, Seung Woo
Yang, Young Seop Chang, Jae Sung Lim,
Yong Gil Na, Daejeon, Korea, Republic of
EARLY-ONSET SYMPTOMATIC BPH
TISSUES OF MEN LESS THAN OR EQUAL
TO 50 YEARS OLD APPEARED TO BE
INCREASED STROMAL COMPONENTS
AND VASCULARITY
Yang Yang*, Shuai Hu, Zhenhua Liu, Yun
Cui, Yu Fan, Qun He, Wei Yu, Jie Jin,
MP44-13 EFFECTS OF THE RECEPTOR
ANTAGONIST PICOTAMIDE ON
ENDOTHELIN-1-, ⴚ2- AND ⴚ3-INDUCED
CONTRACTIONS IN HUMAN PROSTATE
SMOOTH MUSCLE
Alexander Tamalunas*, Christian Gratzke,
Frank Strittmatter, Raphaela Waidelich,
Christian Stief, Martin Hennenberg, Munich,
Germany
MP44-06 THE ROLE OF EGF IN BPH DIAGNOSTICS
AND PROGRESSION MONITORING.
Leonid Spivak*, Yury Doludin, Ekaterina
Lartsova, Sergei Lutsenko, Moscow, Russian
Federation
MP44-14 INHIBITION OF ADRENERGIC AND NONADRENERGIC SMOOTH MUSCLE
CONTRACTION IN THE HYPERPLASTIC
HUMAN PROSTATE BY THE
PHOSPHODIESTERASE 10-SELECTIVE
INHIBITOR TC-E 5005
Martin Hennenberg*, Melanie Schott, Patrick
Keller, Alexander Tamalunas, Anna
Ciotkowska, Beata Rutz, Raphaela Waidelich,
Frank Strittmatter, Christian Stief, Christian
Gratzke, Munich, Germany
MP44-07 THE USE OF CLARITY-OPTIMIZED LIGHTSHEET MICROSCOPY (COLM) FOR HIGH
RESOLUTION IMAGING OF THE ADULT
MOUSE PROSTATE
Yan Liu, Herbert Lepor, Xue-Ru Wu, Ellen
Shapiro*, New York, NY
MP44-08 FETAL PROGRAMMING BY HIGH-FAT
DIET ALTERS PROSTATE MORPHOLOGY
IN WISTAR RATS’ OFFSPRING
Pamella Campos-Silva, Angelo SouzaFernandes, Diogo De Souza, Rio de Janeiro,
Brazil, Fernanda Nascimento, Macae, Brazil,
Waldemar Costa, Francisco Sampaio, Bianca
Gregorio*, Rio de Janeiro, Brazil
MP44-15
MP44-09 NON-ALCOHOLIC FATTY LIVER DISEASE
IS ASSOCIATED WITH GREATER
SEVERITY OF INTRA PROSTATIC
INFLAMMATION IN PATIENTS WITH
Giorgio Ivan Russo*, Sebastiano Cimino,
Giulio Reale, Daniele Urzı̀, Luca Vanella,
Fabio Motta, Rosario Caltabiano, Lidia Puzzo,
Valeria Sorrenti, Giuseppe Morgia, Catania,
Italy
MP44-16 SMOOTH MUSCLE CONTRACTION AND
GROWTH OF STROMAL CELLS IN THE
HUMAN PROSTATE ARE BOTH INHIBITED
BY THE SRC FAMILY KINASE
INHIBITORS, AZM475271 AND PP2
Yiming Wang*, Alexander Tamalunas, Frank
Strittmatter, Beata Rutz, Anna Ciotkowska,
Raphaela Waidelich, Munich, Germany,
Chunxiao Liu, Guangzhou, China, People’s
Republic of, Christian Stief, Christian Gratzke,
Martin Hennenberg, Munich, Germany
MP44-10 CD8ⴙ T CELLS PROMOTE
PROLIFERATION OF BENIGN PROSTATIC
HYPERPLASIA EPITHELIAL CELLS IN THE
CONDITION OF LOW ANDROGEN VIA
MODULATION OF CCL5 -> STAT5 ->
CYCLIN D1 SIGNALING
Yang Yang*, Shuai Hu, Yun Cui, Yu Fan,
Tianjing Lv, Qun He, Wei Yu, Jie Jin, Beijing,
*Presenting author
SPONTANEOUS MYOGENIC
CONTRACTILITY IN THE HUMAN
PROSTATE GLAND: IMPLICATIONS FOR
THE TREATMENT OF LUTS ASSOCIATED
WITH BPH.
Betty Exintaris*, Sophie Lee, Basu
Chakrabarty, Brad Wittmer, Melissa
Papargiris, John Pedersen, Shane Battye,
Mark Frydenberg, Nathan Lawrentschuk,
Stuart Ellem, Gail Risbridger, Melbourne,
Australia
161
SUNDAY
MP44-05
MP44-12 ESTROGEN DIRECTLY MODULATES
SPONTANEOUS CONTRACTILITY WITHIN
THE HUMAN PROSTATE
Sophie Lee*, Melbourne, Australia, Basu
Chakrabarty, Parkville, Australia, Melissa
Papargiris, Jenna Van Gramberg, Mark
Frydenberg, Jeremy Grummet, Ross Snow,
John Pederson, Shane Battye, Stuart Ellem,
Melbourne, Australia, Betty Exintaris,
Parkville, Australia, Gail Risbridger,
MP44-17 EPITHELIAL SENSORY PROTEIN
EXPRESSIONS OF THE BLADDER
MUCOSA IN PATIENTS WITH DIFFERENT
SUBTYPES OF BLADDER OUTLET
OBSTRUCTION
Yuan-Hong Jiang*, Cheng-Ling Lee, Shu-Yu
Wu, Hann-Chorng Kuo, Hualien, Taiwan
MP44-19 MOLECULAR CHARACTERIZATION OF
BLADDER OUTLET OBSTRUCTION
IDENTIFIES MICRORNA BIOMARKERS OF
BLADDER DYSFUNCTION
Ali Hashemi Gheinani*, Fiona C. Burkhard,
Bern, Switzerland, Hubert Rehrauer,
Catharine Aquino Fournier, Zurich,
Switzerland, Irene Keller, Rémy Bruggmann,
Katia Monastyrskaya, Bern, Switzerland
MP44-18 INHIBITION OF SMOOTH MUSCLE
CONTRACTION BY THE INHIBITOR FOR
CYTOHESIN FAMILIY GUANOSINE
NUCLEOTIDE EXCHANGE FACTORS,
SECIN H3 IN THE HYPERPLASTIC HUMAN
PROSTATE
Martin Hennenberg*, Patrick Keller, Melanie
Schott, Alexander Tamalunas, Anna
Ciotkowska, Beata Rutz, Raphaela Waidelich,
Frank Strittmatter, Christian Stief, Christian
Gratzke, Munich, Germany
MP44-20 EFFECT OF CHOLINESTERASE INHIBITOR
NEOSTIGMINE AND ADRENOBLOCKER
DOXAZOSIN ON PARASYMPATHETIC AND
CONTRACTILE ACTIVITIES OF
OBSTRUCTED BLADDER IN RATS
Irina Mudraya*, Vladimir Kirpatovsky, Irina
Kabanova, Moscow, Russian Federation
CREDITTM
Sunday, May 8, 2016
10:30 am - 12:30 pm
BLADDER CANCER: BASIC RESEARCH & PATHOPHYSIOLOGY I
Moderators: Peter Black and Ralph deVere White
ABSTRACT
NUMBER TITLE
MP45-01 EXOSOMAL MIRNAS: KEY REGULATORS
OF CELL-CELL COMMUNICATION
BETWEEN BLADDER CANCER CELLS AND
TUMOR MICROENVIRONMENT
Sophie Baumgart, Joana Heinzelmann, Elmar
Krause, Homburg, Germany, Marie Stampe
Ostenfeld, Aarhus, Denmark, Arndt
Hartmann, Erlangen, Germany, Michael
Stöckle, Kerstin Junker*, Homburg, Germany
MP45-02
ABSTRACT
NUMBER TITLE
MP45-05 UROTHELIUM-SPECIFIC AND
TEMPORALLY CONTROLLED BI-ALLELIC
INACTIVATION OF BOTH PTEN AND P53
TRIGGERS BASAL-SUBTYPE MUSCLEINVASIVE BLADDER CANCER
Feng He, Yan Liu, Herbert Lepor, Moonshong Tang, Chuanshu Huang, Xue-Ru Wu*,
New York, NY
CDODA-ME DECREASES SPECIFICITY
PROTEIN TRANSCRIPTION FACTORS AND
INDUCES APOPTOSIS IN BLADDER
CANCER CELLS THROUGH INDUCTION
OF REACTIVE OXYGEN SPECIES
Hisashi Takeuchi*, Ibaraki, Japan, Rikiya
Taoka, Kagawa, Japan, Goodwin G Jinesh,
Chinedu O Mmeje, Houston, TX, Stephen
Safe, College Station, TX, Teiichiro Aoyagi,
Ibaraki, Japan, Masaaki Tachibana, Tokyo,
Japan, Ashish M Kamat, Houston, TX
MP45-03
TAILLESS PTEN: A POTENT TUMOR
SUPPRESSOR IN UROTHELIAL
CARCINOMA CELLS
New York, NY
MP45-04
PATERNALLY EXPRESSED GENE-10
PROMOTES CELL GROWTH AND
INVASION OF BLADDER CANCER.
Yoshihisa Kawai*, Vancouver, Canada,
Shusuke Akamatsu, Kyoto, Japan, Tetsutaro
Hayashi, Hiroshima, Japan, Eliana Beraldi,
Fan Zhang, Roland Seiler, Jeffrey Leong,
Htoo Oo, Igor Moskalev, Ladan Fazli,
Vancouver, Canada, Hideyasu Matsuyama,
Ube, Japan, Peter Black, Colin Collins, Martin
Gleave, Vancouver, Canada
162
MP45-06
CLINICAL SIGNIFICANCE AND
BIOLOGICAL ROLES OF RAB23 IN HUMAN
BLADDER CANCER
Yuanjun Jiang*, Yushuang Han, Qiao Qiao,
Shenyang, China, People’s Republic Of
MP45-07
ADVANCED TWO-STEP
TRANSCRIPTIONAL AMPLIFICATION AS A
NOVEL SYSTEM FOR DETECTING VIABLE
BLADDER CANCER CELLS
Takuya Sadahira*, Masami Watanabe, Motoo
Araki, Shin Ebara, Toyohiko Watanabe,
Yasutomo Nasu, Okayama, Japan
MP45-08
STABILIZATION OF INVADOPODIA BY
PLECTIN- MEDIATED CONJUNCTION TO
VIMENTIN INTERMEDIATE FILAMENT IS A
CRITICAL MOLECULAR STEP OF
INVASION AND EXTRAVASATION FOR
METASTASIS IN BLADDER CANCER.
Mihoko Sutoh Yoneyama*, Shingo
Hatakeyama, Hirosaki, Japan, Tomonori
Habuchi, Takamitsu Inoue, Akita, Japan,
Toshiya Nakamura, Tomihisa Funyu,
Hirosaki, Japan, Gerhard Wiche, Vienna,
Austria, Shigeru Tsuboi, Chikara Ohyama,
Hirosaki, Japan
MP45-10
MP45-11
MP45-12
MP45-13
MP45-14
*Presenting author
CIRCULATING TUMOR CELLS (CTC)
IDENTIFICATION IN BLADDER CANCER
USING EPCAM (EPITHELIAL CELL
ADHESION MOLECULE): COMPARISON
BETWEEN MANUAL AND AUTOMATED
SYSTEM OF ISOLATION AND FUTURE
PROSPECTIVE
Gian Maria Busetto*, Riccardo Giovannone,
Gabriele Antonini, Paola Gazzaniga,
Vincenzo Gentile, Ettore De Berardinis,
Roma, Italy
IDENTIFICATION OF DOWNSTREAM
GENES OF THE MTOR PATHWAY THAT
PREDICT RECURRENCE AND
PROGRESSION IN NON-MUSCLE
INVASIVE HIGH-GRADE UROTHELIAL
CARCINOMA OF THE BLADDER
Jin wook Kim*, Young Tae Moon, Kyung Do
Kim, Tae-Hyoung Kim, Soon Chul Myung,
Seung Hyun Ahn, Jae Duck Choi, Jung Hoon
Kim, Min Soo Kim, Shin Young Lee, Byung
Hoon Chi, In Ho Chang, Seoul, Korea,
Republic of
PROGNOSTIC IMPACT OF
PERIOPERATIVE LYMPHOCYTEMONOCYTE RATIO IN PATIENTS WITH
RADICAL CYSTECTOMY
Takashi Yoshida*, Hidefumi Kinoshita, Kenji
Yoshida, Takao Mishima, Masaaki Yanishi,
Yoshihiro Komai, Motohiko Sugi, Takaaki
Inoue, Takashi Murota, Katsuya Fukui, Gen
Kawa, Jiro Harada, Tadashi Matsuda, Osaka,
Japan
PROGNOSTIC VALUE OF DNA DAMAGE
RESPONSE RELATED PROTEINS IN NONMUSCLE INVASIVE BLADDER CANCER
Albert Frances*, Nuria Juanpere, Judith
Penafiel, Gloria Nohales, Cristina Camara,
Alex Garcia-Larrosa, Jose Maria Abascal,
Joan Vila, Josep Lloreta, Lluis Cecchini,
Barcelona, Spain
CENTROSOME AMPLIFICATION AS A
PUTATIVE PROGNOSTIC BIOMARKER
FOR IMPROVED OBJECTIVE
CLASSIFICATION OF UROTHELIAL
CARCINOMA
Yoshiaki Yamamoto*, Yoshihisa Kawai, Ryo
Inoue, Hiroaki Matsumoto, Kazuhiro Nagao,
Hideyasu Matsuyama, Ube, Japan
MP45-15
NON-INVASIVE UROTHELIAL CANCER
BIOMARKERS
Hiroshi Harada*, Sapporo, Japan, Taku
Murakami, Cindy M Yamamoto, Irvine, CA,
Tomoshige Akino, Hiroshi Tanaka, Nobuyuki
Fukuzawa, Toshimori Seki, Sapporo, Japan,
Masato Mitsuhashi, Irvine, CA
MP45-16
RADICAL CYSTECTOMY AND URINARY
DIVERSION LEAD TO METABOLIC
ACIDOSIS AND INCREASED BONE
TURNOVER WHICH PERSISTS AT LEAST
ONE YEAR AFTER SURGERY
Nathan Brooks*, Coralville, IA, Michael
Brumm, Sundeep Deorah, Michael O’Donnell,
Manish Suneja, Amit Gupta, Iowa City, IA
MP45-17
CLINICAL SIGNIFICANCE OF PD-L1
PROTEIN EXPRESSION AND TUMOR
INFILTRATING LYMPHOCYTES IN EARLY
STAGE UROTHELIAL BLADDER
CARCINOMAS
Tomas De Mayo, Mario Fernandez*, Marcela
Schultz, Alberto Bustamante, Kurt Schalper,
Santiago, Chile
MP45-18
A POTENTIAL ROLE FOR 6-SULFO SIALYL
LEWISX IN METASTASIS OF BLADDER
Minekatsu Taga*, Hitomi Hoshino, Shulin
Low, Yoshiaki Imamura, Hideaki Ito, Motohiro
Kobayashi, Osamu Yokoyama, Eiheiji-cho
Yoshida-gun, Japan
MP45-19
BRUCE BRIDGES AUTOPHAGY AND
APOPTOSIS IN SILIBININ-INDUCED CELL
DEATH IN BLADDER CANCER
Jin Zeng*, Wei Liu, Feng Li, Yi Sun, Lei Li,
Xinyang Wang, Dalin He, Xi’an, China,
MP45-20
RASAL2, A NOVEL RAS GTPASE
ACTIVATING PROTEIN, INHIBITS
STEMNESS AND EPITHELIALMESENCHYMAL TRANSITION VIA MAPK/
SOX2 PATHWAY IN BLADDER CANCER
Ke Hui*, Kaijie Wu, Jinhai Fan, Dalin He,
Xi’an, China, People’s Republic of
CREDITTM
EPIGENETIC REGULATION OF
CANDIDATE TUMOR SUPPRESSOR GENE
ADAMTS18 IN HUMAN BLADDER CANCER
ASSOCIATED WITH ITS PROGNOSIS
Yu Fan*, Lu Wang, Qian Zhang, Jie Jin,
163
SUNDAY
MP45-09
Sunday, May 8, 2016
10:30 am - 12:30 pm
GENERAL & EPIDEMIOLOGICAL TRENDS & SOCIOECONOMICS: VALUE OF CARE: COST AND OUTCOMES MEASURES II
Moderators: Yair Lotan and J. Quentin Clemens
ABSTRACT
NUMBER TITLE
MP46-01 A NOVEL PREDICTIVE MODEL FOR
EVALUATING THE IMPACT OF CLIMATE
CHANGE AND OTHER RISK FACTORS ON
NEPHROLITHIASIS IN THE US
Tao Cui*, Dan Rukstalis, Winston Salem, NC
ABSTRACT
NUMBER TITLE
MP46-09 THE IMPLEMENTATION OF A
PERIOPERATIVE SURGICAL HOME IS
ASSOCIATED WITH DECREASED
POSTOPERATIVE LENGTH OF STAY AND
COST: A PILOT STUDY
Salim Cheriyan*, Jim Shen, Brian Hu, Gary
Stier, Kristene Myklak, Ruth Belay, Roger Li,
D. Duane Baldwin, Herbert Ruckle, Loma
Linda, CA
MP46-02 EMERGENCY DEPARTMENT SWITCHING
AND DUPLICATE CT SCANS IN PATIENTS
WITH KIDNEY STONES
Parth K. Shah*, Phyllis L. Yan, J. Stuart Wolf
Jr., Brent K. Hollenbeck, Khurshid R. Ghani,
John M. Hollingsworth, Ann Arbor, MI
MP46-10 EVALUATING THE COST-EFFECTIVENESS
OF SURVEILLANCE SCHEDULES FOR
RECURRENCE IN LOW-RISK BLADDER
CANCER PATIENTS
Daan Nieboer, Iris Lansdorp-Vogelaar, Esther
W. de Bekker-Grob, Rotterdam, Netherlands,
Matthew E. Nielsen*, Chapel Hill, NC
MP46-03 REPEAT STONE SURGERY: CLINICAL
VALIDATION OF ADMINISTRATIVE
CLAIMS
Andrew Portis*, Jennifer Portis, Suzanne
Neises, St Paul, MN
MP46-11 A QUANTITATIVE ASSESSMENT OF THE
QUALITY OF RANDOMIZED CONTROLLED
TRIAL REPORTING IN UROLOGICAL
LITERATURE
Vikram Narayan*, Minneapolis, MN, Eugene
Cone, Durham, NC, Daniel Smith,
Minneapolis, MN, Charles Scales, Durham,
NC, Philipp Dahm, Minneapolis, MN
MP46-04 COST-EFFECTIVENESS OF ELECTIVE
URETHROPLASTY WITHOUT PRIMARY
REALIGNMENT IN TREATMENT OF
PELVIC FRACTURE URETHRAL INJURIES
Timothy Tausch*, Yair Lotan, Dallas, TX, Lee
Zhao, New York, NY, Allen Morey, Dallas, TX
MP46-05
UROLOGIST VERSUS PRIMARY CARE
PROVIDER EXPENDITURES ON INITIAL
BPH RELATED CARE
Seth Strope*, Saint Louis, MO, Joel Vetter,
Margaret Olsen, St. Louis, MO
MP46-12 STATISTICAL METHODS IN RANDOMIZED
CONTROLLED TRIALS IN THE
UROLOGICAL LITERATURE: A
SYSTEMATIC REVIEW
Eugene B Cone*, Durham, NC, Vikram
Narayan, Daniel Smith, Philip Dahm,
Minneapolis, MN, Charles D Scales, Durham,
NC
MP46-06 SERIES OF SYSTEMATIC REVIEWS AND
META-ANALYSES OF THE RISK OF
THROMBOSIS AND BLEEDING IN
UROLOGICAL NON-CANCER SURGERY
(ROTBUS NON-CANCER)
Kari Tikkinen*, Helsinki, Finland, Samantha
Craigie, Hamilton, Canada, Arnav Agarwal,
Toronto, Canada, Rufus Cartwright, London,
United Kingdom, Reed Siemieniuk, Toronto,
Canada, Giacomo Novara, Padua, Italy,
Philippe Violette, London, Canada, Richard
Naspro, Bergamo, Italy, Per Morten Sandset,
Oslo, Norway, Michael Gould, Pasadena, CA,
Gordon Guyatt, Hamilton, Canada
MP46-13 RISK OF HOSPITALIZATION FOLLOWING
PRIMARY TREATMENT FOR PROSTATE
CANCER
Stephen Williams*, Zhiganag Duan, Karen
Hoffman, Benjamin Smith, Houston, TX, Jim
Hu, New York, NY, Jay Shah, Sharon
Giordano, Houston, TX
MP46-14 RE-DEFINING AND CONTEXTUALIZING
THE HOSPITAL VOLUME-OUTCOME
RELATIONSHIP FOR ROBOTIC-ASSISTED
IMPLICATIONS FOR CENTRALIZATION OF
CARE
Boris Gershman*, Sarah Meier, Daniel
Moreira, Matthew Tollefson, R. Jeffrey
Karnes, Nilay Shah, Rochester, MN
MP46-07 COST-EFFECTIVENESS OF EXTENDED
VENOUS THROMBOEMBOLISM
PROPHYLAXIS AFTER RADICAL
CYSTECTOMY
Michael Rydberg*, Chicago, IL, Sangtae
Park, Evanston, IL
MP46-08 ASSESSING THE COSTS OF EXTRAURINARY FINDINGS OF CT UROGRAM
AND THE POTENTIAL ROLE OF
ULTRASOUND IN THE EVALUATION OF
ASYMPTOMATIC MICROSCOPIC
HEMATURIA
Win Shun Lai*, James Ellenburg, Peter N.
Kolettis, Mark E. Lockhart, Birmingham, AL
MP46-15
164
COST EFFECTIVENESS OF MRI BEFORE
PROSTATE BIOPSY
Shivani Pahwa*, Nicholas Schiltz, Lee
Ponsky, Ziang Lu, Sara Dastmalchian, Robert
Abouassaly, Mark Griswold, Vikas Gulani,
Cleveland, OH
MP46-16 HOW MUCH ARE PATIENTS WILLING TO
PAY FOR MAGNETIC RESONANCEULTRASOUND FUSION BIOPSY?
Chad Ellimoottil*, Ann Arbor, MI, Marissa
Marcotte, Dan Grace, Maywood, IL,
Alexander Krasnikov, Joan Phillips, Chicago,
IL, Marcus Quek, Robert Flanigan, Gopal
Gupta, Maywood, IL
MP46-19 CASTRATION-RESISTANT PROSTATE
CANCER PATIENTS IN QUEBEC:
MEDICATION USE IN THE LAST YEAR OF
LIFE
Alice Dragomir*, Marie Vanhuyse, Fabio
Cury, Armen Aprikian, Montreal, Canada
MP46-20 A VALUE-BASED MODEL TO INFORM
MANAGEMENT OF SMALL RENAL
MASSES
Ravi J. Shah, Justin T. Matulay*, Marissa C.
Velez, James M. McKiernan, Gina M.
Badalato, New York, NY
MP46-17 TREATMENT VARIATION IN
ECONOMICALLY DISADVANTAGED MEN
WITH ADVANCED PROSTATE CANCER:
COMPARING PUBLIC AND PRIVATE
PROVIDERS
Avi Baskin*, Joseph Shirk, Alan Kaplan,
Lorna Kwan, Jonathan Begman, Mark Litwin,
Los Angeles, CA
CREDITTM
SUNDAY
MP46-18 USE OF ABIRATERONE ACETATE IN THE
MANAGEMENT OF CASTRATIONRESISTANT PROSTATE CANCER: A REALLIFE COST EFFECTIVENESS STUDY
Dragomir Alice*, Joice Rocha, Armen
Aprikian, Marie Vanhuyse, Fabio Cury,
Wassim Kassouf, Montreal, Canada
Sunday, May 8, 2016
10:30 am - 12:30 pm
SEXUAL FUNCTION/DYSFUNCTION: EVALUATION
Moderators: Hossein Sadeghi-Nejad and Ronald Lewis
ABSTRACT
NUMBER TITLE
MP47-01 POOR SLEEP QUALITY PREDICTS
HYPOGONADAL SYMPTOMS AND
SEXUAL DYSFUNCTION IN MALE NONSTANDARD SHIFT WORKERS
Alexander W. Pastuszak*, Young M. Moon,
Jason Scovell, Houston, TX, Justin Badal,
Davis, CA, Dolores J. Lamb, Richard E. Link,
Larry I. Lipshultz, Houston, TX
ABSTRACT
NUMBER TITLE
MP47-04 THE ASSOCIATIONS BETWEEN
TESTOSTERONE AND PREVALENCE OF
SYMPTOMS ASSOCIATED WITH AGING
ARE DIFFERENT BY GENERATIONS:
ANALYSIS OF 1557 HEALTHY YOUNG
AND ELDERLY ADULTS
Shinichiro Fukuhara*, Norichika Ueda, Tetsuji
Soda, Kentaro Takezawa, Hiroshi Kiuchi,
Yasushi Miyagawa, Suita, Japan, Akira
Tsujimura, Urayasu, Japan, Norio Nonomura,
Suita, Japan
MP47-02 SEXUAL FUNCTION AFTER
HYPOFRACTIONATED VERSUS
CONVENTIONALLY FRACTIONATED
CANCER: RESULTS OF THE
PROSPECTIVE, RANDOMIZED PHASE 3
HYPRO TRIAL
Ruud Wortel*, Luca Incrocci, Rotterdam,
Netherlands
MP47-05
MP47-03 ERECTILE FUNCTION AFTER LOW DOSERATE PROSTATE BRACHYTHERAPY LONG TERM FOLLOW-UP FOR 3 YEARS
Andreas Bannowsky*, Osnabrück, Germany,
Leif Bäurle, Flensburg, Germany, Stefan
Ückert, Hannover, Germany, Tillmann Loch,
Flensburg, Germany, Hermann van Ahlen,
Osnabrück, Germany
*Presenting author
LOW SERUM TESTOSTERONE IS
ASSOCIATED WITH ELEVATIONS IN
HIGH-SENSITIVITY CARDIOVASCULAR
DISEASE BIOMARKERS
Alexander W. Pastuszak*, Mark C. Lindgren,
Samuel J. Ohlander, Amin Herati, Houston,
TX, Joel Estis, Alameda, CA, Larry I.
Lipshultz, Houston, TX
MP47-06 CHARACTERISTICS OF SECONDARY,
PRIMARY, AND COMPENSATED
HYPOGONADISM IN CAUCASIANEUROPEAN MEN PRESENTING FOR NEW
ONSET ERECTILE DYSFUNCTION RESULTS OF A CROSS-SECTIONAL
SURVEY
Eugenio Ventimiglia*, Paolo Capogrosso,
Luca Boeri, Andrea Russo, Silvia Ippolito,
Donatella Moretti, Roberta Scano, Rayan
Matloob, Lina Bua, Luca Villa, Franco
Gaboardi, Francesco Montorsi, Andrea
Salonia, Milan, Italy
165
MP47-07 PREDIABETES, HYPOGONADISM &
ERECTILE DYSFUNCTION: GLYCAEMIC
CONTROL IN 109 HYPOGONADAL MEN
TREATED WITH TESTOSTERONE
UNDECANOATE INJECTIONS (TU) FOR UP
TO 8 YEARS: REAL-LIFE DATA FROM
REGISTRY STUDIES
Aksam Yassin*, Dresden, Germany, Ahmad
Haider, Karim Haider, Bremerhaven,
Germany, Gheorghe Doros, Abdulmaged
Traish, Boston, MA, Farid Saad, Berlin,
Germany
MP47-14 SELF-REPORTED ALCOHOL USE AND
HYPOTENSION-AND-SYNCOPE-RELATED
ADVERSE EVENTS IN FLIBANSERINTREATED PREMENOPAUSAL WOMEN
WITH HYPOACTIVE SEXUAL DESIRE
DISORDER
Stuart Apfel*, West Hempstead, NY, Louise
Brown, James Yuan, Raleigh, NC, Sam
Spigelman, Bridgewater, NJ
MP47-15
MP47-08 ERECTILE DYSFUNCITON ANALYSIS
USING “MENⴕS SEXUAL MEDICINE APP®”
USERS DATA
Eduard Garcı́a-Cruz*, Barcelona, Spain,
Paolo Verze, Naples, Italy, Nuno Tomada,
Porto, Portugal, Maarten Albersen, Leuven,
Belgium, Albert Carrión, Alfonso Florensa,
Barcelona, Spain, Giulio Garaffa, London,
United Kingdom, Markus Margreiter, Vienna,
Austria, Bárbara Romano, Barcelona, Spain,
Javier Romero Otero, Madrid, Spain, Ege
Can Serefoglu, Istambul, Turkey, Ines
Tomada, Porto, Portugal, Antonio Alcaraz,
Barcelona, Spain
CHANGES IN ERECTILE DYSFUNCTION
OVER TIME BY AGE: A COMMUNITYBASED POPULATION STUDY
Matthew Ziegelmann*, George C Bailey,
Tanner S Miest, Mary E Westerman, Mary E
Westerman, Landon W Trost, Rochester, MN
MP47-16 EVALUATION OF A POTENTCY FULLNESS
SCALE AT 3 MONTHS IS PREDICTIVE OF
OVERALL 2 YEAR OUTCOMES AFTER
RARP
Douglas Skarecky, Adam Gordon, Thomas
Ahlering*, Orange, CA
MP47-17 RATES OF MORTALITY ARE HIGHER
AMONG PROFESSIONAL MALE
BODYBUILDERS
Daniel Gwartney*, Columbia, MO, Andrew
Allison, Alexander W. Pastuszak, Steven
Canales, William T. Stoll, Mark C. Lindgren,
Houston, TX, Michael L. Eisenberg, Palo Alto,
CA, Larry I. Lipshultz, Houston, TX
MP47-09 COLOR DOPPLER DUPLEX ULTRASOUND
(CDDU) PARAMETERS OF MEN WITHOUT
ORGANIC ERECTILE DYSFUNCTION
Ram Pathak*, Andrew Davidiuk, Issac
Effriong, Zhuo Li, Gregory Broderick,
Jacksonville, FL
MP47-18 SEXUAL OUTCOMES FOLLOWING
TREATMENT OF ABDOMINAL AORTIC
ANEURYSM, ENDOVASCULAR REPAIR
VS. OPEN SURGERY: A PROSPECTIVE
STUDY
Rebibo John-David*, Francois-Xavier
Nouhaud, Benoit Malval, Christian Pfister,
Louis Sibert, Rouen, France
MP47-10 THE COMPARISON OF ERECTILE
FUNCTION BETWEEN RADICAL
NEPHRECTOMY GROUP AND PARTIAL
NEPHRECTOMY GROUP.
Kei Matsushita*, Hideaki Miyake, Takaki
Ishida, Kenta Sumii, Teruo Fukuda, Noritoshi
Enatsu, Koji Chiba, Masato Fujisawa, Kobe,
Japan
MP47-19 DIFFERENCES IN SEXUAL INTEREST
BETWEEN BIOLOGICAL MEN AND
FEMALE-TO-MALE TRANSSEXUAL
PERSONS WITH GENDER IDENTITY
DISORDER
Akira Tsujimura*, Urayasu, Japan, Yasushi
Miyagawa, Shinichiro Fukuhara, Hiroshi
Kiuchi, Tetsuya Takao, Suita, Osaka, Japan,
Yuki Sekiguchi, Yokohama, Japan, Atsushi
Iwasa, Osaka, Japan, Shigeo Horie, BunkyoKu, Tokyo, Japan, Norio Nonomura, Suita,
Osaka, Japan
MP47-11 PERCEPTION VS REALITY: HOW
PRIMARY CARE PHYSICIANS
UNDERSTAND PROSTHETIC UROLOGY
Alek Mishail, Arielle Maggio-Ferguson, Wai
Lee, Abram D’Amato*, Stony Brook, NY
MP47-12 SERUM PSA AS A PREDICTOR OF
SYMPTOMATIC HYPOGONADISM
Kazuhito Matsushita*, Osamu Takahashi,
Masaki Shimbo, Fumiyasu Endo, Osamu
Muraishi, Kazunori Hattori, Tokyo, Japan
MP47-20 PROSPECTIVE EVALUATION OF THE
IMPACT OF TREATMENT FOR
TESTICULAR CANCER ON SEXUAL
FUNCTION
Shinji Fujii*, Shinichi Yamashita, Shigeyuki
Yamada, Hideaki Izumi, Yoshihide Kawasaki,
Naoki Kawamorita, Koji Mitsuzuka, Hisanobu
Adachi, Yasuhiro Kaiho, Akihiro Ito, Yoichi
Arai, Sendai, Japan
MP47-13 AN UNACKNOWLEDGED CLINICAL
DEPRESSION IS HIGHLY PREVALENT IN
TESTOSTERONE DEFICIENT CAUCASIANEUROPEAN MEN SEEKING MEDICAL
HELP FOR SEXUAL DYSFUNCTION
Luca Boeri*, Paolo Capogrosso, Eugenio
Ventimiglia, Giovanni La Croce, Roberta
Scano, Donatella Moretti, Federico Dehò,
Alberto Briganti, Milan, Italy, Vincenzo
Mirone, Naples, Italy, Francesco Montorsi,
Andrea Salonia, Milan, Italy
CREDITTM
166
Sunday, May 8, 2016
10:30 am - 12:30 pm
SEXUAL FUNCTION/DYSFUNCTION: SURGICAL THERAPY
Moderators: Arthur Burnett, II and Ricardo Munarriz
ABSTRACT
NUMBER TITLE
MP48-08 MULTI-INSTITUTIONAL AND LASTING
RESULTS WITH THE MOST (MODIFIED
SLIDING TECHNIQUE) FOR PENILE
LENGTHENING WITH PENILE
PROSTHESIS INSERTION
Aaron Weinberg*, Matthew Pagano, Bronx,
NY, Lee Zhao, Robert Valenzuela, New York,
NY
MP48-02 PENILE PROSTHESIS IMPLANTATION
AFTER FEMALE TO MALE TOTAL
PHALLIC RECONSTRUCTION: A SINGLECENTER RETROSPECTIVE ANALYSIS ON
247 CONSECUTIVE PATIENTS
Marco Falcone*, Giulio Garaffa, London,
United Kingdom, Arianna Gillo, Turin, Italy,
Amr Raheem, Francesco De Luca, Andrew
Nim Christopher, David J Ralph, London,
United Kingdom
MP48-09 PENILE INTRACAVERNOSAL PILLARS:
LESSONS FROM ANATOMY AND
POTENTIAL IMPLICATIONS FOR PENILE
PROSTHESIS PLACEMENT
Matthew Pagano*, Aaron Weinberg, Vanessa
Dudley, Kelvyn Hernandez, Robert
Valenzuela, New York, NY
MP48-03 PREOPERATIVE URINE CULTURES FOR
PROSTHETIC UROLOGICAL SURGERY:
WHAT IS THE EVIDENCE?
Nicholas Kavoussi*, Jordan Siegel, Matthias
Hofer, Billy Cordon, Nabeel Shakir, Jeremy
Scott, Claus Roehrborn, Allen Morey, Dallas,
TX
MP48-10 USE OF DORSAL NERVE BLOCK WITH
BUPIVACAINE LIPOSOME INJECTABLE
SUSPENSION (EXPAREL) FOR PAIN
MANAGEMENT FOLLOWING THREEPIECE PENILE PROSTHESIS SURGERY
Sherita King*, San Diego, CA, Joshua
Gonzalez, Encino, CA, Irwin Goldstein, San
Diego, CA
MP48-04 CLIMACTURIA: AN UNDER-ADDRESSED
SEQUELA OF RADICAL
PROSTATECTOMY, BUT TREATMENT IS
ONLY A SLING AWAY
Brian Christine*, Mountain Brook, AL,
Anthony J. Bella, Ottawa, Canada
MP48-11 CHRONIC NEUROMODULATION AS A
TREATMENT FOR PERSISTENT GENITAL
AROUSAL DISORDER
Brian Odom*, Royal Oak, MI, Michael Ehlert,
Minneapolis, MN, Kim Killinger, Kenneth
Peters, Royal Oak, MI
MP48-05
MP48-12 SMALL BUT PERFECTLY FORMED:
URETHRAL CENTRALISATION AFTER
PARTIAL PENECTOMY (UCAPP)
Varun Sahdev, Mahmoud Ziada*, London,
United Kingdom, Luke Stroman, Reading,
United Kingdom, Jennifer Kranz, Eschweiler,
Germany, Asif Muneer, London, United
Kingdom, Peter Malone, Reading, United
Kingdom
FUNCTIONAL OUTCOMES FOLLOWING
PENILE FRACTURE REPAIR: A TERTIARY
REFERRAL CENTRE EXPERIENCE
Francesco De Luca*, Amr Abdel Raheem,
Evangelos Zacharakis, Majed Shabbir, Marco
Spilotros, Fiona Holden, Clare Akers, Giulio
Garaffa, Nim Christopher, David Ralph,
MP48-06 NATIONAL TRENDS IN PENILE
PROSTHESIS REOPERATIONS: THE
IMPORTANCE OF PATIENT COMORBIDITY
IN PENILE PROSTHESIS OUTCOMES
Daniel Lee*, Bobby Najari, Soo Kim, Michael
Schulster, Phil Bach, Filipe Neto, James
Kashanian, Darius Paduch, John Mulhall,
Bilal Chughtai, Richard Lee, New York, NY
MP48-13 NATIONAL TRENDS IN PENILE
PROSTHETIC SURGERY: THE EFFECT OF
INHIBIZONE
Tung-Chin Hsieh*, San Diego, CA, Dongfeng
Qi, Guanghui Liu, Minneapolis, MN
MP48-14 IMPACT OF SURGICAL APPROACH ON
CORPORAL SIZING FOR INFLATABLE
PENILE PROSTHESIS
Matthew Pagano*, Aaron Weinberg,
Alexander Small, Kelvyn Hernandez, Robert
Valenzuela, New York, NY
MP48-07 SUCCESSFUL MANAGEMENT OF
CLITORODYNIA CLOSED COMPARTMENT
SYNDROME
Sherita King*, San Diego, CA, Joshua
Gonzalez, Encino, CA, Irwin Goldstein, San
Diego, CA
*Presenting author
167
SUNDAY
ABSTRACT
NUMBER TITLE
MP48-01 SUBMUSCULAR ECTOPIC INFLATABLE
PENILE PROSTHESIS RESERVOIR
PLACEMENT: A CADAVERIC STUDY OF
ANATOMIC LOCATION
Matthew Ziegelmann*, Boyd R Viers, Derek J
Lomas, Landon W Trost, Rochester, MN
MP48-15
TESTOSTERONE PELLET IMPLANTATION
PRACTICES AMONG MEMBERS OF THE
SEXUAL MEDICINE SOCIETY OF NORTH
AMERICA (SMSNA)
Brijesh Patel*, Michael Piecuch, Newark, NJ,
Run Wang, Houston, TX, Lawrence Hakim,
Weston, FL, Hossein Sadeghi-Nejad, Newark,
NJ
MP48-19 FACTORS THAT INFLUENCE PENILE
IMPLANT SATISFACTION FROM THE
PROPPER STUDY
Tobias Kohler*, Springfield, IL, Anthony Bella,
Ottawa, Canada, Edward Karpman, Mountain
View, CA, William Brant, Salt Lake City, UT,
Bryan Kansas, Austin, TX, Brian Christine,
Homewood, AL, Leroy Jones, San Antonio,
TX, Mohit Khera, Houston, TX, Nelson
Bennett, Burlington, MA, Eugene Rhee, San
Diego, CA, Gerard Henry, Shreveport, LA
MP48-16 COATED IMPLANTS AND “NO TOUCH”
SURGICAL TECHNIQUE DECREASES
INFECTIONS AND SHIFTS CAUSATIVE
INFECTIOUS MICROORGANISMS IN
INFLATABLE PENILE PROSTHESIS – 9
YEAR UPDATE
Shawn Mendonca*, Nitin Sharma, Joseph
Sarcona, J. Francois Eid, New York, NY
MP48-20 IN CONTRAST TO PRIOR STUDY, NEW
DATA SHOWS BACTERIA FOUND AT
REVISION IPP SURGERY DIFFERS FROM
PREVIOUSLY IDENTIFIED BIOFILM
Martin Gross*, Shreveport, LA, Culley
Carson, Chapel Hill, NC, Steven Wilson,
Indio, CA, John Delk, Little Rock, AR, Craig
Donatucci, Indianapolis, IN, Gerard Henry,
Shreveport, LA
MP48-17 DEVICE AUTOINFLATION FOLLOWING
PENILE IMPLANT SURGERY
Eduardo Miranda*, Yanira Ortega, Serkan
Deveci, Lawrence Jenkins, John Mulhall, New
York, NY
CREDITTM
MP48-18 THE IMPACT OF BARIATRIC SURGERY
ON THE ERECTILE FUNCTION.
SYSTEMATIC REVIEW
Felipe Glina*, Julia Walter de Freitas
Barbosa, Victor Moises Nunes, São Paulo,
Brazil, Sidney Glina, Santo André, Brazil,
Wanderley Marques Bernardo, São Paulo,
Brazil
Sunday, May 8, 2016
10:30 am - 12:30 pm
Podium Session 26
PROSTATE CANCER: DETECTION & SCREENING VI
Moderators: Robert Weiss and Daniel Barocas
ABSTRACT
TIME NUMBER TITLE
10:30 PD26-01 CHANGES IN CLINICO-PATHOLOGICAL
CHARACTERISTICS AT PROSTATE
CANCER DIAGNOSIS DETECTED ON
PROSTATE BIOPSIES IN DANISH MEN
FROM 1995 TO 2011
Nina Klemann*, John T. Helgstrand, M.
Andreas Røder, Klaus Brasso, Copenhagen
N, Denmark, Birgitte Grønkær Toft, Ben
Vainer, Copenhagen Ø, Denmark, Peter
Iversen, Copenhagen N, Denmark
10:40 PD26-02
10:50 PD26-03
ABSTRACT
TIME NUMBER TITLE
11:00 PD26-04 RACIAL AND ETHNIC VARIATION IN TIME
TO PROSTATE BIOPSY AFTER AN
ELEVATED PSA BLOOD LEVEL
SCREENING RESULT
Stephanie Reading*, Kimberly Porter, JinWen Hsu, Pasadena, CA, Lauren Wallner,
Ann Arbor, MI, Ronald Loo, Downey, CA,
Steven Jacobsen, Pasadena, CA
USING A PREBIOPSY CHECKLIST TO
UNDERSTAND RISK FACTORS
ASSOCIATED WITH INFECTION-RELATED
HOSPITALIZATION FOLLOWING
PROSTATE BIOPSY
Richard Sarle*, Dearborn, MI, Yuqing Gao,
David Miller, Susan Linsell, Andrew Brachulis,
Apoorv Dhir, Ann Arbor, MI, Dinesh Telang,
Grosse Pointe, MI, James Montie, Khurshid
Ghani, Ann Arbor, MI
PROSTATE BIOPSY IN THE ERA OF
CONTEMPORARY USPSTF GUIDELINES
William Sterling*, Komal Mehta, David
Schreiber, Nicholas Karanikolas, Jeffrey
Weiss, Brooklyn, NY
168
11:10 PD26-05
DIAGNOSTIC ACCURACY OF PROSTATE
HEALTH INDEX FOR AGGRESSIVE
PROSTATE CANCER. AN INSTITUTIONAL
VALIDATION STUDY
Lucas Regis*, Carlos Gasanz, Enric Miret,
Ana Celma, Jacques Planas, Jose Placer, R
Ferrer, IM de Torres, Juan Morote,
Barcelona, Spain
11:20 PD26-06
CHANGES IN PROSTATE HEALTH INDEX
(PHI) OVER TIME
Alexander Glaser*, Phillip Cooper, Kimberly
Roehl, William Catalona, Chicago, IL
11:30 PD26-07
DOES DIGITAL RECTAL EXAM AFFECT
THE 4KSCORE TEST FOR AGGRESSIVE
PROSTATE CANCER?
Michael Maccini*, Nicholas Westfall, Priya
Werahera, Adrie van Bokhoven, Paul Maroni,
Shandra Wilson, Michael Glode, Paul
Arangua, David Crawford, Aurora, CO
12:10 PD26-11
BIOPSY PATTERNS OF PATIENTS WITH
HGPIN OR ASAP IN THE ERA OF ACTIVE
SURVEILLANCE
Zachary Panfili*, Zachary Hamilton, Tim
Walmann, Eugene Lee, David Duchene,
Hadley Wyre, Brantley Thrasher, Jeffrey
Holzbeierlein, Moben Mirza, Kansas City, KS
11:40 PD26-08
IMPROVED TISSUE YIELD AND
PROSTATE CANCER DETECTION OF A
NOVEL BIOPSY PRESERVATION SYSTEM
Michael Cohen*, Boris Yudkevich, Helena
Yodko, Irit Elmalah, Afula, Israel
12:20 PD26-12
11:50 PD26-09
DOPPLER ULTRASONOGRAPHY-GUIDED
PELVIC PLEXUS BLOCK BEFORE NEEDLE
BIOPSY OF THE PROSTATE: A SINGLE
CENTER, PROSPECTIVE, RANDOMIZED
CONTROLLED TRIAL
Ju Hyun Lim*, Jong Yeon Park, Gangneung,
Korea, Republic of
COMPLICATIONS ASSOCIATED WITH
TRANSRECTAL AND TRANSPERINEAL
PROSTATE MAPPING BIOPSY
Vassilios Skouteris*, Athens, Greece, Nelson
Stone, Vail, CO, Paul Arangua, E. David
Crawford, Aurora, CO
SUNDAY
12:00 PD26-10
CREDITTM
INCIDENCE OF CLINICALLY-SIGNIFICANT
PROSTATE CANCER AFTER A DIAGNOSIS
OF ATYPICAL SMALL ACINAR
PROLIFERATION (ASAP), PROSTATIC
INTRAEPITHELIAL NEOPLASIA (PIN), OR
BENIGN TISSUE
Scott Wiener*, Peter Haddock, Ilene Staff,
Joseph Wagner, Hartford, CT
Sunday, May 8, 2016
10:30 am - 12:30 pm
Podium Session 27
BLADDER CANCER: INVASIVE II
Moderators: Michael Koch and Dipen Parekh
ABSTRACT
TIME NUMBER TITLE
10:30 PD27-01 CONTEMPORARY UTILIZATION TRENDS
AND SURVIVAL OUTCOMES IN PATIENTS
AND BLADDER PRESERVATION THERAPY
FOR MUSCLE INVASIVE BLADDER
CANCER
David Cahn*, Elizabeth Handorf, Michael
Nordsiek, Thomas Churilla, Eric Horwitz,
Benjamin Ristau, David Chen, Rosalia Vitebo,
Richard Greenberg, Alexander Kutikov,
Robert Uzzo, Marc Smaldone, Philadelphia,
PA
10:40 PD27-02
10:50 PD27-03
*Presenting author
ABSTRACT
TIME NUMBER TITLE
11:00 PD27-04 DEVELOPMENT, VALIDATION & CLINICAL
APPLICATION OF AN INTRA-OPERATIVE
ASSESSMENT OF COMPLETION &
APPROPRIATENESS OF LND AFTER
RADICAL CYSTECTOMY: PELVIC
LYMPHADENECTOMY
APPROPRIATENESS & COMPLETION
EVALUATION (PLACE)
Ahmed Hussein*, Buffalo, NY, Nobuyuki
Hinata, Kobe, Japan, Justen Kozlowski,
Buffalo, NY, Hassan Abol-Enein, Mansoura,
Egypt, Ronney Abaza, Dublin, OH, Daniel
Eun, Philadelphia, PA, Shamim Khan,
London, United Kingdom, James Mohler,
Buffalo, NY, Piyush Agrawal, Bethesda, MD,
Kamal Pohar, Coloumbus, OH, Richard Sarle,
Dearborn, MI, Ronald Boris, Indianapolis, IN,
Khurshid Guru, Buffalo, NY
COMPOSITE QUALITY SCORE BASED
ANALYSIS OF 425 ROBOT-ASSISTED
RADICAL CYSTECTOMIES: EVALUATION
OF A DECADE OF EXPERIENCE
Ahmed Hussein*, Buffalo, NY, Nobuyuki
Hinata, Kobe, Japan, Khurshid Guru,
Seyedeh Dibaj, Erinn Field, Buffalo, NY
11:10 PD27-05
ONCOLOGIC SURVEILLANCE FOLLOWING
RADICAL CYSTECTOMY: AN
INDIVIDUALIZED RISK-BASED
APPROACH.
Suzanne Stewart-Merrill*, Hershey, PA,
Stephen Boorjian, R. Houston Thompson,
Rochester, MN, Sarah Psutka, Chicago, IL,
John Cheville, Prabin Thapa, Matthew
Tollefson, Igor Frank, Rochester, MN
169
INCREASED CYSTECTOMY UTILIZATION
IN THE VERY ELDERLY WITHOUT
COMPROMISING PERIOPERATIVE
OUTCOMES: RESULTS FROM THE
NATIONAL CANCER DATA BASE
Bream Matthew*, Matthew Maurice, Simon
Kim, Hui Zhu, Robert Abouassaly, Cleveland,
OH
11:20 PD27-06
THE IMPACT OF CIGARETTE SMOKING
AND SMOKING CESSATION ON
ONCOLOGICAL AGGRESSIVENESS AT
RADICAL CYSTECTOMY – A
PROSPECTIVE, EUROPEAN,
MULTICENTER STUDY OF THE EAU
YOUNG ACADEMIC UROLOGISTS (YAU)
BLADDER CANCER WORKING GROUP
Philipp Gild*, Marianne Schmid, Hamburg,
Germany, Marcus Cumberbatch, Sheffield,
United Kingdom, Jakub Dobruch, Warsaw,
Poland, Paolo Gontero, Torino, Italy, Laura S.
Mertens, Amsterdam, Netherlands, Andrea
Necchi, Milano, Italy, Aidan Noon, Sheffield,
United Kingdom, Mirko Preto, Torino, Italy,
Bas W.G. van Rhijn, Amsterdam,
Netherlands, Morgan Roupret, Paris, France,
Roland Seiler, Berne, Switzerland, Thomas
Seisen, Paris, France, Shahrokh F. Shariat,
Vienna, Austria, Atiqullah Aziz, Felix K. Chun,
Hamburg, Germany, Evanguelos Xylinas,
Paris, France, Michael Rink, Hamburg,
Germany
11:30 PD27-07
BLADDER-SPARING PROTOCOL
CONSISTING OF LOW-DOSE
CHEMORADIOTHERAPY AND
CONSOLIDATIVE PARTIAL CYSTECTOMY
AGAINST MUSCLE-INVASIVE BLADDER
CANCER: COMPARISON OF
ONCOLOGICAL AND FUNCTIONAL
OUTCOMES BETWEEN OLDER AND
YOUNGER PATIENTS
Yasuhisa Fujii*, Kazunori Kihara, Hajime
Tanaka, Kazutaka Saito, Soichiro Yoshida,
Minato Yokoyama, Junichiro Ishioka, Yoh
Matsuoka, Noboru Numao, Tokyo, Japan
11:40 PD27-08
EXERCISE-BASED PREHABILITATION IS
FEASIBLE AND EFFECTIVE IN RADICAL
CYSTECTOMY PATHWAYS - SECONDARY
RESULTS FROM A RANDOMIZED
CONTROLLED TRIAL
Bente Thoft Jensen*, Sussie Laustsen,
Jørgen Bjerggaard Jensen, Michael Borre,
Annemette Krintel Petersen, Aarhus,
Denmark
11:50 PD27-09
12:00 PD27-10
LONG-TERM SURVIVORS WITH AN ILEAL
ORTHOTOPIC BLADDER SUBSTITUTE
MAINTAIN GOOD CONTINENCE AND
RENAL FUNCTION OUTCOMES
Marc-Alain Furrer*, Beat Roth, Daniel P.
Nguyen, Bernhard Kiss, Silvan Boxler, Fiona
C. Burkhard, George N. Thalmann, Urs E.
Studer, Bern, Switzerland
12:10 PD27-11
PARASTOMAL HERNIA AFTER ILEAL
CONDUIT URINARY DIVERSION: REVISITING THE PREDICTORS
RADIOLOGICALLY AND ACCORDING TO
PATIENT REPORTED OUTCOME
MEASURES
Ahmed Harraz*, Amr Elsawy, Mohamed
Elbaset, Ahmed Elkarta, Ali Elsorougy,
Yasser Osman, Ahmed Mosbah, Hassan
Abol-Enein, Atallah Shaaban, Mansoura,
Egypt
12:20 PD27-12
PRIMARY ANALYSIS OF IMVIGOR 210:
ATEZOLIZUMAB IN PLATINUM-TREATED
ADVANCED UROTHELIAL CARCINOMA
Robert Dreicer*, Charlottesville, VA, Michiel
S. van der Heijden, Amsterdam, Netherlands,
Petros Grivas, Cleveland, OH, Jean HoffmanCensits, Philadelphia, PA, Yohann Loriot,
Villejuif, France, Margitta Retz, Munich,
Germany, Nicholas J Vogelzang, Las Vegas,
NV, Jose Luis Perez-Gracia, Pamplona,
Spain, Arash Rezazadeh Kalebasty,
Louisville, KY, Sergio Bracarda, Arezzo, Italy,
Evan Y Yu, Seattle, WA, Christopher Hoimes,
Cleveland, OH, Joaquim Bellmunt, Boston,
MA, David I Quinn, Los Angeles, CA, Daniel
P. Petrylak, New Haven, CT, Syed A
Hussain, Liverpool, United Kingdom, Na Cui,
Sanjeev Mariathasan, Fatema Legrand,
South San Francisco, CA, Jonathan E.
Rosenberg, New York, NY
CREDITTM
INCIDENCE AND SIGNIFICANCE OF
THROMBO-EMBOLIC EVENTS IN
BLADDER UROTHELIAL CARCINOMA
PATIENTS UNDERGOING NEO-ADJUVANT
CHEMOTHERAPY AND RADICAL
CYSTECTOMY: RESULTS FROM MULTICENTRE NORTH-AMERICAN AND
EUROPEAN CONTEMPORARY DATA
Wilhelmina Duivenvoorden, Hamilton,
Canada, Siamak Daneshmand, Los Angeles,
CA, Daniel Canter, Philadelphia, PA, Yair
Lotan, Dallas, TX, Peter Black, Hamidreza
Abdi, Vancouver, Canada, Bas van Rhijn,
Elisabeth Fransen van de Putte, Amsterdam,
Netherlands, Peter Boström, Turku, Finland,
Ilmari Koskinen, Helsinki, Finland, Piotr
Zareba, Hamilton, Canada, Janet Baack
Kukreja, Rochester, NY, Wassim Kassouf,
Samer Traboulsi, Montreal, Canada,
Jehonathan Pinthus*, Hamilton, Canada
170
Sunday, May 8, 2016
10:30 am - 12:30 pm
Podium Session 28
ABSTRACT
TIME NUMBER TITLE
10:30 PD28-01 TESTOSTERONE LOWERING, PSA
RESPONSE AND QUALITY OF LIFE IN
PATIENTS WITH ADVANCED HORMONE
SENSITIVE PROSTATE CANCER
RECEIVING TAK-385, AN ORAL GNRH
ANTAGONIST: PHASE 2 INTERIM
ANALYSIS
Neal D. Shore*, Myrtle Beach, SC, James L.
Bailen, Jeffersonville, IN, Christopher
Pieczonka, Syracuse, NY, Daniel R.
Saltzstein, San Antonio, TX, Paul R. Sieber,
Lancaster, PA, David B. MacLean, Hongliang
Shi, Hélène M. Faessel, Huamao Mark Lin,
Yanyan Zhu, Cambridge, MA, Fred Saad,
Montreal, Canada
10:40 PD28-02
AN IPOD-GUIDED SLOW BREATHING
INTERVENTION TO CONTROL HOT
FLASHES IN ADVANCED PROSTATE
CANCER PATIENTS ON HORMONE
THERAPY
Michael Diefenbach*, Simon Hall, Manhasset,
NY, Vinay Patel, Phapichaya Chaoprang
Herrera, New York, NY
10:50 PD28-03
COMPLIANCE WITH EVIDENCE BASED
BONE HEALTH MANAGEMENT IN MEN ON
CHRONIC ADT: OPPORTUNITIES FOR
IMPROVEMENT
Franklin Gaylis*, San Diego, CA, Jaclyn
Gaylis, Kevin McGill, Sothary Julie Van,
Hilary Prime, San Diego, CA, Jenna
Essakow, Tel Aviv, Israel, Renee Calabrese,
Susan S. Levy, Paul Dato, San Diego, CA
11:00 PD28-04
11:10 PD28-05
*Presenting author
ABSTRACT
TIME NUMBER TITLE
11:20 PD28-06 SURVIVAL OUTCOMES IN
OCTOGENARIAN AND NONAGENARIAN
PATIENTS TREATED WITH FIRST-LINE
ANDROGEN DEPRIVATION THERAPY FOR
Paolo Dell’Oglio, Mohamed Bishr, Katharina
Boehm, Vincent Trudeau, Montreal, Canada,
Alessandro Larcher, Milan, Italy, Zhe Tian,
Fred Saad, Montreal, Canada, Umberto
Capitanio, Alberto Briganti, Milan, Italy,
Francesco Montorsi, Milan, Italy, Pierre
Karakiewicz*, Montreal, Canada
DETECTION OF ANDROGEN RECEPTOR
VARIANT 7 (AR-V7) IN WHOLE BLOOD
RNA OF METASTATIC CASTRATIONRESISTANT PROSTATE CANCER (MCRPC)
PATIENTS TREATED WITH ABIRATERONE
ACETATE (ABI)
Tilman Todenhöfer*, Arun Azad, Jian Gao,
Craig Stewart, Bernie Eigl, Vancouver,
Canada, Arnulf Stenzl, Tuebingen, Germany,
Miriam Teich, Toronto, Canada, Peter Black,
Vancouver, Canada, Anthony Joshua,
Toronto, Canada, Kim Chi, Vancouver,
Canada
FACTORS PREDICTING SKELETALRELATED EVENTS IN PATIENTS WITH
BONE METASTATIC CASTRATIONRESISTANT PROSTATE CANCER
Zachary Klaassen*, Augusta, GA, Lauren
Howard, Amanda de Hoedt, Durham, NC,
Christopher L. Amling, Portland, OR, William
J. Aronson, West Los Angeles, CA, Matthew
R. Cooperberg, San Francisco, CA,
Christopher J. Kane, San Diego, CA, Martha
K. Terris, Augusta, GA, Stephen J.
171
11:30 PD28-07
ASSESSMENT OF THE RATE OF
ADHERENCE TO INTERNATIONAL
GUIDELINES OF ANDROGEN
DEPRIVATION THERAPY WITH EXTERNAL
BEAM RADIATION THERAPY- A
Paolo Dell’Oglio, Hiba Abou-Haidar, SamiRamzi Leyh-Bannurah, Zhe Tian, Montreal,
Canada, Giorgio Gandaglia, Milan, Italy,
Shahrokh Shariat, Vienna, Austria, Umberto
Montorsi, Milan, Italy, Markus Graefen,
Hamburg, Germany, Fred Saad, Pierre
Karakiewicz*, Montreal, Canada
11:40 PD28-08
RADIOTHERAPY FOR PROSTATE IN MEN
WITH METASTATIC PROSTATE CANCER:
A PROPENSITY-SCORE MATCHING
ANALYSIS
Ken-ichi Tabata*, Takefumi Satoh, Hideyasu
Tsumura, Daisuke Ishii, Tetsuo Fujita,
Kazumasa Matsumoto, Kazunari Yoshida,
Masatsugu Iwamura, Sagamihara, Japan
11:50 PD28-09
ABNORMAL HER2 AND HER3
SIGNALLING IN PROSTATE CANCER:
POTENTIALS FOR CLINICAL
APPLICATION.
Kasturi Rao, Massar Alsamraae, Luke
Gaughan, Craig Robson, Stuart McCracken*,
Newcastle upon Tyne, United Kingdom
12:00 PD28-10
COMBINATORIAL THERAPEUTIC
APPROACHES WITH PD-1 INHIBITION IN
PROSTATE CANCER
Benjamin Benzon, Stephanie Glavaris, Brian
Simons, Robert Hughes, Kamyar Ghabili,
Patrick Mullane, Rebecca Miller, Katriana
Nugent, Brian Shinder, Jeffrey Tosoian,
Richard Blosser, Ephraim Fuchs, Phuoc Tran,
Paula Hurley, Milena Vuica-Ross, Baltimore,
MD, Edward Schaeffer, Chicago, IL, Charles
Drake, Ashley Ross*, Baltimore, MD
SUNDAY
PROSTATE CANCER: ADVANCED (INCLUDING DRUG THERAPY) I
Moderators: E. David Crawford and Lance Pagliaro
12:10 PD28-11
NOVEL DRUGS FOR TARGETING
HISTONE DEACETYLASE INHIBITOR TO
CELLS CONTAINING ANDROGEN
RECEPTORS: ANALYSIS OF IN VIVO
EFFECTIVENESS AGAINST HUMAN
PROSTATE CANCER.
Carrie Sun*, Rebecca Arnold, David Gaul,
Subhasish Tapadar, Atlanta, GA, Berkley
Gryder, Bethesda, MD, Adegboyega Oyelere,
John Petros, Atlanta, GA
12:20 PD28-12
A PHASE 1 STUDY OF A THIRDGENERATION ONCOLYTIC HSV-1 G47⌬ IN
PATIENTS WITH CASTRATION
Hiroshi Fukuhara*, Yuta Takeshima, Yukio
Homma, Yasushi Ino, Tomoki Todo, Tokyo,
Japan
CREDITTM
Sunday, May 8, 2016
10:30 am - 12:30 pm
Video Session 6
UROLITHIASIS
Moderators: Altan Ilkay and Carley Davis
ABSTRACT
NUMBER TITLE
V6-01
INTRODUCTION OF A RENAL PAPILLARY
GRADING SYSTEM FOR PATIENTS WITH
NEPHROLITHIASIS
Michael S Borofsky*, Indianapolis, IN, Andrew
J Cohen, Blake B Anderson, Chicago, IL,
Jessica E Paonessa, Syracuse, NY, Andrew
P Evan, James C Williams, Indianapolis, IN,
Fredric L Coe, Elaine M Worcester, Glenn S
Gerber, Chicago, IL, James E Lingeman,
Indianapolis, IN
V6-02
ULTRASOUND GUIDED PERCUTANEOUS
RENAL ACCESS
Manish Patel*, Jorge Gutierrez, WinstonSalem, NC
V6-03
ADVANCED WIRE TECHNIQUES FOR
COMPLEX PERCUTANEOUS
NEPHROLITHOTOMY
Nadya York*, Michael S Borofsky, Casey A
Dauw, Indianapolis, IN, Jessica A Mandeville,
Burlington, MA, James E Lingeman,
Indianapolis, IN
V6-04
FULL IMMERSION SIMULATED
USING 3D PRINTING TECHNOLOGY
Jonathan Stone*, Alexander Fidalgo, Jennifer
Park, Braden Candela, Doran Mix, Michael
Richards, Erdal Erturk, Ahmed Ghazi,
Rochester, NY
V6-05
DIFFERENCES BETWEEN HIGHFREQUENCY AND LONG-PULSE LASER
LITHOTRIPSY – A PRACTICAL
EXPLANATION AND AN OBJECTIVE
EVALUATION
Peter Kronenberg*, Amadora, Portugal,
Olivier Traxer, Paris, France
V6-06
ABSTRACT
NUMBER TITLE
V6-07
DEVELOPMENTS IN URETEROSCOPIC
STONE TREATMENT (DUST): TIPS AND
TRICKS FOR LITHOTRIPSY OF RENAL
STONES USING MULTI-CAVITY HIGHPOWER HOLMIUM LASERS
Khurshid Ghani*, Galina Gagin, John
Hollingsworth, Gary Faerber, William Roberts,
J Stuart Wolf, Jr, Ann Arbor, MI
URINE ACIDITY IS THE MOST IMPORTANT
FACTOR IN URIC ACID STONE
FORMATION: AN ILLUSTRATION
Steeve Doizi*, Kathy Hill, John Poindexter,
Margaret Pearle, Khashayar Sakhaee, Naim
Maalouf, Dallas, TX
172
V6-08
SIMULTANEOUS ROBOTIC
PYELOLITHOTOMY,
URETEROLITHOTOMY, AND
VESICOLITHOTOMY FOR A SEVERELY
ENCRUSTED RETAINED URETERAL
STENT
Mary McHugh*, Francis Schanne,
Philadelphia, PA
V6-09
TRAINING IN A NOVEL FLUOROSCOPY
SIMULATOR (IPERC) REDUCES
EMULATED RADIATION TIME
ASSOCIATED TO PUNCTURE AND
IMPROVES KIDNEY ACCESS TIME IN
SIMULATION AMONG UROLOGISTS WITH
SCARCE SURGICAL EXPERIENCE
Juan Ramón Torres Anguiano*, Efraı́n
Maldonado Alcaraz, Jorge Moreno Palacios,
Guillermo Montoya Martı́nez, Virgilio Augusto
López Sámano, León Octavio Torres
Mercado, Eduardo Alonso Serrano Brambila,
Mexico City, Mexico
V6-10
PYELOCALYCEAL 3D MODEL TO
FACILITATE ACCESS PUNCTURE IN
Doron Vantman*, Nicolas Stutzin, Alfredo
Aliaga, Felipe Aguila, Fernando Marchant,
Santiago, Chile
THE NEW DEVELOPMENTS OF THE
ROBOTIC ASSISTED RETROGRADE
INTRA-RENAL SURGERY (RA-RIRS) WITH
AVICENNA ROBOFLEX
Jens Rassweiler*, Heilbronn, Germany, Kemal
Sarica, Istanbul, Turkey, Petrisor Geavlete,
Bucharest, Romania, Nida Zafer Tokatlý,
Ankara, Turkey, Jan Klein, Ulm, Germany,
Olivier Traxer, Paris, France, AbdulQadir Al
Zarooni, Yasser Farahat, Umm Al Quwain,
United Arab Emirates, David M. Hoenig, Long
Island, NY, Guido Giusti, Milan, Italy, Volkan
Tugcu, Istanbul, Turkey, M.Abdurrahim
Imamoglu, Ankara, Turkey, Ahmet Yaser
Muslumanoglu, Istanbul, Turkey, Murat Savas,
Antalya, Turkey, Remzi Saglam, Ankara,
Turkey, Anup Patel, London, United Kingdom
V6-12
3D LAPAROSCOPIC ANATROPHIC
NEPHROLITHOTOMY FOR STAGHORN
CALCULI
George P Abraham*, Datson George,
Govardhan Reddy, Vijay Radhakrishnan,
COCHIN, India
CREDITTM
Sunday, May 8, 2016
11:00 am - 12:00 pm
SUNDAY
V6-11
SURGICAL TECHNIQUES: PARTIAL NEPHRECTOMY
11:00
SURGICAL TECHNIQUES: PARTIAL
NEPHRECTOMY
Moderator: W. Marston Linehan
Presenters: Monish Aron, Jihad Kaouk, Chandru
Sundaram
12:00
ADJOURN
CREDITTM
Sunday, May 8, 2016
12:00 pm - 5:00 pm
SOCIETY FOR THE STUDY OF MALE REPRODUCTION (SSMR)
Room 20 D @ San Diego Convention Center
12:00
SPECIAL SYMPOSIUM (NON-CME)
1:00
INTRODUCTION
Edmund Ko
VASECTOMY UPDATE - THE PAST, PRESENT,
AND FUTURE
1:10
1:20
1:40
2:00
VASECTOMY, PROSTATE CANCER, AND
OTHER ASSOCIATED CO-MORBIDITIES MYTH OR REALITY?
Lawrence Ross
3:00
BREAK
R & D IN MALE CONTRACEPTION
HISTORY OF MALE CONTRACEPTION &
VASECTOMY
R. Matthew Coward
MEDICAL LEGAL ISSUES OF VASECTOMY
Tung-chin Hsieh
3:15
EMERGING TECHNOLOGIES IN VASECTOMY VASAL GEL/RISUG/ALPHA BLOCKERS/ETC.
Ira Sharlip
3:35
FUTURE DIRECTIONS FOR MALE
CONTRACEPTION
Ajay Nangia
RESIDENT EDUCATION: EFFECTIVELY
TEACHING VASECTOMY TO TOMORROW’S
UROLOGISTS
Jay Sandlow
CONTROVERSIES IN VASECTOMY/CASE
STUDIES/TIPS & TRICKS OF THE TRADE:
PANEL DISCUSSION
VASECTOMY TECHNIQUES AND EFFICACY/
POST VASECTOMY SEMEN ANALYSIS REVIEW OF AUA GUIDELINES
Stanton Honig
VASECTOMY RELATED
CO-MORBIDITIES/HEALTH RISKS OF
VASECTOMY
2:20
2:40
POST-VASECTOMY PAIN
SYNDROME/CHRONIC ORCHALGIA EPIDEMIOLOGY, EVALUATION, AND
TREATMENT
James Hotaling
*Presenting author
3:55
VASECTOMY CONTROVERSIES/CASE
STUDIES
Moderator: Stanton Honig
Panelists: Jay Sandlow, Ajay Nangia, Ira Sharlip
4:40
Q & A WITH PANEL AND DISTINGUISHED
SPEAKERS
5:00
SSMR BUSINESS MEETING
6:00
ADJOURN
CREDITTM
173
Sunday, May 8, 2016
1:00 pm - 3:00 pm
CROSSFIRE: CONTROVERSIES IN UROLOGY: BENIGN
Moderator: Kathleen Kobashi
1:00
MALE REJUVENATION IS DETRIMENTAL TO
YOUR HEALTH
Moderator: Stanton Honig
Debaters - Pro: Martin Miner, Mohit Khera
Debaters - Con: Natan Bar-Chama, Thomas Walsh
2:30
URODYNAMICS ARE ESSENTIAL PRIOR TO
SUI SURGERY
Debaters - Pro: Raymond Rackley, Eric Rovner
Debaters - Con: Deborah Lightner, Anurag Das
1:30
ALPHA BLOCKERS HAVE NO ROLE IN RENAL
COLIC
Moderator: Stephen Nakada
Debater - Pro: James N’Dow, Thomas Chi
Debaters - Con: Philipp Dahm, Brian Matlaga
3:00
ADJOURN
2:00
CREDITTM
PRIMARY URETHRAL ALIGNMENT HAS
BETTER OUTCOMES THAN DELAYED
RECONSTRUCTION AFTER INJURY FROM A
PELVIC FRACTURE
Moderator: Daniel Rosenstein
Debaters - Pro: Charles Best, Bahaa Malaeb
Debaters - Con: Steven Brandes, Sanjay Kulkarni
Sunday, May 8, 2016
1:00 pm - 3:00 pm
AUA / AACU HEALTH POLICY FORUM
1:00
AUA HEALTH POLICY GUEST SPEAKER (CME)
3:00
NARROW NETWORKS: HOW IT IMPACTS
PHYSICIANS AND HOW TO FIGHT BACK
David Brewster
2:00
ADJOURN
CREDITTM
AACU HOFFMAN LECTURER (NON-CME)
TRANSFORMATIVE UROLOGIC HEALTH CARE
DELIVERY MODELS FOR THE 21ST CENTURY
Ronald Loo
Sunday, May 8, 2016
1:00 pm – 3:00 pm
FUNDING OPPORTUNITIES AND GRANTWRITING
GUIDANCE FOR EARLY-CAREER INVESTIGATORS
1:00
COURSE OVERVIEW AND GOALS
Carolyn Best
1:05
NIDDK TRAINING & RESEARCH MECHANISMS
Tracy Rankin
1:17
NIA FUNDING OPPORTUNITIES FOR
UROLOGIC RESEARCH AND TRAINING
Ramesh Vemuri
1:29
1:41
1:53
AUA AND UROLOGY CARE FOUNDATION
OPPORTUNITIES AND EXTERNAL FUNDING
SOURCES
Krystal Brinson
2:05
GRANTWRITING 101
Erika Wolff
2:17
DOD/CDMRP FUNDING OPPORTUNITIES FOR
UROLOGIC RESEARCH AND TRAINING
Melissa Cunningham
PERSPECTIVES FROM AN EARLY-CAREER
INVESTIGATOR
Hyung Kim
2:29
AMERICAN CANCER SOCIETY RESEARCH
GRANTS IN UROLOGY RESEARCH
Michael Melner
PERSPECTIVES FROM A SENIOR
INVESTIGATOR
Dolores Lamb
2:41
Q&A
174
2:53
2:58
OVERVIEW OF THE AUA EARLY CAREER
INVESTIGATORS WORKSHOP
Carolyn Best
3:00
ADJOURN
CREDITTM
CLOSING REMARKS
Carolyn Best
Sunday, May 8, 2016
1:00 pm - 3:00 pm
ABSTRACT
NUMBER TITLE
MP49-01 NEXT GENERATION SEQUENCING OF
CELL FREE DNA REVEALS GENOMIC
ABERRATIONS IN METASTATIC
Tilman Todenhöfer*, Stanislav Volik, Bernie
Eigl, Vancouver, Canada, Scott North,
Edmonton, Canada, Sonal Brahmbhatt, Anne
Haegert, Vancouver, Canada, Johannes
Mischinger, Arnulf Stenzl, Tuebingen,
Germany, Stephane LeBihan, Alexander
Wyatt, Colin Collins, Peter Black, Vancouver,
Canada
ABSTRACT
NUMBER TITLE
MP49-05 PROGNOSTIC IMPACT OF C-REACTIVE
PROTEIN KINETICS ON SURVIVAL OF
PATIENTS WITH ADVANCED UROTHELIAL
CARCINOMA
Junichiro Ishioka*, Kazutaka Saito, Masaharu
Inoue, Masaya Itoh, Soichiro Yoshida, Minato
Yokoyama, Yoh Matsuoka, Noboru Numao,
Japan
MP49-06 ASSESSING CANCER PROGRESSION AND
STABLE DISEASE AFTER NEOADJUVANT
CHEMOTHERAPY FOR MUSCLE-INVASIVE
BLADDER CANCER
Meera Chappidi*, Max Kates, Aaron Brant,
Alexander Baras, George Netto, Noah Hahn,
Phillip Pierorazio, Baltimore, MD, Mark
Schoenberg, Bronx, NY, Trinity Bivalacqua,
Baltimore, MD
MP49-02 A STUDY TO EVALUATE THE
PROGNOSTIC AND PREDICTIVE UTILITY
OF CCP AND HRD ASSAYS AND GENETIC
SEQUENCING IN PATIENTS UNDERGOING
NEOADJUVANT CHEMOTHERAPY IN
BLADDER CANCER
Hristos Kaimakliotis*, Michael Koch, Lee-Wei
Kao, Jane Cho, Richard Bihrle, Roberto Pili,
Clint Cary, Timothy Masterson, Costantine
Albany, Richard Foster, Indianapolis, IN, Julia
Reid, Kristen Timms, Salt Lake City, UT,
Liang Cheng, Indianapolis, IN, Steve Stone,
Salt Lake City, UT
MP49-07 THE RISK OF POSTOPERATIVE VENOUS
THROMBOEMBOLISM ACCORDING TO
THE CIRCULATING TUMOR CELL STATUS
IN PATIENTS WITH UROTHELIAL
CARCINOMA OF THE BLADDER TREATED
WITH RADICAL CYSTECTOMY
Armin Soave*, Sabine Riethdorf, Roland
Dahlem, Lars Weisbach, Valentin Maurer,
Oliver Engel, Sarah Minner, Klaus Pantel,
Margit Fisch, Michael Rink, Hamburg,
Germany
MP49-03 COMPARATIVE EFFECTIVENESS OF
ROBOT-ASSISTED AND OPEN RADICAL
CYSTECTOMY: CANCER CONTROL
Giorgio Gandaglia*, Aalst, Belgium, Karl
Alexander, Munich, Germany, Michele
Zazzara, Aalst, Belgium, Giacomo Novara,
Melle, Belgium, Ruben De Groote, Aalst,
Belgium, Alexander Buchner, Munich,
Germany, Frederiek D’hondt, Aalst, Belgium,
Montorsi Francesco, Milan, Italy, Christian
Stief, Munich, Germany, Alexandre Mottrie,
Aalst, Belgium, Christian Gratzke, Munich,
Germany
MP49-08 PROGNOSTIC SIGNIFICANCE OF DEPTH
OF INVASION IN TRANSURETHRAL
RESECTION OF BLADDER TUMOR
SPECIMENS.
Mahmut Akgul, Bream Matthew*, Nafiseh
Janaki, Hammad Tashkandi, Lee Ponsky,
Gregory MacLennan, Cleveland, OH
MP49-09 IMPROVED OUTCOME WITH ADJUVANT
CHEMOTHERAPY IN LOCALLY
ADVANCED OR LYMPH NODE POSITIVE
TUMORS AFTER RADICAL CYSTECTOMY
Michael Froehner*, Rainer Koch, Ulrike
Heberling, Vladimir Novotny, Sven
Oehlschläger, Matthias Hübler, Manfred P.
Wirth, Dresden, Germany
MP49-04 THE UTILITY OF NEUTROPHIL-TOLYMPHOCYTE RATIO IN DETERMINING
SURVIVAL OUTCOMES IN PATIENTS
TREATED WITH NEOADJUVANT
CHEMOTHERAPY AND RADICAL
CYSTECTOMY FOR HIGH-RISK BLADDER
CANCER
Austen Slade*, Chinedu Mmeje, Rebecca
Slack, Jay Shah, Houston, TX
*Presenting author
175
SUNDAY
BLADDER CANCER: INVASIVE III
Moderators: Khurshid Guru and Mark Soloway
MP49-10 PERIOPERATIVE AND ONCOLOGICAL
OUTCOMES OF OBESE PATIENTS WITH
ROBOTIC ASSISTED RADICAL
CYSTECTOMY
Nariman Ahmadi*, Daniel Roeter, Toshitaka
Shin, Gus Miranda, Jie Cai, Monish Aron,
Mihir Desai, Inderbir Gill, Los Angeles, CA
MP49-16 FACTORS PREDICTING FAILURE TO
FOLLOW PRE-SCHEDULED GEMCITABINE
PLUS CISPLATIN CHEMOTHERAPY
REGIMEN FOR UROTHELIAL CARCINOMA
Tatsuo Gondo*, Yoshio Ohno, Yosuke
Hirasawa, Takeshi Kashima, Kenji
Shimodaira, Yoshihiro Nakagami, Jun
Nakashima, Makoto Ohori, Masaaki
Tachibana, Tokyo, Japan
MP49-11 NEOADJUVANT GEMCITABINE AND
CARBOPLATIN FOLLOWED BY
IMMEDIATE RADICAL CYSTECTOMY FOR
PATIENTS INELIGIBLE FOR CISPLATINBASED CHEMOTHERAPY: A PROPENSITY
SCORE-MATCHED ANALYSIS
Takuya Koie*, Chikara Ohyama, Atsushi Imai,
Shingo Hatakeyama, Takahiro Yoneyama,
Yasuhiro Hashimoto, Tohru Yoneyama, Yuki
Tobisawa, Hirosaki, Japan
MP49-17 CLINICAL OUTCOMES OF PATIENTS
WITH HISTOLOGIC VARIANTS OF
BLADDER CANCER TREATED WITH
TRIMODAL BLADDER-SPARING THERAPY
Ross Krasnow*, Hannah Roberts, Michael
Drumm, Andrzej Niemierko, Chin-Lee Wu,
Adam Feldman, Matthew Wszolek, Richard
Lee, Michael Blute, Anthony Zietman, William
Shipley, Jason Efstathiou, Boston, MA
MP49-18 FDG PET-CT VS CT SCAN IN THE
STAGING OF UROTHELIAL NEOPLASMS
Gaya Josep Maria*, Oscar Rodrı́guez, Pablo
Maroto, Ignasi Carrió, Ruben Parada, Andrés
Kanashiro, Alfonso Gómez de Liaño, Joan
Palou, Barcelona, Spain
MP49-12 NEOADJUVANT CHEMOTHERAPY FOR
INVASIVE BLADDER CANCER: IS IT
RIGHT FOR EVERYONE?
Cooper Benson*, Neema Navai, Jianjun Gao,
Arlene Siefker-Radtke, Graciela Nogueras
Gonzalez, Vishnukamal Golla, Jeffrey
Alliston, Ashish Kamat, Colin Dinney, Jay
Shah, Houston, TX
MP49-19 COMPARATIVE EVALUATION OF HEALTH
RELATED QUALITY OF LIFE (HRQOL)
INSTRUMENTS FOR BLADDER CANCER.
Travis Moncrief*, Priya Balaji, Bruce
Lindgren, Badrinath Konety, Minneapolis, MN
MP49-13 SELECTIVE NEOADJUVANT
CHEMOTHERAPY BY PREDICTION
SYSTEMS IMPROVES THE CHEMOSENSITIVITY OF THE MUSCLE INVASIVE
BLADDER CANCERS
Yoichiro Kato*, Iwate, Japan, Hitoshi
Zembutsu, Tokyo, Japan, Ryo Takata,
Tomohiko Matsuura, Renpei Kato, Mitsugu
Kanehira, Kazuhiro Iwasaki, Jun Sugimura,
So Omori, Takaya Abe, Iwate, Japan, Yusuke
Nakamura, Chicago, IL, Wataru Obara, Iwate,
Japan
MP49-20 EX VIVO FLUORESCENCE IMAGING OF
UROTHELIAL CARCINOMA IN HUMAN
BLADDERS TARGETED BY ICG-PHLIP
Joseph Brito*, Providence, RI, Jovana
Golijanin, Kingston, RI, Timothy Tran,
Providence, RI, Gregory Andreev, Yana
Reshetnyak, Kingston, RI, Ali Amin, Dragan
Golijanin, Providence, RI
CREDITTM
MP49-14 PREDICTIVE VALUE OF RADIOLOGICAL
RESPONSE RATE FOR PATHOLOGICAL
RESPONSE TO NEOADJUVANT
CHEMOTHERAPY AND POSTCYSTECTOMY SURVIVAL OF BLADDER
UROTHELIAL CANCER
Takashi Kobayashi*, Tomohiro Fukui,
Yoshiyuki Matsui, Shigeaki Umeoka, Takahiro
Inoue, Tomomi Kamba, Osamu Ogawa,
Kyoto, Japan
MP49-15
CLINICAL ROLE OF ADDITIONAL
ADJUVANT CHEMOTHERAPY IN
PATIENTS WITH LOCALLY ADVANCED
UROTHELIAL CARCINOMA FOLLOWING
NEOADJUVANT CHEMOTHERAPY AND
CYSTECTOMY
Kamran Zargar Shoshtari*, Michael
Kongnyuy, Pranav Sharma, Mayer N
Fishman, Scott M. Gilbert, Michael A Poch,
Julio M Powsang, Philippe E Spiess,
Jingsong Zhang, Wade J Sexton, Tampa, FL
176
Sunday, May 8, 2016
1:00 pm - 3:00 pm
PROSTATE CANCER: ADVANCED (INCLUDING DRUG THERAPY) II
Moderators: Sam Chang and Daniel Petrylak
MP50-02
MP50-03
MP50-04
*Presenting author
ABSTRACT
NUMBER TITLE
MP50-05 SYNTHETIC LETHAL METABOLIC
TARGETING OF CELLULAR SENESCENCE
IN PROSTATE CANCER WITH THE
REPURPOSED DRUG METFORMIN
Johnathon R. McCormick, Michael L. Blute,
Jr.*, Bing Yang, Nathan Damaschke, David F.
Jarrard, Madison, WI
DOES THE NUMBER OF LYMPH NODES
SAMPLED DURING RADICAL
PROSTATECTOMY IMPACT RISK OF
BIOCHEMICAL RECURRENCE IN
PATIENTS WITH SEMINAL VESICLE
INVASION?
Ketan K. Badani, David J. Paulucci, Eric
Moskowitz, Balaji N. Reddy, New York, NY,
Michael J. Whalen*, New Haven, CT,
Douglas W. Skarecky, Thomas E. Ahlering,
Irvine, CA
SALVAGE RADICAL PROSTATECTOMY
COMPLICATIONS AND FUNCTIONAL
OUTCOMES: OPEN VERSUS ROBOTIC
PROCEDURES.
Paolo Gontero*, Giancarlo Marra, Paolo
Alessio, Marco Oderda, Anna Palazzetti,
Francesca Pisano, Antonino Battaglia,
Stefania Munegato, Claudia Filippini, Bruno
Frea, Turin, Italy, Fernando Munoz, Aosta,
Italy, Estefania Linares, Raphael Sanchez
Salas, Paris, France, Sanchia
Goonewardene, Prokar Dasgupta, Declan
Cahill, Ben Challacombe, London, United
Kingdom, David Gillatt, Raj Persad, Bristol,
United Kingdom, Juan Palou, Barcelona,
Spain, Steven Joniau, Leuven, Belgium,
Salvatore Smelzo, Thierry Piechaud,
Bordeaux, France, Alexandre De La Taille,
Créteil, France, Morgan Roupret, Paris,
France, Derya Tilki, Hamburg, Germany, Rick
Popert, London, United Kingdom
NEOADJUVANT ANDROGEN
DEPRIVATION IN PRIMARILY
INOPERABLE PROSTATE CANCER:
CONSECUTIVE ASSESSMENT OF PERIAND POSTOPERATIVE OUTCOMES
Turkan Hajili*, Carsten Ohlmann, Johannes
Linxweiler, Stefan Siemer, Michael Stoeckle,
Matthias Saar, Homburg, Germany
177
MP50-06
SIMVASTATIN INHIBITS THE
PROLIFERATION, MIGRATION AND
INVASION OF ANDROGEN INDEPENDENT
HUMAN PROSTATE CANCER CELLS VIA
UP-REGULATION OF ANNEXIN A10
Yoshiyuki Miyazawa*, Yoshitaka Sekine,
Haruo Kato, Yosuke Furuya, Hidekazu Koike,
Kazuhiro Suzuki, Gunma, Maebashi, Japan
MP50-07
CURRENT EVIDENCE DOES NOT
SUPPORT THE HYPOTHESIS THAT
STATIN USE REDUCES THE RISK OF
PROSTATE CANCER
Ping Tan, Lu Yang, Shiyou Wei, Liang Gao,
Zhuang Tang, Qiang Wei*, Chengdu, China,
MP50-08
CAN ANGIOTENSIN-CONVERTING
ENZYME INHIBITORS REDUCE THE
INCIDENCE, SEVERITY, AND DURATION
OF RADIATION PROCTITIS?
Abduelmenem Alashkham*, Catherine
Paterson, Petra Rauchhaus, Ghulam Nabi,
Dundee, United Kingdom
MP50-09
LUTEINIZING HORMONE-RELEASING
HORMONE ANTAGONIST REDUCE SERUM
ADRENAL ANDROGEN LEVELS IN
Yoshiyuki Miyazawa*, Haruo Kato, Yosuke
Furuya, Takashi Nitta, Yoshitaka Sekine,
Hidekazu Koike, Hiroshi Matsui, Yasuhiro
Shibata, Kazuto Ito, Kazuhiro Suzuki,
Maebashi, Gunma, Japan
MP50-10
THE INCIDENCE AND RISK OF
BIOCHEMICAL RECURRENCE
FOLLOWING RADICAL RADIOTHERAPY
FOR PROSTATE CANCER IN MEN ON
ANGIOTENSIN-CONVERTING ENZYME
INHIBITORS (ACEIS) OR ANGIOTENSIN
RECEPTOR BLOCKERS (ARB)
Abduelmenem Alashkham*, Catherine
Paterson, Phyllis Windsor, Allan Struthers,
Petra Rauchhaus, Ghulam Nabi, Dundee,
United Kingdom
SUNDAY
ABSTRACT
NUMBER TITLE
MP50-01 SURVIVAL ANALYSIS OF PATIENTS WITH
NODE POSITIVE PROSTATE CANCER
COMPARING OBSERVATION VS.
ADJUVANT ANDROGEN DEPRIVATION
THERAPY ALONE VS. ADJUVANT
ANDROGEN DEPRIVATION PLUS
EXTERNAL BEAM RADIATION THERAPY
Karim Touijer*, New York, NY, Jeffrey
Karnes, Rochester, MN, Daniel Sjoberg,
Niccolo Passoni, Melissa Assel, Andrew
Vickers, James Eastham, Peter Scardino,
New York, NY, Francesco Montorsi, Alberto
Briganti, Milan, Italy
MP50-11
THE ROLE OF SALVAGE EXTENDED
LYMPH NODE DISSECTION (LND) IN
PATIENTS WITH RISING PSA AND PET/CT
SCAN DETECTED NODAL RECURRENCE
OF PROSTATE CANCER
Daniel Porres*, Cologne, Germany, Daniar
Osmonov, Alexey Aksenov, Kiel, Germany,
Andrea Katharina Thissen, Timur Kuru,
Cologne, Germany, David Pfister, Aachen,
Germany, Klaus-Peter Junemann, Kiel,
Germany, Axel Heidenreich, Cologne,
Germany
MP50-12
THE IMPACT OF LOCAL TREATMENT ON
OVERALL MORTALITY IN PATIENTS
DIAGNOSED WITH PRIMARY
Björn Löppenberg*, Deepansh Dalela, Patrick
Karabon, Akshay Sood, Jesse Sammon,
Detroit, MI, Quoc-Dien Trinh, Christian Meyer,
Maxine Sun, Boston, MA, James Peabody,
Mani Menon, Detroit, MI, Firas Abdollah,
Royal Oak, MI
MP50-13
MP50-14
MP50-15
VALIDATION OF A BONE SCAN
POSITIVITY RISK TABLE IN NONMETASTATIC CASTRATION-RESISTANT
PROSTATE CANCER
Daniel Moreira*, Rochester, MN, Lauren
Howard, Brian Hanyok, Vishnu Kadiyala,
Jameson Kuang, Colette Whitney, Floyd
Wilks, Durham, NC, Christopher Kane, San
Diego, CA, Martha Terris, Augusta, GA,
Christopher Amling, Portland, OR, Matthew
Cooperberg, San Francisco, CA, William
Aronson, Stephen Freedland, Los Angeles,
CA
OSTEOPOROSIS AMONG MEN WITH
PROSTATE CANCER DURING
TREATMENT WITH ANDROGEN
DEPRIVATION THERAPY
Mads Poulsen*, Morten Frost, Odense,
Denmark, Bo Abrahamsen, Holbæk,
Denmark, Oke Gerke, Steen Walter, Odense,
Denmark
ASSOCIATION BETWEEN WEIGHT GAIN
AND SARCOPENIC OBESITY IN PATIENTS
WITH PROSTATE CANCER TREATED
WITH ANDROGEN DEPRIVATION
THERAPY
Koji Mitsuzuka*, Miyagi, Japan, Atsushi Kyan,
Tomonori Sato, Shirakawa, Japan, Kazuhiko
Orikasa, Kesen-numa, Japan, Hiroshi Aoki,
Sendai, Japan, Minoru Miyazato, Okinawa,
Japan, Shintaro Narita, Akita, Japan, Takuya
Koie, Hirosaki, Japan, Tomonori Habuchi,
Akita, Japan, Chikara Ohyama, Hirosaki,
Japan, Yoichi Arai, Miyagi, Japan
MP50-16
RADIUM-223 RE-TREATMENT:
EXPERIENCE FROM AN INTERNATIONAL,
MULTICENTER, PROSPECTIVE STUDY IN
PATIENTS WITH CASTRATIONRESISTANT PROSTATE CANCER AND
BONE METASTASES
Luke Nordquist*, Omaha, NE, Daniel Keizman,
Kfar Saba, Israel, Neil Mariados, Syracuse, NY,
Maria José Méndez Vidal, Cordoba, Spain,
Camilla Thellenberg-Karlsson, Umeå, Sweden,
Avivit Peer, Haifa, Israel, Giuseppe Procopio,
Milan, Italy, Stephen J. Frank, Jerusalem,
Israel, Kalevi Pulkkanen, Kuopio, Finland,
Stefano Severi, Meldola, Italy, Jose Manuel
Trigo Perez, Málaga, Spain, Paul
Schwarzenberger, Rui Li, Whippany, NJ, Oliver
Sartor, New Orleans, LA
MP50-17
THE BURDEN OF SYMPTOMATIC
SKELETAL EVENTS IN CASTRATERESISTANT PROSTATE CANCER
PATIENTS WITH BONE METASTASES AT
THREE CANADIAN URO-ONCOLOGY
CENTRES
Fred Saad*, Montreal, Canada, Neil E.
Fleshner, Toronto, Canada, Alan So,
Vancouver, Canada, Jacques Le Lorier,
Montreal, Canada, Louise Perrault, Zug,
Switzerland, Melanie Poulin-Costello, Raina
Rogoza, Ewan J.D. Robson, Mississauga,
Canada
MP50-18
STUDY OF PSMA-TARGETED 18F-DCFPYL
PET/CT IN THE EVALUATION OF MEN
WITH AN ELEVATED PSA FOLLOWING
Michael A. Gorin*, Steven P. Rowe, Margarita
Mana-ay, Zsolt Szabo, Edward M. Schaeffer,
Phuoc T. Tran, Mohamad E. Allaf, Curtiland
Deville, Trinity J. Bivalacqua, Baltimore, MD,
Steve Y. Cho, Madison, WI, Martin G.
Pomper, Ashley E. Ross, Baltimore, MD
MP50-19
DOSEⴚFRACTIONATED ANTIⴚPSMA
RADIOIMMUNOTHERAPY (177LUⴚJ591)
FOR MCRPC
Jaspreet S. Batra*, Beerinder Karir, Kavya
Pinto-Chengot, Yuliya S. Jhanwar, Shankar
Vallabhajosula, Paul J. Christos, Gillian
Hodes, Linda Lam, Ana Molina, Himisha
Beltran, Stanley J. Goldsmith, David M.
Nanus, Neil H. Bander, Scott T. Tagawa,
New York, NY
MP50-20
IMPACT OF ABIRATERONE ACETATE IN
PROSTATE SPECIFIC ANTIGEN TRIAL
UPDATE: EFFECT OF ABIRATERONE
ACETATE AND LOW DOSE PREDNISONE
ON PROSTATE-SPECIFIC ANTIGEN AND
RADIOGRAPHIC DISEASE PROGRESSION
IN PATIENTS WITH NON-METASTATIC
Charles Ryan*, San Francisco, CA, E. David
Crawford, Aurora, CO, Neal D Shore, Myrtle
Beach, SC, Willie Underwood, Elm and
Carlton Streets, NY, Anil Londhe, Spring
House, PA, Shawn Black, Tracy McGowan,
Horsham, PA, Philip W. Kantoff, Boston, MA
CREDITTM
178
Sunday, May 8, 2016
1:00 pm - 3:00 pm
STONE DISEASE: SURGICAL THERAPY V
Moderators: Mark Noble and Bodo Knudsen
MP51-02
ASSESSMENT OF CLINICAL FEATURES
AND MANAGEMENT OUTCOMES IN
PATIENTS PRESENTING WITH A
FORNICEAL RUPTURE
Aziz Khambati*, Yasin Bhanji, Christopher
Morrison, Robert Nadler, Chicago, IL
MP51-03
COMPARISON OF A NEW SINGLE-USE
DIGITAL FLEXIBLE URETEROSCOPE
(LITHOVUE TM) TO A NON-DISPOSABLE
FIBRE-OPTIC FLEXIBLE URETEROSCOPE
IN A LIVE PORCINE MODEL
Oliver Wiseman*, Cambridge, United
Kingdom, Francis Keeley, Bristol, United
Kingdom, Olivier Traxer, Paris, France, Guido
Giusti, Milan, Italy, Michael Lipkin, Glenn
Preminger, Durham, NC
MP51-04
MP51-05
MP51-06
MP51-07
*Presenting author
ABSTRACT
NUMBER TITLE
MP51-08 SAME-SESSION BILATERAL
URETEROSCOPY: SAFETY AND
OUTCOMES
Johann Ingimarsson*, John Knoedler,
Krambeck Amy, Rochester, MN
A NOVEL TECHNIQUE OF SUCTIONING
FLEXIBLE URETEROSCOPY WITH
AUTOMATIC CONTROL OF RENAL PELVIC
PRESSURE: AN INITIAL EXPERIENCE OF
37 CASES
Leming Song*, Xiaolin Deng, Donghua Xie,
Difu Fan, Zuofeng Peng, Tairong Liu,
Ganzhou, China, People’s Republic of,
Zhangqun Ye, Wuhan, China, People’s
Republic of
FACTORS PREDICTING SUCCESS OF
EMERGENCY URETEROSCOPIC
TREATMENT OF URETERAL STONES: A 3
YEARS SINGLE CENTER EXPERIENCE IN
212 PATIENTS
Paolo Umari*, Stefano Bucci, Michele Rizzo,
Nicola Pavan, Giovanni Liguori, Carlo
Trombetta, Trieste, Italy
DEFINITIVE URETERAL STONE
TREATMENT (DUST) SCORE PREDICTS
SUCCESS OF URETEROSCOPY IN
ACUTELY OBSTRUCTING PROXIMAL
URETERAL STONES
Timothy Tran*, Simone Thavaseelan, Gyan
Pareek, Providence, RI
FLEXIBLE URETEROSCOPY AND LASER
LITHOTRIPSY FOR RENAL STONES
USING POP-DUSTING’: COMPARISON OF
OUTCOMES BETWEEN TRADITIONAL
DUSTING SETTINGS VERSUS ULTRAHIGH FREQUENCY SETTINGS
James Tracey*, Galina Gagin, Duncan
Morhardt, John Hollingsworth, Khursid Ghani,
Ann Arbor, MI
179
MP51-09
PRIMARY VERSUS DEFERRED
URETEROSCOPY FOR MANAGEMENT OF
CALCULUS ANURIA: A PROSPECTIVE
RANDOMIZED TRIAL
Mohammed A. Elgammal, Ahmad A
Elderwy*, Mohamed M. Gadelmoula, Diaa A.
Hameed, Hosny M Behnsawy, Mahmoud M.
Osman, Adel Kurkar, Assiut, Egypt
MP51-10
URETERAL STRICTURES AFTER
URETEROSCOPY FOR NEPHROLITHIASIS:
MULTI-INSTITUTIONAL OUTCOMES
Philip May*, Seattle, WA, Ryan Hsi, San
Francisco, CA, Henry Tran, Vancouver,
Canada, Marshall Stoller, San Francisco, CA,
Ben Chew, Vancouver, Canada, Thomas Chi,
Manint Usawachintachit, San Francisco, CA,
Brian Duty, Portland, OR, John Gore,
Jonathan Harper, Seattle, WA
MP51-11
RATE OF URETERAL STRICTURE
FOLLOWING URETEROSCOPY FOR
NEPHROLITHIASIS USING A NATIONAL
DATABASE OF INSURED PATIENTS
Philip May*, Sarah Holt, Joshua Calvert,
Jonathan Harper, Seattle, WA
MP51-12
COST SAVINGS WITH SELECTIVE GUIDE
WIRE USE DURING RETROGRADE
URETERAL ACCESS
Mike Fascelli, Scott Hubosky*, Kelly Healy,
Mihir Shah, Demetrius Bagley, Philadelphia,
PA
MP51-13
EMPLOYMENT OF THE NOVEL LASER
DIRECT ALIGNMENT RADIATION
REDUCTION TECHNIQUE (DARRT) FOR
ACCESS
Patrick Yang, Samuel Abourbih*, Jim Shen,
Salim Cheriyan, Mohamed Keheila, Jason
Smith, D. Duane Baldwin, Loma Linda, CA
MP51-14
AFTER RECENT UROLITHIASIS RELATED
SEPSIS: WHAT SHOULD PATIENTS
EXPECT? ANSWERS FROM A MATCHED
PAIR ANALYSIS
Ramy F Youssef*, Orange, CA, Andreas
Neisius, Mainz, Germany, Melissa Suarez,
Simone L Vernez, Orange, CA, Gastòn M
Astroza, Santiago, Chile, Zachariah G
Goldsmith, Momin Ghaffar, Matvey Tsivian,
Glenn Preminger, Michael E Lipkin, Durham,
NC
SUNDAY
ABSTRACT
NUMBER TITLE
MP51-01 SIXTY-DAY OUTCOMES AFTER SURGICAL
VS. MEDICAL TREATMENT OF ACUTE
RENAL COLIC
Taylor Remondini*, Samir Sami, Bryce
Weber, Dean Wong, Anthony Cook, Grant
Innes, Calgary, Canada
MP51-15
PRE- AND POST-OPERATIVE
PREDICTORS OF INFECTION RELATED
COMPLICATIONS IN PATIENTS
UNDERGOING PERCUTANEOUS
NEPHROLITHOTOMY
Marcelino Rivera*, Boyd Viers, Amy
Krambeck, Rochester, MN
MP51-16
IMPACT OF IRRIGATION FLUID
PRESSURE ON THE RISK OF SYSTEMIC
INFLAMMATORY RESPONSE SYNDROME
AFTER CONVENTIONAL PERCUTANEOUS
NEPHROLITHOTOMY: A RANDOMIZED
CLINICAL TRIAL
Mohamed Omar*, Mark Noble, Sri
Sivalingam, Cleveland, OH, Alla El Mahdy,
Ahmed Gamal, Cairo, Egypt, Manoj Monga,
Cleveland, OH
MP51-17
MP51-18
POST PERCUTANEOUS
NEPHROLITHOTOMY HEMORRHAGE:
ASSESSMENT OF FACTORS ASSOCIATED
WITH A NEGATIVE RENAL ANGIOGRAM
Ricardo Palmerola*, Vinay Patel, Paras Shah,
Christopher Hartman, New Hyde Park, NY,
Nikhil Waingankar, New York, NY, Manish
Vira, Arthur Smith, Zeph Okeke, New Hyde
Park, NY
MP51-19
PERCUTANEOUS NEPHROLITHOTOMY AS
AN OUTPATIENT PROCEDURE;
Ahmed fahmy*, Omer Algebaly, Wael Sameh,
Alexandria, Egypt
MP51-20
AMBULATORY PCNL: INITIAL CASE
SERIES
Julio G. Davalos, Glen Burnie, MD, Joel E.
Abbott*, San Diego, CA
IMPACT OF PERCUTANEOUS
NEPHROLITHOTRIPSY ON EARLY AND
LONG-TERM RENAL FUNCTION IN
PATIENTS WITH A SOLITARY KIDNEY
Siobhan Telfer*, Husain Alenezi, Marie Dion,
Daniel Olvera-Posada, John D. Denstedt,
Hassan Razvi, London, Canada
CREDITTM
Sunday, May 8, 2016
1:00 pm - 3:00 pm
TRAUMA/RECONSTRUCTION/DIVERSION: URETHRAL RECONSTRUCTION (INCLUDING STRICTURE, DIVERTICULUM) II
Moderators: Jerilyn Latini and Keith Rourke
ABSTRACT
NUMBER TITLE
MP52-01 CORRELATION OF CYSTOSCOPIC
URETHRAL STRICTURE STAGE WITH
URINARY FLOW AND POSTOPERATIVE
IMPROVEMENT
Nicholas Hauser*, Bobby Najari, New York,
NY, Frank Copeli, Frank Myers, Brooklyn,
NY, Rajveer Purohit, New York, NY
MP52-02
MP52-03
MP52-04
ABSTRACT
NUMBER TITLE
MP52-05 ANTERIOR URETHROPLASTY HAS
TRANSITIONED TO AN OUTPATIENT
PROCEDURE, BUT WITH INCREASED
COMPLICATIONS: DATA FROM NSQIP
Susan MacDonald*, Devin Haddad, Marc
Colaco, Ryan Terlecki, Winston Salem, NC
USE OF DYNAMIC MRI
CYSTOURETHROGRAM IN EVALUATION
OF ANASTOMOTIC STENOSIS AFTER
RADICAL PROSTATECTOMY.
Matheus Miranda, André Cavalcanti*, Carlos
Felipe Trujillo, Gustavo Fiedler, Carlos Araújo
Júnior, Leonardo Bittencourt, Rio de Janeiro,
Brazil
BURDEN OF DISEASE FOR URETHRAL
STRICTURE MANAGED BY REPEAT
ENDOSCOPIC TREATMENT VERSUS
SINGLE ENDOSCOPIC TREATMENT OR
URETHROPLASTY IN THE VETERANS
AFFAIRS POPULATION
Kiranpreet K Khurana*, Yuka Yamaguchi,
Dawn Walter, Danil Makarov, Lee C Zhao,
New York, NY
A NOVEL USE OF METHYLENE BLUE IN
ANTERIOR URETHROPLASTY
Sanjay kulkarni*, Pankaj Joshi, Sandesh
Surana, Atef Homuda, Jyotsna Kulkarni,
Pune, India
180
MP52-06
PROSPECTIVE ASESSMENT OF
EJACULATORY FUNCTION FOLLOWING
URETHROPLASTY: RELATIONSHIP TO
PATIENT AGE & STRICTURE LOCATION
Trevor Haines*, Keith Rourke, Edmonton,
Canada
MP52-07
CRITICAL ANALYSIS OF
BULBOSPONGIOSUS SPARING BULBAR
URETHROPLASTY ON EJACULATORY
FUNCTION AND POST-VOID DRIBBLING
Ariel Fredrick*, Burlington, MA, Bradley
Erickson, Iowa City, IA, Kristian Stensland,
Alex Vanni, Burlington, MA
MP52-08
EXCISION AND PRIMARY ANASTOMOSIS
VS. DORSAL BUCCAL GRAFTING FOR
BULBAR URETHRAL STRICTURES:
COMPARISON OF OUTCOMES AND
QUALITY OF LIFE
Eric Wisenbaugh*, Simone Vernez, Rahul
Dutta, Quynh Mai, Joel Gelman, Orange, CA
STRICTURE LENGTH, PATIENT
COMORBIDITY, INFECTIOUS ETIOLOGY
AND OBESITY INFLUENCES STRICTURE
RECURRENCE AFTER BULBAR
URETHROPLASTY: MULTIVARIATE
ANALYSIS OF BULBAR URETHROPLASTY
OUTCOMES
David Chapman*, Adam Kinnaird, Keith
Rourke, Edmonton, Canada
MP52-10
ANTIMICROBIAL PRACTICE PATTERNS
FOR URETHROPLASTY AMONG GU
RECONSTRUCTION EXPERTS: A CALL
FOR STANDARDIZATION
Michelle McDonald*, Jill Buckley, San Diego,
CA
MP52-11
CAN HISTOPATHOLOGICAL DIAGNOSIS
OF LICHEN SCLEROSUS IN PATIENTS
WITHOUT CLINICAL FINDINGS PREDICT
URETHRAL RECONSTRUCTION
OUTCOMES?
Oscar A. Storme*, Jeremy B. Tonkin,
Jefferson Lin, Ramón Virasoro, Jack M.
Zuckerman, Jessica M. DeLong, Kurt A.
McCammon, Norfolk, VA
MP52-12
RECONSTRUCTION OF LICHEN
SCLEROSUS RELATED URETHRAL
STRICTURES: OUTCOMES OF LONG
PENILE AND PANURETHRAL
STRICTURES
David Chapman*, Keith Rourke, Edmonton,
Canada
MP52-13
CHANGING TRENDS IN MANAGEMENT OF
PANURETHRAL STRICTURE WITH ONE
STAGE BUCCAL GRAFT AUGMENTATION
URETHROPLASTY
Pankaj Joshi*, Sandesh Surana, Atef
Homuda, Sanjay Kulkarni, Pune, India
MP52-14
NATURAL HISTORY OF PATIENTS WITH
HYPOSPADIAS WHO UNDERWENT
SURGICAL REPAIR: AN OBSERVATIONAL
DESCRIPTIVE ANALYSIS WITH A FINAL
SURPRISE
Guido Barbagli*, Arezzo, Italy, Salvatore
Sansalone, Valerio Iacovelli, Rome, Italy,
Francesco Montorsi, Massimo Lazzeri, Milan,
Italy
MP52-15
*Presenting author
MP52-16
PREDICTORS OF BLADDER NECK
CONTRACTURE FOLLOWING RADICAL
PROSTATECTOMY
Boyd Viers*, Vidit Sharma, Daniel Elliott, R.
MP52-17
ENDOSCOPIC TREATMENT OF
POSTERIOR URETHRAL STRICTURES
FOLLOWING SIMPLE AND RADICAL
PROSTATECTOMY: SUCCESS AND
INCONTINENCE RATES
Clemens M. Rosenbaum*, Tim A. Ludwig,
Philip Reiss, Georg Salomon, Margit Fisch,
Hamburg, Germany, Sascha A. Ahyai,
Göttingen, Germany
MP52-18
CHRONIC SUPRAPUBIC TUBE URINARY
DIVERSION AS A MINIMALLY INVASIVE
STRATEGY FOR RESOLUTION OF
INCONTINENCE FOR COMPLEX
RADIATION-INDUCED STRICTURES
Kunj R. Sheth*, Matthias D. Hofer, Nicholas
L. Kavoussi, Billy H. Cordon, Jeremy M.
Scott, Allen F. Morey, Dallas, TX
MP52-19
SURGICAL LEARNING CURVE OF
POSTERIOR URETHROPLASTY FOR
RADIATION-INDUCED
BULBOMEMBRANOUS URETHRAL
STRICTURES
Joceline S Liu*, Matthias D Hofer, Billy H
Cordon, Jeremy Scott, Allen F Morey, Dallas,
TX
MP52-20
PLGA MESH-COLLAGEN HYBRID
SCAFFOLDS IN SUBSTITUTION
URETHROPLASTY: PRECLINICAL TRIAL
Denis Butnaru*, Petr Glybochko, Yuriy
Alyaev, Andrey Vinarov, Leonid Marisov,
Damir Kantimerov, Anatoly Shehter, Leonid
Istranov, Elena Istranova, Ruben Aboyanc,
Alexey Lundup, Alexander Kurkov, Elizabheta
Saphronova, Elizabheta Vorobyeva, Michail
Irityan, Moscow, Russian Federation
CREDITTM
SURGICAL TREATMENT OF
HYPOSPADIAS AFTER PUBERTY:
CHALLENGES AND STRATEGIES
Mujun Lu*, Dachao Zheng, Haijun Yao,
Dongdong Xiao, Zhong Wang, Shanghai,
181
SUNDAY
MP52-09
Sunday, May 8, 2016
1:00 pm - 3:00 pm
PROSTATE CANCER: DETECTION & SCREENING VII
Moderators: Alan Partin and Quoc-Dien Trinh
ABSTRACT
NUMBER TITLE
MP53-01 DEFINING DELIVERABLES OF
RESONANCE IMAGING
(MPMRI)/ULTRASOUND (US) FUSIONGUIDED TARGETED PROSTATE BIOPSY:
ACTIONABLE INTELLIGENCE METRIC
(AIM) AND REDUCTION METRIC (RM)
Benjamin Ristau*, Aseem Malhotra, Serge
Ginzburg, David Chen, Rosaleen Parsons,
Barton Milestone, Marion Brody, Michael
Haifler, Mohammed Haseebuddin, Nikhil
Waingankar, Rosalia Viterbo, Richard
Greenberg, Marc Smaldone, Robert Uzzo,
MP53-02
NEGATIVE PREDICTIVE VALUE OF A
NEGATIVE MULTI-PARAMETRIC MRI OF
PROSTATE
Joseph Mahon, Ronald P Kaufman Jr.,
Rebecca O’Malley, Badar Mian*, Hugh
Fisher, Ahmed Essa, Albany, NY
MP53-03
TRANSPERINEAL MRI VISUALLYTARGETED PROSTATE BIOPSIES
COMPARED TO TEMPLATE MAPPING
BIOPSY IN 534 MEN REQUIRING
FURTHER RISK STRATIFICATION
Alistair Grey*, Tom Hartingon, Clare Allen,
Manit Arya, Mark Emberton, Alex Freeman,
Caroline Moore, Shonit Punwani, Navin
Ramachandran, Giorgia Trevisan, Miles
Walkden, Hashim Ahmed, London, United
Kingdom
MP53-04
IDENTIFICATION OF HIGH-GRADE
PROSTATE CANCER USING URINEBASED MOLECULAR BIOMARKERS
COMBINED WITH CLINICAL RISK
FACTORS
Leander Van Neste, Maastricht, Netherlands,
Geert Trooskens, Ghent, Belgium, Rianne
J. Hendriks, Jack Schalken, Nijmegen,
Netherlands, Wim Van Criekinge*, Ghent,
Belgium
MP53-05
ABSTRACT
NUMBER TITLE
MP53-06 CONTROLLING THE PROSTATE BIOPSY
RELATED INFECTIOUS COMPLICATIONS
THROUGH VIGILANT SCREENING AND
ENHANCED ANTIBIOTIC PROPHYLAXIS
Ardalan E. Ahmad*, Igor Sorokin, Himanshu
Aggarwal, Ashish Bosukonda, Amina Khalid,
Badar Mian, Albany, NY
PERFORMANCE OF 3T
MULTIPARAMETERIC MRI IN DIAGNOSIS
OF PROSTATE CANCER IN COMPARISON
WITH WHOLE MOUNT HISTOPATHOLOGY:
A 5 YEAR EXPERIENCE
Pornphan Wibulpolprasert*, Bangkok,
Thailand, Steven S. Raman, Pooria
Khoshnoodi, Weixia Yu, William Hsu, Nelly
Tan, Jiaoti Huang, David Lu, Danial J
Margolis, Robert Reiter, Los Angeles, CA
182
MP53-07
CANCER DETECTION RATE OF
CONVENTIONAL VS 3D TEMPLATE
PROSTATE BIOPSY IN A MRI/US FUSION
DEVICE
Shyam Natarajan*, Jiaoti Huang, Leonard
Marks, Los Angeles, CA
MP53-08
RECENT TRENDS IN PROSTATE MRI
UTILIZATION, REFERRAL PATTERNS,
AND CLINICAL UTILITY
Michelle Kim*, Alexander Ryu, Garry Choi,
Dicken Ko, Boston, MA
MP53-09
SINGLE-CENTRE EXPERIENCE WITH
SYSTEMATIC TRANSPERINEAL
STEREOTACTIC PROSTATE BIOPSY PLUS
MAGNETIC RESONANCE IMAGING
TARGETED, TRANSRECTAL
ULTRASOUND GUIDED FUSION BIOPSY
Michael Musch*, Amena Batul Malik-Patsalis,
Ulla Roggenbuck, Jan Lukas Hohenhorst,
Baris Taskiran, Roman Herholz, Thomas
Ebel, Jens-Albrecht Koch, Susanne Krege,
Darko Kroepfl, Essen, Germany
MP53-10
PROBABILISTIC INCIDENCE MAP OF
PROSTATE CANCER FOCI DETECTED BY
MRI-ULTRASOUND FUSION TARGETED
BIOPSY AMONG MEN WITH PRIOR
NEGATIVE BIOPSIES
Neil Mendhiratta*, Andrew Rosenkrantz,
Artem Mikheev, Henry Rusinek, Samir
Taneja, New York, NY
MP53-11
A PRE-BIOPSY NOMOGRAM FOR
PREDICTION OF THE RISK OF GLEASON
SCORE > 7 PROSTATE CANCER ON
COMBINED MRI-US FUSION TARGETED
AND SYSTEMATIC PROSTATE BIOPSY
AMONG MEN WITH NO PREVIOUS BIOPSY
Marc Bjurlin*, James Wysock, New York, NY,
Saradwata Sakar, Rajesh Venkataraman,
Grass Valley, CA, Neil Mendhiratta, Xiaosong
Meng, Andrew Rosenkrantz, William Huang,
Herbert Lepor, Samir Taneja, New York, NY
THE ROLE OF PROSTATE CANCER
ANTIGEN 3 (PCA3) TEST AND MULTIPARAMETRIC PROSTATIC MAGNETIC
RESONANCE IMAGING (MPMRI) AMONG
PATIENTS WITH PRIOR NEGATIVE
BIOPSY: CORRELATION WITH RADICAL
PROSTATECTOMY PATHOLOGY
Thamir Alkasab*, Ardalan Ahmad, Patrick
Rechard, Aza Mohamed, Juan Garisto,
Kamel Fadaak, Antonio Finelli, Robert
Hamilton, Girish Kulkarni, Michael Jewett,
Alexandre Zlotta, Neil Fleshner, Toronto,
Canada
MP53-13
AN UPDATE ON HOSPITAL ADMISSION
RATES FOR UROLOGICAL
COMPLICATIONS AFTER TRANSRECTAL
ULTRASOUND GUIDED PROSTATE
BIOPSY
Alaina Garbens*, Chris Wallis, Refik Saskin,
Ying Liu, Robert Nam, Toronto, Canada
MP53-14
MP53-15
MP53-16
*Presenting author
COST EFFECTIVENESS OF MAGNETIC
RESONANCE/ULTRASOUND FUSION
PROSTATE BIOPSY VS STANDARD OF
CARE (TRANSRECTAL ULTRASOUND
(TRUS)-GUIDED BIOPSY)
Kaitlan Cobb*, Washington, DC, Amichai
Kilchevsky, Bethesda, MD, John Michael
DiBianco, Washington, DC, Daniel Su,
Thomas Frye, Bethesda, MD, Vikram
Sabarwal, Washington, DC, Baris Turkbey,
Bethesda, MD
MULTI-INSTITUTIONAL ASSESSMENT OF
MULTIPARAMETRIC MRI AND FUSION
BIOPSY OF THE PROSTATE IN A BIOPSYNAÏVE POPULATION
Arvin George, Meet Kadakia*, Bethesda, MD,
Minhaj Siddiqui, College Park, MD, Soroush
Rais-Bahrami, Birmingham, AL, Ardeshir
Rastinehad, New Hyde Park, NY, Srinivas
Vourganti, Syracuse, NY, Michele Fascelli,
Michael Kongnyuy, Akhil Muthigi, Abhinav
Sidana, Amichai Kilchevsky, Thomas Frye,
Daniel Su, Bethesda, MD, John Thomas,
Vidhush Yarlagadda, Vidhush Yarlagadda,
Birmingham, AL, Maria Merino, Peter
Choyke, Baris Turkbey, Bradford Wood, Peter
Pinto, Bethesda, MD
MP53-17
CANCER DETECTION ON MRI FUSION
BIOPSY IS INDEPENDENT OF PRIOR
NEGATIVE BIOPSY HISTORY: A MULTIINSTITUTIONAL ANALYSIS
Abhinav Sidana*, Meet Kadakia, Mahir Maruf,
Arvin George, Michael Kongnyuy, Akhil
Muthigi, Amichai Kilchevsky, Daniel Su, Maria
Merino, Bethesda, MD, M. Minhaj Siddiqui,
Baltimore, MD, Soroush Rais Bahrami,
Birmingham, AL, Ardeshir Rastinehead, New
York, NY, Srinivas Vourganti, Syracuse, NY,
Thomas Frye, Bethesda, MD, Jennifer
Gordetsky, Birmingham, AL, Michele Fascelli,
Bethesda, MD, Jeffery Nix, Birmingham, AL,
Baris Turkbey, Peter Choyke, Bradford Wood,
Peter Pinto, Bethesda, MD
MP53-18
ZERO SEPSIS IN 608 CONSECUTIVE
TRANSPERINEAL PROSTATE BIOPSIES
Sean Huang*, Armadale, Australia, Guan Hee
Tan, Sarah Mann, Wee Loon Ong, Adam
Landau, Ross Snow, Uri Hanegbi, Daniel
Moon, Mark Frydenberg, Jeremy Grummet,
MP53-19
INTERACTION OF PSA AND MRI
SUSPICION SCORE ON THE CANCER
DETECTION RATE OF MRI FUSION
TARGETED BIOPSY
Xiaosong Meng*, Andrew B. Rosenkrantz, Neil
Mendhiratta, Pauline Guiffart, Richard Huang,
Fang-Ming Deng, Ming Zhou, Jonathan
Melamed, William C. Huang, Herbert Lepor,
Samir S. Taneja, New York, NY
MP53-20
CAN PSA DENSITY AND
FREEⴚTOⴚTOTAL PSA RATIO IMPROVE
OUR ABILITY TO PREDICT PROSTATE
CANCER ON BIOPSY? RESULTS FROM A
PROSPECTIVE, MULTIⴚINSTITUTIONAL,
AND CONTEMPORARY COHORT
Samarpit Ray*, Nachiketh
Soodana⫺Prakash, Miami, FL, Nicola Pavan,
Trieste, Italy, Bruno Nahar, Amil Patel, Miami,
FL, Yang Dong, Nashville, TN, Ramgopal
Satyanarayana, Dipen J. Parekh, Sanoj
Punnen, Miami, FL
CREDITTM
OUTCOMES AND SAFETY PROFILE OF
TRANSPERINEAL PROSTATE BIOPSY:
RESULTS FROM THE VICTORIAN
TRANSPERINEAL BIOPSY
COLLABORATION
Sean Huang*, Declan Murphy, Homayoun
Zargar, Sarah Mann, Douglas Tjandra, Wee
Loon Ong, Daniel Moon, Nathan
Lawrentschuk, Mark Frydenberg, Jeremy
Grummet, Melbourne, Australia
183
SUNDAY
MP53-12
Sunday, May 8, 2016
1:00 pm - 3:00 pm
Podium Session 29
KIDNEY CANCER: LOCALIZED: SURGICAL THERAPY II
Moderators: Jose Karam, Alejandro Rodriguez and Matthew Tollefson
TIME
1:00
1:10
1:20
1:30
ABSTRACT
NUMBER TITLE
PD29-01 LONG TERM RENAL FUNCTION AFTER
PARTIAL NEPHRECTOMY VS RADICAL
NEPHRECTOMY IN PATIENTS WITH
PREEXISTING CHRONIC KIDNEY
DISEASE: A PROPENSITY SCOREMATCHED ANALYSIS
Leonardo Borregales*, Lisly Chery, Mehrad
Adibi, Arun Thomas, Xuemei Wang, Rodolfo
Dos Reis, Akshat Kumar, Jessica Brandt,
Devin Gu, Matthew Wiemers, Surena Matin,
Jose Karam, Christopher Wood, Houston, TX
PD29-02
PD29-03
PD29-04
ABSTRACT
TIME NUMBER TITLE
1:40 PD29-05 HEMOSTATIC AGENTS DO NOT REDUCE
BLEEDING AFTER ROBOTIC PARTIAL
NEPHRECTOMY
Matthew J. Maurice*, Daniel Ramirez, Peter
A. Caputo, Onder Kara, Jihad H. Kaouk,
Cleveland, OH
PRESENCE OF BLAND THROMBUS IS A
NEGATIVE INDICATOR FOR CANCER
SPECIFIC SURVIVAL IN PATIENTS
UNDERGOING NEPHRECTOMY FOR
KIDNEY TUMORS WITH VENOUS TUMOR
THROMBUS
Gong Chen, Charles Rew*, Ryan Hutchinson,
Nirmish Singla, Kunj Sheth, Matthew
Meissner, Ahmed Haddad, Dallas, TX,
Michael Mann, E. Jason Abel, Madison, WI,
Vitaly Margulis, Dallas, TX, R. Houston
Thompson, Rochester, MN
DOES AN UNEXPECTED FINAL
PATHOLOGY OF PT3A RENAL
CARCINOMA UNDERMINE CANCER
CONTROL IN CLINICALLY T1N0M0
PATIENTS WHO WERE INITIALLY
TREATED WITH NEPHRON SPARING
SURGERY?
Umberto Capitanio*, Milan, Italy, Grant
Stewart, Edinburgh, United Kingdom, Tobias
Klatte, Vienna, Austria, Alessandro Volpe,
Novara, Italy, Bulent Akdogan, Ankara,
Turkey, Marco Roscigno, Bergamo, Italy,
Hans Langenhuijsen, Nijmegen, Netherlands,
Martin Marszalek, Vienna, Austria, Oscar
Rodriguez Faba, Barcelona, Spain, Maciej
Salagierski, Canterbury, United Kingdom,
Marco Carini, Florence, Italy, James Lingard,
Edinburgh, United Kingdom, Luigi Da Pozzo,
Bergamo, Italy, Christian Stief, Munich,
Germany, Andrea Minervini, Florence, Italy,
Sabine Brookman-May, Munich, Germany
NATIONAL UTILIZATION OF
DISSECTION AMONG PATIENTS WITH
KIDNEY CANCER AND CLINICAL
LYMPHADENOPATHY UNDERGOING
NEPHRECTOMY
Bream Matthew*, Robert Abouassaly,
Cleveland, OH, Marc Smaldone, Alex
Kutikov, Philadelphia, PA, Nilay Shah,
Stephen Boorjian, R. Houston Thompson,
Rochester, MN, Christopher Gonzalez, Hui
Zhu, Simon Kim, Cleveland, OH
184
1:50
PD29-06
ASSESSMENT OF LONG TERM
FUNCTIONAL OUTCOMES IN MORE THAN
1000 PATIENTS TREATED WITH
MINIMALLY ISCHEMIC PARTIAL
NEPHRECTOMY
Giuseppe Simone*, Rocco Papalia,
Mariaconsiglia Ferriero, Gabriele Tuderti,
Riccardo Mastroianni, Francesco Minisola,
Leonardo Misuraca, Manuela Costantini,
Salvatore Guaglianone, Vincenzo Pompeo,
Giovanni Muto, Michele Gallucci, Rome, Italy
2:00
PD29-07
REDUCTION OF RENAL FUNCTION IN
ROBOT-ASSISTED PARTIAL
NEPHRECTOMY (RPN) WITH WARM
ISCHEMIA (“ON CLAMP”) AND WITHOUT
ISCHEMIA (“OFF CLAMP”)
Ioanna Paramythelli*, Volker Zimmermanns,
Sven Lahme, Pforzheim, Germany
2:10
PD29-08
RELATIONSHIP OF POST-OPERATIVE
CHRONIC KIDNEY DISEASE SUBTYPE
STATUS AND OUTCOMES IN PATIENTS
UNDERGOING RENAL SURGERY
miki haifler*, Robert Uzzo, Tianyu Li, Ron
Gor, Dan Parker, Serge Ginzburg,
haseebudin mohammed, Nakhil Waingankar,
Ben Ristau, David Y.T Chen, Rosalia Viterbo,
Richard Greenberg, Marc Smaldone,
Alexander Kutikov, philadelphia, PA
2:30
PD29-09
PD29-10
PARTIAL NEPHRECTOMY IN A COHORT
OF “ENUCLEORESECTIVE” CENTERS:
INSIGHTS FROM THE
SURFACE–INTERMEDIATE–BASE (SIB)
MARGIN SCORE INTERNATIONAL
CONSORTIUM
Andrea Minervini, Campi Riccardo, Riccardo
Campi, Andrea Mari, Florence, Italy, Ottavio
DeCobelli, Milan, Italy, Francesco
Sanguedolce, Christian Villeda Sandoval,
Bristol, United Kingdom, Brian Lane, Grand
Rapids, MI, Georgios Hatzichristodoulou,
Munich, Germany, Alessandro Antonelli,
Brescia, Italy, Bulent Akdogan, Munich,
Germany, Umberto Capitanio, Milan, Italy,
Martin Marszalek, Vienna, Austria,
Alessandro Volpe, Novara, Italy, Nihat
Karakoyunlu, Ankara, Turkey, Hans
Langenhuijsen, Nijmegen, Netherlands,
Tobias Klatte, Vienna, Austria, Oscar
Rodriguez-Faba, Barcelona, Spain, Miki
Haifler, Philadelphia, PA, Sabine BrookmanMay, Munich, Germany, Marco Roscigno,
Bergamo, Italy, Robert Uzzo, Philadelphia,
PA, Alberto Lapini, Florence, Italy, Alexander
Kutikov*, Philadelphia, PA
2:40
PD29-11
SURVIVAL OUTCOMES FOR LOCALIZED
RENAL CELL CARCINOMA ACCORDING
TO TUMOR LOCATION AND OPERATION
METHOD (RADICAL VERSUS PARTIAL
NEPHRECTOMY): A PROPENSITY
MATCHED ANALYSIS
Myungsun Shim*, Anyang-si, Korea, Republic
of, Myungchan Park, Myong Kim, Cheryn
Song, Tai Young Ahn, Hanjong Ahn, Seoul,
Korea, Republic of
2:50
PD29-12
LONGITUDINAL RENAL FUNCTION
RECOVERY AFTER RADICAL
NEPHRECTOMY AND RISK FACTORS FOR
POSTOPERATIVE SEVERE RENAL
IMPAIRMENT: A JAPANESE
MULTICENTER STUDY
Minato Yokoyama*, Naoko Kawamura,
Yasuhisa Fujii, Masaharu Inoue, Junichiro
Ishioka, Noboru Numao, Yoh Matsuoka,
Kazutaka Saito, Chizuru Arisawa, Tokyo,
Japan, Tetsuo Okuno, Toride, Japan, Akira
Noro, Saitama, Japan, Shinji Morimoto,
Tsuchiura, Japan, Kazunori Kihara, Tokyo,
Japan
CREDITTM
ACUTE KIDNEY INJURY AFTER PARTIAL
NEPHRECTOMY: ROLE OF
PARENCHYMAL MASS REDUCTION AND
ISCHEMIA AND IMPACT ON
SUBSEQUENT FUNCTIONAL RECOVERY
Zhiling Zhang*, Juping Zhao, Erick Remer,
Jianbo Li, Joseph Zabell, Steven Campbell,
Cleveland, Oh
Sunday, May 8, 2016
1:00 pm - 3:00 pm
Podium Session 30
PROSTATE CANCER: LOCALIZED: SURGICAL THERAPY II
Moderators: Maxwell Meng and Thomas Ahlering
TIME
1:00
1:10
ABSTRACT
NUMBER TITLE
PD30-01 HIGH PREOPERATIVE
NEUTROPHIL–LYMPHOCYTE RATIO
PREDICTS BIOCHEMICAL RECURRENCE
IN PATIENTS WITH LOCALIZED
PROSTATE CANCER AFTER RADICAL
PROSTATECTOMY
Hakmin Lee*, Kwangmo Kim, Sung Kyu
Hong, Seok-Soo Byun, Sang Eun Lee, Jong
Jin Oh, Seongnam, Korea, Republic of
PD30-02
*Presenting author
ABSTRACT
TIME NUMBER TITLE
1:20 PD30-03 DEVELOPMENT AND VALIDATION OF
PROSTATECTOMY ASSESSMENT AND
COMPETENCY EVALUATION SCORING
FOR ROBOT-ASSISTED RADICAL
PROSTATECTOMY
Ahmed Hussein*, Buffalo, NY, Khurshid
Ghani, James Peabody, Detroit, MI, Brian
Lane, East Lansing, MI, Richard Sarle,
Dearborn, MI, Ronney Abaza, Dublin, OH,
Jim Hu, New York, NY, Michael Fumo,
Rockford, IL, Jeffrey Montgomery, Ann Arbor,
MI, Daniel Eun, Philadelphia, PA, Deborah
Rooney, Bryan Comstock, Susan Linsell,
David Miller, Ann Arbor, MI, Khurshid Guru,
Buffalo, NY
IMPACT OF PREBIOPSY MAGNETIC
RESONANCE IMAGING (MRI) ON
PREOPERATIVE RISK STRATIFICATION
FOR BIOCHEMICAL RECURRENCE AFTER
Yoh Matsuoka*, Junichiro Ishioka, Hiroshi
Tanaka, Takayuki Nakayama, Masaharu
Inoue, Masaya Ito, Soichiro Yoshida, Minato
Yokoyama, Noboru Numao, Kazutaka Saito,
Japan
185
SUNDAY
2:20
1:30
PD30-04
REASSESSMENT OF RISK FACTORS FOR
BIOCHEMICAL RECURRENCE IN D’AMICO
INTERMEDIATE-RISK PROSTATE CANCER
TREATED BY RADICAL PROSTATECTOMY
Shintaro Narita*, Akita, Akita, Japan, Koji
Mitsuzuka, Sendai, Japan, Norihiko Tsuchiya,
Yamagata, Japan, Takuya Koie, Hirosaki,
Japan, Sadafumi Kawamura, Natori, Japan,
Chikara Ohyama, Hirosaki, Japan, Tatsuo
Tochigi, Natori, Japan, Takuhiro Yamaguchi,
Yoichi Arai, Sendai, Japan, Tomonori
Habuchi, Akita, Akita, Japan
1:40
PD30-05
THE IMPACT OF DOWNGRADING FROM
BIOPSY GLEASON SCORE 7 TO RADICAL
PROSTATECTOMY GLEASON SCORE 6
ON BIOCHEMICAL RECURRENCE
Won Sik Ham, Seoul, Korea, Republic of,
Heather J. Chalfin*, Zhaoyong Feng, Bruce J.
Trock, Elizabeth Humphreys, Jonathan I.
Epstein, Alan W. Partin, Misop Han,
Baltimore, MD
1:50
PD30-06
ASSESSING THE ROLE OF TIME FROM
PROSTATE CANCER DIAGNOSIS TO
RADICAL PROSTATECTOMY: CAN
SURGERY BE POSTPONED SAFELY?
Vito Cucchiara*, Nicola Fossati, Nazareno
Suardi, Andrea Gallina, Armando Stabile,
Marta Picozzi, Emanuele Zaffuto, Giorgio
Gandaglia, Paolo Dell’Oglio, Alessandro
Larcher, Andrea Salonia, Francesco Montorsi,
2:00
PD30-07
QUANTITATION OF LONG TERM
STABILITY AND SPECIFIC RELIEF OF
(LUTS) AFTER ROBOT-ASSISTED
Adam Gordon*, Douglas Skarecky, Kathyrn
Osann, Harleen Dhaliwal, Blanca Morales,
Thomas Ahlering, Orange, CA
2:10
PD30-08
INTRAOPERATIVE FROZEN SECTION
MONITORING DURING NERVE-SPARING
EVALUATION OF PARTIAL SECONDARY
RESECTION OF NEUROVASCULAR
BUNDLES AND ITS EFFECT ON
ONCOLOGIC AND FUNCTIONAL
OUTCOME
Georgios Hatzichristodoulou*, Munich,
Germany, Stefan Wagenpfeil, Homburg,
Germany, Gregor Weirich, Jürgen Gschwend,
Hubert Kübler, Munich, Germany
2:20
PD30-09
A COMPARISON OF THE INCIDENCE AND
LOCATION OF POSITIVE SURGICAL
MARGIN AMONG OPEN, LAPAROSCOPIC,
AND ROBOT-ASSISTED RADICAL
PROSTATECTOMIES: A SINGLE
INSTITUTIONAL ANALYSIS
Atsushi Koizumi*, Shintaro Narita, Taketoshi
Nara, Koichiro Takayama, Kazuyuki
Numakura, Hiroshi Tsuruta, Atsushi Maeno,
Mitsuru Saito, Takamitsu Inoue, Shigeru
Satoh, Tomonori Habuchi, Akita, Japan
2:30
PD30-10
THREE-DIMENSIONAL PRINTED MODEL
OF PROSTATE ANATOMY AND
TARGETED BIOPSY-PROVEN INDEX
TUMOR TO FACILITATE NERVE-SPARING
PROSTATECTOMY
Toshitaka Shin*, Osamu Ukimura, Andre Luis
de Castro Abreu, Los Angeles, CA, Shuji
Isotani, Tokyo, Japan, Norio Fukuda, Nara,
Japan, Toru Matsugasumi, Kyoto, Japan,
Manju Aron, Los Angeles, CA, Hiromitsu
Mimata, Oita, Japan, Inderbir S. Gill, Los
Angeles, CA
2:40
PD30-11
PROGNOSTIC FACTORS FOR
BIOCHEMICAL RECURRENCE MORE
THAN TEN YEARS AFTER RADICAL
PROSTATECTOMY
Kathleen Herkommer*, Lea A. Liesenfeld,
Munich, Germany, Martina Kron, Ulm,
Germany, Juergen E. Gschwend, Munich,
Germany
2:50
PD30-12
PREDICTIVE FACTORS AND
ONCOLOGICAL OUTCOMES OF
PERSISTENTLY ELEVATED PROSTATESPECIFIC ANTIGEN IN PATIENTS
FOLLOWING ROBOT ASSISTED RADICAL
PROSTATECTOMY
Anup Kumar*, New Delhi, India, Srinivas
Samavedi, Vladimir Mouraviev, Hariharan
PG, Bernardo Rocco, Rafael F Coelho, Vipul
R Patel, Celebration, FL
CREDITTM
186
Sunday, May 8, 2016
1:00 pm - 3:00 pm
Podium Session 31
STONE DISEASE: MEDICAL & DIETARY THERAPY
Moderators: Kristina Penniston and Margaret Pearle
1:10
1:20
1:30
1:40
1:50
ABSTRACT
NUMBER TITLE
PD31-01 ADMINISTRATION OF THE SELECTIVE
ALPHA 1A ADRENOCEPTOR
ANTAGONIST SILODOSIN FACILITATES
EXPULSION OF SIZE 5 - 10 MM DISTAL
URETERAL STONES, AS COMPARED TO
CONTROL.
Yasunori Itoh*, Atsushi Okada, Kazumi
Taguchi, Yasuhiko Hirose, Yasuhiro Fujii,
Takahiro Kobayashi, Masayuki Usami, Shuzo
Hamamoto, Masahito Hirose, Keiichi Tozawa,
Shoichi Sasaki, Kenjiro Kohri, Takahiro Yasui,
Nagoya, Japan
PD31-02
PD31-03
PD31-04
PD31-05
PD31-06
*Presenting author
ABSTRACT
TIME NUMBER TITLE
2:00 PD31-07 COMPARISON OF POTASSIUM CITRATE,
CITRIC ACID AND PLACEBO ON CALCIUM
PHOSPHATE STONES RECURRENCE:
PRELIMINARY RESULTS
Steeve Doizi*, Naim Maalouf, John
Poindexter, Beverley Huet, Margaret Pearle,
Khashayar Sakhaee, Dallas, TX
SILODOSIN IN TREATMENT OF DISTAL
URETERAL STONES IN CHILDREN: A
PROSPECTIVE,RANDOMIZED,PLACEBO
CONTROLLED STUDY
Hazem Elgalaly, Ahmed Eliwa, Mohamed
Seleem*, Haitham shello, Emad Salem,
Mostafa Youssef, Salem khalil, Zagazig,
Egypt
SHOULD WE STILL PRESCRIBE ALPHA
BLOCKERS FOR URETERAL CALCULI? A
SYSTEMATIC REVIEW AND METAANALYSIS
Benjamin K. Canales*, Gainesville, FL, John
M. Hollingsworth, Mary A. M. Rogers, Ann
Arbor, MI, Shyam Sukamar, Minneapolis, MN,
Phyllis Yan, Ann Arbor, MI, Gretchen Kuntz,
Gainesville, FL, Philipp Dahm, Minneapolis,
MN
MEDICAL EXPULSIVE THERAPY,
EVIDENCE FROM RANDOMISED TRIALS
META-ANALYSIS
Tarik Amer*, Martin Mariappan, Glasgow,
United Kingdom, Ameet Gupta,
Wolverhampton, United Kingdom, Bhaskar
Somani, Southampton, United Kingdom,
Frank Keeley, Bristol, United Kingdom, Allan
Johnston, Glasgow, United Kingdom, Omar
Aboumarzouk, Bristol, United Kingdom
TITLE: PAIN FOLLOWING URETERAL
STENT REMOVAL: PREVALENCE AND
TREATMENT
Gabriel Belanger*, Lisa Beaule, Portland, ME
2:10
PD31-08
PREVENTIVE EFFECT OF CITRATE
AGAINST RECURRENT CALCIUM STONES
DETECTED AS MICROCALCULI ON
COMPUTED TOMOGRAPHY
Rei Unno*, Atsushi Okada, Kazumi Taguchi,
Shuzo Hamamoto, Ryosuke Ando, Keiichi
Tozawa, Kenjiro Kohri, Takahiro Yasui,
Nagoya, Japan
2:20
PD31-09
DIABETICS ON METFORMIN EXPERIENCE
INCREASED STONE EPISODES
COMPARED TO NON-METFORMIN USERS.
Balaji Reddy*, Haresh Thummar, Mantu
Gupta, New York, NY
2:30
PD31-10
STATIN INTAKE REDUCES KIDNEY
STONE FORMATION
Andrew Cohen*, Melanie Adamsky, Charles
Nottingham, Chicago, IL, Jaclyn Pruitt,
Brittany Lapin, Sangtae Park, Evanston, IL
2:40
PD31-11
ALLN-177 REDUCES HYPEROXALURIA IN
A PORCINE MODEL OF SECONDARY
HYPEROXALURIA (2°HO) INDUCED BY A
HUMAN-LIKE OXALATE RICH DIET
Danica Grujic*, Lee Brettman, Boston, MA,
Craig Langman, Chicago, IL, Olexandr
Fedkiv, Kataryna Goncharova, Marek Kardas,
Stefan Pierzinowski, Lund, Sweden
2:50
PD31-12
PROTECTIVE EFFECTS OF MELATONIN
ON URINARY SYSTEM STONE DISEASE IN
RATS
Tarik Emre Sener*, Istanbul, Turkey, Ozge
Cevik, Sivas, Turkey, Pinar Eker, Sule
Cetinel, Goksel Sener, Istanbul, Turkey,
Olivier Traxer, Paris, France, Yiloren Tanidir,
Cem Akbal, Istanbul, Turkey
CREDITTM
THE EFFECT OF NAFTOPIDIL 75MG FOR
THE DOUBLE-J STENT RELATED
DISCOMFORT: MULTICENTER,
RANDOMIZED, DOUBLE-BLIND, PLACEBO
CONTROLLED STUDY.
Jong Jin Oh*, Seongnam-si, Korea, Republic
of, Sung Yong Jo, Seoul, Korea, Republic of,
Sangchul Lee, Seongnam-si, Korea, Republic
of, Sang Wook Lee, ChunCheon, Korea,
Republic of, Min Chul Jo, Woong Na, Ju
Hyeon Park, Chang Wook Jeong, Seoul,
Korea, Republic of
187
SUNDAY
TIME
1:00
Sunday, May 8, 2016
1:00 pm - 3:00 pm
Video Session 7
PEDIATRICS
Moderators: Jennifer Yang and Mohan Gundeti
ABSTRACT
NUMBER TITLE
V7-01
COMPLETELY INTRACORPOREAL
ILEAL URETER FOR DIFFUSE URETERAL
NEPHROGENIC ADENOMA
Joel Koenig*, Adam Rensing, Paul Austin,
Gino Vricella, Saint Louis, MO
V7-02
TRANSLABIAL CORPORAL SPARING
CLITOROPLASTY
Shuvro De*, Varun Sundaram, Vani S.
Menon, Linda A. Baker, Dallas, TX
V7-03
COMPLETE ROBOTIC RECONSTRUCTION
FOR PEDIATRIC NEUROGEINC BOWEL
AND BLADDER
Jonathan Riddell*, Syracuse, NY
V7-04
MULTI-INSTITUTIONAL BLADDER
EXSTROPHY CONSORTIUM: TECHNICAL
STANDARDIZATION OF DISTAL
EPISPADIAS REPAIR IN A BOY
John Ward*, David Chu, Jason Van Batavia,
Aseem Shukla, Dana Weiss, Philadelphia,
PA, Joseph Borer, Evalynn Vasquez, Boston,
MA, John Kryger, Travis Groth, Michael
Mitchell, Milwaukee, WI, Douglas Canning,
Philadelphia, PA
V7-05
ABSTRACT
NUMBER TITLE
V7-08
RETROCAVAL URETER REPAIR
Richard Fantus*, Joseph Pariser, Mohan
Gundeti, Chicago, IL
TWO-STAGE CLOACAL EXSTROPHY
CLOSURE IN A MALE: A CASE FROM THE
MULTI-INSTITUTIONAL BLADDER
EXSTROPHY CONSORTIUM (MIBEC)
Joseph G. Borer*, Evalynn Vasquez, Craig
W. Lillehei, Young-jo Kim, Boston, MA,
Douglas A. Canning, Philadelphia, PA, John
V. Kryger, Travis Groth, Milwaukee, WI, Dana
A. Weiss, Aseem R. Shukla, Philadelphia,
PA, Michael E. Mitchell, Milwaukee, WI
V7-06
PEDIATRIC ROBOTIC-ASSISTED
LAPAROSCOPIC
APPENDICOVESICOSTOMY REVISION
David M. Hatcher*, Joseph J. Pariser, Mohan
S. Gundeti, Chicago, IL
V7-07
PEDIATRIC LAPAROSCOPIC
CONGENITAL VESICO-VAGINAL FISTULA
REPAIR FOR VAGINAL AGENESIS
Frank J. Penna*, Paul R. Bowlin, Rakan I.
Odeh, Lisa M. Allen, Walid A. Farhat,
Toronto, Canada
V7-09
MINIMALLY INVASIVE APPROACH TO YTYPE URETHRAL DUPLICATION.
Matthew Schaff*, Charles Concodora,
Michael Packer, Daniel Eun, Gregory Dean,
Philadelphia, PA
V7-10
NEPHROURETERECTOMY OF A RIGHT
PELVIC KIDNEY IN A PEDIATRIC PATIENT
Michael V. Hollis*, Patricia S. Cho, Evalynn
Vasquez, David A. Diamond, Richard N. Yu,
Boston, MA
V7-11
PEDIATRIC ROBOT-ASSISTED
LAPAROSCOPIC EXCISION OF ECTOPIC
DISTAL URETERAL STUMP
Michael Hollis*, Patricia S. Cho, Evalynn
Vasquez, Erin R. McNamara, Stuart B.
Bauer, Richard N. Yu, Boston, MA
V7-12
PYELOURETEROSTOMY IN INFANTS
WITH DUPLEX SYSTEMS WITH UPPER
POLE URETERAL OBSTRUCTION:
VARIATIONS IN DOUBLE J URETERAL
STENTING TECHNIQUES
Minki Baek*, Jason Au, Chester Koh,
Houston, TX
CREDITTM
188
Sunday, May 8, 2016
1:00 pm - 4:30 pm
SOCIETY FOR INFECTION AND INFLAMMATION IN UROLOGY (SIIU)
Marina F @ Marriott
1:00
OPENING REMARKS
Moderator: Joel Teichman
1:10
DEBATE: UNDERSTANDING AND MANAGING
UROLOGIC CHRONIC PELVIC PAIN
SYNDROME (UCPSS): UPOINT VERSUS
LOWER URINARY DYSFUNCTIONAL
EPITHELIUM (LUDE)
Debaters: J. Curtis Nickel, C. Lowell Parsons
2:30
2:45
SCIENTIFIC PRESENTATIONS
3:30
SIIU GENERAL MEETING
4:30
ADJOURN
CREDITTM
MEMORIUM TRIBUTE TO DR. GRANT
MULHOLLAND
Sunday, May 8, 2016
1:00 pm - 5:00 pm
12:55
1:00
WELCOME AND INTRODUCTION OF
PROGRAM
James Porter
SUNDAY
SOCIETY OF UROLOGIC ROBOTIC SURGERY (SURS)
Marina D @ Marriott
2:55
QUESTIONS AND DISCUSSION
3:05
SESSION III: ROBOTIC SURGERY-KIDNEY
CANCER
SESSION I: ROBOTIC TRAINING AND
PROGRAM DEVELOPMENT
COMPLEX RENAL MASSES
Daniel Eun
ROBOTIC TRAINING CURRICULUM IN
EUROPE
Alessandro Volpe
3:20
RENAL MASS BIOPSY DEBATE - FOR
Debater: Jaime Landman
1:15
NEW DEVELOPMENTS IN ROBOTIC SURGERY
Alexandre Mottrie
3:35
RENAL MASS BIOPSY DEBATE - AGAINST
Debater: Ronney Abaza
1:30
QUALITY OUTCOMES IN ROBOTIC SURGERY
3:50
1:45
4:00
1:55
SESSION II: ROBOTIC SURGERY-PROSTATE
CANCER
SESSION IV: ROBOTIC SURGERY-BLADDER
AND TESTIS CANCER
ROBOTIC CYSTECTOMY AND DIVERSION
Raj Pruthi
ROBOTIC PROSTATECTOMY FOR HIGH RISK
PROSTATE CANCER
Christopher Kane
2:10
ROBOTIC SURGERY FOR PROSTATE CANCER
AT JOHNS HOPKINS
Mohamad Allaf
2:25
PAST PRESIDENTS PANEL DISCUSSION: MY
MOST CRITICAL TECHNIQUE DURING
ROBOTIC PROSTATECTOMY
Moderator: James Porter
Panelists: Jean Joseph, John Davis, Erik Castle,
Chandru Sundaram
4:15
POST CHEMOTHERAPY ROBOTIC RPLND?
James L’Esperance
4:30
SURS BUSINESS MEETING
5:00
ADJOURN
CREDITTM
Sunday, May 8, 2016
1:00 pm – 5:00 pm
KOREAN WORLD UROLOGIC CONGRESS (KWUC)
Ballroom 20A @ San Diego Convention Center
1:00
WELCOME ADDRESS BY KUA PRESIDENT &
AUA
Myung-Soo Choo
*Presenting author
PROSTATE CANCER
Moderators: Gerald Andriole, Han Yong Choi,
Jonathan Hwang
189
1:10
ANDROGEN DEPRIVATION THERAPY AND
ALZHEIMER’S DISEASE
Gerald Andriole
3:10
UPDATE OF DIAGNOSIS AND TREATMENT OF
PREMATURE EJACULATION (PE)
Run Wang
1:30
ROLE OF PALLIATIVE SURGERY (TURP) IN
CRPC
Seok-Ho Kang
3:30
PHOSPHODIESTERASE TYPE 5 INHIBITORS IN
THE TREATMENT OF PE
Arthur Burnett
1:50
TREATMENT OF CRPC: RECOMMENDATIONS
FOR DAILY ROUTINE
Neal Shore
3:50
ROLE OF SELECTIVE DORSAL NEUROTOMY
FOR PE
Dae-Yul Yang
Moderators: Benjamin I. Chung, Jae Mann Song
4:10
PANEL DISCUSSION: WHICH IS MORE
RELIABLE DIAGNOSTIC CRITERIA FOR PE,
OBJECTIVE PARAMETERS (IET) OR
SUBJECTIVE SYMPTOMS? / ROLE OF
SURGERY FOR PE
Case Presenter: Hyun Jun Park
Panelists: Arthur Burnett, Du Geon Moon, Run
Wang, Dae-Yul Yang
2:10
DIAGNOSIS, TREATMENT AND PROGNOSIS
OF XP 11.2 TRANSLOCATION RCC
Benjamin I. Chung
2:30
R.E.N.A.L. NEPHROMETRY SCORING SYSTEM
FOR PARTIAL NEPHRECTOMY
Sung Hyun Paick
4:25
IMMUNE CHECKPOINT INHIBITORS IN
METASTATIC RCC
Peter Clark
KUA/SKAU FELLOW/RESIDENT
PRESENTATIONS
Moderators: Isaac Kim, Kyu-Sung Lee
5:00
ADJOURN
2:50
MALE SEXUAL DYSFUNCTION: PREMATURE
EJACULATION (PE)
Moderators: Wayne Hellstrom, Se Woong Kim,
Eugene Rhee
CREDITTM
Sunday, May 8, 2016
1:00 pm - 4:40 pm
History Forum I
HISTORY OF UROLOGY: HISTORY FORUM I
TIME
1:00
1:10
ABSTRACT
NUMBER TITLE
FRI-01
PHILATELIC AND NUMISMATIC RAMBLE
THROUGH THE HISTORY OF SIGNS AND
DIAGNOSIS
Erwin Rugendorff*, San Diego, CA
FRI-02
FROM GIRLS TO BOYS TO OLDER MEN,
THE INTERESTING TALE OF THE
GUEVEDOCES AND 5-ALPHA REDUCTASE
INHIBITORS
Sandeep Gurram*, Richard Ashley, New
Hyde Park, NY
1:20
FRI-03
THE HISTORY OF PROSTATE CANCER
FROM ANTIQUITY: REVIEW OF
PALEOPATHOLOGICAL STUDIES
Kamyar Ghabili Amirkhiz*, Jeffrey J. Tosoian,
Benjamin Benzon, Edward M. Schaeffer,
Ashley E. Ross, Baltimore, MD
1:30
FRI-04
GENITOURINARY TUBERCULOSIS: FROM
MUMMIES TO MODERN DAY
Jonathan Pavlinec*, Rishi Modh, Thomas
Stringer, Gainesville, FL
1:40
FRI-05
ABSTRACT
TIME NUMBER TITLE
1:50 FRI-06
PRIAPISM – A HISTORICAL PERSPECTIVE
FROM ANTIQUITY TO THE MORE RECENT
PAST
Alberto Coscione*, Michalis Varnavas, Samer
Katmawi-Sabbagh, London, United Kingdom
THE RISE AND FALL OF OCCUPATIONAL
BLADDER CANCER IN THE WESTERN
WORLD
Michael Wanis*, Leicester, United Kingdom,
Marios Hadjipavlou, Portsmouth, United
Kingdom
190
2:00
FRI-07
REVOLUTIONARY UROLOGISTS: CUBA’S
CONTRIBUTION TO UROLOGIC HISTORY
Jorge Pereira*, New York, NY, Ricardo
Palmerola, New Hyde Park, NY, Jeffrey A.
Stock, New York, NY
2:10
FRI-08
ON DIFFERENT SHORES: REYNALDO DOS
SANTOS OF LISBON AND MOSES SWICK
OF NEW YORK, THE FATHERS OF
MODERN UROLOGIC IMAGING
Lorenzo Marconi*, Coimbra, Portugal,
Jonathan Bloom, Valhalla, NY, John Phillips,
Sleepy Hollow, NY
2:20
FRI-09
THE CREATION OF THE NEOVAGINA: A
HISTORY OF VAGINAL
RECONSTRUCTION
Ricardo Palmerola*, Christopher Hartman,
Farzeen Firoozi, New Hyde Park, NY
2:30
FRI-10
PIONEERING ANATOMICAL RESEARCH
ON FEMALE PELVIS AND VESICOVAGINAL FISTULAS AT THE UNIVERSITY
OF PADUA (15TH-18TH CENTURY)
Mariangela Mancini*, Marialaura Righetto,
Filiberto Zattoni, Padova, Italy
FRI-11
2:50
TO STIMULATE OR NOT TO STIMULATE:
MEDICAL MASTURBATION, FEMALE
FRIGIDITY AND CONTEMPORARY
UNDERSTANDINGS OF FEMALE SEXUAL
DYSFUNCTION
Unwanaobong Nseyo*, San Diego, CA
THE 2015 AUA EARL NATION
RETROSPECTROSCOPE AWARD
Yefim Sheynkin for “Levi Jay Hammond and
the First Human Organ Transplantations of
1911”
3:00
BICKNELL LECTURE
M. Donald Blaufox, MD, PhD: “Urologic
Equivalents in Physical Diagnosis”
3:30
FRI-12
MICROSCOPY AND UROLOGY- THE
ADVANCE OF SIGHT
Michael Moran*, McComb, MS
3:40
FRI-13
THE UROSCOPY WHEEL: A TOOL FOR
STREAMLINED DIAGNOSIS
Brendan Browne*, Daniel Kaufman, Ariel
Fredrick, Lara S Maclachlan, Burlington, MA
3:50
FRI-14
4:00
FRI-15
THE HISTORY OF URINE AS HEALING
AGENT
Jay Motola*, New York, NY
4:10
FRI-16
MICROSCOPE, HEMOCYTOMETER AND
SEXUAL REVOLUTION: THE HISTORY OF
SEMEN ANALYSIS
April Szafran*, David Schulsinger, Yefim
Sheynkin, Stony Brook, NY
4:20
FRI-17
DR JOSEPH BELL: SURGICAL SLEUTH
AND THE INSPIRATION BEHIND
SHERLOCK HOLMES
Tracy M Downs*, Sutchin R Patel, Madison,
WI
4:30
FRI-18
NOT YOUR PAPPY’S TEST: THE ORIGINS
OF THE PAP’ SMEAR
Daniel Rittenberg, Merrit DeBartolo, Howard
Adler*, Stony Brook, NY
4:40
ADJOURN
URINARY FEVER: A FORGOTTEN
CONCEPT IN UROLOGIC AND MEDICAL
HISTORY
Friedrich Moll*, Cologne, Germany, Thorsten
Halling, Matthis Krischel, Heiner Fangerau,
Duesseldorf, Germany
Sunday, May 8, 2016
4:40 pm - 5:30 pm
History Forum II
HISTORY OF UROLOGY: HISTORY FORUM II
TIME
4:40
ABSTRACT
NUMBER TITLE
FRII-01
THE IMPACT OF VENEREAL DISEASE
DURING WORLD WAR I: HUGH HAMPTON
YOUNG AND THE CHASTE OF AMERICAN
SOLDIERS
Zachary Klaassen*, Shenelle N. Wilson,
Augusta, GA, Kayla Dmytruk, Basseterre,
Saint Kitts and Nevis, Reena Kabaria,
Michael Kemper, Martha K. Terris, Ronald W.
Lewis, Durwood E. Neal, Jr, Arthur M. Smith,
Augusta, GA
4:43
FRII-02
THE MANAGEMENT OF GENITOURINARY
TRAUMA IN WORLD WAR II
Joseph Sterbis*, Ronald Caras, John Musser,
Ryan Speir, Honolulu, HI
4:46
FRII-03
LAZZARO SPALLANZANI (1729-1799):
THE FIRST SUCCESSFUL ARTIFICIAL
INSEMINATION EXPERIMENTS
Giorgio Bozzini*, Mauro Seveso, Pietro Bono,
Oliviero De Francesco, Alberto Mandressi,
Gianluigi Taverna, Castellanza VA, Italy
4:49
FRII-04
*Presenting author
ABSTRACT
TIME NUMBER TITLE
4:52 FRII-05
THE CONTRIBUTION OF SIR THOMAS
SPENCER WELLS TO UROLOGY
Michael Wanis*, Jonathan Goddard,
Leicester, United Kingdom
JOZEF DIETL AND THE STORY BEHIND
ⴕDIETL’S CRISISⴕ
Helen Levey Bernie*, William Hulbert, Jimena
Cubillos, Ronald Rabinowitz, Rochester, NY
191
4:55
FRII-06
A PEACEABLE KINGDOM: THE STORY OF
DR. CHARLES C. HIGGINS FORMER
PRESIDENT OF THE AUA
Joseph Mahon*, R. Charles Welliver, Albany,
NY
4:58
FRII-07
HISTORY OF FORMER AMERICAN
UROLOGICAL ASSOCIATION HISTORIAN
DR. RALPH LANDES: A MAN OF ALL
SEASONS
Sevann Helo*, Loudonville, NY, Mark White,
Albany, NY
5:01
FRII-08
AMERICAN WOMEN IN UROLOGY: A
FASCINATING HISTORY
Kymora Scotland*, Patricia Lewandoski, Amar
Raval, Alana Murphy, Philadelphia, PA
5:04
FRII-09
BLADDER EXSTROPHY AND THE
ORIGINAL MONSTER MANUAL: THE LIFE
OF JOHANNES SCHENCK VON
GRAFENBERG
Janae Preece*, Columbus, OH, Kristina
Suson, Detroit, MI
SUNDAY
2:40
5:07
5:10
5:13
FRII-10
FRII-11
FRII-12
HISTORICAL PERSPECTIVES ON THE
UROLOGIC MANAGEMENT OF SPINA
BIFIDA PRE AND POST THE ADVENT OF
CLEAN INTERMITTENT
CATHETERIZATION.
Rajeev Chaudhry*, Pankaj Dangle, Glenn
Cannon, Michael Ost, Francis Schneck, Heidi
Stephany, Pittsburgh, PA
FROM MOON ROCKS TO KIDNEY
STONES: A LOOK AT THE EVOLUTION OF
THE CYBERWAND
Rutveej Patel*, Izak Faiena, Sammy Elsamra,
New Brunswick, NJ
BIOLOGIC OR NATIVE TISSUE
CYSTOCELE REPAIR INSTEAD OF
SYNTHETIC MESH- DID WE COME FULL
CIRCLE? A HISTORICAL PERSPECTIVE.
Kirin Syed, Miramar, FL, Michael Consolo*,
Stratford, NJ, David Sussman, Voorhees, NJ,
Angelo Gousse, Miramar, FL
5:16
FRII-13
VITAMIN D: FROM ITS DISCOVERY TO
ⴕSUNSHINE BEERⴕ TO ITS ROLE IN
UROLOGY
Tracy M. Downs*, Madison, WI, Kristina L.
Penniston, Sutchin R. Patel, Stephen Y.
Nakada, Madison, WI
5:19
FRII-14
THE CHRISTMAS CAROL DISEASE: THE
KIDNEY DISEASE OF CHARLES DICKENS’
TINY TIM
Daniel Marchalik*, Washington, DC
5:22
FRII-15
A CENTURY OF UROLOGICAL MAYHEM
FROM ZIPPERS
Lawrence Wyner*, Huntington, WV
5:30
ADJOURN
Sunday, May 8, 2016
1:00 pm - 5:30 pm
GERIATRIC UROLOGICAL SOCIETY (GUS)
Marina G @ Marriott
1:00
WELCOME AND INTRODUCTIONS
Society President: Tomas Griebling
Past President: Ananias Diokno
1:15
STATE OF THE ART LECTURE:
ANTICOAGULATION IN GERIATRIC PATIENTS:
UROLOGICAL CONSIDERATIONS
Daniel Culkin
2:55
NOCTURNAL ENURESIS: A POTENTIAL
MARKER FOR FALLS RISK IN OLDER WOMEN
WITH URINARY INCONTINENCE
Diane Newman
3:05
3:15
BREAK
3:30
MULTINATIONAL GERIATRIC ABSTRACT
PRESENTATIONS
1:45
PM TRANSLATIONAL SCIENCE PODIUM
1:45
OVERACTIVE BLADDER AND AGE
DEPENDENT CHANGES IN PURINERGIC
RECEPTOR EXPRESSION
Vivian Cristofaro
2:00
INFLUENCE OF AGING ON BLADDER
REMODELING AND SIGNALING
Lori Birder
3:40
ADULT STEM CELL AND UNDERACTIVE
BLADDER
Michael Chancellor
2:15
PANEL DISCUSSION: UPDATE ON GERIATRIC
URINARY INCONTINENCE IN COMMUNITY
DWELLING ELDERLY WOMEN
3:50
2:15
BEHAVIORAL MODIFICATION PROGRAM FOR
URINARY INCONTINENCE: UPDATE ON THE
TULIP AND GLADIOLUS NIH FUNDED
RESEARCH TRIALS
Diane Newman
CATHETER ASSOCIATED UTI IN ELDERLY
PEOPLE: LOCAL STUDY VALIDATES
INTERNATIONAL RECOMMENDATION OF
URINE SAMPLING TECHNIQUE
Deepak Batura
4:00
GERIATRIC UROONCOLOGY IN HUNGARY
Peter Nyirady
4:10
LAPAROSCOPIC RENAL SURGERY
OUTCOMES IN ELDERLY PATIENTS IN
MEXICO CITY
Jesus E. Rosas Nava
4:20
EFFECT OF ANDROGEN DEPRIVATION
THERAPY IN ASIAN PATIENTS WITH
PROSTATE CANCER
Chi-Fai Ng
4:30
UPDATE ON DIETARY MODIFICATIONS TO
DECREASE THE RISK OF PROSTATE CANCER
IN THE GERIATRIC POPULATION
Barbara Shorter
2:35
2:45
NATIONAL HISTORY OF LUTS IN OLDER MEN:
PERSPECTIVES FROM THE CONCORD
HEALTH AND AGING PROJECT (CHAMP)
Lewis Chan
THE GERIATRIC UROLOGIST’S ROLE IN
MAINTAINING QUALITY CONTROL IN
MULTICENTER RESEARCH PROGRAMS
TESTING BEHAVIORAL MODIFICATION
EFFECTIVENESS
Tomas Griebling
A NEW QUESTIONNAIRE TO PREDICT UI IN
ELDERLY WOMEN
Ananias Diokno
192
4:40
4:50
DOES USING ALPRAZOLAM DURING
OUTPATIENT FLEXIBLE CYSTOSCOPY
DECREASE ANXIETY AND PAIN IN GERIATRIC
PATIENTS?
Ibrahim Cevik
5:30
ADJOURN
CREDITTM
THE UPDATED AGS BEERS CRITERIA FOR
POTENTIALLY INAPPROPRIATE MEDICATION
USE IN OLDER ADULTS: IMPLICATIONS OF
UROLOGY
Tomas Griebling
Sunday, May 8, 2016
2:00 pm - 5:00 pm
2:00
OPENING REMARKS
2:05
PROSTATE CANCER –TREATMENT OF HIGH
RISK PROSTATE CANCER
Moderators: Shiro Saito, James Eastham
2:05
2:15
2:30
LECTURE 1: IS SURGERY SUPERIOR TO
RADIOTHERAPY FOR HIGH RISK PROSTATE
CANCER?
James Eastham
PANEL DISCUSSION: TREATMENT OF HIGH
RISK PROSTATE CANCER- WHAT IS THE
BEST MANAGEMENT?
Panelists: Kazuto Ito, Motoo Araki, Daniel Lin,
Monish Aron
Moderators: Masatoshi Eto, Robert Uzzo
3:00
LECTURE 1: HOW FAR CAN WE GO WITH
ROBOTIC SURGERY IN URO-ONCOLOGY?
Inderbir Gill
3:10
LECTURE 2: THE CURRENT STATUS OF
RENAL CELL CARCINOMA IN JAPAN
Masato Fujisawa
PANEL DISCUSSION: WHAT IS YOUR CHOICE
OF TREATMENT FOR THIS SITUATION?
Panelists: Junya Furukawa, Tsunenori Kondo,
Inderbir Gill, Robert Uzzo
3:50
BREAK
4:05
BLADDER CANCER
Moderators: Yasuhisa Fujii, Ashish Kamat
LECTURE 1: SALVAGE AFTER FAILURE OF
BCG THERAPY
Ashish Kamat
LECTURE 2: BASIS FOR
MULTIINSTITUTIONAL RANDOMIZED TRIAL
USING TRIMODALITY THERAPY FOR HIGH
RISK PROSTATE CANCER IN JAPAN (TRIP
STUDY)
Shiro Saito
3:00
3:20
4:15
LECTURE 2: PREDICTING RESPONSE TO BCG
IMMUNOTHERAPY FOR BLADDER CANCER
Yasuhisa Fujii
4:25
PANEL DISCUSSION: APPROACHES TO
COMPLICATED CASES OF BLADDER CANCER
Panelists: Rikiya Taoka, Tetsuya Shindo, Badrinath
Konety, Hooman Djaladat
4:55
CLOSING REMARKS
Masato Fujisawa
5:10
ADJOURN
CREDITTM
Sunday, May 8, 2016
2:00 pm - 5:10 pm
BRITISH ASSOCIATION OF UROLOGICAL SURGEONS (BAUS) / BJU INTERNATIONAL (BJUI) / UROLOGICAL SOCIETY OF
AUSTRALIA AND NEW ZEALAND (USANZ)
Seaport FGH @ Hyatt
2:00
WELCOME REMARKS
2:25
2:05
TREATMENT EFFECTIVENESS IN PROSTATE
CANCER – EARLY THOUGHTS FROM THE
PROTECT STUDY
Freddie Hamdy
WHAT WE KNOW AND WHAT WE DON’T
KNOW ABOUT THE ROLE OF MRI IN THE
PROSTATE CANCER DIAGNOSTIC PATHWAY
Mark Emberton
2:45
FOCAL THERAPY – READY FOR PRIME TIME?
Hashim Ahmed
*Presenting author
193
SUNDAY
JAPANESE UROLOGICAL ASSOCIATION (JUA)
San Diego A @ Marriott
3:05
A RANDOMISED CONTROLLED TRIAL OF
ROBOTIC VS. OPEN RADICAL
PROSTATECTOMY
Geoff Coughlin
4:10
THE PUBLICATION OF UROLOGIST
IDENTIFIABLE SURGICAL OUTCOME DATA –
AN ENGLISH EXPERIENCE
Mark Speakman
3:20
PROSPECTIVE NON-RANDOMISED
LONGITUDINAL COMPARATIVE STUDY OF
OUTCOMES AFTER PRIMARY SURGICAL
TREATMENT FOR LOCALIZED PROSTATE
CANCER
Mark Frydenberg
4:30
HOW MIGHT THE BAUS NATIONAL PCNL
DATABASE IMPROVE OUTCOMES?
Oliver Wiseman
4:50
SOCIAL MEDIA IN UROLOGY
Stacy Loeb
3:40
TEA BREAK
5:10
ADJOURN
3:50
RECENT ADVANCES IN PAEDIATRIC ROBOTIC
SURGERY
Mohan Gundeti
CREDITTM
Sunday, May 8, 2016
2:00 pm - 6:00 pm
SOCIEDAD ARGENTINA DE UROLOGIA (SAU)
San Diego Ballroom B @ Marriott
2:00
APERTURA (OPENING)
3:45
BREAK
2:05
ROL ACTUAL DE LA RESONANCIA
MULTIPARAMÉTRICA DE PRÓSTATA EN LA
PRÁCTICA CLÍNICA (CURRENT ROLE OF
PROSTATE MULTIPARAMETRIC MRI IN THE
CLINICAL PRACTICE)
Moderators: Esteban Casabe, Adrian Momesso
Speaker: Pablo Contreras
4:15
CÓMO RESOLVER Y EVITAR
COMPLICACIONES EN LA NEFRECTOMÍA
PARCIAL LAPAROSCÓPICA (HOW TO
RESOLVE AND AVOID COMPLICATIONS OF
LAPAROSCOPIC PARTIAL NEPHRECTOMY)
Moderators: Martin Del Sordo, Jose Juan Rozanec
Speaker: Gonzalo Vitagliano
2:25
TRUCOS Y SECRETOS EN EL MANEJO DE LAS
COMPLICACIONES DE LA NEFRECTOMÍA
RADICAL LAPAROSCÓPICA (TRICKS AND
SECRETS IN THE MANAGEMENT OF
COMPLICATIONS OF LAPAROSCOPIC
RADICAL NEPHRECTOMY)
Moderators: Claudio Graziano, Carlos Palazzo
Speaker: A. Martin Piana
4:35
UTILIDAD DE LA CIRUGÍA ROBÓTICA EN TA
CISTECTOMÍA RADICAL SEGÚN LA
DERIVACIÓN URINARIA A REALIZAR (UTILITY
OF ROBOTIC ASSISTED RADICAL
CYSTECTOMY DEPENDING ON THE URINARY
DIVERSION TO BE PERFORMED)
Moderators: Claudio Koren, Hector Malagrino
Speaker: Wenceslao Villamil
2:45
CIRUGÍA PERCUTÁNEA RENAL CON
CONTROL ECOGRÁFICO Y FLUOROSCÓPICO
(PERCUTANEOUS NEPHROLITHOTOMY
UNDER ECOGRAPHIC AND FLUOROSCOPIC
CONTROL)
Moderators: Roberto Hernandez, Federico Ferraris
Speaker:Norberto Bernardo
4:55
DISCUSIÓN DE CASOS CLÍNICOS
(DISCUSSION OF CLINICAL CASES)
Moderator: Miguel Costa
Panelists: Alberto Casabe, Ricardo Nardone, Carlos
Scorticati
5:55
CIERRE DEL SIMPOSIO (CLOSING OF THE
SYMPOSIUM)
6:00
ADJOURN
3:05
“RADIUM 223 EN MCRPC” (“RADIUM 223 IN
MCRPC”)
Miguel Costa, Mauricio Castaneda
Sunday, May 8, 2016
2:00 pm - 6:00 pm
UROLOGICAL CONGENITALISM FORUM
Harbor Ballroom AB @ Hyatt
2:00
INTRODUCTIONS AND WELCOME
2:30
CON - BN CLOSURE
Rosalia Misseri
2:40
GROUP COMMENTARY
2:50
CASE PRESENTATION: SECONDARY
INCONTINENCE AFTER AUGMENTATION
CYSTOPLASTY AND BORDERLINE RENAL
FUNCTION
Stuart Bauer
PERSISTENT INCONTINENCE SESSION
2:10
2:20
CASE PRESENTATION: PERSISTENT
INCONTINENCE, S/P MANY PRIOR BN
OPERATIONS. HOW TO GET DRY?
PRO - BN CLOSURE
Melissa R. Kaufman
194
3:00
PRESERVE THE ILEO-CECAL VALVE!
John S. Wiener
3:10
INDIANA STYLE AUGMENTATION
Jeremy B. Myers
4:45
EVALUATION AND TREATMENT OF MALE
SEXUAL DYSFUNCTION IN SB
Mohit Khera
5:00
TOMAX APPROACH/ TECHNIQUE
Thomas S. Lendvay
5:10
TOMAX PRELIMINARY OUTCOMES
Nathan C. Osbun
Claire C. Yang
GROUP COMMENTARY
3:30
BREAK
3:45
CASE PRESENTATION: ADULT WITH A VP
SHUNT AND PERSISTENT INCONTINENCE,
WITHOUT APPENDIX: OPTIONS MONTI-YANG
OR PLICATED TI?
5:20
EVALUATION AND TREATMENT OF
INFERTILITY IN THE SPINA BIFIDA PATIENT
Larry I. Lipshultz
3:55
ENDOSCOPIC, BEHAVIORAL OPTIONS
Michael Hsieh
5:30
Q & A: SEXUALITY/ FERTILITY IN EMERGING
ADULT MALES WITH SB
4:05
SURGICAL OPTIONS
Sean P. Elliott
5:45
4:15
GROUP COMMENTARY
GROUP COMMENTARY AND
RECOMMENDATIONS OF TOPICS FOR NEXT
YEAR
6:00
ADJOURN
MALE SEXUALITY AND FERTILITY IN THE
EMERGING ADULT WITH SB
4:30
SUNDAY
3:20
TIMING AND APPROACH IN THE EMERGING
ADULT
Brian VanderBrink
Sunday, May 8, 2016
2:00 pm - 7:00 pm
R. FRANK JONES UROLOGICAL SOCIETY
Marina E @ Marriott
2:00
WELCOME AND PRESIDENT’S UPDATE
Society President: Kevin Billups
5:00
AUDIENCE RESPONSE/QUESTIONS AND
ANSWERS
2:10
INTRODUCTION
5:05
BREAK
2:20
PROSTATE CANCER
Robert Waterhouse, Walter Rayford
5:15
2:50
QUESTIONS & ANSWERS/AUDIENCE
RESPONSE TECHNOLOGY
2:55
BLADDER CANCER
Tracy Downs
ROUND TABLE: STRATEGIES TO INCREASE
THE NUMBER OF AFRICAN AMERICAN
UROLOGISTS
Moderator: Charles Walker
Panelists: Rodney Davis, Courtney Hollowell, Byron
Joyner, Linda McIntire, W. Bedford Waters, O.
Lenaine Westney
3:25
RESPONSE TECHNOLOGY
6:30
AUDIENCE RESPONSE/QUESTIONS AND
ANSWER
3:30
KIDNEY CANCER
Heinric Williams
6:50
CONCLUDING REMARKS
7:00
ADJOURN
4:00
RESPONSE TECHNOLOGY
4:30
PATIENT CENTERED APPROACH TO
PROSTATE CANCER
Willie Underwood
*Presenting author
CREDITTM
195
Sunday, May 8, 2016
3:00 pm - 5:00 pm
SECOND OPINION CASES: MALIGNANT
Moderator: Steven Campbell
3:00
BLADDER CANCER
Moderator: Stanley Malkowicz
Panelists: Yair Lotan, Marcus Quek
4:30
PROSTATE CANCER
Moderator: Michael Cookson
Panelists: Jeffrey Holzbeierlein, James McKiernan
3:30
TESTIS CANCER
Moderator: Timothy Masterson
Panelists: Christopher Weight, Siamak Daneshmand
5:00
ADJOURN
4:00
CREDITTM
RENAL CANCER
Moderator: Bradley Leibovich
Panelists: Christopher Wood, Gaetano Ciancio
Sunday, May 8, 2016
3:00 pm – 5:30 pm
AUA RESEARCH FORUM
EARLY-CAREER INVESTIGATORS SHOWCASE
Room 6 D/E @ San Diego Convention Center
3:00
EARLY CAREER INVESTIGATORS POSTER
VIEWING
3:30
PROGRAM INTRODUCTION
Carolyn Best
3:35
PATIENT-CENTERED DESIGN AND
IMPLEMENTATION OF SURVIVORSHIP TOOLS
FOR MEN WITH PROSTATE CANCER
John Gore
3:45
ROLE OF EXOSOMES IN BLADDER CANCER
DIAGNOSIS, PROGRESSION AND
THERAPEUTICS
Gopal Gupta
3:55
GHRELIN INHIBITS POST-OPERATIVE
ADHESIONS VIA BLOCKAGE OF THE TGF-〉
SIGNALING
Kathleen Hwang
4:05
VALUE-BASED CARE REDESIGN IN MEN WITH
BPH
Alan Kaplan
4:15
INCREASED UNDERSTANDING OF CENTRAL
NERVOUS SYSTEM CONTROL OF
MICTURITION IN LOWER URINARY TRACT
DISORDERS
Rose Khavari
4:25
GENE EXPRESSION PROFILING OF
CIRCULATING TUMOR CELLS TO
UNDERSTAND MECHANISMS OF
THERAPEUTIC RESISTANCE IN ADVANCED
PROSTATE CANCER
Todd Morgan
196
4:35
CHARACTERIZATION OF GENES
PREDISPOSING TO PEYRONIE’S AND
DUPUYTREN’S DISEASES
Alexander W. Pastuszak
4:45
PERFUSION MRI AS A DIAGNOSTIC,
THERAPEUTIC, AND PROGNOSTIC
BIOMARKER FOR KIDNEY CANCER
Eric Singer
4:55
PROSTATE-SPECIFIC ANTIGEN SCREENING
AND PROSTATE CANCER INCIDENCE
FOLLOWING THE 2012 UNITED STATES
RECOMMENDATIONS
Quoc-Dien Trinh
5:05
THE ROLE OF AGING ON THE MALE GAMETE
Timothy Jenkins
5:15
AUA/UROLOGY CARE FOUNDATION
RESEARCH ACTIVITIES
Krystal Brinson
5:25
PRESENTATION OF AWARDS
5:30
ADJOURN
Sunday, May 8, 2016
3:30 pm - 5:30 pm
3:30
WELCOME BY THE AFU DELEGATE OF THE
AUA INTERNATIONAL MEMBER COMMITTEE
Emmanuel J. Chartier-Kastler
5:25
CONCLUSION AND SUMMARY BY THE
PRESIDENT OF AFU
Jean-Luc G. Descotes
3:35
KIDNEY CANCER AND NEW SURGICAL
MODALITIES
Karim C. Bensalah
Alexander Kutikov
5:30
ADJOURN
4:30
ERECTILE DYSFUNCTION MANAGEMENT:
FOCUS ON PENILE PROSTHESIS AND
LAPEYRONIE’S DISEASE
Stephane Droupy
Wayne J.G. Hellstrom
Sunday, May 8, 2016
3:30 pm - 5:30 pm
STONE DISEASE: SHOCK WAVE LITHOTRIPSY
Moderators: Christian Chaussy, Kenneth Pace and Giuseppe Carrieri
ABSTRACT
NUMBER TITLE
MP54-01 DYNAMIC CONTRAST ENHANCED MRI
(DCE-MRI) FOR EVALUATION OF THE
EFFECTS OF RENO-PROTECTIVE DRUGS
ON RENAL PERFUSION AFTER SWL
Ahmed EL-Nahas*, Mohamed Abo EL-Ghar,
Diaa-Eldin Taha, Mohamed Elsaadany,
Ahmed Elshal, Khaled Sheir, Mansoura,
Egypt
MP54-02
DEVELOPMENT OF A NOVEL MAGNETIC
RESONANCE IMAGING (MRI)
ACQUISITION AND ANALYSIS
WORKFLOW FOR THE QUANTIFICATION
OF RENAL HEMORRHAGIC INJURY.
Paul Territo, Rajash Handa*, Philip Blomgren,
Lin Chen, Cynthia Johnson, Lie Jiang, Bret
Connors, Gary Hutchins, Indianapolis, IN
MP54-03
ROUTINE PRE-OPERATIVE
ELECTROCARDIOGRAMS IN PATIENTS
AT LOW RISK FOR CARDIAC
COMPLICATIONS DURING SHOCKWAVE
LITHOTRIPSY, ARE THEY USEFUL?
Robert J Sowerby*, Daniela Ghiculete, Aaron
Hong, Monica A. Farcas, Keith Barrett, Jason
Lee, Michael Ordon, Kenneth T. Pace, R.
John D’A. Honey, Toronto, Canada
MP54-04
*Presenting author
ABSTRACT
NUMBER TITLE
MP54-05 EXTRACORPOREAL SHOCKWAVE
LITHOTRIPSY AND THE RISK OF
DIABETES MELLITUS: A POPULATIONBASED COHORT STUDY
Michael Ordon*, Toronto, Canada, Blayne
Welk, London, Canada, Jason Lee, R. D’A
John Honey, Kenneth Pace, Toronto, Canada
SIMPLE AND PRACTICAL NOMOGRAMS
FOR PREDICTING STONE-FREE RATE
AFTER EXTRACORPOREAL SHOCK WAVE
LITHOTRIPSY IN PATIENTS WITH
SOLITARY STONE IN UPPER URINARY
TRACT
Naoya Niwa*, Kazuhiro Matsumoto, Hiroaki
Kobayashi, Tokyo, Japan, Makoto Miyahara,
Sayama, Japan, Eiji Kikuchi, Akira Miyajima,
Tokyo, Japan, Kazutoyo Miyata, Sayama,
Japan, Mototsugu Oya, Tokyo, Japan
197
MP54-06
IS AN INCREASE OF FOCAL SHOCK
WAVE ENERGY THROUGH AN EXPANDED
NUMBER OF SHOCKWAVES PER SESIÓN
EFFICIENT AND SAFE IN
EXTRACORPOREAL LITHOTRIPSY? A
COST-EFFECTIVENESS ANALYSIS.
Alberto Budı́a*, Vicent Caballer, José Daniel
López-Acón, David Vivas-Consuelo, Pilar
Bahı́lo, Marta Trassierra, Francisco Boronat,
Valencia, Spain
MP54-07
COMPARISION OF EXTRACORPOREAL
SHOCK WAVE LITHOTRIPSY VERSUS
RETROGRADE INTRARENAL SURGERY IN
THE MANAGEMENT OF SMALL
MODERATED-SIZED RENAL STONES: A
COST-EFFECTIVENESS ANALYSIS.
Pilar Bahı́lo, Vicent Caballer, José Daniel
López-Acón, Alberto Budı́a*, David VivasConsuelo, Marta Trassierra, Francisco
Boronat, Valencia, Spain
MP54-08
SHOCKWAVE LITHOTRIPSY: INFLUENCE
OF ACETYLSALICYLIC ACID AND LOW
MOLECULAR WEIGHT HEPARIN ON
FORMATION OF PERIRENAL HEMATOMA
Christoph Schregel*, Isabelle Keller, Hubert
John, Winterthur, Switzerland
SUNDAY
ASSOCIATION FRANÇAISE D’UROLOGIE (AFU)
Hillcrest ABC @ Hyatt
MP54-09
COMPARISON OF EXTRACORPOREAL
SHOCK WAVE LITHOTRIPSY FOR
UROLITHIASIS BETWEEN CHILDREN AND
ADULTS: A SINGLE CENTRE STUDY.
Nadeem Iqbal, Rawalpindi, Pakistan,
Muhammad Yasir, Muhammad Usman
Shabbir, salman Assad, Nomah Mahnoor,
Sidra Ali Naqvi, Abdullah Zaki, Ijaz Hussain,
Saeed Akhter*, Islamabad, Pakistan
MP54-10
COMPARISON OF RENAL INJURY IN THE
PIG USING THE DORNIER COMPACT S
LITHOTRIPTER OPERATING AT POWER
LEVEL 6 AND 120 SHOCKS/MINUTE OR 60
SHOCKS/MINUTE
Bret Connors*, Rajash Handa, Cynthia
Johnson, James Lingeman, Indianapolis, IN
MP54-11
MP54-12
MP54-13
ARE WE BANGING OUR HEADS AGAINST
THE WALL? THE EFFECT OF TREATMENT
HEAD WEAR ON THE OUTCOMES OF
LITHOTRIPSY
Nathan Hoy*, Derek Bochinski, Trevor
Schuler, Timothy Wollin, Shubha De,
Edmonton, Canada
LONG-TERM EFFECT OF SHOCK WAVE
LITHOTRIPSY ON URINE PH: A STUDY
USING METABOLIC SYNDROME PIGS.
Rajash Handa*, Bret Connors, Ziyue Liu,
Cynthia Johnson, Indianapolis, IN
DETECTION AND ASSESSMENT OF
HEMORRHAGIC KIDNEY INJURY CAUSED
BY BURST WAVE LITHOTRIPSY USING
ULTRASOUND AND MAGNETIC
RESONANCE IMAGING
Adam Maxwell*, Wayne Kreider, Yak-Nam
Wang, Philip May, Donghoon Lee, Joshua
Park, Bryan Cunitz, Mathew Sorensen,
Seattle, WA, Rajash Handa, Indianapolis, IN,
Michael Bailey, Jonathan Harper, Seattle, WA
MP54-14 OPTIMAL SKIN-TO-STONE DISTANCE IS A
POSITIVE PREDICTOR FOR SUCCESSFUL
OUTCOMES IN UPPER URETER CALCULI
FOLLOWING EXTRACORPOREAL SHOCK
WAVE LITHOTRIPSY: A BAYESIAN MODEL
AVERAGING APPROACH
Dong Hyuk Kang*, Kang Su Cho, Seoul, Korea,
Republic of, Hae Do Jung, Incheon, Korea,
Republic of, Doo Yong Chung, Jong Kyou Kwon,
Seoul, Korea, Republic of, Jae Hung Jung,
Wonju, Korea, Republic of, Seung Hwan Lee,
Won Sik Ham, Young Deuk Choi, Joo Yong Lee,
MP54-15
MP54-16
COMPUTED TOMOGRAPHY-BASED
NOVEL PREDICTION MODEL FOR THE
OUTCOME OF SWL IN PROXIMAL
URETERAL STONE
Cheol Yong Yoon*, Mi Kyung Kong, Hyun
Gyu Ahn, Seung Gu Kang, Jang Hee Han,
Yong Jin Kang, Won Sik Jang, Joong Shik
Lee, Seoul, Korea, Republic of, Young Sik
Kim, Goyang, Korea, Republic of, Hong Seuk
Park, Seoul, Korea, Republic of, In Rae Cho,
Gimhae, Korea, Republic of, Jun Cheon,
Young Deuk Choi, Seoul, Korea, Republic of
MP54-17
A PROSPECTIVE STUDY ON THE EFFECT
OF SHOCKWAVE LITHOTRIPSY ON
RENAL FIBROSIS
Chi-Fai Ng*, Sylvia Luke, Chi-Hang Yee, Kim
Lee, John Yuen, Danny Gohel, Hong Kong,
Hong Kong
MP54-18
EMERGENCY EXTRACORPOREAL
SHOCKWAVE LITHOTRIPSY (EESWL) FOR
ACUTE RENAL COLIC DUE TO URETERAL
STONES
Paolo Umari*, Stefano Bucci, Michele Rizzo,
Nicola Pavan, Giovanni Liguori, Diego
Marega, Carlo Trombetta, Trieste, Italy
MP54-19
VERSUS SHOCK WAVE LITHOTRIPSY
FOR MODERATE-SIZED HIGH DENSITY
KIDNEY STONES: A PROSPECTIVE
RANDOMIZED TRIAL
Ahmad A Elderwy, Mohamed Gadelmoula*,
Ghaleb Althamthami, Ahmad Abdulmoneim,
Assiut, Egypt
MP54-20
ACCURACY OF ULTRASONOGRAPHY FOR
THE EVALUATION OF UROLITHIASIS IN
PATIENTS UNDERGOING
LITHOTRIPSY: COMPARISON WITH NONCONTRAST COMPUTED TOMOGRAPHY
Lih-Ming Wong*, Vy Tran, Mark Jenkins,
Anita Clarke, Jeremy Goad, Janelle Brennan,
Owen Niall, Catherine Temelcos, Daniel
Lenaghan, Melbourne, Australia
CREDITTM
STONE HETEROGENEITY INDEX DEFINED
AS THE STANDARD DEVIATION OF
HOUNSFIELD UNITS ON NON-CONTRAST
COMPUTED TOMOGRAPHY IS A NOVEL
PREDICTOR FOR SHOCK-WAVE
LITHOTRIPSY OUTCOMES IN URETERAL
CALCULI
Joo Yong Lee, Dong Hyuk Kang*, Doo Yong
Chung, Jae Heon Kim, Yong Jin Kang, Seoul,
Korea, Republic of, Hae Do Chung, Incheon,
Korea, Republic of, Jong Kyou Kwon, Won
Sik Ham, Young Deuk Choi, Kang Su Cho,
198
Sunday, May 8, 2016
3:30 pm - 5:30 pm
PEDIATRICS: URINARY TRACT INFECTION AND VESICOURETERAL REFLUX
Moderators: Katherine Hubert and Christopher Cooper
MP55-02
BLADDER WALL THICKNESS IN
SONOGRAPHY FOR YOUNG CHILDREN
WITH VUR
Ho Song Yu*, Yang Hyun Cho, Je Guk Ryu,
Deokhyeon Nam, Seong Woong Na, Bo Sung
Shin, Ho Seok Chung, Eu Chang Hwang,
MP55-03
INTER-RATER RELIABILITY OF DISTAL
URETERAL DIAMETER RATIO COMPARED
TO GRADE FOR VESICOURETERAL
REFLUX
Amanda Swanton*, Angela M. Arlen, Siobhan
E. Alexander, Kathleen Kieran, Douglas W.
Storm, Christopher S. Cooper, Iowa City, IA
MP55-04
REVISITING THE ROLE OF GENDER ON
EARLY DIAGNOSED PRIMARY
VESICOURETERAL REFLUX IN INFANTS
WITH PRENATAL HYDRONEPHROSIS
Tomer Erlich*, Nathan Wong, Kizanee
Jegatheeswaran, Melissa McGrath, Mandy
Rickard, Bethany Easterbrook, Hamilton,
Canada, Armando J Lorenzo, Toronto,
Canada, Jacob Ramon, Yoram Mor, TelHashomer, Israel, Luis H Braga, Hamilton,
Canada
MP55-05
PARENTAL PREFERENCE ASSESSMENT
FOR VESICOURETERAL REFLUX
MANAGEMENT IN CHILDREN
Geraldine Tran*, San Francisco, CA, Anand
Bodapati, Los Angeles, CA, Jonathan Routh,
Durham, NC, Christopher Saigal, Los Angeles,
CA, Hillary Copp, San Francisco, CA
MP55-06
UTILITY ESTIMATION FOR PEDIATRIC
VESICOURETERAL REFLUX:
METHODOLOGICAL CONSIDERATIONS
USING AN ONLINE SURVEY PLATFORM
Rohit Tejwani*, Hsin-Hsiao Wang, Jessica
Lloyd, Jonathan Routh, Durham, NC
MP55-07
*Presenting author
ABSTRACT
NUMBER TITLE
MP55-08 PREVALENCE AND RISK FACTORS OF
SYMPTOMATIC URINARY TRACT
INFECTION AFTER ENDOSCOPIC
INCISION FOR THE TREATMENT OF
URETEROCELE IN CHILDREN.
Kimihiko Moriya*, Michiko Nakamura, Yoko
Nishimura, Takeya Kitta, Kanno Yukiko,
Hiroki Chiba, Masafumi Kon, Nobuo
Shinohara, Sapporo, Japan
HISTOPATHOLOGICAL CHANGES
ASSOCIATED WITH POLYACRYLATE
POLYALCOHOL BULKING COPOLYMER
(PPC, VANTRIS) INJECTION FOR
PAEDIATRIC VESICOURETERAL REFLUX
(VUR)
Boris Chertin*, Stanislav Kocherov, Jerusalem,
Israel, Ermelinda Mele, Simona Gerocarni
Nappo, Nicola Capozza, Rome, Italy
199
MP55-09
LONG-TERM RESULTS AND SAFETY OF
POLYACRYLAMIDE HYDROGEL FOR THE
ENDOSCOPIC TREATMENT OF
VESICOURETERAL REFLUX IN CHILDREN
Sophie Ramsay*, Anne-Sophie Blais, Fannie
Morin, Katherine Moore, Stéphane Bolduc,
Quebec City, Canada
MP55-10
DELAYED OBSTRUCTION WITH SILENT
LOSS OF RENAL FUNCTION AFTER
DEXTRANOMER/HYALURONIC ACID
COPOLYMER (DEFLUX) INJECTION FOR
VESICOURETERAL REFLUX: A CLOSE
LOOK AT A DISTURBING OUTCOME
Dimitri Papagiannopoulos*, Ilina Rosoklija,
Earl Cheng, Elizabeth Yerkes, Chicago, IL
MP55-11
MULTI-INSTITUTIONAL REVIEW OF
OUTCOMES AND COMPLICATIONS OF
EXTRAVESICAL URETERAL
REIMPLANTATION (RALUR-EV) FOR
TREATMENT OF PRIMARY
VESICOURETERAL REFLUX (VUR) IN
CHILDREN
William Boysen*, Lauren Belleville, Chicago,
IL, Ardavan Ahkavan, Jonathan Ellison,
Thomas S. Lendvay, Seattle, WA, Jonathan
Huang, Andrew Kirsch, Atlanta, GA, Christina
Kim, Hartford, CT, Minki Baek, Chester Koh,
Houston, TX, Paul Noh, Marion Schulte,
Cincinnati, OH, Dhirendra Shrivastava,
Aseem Shukla, Arun Srinivasan, Philadelphia,
PA, Francesca Monn, Benjamin Whittam,
Indianapolis, IN, Blake Palmer, Oklahoma
City, OK, Mohan Gundeti, Chicago, IL
MP55-12
BILATERAL NERVE-SPARING
EXTRAVESICAL REPAIR (BNSEVR) OF
URETERAL REFLUX IS SAFE AND
EFFECTIVE, WITH NO LONG TERM
URINARY RETENTION
Jennifer Reifsnyder*, Kerlly Bernabe, Diane
Felsen, Dix Poppas, New York, NY
MP55-13
IPSILATERAL URETEROURETEROSTOMY:
A REPORT OF EFFICACY AND
COMPARISON TO OPEN SURGERY
Arun Srinivasan, Dhirendra Shrivastava*,
Carmen Tong, Aseem Shukla, Philadelphia,
PA
SUNDAY
ABSTRACT
NUMBER TITLE
MP55-01 CONTEMPORARY PRACTICE PATTERNS
IN VOIDING CYSTOURETHROGRAM
(VCUG) USE: THE IMPACT OF EVIDENCEBASED GUIDELINES
Linda Lee*, Armando Lorenzo, Rakan Odeh,
Paul Bowlin, Jeffrey Traubici, Martin Koyle,
Toronto, Canada
MP55-14
SURGICAL SCAR LOCATION
PREFERENCE FOR PEDIATRIC KIDNEY
AND BLADDER SURGERY: A CROWDSOURCED POPULATION-BASED SURVEY
Michael Garcia-Roig*, Curtis Travers, Jared
Kirsch, Andrew Kirsch, Atlanta, GA
MP55-18
CAN WE RELY ON PYURIA AS A MARKER
FOR UTI IN THE NEUROGENIC
BLADDER?: AN 11 YEAR LONGITUDINAL
ANALYSIS
Ruthie Su*, Mari Palta, Amy Lim, Christina
Sauder, Ellen Wald, Madison, WI
MP55-15
CATHETER-ASSOCIATED ANTIBIOTIC
USE IN PEDIATRIC UROLOGY: A SURVEY
OF MEMBERS OF THE SOCIETY FOR
PEDIATRIC UROLOGY
Alexander Glaser*, Ilina Rosoklija, Emilie
Johnson, Elizabeth Yerkes, Chicago, IL
MP55-19
MP55-16
VARIATION IN PERIOPERATIVE
ANTIBIOTIC PROPHYLAXIS FOR
OUTPATIENT PEDIATRIC UROLOGIC
PROCEDURES AT U.S. CHILDREN’S
HOSPITALS
Katherine Hubert*, Teresa Bell, Brian
Benneyworth, Mark Cain, Aaron Carroll,
Indianapolis, IN
UTILITY OF RETROGRADE
URETEROCELEOGRAM IN MANAGEMENT
OF COMPLEX URETEROCELE
Michelle K Arevalo*, Dallas, TX, Juan Carlos
Prieto, San Antonio, TX, Nicholas Cost,
Aurora, CO, Geoffrey Nuss, Linda A Baker,
Dallas, TX
MP55-20
IS THE USE OF SMALL STENTS SAFE IN
FOLLOWING PYELOPLASTY? OUR
EXPERIENCE WITH 3 FRENCH STENTS
Andres Correa*, Audry Kang, Pankaj Dangle,
Heidi Stephany, Glenn Cannon, Francis
Schneck, Michael Ost, Pittsburgh, PA
MP55-17
CREDITTM
URINARY TRACT INFECTION AFTER
RETROGRADE URETHROGRAM IN
CHILDREN: A MULTICENTER STUDY
Neha Malhotra*, Jared Green, Cynthia
Rigsby, Jane Holl, Earl Cheng, Emilie
Johnson, Chicago, IL
Sunday, May 8, 2016
3:30 pm - 5:30 pm
TRAUMA/RECONSTRUCTION/DIVERSION: URETER (INCLUDING PYELOPLASTY) AND BLADDER RECONSTRUCTION (INCLUDING
FISTULA), AUGMENTATION, SUBSTITUTION, DIVERSION II
Moderators: Justin Chee and Arnulf Stenzl
ABSTRACT
NUMBER TITLE
MP56-01 THE IMPACT OF CLOSING THE
MESENTERIC WINDOW WHEN
HARVESTING ILEUM IN GENITOURINARY
RECONSTRUCTIVE SURGERY
Michael Avallone*, Peter Dietrich, Shanta
Shepherd, Mona Lalehzari, R. Corey
O’Connor, Michael Guralnick, Milwaukee, WI
MP56-02
MP56-03
ABSTRACT
NUMBER TITLE
MP56-04 THE MEDIUM TERM OUTCOMES OF
STOMA FORMATION FOR PATIENTS
UNDERGOING CONDUIT DIVERSION FOR
FUNCTIONAL AETIOLOGY: 5 YEAR
FOLLOW-UP
Osman Kose*, Eskinder Solomon, Mahreen
Pakzad, Rizwan Hamid, Julian Shah, Tamsin
Greenwell, Jeremy Ockrim, London, United
Kingdom
EMPIRIC TREATMENT OF IDENTIFIED
CLOSTRIDIUM DIFFICILE CARRIERS AT
TIME OF CYSTECTOMY: PRELIMINARY
OUTCOMES
Joseph M. Jacob*, Hristos Z. Kaimakliotis,
Nick W. Liu, Jane S. Cho, Francesca Monn,
Clint Cary, Timothy A. Masterson, Tom A.
Gardner, Richard S. Foster, Richard Bihrle,
Michael O. Koch, Indianapolis, IN
USE OF A NEIGHBORING UNINJURED
NERVE FOR RESTORATION OF TISSUE
FUNCTION
Bukyu Lee, Young Min Ju, Jaeku Cho, John
Jackson*, Sang Jin Lee, James Yoo, Anthony
Atala, Winston Salem, NC
200
MP56-05
COMPARATIVE ANALYSIS OF HOSPITALBASED OUTCOMES IN PATIENTS
UNDERGOING URINARY DIVERSION FOR
BENIGN DISEASE
Charles Nottingham*, Joseph Pariser, Andrew
Cohen, Vignesh Packiam, Sarah Faris, Greg
Bales, Chicago, IL
MP56-06
COMPLICATIONS OF CONTINENT
CUTANEOUS DIVERSIONS
Soroush T Bazargani*, Eric Hwang, Jie Cai,
Gus Miranda, Hooman Djaladat, Anne
Schuckman, Siamak Daneshmand, Los
Angeles, CA
MP56-07
URETERAL RECONSTRUCTION WITH
APPENDIX IN 21 PATIENTS
Boris Komyakov, Viktor Ochelenko*, Bahman
Guliev, Saint-Petersburg, Russian Federation
INCIDENCE OF UROLOGIC ISSUES IN
PATIENTS WITH SPINA BIFIDA AT INITIAL
PRESENTATION TO TRANSITIONAL
UROLOGY CLINIC
McCabe C. Kenny*, Kirk M. Anderson, Ty T.
Higuchi, Aurora, CO
MP56-09
UPPER URINARY TRACT AFFECTION
AFTER MANAGEMENT OF BLADDER
EXSTROPHY A LONG-TERM FOLLOW UP
Ahmed Shoukry*, Mahmoud Ragab,
Mohamed El Sheemy, Ahmed Shouman,
Wasim Abouella, Karim Daw, Mohamed El
Ghonimy, Hisham El Ghamrawy, Hani Morsi,
Hisham Badawy, Cairo, Egypt
MP56-10
POST-OPERATIVE COMPLICATIONS OF
SPINA BIFIDA PATIENTS UNDERGOING
UROLOGICAL EXPLORATORY
LAPAROTOMIES- A MULTIINSTITUTIONAL ANALYSIS
Christopher J. Loftus*, Cleveland, OH, David
C. Moore, Joshua A. Cohn, Douglas F.
Milam, Roger R. Dmochowski, Nashville, TN,
Dan Wilby, Portsmouth, United Kingdom, Dan
Wood, London, United Kingdom, Melissa R.
Kaufman, Nashville, TN, Hadley M. Wood,
Cleveland, OH
MP56-11
ROBOTIC INTERVENTION OF BLADDER
DIVERTICULA AND CONCOMITANT
OUTLET PROCEDURES
Laura L. Giusto*, Aseem Malhotra, Ziho Lee,
Joshua D. Jones, Joshua Kaplan, Daniel D.
Eun, Philadelphia, PA
MP56-12
LAPAROSCOPIC REMOVAL OF KIDNEY
AND RENAL AUTO TRANSPLANTATION
FOLLOWING LONG SEGMENT URETERIC
INJURY
Anant Kumar*, Vimal Dassi, Manoj Kumar,
Delhi, India
MP56-13
MP56-14
*Presenting author
ORTHOTOPIC SIGMOID RESERVOIR:
MORE THAN TWENTY YEARS
EXPERIENCE
Alberto Martini*, Donata Villari, Florence,
Italy, Maria Teresa Filocamo, Cuneo, Italy,
Calogero Saieva, Maria Cristina Paoletti,
Barbara Bigazzi, Aldo Tosto, Giulio Nicita,
Florence, Italy
MP56-15
URODYNAMIC FEATURES OF PUBIC
SYMPHYSIS OSTEOMYELITIS IN THE
PROSTATE CANCER SURVIVOR
MP56-16
RADIOGRAPHIC MANIFESTATIONS OF
PUBIC SYMPHYSIS OSTEOMYELITIS IN
THE PROSTATE CANCER SURVIVOR:
DEFINITIVE DIAGNOSIS LIES IN FINDINGS
ON MAGNETIC RESONANCE IMAGING
MP56-17
RECENT TRENDS IN POST-CYSTECTOMY
(QOL) FAVOURS NEOBLADDER
DIVERSION: SYSTEMATIC REVIEW OF
THE LITERATURE
Anngona Ghosh*, Bhaskar Somani,
Southampton, United Kingdom
MP56-18
AFTER RADICAL CYSTECTOMY:
COMPARATIVE STUDY BETWEEN
ORTHOTOPIC SIGMOID VERSUS ILEAL
NEOBLADDERS
Hideaki Miyake*, Hamamatsu, Japan, Junya
Furukawa, Masato Fujisawa, Kobe, Japan
MP56-19
A PROSPECTIVE RANDOMIZED SINGLEBLINDED COMPARISON OF URETERAL
STENT WITH DISTAL LOOP DESIGN AND
ITS EFFECT ON EARLY STENT
DISCOMFORT AND QOL.
Kheng Sit Lim*, Zhi Wei Law, Marcus Way
Lunn Chow, Allen Soon Phang Sim, Tsung
Wen Chong, Henry Sun Sien Ho, 169608,
Singapore
MP56-20
THE NON-SIDE HOLE URETERAL STENT
REDUCES FREQUENCY OF STENT
FAILURE IN MALIGNANT OBSTRUCTION
OR RETROPERITONEAL FIBROSIS,
COMPARED TO THE SIDE HOLE STENT
Tomonori Ota*, Hiroka Komori, Kamogawa,
Chiba, Japan, Sho Uehara, Tokyo, Japan,
Yohei Omori, Chiba, Japan, Jyunji Yonese,
Tokyo, Japan
CREDITTM
FACTORS INFLUENCING
POSTOPERATIVE CONTINENCE STATUS
IN FEMALES AFTER ORTHOTOPIC ILEAL
BLADDER SUBSTITUTION
Tobias Gross*, Susan D. Meierhans Ruf,
Claudia Meissner, Katharina Ochsner, Urs E.
Studer, Bern, Switzerland
201
SUNDAY
MP56-08
Sunday, May 8, 2016
3:30 pm - 5:30 pm
PROSTATE CANCER: LOCALIZED: SURGICAL THERAPY III
Moderators: Judd Moul and Andrew Stephenson
ABSTRACT
NUMBER TITLE
MP57-01 THE DIAGNOSTIC ACCURACY OF 68GAPSMA-PET/CT FOR DETECTION OF
LYMPH NODE METASTASES IN THE
SETTING OF SALVAGE LYMPH NODE
DISSECTION
Cordula A. Jilg*, Vanessa Drendel, Christian
H. Rischke, Teresa Beck, Anca-L. Grosu,
Martin Werner, Ulrich Wetterauer, Philipp T
Meyer, Wolfgang Schultze-Seemann,
Freiburg, Germany
MP57-02
IS THERE A ROLE FOR CHOLINE PET
SCANNING IN SALVAGE
PROSTATECTOMY?
Sanchia Goonewardene*, London, United
Kingdom, Gideon Bletcher, Rick Catterwell,
Declan Cahill, Raj Persad, London, United
Kingdom, David Gillatt, Sydney, United
Kingdom, Ben Challacombe, Prokar
Dasgupta, Rick Popert, London, United
Kingdom
MP57-03
IS A NEGATIVE MPMRI REALLY ABLE TO
RULE OUT SIGNIFICANT PROSTATE
CANCER?
Nicolas Branger, Thomas Maubon, Miriam
Traumann, Jeanne Thomassin-Piana, Maria
Paciencia, Serge Brunelle, Naji Salem,
Gwenaelle Gravis, Jochen Walz*, Marseille,
France - Metropolitan
MP57-04
MP57-05
MP57-06
ABSTRACT
NUMBER TITLE
MP57-07 TRANSPERINEAL PROSTATE MAPPING
BIOPSY CORRECTLY IDENTIFIES
CANDIDATES FOR RADICAL
PROSTATECTOMY
E. David Crawford*, Aurora, CO, Vassilios
Skouteris, Athens, Greece, Paul Arangua,
Aurora, CO, Nelson Stone, Vail, CO
PREOPERATIVE PROSTATE IMAGING
REPORTING AND DATA SYSTEM SCORE:
AN INDEPENDENT PREDICTOR OF
POSITIVE SURGICAL MARGIN AFTER
PROSTATECTOMY
Taichi Kanzawa*, Junpei Iizuka, Yasunobu
Hashimoto, Tsunenori Kondo, Toshio Takagi,
Tokyo, Japan, Masashi Inui, Chiba, Japan,
Hideki Ishida, Kazunari Tanabe, Tokyo,
Japan
DOES A SHORTER INTERVAL BETWEEN
THE PERFORMANCE OF PROSTATE
BIOPSY AND ROBOT-ASSISTED RADICAL
PROSTATECTOMY AFFECT OUTCOMES?
Won Sik Jang*, Jong Soo Lee, Mark
Abalajon, Cheol Yong Yoon, Joo Yong Lee,
Kang Su Cho, Won Sik Ham, Joong Shik
Lee, Seoul, Korea, Republic of, In Rae Cho,
Gimhae, Korea, Republic of, Young Deuk
Choi, Ji Eun Heo, Seoul, Korea, Republic of
RADICAL PROSTATECTOMY AFTER
REPEAT BIOPSY: ONCOLOGICAL AND
PERIOPERATIVE OUTCOME
Clemens M. Rosenbaum*, Philipp Mandel,
Pierre Tennstedt, Hans Heinzer, Markus
Graefen, Georg Salomon, Hamburg,
Germany
202
MP57-08
PROSTATE-SPECIFIC ANTIGEN DENSITY
IS THE MOST APPROPRIATE FACTOR
FOR DETECTING UNFAVORABLE
PATHOLOGY AFTER RADICAL
PROSTATECTOMY IN MEN ELIGIBLE FOR
ACTIVE SURVEILLANCE FROM MUTLIINSTITUTIONAL STUDY
Takahiro Inoue*, Kyoto, Japan, Kei Mizuno,
Otsu, Japan, Hidefumi Kinoshita, Hirakata,
Japan, Toshifumi Yano, Kobe, Japan, Hiroaki
Kawanishi, Tenri, Japan, Hideki Kanda, Tsu,
Japan, Naoki Terada, Tomomi Kamba, Kyoto,
Japan, Kazuhiro Okumura, Tenri, Japan,
Mutsushi Kawakita, Kobe, Japan, Keiji Ogura,
Otsu, Japan, Yoshiki Sugimura, Tsu, Japan,
Tadashi Matsuda, Hirakata, Japan, Osamu
Ogawa, Kyoto, Japan
MP57-09
PROXIMITY OF POSITIVE PROSTATE
BIOPSY CORE TO CAPSULAR MARGIN
MAY HELP PREDICT EXTRACAPSULAR
EXTENSION AND POSITIVE MARGIN AT
PROSTATECTOMY
Nirmish Singla*, Niccolo Passoni, Jordon
Walker, Karen De La Fuente, Claus
Roehrborn, Dallas, TX
MP57-10
ASSOCIATION BETWEEN PREOPERATIVE
INITIAL PSA AND NADIR PSA AFTER
PROSTATECTOMY IN HIGH RISK
Republic of, Young Sig Kim, Goyang, Korea,
Republic of, Young Deuk Choi, Myung Soo
Kim*, Seoul, Korea, Republic of
MP57-11
PATHOLOGICAL OUTCOMES IN MEN
WITH PROSTATE CANCER DIAGNOSED
ON REPEAT TRANSRECTAL
ULTRASOUND PROSTATE BIOPSY AFTER
INITIAL HIGH RISK BENIGN PATHOLOGY
Ahmed Elshafei, Ganesh Kartha*, Eric Klein,
J.Stephen Jones, Cleveland, OH
THE IMPACT OF INFECTIOUS
COMPLICATIONS AFTER PROSTATE
BIOPSY ON RADICAL PROSTATECTOMY
SURGICAL OUTCOMES: A POPULATIONBASED ANALYSIS
Daniel Olvera-Posada*, Blayne Welk, J.
Andrew McClure, Jennifer Winick-Ng,
Jonathan I. Izawa, Stephen E. Pautler,
London, Canada
MP57-13
THE EFFECT OF SMOKING ON 30-DAY
MORBIDITY FOLLOWING MALIGNANCYRELATED PROSTATECTOMY.
David Byun*, Matthew Cohn, Samir Patel,
Marc Bjurlin, New York, NY
MP57-14
MP57-15
MP57-16
DOES DEHYDRATED AMNIOTIC/CHORION
HUMAN MEMBRANE (DACHM),
ACCELERATES THE RETURN TO
POTENCY FOLLOWING ROBOT-ASSISTED
REGARDLESS THE DEGREE OF NERVE
SPARING?: PROPENSITY SCOREMATCHED ANALYSIS
Gabriel Ogaya-Pinies*, Hariharan
Palayapalayam Ganapathi, Vladimir
Mouraviev, Tracey Woodlief, Travis Rogers,
Cathy Jenson, Vipul R. Patel, Celebration, FL
COMPARISON OF BIOCHEMICAL
RECURRENCE-FREE SURVIVAL
BETWEEN ROBOTIC-ASSISTED RADICAL
PROSTATECTOMY AND RETROPUBIC
RADICAL PROSTATECTOMY: A
PROPENSITY SCORE MATCHING
ANALYSIS
Yosuke Hirasawa*, Makoto Ohori, Kenji
Shimodaira, Takeshi Kashima, Tatsuo
Gondo, Yoshihiro Nakagami, Yutaka
Horiguchi, Yoshio Ohno, Kazunori Namiki,
Kunihiko Yoshioka, Jun Nakashima, Masaaki
Tachibana, Tokyo, Japan
MP57-17
EXTENT OF PELVIC LYMPH NODE
DISSECTION IN LYMPH NODE NEGATIVE
PROSTATE CANCER IS SIGNIFICANT IN
PREDICTING RISK OF BIOCHEMICAL
RECURRENCE
Francis Ting*, Pim J Van Leeuwen, Warick
Delprado, Thomas Cusick, Phillip Brenner,
Raji Kooner, Carlo Yuen, Gordon O’Neill,
David Ende, Anne-Maree Haynes, Phillip D
Stricker, Sydney, Australia
MP57-18
EXPRESSION OF STEROID HORMONE
RECEPTORS IN RESIDUAL CANCER AND
STROMAL CELLS AFTER NEOADJUVANT
CHEMOHORMONAL THERAPY WITH
DOCETAXAL FOR HIGH-RISK LOCALIZED
PROSTATE CANCER
Shintaro Narita*, Taketoshi Nara, Mingguo
Huang, Koichiro Takayama, Kazuyuki
Numakura, Hiroshi Tsuruta, Atsushi Maeno,
Mitsuru Saito, Takamitsu Inoue, Akita, Akita,
Japan, Norihiko Tsuchiya, Yamagata, Japan,
Hiroshi Nanjo, Shigeru Satoh, Tomonori
Habuchi, Akita, Akita, Japan
MP57-19
THE INFLUENCE OF BOARD
CERTIFICATION ON OUTCOMES AFTER
Daniel Rosen*, Julian Hanske, Gally Reznor,
Christopher Allard, Christian Meyer, Jairam
Eswara, Steven Chang, Maxine Sun, Paul
Nguyen, Adam Kibel, Quoc-Dien Trinh, Mark
Preston, Boston, MA
MP57-20
PATTERNS OF CLINICAL RECURRENCE
AND PREDICTORS OF SYSTEMIC
PROGRESSION OF PROSTATE CANCER
PATIENTS WITH PSA PERSISTENCE
Giorgio Gandaglia*, Nicola Fossati, Paolo
Dell’Oglio, Milan, Italy, Rocco Damiano,
Marco Bianchi, Catanzaro, Italy, Marta
Picozzi, Elena Farina, Vito Cucchiara,
Roberto Bertini, Federico Dehò, Francesco
Montorsi, Alberto Briganti, Milan, Italy
THE LEVEL OF EDUCATION AS
INDEPENDENT PREDICTOR OF OVERALL,
NON-CANCER AND SECOND CANCER
MORTALITY AFTER RADICAL
PROSTATECTOMY
Michael Froehner*, Stefan Propping, Rainer
Koch, Matthias Hübler, Manfred P. Wirth,
Dresden, Germany
CREDITTM
Sunday, May 8, 2016
3:30 pm - 5:30 pm
Podium Session 32
PROSTATE CANCER: ADVANCED (INCLUDING DRUG THERAPY) III
Moderators: Stephen Freedland and Joseph Renzulli
TIME
3:30
ABSTRACT
NUMBER TITLE
PD32-01 PRE-CLINICAL RATIONALE FOR
COMBINATION PI3K AND BRD4
INHIBITION IN ADVANCED PROSTATE
CANCER
Paul Toren*, Québec, Canada, Jared Allman,
Soojin Kim, Amina Zoubeidi, Vancouver,
Canada
*Presenting author
ABSTRACT
TIME NUMBER TITLE
3:40 PD32-02 NOVEL PI3K/P110BETA-SPECIFIC
INHIBITORS ELIMINATE ENZALUTAMIDE
RESISTANCE IN PROSTATE CANCER
Marcus Austenfeld*, Chenchen He, Yifen
Wang, Qingting Hu, Brantley Thrasher, Benyi
Li, Kansas City, KS
203
SUNDAY
MP57-12
3:50
PD32-03
A PHASE 2 OPEN-LABEL TRIAL OF GTX758 IN MEN WITH CASTRATIONRESISTANT PROSTATE CANCER, FINAL
ANALYSIS OF THE PRIMARY ENDPOINT
William Aronson*, Los Angeles, CA, Evan Yu,
Seattle, WA, Michael Hancock, Memphis, TN,
Tamás Babicz, Nyı́regyháza, Hungary,
Ronald Tutrone, Baltimore, MD, Christopher
Ng, Los Angeles, CA, Laurence Belkoff, Bala
Cynwyd, PA, Zsuzsanna Pápai, Lajos Géczi,
Budapest, Hungary, Robert Getzenberg,
Memphis, TN
4:00
PD32-04
PHASE I/II CLINICAL TRIAL TO ASSESS
SAFETY AND EFFICACY OF
INTRATUMORAL AND SUBCUTANEOUS
INJECTION OF HVJ-E TO CASTRATION
PATIENTS
Kazutoshi Fujita*, Yasutomo Nakai, Koji
Hatano, Norihiko Kawamura, Atsunari
Kawashima, Takeshi Ujike, Akira Nagahara,
Motohide Uemura, Yasufumi Kaneda, Norio
Nonomura, Suita, Japan
4:10
4:20
4:30
PD32-05
PD32-06
PD32-07
PHASE I CLINICAL STUDY ON THE
COMBINATION THERAPY OF CHP-NYESO-1 CANCER VACCINE AND MIS416
FOR THE TREATMENT OF PATIENTS
WITH NY-ESO-1 EXPRESSING
REFRACTORY UROTHELIAL CANCER OR
CANCER
Takeshi Sasaki*, Mikiya Ishihara, Hideki
Kanda, Tsu, Mie, Japan, Yasuhide Hori,
Kameyama, Mie, Japan, Norihito Soga,
Nagoya, Aichi, Japan, Naozumi Harada,
Yoshihiro Miyahara, Shinichi Kageyama,
Hiroshi Shiku, Yoshiki Sugimura, Tsu, Mie,
Japan
LONG-TERM SAFETY AND ANTITUMOR
ACTIVITY OF ODM-201 IN
CHEMOTHERAPY AND CYP17-INHIBITOR
NAÏVE PATIENTS FROM THE ARADES
AND THE ARAFOR TRIALS
Neal Shore*, Myrtle Beach, SC, Teuvo
Tammela, Tampere, Finland, Christophe
Massard, Villejuif, France, Petri Bono,
Helsinki, Finland, John Aspegren, Mika
Mustonen, Espoo, Finland, Karim Fizazi,
Villejuif, France
4:40
PD32-08
SYNERGISTIC ANTICANCER EFFECT OF
COMBINATION TREATMENT WITH MEK
INHIBITOR AND PI3K /MTOR DUAL
INHIBITOR IN CASTRATION-RESISTANT
PROSTATE CANCER IN VIVO AND EX
VIVO
Se Young Choi*, Jaeyoon Jung, Jae Hyeon
Han, Junghyun Shin, Jeong-Woen Moon,
Sang Hoon Song, Dalsan You, Jung Jin
Hwang, Choung-Soo Kim, Seoul, Korea,
Republic of
4:50
PD32-09
COMBINATION EFFECT OF THERAPIES
TARGETING THE PI3K-MTOR AND AR
SIGNALING PATHWAYS IN PROSTATE
CANCER
Jinyi Li, Shalini S Yadav, James O’Connor,
Bryan Herzog, Cordelia Elaiho, Kamlesh K
Yadav*, Ashutosh K Tewari, New York, NY
5:00
PD32-10
PHOSPHORYLATION OF AMPK␣ AT SER485/491 IS ASSOCIATED WITH
METASTASIS AND CASTRATIONRESISTANCE IN PROSTATE CANCER: A
CLINICAL STUDY
Melissa Babcook*, Toledo, OH, Mahmut
Akgul, Seunghee Margevicius, Gregory
MacLennan, Pingfu Fu, Robert Abouassaly,
Sanjay Gupta, Cleveland, OH
5:10
PD32-11
GENE EXPRESSION ANALYSIS OF BONE
METASTASIS AND CIRCULATING TUMOR
CELLS FROM METASTATIC CASTRATERESISTANT PROSTATE CANCER
PATIENTS
Won-Jin Cho, Michael Cher*, Daniel Oliveira,
Abdo Najy, Leandro Mainetti, Elisabeth
Heath, Kim Hyeong-Reh, R. Daniel Bonfil,
Detroit, MI
5:20
PD32-12
LONG-TERM FOLLOW-UP OF
CIRCULATING TUMOR CELLS AS
PREDICTORS FOR SURVIVAL IN MEN
TREATED WITH ABIRATERONE ACETATE
FOR CASTRATION RESISTANT
PROSTATE CANCER FOLLOWING
CHEMOTHERAPY
Christian Meyer*, Petra Strölin, Hans Heinzer,
Klaus Pantel, Sabine Riethdorf, Thomas
Steuber, Hamburg, Germany
CREDITTM
GALETERONE SHOWS ANTI-TUMOR
ACTIVITY IN MULTIPLE PRE-CLINICAL
MODELS THAT EXPRESS ANDROGEN
RECEPTOR SPLICE VARIANTS,
SUPPORTING CORRELATIVE PATIENT
DATA SEEN IN ARMOR2
Vincent Njar*, Baltimore, MD, Amina
Zoubeidi, Vancouver, Canada, Eva Corey,
Elahe Mostaghel, Seattle, WA, Andrew
Kwegyir-Afful, Senthilmurugan Ramalingam,
Baltimore, MD, Douglas Jacoby, Boston, MA
204
Sunday, May 8, 2016
3:30 pm - 5:30 pm
Podium Session 33
BLADDER CANCER: INVASIVE IV
Moderators: Raj Pruthi and Michael Cookson
3:40
3:50
4:00
4:10
ABSTRACT
NUMBER TITLE
PD33-01 OUTCOME OF METASTASECTOMY FOR
UROTHELIAL CARCINOMA: A MULTIINSTITUTIONAL RETROSPECTIVE STUDY
Tohru Nakagawa*, Satoru Taguchi, Atsushi
Kanatani, Masaomi Ikeda, Akihiko
Matsumoto, Taketo Kawai, Kanae Yoshida,
Daisuke Yamada, Yoshimitsu Komemushi,
Shinji Urakami, Motofumi Suzuki, Yutaka
Enomoto, Yasushi Kondo, Yasushi Nagase,
Hiroaki Nishimatsu, Yoshikazu Hirano,
Toshikazu Okaneya, Yoshinori Tanaka,
Shigeru Minowada, Hideyo Miyazaki, Tetsuya
Fujimura, Hiroshi Fukuhara, Haruki Kume,
Yukio Homma, Tokyo, Japan
PD33-02
PD33-03
PD33-04
PD33-05
*Presenting author
ABSTRACT
TIME NUMBER TITLE
4:20 PD33-06 IS PATHOLOGIC DOWNSTAGING AT
RADICAL CYSTECTOMY FOR CLINICALLY
ORGAN CONFINED BLADDER CANCER
ASSOCIATED WITH A BETTER
OUTCOME?
Daniel Furlong*, Soroush Bazargani, Jie Cai,
Gus Miranda, Siamak Daneshmand, Hooman
Djaladat, Los Angeles, CA
VARIANT HISTOLOGIC DIFFERENTIATION
IN BLADDER CANCER TREATED WITH
RADICAL CYSTECTOMY: INCIDENCE AND
LONG TERM SURVIVAL IN A SINGLE
INSTITUTION STUDY.
Marco Moschini, Vito Cucchiara, Stefano
Luzzago, Paolo Dell’Oglio, Giusy Burgio,
Milan, Italy, Vincenzo Serretta, Palermo, Italy,
Shahrokh Francois Shariat, Vienna, Austria,
Andrea Salonia, Alberto Briganti, Francesco
Montorsi, Renzo Colombo, Andrea Gallina*,
Milan, Italy
ADJUSTED CLINICAL OUTCOMES IN
PATIENTS WITH SARCOMATOID VARIANT
UROTHELIAL CARCINOMA UNDERGOING
RADICAL CYSTECTOMY FOR MUSCLE
INVASIVE DISEASE
Joseph M. Jacob*, Francesca Monn, Tim
Large, Jane S. Cho, Benjamin R. Judge,
Jose Pedrosa, Richard Bihrle, Liang Cheng,
Michael O. Koch, Hristos Z. Kaimakliotis,
Indianapolis, IN
PATHOLOGICAL CHARACTERISTICS AND
PROGNOSTIC INDICATORS OF
DIFFERENT HISTOPATHOLOGICAL TYPES
FOLLOWING RADICAL CYSTECTOMY: A
LARGE COHORT WITH LONG-TERM
FOLLOW-UP
Simone L Vernez*, Ahmed Abdelhalim, Rahul
Dutta, Orange, CA, Ahmed Shokeir, Hassan
Abol-Enein, Ahmed Mosbah, Mohamed
Ghoneim, Mansoura, Egypt, Ramy F
Youssef, Orange, CA
THE PROMISE AND DISAPPOINTMENT OF
SEQUENTIAL THERAPY AFTER
NEOADJUVANT CHEMOTHERAPY FOR
MUSCLE-INVASIVE BLADDER CANCER:
UPDATED RESULTS AND LONG-TERM
FOLLOW-UP
Stanley Yap*, Neil Pugashetti, Thenappan
Chandrasekar, Marc Dall’Era, Christopher
Evans, Primo Lara, Ralph deVereWhite,
Sacramento, CA
205
4:30
PD33-07
PARTIAL VS. COMPLETE RESPONSE TO
PATIENTS: A COMPARISON OF POSTCYSTECTOMY OUTCOMES
Aaron Brant*, Max Kates, Meera Chappidi,
Hiten Patel, Nikolai Sopko, Trinity Bivalacqua,
Baltimore, MD
4:40
PD33-08
UTILITY OF URETHRAL FROZEN
SECTIONS DURING RADICAL
Max Kates*, Mark Ball, Meera Chappidi,
Nikolai Sopko, Phillip Pierorazio, Trinity
BIvalacqua, Baltimore, MD, Mark
Schoenberg, New York, NY
4:50
PD33-09
PATTERN OF METASTATIC SPREAD
AFTER BLADDER-SPARING THERAPY
FOR INVASIVE BLADDER CANCER
Valary Raup*, Jairam Eswara, Manuel
Ozambela, W. Scott McDougal, Boston, MA
5:00
PD33-10
THE PRESENCE OF RESIDUAL
CARCINOMA IN SITU ALONE (PTIS) IN
PATIENTS TREATED WITH RADICAL
CYSTECTOMY DOES NOT AFFECT LONG
TERM RECURRENCE AND SURVIVAL
RATES
Marco Moschini, Ettore Di Trapani, Stefano
Luzzago, Giusy Burgio, Milan, Italy, Agostino
Mattei, Lucerne, Switzerland, Shahrokh
Francois Shariat, Vienna, Austria, Rocco
Damiano, Catanzaro, Italy, Andrea Salonia,
Alberto Briganti, Francesco Montorsi, Renzo
Colombo, Andrea Gallina*, Milan, Italy
5:10
PD33-11
BLADDER CANCER: P53-NESS IS
ASSOCIATED WITH CHEMO-RESISTANCE
AND UNFAVORABLE OUTCOME
Roland Seiler*, Vancouver, Canada,
Woonyoung Choi, Houston, TX, Nicholas
Erho, Vancouver, Canada, Bernhard Kiss,
Bern, Switzerland, Lucia L Lam, Qici Wang,
Christine Bürki, Elai Davicioni, Vancouver,
Canada, George N Thalmann, Bern,
Switzerland, David J McConkey, Houston,
TX, Peter C Black, Vancouver, Canada
SUNDAY
TIME
3:30
5:20
PD33-12
SINGLE LYMPH NODE MALIGNANT
INVOLVEMENT POST RADICAL
CYSTECTOMY FOR UROTHELIAL
CARCINOMA OF THE BLADDER: CLINICAL
OUTCOMES AND PROGNOSTIC
IMPLICATIONS
Mohamed M. Elsaadany, Ahmed M.
Mansour*, Nasr A. El-Tabey, Mahmoud R.
El-Kenawy, Hassan Abol-Enein, Mansoura,
Egypt
CREDITTM
Sunday, May 8, 2016
3:30 pm - 5:30 pm
Video Session 8
BLADDER ONCOLOGY/TESTIS/TRANSPLANTATION/TRAUMA
Moderators: Reza Ghavamian and Phillip Pierorazio
ABSTRACT
NUMBER TITLE
V8-01
FULL PROCEDURAL SIMULATION FOR
TRANSURETHRAL RESECTION OF
BLADDER TUMORS (TURBT) USING 3-D
PRINTING TECHNOLOGY.
Ahmed Ghazi*, Jonathan Stone, Jennifer
Park, Braden Candela, Janet Kukreja, Hani
Rashid, Edward Messing, Rochester, NY
V8-02
COMPLETELY INTRACORPOREAL
ROBOTIC RENAL AUTOTRANSPLANTION
Bradley Gill*, Daniel Ramirez, Venkatesh
Krishnamurthi, David Goldfarg, GeorgesPascal Haber, Cleveland, OH
V8-03
DISSECTION FOR NON-SEMINOMATOUS
GERM CELL TUMORS IN THE POSTCHEMOTHERAPY SETTING
Michael Marshall*, San Diego, CA, Haidar
Abdul-Muhsin, Phoenix, AZ, Sean Stroup,
San Diego, CA, Michael Woods, Chapel Hill,
NC, James Porter, Seattle, WA, Erik Castle,
Phoenix, AZ, James L’Esperance, San Diego,
CA
V8-04
V8-05
ABSTRACT
NUMBER TITLE
V8-06
EARLY ENDOSCOPIC REALIGNMENT FOR
PELVIC FRACTURE URETHRAL INJURY
Lindsay A. Hampson*, Seattle, WA, Kevin
Curtiss, Baltimore, MD, Saneal Rajanahally,
Judith Hagedorn, Hunter Wessells, Bryan
Voelzke, Seattle, WA
ROBOTIC-ASSISTED VERSUS
LAPAROSCOPIC LIVING DONOR
NEPHRECTOMY: A 12-STEP
COMPARISON OF SURGICAL TECHNIQUE
Michael Palese, Jamie Pak*, Edward Chin,
Greg Gin, Daniel Herron, Susan Lerner,
Dianne LaPointe Rudow, Antonios Arvelakis,
Scott Ames, Alan Benvenisty, Ron Shapiro,
Sander Florman, New York, NY
ROBOTIC KIDNEY TRANSPLANTATION:
OUR FIRST CASE
Alberto Breda*, Lluı́s Gausa, Angelo Territo,
Ivan Schwartzmann, Oscar Rodrı́guez, Jorge
Caffaratti, Javier Ponce de León, Humberto
Villavicencio, Barcelona, Spain
206
V8-07
MAPPING BIOPSIES: A NEW TACTIC IN
THE SURGICAL MANAGEMENT OF
EXTRAMAMMARY PAGET’S DISEASE
Jonathan Beilan*, Barrett McCormick, Adam
Baumgarten, Gerard Mosiello, Jasreman
Dhillon, Philippe Spiess, Tampa, FL
V8-08
MINIMAL INVASIVE HYDROCELECTOMY
TECHNIQUE, ONOL (OUTPATIENT NOVEL
OUT LEAF) PROCEDURE: 10 YEARS
EXPERIENCE
Sinasi Yavuz Onol*, Fikret Fatih Onol, Ismail
Basibuyuk, Mehmet Remzi Erdem, Istanbul,
Turkey
V8-09
BLUE LIGHT CYSTOSCOPY: THE USC
EXPERIENCE
Soroush T Bazargani*, Hooman Djaladat,
Anne Schuckman, Cory Hugen, Siamak
V8-10
AN EFFICIENT TECHNIQUE TO ENGAGE
AND CATHETERIZE A URETERAL ORIFICE
IN DIFFICULT SITUATIONS
Cu Phan, Stephanie Y. Johng, Stephanie G.
Wong*, Alan Hung, Dominic D. Tran-Nguyen,
Newport Beach, CA
V8-11
ROBOTIC INTRACORPOREAL ILEAL
CONDUIT: FOCUSING ON THE BEDSIDE
ASSISTANT
Daniel Ramirez*, Matthew J. Maurice, Peter
A. Caputo, Ryan J. Nelson, Ercan Malkoc,
Onder Kara, Georges-Pascal Haber, Jihad H.
Kaouk, Cleveland, OH
EN BLOC THULIUM LASER RESECTION
OF BLADDER TUMORS: INDICATIONS,
SURGICAL TIPS, AND 3-YR ONCOLOGIC
OUTCOMES
Giuseppe Simone*, Rome, Italy, Alessandro
Giacobbe, Turin, Italy, Rocco Papalia, Rome,
Italy, Devis Collura, Leonardo D’Urso,
Emanuele Castelli, Gianluca Muto, Turin,
Italy, Riccardo Mastroianni, Mariaconsiglia
Ferriero, Francesco Minisola, Leonardo
Misuraca, Gabriele Tuderti, Michele Gallucci,
Giovanni Muto, Rome, Italy
CREDITTM
SUNDAY
V8-12
*Presenting author
207
NOTES
Plenary Session
Monday, May 9, 2016
7:28 am - 12:00 pm
7:28
7:30
HIGHLIGHTS: SOCIETY OF GENITOURINARY RECONSTRUCTIVE SURGEONS PROGRAM
Bryan Voelzke
7:35
HIGHLIGHTS: SOCIETY OF URODYNAMICS, FEMALE PELVIC MEDICINE AND UROGENITAL RECONSTRUCTION
PROGRAM
Nirit Rosenblum
7:40
HIGHLIGHTS: SOCIETY OF UROLOGIC ONCOLOGY PROGRAM
Leonard Gomella
7:45
POINT-COUNTERPOINT: TESTIS CANCER SURVEILLANCE: LOW DOSE CT IS BETTER THAN MRI
Moderator:
Pat Fulgham
Debater - Con: Christian Kollmannsberger
Debater - Pro: Craig Nichols
8:10
STATE-OF-THE-ART LECTURE: PRECURSORS TO THE RANDALL PLAQUE: NOVEL PERSPECTIVES ON
NEPHROLITHIASIS
Marshall Stoller
8:25
PANEL DISCUSSION: NIDDK: MAPPING A PATH TO A CURE FOR CHRONIC PELVIC PAIN
Moderator:
Robert Moldwin
Panelists:
J. Curtis Nickel
John Krieger
Michel Pontari
8:50
PRESIDENTIAL ADDRESS: U.S. HEALTHCARE REFORM: PAST, PRESENT AND FUTURE
AUA President: William Gee
9:10
RAMON GUITERAS LECTURE: CANCER MOONSHOT 2020 UROLOGY
Patrick Soon-Shiong
9:30
PANEL DISCUSSION: MESH FOR POP AND SUI: AN INTERNATIONAL PERSPECTIVE
Moderator:
J. Christian Winters
Panelists:
Satoru Takahashi
Tamsin Greenwell
Mauricio Plata
9:55
AUA GUIDELINE: SURGICAL MANAGEMENT OF RENAL CALCULI
Ojas Shah
10:05
AUA GUIDELINE: SURGICAL MANAGEMENT OF URETERAL CALCULI
Dean Assimos
10:15
UROLOGICAL ASSOCIATION OF ASIA (UAA) LECTURE: MEN’S HEALTH IN ASIA
Hui-Meng Tan
10:35
PANEL DISCUSSION: WHAT MAKES A BETTER SURGEON?
Moderator:
John Denstedt
Panelists:
Robert Sweet
Lee Richstone
Timothy Kowalewski
10:55
EUROPEAN ASSOCIATION OF UROLOGY (EAU) LECTURE: THE UNDERACTIVE BLADDER: WHERE DO WE
STAND IN 2016?
Christopher Chapple
11:15
CRITICAL DISCUSSION: PERIOPERATIVE PREPARATION OF THE GERIATRIC PATIENT
Ananias Diokno
Presenters:
Daniel Culkin
Philippe Zimmern
11:35
UROLOGY CARE FOUNDATION: OUR FOUNDATION. BECAUSE WE CARE.
John Lynch
*Presenting author
209
MONDAY
PLENARY I - MONDAY
11:40
LATE BREAKING ABSTRACTS
PI-LBA 01:
SACRAL NEUROMODULATION VERSUS ONABOTULINUMTOXINA FOR REFRACTORY OVERACTIVE BLADDER
Cindy L. Amundsen*, Durham, NC, Holly E. Richter, Birmingham, AL, Shawn A. Menefee, San Diego, CA, Yuko M.
Komesu, Albuquerque, NM, Lily A. Arya, Philadelphia, PA, W. Thomas Gregory, Portland, OR, Deborah L. Myers,
Providence, RI, Halina M. Zyczynski, Pittsburgh, PA, Sandip Vasavada, Cleveland, OH, Tracy L. Nolen, Dennis
Wallace, Research Triangle Park, NC, Susan F. Meikle, Rockville, MD
PI-LBA 02:
REEVALUATING PSA TESTING RATES IN THE PLCO TRIAL
Jonathan Shoag*, Sameer Mittal, Joshua Halpern, Richard Lee, Douglas Scherr, Christopher Barbieri, Peter Schlegel,
PI-LBA 03:
TESTOSTERONE THERAPY AND PROSTATE CANCER RISK
Stacy Loeb*, New York, NY, Yasin Folkvaljon, Uppsala, Sweden, Jan-Erik Damber, Gothenburg, Sweden, Joseph
Alukal, New York, NY, Mats Lambe, Stockholm, Sweden, Pär Stattin, Uppsala, Sweden
PI-LBA 04:
HEMIABLATION HIFU FOR UNILATERAL LOCALIZED PROSTATE CANCER: A PROSPECTIVE MULTICENTER
TRIAL
Pascal Rischmann*, Toulouse, France, Albert Gelet, Lyon, France, Arnauld Villers, Lille, France, Gilles Pasticier,
Bordeaux, France, Olivier Rouvière, Lyon, France
PI-LBA 05:
UNDERSTANDING THE SEXUAL HABITS OF MEN TAKING MEDICATION FOR ERECTILE DYSFUNCTION (ED):
SURVEY RESULTS FROM 7 COUNTRIES
John P. Mulhall*, Tarek A. Hassan, New York, NY, James Rienow, Walton Oaks, Surrey, United Kingdom
12:00
SESSION CONCLUDES
Monday, May 9, 2016
8:00 am - 10:00 am
STONE DISEASE: BASIC RESEARCH & PATHOPHYSIOLOGY I
Moderator: Benjamin Canales
ABSTRACT
NUMBER TITLE
MP58-01 DISCOVERY OF RANDALL’S PLAQUE
GENE EXPRESSION PROFILING IN
CALCIUM OXALATE STONE FORMERS BY
IMMUNOHISTOCHEMICAL GENOME-WIDE
ANALYSIS
Kazumi Taguchi*, Shuzo Hamamoto, Atsushi
Okada, Rei Unno, Hideyuki Kamisawa, Taku
Naiki, Ryosuke Ando, Keiichi Tozawa, Kenjiro
Kohri, Takahiro Yasui, Nagoya, Japan
MP58-02
MP58-03
ABSTRACT
NUMBER TITLE
MP58-04 DISCOVERY AND IMPLICATIONS OF
INAPPROPRIATELY ALKALINE
MICROENVIRONMENTS WITHIN THE
FUNCTIONING HUMAN KIDNEY
Michael S Borofsky*, Andrew P Evan, James
C Williams, Rajash K Handa, Casey A Dauw,
Sharon Bledsoe, Indianapolis, IN, Fredric L
Coe, Elaine M Worcester, Chicago, IL, James
E Lingeman, Indianapolis, IN
NOVEL INSIGHT INTO STONE
FORMATION MECHANISMS USING MICRO
CT: VERIFICATION THAT RANDALL’S
PLAQUES AND DUCTAL PLUGS CAN
PRODUCE CLINICALLY SIGNIFICANT
STONES
James C. Williams, Jr.*, Michael S. Borofsky,
Andrew P. Evan, Indianapolis, IN, Fredric
Coe, Elaine Worcester, Chicago, IL, James
E. Lingeman, Indianapolis, IN
NONCOLLAGENOUS PROTEINS IN
RANDALL’S PLAQUE: A COMPARATIVE
ANALYSIS WITH HIGH RESOLUTION
MICROSCOPY
Ling Chen*, Ryan Hsi, Marshall Stoller,
Sunita Ho, San Francisco, CA
210
MP58-05
ENDOSCOPIC AND HISTOLOGIC
FINDINGS IN A COHORT OF APATITE,
BRUSHITE AND CALCIUM OXALATE
STONE FORMERS
Johann Ingimarsson*, Lisa Vaughan, FeliCity
Enders, John Leiske, Amy Krambeck,
Rochester, MN
MP58-06
PREDICTORS OF PROGRESSIVE STONE
DISEASE IN CALCIUM PHOSPHATE
STONE FORMERS
Steeve Doizi*, Margaret Pearle, John
Poindexter, Beverley Huet, Khashayar
Sakhaee, Naim Maalouf, Dallas, TX
MP58-07
SELECTIVE PROTEIN ENRICHMENT IN
CALCIUM OXALATE STONE MATRIX
Jeffrey Wesson*, Ann Kolbach-Mandel, Neil
Mandel, Jack Kleinman, Milwaukee, WI
KIDNEY STONES COMPARED TO DENTAL
CALCULI AND SALIVARY STONES:
COMPARATIVE ANALYSES OF MINERAL
DENSITY AND ULTRASTRUCTURE
Sunita Ho*, Ryan Hsi, Ling Chen, Feifei
Yang, Sophie You, David Killilea, Krishna
Ramaswamy, Jolie Chang, Thomas Chi,
Marshall Stoller, San Francisco, CA
MP58-09
HYDROXYAPATITE INDUCES CALCIUM
OXALATE TOLERANCE IN PRIMARY
HUMAN MONOCYTES
Paul Dominguez Gutierrez, Sergei
Kusmartsev, Benjamin Canales, Vincent Bird,
Johannes Vieweg, Saeed Khan*, Gainesville,
FL
MP58-10
MP58-11
CLASSIFICATION OF STONE PATIENTS
BY MICRO CT STUDY OF STONES:
CORRELATION WITH PAPILLARY
PATHOLOGY
James C. Williams, Jr.*, Michael S. Borofsky,
Casey Dauw, Andrew P. Evan, Indianapolis,
IN, Fredric Coe, Elaine Worcester, Chicago,
IL, James E. Lingeman, Indianapolis, IN
COMBINATION OF MICRO CT WITH
INFRARED SPECTROSCOPY PROVIDES
THE MOST COMPLETE APPROACH FOR
STONE ANALYSIS
James C. Williams, Jr.*, James E. Lingeman,
Indianapolis, IN
MP58-12
GENETIC ALTERATIONS RELATED TO
CYSTINURIA – A GENOME WIDE
ASSOCIATION ANALYSIS
Sabrina Reis*, Nayara Viana, Katia Leite,
Felipe Magioni, Fabio Torricelli, Giovanni
Marchinni, Miguel Srougi, Eduardo
Mazzucchi, Sao Paulo, Brazil
MP58-13
THE MECHANISM OF RENAL STONE
FORMATION AND RENAL FAILURE
INDUCED BY MELAMINE AND CYANURIC
ACID; LONG-TERM EXPERIMENT
RESULTS
Takahiro Kobayashi*, Anjo, Japan, Atsushi
Okada, Ryossuke Ando, Keiichi Tozawa,
Kenjiro Kohri, Takahiro Yasui, Nagoya, Japan
MP58-14
NEUTROPHIL GELATINASE-ASSOCIATED
LIPOCALIN (NGAL) AS A BIOMARKER OF
RENAL INJURY IN PATIENTS WITH
URETERIC STONES
Marco Bolgeri*, Khaled Farrag, Antonio
Reche, Padmini Manghat, Seshadri
Sriprasad, Dartford, United Kingdom
MP58-15
SUCTIONING FLEXIBLE URETEROSCOPY
WITH AUTOMATIC CONTROL OF RENAL
PELVIC PRESSURE: A PORCINE MODEL
Leming Song*, Xiaolin Deng, Donghua Xie,
Difu Fan, Zuofeng Peng, Tairong Liu,
Ganzhou, China, People’s Republic of,
Republic of
*Presenting author
MP58-16
DAMAGE TO
POLYTETRAFLUOROETHYLENE-COATED
GUIDEWIRES: A POTENTIAL FOREIGN
BODY RISK
Alison Wong*, Wayne Kelln, Danilo Boskovic,
Alex Erskine, Andrew Kutzner, Cayde Ritchie,
Brian Chung, Samuel Abourbih, Salim
Cheriyan, Mohamed Keheila, Jim Shen,
Patrick Yang, D. Duane Baldwin, Loma Linda,
CA
MP58-17
DOES MATRIX MATERIAL AFFECT
URINARY STONE FORMATION AND
COMPOSITION?
Mahmoud El-Naggar*, Al Ain, United Arab
Emirates, Emad Elsobky, Abu Dhabi, United
Arab Emirates, Bedeir Ali-El-Dein, Mansoura,
Egypt
MP58-18
EXOGENOUS HYDROGEN SULFIDE
TREATMENT REDUCES RENAL FIBROSIS
ASSOCIATED WITH CHRONIC URETERAL
OBSTRUCTION BY ATTENUATING
EPITHELIAL-MESENCHYMAL TRANSITION
Shouzhe Lin*, Fazil Visram, Ian Lobb,
Weihua Liu, Aaron Haig, Jifu Jiang, Amy
Mok, Dameng Lian, London, Canada, Mark
E. Wood, Matthew Whiteman, Exeter, United
Kingdom, Alp Sener, London, Canada
MP58-19
INVESTIGATIONS OF THE MICROELEMENTAL COMPOSITION OF THE
URINARY STONES IN ADULTS AND
CHILDREN: A COMPARATIVE
PROSPECTIVE STUDY
Mahmoud El-Naggar*, Al Ain, United Arab
Emirates, Emad Elsobky, Abu Dhabi, United
Arab Emirates, Bedeir Ali-El-Dein, Mansoura,
Egypt
MP58-20
TRANSIENT RECEPTOR POTENTIAL V4
(TRPV4)-ION CHANNEL-ACTIVE DRUGS
MODIFY NORMAL AND PATHOLOGICAL
URETER IN VIVO PERISTALSIS IN RATS
Philipp Dr. Weinhold*, Frank Strittmatter,
Christian Stief, Christian Gratzke, Munich,
Germany, Francesco Montorsi, Arianna
Bettiga, Fabio Benigni, Milan, Italy, Petter
Hedlund, Linköping, Sweden
CREDITTM
211
MONDAY
MP58-08
Monday, May 9, 2016
8:00 am - 10:00 am
TRAUMA/RECONSTRUCTION/DIVERSION: EXTERNAL GENITALIA RECONSTRUCTION AND UROTRAUMA
Moderators: Steven Brandes and Richard Santucci
ABSTRACT
NUMBER TITLE
MP59-01 PATIENT REPORTED SOCIAL,
PSYCHOLOGICAL, AND UROLOGIC
OUTCOMES AFTER ADULT BURIED PENIS
REPAIR
Maria Voznesensky*, W. Thomas Lawrence,
Jerrod Keith, Bradley Erickson, Iowa City, IA
MP59-02
MP59-03
MP59-04
MP59-05
ABSTRACT
NUMBER TITLE
MP59-09 ASSESSING THE CLINICAL AND
RADIOLOGICAL UPTAKE AND UTILITY OF
THE 2009 REVISION TO THE 1989
AMERICAN ASSOCIATION FOR THE
SURGERY OF TRAUMA RENAL INJURY
SCALE: A SINGLE INSTITUTION SERIES
Omer Raheem, Eric Ballon-Landa*, Leslie
Kobayashi, Jill Buckley, San Diego, CA
ADULT BURIED PENIS: EXPERIENCE AND
OUTCOMES
Omar Soto-Aviles*, Brandi Miller, Richard
Santucci, Detroit, MI
OUTCOMES OF SPLIT-THICKNESS SKIN
GRAFT RECONSTRUCTION FOR MAJOR
GENITAL SKIN LOSS: THE ADVERSE
IMPACT OF SYSTEMIC DISEASE
PROCESSES
Ryan McLarty*, Keith Rourke, Edmonton,
Canada
RECONSTRUCTION OF MASSIVE
LOCALIZED EDEMA OF THE SCROTUM:
RESULTS, COMPLICATIONS AND
QUALITY OF LIFE IMPROVEMENTS
Eric Wisenbaugh*, Dena Moskowitz, Joel
Gelman, Orange, CA
IN VIVO IMPLANTATION OF BIOPRINTED
SKIN GRAFTS FOR SURGICAL
RECONSTRUCTION AND WOUND
HEALING
Julie Marco, Claire Jeong, John Jackson*,
James Yoo, Anthony Atala, Winston Salem,
NC
MP59-06
ROLE OF ULTRASONOGRAPHY FOR
TESTICULAR INJURIES IN PENETRATING
SCROTAL TRAUMA
Gauthami Churukanti*, Andrew Kim, Kyle
Schuyler, Garjae Lavien, Deborah Stein, M.
Minhaj Siddiqui, Baltimore, MD
MP59-07
UTILITY OF PREOPERATIVE
ULTRASOUND FOR THE EVALUATION OF
TESTICULAR RUPTURE IN THE SETTING
OF PENETRATING SCROTAL TRAUMA
Stephen Hurley*, Edward Park, Ryan Powers,
Patricia Vidal, Sarah Psutka, Courtney
Hollowell, Chicago, IL
MP59-08
PRACTICE PATTERNS OF ANGIOGRAPHY
AND ANGIOEMBOLIZATION
PERFORMANCE FOR ISOLATED LOW
GRADE RENAL TRAUMA: RESULTS FROM
A LARGE, STATEWIDE TRAUMA
REGISTRY
Ronak Gor*, Brett Styskel, Tianyu Li, Jay
Simhan, Philadelphia, PA
212
MP59-10
COST-EFFECTIVE MANAGEMENT OF
PELVIC FRACTURE URETHRAL INJURIES
USING DECISION TREE ANALYSIS
Niels Johnsen*, David Penson, Elizabeth T
Brown, Joshua Cohn, W Stuart Reynolds,
Douglas Milam, Roger Dmochowski, Melissa
Kaufman, Nashville, TN
MP59-11
TRANSFERS OF CARE AND MORBIDITY
OF FOURNIER’S GANGRENE
Nathan Osbun*, Lindsay Hampson, Sarah
Holt, John Gore, Hunter Wessells, Bryan
MP59-12
EPIDEMIOLOGY OF COMORBID
GENITOURINARY INJURY AND
EXTREMITY AMPUTATION IN OPERATION
IRAQI FREEDOM AND OPERATION
ENDURING FREEDOM
Steven Hudak*, Jean Orman, Judson Janak,
Nina Nnamani, Douglas Soderdahl, Fort Sam
Houston, TX
MP59-13
BURNS TO THE PERINEAL REGION
INCREASE THE RISK OF DEATH AMONG
U.S. SERVICE MEMBERS SUSTAINING
COMBAT-RELATED BURNS DURING
OPERATION IRAQI FREEDOM AND
OPERATION ENDURING FREEDOM
Michael Clemens, Judson Janak, Julie Rizzo,
Michelle Buehner, Steven Hudak*, John
Graybill, Kevin Chung, Fort Sam Houston, TX
MP59-14
DIFFERENCE IN OUTCOMES AFTER
TOTAL PHALLIC RECONSTRUCTION IN
THE TRANSGENDER AND NONTRANSGENDER POPULATION
Oscar Suarez Fernandez De Lara*, Jack M.
Zuckerman, Ramon Virasoro, Jeremy Tonkin,
Jessica Delong, Kurt A. McCammon, Norfolk,
VA
MP59-15
FASCIOCUTANEOUS FLAP
REINFORCEMENT OF VENTRAL ONLAY
BUCCAL MUCOSA GRAFTS ENABLES
NEOPHALLUS REVISION
URETHROPLASTY
Lee C Zhao, New York, NY, Kiranpreet K
Khurana*, New York, NJ, Stelios C Wilson,
John T Stranix, Jamie P Levine, New York,
NY
SIGMOID VAGINOPLASTY AND ITS
IMPACT ON PSYCHOSOCIAL AND
SEXUAL LIFE IN PATIENTS WITH
VAGINAL AGENESIS
Miroslav Djordjevic*, Marta Bizic, Vladimir
Kojovic, Borko Stojanovic, Marko Majstorovic,
Ljiljana Labus, Dusan Stanojevic, Belgrade,
Serbia
MP59-17
A MODEL OF HUMAN PENILE
TRANSPLANTATION TO INVESTIGATE
THE EFFECTS AND PATHOPHYSIOLOGY
OF REJECTION AND CYCLOSPORIN A
TREATMENT ON ERECTILE FUNCTION
Nikolai A. Sopko*, Hotaka Matsui, Denver M.
Lough, Richard Redett, Arthur L. Burnett,
Trinity J. Bivalacqua, Baltimore, MD
MP59-18
MP59-19
A RETROSPECTIVE EVALUATION OF THE
SAFETY AND EFFECTIVENESS OF A
SILICONE BLOCK IMPLANT FOR
ELECTIVE COSMETIC SURGERY OF THE
PENIS
James Elist, Beverly Hills, CA, Gottfried
Lemperle*, Frankfurt, Germany, Allen
Kamrava, Alireza Hosseini, Omead Mirgoli,
Beverly Hills, CA
MP59-20
TOTAL PHALLIC RECONSTRUCTION
USING RADIAL ARTERY BASED
FOREARM FREE FLAP AFTER PENILE
LOSS SECONDARY TO TRAUMA
Marco Falcone*, Giulio Garaffa, Francesco
De Luca, Amr Raheem, Andrew Nim
Christopher, David Joseph Ralph, London,
United Kingdom
SYNCHRONOUS IPSILATERAL HIGH
SUBMUSCULAR PLACEMENT OF
PROSTHETIC BALLOONS AND
RESERVOIRS
Nicholas Kavoussi*, Ryan Mooney, Jeremy
Scott, Billy Cordon, Matthias Hofer, Allen
Morey, Dallas, TX
CREDITTM
Monday, May 9, 2016
8:00 am - 10:00 am
URODYNAMICS/LOWER URINARY TRACT DYSFUNCTION/FEMALE PELVIC MEDICINE:
BASIC RESEARCH & PATHOPHYSIOLOGY I
Moderators: Larissa Rodriguez and Priya Padmanabhan
ABSTRACT
NUMBER TITLE
MP60-01 IN VIVO OPTICAL STIMULATION OF
CHANNELRHODOPSIN-EXPRESSING
BLADDER SENSORY NEURONS EVOKES
HOMEOSTATIC AND NOCICEPTIVE
REFLEX BEHAVIORS
Timothy Fernandez*, Birmingham, AL, Brian
Davis, Pittsburgh, PA, Jennifer DeBerry,
Birmingham, AL
ABSTRACT
NUMBER TITLE
MP60-04 INTRAVESICAL ADMINISTRATION OF
SENSORY NEURON-SPECIFIC RECEPTOR
AGONIST SUPPRESSES
CYCLOPHOSPHAMIDE-INDUCED
BLADDER OVERACTIVITY
Masashi Honda*, Yonago, Japan, Naoki
Yoshimura, Pittsburgh, PA, Bunya Kawamoto,
Tsounapi Panagiota, Yonago, Japan, Shogo
Shimizu, Nankoku, Japan, Shuichi Morizane,
Hikita Katsuya, Kuniyasu Muraoka, Yonago,
Japan, Takahiro Shimizu, Nankoku, Japan,
Takehiro Sejima, Yonago, Japan, Motoaki
Saito, Nankoku, Japan, Michael Chancellor,
Royal Oak, MI, Atsushi Takenaka, Yonago,
Japan
MP60-02 LARGE-SCALE GENE EXPRESSION
ANALYSIS OF LASER CAPTURE
MICRODISSECTED DETRUSOR MUSCLE
SAMPLES IN FEMALE OVERACTIVE
BLADDER PATIENTS AND CONTROLS
Beat Foerster*, Winterthur, Switzerland,
Nadine Brader, Hubert Rehrauer, Caroline
Maake, Zurich, Switzerland, Hubert John,
Winterthur, Switzerland
MP60-05
MP60-03 THE IMPACT OF INTRAVESICAL
LIPOSOME-BASED NGF ANTISENSE
THERAPY ON BLADDER OVERACTIVITY
AND NOCICEPTION IN A RAT MODEL OF
CYSTITIS INDUCED BY HYDROGEN
PEROXIDE
Tsuyoshi Majima*, Nagoya, Japan, Pradeep
Tyagi, Pittsburgh, PA, Koji Dogishi, Kyoto,
Japan, Mahendara Kashyap, Pittsburgh, PA,
Momokazu Gotoh, Nagoya, Japan, Michael
Chancellor, Rayal Oak, MI, Naoki Yoshimura,
Pittsburgh, PA
*Presenting author
5-HT IN THE RAT PREFRONTAL CORTEX
CONTROLS THE MICTURITION REFLEX
VIA 5-HT2A AND 5-HT7.
Hiroki Chiba*, Sapporo, Japan, Takahiko
Mitsui, Yamanashi, Japan, Takeya Kitta, Yu
Ohmura, Kimihiko Moriya, Yukiko Kanno,
Mitsuhiro Yoshioka, Nobuo Shinohara,
Sapporo, Japan
MP60-06 PATHOGENIC ROLE OF TRUNCATED
TRKB RECEPTOR ISOFORM (TRKB.T1) IN
BDNF INDUCED DETRUSOR
OVERACTIVITY (DO)
Mahendra Kashyap*, William C deGroat,
Naoki Yoshimura, Pradeep Tyagi, Pittsburgh,
PA
213
MONDAY
MP59-16
MP60-07 SACRAL NEUROMODULATION OF
BLADDER OVERACTIVITY IN CATS
Zhaocun Zhang, Jathin Bandari*, Audry
Kang, Vladimir Lamm, Jicheng Wang, Bing
Shen, James Roppolo, William de Groat,
Changfeng Tai, Pittsburgh, PA
MP60-15
MP60-08 CHRONIC PSYCHOLOGICAL STRESS
INDUCES CHANGES IN BLADDER
CONTRACTILITY
Yunliang Gao*, Huiyi Chang, Rong Zhang,
Larissa Rodriguez, Los Angeles, CA
SUPRASPINAL LOWER URINARY TRACT
CONTROL IN SPINAL CORD INJURY
PATIENTS: A STRUCTURAL AND
FUNCTIONAL MRI STUDY
Switzerland, Matthias Walter, Zürich,
Switzerland, Martina D. Liechti, London,
United Kingdom, Lars Michels, Spyros
Kollias, Patrick Freund, Ulrich Mehnert,
Thomas M. Kessler, Zürich, Switzerland
MP60-16 THE MIC-KEY BUTTON VESICOSTOMY: A
SUPERIOR ALTERNATIVE FOR SUPRAPUBIC BLADDER DRAINAGE?
Jai Seth*, Elaine Hazell, Winnie Nugent,
Claire Taylor, Arun Sahai, Jonathon
Olsburgh, London, United Kingdom
MP60-09 HYPERPOLARIZATION-ACTIVATED AND
CYCLIC NUCLEOTIDE-GATED CATION
(HCN) CHANNELS MODULATE
SPONTANEOUS AND NEUROGENIC
CONTRACTIONS OF HUMAN BLADDER
Mahendra Kashyap*, Naoki Yoshimura,
Pradeep Tyagi, Pittsburgh, PA
MP60-17 THE TEMPORAL CORRELATION
BETWEEN SPONTANEOUS
CONTRACTIONS AND INTRINSIC ATP
RELEASE FROM THE MUCOSAL LAYER IN
THE BLADDER
Nobuhiro Kushida*, Hidenori Akaihata,
Jyunya Hata, Seiji Hoshi, Michihiro Yabe, Kei
Ishibashi, Ken Aikawa, Yoshiyuki Kojima,
Yoshiyuki Kojima, Fukushima, Japan,
Christopher Fry, Bristol, United Kingdom
MP60-10 LOCAL PHARMACOLOGICAL
REGULATORY CHANGES IN ISOLATED
BLADDERS OF ALZHEIMER MICE
Aryo Zare*, Maastricht, Netherlands,
Mohammad Sajjad Rahnamai, Heerlen,
Netherlands, Gommert A. van Koeveringe,
Celine Meriaux, Ramona Hohnen, Maastricht,
Netherlands
MP60-18 DECREASED CONTRACTILITY AND
INCREASED RESIDUAL URINE VOLUME
OF THE BLADDER IN A CHRONIC
ISCHEMIC MODEL IN THE RAT; A
POSSIBLE PATH TO THE UNDERACTIVE
BLADDER
Norifumi Sawada*, Satoru Kira, Takahiko
Mitsui, Masayuki Takeda, Yamanashi, Japan
MP60-11 WIRELESS URODYNAMIC DEVICE
DEMONSTRATES SUBMUCOSAL SENSOR
IS COMPARABLE TO URODYNAMIC
CATHETER
Joshua Roth*, Indianapolis, IN, Albert Kim,
West Lafayette, IN, Mouhamad Alloosh,
Michael Sturek, Indianapolis, IN, Babak Ziaie,
West Lafayette, IN, CR Powell, Indianapolis,
IN
MP60-19 MUSCARINIC INDUCED BLADDER
CONTRACTILITY IS ALTERED IN AN
ANIMAL MODEL FOR NEUROGENIC
Karel Dewulf*, Emmanuel Weyne, Yves
Deruyver, Rieta Van Bree, Dirk De Ridder,
Maarten Albersen, Wouter Everaerts, Leuven,
Belgium
MP60-12 DETRUSOR UNDERACTIVITY IS SEEN IN
AN ANIMAL MODEL FOR METABOLIC
SYNDROME
Joshua Roth*, Indianapolis, IN, Albert Kim,
West Lafayette, IN, Mouhamad Alloosh,
Indianapolis, IN, Babak Ziaie, West Lafayette,
IN, Michael Sturek, CR Powell, Indianapolis,
IN
MP60-20 ESTROGEN REPLACEMENT REDUCES
OXIDATIVE STRESS AND RESTORES
BLADDER AND PELVIC FLOOR
CONTRACTILE FUNCTION IN AN ANIMAL
MODEL OF MENOPAUSE AND TISSUE
ISCHEMIA
Amy D. Dobberfuhl*, Stanford, CA, Catherine
Schuler, Robert E. Leggett, Elise J.B. De,
Robert M. Levin, Albany, NY
MP60-13 URINARY NERVE GROWTH FACTOR AS A
POTENTIAL BIOMARKER FOR
PREDICTION OF TREATMENT EFFICACY
AND RECURRENCE IN OVERACTIVE
BLADDER PATIENTS
Yoon Seok Suh*, Jae Ho Yoo, Hyun Hwan
Sung, Hyun Woo Kim, Seoul, Korea,
Republic of, Joon Chul Kim, Bucheon,
Kyunggi-do, Korea, Republic of, Jong Bo
Choi, Suwon, Korea, Republic of, Jeongyun
Jeong, Kyu-Sung Lee, Heung Jae Park,
CREDITTM
MP60-14 URINARY INCONTINENCE IN A RAT
MODEL OF SURGICAL MENOPAUSE:
EFFECTS OF GONADAL HORMONE
REPLACEMENT THERAPY
José Luis Palacios*, Tlaxcala, Mexico, Alvaro
Munoz, Houston, Tx, Margarita Juárez,
Tlaxcala, Mexico, Margot S Damaser,
Cleveland, Oh, Jiang Hai-Hong, Wenzhou,
China, People’s Republic Of, Yolanda Cruz,
Tlaxcala, Mexico
214
Monday, May 9, 2016
8:00 am - 10:00 am
BLADDER CANCER: BASIC RESEARCH & PATHOPHYSIOLOGY II
Moderators: Robert Svatek and James McKiernan
ABSTRACT
NUMBER TITLE
MP61-06 PHOTODYNAMIC THERAPY FOR NONMUSCLE INVASIVE BLADDER CANCER
MEDIATED BY INSTILLED
PHOTOSENSITIZER TLD1433 AND GREEN
LIGHT ACTIVATION
Savo Lazic, Pavel Kaspler, Arkady Mandel,
Michael A.S. Jewett, Girish Kulkarni, Lothar
Lilge*, Toronto, Canada
MP61-07 THE EFFECT OF LEVOFLOXACIN ON
BACILLUS CALMETTE-GUERIN INDUCED
TOXICITY IN PATIENTS WITH
NONMUSCLE-INVASIVE BLADDER
CANCER: RESULTS OF A RANDOMIZED,
PROSPECTIVE, MULTICENTER STUDY
Kazuyuki Numakura*, Norihiko Tsuchiya,
Hiroshi Tsuruta, Mitsuru Saito, Takamitsu
Inoue, Shintaro Nariata, Mingguo Huang,
Shigeru Satoh, Tomonori Habuchi, Akita, Japan
MP61-02 ANTI-GLI1 AND ANTI-GLI2 AS NOVEL
THERAPY TO INHIBIT BLADDER CANCER
PROGRESSION
Peter A. Raven*, Sebastian K. Frees, Betty
B.H. Zhou, Claudia I. Chavez-Munoz, Michael
E. Cox, Alan I. So, Vancouver, Canada
MP61-03 EVALUATION OF LACTATE
TRANSPORTERS AS POTENTIAL
THERAPEUTIC TARGET IN UROTHELIAL
CARCINOMA
Tilman Todenhöfer*, Roland Seiler, Craig
Stewart, Igor Moskalev, Jian Gao, Alireza
Kamyabi, Nader Al Nakouzi, Tetsuharo
Hayashi, Stephen Choi, Yuzhou Wang, Mads
Daugaard, Sebastian Frees, Htoo Zarni Oo,
Vancouver, Canada, Jörg Hennenlotter, Jens
Bedke, Tuebingen, Germany, Ladan Fazli,
Vancouver, Canada, Arnulf Stenzl,
Tuebingen, Germany, Peter Black,
Vancouver, Canada
MP61-08 PHOTOTHERMAL ABLATION OF
BLADDER CANCER USING
PHOSPHATIDYLSERINE TARGETED
CARBON NANOTUBES
Needa Virani, Norman, OK, Joel Slaton*,
Winston-Salem, NC, Carole Davis, Robert
Hurst, Paul Hauser, Oklahoma City, OK,
Roger Harrison, Norman, OK
MP61-09 EARLY DEVELOPMENT OF
INTRAVESICAL REFLECTANCE
SPECTROSCOPY FOR BLADDER TUMOR
DETECTION AND STAGING
Joel Slaton*, Winston-Salem, NC, Robert
Hurst, Carole Davis, Oklahoma City, OK,
Pallavi Rajaputra, Stillwater, OK, Youngjae
You, Oklahoma City, OK, Kenneth Bartels,
Daqing Piao, Stillwater, OK
MP61-04 ALTERATIONS IN CELL LINE SENSITIVITY
TO SMALL MOLECULE INHIBITORS
BETWEEN UROTHELIAL CANCER LINES
AND THEIR METASTATIC DERIVATIVES
Louis Krane*, Reema Railkar, Iawan Hsu,
Abhinav Sidana, Kai Hammerich, Cathy
Vocke, Paul Meltzer, Craig Thomas, Marc
Ferrer, Piyush Agarwal, Bethesda, MD
MP61-05
*Presenting author
MP61-10 DNA METHYLATION INHIBITORS MAY
REVERSE DRUG-RESISTANCE IN HUMAN
Naotaka Nishiyama*, Sapporo, Japan,
Stephanie Yi, Christopher E. Duymich, Siamak
Daneshmand, Los Angeles, CA, Peter A.
Jones, Grand Rapids, MI, Hooman Djaladat,
Los Angeles, CA, Naoya Masumori, Sapporo,
Japan, Gangning Liang, Los Angeles, CA
INTRAVESICAL INSTILLATION OF
EXOGENOUS MICRORNA-145 AS A
THERAPY FOR MOUSE ORTHOTOPIC
HUMAN BLADDER CANCER XENOGRAFT
Teruo Inamoto*, Osaka, Japan, Kohei
Taniguchi, Gifu, Japan, Kiyoshi Takahara,
Osaka, Japan, Ayako Iwatsuki, Gifu, Japan,
Tomoaki Takai, Taizo Uchimoto, Kenkichi Saito,
Naoki Tanda, Yuki Yoshikawa, Koichiro
Minami, Hajime Hirano, Hayahito Nomi, Satoshi
Kiyama, Osaka, Japan, Yukihiro Akao, Gifu,
Japan, Haruhito Azuma, Osaka, Japan
MP61-11 ENHANCED SENSITIVITY TO NVP-BEZ235
BY INHIBITION OF P62/SQSTM1 IN
HUMAN BLADDER CANCER KOTCC-1
CELLS BOTH IN VITRO AND IN VIVO
Bing Liu*, Kobe, Japan, Hideaki Miyake,
Japan
215
MONDAY
ABSTRACT
NUMBER TITLE
MP61-01 ANTITUMOR ACTIVITY OF SULFATED
ANGIOGENIC FRAGMENTS: A NOVEL
HYALURONIDASE INHIBITOR
Martin J. P. Hennig*, Lübeck, Germany,
Soum D. Lokeshwar, Miami, FL, Shenelle N.
Wilson, Augusta, GA, Andre R. Jordan, Juan
Chipollini, Miami, FL, Marie C. Hupe, Mario
W. Kramer, Lübeck, Germany, Luis E. Lopez,
Augusta, GA, Axel S. Merseburger, Lübeck,
Germany, Vinata B. Lokeshwar, Augusta, GA
MP61-12 NEW TARGETS FOR IMMUNE
CHECKPOINT INHIBITION IN
Alexander Sankin*, Benjamin Gartrell, Kerwin
Cumberbatch, Hongying Huang, Mark
Schoenberg, Xingxing Zang, Bronx, NY
MP61-17 ASSOCIATIONS OF PROGRESSION IN
T1G3 BLADDER CANCERS AND
MUTATION HETEROGENEITY IN 20
CANCER-RELATED GENES
Karsten Salomo*, Doreen Huebner, Jana
Hahm, Joern Meinel, Vladimir Novotny, Manja
Boehme, Susanne Fuessel, Manfred P. Wirth,
Dresden, Germany
MP61-13 PROGRANULIN TARGETING IN
UROTHELIAL CANCER CELLS INHIBITS
MOTILITY, ANCHORAGE-INDEPENDENT
GROWTH, TUMOR FORMATION IN VIVO
AND SENSITIZES CELLS TO CISPLATIN
Simone Buraschi, Shi-Qiong Xu, Manuela
Stefanello, Philadelphia, PA, Igor Moskalev,
Vancouver, Canada, Alaide Morcavallo,
Marco Genua, Ryuta Tanimoto, Thomas Neill,
Stephen C Peiper, Leonard G Gomella,
Philadelphia, PA, Peter C Black, Vancouver,
Canada, Antonino Belfiore, Catanzaro, Italy,
Renato V Iozzo, Andrea Morrione*,
Philadelphia, PA
MP61-18 A NOVEL FORMULATION OF DOCETAXEL
WITH ACTIVITY IN MUSCLE INVASIVE
BLADDER CANCER XENOGRAFTS
Clement Mugabe, Richard Liggins, Igor
Moskalev, Michael Parr, Jayachandran
Kizhakkedathu, Don Brooks, Helen Burt, Alan
So*, Vancouver, Canada
MP61-19 CONCURRENT AUTOPHAGY INHIBITION
POTENTIATES THE ANTI-CANCER
EFFECTS OF EGFR INHIBITOR IN HUMAN
Minyong Kang*, Seongnam, Korea, Republic
of, Kyoung-Hwa Lee, Hye Sun Lee, Chang
Wook Jeong, Cheol Kwak, Hyeon Hoe Kim,
Ja Hyeon Ku, Seoul, Korea, Republic of
MP61-14 THE IMPACT OF NEOADJUVANT
CHEMOTHERAPY ON THE TIMING AND
SITE OF RECURRENCE FOLLOWING
RADICAL CYSTECTOMY
Harras Zaid*, Igor Frank, William Parker, R.
Houston Thompson, Matthew Tollefson,
Prabin Thapa, John Cheville, Stephen
Boorjian, Rochester, MN
MP61-15
MP61-20 PRIMARY APPLICATION STUDY IN EARLY
DIAGNOSIS OF BLADDER CANCER BY
CELL-PERMEABLE PEPTIDES R11
Jinhai Fan*, Chen Ding, Yiqing Du, Kaijie Wu,
Xi’an, China, People’s Republic of
CLOSTRIDIUM PERFRINGES
ENTEROTOXIN AS A POTENTIAL
THERAPEUTIC FOR INTRAVESICAL
TREATMENT OF BLADDER CANCER
Victor Romanov*, Wayne Waltzer, Terry
Whyard, Olga Povcher, April Szafran,
Theodore Gabig, Stony Brook, NY
CREDITTM
MP61-16 DETERMINATION OF IMMUNE
POLARIZATION (TH1 VS TH2) IN TUMOUR
TISSUE AS A PROGNOSTIC MARKER TO
BCG RESPONSE IN PATIENTS WITH HIGH
GRADE NON-MUSCLE INVASIVE
BLADDER CÁNCER.
Roberto Martinez*, Gustavo Tapia, Mario
Alves, Carlos Gonzalez, Elisabet Garcia,
Elisabet Gomez, Luis Ibarz, Julia Blanco,
Bonaventura Clotet, Cecilia Cabrera,
Badalona, Spain
Monday, May 9, 2016
8:00 am - 10:00 am
PROSTATE CANCER: BASIC RESEARCH & PATHOPHYSIOLOGY I
Moderator: Ralph Buttyan
ABSTRACT
NUMBER TITLE
MP62-01 TARGETING THE DNA BINDING DOMAIN
OF THE ANDROGEN RECEPTOR:
EFFICACY OF PROSTATE CANCER
COMPOUND WITH NOVEL MECHANISM
OF ACTION
Hendrik Borgmann*, Kush Dalal, Eliana
Beraldi, Artem Cherkasov, Paul Rennie,
Martin Gleave, Vancouver, Canada
ABSTRACT
NUMBER TITLE
MP62-02 ERG ONCOGENE SPECIFIC INHIBITORS
FOR PROSTATE CANCER
Ahmed Mohamed*, Rockville, MD,
Gauthaman Sukumar, Bethesda, MD, Charles
Xavier, Shilpa Katta, Lakshmi Ravindranath,
Muhammad Jamal, Taduru Sreenath, Gyorgy
Petrovics, Albert Dobi, Rockville, MD, Meera
Srivastava, Clifton Dalgard, Bethesda, MD,
Shiv Srivastava, Rockville, MD
216
MP62-03 NOVEL SELECTIVE LYSINE-SPECIFIC
DEMETHYLASE 1 INHIBITORS AND
AUTOPHAGY INHIBITORS EFFECTIVELY
IMPAIR CASTRATION-RESISTANT
PROSTATE CANCER GROWTH
Toshiki Etani*, Komono, Japan, Taku Naiki,
Nagoya, Japan, Takayoshi Suzuki, Kyoto,
Japan, Takashi Nagai, Keitaro Iida, Ryosuke
Ando, Noriyasu Kawai, Keiichi Tozawa,
Nagoya, Japan, Tohru Mogami, Komono,
Japan, Kenjiro Kohri, Takahiro Yasui,
Nagoya, Japan
MP62-11 CHARACTERIZATION OF PROSTATE
CANCER IN A FUNCTIONAL EUNUCH
Michael Fiandalo*, John Stocking, Elena Pop,
John Wilton, Gissou Azabdaftari, James
Mohler, Buffalo, NY
MP62-12 ORTHOTOPIC XENOGRAFTS USING
LUCAP136 SPHEROID CULTURES
PROVIDE A VERSATILE PRECLINICAL
MODEL OF PROSTATE CANCER
Matthias Saar*, Johannes Linxweiler,
Homburg/Saar, Germany, Maija Valta, Turku,
Finland, Christina Körbel, Andreas Müller,
Kerstin Junker, Michael Stöckle, Michael D.
Menger, Homburg/Saar, Germany, Donna M
Peehl, Stanford, CA
MP62-04 MOLECULAR MECHANISM MEDIATING
CYTOTOXIC ACTIVITY OF CABAZITAXEL
IN DOCETAXEL-RESISTANT HUMAN
PROSTATE CANCER CELLS
Akira Miyazaki*, Kobe, Japan, Hideaki
Miyake, Hamamatsu, Japan, Masato
Fujisawa, Kobe, Japan
DRUG, DISEASE, GENE INTERACTION:
SIMVASTATIN, PROSTATE CANCER AND
THE MITOCHONDRIAL GENOME.
Rebecca Arnold*, Qian Sun, John Petros,
Atlanta, GA
MP62-14 ACTIVATION OF ABERRANT ANDROGEN
RECEPTOR SIGNALING IN CARCINOMA
ASSOCIATED FIBROBLASTS INDUCES
PROSTATE CANCER PROGRESSION
Omar E Franco*, Rodrigo Javier, Susan E
Crawford, Evanston, IL, Gustavo E Ayala,
Houston, TX, Simon W Hayward, Evanston,
IL
MP62-06 COMBINED AKT AND MEK PATHWAY
BLOCKADE IN PRE-CLINICAL MODELS OF
ENZALUTAMIDE-RESISTANT PROSTATE
CANCER
Paul Toren*, Québec, Canada, Soojin Kim,
Amina Zoubeidi, Vancouver, Canada
MP62-15
MP62-07 NEOADJUVANT IMMUNOMODULATION
COMBINED WITH VASCULAR TARGETED
THERAPY PREVENTS METASTASES AND
IMPROVES SURVIVAL IN RATS WITH
LOCALLY ADVANCED PROSTATE
CANCER.
Uri Lindner*, Dina Preise, Rehovot, Israel,
Natasha Kudinova, Ness Ziona, Israel,
Arkady Agarounov, Yoram Salomon,
Rehovot, Israel, Jonathan A. Coleman, New
York, NY, Dan Leibovici, Avigdor Scherz,
Rehovot, Israel
MP62-16 THE EXPLORATION OF THE ORDER IN
THE HETEROGENEITY OF PROSTATE
CANCER-ASSOCIATED STROMA
ENVIRONMENT.
Manabu Kato*, Tsu, Japan, Takeshi Sasaki,
Evanston, Il, Kenichirou Ishii, Manabu Miki,
Kohei Nishikawa, Kiminobu Arima, Taizo
Shiraishi, Tsu, Japan, Neil Bhowmick, L.A.,
Ca, Yoshiki Sugimura, Tsu, Japan
MP62-08 THE CATALYTIC SITE COMMON TO FOUR
3〈-OXIDOREDUCTASES CONTRIBUTES
TO INTRACRINE SYNTHESIS OF DHT
Michael Fiandalo*, John Wilton, John
Stocking, Krystin Mongiardo, Elena Pop, Yun
Li, Kris Attwood, Buffalo, NY, Elisabeth
Wilson, Chapel Hill, NC, James Mohler,
Buffalo, NY
MP62-17 A NEW INSIGHT OF CELL-CELL
INTERACTIONS IN TUMOR STROMA OF
PROSTATE CANCER
Kenichiro Ishii*, Takeshi Sasaki, Manabu
Miki, Manabu Kato, Hideki Kanda, Kiminobu
Arima, Taizo Shiraishi, Yoshiki Sugimura,
Tsu, Japan
MP62-09 CLASS I HDAC INHIBITION AND P53
ACTIVATION UPREGULATES MASPIN IN
HUMAN PROSTATE CANCER
Eswar Shankar*, Rajnee Kanwal, Mario
Candamo, Albert Lee, Mitali Pandey, Vijay
Thakur, Pingfu Fu, Gregory MacLennan,
Sanjay Gupta, Cleveland, OH
MP62-18 CONVERSION OF ADENOCARCINOMA TO
SMALL CELL CARCINOMA-LIKE BY
REPROGRAMMING
Gisely Borges*, Eneida Vencio, Sue-Ing
Quek, Adeline Chen, Seattle, WA, Diego
Salvanha, Ricardo Vencio, Sao Paulo, Brazil,
Holly Nguyen, Robert Vessella, Christopher
Cavanaugh, Carol Ware, Pamela Troisch,
Alvin Liu, Seattle, WA
MP62-10 TMPRSS2-ERG GENE FUSION IS AN
UNCOMMON SOMATIC ALTERATION IN
HYPOGONADAL MEN WITH PROSTATE
CANCER
Bobby Najari*, Daniel Lee, Jonathan Shoag,
Kyung Park, Bing He, Juan Miguel Mosquera,
Mark Rubin, Peter Schlegel, Christopher
*Presenting author
FIBROBLASTS PROLONG SERUM
PROSTATE-SPECIFIC ANTIGEN DECLINE
AFTER ANDROGEN DEPRIVATION
THERAPY IN PROSTATE CANCER
Takeshi Sasaki*, Kenichiro Ishii, Manabu
Miki, Hideki Kanda, Kiminobu Arima, Taizo
Shiraishi, Yoshiki Sugimura, Tsu, Mie, Japan
217
MONDAY
MP62-05
MP62-13 NOVEL IN VIVO MODEL FOR
COMBINATORIAL FLUORESCENCE
LABELING IN MOUSE PROSTATE
Xiaolan Fang, Michael B. Rothberg*, Kenneth
Gyabaah, Bita Nick Kholgh, J. Marc Cline,
K.C. Balaji, Winston-Salem, NC
MP62-19 AKR1C3 OVEREXPRESSION IN
PROSTATE CANCER PROMOTES
EPITHELIAL-MESENCHYMAL TRANSITION
AND METASTASIS VIA ACTIVATION OF
MAPK/ERK SIGNALING AND
UPREGULATION OF ZEB1
Bin Wang, Kaijie Wu*, Jun Huang, Xi’an,
China, People’s Republic of, Jer-Tsong
Hsieh, Dallas, TX, Dalin He, Xi’an, China,
MP62-20 CROSSTALK BETWEEN EPITHELIALMESENCHYMAL TRANSITION AND
CASTRATION RESISTANCE IN PROSTATE
CANCER
Masaki Shiota*, Momoe Itsumi, Ario
Takeuchi, Kenjiro Imada, Akira Yokomizo,
Fukuoka, Japan, Hidetoshi Kuruma, Tokyo,
Japan, Junichi Inokuchi, Katsunori Tatsugami,
Takeshi Uchiumi, Yoshinao Oda, Seiji Naito,
Masatoshi Eto, Fukuoka, Japan
CREDITTM
Monday, May 9, 2016
8:00 am - 10:00 am
BLADDER CANCER: INVASIVE V
Moderators: Joseph Chin, Arturo Mendoza-Valdes and John Gore
ABSTRACT
NUMBER TITLE
MP63-01 A PROPOSAL FOR A NOVEL PERIOPERATIVE MORTALITY RISK
ASSESSMENT TOOL IN CONTEMPORARY
PATIENTS TREATED WITH RADICAL
CYSTECTOMY
Paolo Dell’Oglio, Zhe Tian*, Sami-Ramzi
Leyh-Bannurah, Vincent Trudeau, Montreal,
Canada, Alessandro Larcher, Umberto
Montorsi, Milan, Italy, Pierre Karakiewicz,
Montreal, Canada
ABSTRACT
NUMBER TITLE
MP63-06 RACIAL DISPARITIES IN QUALITY
METRICS OF MUSCLE INVASIVE
BLADDER CANCER
Christian Meyer*, Stephanie Mullane,
Joaquim Bellmunt, Nawar Hanna, Boston,
MA, Mani Menon, Jesse Sammon, Detroit,
MI, Thomas Seisen, Jeffrey Leow, Mark
Preston, Adam Kibel, Maxine Sun, Quoc-Dien
Trinh, Boston, MA
MP63-07 THE ASSOCIATION BETWEEN
PREOPERATIVE LEUKOCYTOSIS AND
POSTOPERATIVE OUTCOMES
FOLLOWING CYSTECTOMY FOR
BLADDER CANCER
Matthew Macey*, Jason Lomboy, Troy
Sukhu, Allison Deal, Eric Wallen, Michael
Woods, Raj Pruthi, Matthew Nielsen, Angela
Smith, Chapel Hill, NC
MP63-02 A PHASE I/II TRIAL OF PREHABILITATION
IN PATIENTS UNDERGOING
Jeffrey Montgomery*, Todd Morgan, Steven
Thelen-Perry, Chang He, Cheryl Lee,
Christine Parker, Heidi IglayReger, Khaled
Hafez, Brent Hollenbeck, Alon Weizer, Ann
Arbor, MI
MP63-08 VALIDATION OF THE CAPRINI RISK
ASSESSMENT MODEL IN RADICAL
CYSTECTOMY PATIENTS
Ross Krasnow*, Francisco GelpiHammerschmidt, Mark Preston, Boston, MA,
Benjamin Chung, Palo Alto, CA, Adam Kibel,
Steven Chang, Boston, MA
MP63-03 THE OPTIMAL ANTIBIOTIC PROPHYLAXIS
FOR RADICAL CYSTECTOMY: A
POPULATION-BASED ANALYSIS
Ross Krasnow*, Sophia Koo, David Kubiak,
Francisco Gelpi-Hammerschmidt, Mark
Preston, Boston, MA, Benjamin Chung, Palo
Alto, CA, Adam Kibel, Steven Chang, Boston,
MA
MP63-09 NUTRITIONAL EDUCATION AND
SUPPLEMENTATION MAY REDUCE
HOSPITAL STAY AND WEIGHT LOSS
AFTER CYSTECTOMY
Michael Lam*, Amanda Bryant, Brian Junio,
Theresa Koppie, Christopher Amling,
Portland, OR
MP63-04 ALLOGENEIC BLOOD TRANSFUSION
INCREASES INFECTIOUS
COMPLICATIONS BUT NOT MORTALITY
AFTER RADICAL CYSTECTOMY
Jen-Jane Liu*, Ann Martinez Acevedo,
Christopher Amling, Portland, OR
MP63-05
MP63-10 PREOPERATIVE DETERMINANT AND
PREDICTION OF EARLY POSTOPERATIVE
RENAL FUNCTION FOLLOWING RADICAL
CYSTECTOMY AND INTESTINAL
URINARY DIVERSION
Tatsuo Gondo*, Jun Nakashima, Yoshio
Ohno, Yosuke Hirasawa, Takeshi Hashimoto,
Yoshihiro Nakagami, Masaaki Tachibana,
Tokyo, Japan
LONGER DURATION BLOOD STORAGE IS
LINKED TO INFECTION AND MORBIDITY
IN RADICAL CYSTECTOMY PATIENTS
WHO RECEIVE BLOOD TRANSFUSION
Heather J. Chalfin*, Meera R. Chappidi,
Daniel J. Johnson, Nilay Gandhi, Jen-Jane
Liu, Steven M. Frank, Trinity J. Bivalacqua,
Baltimore, MD
218
MP63-11 PREOPERATIVE PLATELET TO
LYMPHOCYTE RATIO AS A PREDICTOR OF
SURVIVAL AFTER RADICAL CYSTECTOMY
DUE TO BLADDER CANCER
Giovanni La Croce*, Marco Moschini, Paolo
Capogrosso, Eugenio Ventimiglia, Stefano
Luzzago, Milan, Italy, Shahrokh Francois
Shariat, Vienna, Austria, Rafael Sanchez Salas,
Xavier Chatelineau, Paris, France, Andrea
Salonia, Alberto Briganti, Francesco Montorsi,
Renzo Colombo, Andrea Gallina, Milan, Italy
MP63-16 UNPLANNED REOPERATION FOLLOWING
OPEN AND MINIMALLY INVASIVE
RADICAL CYSTECTOMY. ANALYSIS OF
THE NATIONAL SURGICAL QUALITY
IMPROVEMENT PROGRAM (NSQIP)
DATABASE
Ahmad Shabsigh*, Columbus, OH
MP63-17 WEEKEND DISCHARGE AFTER RADICAL
CYSTECTOMY AND THE RISK OF
READMISSION
James Tracey*, Sapan Ambani, Takahiro
Osawa, Ted Skolarus, Chang He, Tudor
Borza, Alon Weizer, Jeffrey Montgomery,
Khaled Hafez, Brent Hollenbeck, Cheryl Lee,
Todd Morgan, Ann Arbor, MI
MP63-12 DOES ENHANCED RECOVERY IMPACT
CYSTECTOMY?
Erika Wood*, Neema Navai, Debashish
Sundi, Wei Qiao, Ashish Kamat, Colin
Dinney, Jay Shah, Houston, TX
MP63-13 ENHANCED RECOVERY AFTER SURGERY
AND RADICAL CYSTECTOMY: BENEFITS
OF A MULTIDISCIPLINARY APPROACH
Gregory Diorio*, Andrew Leone, Sephalie
Patel, Rosemarie Garcia Getting, Jae Lee, Lu
Chen, Scott Gilbert, Philippe Spiess, Wade
Sexton, Michael Poch, Tampa, FL
MP63-14 THE IMPACT OF A MINIMUM
CYSTECTOMY VOLUME POLICY ON THE
CENTRALIZATION AND QUALITY OF
BLADDER CANCER CARE IN THE
NETHERLANDS
Harman Maxim Bruins*, Nijmegen,
Netherlands, Elies Fransen-van de Putte,
Amsterdam, Netherlands, Rob Verhoeven,
Utrecht, Netherlands, Inge van Oort,
Nijmegen, Netherlands, Simon Horenblas,
Amsterdam, Netherlands
MP63-15
MP63-19 THE CHANGING FACE OF
READMISSIONS: ASSESSING THE
IMPACT OF A CYSTECTOMY CARE
PATHWAY
John A. Brockman*, Joel Vetter, Seth A.
Strope, Saint Louis, MO
MP63-20 30ⴚDAY AND 90ⴚDAY MORTALITY
RATES IN OCTOGENARIANS
Ahmed Saeed Goolam*, Alfredo Harb De la
Rosa, Miami, FL, Hariharan Palayapalayam
Ganapathi, Celebration, FL, Chad Ritch,
Murugesan Manoharan, Miami, FL
VALIDATION OF PERI-OPERATIVE BLOOD
TRANSFUSION AS A SURGICAL QUALITY
INDICATOR OF CYSTECTOMY: A
D. Robert Siemens*, Melanie Jaeger, Xuejiao
Wei, Francisco Vera-Badillo, Christopher
Booth, Kingston, Canada
CREDITTM
Monday, May 9, 2016
8:00 am - 10:00 am
KIDNEY CANCER: LOCALIZED: SURGICAL THERAPY III
Moderators: Jeffrey Cadeddu and Gyung Sung
ABSTRACT
NUMBER TITLE
MP64-01 RETROPERITONEAL LYMPH NODE
DISSECTION IS NOT ASSOCIATED WITH
SURVIVAL OUTCOMES AMONG PATIENTS
UNDERGOING RADICAL NEPHRECTOMY
FOR NON-METASTATIC RENAL CELL
CARCINOMA: A PROPENSITY-SCORE
BASED ANALYSIS
*Presenting author
ABSTRACT
NUMBER TITLE
MP64-02 COMPARISON OF ONCOLOGIC
OUTCOMES AFTER RADICAL OR PARTIAL
NEPHRECTOMY FOR CT2 RENAL CELLS
CARCINOMA
Ettore Di Trapani*, Alessandro Larcher, Paolo
Dell’Oglio, Federico Dehò, Milan, Italy,
Philippe Sebe, Paris, France, Rayan Matloob,
Alessandro Nini, Cristina Carenzi, Umberto
Capitanio, Francesco Montorsi, milan, Italy,
Hein Van Poppel, Leuven, Belgium, Patrizio
Rigatti, milan, Italy, Bertrand Guillonneau,
Paris, France, Roberto Bertini, Milan, Italy
219
MONDAY
MP63-18 COMPARISON OF READMISSION
PARAMETERS FOR CYSTECTOMY
VERSUS OTHER MAJOR ABDOMINAL
AND CHEST SURGERY
Tudor Borza*, Ann Arbor, MI, Bruce L
Jacobs, Pittsburgh, PA, Benjamin Y Li,
Chang He, Ann Arbor, MI, Jonathan E Helm,
Bloomington, IN, Mariel S Lavieri, Brent K
Hollenbeck, Ted A Skolarus, Ann Arbor, MI
MP64-11 EVALUATION OF SURGICAL
COMPLICATIONS IN A CONTEMPORARY
SERIES OF PARTIAL NEPHRECTOMY
PATIENTS
Harras Zaid*, R. Houston Thompson, William
Parker, Christine Lohse, John Cheville,
Stephen Boorjian, Bradley Leibovich,
Rochester, MN
MP64-03 FRAILTY IS AN INDEPENDENT
PREDICTOR OF MAJOR POST-OPERATIVE
COMPLICATION AFTER ROBOTIC
PARTIAL NEPHRECTOMY
A. Caputo, Ryan J. Nelson, Onder Kara,
Jihad H. Kaouk, Cleveland, OH
MP64-04 CRYOABLATION VERSUS PARTIAL
NEPHRECTOMY FOR CLINICAL T1B
TUMORS: A MATCHED GROUP ANALYSIS
Peter Caputo*, Homayoun Zargar, Daniel
Ramirez, Matthew Maurice, Jihad Kaouk,
Cleveland, OH
MP64-05
MP64-12 THE UTILITY OF CHEST X-RAYS FOR
PATHOLOGIC T1A RENAL CELL
CARCINOMA SURVEILLANCE
Noah Canvasser*, Kylee Stouder, Aaron Lay,
Jeffrey Gahan, Yair Lotan, Vitaly Margulis,
Ganesh Raj, Arthur Sagalowsky, Jeffrey
Cadeddu, Dallas, TX
SURGICAL SALVAGE OF THERMAL
ABLATION FAILURES FOR RENAL CELL
CARCINOMA
Juan Jiménez*, Zhiling Zhang, Juping Zhao,
Robert Abouassaly, Amr Fergany, Michael
Gong, Jihad Kaouk, Venkatesh
Krishnamurthi, Robert Stein, Andrew
Stephenson, Steven Campbell, Cleveland,
OH
MP64-13 IMPACT OF SURGICAL VOLUME ON
PERIOPERATIVE OUTCOMES AFTER
NEPHRECTOMY WITH TUMOR
THROMBECTOMY
Estefania Linares Espinos*, Juan Ignacio
Martinez-Salamanca, Joaquı́n Carballido,
Javier González, Madrid, Spain, Umberto
Capitanio, Milan, Italy, Venancio Chantada,
Coruña, Spain, Thomas Chromecki, Graz,
Germany, Gaetano Ciancio, Miami, FL,
Siamak Daneshmand, Los Angeles, CA,
Christopher P. Evans, Sacramento, CA,
Paolo Gontero, Turin, Italy, Axel Haferkamp,
Frankfurt, Germany, Markus Hohenfellner,
Heidelberg, Germany, William C. Huang, New
York, NY, Theresa M. Koppie, Portland, OR,
Adam Lorentz, Viraj A. Master, Atlanta, GA,
James M. McKiernan, New York, NY,
Francesco Montorsi, Milan, Italy, Padraic
O’Malley, New York, NY, Sascha Pahernik,
Heidelberg, Germany, Juan Palou, Barcelona,
Spain, José Luis Pontones Moreno, Valencia,
Spain, Raj S. Pruthi, Chappel Hill, NC, Oscar
Rodriguez Faba, Barcelona, Spain, Paul
Russo, Douglas S. Scherr, New York, NY,
Martin Spahn, Würzburg, Germany, Carlo
Terrone, Novara, Italy, Derya Tilki,
Sacramento, CA, Dario Vázquez-Martul,
Coruña, Spain, Cesar Vera Donoso,
Valencia, Spain, Daniel Vergho, Würzburg,
Germany, Eric M. Wallen, Chappel Hill, NC,
Zigeuner Richard, Graz, Germany, John A.
Libertino, Burlington, MA
MP64-06 UPPER TRACT UROTHELIAL CARCINOMA
LOCATED IN THE RENAL PELVIS HAS
WORSE CLINICAL OUTCOMES
COMPARED TO THE URETER: A
POPULATION-BASED ANALYSIS
Zachary Klaassen*, Benjamin T. Harper, Rita
P. Jen, Grace Yaguchi, John M. DiBianco,
Augusta, GA, Kayla Dmytruk, Basseterre,
Saint Kitts and Nevis, Shenelle N. Wilson,
Martha K. Terris, Rabii Madi, Augusta, GA
MP64-07 DIABETES MELLITUS AS AN
INDEPENDENT PREDICTOR OF SURVIVAL
OF PATIENTS SURGICALLY TREATED
FOR RENAL CELL CARCINOMA: A
PROPENSITY SCORE MATCHING STUDY
Hakmin Lee, Seongnam, Korea, Republic of,
Cheol Kwak, Hyeon Hoe Kim, Seoul, Korea,
Republic of, Seok-Soo Byun, Sang Eun Lee,
Sung Kyu Hong*, Seongnam, Korea,
Republic of
MP64-08 CONTEMPORARY UTILIZATION OF THE
SSIGN SCORE
William Parker*, Igor Frank, Harras Zaid,
Christine Lohse, John Cheville, Stephen
Boorjian, Bradley Leibovich, R. Houston
Thompson, Rochester, MN
MP64-14 MAYO ADHESIVE PROBABILITY (MAP)
SCORE IS ASSOCIATED WITH LOCALIZED
RENAL CELL CARCINOMA PROGRESSION
FREE SURVIVAL
David Thiel, Andrew Davidiuk*, Camille
Meschia, Daniel Serie, Kaitlynn Custer,
Steven Petrou, Alex Parker, Jacksonville, FL
MP64-09 MULTIPLE TUMOR EXCISIONS INCREASE
COMPLICATIONS AFTER PARTIAL
NEPHRECTOMY
A. Caputo, Onder Kara, Jihad H. Kaouk,
Cleveland, OH
MP64-15
MP64-10 PERIOPERATIVE ASPIRIN DOES NOT
HAVE SIGNIFICANT IMPACT ON
BLEEDING COMPLICATIONS FOLLOWING
Vignesh T. Packiam*, Charles U. Nottingham,
Andrew J. Cohen, Shane M. Pearce, Arieh L.
Shalhav, Scott E. Eggener, Chicago, IL
220
A CRITICAL ANALYSIS OF
POSTOPERATIVE MORBIDITY IN
MORBIDLY OBESE PATIENTS
FOLLOWING RENAL CANCER SURGERY
Matthew D. Grimes*, Michael L. Blute, Jr.,
Michael A. Mann, Tracy M. Downs, Fangfang
Shi, David F. Jarrard, Sara L. Best, Kyle A.
Richards, Stephen Y. Nakada, E. Jason Abel,
Madison, WI
MP64-16 COMPARISON OF 1,800 ROBOTIC AND
OPEN PARTIAL NEPHRECTOMIES FOR
RENAL TUMORS
Benoit Peyronnet*, Rennes, France,
Christophe Vaessen, Paris, France, Yohann
Grassano, Bordeaux, France, Thibaut Benoit,
Toulouse, France, Julie Carrouget, Angers,
France, Benjamin Pradère, Rennes, France,
Anthony Giwerc, Rouen, France, JeanBaptiste Beauval, Toulouse, France, Thomas
Seisen, Paris, France, Francois-Xavier
Nouhaud, Rouen, France, Pierre Bigot,
Angers, France, Nicolas Doumerc, Toulouse,
France, Jean-Christophe Bernhard,
Bordeaux, France, Arnaud Mejean, Paris,
France, Jean-Jacques Patard, KremlinBicetre, France, Morgan Rouprêt, Paris,
France, Karim Bensalah, Rennes, France
MP64-18 CHEMOPREVENTION IN KIDNEY
CANCER: SURVIVAL OUTCOMES IN
DIABETICS
Madhur Nayan*, David Juurlink, Peter Austin,
Erin Macdonald, Antonio Finelli, Girish
Kulkarni, Robert Hamilton, Toronto, Canada
MP64-19 FACTORS PREDICTING BLOOD LOSS AND
POSITIVE MARGINS AT TIME OF PARTIAL
NEPHRECTOMY: ANALYSIS OF A
CONTEMPORARY COHORT
Harras Zaid*, Stephen Boorjian, William
Parker, Christine Lohse, John Cheville,
Bradley Leibovich, R. Houston Thompson,
Rochester, MN
MP64-20 RETROPERITONEOSCOPIC RADICAL
NEPHRECTOMY WITH THE PATIENT IN A
COMPLETELY SUPINE POSITION
Han-Yu Weng*, Chien-Hui Ou, Wen-Horng
Yang, Tainan, Taiwan
MP64-17 RISK FACTORS FOR ASYMPTOMATIC
RENAL ARTERY PSEUDOANEURYSM
AFTER PARTIAL NEPHRECTOMY
DETECTED BY ENHANCED CT IN THE
EARLY POSTOPERATIVE PERIOD
Toshio Takagi*, Tsunenori Kondo, Kenji
Omae, Junpei Iizuka, Hirohito Kobayashi,
Yasunobu Hashimoto, Kazunari Tanabe,
Tokyo, Japan
MONDAY
CREDITTM
Monday, May 9, 2016
8:00 am - 10:00 am
Podium Session 34
SEXUAL FUNCTION/DYSFUNCTION: PENIS/TESTIS/URETHRA: BENIGN DISEASE & MALIGNANT DISEASE I
Moderators: Jeffrey Holzbeierlein and Hadley Wood
TIME
8:00
8:10
8:20
ABSTRACT
NUMBER TITLE
PD34-01 SURVIVAL OUTCOMES OF ADOLESCENT
PATIENTS WITH NONⴚSEMINOMA
TESTICULAR GERMⴚCELL TUMORS: A
POPULATIONⴚBASED STUDY
Arya Amini, Timothy Waxweiler, Paul Maroni,
Elizabeth Kessler, Carrye Cost, Brian Greffe,
Timothy Garrington, Arthur Liu, Aurora, CO,
Nicholas Cost*, Denver, CO
PD34-02
PD34-03
*Presenting author
ABSTRACT
TIME NUMBER TITLE
8:30 PD34-04 ACTIONABLE TARGETS IN PATIENTS
WITH CISPLATIN-RESISTANT ADVANCED
GERM CELL TUMORS
Aditya Bagrodia*, Samuel Kaffenberger,
Byron Lee, William Lee, Eugene Cha, John
Sfakianos, Paul Gao, Emily Zabor, Irina
Ostrovnaya, Jana Eng, Michael Berger, Dean
Bajorin, Nikolaus Schultz, Joel Sheinfeld,
George Bosl, Hikmat Al-Ahmadie, David Solit,
Darren Feldman, New York, NY
IS PERCENT SEMINOMA ASSOCIATED
WITH INTRAOPERATIVE MORBIDITY
DURING POST-CHEMOTHERAPY RPLND?
Pranav Sharma*, Kamran Zargar-Shoshtari,
Michael Poch, Julio Pow-Sang, Wade Sexton,
Philippe Spiess, Scott Gilbert, Tampa, FL
THE INCIDENCE AND TREATMENT OF
HYPOGONADISM IN PATIENTS WITH
TESTICULAR CANCER
Jamal Nabhani*, Diana Jin, Siamak
221
8:40
PD34-05
THE EFFICACY OF DYNAMIC SENTINEL
NODE BIOPSY IN PENILE CANCER:
OUTCOMES FROM 5 YEARS EXPERIENCE
AT A SINGLE UK CENTRE
Michael Wanis*, Ismet Boral, Duncan
Summerton, Jonathan Goddard, Thomas
Swallow, John Dormer, Leicester, United
Kingdom
8:50
PD34-06
SALVAGE CHEMOTHERAPY WITH
PACLITAXEL, IFOSFAMIDE AND
NEDAPLATIN (TIN) FOR REFRACTORY OR
RELAPSED GERM CELL TUMORS IN
PATIENTS WITH IMPAIRED RENAL
FUNCTION
Takumi Shiraishi*, Terukazu Nakamura,
Masakatsu Oishi, Takashi Ueda, Hiroyuki
Nakanishi, Yoshio Naya, Fumiya Hongo,
Kazumi Kamoi, Koji Okihara, Osamu
Ukimura, Kyoto, Japan
9:00
PD34-07
DOES TERATOMA METASTASIZE?
PRESENCE OF TERATOMA IN THE
PRIMARY RETROPERITONEAL LYMPH
NODE DISSECTION SETTING
Joseph M. Jacob*, Clint Cary, Lawrence H.
Einhorn, Richard S. Foster, Indianapolis, IN
9:10
PD34-08
IMMUNE PROFILING OF TESTICULAR
GERM CELL TUMORS REVEALS HIGH
EXPRESSION OF PD-L1 AND PD-1
Diana Taheri, Maria A Mendoza Rodriguez,
Alcides Chaux, Charles Drake, Trinity J
Bivalacqua, Alan Meeker, Janis Taube, Nilda
Gonzalez-Roibon, William Nelson, Sirinivasan
Yegnasubramanian, George Netto, Michael
Haffner*, Baltimore, MD
9:20
9:30
PD34-09
PD34-10
9:40
PD34-11
CLINICOPATHOLOGIC FEATURES AND
PROGNOSTIC FACTORS IN PATIENTS
WITH PENILE CANCER WHO UNDERWENT
INGUINAL LYMPHADENECTOMY WITH
HISTOLOGICALLY NEGATIVE LYMPH
NODES
Giuliano Aita*, Teresina, Brazil, Stênio Zequi,
Gustavo Guimarães, Walter da Costa,
Isabela Cunha, Fernando Soares, São Paulo,
Brazil
9:50
PD34-12
IMPORTANCE OF WIDE RE-RESECTION IN
ADULT SPERMATIC CORD SARCOMAS:
REPORT ON ONCOLOGIC OUTCOMES AT
A SINGLE INSTITUTION
Katie Murray*, Emily Vertosick, Massimiliano
Spaliviero, Joseph Mashni, Daniel Sjoberg,
Harry Herr, Paul Russo, Jonathan Coleman,
New York, NY
SURGICAL AND ONCOLOGICAL
OUTOCMES AFTER VIDEO ENDOSCOPIC
INGUINAL LYMPHADENECTOMY (VEIL):
SINGLE INSTITUTE SERIES
Yuvaraja Thyavihally*, Nikhil Dharmadhikari,
Abhinav Pednekar, Harshvardhan Rao, Nikhil
Gulavani, Mrunal Parab, Tirathram Kaushik,
Amit Patil, Kalyan Chakradhar, Santosh
Waigaonkar, Mumbai, India
CREDITTM
PROGNOSTIC AND PATHOLOGIC
FACTORS DETERMINING OUTCOMES IN
PT2/PT3 PENILE CARCINOMAS: TIME FOR
A REVISED STAGING SYSTEM
Priya Rao*, Houston, TX, Jasreman Dhillon,
Tampa, FL, Benjamin Naovarat, Vipulkumar
Dadhania, Xuemei Wang, Hsiang-Chun
Chen, Houston, TX, Philippe Spiess, Tampa,
FL, Curtis Pettaway, Pheroze Tamboli,
Houston, TX
Monday, May 9, 2016
8:00 am - 10:00 am
Podium Session 35
STEM CELL RESEARCH
Moderators: Anthony Atala and Adonis Hijaz
TIME
8:00
8:10
ABSTRACT
NUMBER TITLE
PD35-01 RENAL ARTERIAL INFUSION OF ADIPOSE
TISSUE-DERIVED STROMAL VASCULAR
FRACTION PROTECTS THE RENAL
FUNCTION AGAINST ACUTE KIDNEY
INJURY INDUCED BY ISCHEMIAREPERFUSION INJURY
Myoung Jin Jang*, Bo Hyun Kim, Chunwoo
Lee, Dalsan You, In Gab Jeong, Chung-Soo
Kim, Seoul, Korea, Republic of
PD35-02
ABSTRACT
TIME NUMBER TITLE
8:20 PD35-03 HUMAN ADIPOSE-DERIVED STEM CELLS
SEEDED ON MULTILAYERED POLY (LLACTIDE-CO-⌴-CAPROLACTONE)
FACILITATE BLADDER COMPLIANCE AND
CONTRACTILITY IN A MUCOSA
PRESERVING PARTIAL CYSTECTOMY
RAT MODEL
Ohseong Kwon*, Jin Bong Choi, Yong Hyun
Park, Woong Jin Bae, Hyuk Jin Cho, U-Syn
Ha, Sung Hoo Hong, Se Woong Kim, Ji Youl
Lee, Seoul, Korea, Republic of
ISOLATION OF NEPHRON PROGENITORS
CELLS EXPRESSING SIX2CITED1ⴙ FROM
HUMAN FETAL KIDNEYS AND AMNIOTIC
FLUID
Stefano Da Sacco*, Astgik Petrosyan,
Matthew Thornton, Brendan Grubbs, Roger
De Filippo, Laura Perin, Los Angeles, CA
8:30
222
PD35-04
TREATMENT OF RAT FISTURA MODEL BY
SCAFFOLD-FREE PATCH (ZUBUTON)
FROM MULTICELLULAR SPHEROIDS
MADE OF ADIPOSED DRIVED CELL WITH
MANNOSE USING A NEWLY DEVELOPED
SCAFFORD FREE BIO-3D PRINTER
Tokunori Yamamoto*, Yasuhito Funahashi,
Yoshihisa Mastukawa, hideki mizuno,
nagoya, Japan, Koichi Nakayama, saga,
Japan, Momokazu Gotoh, nagoya, Japan
PD35-05
HUMAN URINE-DERIVED STEM CELLS OR
THEIR SECRETOME ALONE FACILITATE
FUNCTIONAL RECOVERY IN A RAT
MODEL OF STRESS URINARY
INCONTINENCE
Christine Tran*, Abhi Tangada, Cleveland,
OH, Hualin Yi, WInston-Salem, NC, Brian
Balog, Cleveland, OH, Yuanyuan Zhang,
Winston-Salem, NC, Margot Damaser,
Cleveland, OH
8:50
PD35-06
RECONSTRUCTION OF EXPERIMENTAL
URETHRAL DAMAGE IN RAT USING
HUMAN SKELETAL MUSCLE-DERIVED
STEM CELLS
Nobuyuki Nakajima*, Tetsuro Tamaki, Maki
Masuda, Masahiro Nitta, Akio Hoshi, Toshiro
Terachi, Isehara, Japan
9:00
PD35-07
USE OF STROMAL VASCULAR FRACTION
OF ADIPOSE TISSUE IN PATIENTS WITH
VASCULOGENIC ERECTILE
DYSFUNCTION: EVALUATION OF
CLINICAL EFFECTIVENESS AND SAFETY
(PRELIMINARY RESULTS: PHASES 1-2, 6
MONTHS OF FOLLOW-UP) NCT02472431
Michael Chalyy, Maya Epifanova, Alexander
Krasnov*, Moscow, Russian Federation
9:10
PD35-08
9:20
PD35-09
DIFFERENTIAL ACTIONS OF ER␣ AND
ER␤ VIA NON-GENOMIC SIGNALING IN
HUMAN PROSTATE STEM-PROGENITOR
CELLS
Shyama Majumdar, Neha Malhotra*, Chicago,
IL, Susan Kasper, Cincinnati, OH, Lishi Xie,
Timothy Gauntner, Wen-yang Hu, Gail Prins,
Chicago, IL
9:30
PD35-10
IN-DEPTH PROTEOMICS ANALYSIS FOR
PROSTATE CANCER REVEALS
SIMILARITY BETWEEN TUMOR AND
SPERMATOGENESIS
Shangqian Wang*, Binbin Shao, Bo Zheng,
Dan Zhao, Chao Qin, Pengfei Shao, Zengjun
Wang, Xuejiang Guo, Changjun Yin, Jiahao
Sha, Nanjing, China, People’S Republic Of
9:40
PD35-11
CISPLATIN INDUCED TESTICULAR
TOXICITY IN RATS: ROLE OF
MESENCHYMAL STEM CELLS.
Iman Sherif, Azza Abdel-Aziz, Osama
Sarhan*, Mansoura, Egypt
9:50
PD35-12
KDM5A, A HISTONE H3K4
DEMETHYLASE, REGULATES
SPERMATOGENESIS VIA ITS ACTION ON
GERM CELL
Hidenori Nishio*, Kentaro Mizuno, Moritoki
Yoshinobu, Hideyuki Kamisawa, Akihiro
Nakane, Satoshi Kurokawa, Tetsuji
Maruyama, Yutaro Hayashi, Takahiro Yasui,
Nagoya, Japan
EFFECT OF A SINGLE INTRACAVERNOUS
INJECTION OF AUTOLOGOUS ADIPOSEDERIVED STEM CELLS ON ERECTILE
DYSFUNCTION FOLLOWING RADICAL
PROSTATECTOMY.
Martha Haahr*, Ditte Andersen, Charlotte
Harken, Navid Toyserkani, Jens Ahm
Sørensen, Per Damkier, Søren Sheikh, Lars
Lund, Odense, Denmark
CREDITTM
Monday, May 9, 2016
8:00 am - 10:00 am
Podium Session 36
URODYNAMICS/LOWER URINARY TRACT DYSFUNCTION/FEMALE PELVIC MEDICINE: FEMALE INCONTINENCE: THERAPY I
Moderators: M. Lynn Stothers and Sandip Vasavada
TIME
8:00
ABSTRACT
NUMBER TITLE
PD36-01 IMPROVED PATIENT-REPORTED
OUTCOMES (PROS) WITH MIRABEGRON
ADD-ON TREATMENT IN A RANDOMIZED,
DOUBLE-BLIND, PHASE 3B STUDY IN
INCONTINENT OVERACTIVE BLADDER
(OAB) PATIENTS WITH AN INADEQUATE
RESPONSE TO SOLIFENACIN
Scott MacDiarmid*, Greensboro, NC, Salman
Al-Shukri, Saint Petersburg, Russian
Federation, Jack Barkin, Toronto, Canada,
Aino Fianu-Jonasson, Huddinge Stockholm,
Sweden, Philippe Grise, Rouen, France,
Sender Herschorn, Toronto, Canada, Moses
Huang, Emad Siddiqui, Chertsey, United
Kingdom, Matthias Stölzel, Leiden,
Netherlands, Claire Hemsted, Chertsey,
United Kingdom, Marcus Drake, Bristol,
United Kingdom
*Presenting author
ABSTRACT
TIME NUMBER TITLE
8:10 PD36-02 MIRABEGRON ADD-ON TREATMENT TO
SOLIFENACIN IN INCONTINENT
OVERACTIVE BLADDER (OAB) PATIENTS:
A RESPONDER ANALYSIS OF A
RANDOMIZED, DOUBLE BLIND, PHASE 3B
STUDY
Scott MacDiarmid*, Greensboro, NC, Salman
Al-Shukri, Saint Petersburg, Russian
Federation, Jack Barkin, Toronto, Canada,
Aino Fianu-Jonasson, Huddinge Stockholm,
Sweden, Philippe Grise, Rouen, France,
Sender Herschorn, Toronto, Canada, Moses
Huang, Emad Siddiqui, Chertsey, United
Kingdom, Matthias Stölzel, Leiden,
Netherlands, Claire Hemsted, Chertsey,
United Kingdom, Marcus Drake, Bristol,
United Kingdom
223
MONDAY
8:40
8:20
PD36-03
URGE 1 STUDY - RANDOMIZED CLINICAL
TRIAL TO COMPARE SOLIFENACIN AND
BILATERAL MESH REPLACEMENT OF
THE UTEROSACRAL LIGAMENTS IN THE
TREATMENT OF URGENCY URINARY
INCONTINENCE IN WOMEN
Sebastian Ludwig*, Martin Stumm, Peter
Mallmann, Wolfram Jager, Cologne, Germany
8:30
PD36-04
PERCUTANEOUS NERVE STIMULATION
FOR OVERACTIVE BLADDER: COSTEFFECTIVENESS COMPARED TO MONO
AND DUAL PHARMACOTHERAPY
Julie Jenks*, Eskinder Solomon, Mahreen
Pakzad, Rizwan Hamid, Tamsin Greenwell,
Jeremy Ockrim, London, United Kingdom
8:40
8:50
9:00
PD36-05
PD36-06
PD36-07
RATE AND RISK FACTORS FOR SACRAL
NERVE STIMULATOR LEAD BREAKAGE
AT THE TIME OF LEAD REVISION OR
EXPLANTATION
Javier Pizarro-Berdichevsky*, Marisa M
Clifton, Elodi J Dielubanza, Bradley C Gill,
Henry T Okafor, Anna E Faris, Raymond R
Rackley, Courtenay K Moore, Sandip P
Vasavada, Howard B Goldman, Adrienne
Quirouet, Cleveland, OH
LOWER RISK OF LEAD REVISION BASED
ON “OPTIMAL”LEAD PLACEMENT
DURING STAGE 1 SACRAL
NEUROMODULATION
Javier Pizarro-Berdichevsky*, Adrienne
Quirouet, Marisa M Clifton, Bradley C Gill,
Elodi J Dielubanza, Henry T Okafor, Anna E
Faris, Courtenay K Moore, Raymond R
Rackley, Sandip P Vasavada, Howard B
Goldman, Cleveland, OH
9:10
PD36-08
HOW TO IMPROVE PUBOVAGINAL SLING
OUTCOMES: COMPARISON OF TWO
TECHNIQUES FOR SLING TENSIONING IN
177 PATIENTS
Michael Maccini*, Tamara Lhungay, Tyler
Doumaney, Stephen Blakely, Brian Flynn,
Aurora, CO
9:20
PD36-09
PREDICTORS OF VAGINAL MESH
EXPOSURE AFTER MIDURETHRAL SLING
PLACEMENT: A CASE-CONTROL STUDY
Brian Linder*, Sherif El-Nashar, Daniel
Carranza, Emanuel Trabuco, Rochester, MN
9:30
PD36-10
RISK FACTORS FOR URINARY TRACT
INFECTION FOLLOWING MIDURETHRAL
SLING SURGERY
Humberto R Vigil*, Ranjeeta Mallick, Luke T
Lavallee, Rodney H Breau, Duane R Hickling,
Ottawa, Canada
9:40
PD36-11
BIOCOMPATIBILITY OF WOVEN
COLLAGEN MESH AS A NOVEL
BIOMATERIAL FOR FUTURE SLINGS.
Ahmad Khalifa*, Katherine Chapin,
Cleveland, OH, Osama Abdelgawad, Shebin
Al Kom, Egypt, James Anderson, Ozan
Akkus, Adonis Hijaz, Cleveland, OH
9:50
PD36-12
MID-TERM OUTCOMES FOLLOWING SUBURETHRAL SYNTHETIC SLING REMOVAL
IN WOMEN
Jeannine Foster*, Nirmish Singla, Himanshu
Aggarwal, Feras Alhalabi, Gary Lemack,
CREDITTM
INFECTION RATE AFTER SACRAL
NEUROMODULATION SURGERY: A
REVIEW OF 1033 INTERSTIM
PROCEDURES
Marisa Clifton*, Adrienne Quirouet, Javier
Pizarro-Berdichevsky, Bradley Gill, Elodi
Dielubanza, Henry Okafor, Anna Faris,
Courtenay Moore, Sandip Vasavada,
Raymond Rackley, Howard Goldman,
Cleveland, OH
224
Monday, May 9, 2016
8:00 am - 10:00 am
Podium Session 37
TIME
8:00
ABSTRACT
NUMBER TITLE
PD37-01 CONTEMPORARY TRENDS IN
TREATMENT PATTERNS FOR MEN
DIAGNOSED WITH CLINICALLY
Deepansh Dalela*, Jesse Sammon, Akshay
Sood, Wooju Jeong, Detroit, MI, Bjorn
Loeppenberg, Boston, MA, Patrick Karabon,
Detroit, MI, Maxine Sun, Toni Choueiri,
Boston, MA, Mani Menon, Detroit, MI, QuocDien Trinh, Boston, MA, Firas Abdollah,
Royal Oak, MI
8:10
PD37-02
SURVIVAL OUTCOMES AFTER
PROSTATECTOMY IN A HEALTHY
POPULATION OF VETERANS:
COMPARISON TO THE SURGICAL
COHORT FROM PIVOT
Eric Kim*, Suhong Luo, Katiuscia O’Brian,
Niraj Badhiwala, Bettina Drake, Kenneth
Carson, M’Liss Hudson, Robert Grubb, St.
Louis, MO
8:20
PD37-03
IS THE PROSTATE CANCER
INTERVENTION VERSUS OBSERVATION
TRIAL REFLECTIVE OF THE
CONTEMPORARY US POPULATION
DIAGNOSED WITH PROSTATE CANCER?
RESULTS FROM THE NATIONAL CANCER
DATABASE 2004-2011
Dalela, Patrick Karabon, Jesse Sammon,
Akshay Sood, Björn Löppenberg, Detroit, MI,
Quoc-Dien Trinh, Maxine Sun, Christian
Meyer, Boston, MA, James Peabody, Mani
Menon, Detroit, MI
8:30
8:40
PD37-04
PD37-05
*Presenting author
ABSTRACT
TIME NUMBER TITLE
8:50 PD37-06 CAN WE PREDICT LATE RECURRENCES
AFTER RADICAL PROSTATECTOMY IN
MEN WITH HIGH RISK PROSTATE
CANCER? A VERY LONG TERM ANALYSIS
FROM A LARGE, MULTI-INSTITUTIONAL
ANALYSIS
Marco Bianchi*, Alberto Briganti, Milan, Italy,
Jeffrey R. Karnes, Rochester, MN, Giorgio
Gandaglia, Nicola Fossati, Milan, Italy, Martin
Spahn, Bern, Switzerland, Paolo Gontero,
Turin, Italy, Lorenzo Tosco, Leuven, Belgium,
Burkhard Kneitz, Wurzburg, Germany, Felix
Chun, Hamburg, Germany, Emanuele
Zaffuto, Milan, Italy, Dirk De Ridder, Leuven,
Belgium, Maxine Sun, Montreal, Canada,
Giansilvio Marchioro, Novara, Italy, Detlef
Frohneberg, Karlsruhe, Germany, Bertrand
Guilloneau, New York, NY, Rafael SanchezSalas, Xavier Cathelineau, Paris, France,
Simone Giona, Turin, Italy, Pierre
Karakiewicz, Montreal, Canada, Hein Van
Poppel, Leuven, Belgium, Francesco
Montorsi, Milan, Italy, Steven Joniau, Leuven,
Belgium
A PHASE II, RANDOMIZED, OPEN LABEL
STUDY OF NEOADJUVANT DEGARELIX
VERSUS LHRH AGONIST IN PROSTATE
CANCER PATIENTS PRIOR TO RADICAL
PROSTATECTOMY
Rashid Sayyid*, Toronto, Canada, Martin
Gleave, Vancouver, Canada, Karen Hersey,
Ranjena Maloni, Toronto, Canada, Antonio
Hurtado-Coll, Vancouver, Canada, Andrew
Evans, Girish Kulkarni, Antonio Finelli,
Alexandre Zlotta, Robert Hamilton, Michael
Jewett, Neil Fleshner, Toronto, Canada
OUTCOMES OF VETERAN’S
ADMINISTRATION PROSTATE CANCER
PATIENTS: DO TREATMENT PATTERNS
AND ACCESS TO CARE MAKE A
DIFFERENCE?
Daniel Sackman*, Ann Martinez Acevedo,
Byung Park, Christopher Amling, Portland,
OR
225
9:00
PD37-07
METABOLIC SYNDROME AND POOR
SURVIVAL IN PATIENTS OF LOCALLYADVANCED PROSTATE CANCER AFTER
Woo Jin Ko*, Goyang, Korea, Republic of,
Hyun Ho Han, Tag Keun Yoo, Seoul, Korea,
Republic of, Tae Hee Oh, Changwon, Korea,
Republic of, Duk Yoon Kim, Daegu,
Korea, Republic of, Dong Deuk Kwon,
Gwangju, Korea, Republic of, Seok-Soo
Byun, Seongnam, Korea, Republic of, Sun Il
Kim, Suwon, Korea, Republic of, Tae Young
Jung, Seoul, Korea, Republic of
9:10
PD37-08
IMPACT OF TIME FROM BIOPSY TO
PROSTATECTOMY ON RISK OF
BIOCHEMICAL RECURRENCE:
MULTIVARIABLE MODEL USING
VALIDATED PREDICTIVE NOMOGRAM
Joseph Zabell*, Andrew J. Stephenson, Ryan
Berglund, Cleveland, OH
9:20
PD37-09
LAPAROSCOPIC VERSUS ROBOTASSISTED RADICAL PROSTATECTOMY:
FOUR-YEAR RESULTS OF A
PROSPECTIVE RANDOMISED TRIAL
Cristian Fiori*, Ivano Morra, Matteo Manfredi,
Fabrizio Mele, Riccardo Bertolo, Giovanni
Cattaneo, Massimiliano Poggio, Daniele
Amparore, Sabrina De Cillis, Enrico
Checcucci, Stefano De Luca, Francesco
Porpiglia, Orbassano, Torino, Italy
MONDAY
PROSTATE CANCER: LOCALIZED: SURGICAL THERAPY IV
Moderator: Ketan Badani
9:30
PD37-10
LONG-TERM ONCOLOGICAL OUTCOMES
IN PATIENTS WITH BIOCHEMICAL
RECURRENCE AFTER RADICAL
PROSTATECTOMY
Raisa Pompe*, Philipp Gild, Philipp Mandel,
Felix Chun, Hartwig Huland, Markus Graefen,
Derya Tilki, Hamburg, Germany
9:40
PD37-11
FUNCTIONAL OUTCOMES AFTER
EXTENDED VS. SUPER-EXTENDED
PELVIC LYMPH NODE DISSECTION FOR
INTERMEDIATE AND HIGH-RISK
LOCALIZED PROSTATE CANCER.
Steven Joniau*, Pieter Janssen, Lorenzo
Tosco, Wouter Everaerts, Maarten Albersen,
Ben Van Cleynenbreugel, Hein Van Poppel,
Leuven, Belgium
9:50
PD37-12
COMPARISON OF ROBOT-ASSISTED AND
RETROPUBIC PELVIC LYMPH NODE
DISSECTION IN RADICAL
PROSTATECTOMY – A PROPENSITY
SCORE MATCHING ANALYSIS
Julia Schwerfeld-Bohr*, Michael Musch, Ulla
Roggenbuck, Michaela Vanberg, Anne
Pailliart, Susanne Krege, Darko Kroepfl,
Essen, Germany
CREDITTM
Monday, May 9, 2016
8:00 am - 10:00 am
Video Session 9
ROBOTICS – RENAL
Moderators: Jay Raman and Craig Rogers
ABSTRACT
NUMBER TITLE
V9-01
ROBOTIC-ASSISTED LEVEL III IVC
TUMOR THROMBECTOMY: DUPLICATING
THE OPEN APPROACH
Daniel Ramirez*, Matthew J. Maurice,
Benjamin Cohen, Venkatesh Krishnamurthi,
Georges-Pascal Haber, Cleveland, OH
V9-02
V9-03
ABSTRACT
NUMBER TITLE
V9-06
TECHNICAL INNOVATIONS TO ROBOTIC
LEVEL II AND III THROMBECTOMY: STEP
BY STEP
Andre Luis de Castro Abreu*, Sameer
Chopra, Chandan Kundavaram, Daniel Shin,
Charles Metcalfe, Nariman Ahmadi, Andre
Berger, Los Angeles, CA, Giuseppe Simone,
Roma, Italy, Osamu Ukimura, Los Angeles,
CA, Michelle Gallucci, Roma, Italy, Monish
Aron, Mihir Desai, Rene Sotelo, Inderbir Gill,
Los Angeles, CA
PATIENT-SPECIFIC CAST RENAL MODELS
FOR PREOPERATIVE SIMULATION OF
TUMOR RESECTION DURING ROBOTIC
PARTIAL NEPHRECTOMY
Friedrich-Carl von Rundstedt*, Jason Scovell,
Smriti Agrawal, Jacques Zaneveld, Richard E.
Link, Houston, TX
HILAR TUMORS
A. Caputo, Ryan J. Nelson, Onder Kara,
Ercan Malkoc, Jihad H. Kaouk, Cleveland,
OH
V9-04
ROBOTIC PARTIAL NEPHRECTOMY IN
THE SETTING OF IDIOPATHIC IVC
OBSTRUCTION: A MULTIDISCIPLINARY
APPROACH
Matthew J. Maurice*, Daniel G. Clair, Maria
del Pilar Bayona Molano, Daniel Ramirez,
Peter A. Caputo, Ryan J. Nelson, Onder
Kara, Ercan Malkoc, Christine N. Tran,
Georges-Pascal Haber, Jihad H. Kaouk,
Robert J. Stein, Cleveland, OH
V9-05
RETROPERITONEAL ACCESS FOR
ROBOTIC RENAL SURGERY
Barrett Anderson*, Alec Wright, Aaron
Potretzke, R. Sherburne Figenshau, St.
Louis, MO
226
V9-07
DURING PREGNANCY: CASE REPORT
AND SPECIAL CONSIDERATIONS
Nima Almassi*, Daniel Ramirez, Matthew J.
Maurice, Catherine Seager, Georges-Pascal
Haber, Cleveland, OH
V9-08
ROBOT ASSISTED RADICAL
NEPHRECTOMY AND INFERIOR VENA
CAVA THROMBECTOMY: SURGICAL
TECHNIQUE, PERIOPERATIVE AND
EARLY ONCOLOGIC OUTCOMES
Giuseppe Simone*, Mariaconsiglia Ferriero,
Rocco Papalia, Riccardo Mastroianni,
Francesco Minisola, Leonardo Misuraca,
Gabriele Tuderti, Salvatore Guaglianone,
Manuela Costantini, Vincenzo Pompeo,
Rome, Italy, Andre Luis De Castro Abreu,
Monish Aron, Mihir Desai, Inderbir Singh Gill,
Los Angeles, CA, Michele Gallucci, Rome,
Italy
V9-09
ROBOTIC RESECTION OF LOCALLY
RECURRENT RENAL CELL CARCINOMA
Weil Lai*, Gregory Mitchell, Benjamin Lee,
New Orleans, LA
V9-10
TECHNICAL CAVEATS IN ROBOTIC
PARTIAL NEPHRECTOMY IN UPPER
POLAR RENAL TUMOR
Varun Mittal*, Gagan Gautam, Puneet
Ahluwalia, Rajesh Ahlawat, Gurgaon, India
V9-11
COMPLETELY ENDOPHYTIC RENAL
MASSES: VARIATIONS IN SURGICAL
TECHNIQUE
A. Caputo, Ryan J. Nelson, Ercan Malkoc,
Onder Kara, Jihad H. Kaouk, Cleveland, OH
V9-12
RESECTION OF RENAL VEIN
LEIOMYOSARCOMA
Monty Aghazadeh*, Edward Sanchez, Alvin
Goh, Houston, TX
CREDITTM
Monday, May 9, 2016
8:00 am - 11:00 am
8:00
DIGITAL URETERORENOSCOPY WITH IMAGE
ENHANCEMENT AND A SHEATHED LASER
FIBER
Surgeon: Gerhard Fuchs
Moderators: Andreas Gross, Lorenzo Defidio
9:00
ROBOTIC RPLND
Surgeon: James Porter
Moderators: Erik Castle, William Ellis
10:00
ROBOTIC CYSTECTOMY: INTRACORPOREAL
DIVERSION
Surgeon: Mihir Desai
Moderators: Dipen Parekh, Ralph deVere White
11:00
ADJOURN
CREDITTM
Monday, May 9, 2016
10:30 am - 12:30 pm
URODYNAMICS/LOWER URINARY TRACT DYSFUNCTION/FEMALE PELVIC MEDICINE: FEMALE INCONTINENCE: THERAPY II
Moderators: Donna Deng and Steven Siegel
ABSTRACT
NUMBER TITLE
MP65-01 STROMAL CELL DERIVED FACTOR-1
ACCELERATES RECOVERY OF
CONTINENCE IN RAT MODEL OF
VAGINAL DISTENSION INJURY
Ahmad Khalifa*, Amr Mahran, Michael
Kavran, Juliana Woda, Cleveland, OH, Marc
Penn, Akron, OH, Adonis Hijaz, Cleveland,
OH
MP65-02
MP65-03
*Presenting author
ABSTRACT
NUMBER TITLE
MP65-04 A NOVEL REGENERATIVE TREATMENT
FOR FEMALE STRESS URINARY
INCONTINENCE: LONG-TERM OUTCOME
OF INITIAL THREE CASES UNDERGOING
PERIURETHRAL INJECTION OF
AUTOLOGOUS ADIPOSE-DERIVED
REGENERATIVE CELLS
Momokazu Gotoh*, Tokunori Yamamoto,
Yoshihisa Matsukawa, Yasuhito Funahashi,
Nagoya, Japan
EFFECTS OF A SELECTIVE ANDROGEN
RECEPTOR MODULATOR, GSK2849466A
AND TESTOSTERONE ON STRESS
URINARY INCONTINENCE IN
OVARIECTOMIZED RATS
Takahiro Shimizu*, Katsumi Kadekawa, Naoki
Kawamorita, Pittsburgh, PA, Philip Turnbull,
Alan Russell, Durham, NC, Naoki Yoshimura,
Pittsburgh, PA
MP65-05
STROMAL DERIVED FACTOR-1〈
MEDIATED TISSUE REGENERATION IN
CHRONIC INTRINSIC URINARY
SPHINCTER DEFICIENCY
James Williams*, Winston-Salem, NC, KarlErik Andersson, Aarhus, Sweden, Ashley
Dean, Gopal Badlani, Winston-Salem, NC
227
POLYACRYLAMIDE HYDROGEL
(BULKAMID®) IN THE TREATMENT OF
FEMALE STRESS URINARY
INCONTINENCE: THREE YEAR FOLLOW
UP OUTCOMES.
Aakash Pai*, Waleed Al-Singary, Worthing,
United Kingdom
MONDAY
LIVE SURGERY II
Moderator: Inderbir Gill
MP65-06
MP65-07
MP65-08
MP65-09
MP65-10
MP65-11
MP65-12
ARTIFICIAL URINARY SPHINCTER
IMPLANTATION IN WOMEN WITH STRESS
URINARY INCONTINENCE: PRELIMINARY
COMPARISON OF THE ROBOT-ASSISTED
AND OPEN APPROACHES
Benoit Peyronnet*, Sébastien Vincendeau,
Lauranne Tondut, Benjamin Pradère, Quentin
Alimi, Rennes, France, Nelly Senal, Rennnes,
France, Karim Bensalah, Isabelle Bonan,
Mireille Damphousse, Andrea Manunta,
Rennes, France
LAPAROSCOPIC APPROACH FOR
IMPLANTATION IN WOMEN WITH
URINARY STRESS INCONTINENCE: 10
YEARS EXPERIENCE
Carlos Ferreira*, Eric Mandron, PierreEmmanuel Bryckaert, Le Mans, France
12 MONTH FOLLOWUP OF 22 PATIENTS
IN THE SOLECT TRIAL FOR SUI
Stephan De Wachter*, Evert Koldewijn, JeanJacques Wyndaele, Antwerp, Belgium,
Giovanni Tommaselli, Naples, Italy, Roberto
Angioli, Rome, Italy, Michel de Wildt, Wout
Scheepens, Eindhoven, Netherlands, Karel
Everaert, Francoise Spinoit, Ghent, Belgium,
Dirk Michielsen, Brussels, Belgium, Dennis
Oerlemans, Gommert van Koeveringe,
Maastricht, Netherlands
ANALYSIS OF UTI RESOLUTION AND
SEDIMENT FORMATION ON
INTRAVESICAL BALLOON FOR THE
TREATMENT OF SUI FROM TWO
MULTICENTER RANDOMIZED
CONTROLLED STUDIES
Karny Jacoby*, Mountlake Terrace, WA,
Stephan De Wachter, Jean-Jacques
Wyndaele, Antwerp, Belgium, Eric Rovner,
Charleston, SC, Roger Dmochowski,
Nashville, TN, Giovanni Tommaselli, Naples,
Italy, Susan Kalota, Tuscon, AZ, Gommert
van Koeveringe, Maastricht, Netherlands
THE EFFECTS OF A HEATING PAD ON
ANXIETY, PAIN AND DISTRESS DURING
URODYNAMIC STUDY IN THE FEMALE
PATIENTS WITH STRESS URINARY
INCONTINENCE
Ji Yun Chae*, Hyun Ju Kim, Young Joo Park,
Hyoung Kook Jeong, Jong Jin Park, Jong
Wook Kim, Jae Hyun Bae, Seok Ho Kang,
Hong Seok Park, Du Geon Moon, Jun
Cheon, Jeong Gu Lee, Je Jong Kim, Mi Mi
Oh, Seoul, Korea, Republic of
ADJUSTMENT OF MESH TENSION COULD
BE IMPROVING THE SUCCESS RATE OF
ANTI-INCONTINENCE SURGERY: THE
EFFICACY AND SAFETY OF
TRANSOBTURATOR ADJUSTABLE TAPE
(TOA) SLING OPERATION
Myung Ki Kim*, Jeonju, Korea, Republic of
AUTOLOGOUS TRANSOBTURATOR
URETHRAL SLING PLACEMENT FOR
FEMALE STRESS URINARY
INCONTINENCE
Brian Linder*, Daniel Elliott, Rochester, MN
MP65-13
PROSPECTIVE EVALUATION OF THE
EFFECT OF THIGH DISSECTION FOR
REMOVAL OF TRANSOBTURATOR
MIDURETHRAL SLINGS ON REFRACTORY
THIGH PAIN
Ashley King*, Christopher Tenggardjaja,
Howard Goldman, Cleveland, OH
MP65-14
FACTORS ASSOCIATED WITH
THERAPEUTIC EFFICACY OF
INTRAVESICAL ONABOTULINUMTOXINA
INJECTION FOR OVERACTIVE BLADDER
SYNDROME
Chung-Cheng Wang*, New Taipei, Taiwan,
Shu-Yu Wu, Hualien, Taiwan, Sheng-Mou
Hsiao, New Taipei, Taiwan, Hann-Chorng
Kuo, Hualien, Taiwan
MP65-15
THE ASSOCIATION BETWEEN URINARY
INCONTINENCE AND DELIVERY: A
CROSS-SECTIONAL STUDY AMONG
JAPANESE WOMEN.
Yoshitaka Aoki*, Manami Tsutsumiuchi, Akiko
Itoga, Masaya Seki, Yosuke Matsuta, Hideaki
Ito, Chieko Matsumoto, Yukinori Kusaka,
Osamu Yokoyaka, Fukui, Japan
MP65-16
PREDICTOR FACTORS FOR SUCCESSFUL
TREATMENT OF SOLIFENACIN IN
PATIENTS WITH OVERACTIVE BLADDER
Chung-Cheng Wang*, New Taipei, Taiwan,
Hueih-Ling Ong, Hann-Chorng Kuo, Hualien,
Taiwan
MP65-17
LOW-FREQUENCY TRANSCUTANEOUS
ELECTRICAL STIMULATION OF FOOT
CAN BE A NOVEL HOME-BASED
TREATMENT FOR REFRACTORY OAB
Yosuke Matsuta*, Norikazu Hashimoto,
Yoshitaka Aoki, Hironobu Akino, Osamu
Yokoyama, Fukui, Japan
MP65-18
FEMALE URETHRAL DIVERTICULA:
CORRELATION OF MRI FINDINGS WITH
PRE-OPERATIVE SIGNS AND SYMPTOMS
OR POST-OPERATIVE OUTCOMES
Nima Baradaran*, Leah Chiles, Drew Freilich,
William Rawls, Lindsey Cox, Ross Rames,
Eric Rovner, Charleston, SC
MP65-19
TRANSLATING UNIQUE LEARNING FOR
INCONTINENCE PREVENTION, THE TULIP
PROJECT: COMPARATIVE
EFFECTIVENESS STUDY OF A DIVERSE
POPULATION OF ADULT WOMEN
RECEIVING BLADDER HEALTH
EDUCATION
Diane Newman*, Philadelphia, PA, Carolyn
Sampselle, Trivellore Raghunathan, Janis
Miller, Keri Kirk, Ann Arbor, MI, Rebecca
Kimmel, Maryann DiCamillo, Philadelphia, PA
MP65-20
SLING PROCEDURES FOR FEMALE
STRESS INCONTINENCE: DOES
SURGICAL SPECIALTY MATTER?
Björn Löppenberg*, Christian Meyer, Nawar
Hanna, Alexander Cole, Malte Vetterlein,
Boston, MA, Mani Menon, Jesse Sammon,
Detroit, MI, Jeffrey Leow, Adam Kibel,
Boston, MA, Joachim Noldus, Herne,
Germany, Quoc-Dien Trinh, Boston, MA
CREDITTM
228
Monday, May 9, 2016
10:30 am - 12:30 pm
ABSTRACT
NUMBER TITLE
MP66-01 GENE KNOCKOUT OF NANOG AND
NANOGP8 MEDIATED BY CRISPR/CAS9
DECREASES THE MALIGNANT
POTENTIAL OF PROSTATE CANCER
CELLS.
Norihiko Kawamura*, Keisuke Nimura,
Hiromichi Nagano, Takahiro Yoshida,
Atsunari Kawashima, Takeshi Ujike, Akira
Nagahara, Kazutoshi Fujita, Motohide
Uemura, Yasufumi Kaneda, Norio Nonomura,
Suita, Japan
ABSTRACT
NUMBER TITLE
MP66-05 A NOVEL DELETION OF THE LSAMP
GENE LOCUS ASSOCIATES WITH RAPID
PROGRESSION OF PROSTATE CANCER
AMONG AFRICAN AMERICAN MEN
Shyh-Han Tan*, Gyorgy Petrovics, Hua Li,
Rockville, MD, Tanja Stümpel, Munich,
Germany, Denise Young, Shilpa Katta,
Rockville, MD, Qiyuan Li, Xiamen, China,
People’s Republic of, Kai Ying, Rockville,
MD, Bernward Klocke, Munich, Germany,
Lakshmi Ravindranath, Indu Kohaar,
Yongmei Chen, Rockville, MD, Dezsö Ribli,
Budapest, Hungary, Korbinian Grote, Munich,
Germany, Hua Zou, Joseph Cheng, Rockville,
MD, Clifton L. Dalgard, Rockville, MD, Shimin
Zhang, Silver Spring, MD, István Csabai,
Budapest, Hungary, Joseph Kagan,
Bethesda, MD, David Takeda, Massimo
Loda, Boston, MA, Sudhir Srivastava,
Bethesda, MD, Matthias Scherf, Martin
Seifert, Munich, Germany, Timo Gaiser,
Mannheim, Germany, David G. McLeod,
Rockville, MD, Zoltan Szallasi, Lyngby,
Denmark, Reinhard Ebner, Rockville, MD,
Thomas Werner, Munich, Germany, Isabell A.
Sesterhenn, Silver Spring, MD, Matthew
Freedman, Boston, MA, Albert Dobi, Shiv
Srivastava, Rockville, MD
MP66-02 DOWN-REGULATION OF CDKN3
INHIBITED PROSTATE CANCER
PROLIFERATION IN VITRO AND IN VIVO
VIA REGULATING CELL CYCLE AND DNA
REPLICATION SIGNALING
Yiping Zhu*, Dingwei Ye, Bo Dai, Shanghai,
China, People’S Republic Of
MP66-03 THE CHROMATIN ASSOCIATED SIN3B
PROTEIN RESTRICTS PROSTATE
CANCER PROGRESSION.
Anthony Bainor, Yu Wang, Peng Lee, Susan
Logan, Gregory David*, New York, NY
MP66-04 CIGARETTE SMOKING AND CYP1A1
ENHANCE PROSTATE CANCER
PROGRESSION THROUGH DNA
PROMOTER HYPOMETHYLATION
Yozo Mitsui*, Izumo, Japan, Inik Chang,
Seoul, Korea, Democratic People’s Republic
of, Shinichiro Fukuhara, Osaka, Japan, Miho
Hiraki, Naoko Arichi, Hiroaki Yasumoto,
Hiroaki Shiina, Izumo, Japan, Rajvir Dahiya,
Yuichiro Tanaka, San Francisco, CA
MP66-06 THE ROLE OF THE PKD1-〉-CATENINANDROGEN RECEPTOR AXIS IN
PROSTATE CANCER PROGRESSION
Bita Nick Kholgh, Michael B. Rothberg*,
Sittadjody Sivanandane, Xiaolan Fang, K.C.
Balaji, Winston-Salem, NC
MP66-07 ARACHIDONIC ACID METABOLISM IN
PROSTATE CANCER IS ASSOCIATED
WITH GENETIC AND EPIGENETIC
VARIATIONS WITHIN THE FADS CLUSTER
Austin Hester*, Tao Cui, Leslie Miller, Susan
Sergeant, Michael Seeds, Ski Chilton,
Winston Salem, NC
MP66-08 POLYMORPHISMS OF GENES RELATED
TO OESTROGEN METABOLISM AND THE
RISK OF PROSTATE CANCER IN TWO
POPULATIONS OF AFRICAN DESCENT.
Laurent Brureau*, Pointe-A-Pitre,
Guadeloupe, Dieudonne Moningo, Kinshasa,
Congo, Elise Emeville, Severine Ferdinand,
Marc Romana, Pascal Blanchet, Luc
Multigner, Pointe-A-Pitre, Guadeloupe
MP66-09 INVADOPODIA ARE CRITICAL FOR
PROSTATE CANCER METASTASIS
Khurram Siddiqui*, Matthew Arora, Yohan
Kim, Patrick Telmer, David DiSantis, Emily
Jardine, Joseph Chin, Jonathan Izawa, Hon
Leong, London, Canada
*Presenting author
229
MONDAY
PROSTATE CANCER: BASIC RESEARCH & PATHOPHYSIOLOGY II
Moderators: Natasha Kyprianou and Isla Garraway
MP66-10 TARGET GENES ANALYSIS OF PAIRED
BOX2, REGULATOR OF PROSTATE
CANCER CELL INVASION
Takashi Ueda*, Saya Ito, Takumi Shiraishi,
Naruhiro Kayukawa, Hidefumi Taniguchi,
Yoshio Naya, Fumiya Hongo, Koji Okihara,
Osamu Ukimura, Kyoto, Japan
MP66-16 REGENERATING ISLET-DERIVED
RELATED PROTEIN 4 AS A CANDIDATE
OF A NOVEL BIOMARKER IN
CANCER PATIENTS
Jun Teishima*, Hirotaka Nagamatsu, Koichi
Shoji, Ryoken Yamanaka, Kohei Kobatake,
Hiroyuki Kitano, Keisuke Goto, Tetsutaro
Hayashi, Norihide Oue, Wataru Yasui, Akio
Matsubara, Hiroshima, Japan
MP66-11 LIM-SH3 DOMAIN PROTEIN 1
CORRELATES WITH CELL INVASION AND
STEMNESS IN PROSTATE CANCER AND
EARLY METASTASIS AFTER RADICAL
PROSTATECTOMY
Takashi Dejima*, Ario Takeuchi, Fukuoka,
Japan, Kevin Tam, Vancouver, Canada,
Masatoshi Eto, Fukuoka, Japan, Martin
Gleave, Christopher Ong, Vancouver,
Canada
MP66-17 EXPRESSION OF GLUCOCORTICOID
RECEPTORS, ANDROGEN RECEPTORS
AND ITS SPLICE VARIANTS IN PROSTATE
CANCER: COMPARISON BETWEEN
HORMONE DEPENDENT AND CASTRATERESISTANT PROSTATE CANCER
Myungsun Shim*, Anyang-si, Korea, Republic
of, Yunlim Kim, Myungchan Park, Myong
Kim, Tai Young Ahn, Hanjong Ahn, Seoul,
Korea, Republic of
MP66-12 THE EXPRESSION PROFILES OF MIR-210,
MIR-375, MIR-378, MIR-345, MIR-143 MIR183 AND MIR-98 IN THE PROGRESSION
OF PROSTATE CANCER FROM HIGHGRADE PROSTATIC INTRAEPITHELIAL
NEOPLASIA TO METASTATIC DISEASES
Okyaz Eminaga*, Jochen Fries, Cologne,
Germany, Fabian Woetzel, Muenster,
Germany, Hakan Alakus, Ute WarneckeEberz, Axel Heidenreich, Cologne, Germany
MP66-18 IDENTIFICATION OF DUAL TUMORSUPPRESSORS (MIR-222-5P/MIR-222-3P)
BASED ON MICRORNA EXPRESSION
SIGNATURE BY DEEP SEQUENCING OF
CRPC
Yusuke Goto*, Chiba, Japan, Satoko Kojima,
Ichihara, Japan, Akira Kurozumi, Mayuko
Kato, Atsushi Okato, Chiba, Japan, Yukio
Naya, Ichihara, Japan, Hideki Enokida,
Ryosuke Matsushita, Masayuki Nakagawa,
Kagoshima, Japan, Tomohiko Ichikawa,
Naohiko Seki, Chiba, Japan
MP66-13 MIR-130A MODULATES HIGH-FAT DIETINDUCED PROSTATE CANCER
PROGRESSION THROUGH THE
ACTIVATION OF MET
Taketoshi Nara*, Shintaro Narita, Huang
Mingguo, Toshiaki Yoshioka, Koichiro
Takayama, Kazuyuki Numakura, Hiroshi
Tsuruta, Atsushi Maeno, Mitsuru Saito,
Takamitsu Inoue, Shigeru Satoh, Tomonori
Habuchi, Akita City, Japan
MP66-19 PROSTATE-SPECIFIC MEMBRANE
ANTIGEN INTERACTS WITH DIETARY
FOLATE TO FACILITATE PROSTATE
CARCINOGENESIS AND PROGRESSION
Dean Bacich*, Shahida Flores, San Antonio,
TX, Sean Pennetti, Pittsburgh, PA, Kyle
Johnson, Ashley Silvia, San Antonio, TX,
Benjamin Ristau, Jennifer Gregg, Pittsburgh,
PA, Denise O’Keefe, San Antonio, TX
MP66-14 PROSTATE CANCER BONE METASTASISSPECIFIC MITOCHONDRIAL DNA
MUTATION INCREASES REACTIVE
OXYGEN.
Carrie Sun*, John Petros, Rebecca Arnold,
Atlanta, GA
MP66-15
MP66-20 PROSTATE-SPECIFIC MEMBRANE
ANTIGEN IS DIRECTLY REGULATED BY
MIR-660
Kati Erdmann*, Felix Bienert, Susanne
Fuessel, Manfred P. Wirth, Dresden,
Germany
TGF-〉1 AND CCL2 AS POTENTIAL
BIOMARKERS AND TREATMENT
TARGETS FOR PROSTATE CANCER BONE
METASTASIS
Kouji Izumi*, Hiroaki Iwamoto, Ariunbold
Natsagdorji, Aerken Maolake, Atsushi
Mizokami, Mikio Namiki, Kanazawa, Japan
CREDITTM
230
Monday, May 9, 2016
10:30 am - 12:30 pm
STONE DISEASE: BASIC RESEARCH & PATHOPHYSIOLOGY II
Moderators: Saeed Khan and James Williams, Jr.
ABSTRACT
NUMBER TITLE
MP67-01 PRELIMINARY EVIDENCE SUGGESTS
PERIURETERAL BOTULINUM TOXIN TYPE
A INJECTION IMPROVES URETERAL
STONE PASSAGE IN THE PORCINE
MODEL
Necole M Streeper*, Hershey, PA, Stephen Y
Nakada, Margaret L Wertheim, Sara L Best,
Madison, WI
ABSTRACT
NUMBER TITLE
MP67-08 HYPEROXALURIA-INDUCED TUBULAR
ISCHEMIA: THE EFFECTS OF VERAPAMIL
ON THE ANTIOXIDANT CAPACITY OF THE
AFFECTED KIDNEYS
Kemal Sarica*, Alper Kafkasli, Kamil Fehmi
Narter, Oguz Ozturk, Ozgur Yazici, Bilal
Hamarat, Istanbul, Turkey
MP67-10 IDENTIFICATION OF URINARY
MACROPHAGE-RELATED FACTORS
SPECIFIC TO PATIENTS WITH CALCIUM
OXALATE STONES USING MULTIPLEX
ANALYSIS
Atsushi Okada*, Kazumi Taguchi, Yasuhiro
Fujii, Shuzo Hamamoto, Masahito Hirose,
Yasunori Itoh, Keiichi Tozawa, Shoichi
Sasaki, Yutaro Hayashi, Kenjiro Kohri,
Takahiro Yasui, Nagoya, Japan
MP67-03 MITOCHONDRIAL IMPLICATIONS OF
GLYCOLATE METABOLISM IN PRIMARY
HYPEROXALURIA
Sonia Fargue*, Tanecia Mitchell, John Knight,
Ross Holmes, Birmingham, AL
MP67-04 OXALATE HANDLING AND
OXALOBACTER FORMIGENES
COLONIZATION IN A GNOTOBIOTIC
MOUSE MODEL
Xingsheng Li, John Knight*, Birmingham, AL
MP67-05
MP67-11 DIABETES MELLITUS PROMOTES
URETERAL SMOOTH MUSCLE CELL
PROLIFERATION: A RESEARCH ON THE
MECHANISM.
Yong Ho Shin*, Taesoo Choi, Seung-Kwon
Choi, Dong-Gi Lee, Gyeong Eun Min, HyungLae Lee, Sang Hyub Lee, Seung Hyun Jeon,
Sun-Ju Lee, Choong-Hyun Lee, Sung-Goo
Chang, Koo Han Yoo, SEOUL, Korea,
Republic of
CHARACTERIZATION OF THE
MICROBIOTA ASSOCIATED WITH
DROSOPHILA MODELS OF
NEPHROLITHIASIS
Kait Al*, Sohrab Naushad Ali, Jihye Kim, Hon
Leong, Hassan Razvi, Jeremy Burton,
London, Canada
MP67-06 GENETIC ANALYSIS OF HUMAN AND
ANIMAL ISOLATES OF OXALOBACTER
FORMIGENES, AN ORGANISM OF
IMPORTANCE TO NEPHROLITHIASIS
RISK
Robertson Venema*, London, Canada,
Lauren Brinkac, Rockwell, MD, Ryan Chanyi,
Hassan Razvi, London, Canada, Dirk Lange,
Vancouver, Canada, Jeremy Burton, London,
Canada
MP67-12 BISPHOSPHONATES DO NOT REDUCE
RISK OF NEW KIDNEY STONE
FORMATION
Charles Nottingham*, Chicago, IL, Jaclyn
Pruitt, Brittany Lapin, Evanston, IL, Andrew
Cohen, Chicago, IL, Chi-Hsiung Wang,
Sangtae Park, Evanston, IL
MP67-13 HIGH DIETARY FAT PROMOTES OXALATE
TRANSPORT IN THE RAT COLON
INDEPENDENT OF GASTRIC BYPASS
SURGERY
Benjamin K. Canales*, Marguerite Hatch,
Gainesville, FL
MP67-07 THE PROTECTIVE EFFECTS OF
PROPOLIS ON OXIDATIVE STRESS AND
CRYSTAL DEPOSITION WITH
HYPEROXALURIA INDUCED TUBULAR
CELL INJURY IN RAT MODEL
Kamil Fehmi Narter*, Alper Kafkasli, Oguz
Ozturk, Ozgur Yazici, Bilal Hamarat, Sukran
Sarikaya, Kemal Sarica, Istanbul, Turkey
*Presenting author
231
MONDAY
MP67-09 HIGH-THROUGHPUT AND NON-INVASIVE
FUNCTIONAL DRUG SCREENING
PLATFORM FOR DROSOPHILA
MELANOGASTER MODELS OF
NEPHROLITHIASIS
Sohrab Naushad Ali*, Jihye Kim, London,
Canada, Paul Spagnuolo, Waterloo, Canada,
Hassan Razvi, Hon Leong, London, Canada
MP67-02 THE EFFECT OF ALANINE ON CELL
VIABILITY AND AGT ACTIVITY IN
TRANSFORMED CHINESE HAMSTER
OVARY CELLS
Win Shun Lai, Mary Elaine Killian*, Sonia
Fargue, John Knight, Ross Holmes, Dean
Assimos, Birmingham, AL
MP67-14 LOSS OF FLEXIBLE URETEROSCOPE
FLEXION IS ASSOCIATED WITH
INCREASED REPAIR RATES: A
PROSPECTIVE MULTI-CENTER STUDY
Manint Usawachintachit*, Carissa Chu,
Angela Xu, Isabel Allen, San Francisco, CA,
Brian Duty, Portland, OR, Roger Sur, David
Wenzler, La Jolla, CA, Uwais Zaid, Eric
Taylor, Krishna Ramaswamy, San Francisco,
CA, Mathew Sorensen, Jonathan Harper,
Seattle, WA, Michael Conlin, Portland, OR,
Marshall Stoller, Thomas Chi, San Francisco,
CA
MP67-15
MP67-17 EVALUATION OF CONTACT
ELECTROPULSE LITHOTRIPSY: IN VITRO
ASSESMENT OF CAVITATION AND STONE
FRAGMENTATION
Adam Kaplan*, Georgy Sankin, Morgan
Gautho, Chen Yang, Joanne Dale, Glenn
Preminger, Michael Lipkin, Pei Zhong,
Durham, NC
MP67-18 A NOVEL QUANTITATIVE TECHNIQUE
FOR THE ASSESSMENT OF URETIC
STENT ENCRUSTATION AND
INCRUSTATION
Aditya Raja*, Mohamed Sherif, Hrishi Joshi,
DIFFERENT ROLES OF M1/M2
MACROPHAGE PHENOTYPE FOR RENAL
CRYSTAL FORMATION
Kazumi Taguchi*, Atsushi Okada, Rei Unno,
Yasuhiro Fujii, Yasuhiko Hirose, Masayuki
Usami, Shuzo Hamamoto, Ryosuke Ando,
Yasunori Itoh, Keiichi Tozawa, Kenjiro Kohri,
Takahiro Yasui, Nagoya, Japan
MP67-19 ALISKIREN PROVIDES INCOMPLETE
PROTECTION OF THE KIDNEY IN
UNILATERAL URETERIC OBSTRUCTION
IN THE RAT
Fayez Hammad*, Loay Lubbad, Al Ain,
United Arab Emirates
MP67-16 PREDICTIVE FACTORS OF STONE
FORMATION IN PRIMARY
HYPERPARATHYROIDISM PATIENTS
Steeve Doizi*, John Poindexter, Beverley
Huet, Margaret Pearle, Naim Maalouf,
Khashayar Sakhaee, Dallas, TX
Monday, May 9, 2016
10:30 am - 12:30 pm
URODYNAMICS/LOWER URINARY TRACT DYSFUNCTION/FEMALE PELVIC MEDICINE:
BASIC RESEARCH & PATHOPHYSIOLOGY II
Moderators: Margot Damaser and Henry Lai
ABSTRACT
NUMBER TITLE
MP68-01 CELL THERAPY FOR NEUROGENIC
DETRUSOR OVERATIVITY RESULTING
FROM CHRONIC SPINAL CORD INJURY
(SCI) IN RATS
Bradley A. Potts*, Danielle J. Degoski, Jillene
M. Brooks, Andrew C. Peterson, Durham,
NC, Dwight E. Nelson, Thaddeus S. Brink,
Minneapolis, MN, Matthew O. Fraser, Apex,
NC
ABSTRACT
NUMBER TITLE
MP68-03 EVALUATION OF CANDIDATE URINARY
BIOMARKERS FOR UROLOGIC CHRONIC
PELVIC PAIN SYNDROME (UCPPS)
Adam Curatolo, Adelle Dagher, Monisha
Sachdev, Boston, MA, Alisa J. StephensShields, Philadelphia, PA, Andrew El-Hayek,
Boston, MA, Chris Mullins, Bethesda, MD, J.
Richard Landis, Philadelphia, PA, Adrie van
Bokhoven, Aurora, CO, Roopali Roy, Jiang
Yang, John Froehlich, Andrew C. Briscoe,
Boston, MA, Michel A. Pontari, Philaelphia,
PA, David Zurakowski, Richard S. Lee,
Marsha A. Moses*, Boston, MA
MP68-02 THERAPEUTIC EFFECT OF LOW
INTENSITY PULSED ULTRASOUND IN
STRESS URINARY INCONTINENCE
Bicheng Yang, Hongen Lei, Ruili Guan,
Zhezhu Gao, Zhongcheng Xin*, Beijing,
MP68-04 CLOCK GENES REGULATE CIRCADIAN
RHYTHM OF VNUT
EXPRESSION,CONNEXIN26 EXPRESSION
AND STRETCH-EVOKED ATP RELEASE IN
THE CULTURED UROTHELIAL CELLS
Tatsuya Ihara*, yamanashi, Japan, Satoru
Kira, Tatsuya Miyamoto, Norifumi Sawada,
Hiroshi Nakagomi, Takahiko Mitsui, Hideki
Kobayashi, Mitsuharu Yoshiyama, Masayuki
Takeda, Yuki Nakamura, Atsuhito Nakao, Eiji
Shigetomi, Yohichi Shinozaki, Shuichi
Koizumi, Chuo, Japan
232
COMPARISON OF THE EFFECTS OF
BRAIN-DERIVED NEUROTROPHIC
FACTOR (BDNF) AND NERVE GROWTH
FACTOR (NGF) INHIBITION ON BLADDER
FUNCTION OF MICE WITH SPINAL CORD
INJURY (SCI)
Naoki Wada*, Takahiro Shimizu, Shun Takai,
Nobutaka Shimizu, Pradeep Tyagi, William de
Groat, Anthony Kanai, Pittsburgh, PA,
Hidehiro Kakizaki, Asahikawa, Japan, Naoki
Yoshimura, Pittsburgh, PA
MP68-13 THE EFFECT OF EICOSAPENTAENOIC
ACID FOR DIABETES-INDUCED
OVERACTIVE BLADDER IN A RAT MODEL
Yasuhito Funahashi*, Tsuyoshi Majima,
Yoshihisa Matsukawa, Tokunori Yamamoto,
Nagoya, Japan, Masaki Yoshida, Ohbu,
Japan, Momokazu Gotoh, Nagoya, Japan
MP68-14 FUNCTIONAL INVOLVEMENT OF TRPV3
CATION CHANNELS IN BLADDER
OVERACTIVITY
Michael Lam*, Portland, OR, Travis MannGow, Peter Zvara, Burlington, VT
MP68-06 FORMATION OF DOUBLE-STRANDED RNA
ACTIVATES STRESS KINASES AND
INITIATES CYTOSKELETON
ORGANIZATION AND CELL
DEGENERATION IN BLADDER ISCHEMIA
Jing-Hua Yang, Zuohui Zhao, Han-Pil Choi,
Kazem Azadzoi*, Boston, MA
MP68-15
MP68-07 A NOVEL MECHATRONIC INFUSIONDRAINAGE DEVICE TO ASSESS LUT
FUNCTION IN NEURO-IMAGING
Switzerland, Matthias Walter, Johann Wanek,
Zürich, Switzerland, Jörg Diefenbacher,
Märstetten, Switzerland, Lars Michels, Zürich,
Switzerland, Martina D. Liechti, London,
United Kingdom, Thomas M. Kessler, Ulrich
MP68-16 FUNCTIONAL SIGNFICANCE OF
INCREASED BLADDER PERMEABILITY: A
NOVEL ROLE IN VISCERAL ORGAN
CROSSTALK.
Ehsan Mohammadi*, Brian Kliewer, Karl
Tyler, Robert Hurst, Beverley GreenwoodVan Meerveld, Oklahoma City, OK
MP68-17 CRUCIAL ROLES OF NITRIC OXIDE
SYNTHASES IN 〉-ADRENOCEPTORMEDIATED BLADDER RELAXATION IN
MICE
Yohei Satake*, Yasuhiro Kaiho, Kimio Satoh,
Sendai, Japan, Masato Tsutsui, Okinawa, Japan,
Hiroaki Shimokawa, Yoichi Arai, Sendai, Japan
MP68-08 INHIBITION OF NEUROGENIC,
CHOLINERGIC, AND ADRENERGIC
CONTRACTION OF HUMAN BLADDER
SMOOTH MUSCLE BY THE
THROMBOXANE RECEPTOR
ANTAGONIST, PICOTAMIDE
Martin Hennenberg*, Yiming Wang, Frank
Strittmatter, Anna Ciotkowska, Beata Rutz,
Christian Stief, Christian Gratzke, Munich,
Germany
MP68-18 EXPRESSION OF UROTHELIAL
FUNCTIONAL PROTEINS IN OVERACTIVE
BLADDER PATIENTS WITH DIFFERENT
URODYNAMIC CHARACTERISTICS AND
CLINICAL RELEVANCE
Jia-Fong Jhang*, Cheng-Ling Lee, YuanHong Jiang, Hann-Chorng Kuo, Hualien,
Taiwan
MP68-09 URODYNAMICS IN UNDERACTIVE
BLADDER: ABNORMAL VOLUME
MANAGEMENT VS. DETRUSOR
DEFICIENCY
Gerard Pregenzer*, Jason K Frankel, Phillip
Smith, Farmington, CT
MP68-19 MESENCHYMAL STEM CELLS
ATTENUATES KETAMINE-INDUCED
INTERSTITIAL CYSTITIS
Aram Kim*, Hwan Yeul Yu, Jung-Hyun Shin,
Dong-Myung Shin, Myung-Soo Choo, Seoul,
Korea, Republic of
MP68-10 IDENTIFICATION OF THE HUMAN
URINARY BLADDER STRUCTURES
EXPRESSING BETA-3 ADRENORECEPTOR
Ana Coelho, Porto, Portugal, James Gillespie,
Newcastle, United Kingdom, Francisco Cruz*,
Porto, Portugal
MP68-20 LUMBAR TO SACRAL ROOT REROUTING TO
RESTORE VOIDING FUNCTION IN A FELINE
SPINAL CORD INJURY MODEL:
URODYNAMIC AND RETROGRADE NERVE
TRACING RESULTS FROM A PILOT STUDY
Ornella Lam van ba*, Montreal, Canada,
Mary F. Barbe, Philadelphia, PA, Romain
Caremel, Shachar Aharony, Oleg Loutochin,
Line Jacques, Montreal, Canada, Matthew
Woods, Philadelphia, PA, Gerald F. Tuite,
Saint Petersburg, FL, Michael R. Ruggieri, Sr,
Philadelphia, PA, Lysanne Campeau,
Jacques Corcos, Montreal, Canada
MP68-11 URETHRAL DYSFUNCTION IN AGING
RATS
Ryu Kimura*, Takuma Oshiro, Asuka
Ashikari, Minoru Miyazato, Seichi Saito,
Okinawa, Japan
MP68-12 IN VITRO RELAXING RESPONSE OF
PHOSPHODIESTERASE-5 INHIBITORS
AND 〉-ADRENOCEPTOR AGONISTS IN
MICE BLADDER
Bruno Lima Linhares*, Lúcio F GonzagaSilva, Nilberto R F Nascimento, Marcos F
Carvalho, Rommel P Regadas, Lucas B
Marinho, Pedro R R Sousa, Ricardo Reges,
Fortaleza, Brazil
*Presenting author
ELECTRICAL STIMULATION OF
AFFERENT NERVES IN THE FOOT WITH
TRANSCUTANEOUS ADHESIVE PAD
ELECTRODES IMPROVES OVERACTIVE
BLADDER SYMPTOMS IN WOMEN
Christopher Chermansky*, Bing Shen, Jon
Shepherd, Shachi Tyagi, Jeremy Reese, William
de Groat, Changfeng Tai, Pittsburgh, PA
CREDITTM
233
MONDAY
MP68-05
Monday, May 9, 2016
10:30 am - 12:30 pm
PROSTATE CANCER: LOCALIZED: SURGICAL THERAPY V
Moderators: Christopher Amling, Francesco Montorsi and Herbert Lepor
ABSTRACT
NUMBER TITLE
MP69-01 LIMITED VERSUS EXTENDED PELVIC
LYMPHADENECTOMY DURING ROBOTASSISTED RADICAL PROSTATECTOMY:
IMPACT ON THE NUMBER OF NODES AND
ON NODAL INVASION.
Francesco Alessandro Mistretta*, Elisa De
Lorenzis, Angelica Anna Chiara Grasso,
Giancarlo Albo, Bernardo Rocco, Francesco
Rocco, Milan, Italy
ABSTRACT
NUMBER TITLE
MP69-07 IMPACT OF PELVIC LYMPH NODE
DISSECTION DURING RADICAL
PROSTATECTOMY ON 30ⴚDAY POST
OPERATIVE COMPLICATIONS: RESULTS
FROM A LARGE NATIONAL DATABASE
Nicola Pavan*, Trieste, Italy, Samarpit Ray,
Nachiketh Soodana⫺Prakash, Raymond R.
Balise, Carmen Mir, Bruno Nahar, Fernando
Marsicano, Miami, FL, Carlo Trombetta,
Trieste, Italy, Chad R. Ritch, Dipen J. Parekh,
Mark L. Gonzalgo, Miami, FL
MP69-02 COMPARISON OF TWO TEMPLATES OF
LYMPHADENECTOMY IN PATIENTS WITH
HIGH RISK PROSTATE CANCER
Roberto Sanseverino*, Tommaso Realfonso,
Olivier Intilla, Umberto Di Mauro, Giorgio
Napodano, Nocera Inferiore, Italy
MP69-08 AN ANALYSIS OF THE MORBIDITY OF
LIMITED, EXTENDED, AND SUPEREXTENDED PELVIC LYMPHADENECTOMY
TEMPLATES DURING RADICAL
PROSTATECTOMY
Vidit Sharma*, Alessandro Morlacco, Jason E
Joseph, Avinash K Nehra, Matthew K
MP69-03 ASSOCIATION BETWEEN LYMPH NODE
COUNTS AND ONCOLOGICAL OUTCOMES
IN LYMPH NODE POSITIVE PROSTATE
CANCER PATIENTS
Philipp Mandel*, Felix Chun, Markus Graefen,
Hartwig Huland, Derya Tilki, Hamburg,
Germany
MP69-09 TOPOGRAPHY OF RECURRENT
PROSTATE CANCER BASED ON SALVAGE
RADICAL PROSTATECTOMY TUMOR
MAPS
Toshikazu Takeda*, Amy Tin, Renato
Corradi, Maha Mamoor, Nicole Benfante,
Daniel Sjoberg, Samson Fine, James
Eastham, Peter Scardino, Karim Touijer, New
York, NY
MP69-04 SINGLE POSITIVE LYMPH NODE
PROSTATE CANCER CAN BE
SURGICALLY CURED IN SELECTIVE
CASES
Dae Keun Kim, Kyo Chul Koo, Ki Hong Kim,
Ali Abdel Raheem*, Byung Ha Chung, Young
Deuk Choi, Koon Ho Rha, Seoul, Korea,
Republic of
MP69-05
MP69-10 PROGNOSTIC SIGNIFICANCE OF PSA
AND TUMOR VOLUME AS A PREDICTOR
FOR BCR IN PROSTATE CANCER WITH
EXCLUSIVE APEX MARGIN
INVOLVEMENT
Kim, Goyang, Korea, Republic of, Hong Seok
ONCOLOGIC OUTCOMES AND
BIOCHEMICAL PREDICTORS FOLLOWING
SALVAGE LYMPH NODE DISSECTION FOR
PROSTATE CANCER
Fabio Zattoni*, Avinash Nehra, Val Lowe,
Laureano Rangel, Lance A. Mynderse,
Eugene Kwon, R. Jeffrey Karnes, Rochester,
MN
MP69-06 THE ROLE OF EXTENDED OR SUPEREXTENDED LYMPH NODE DISSECTION
FOR STAGING OF HIGH-RISK PROSTATE
CANCER
Lorenzo Tosco*, Sofie Isebaert, Evelyne
Lerut, Wouter Everaerts, Maarten Albersen,
Laura Van den Bergh, Christophe Deroose,
Karolien Goffin, Karin Haustermans, Hein
Van Poppel, Steven Joniau, Leuven, Belgium
MP69-11 MINIMALLY INVASIVE VS. OPEN RADICAL
PROSTATECTOMY: AN ANALYSIS OF 30DAY POSTOPERATIVE COMPLICATIONS,
UNPLANNED READMISSIONS, AND
MORTALITY
Christian Meyer*, Boston, MA, Akshay Sood,
Firas Abdollah, Jesse Sammon, Detroit, MI,
Malte Vetterlein, Björn Löppenberg, Julian
Hanske, Jeffrey Leow, Alexander Cole, Adam
Kibel, Maxine Sun, Boston, MA, Mani Menon,
Detroit, MI, Quoc-Dien Trinh, Boston, MA
234
MP69-12 PREDICTORS OF SURGICAL CURE IN
MEN WITH VERY HIGH RISK PROSTATE
CANCER
Antonarakis, Jeffrey Tosoian, Meera
Chappidi, Ridwan Alam, Stephanie Glavaris,
Kamyar Ghabili, Mohamad Allaf, Trinity
Bivalacqua, Kenneth Pienta, Phuoc Tran,
Baltimore, MD, Edward Schaeffer, Chicago,
IL, Ashley Ross, Baltimore, MD
MP69-16 UTILITY OF INTRAOPERATIVE APICAL
SOFT TISSUE MARGIN ASSESSMENT
DURING OPEN RADICAL RETROPUBIC
PROSTATECTOMY
Elton Llukani*, Herbert Lepor, New York, NY
MP69-17 EVALUATING THE TIMING OF SURGICAL
COMPLICATIONS FOLLOWING
PROSTATECTOMY
Jason Lomboy*, Matthew Macey, Troy
MP69-13 EXTRAPERITONEAL VS.
TRANSPERITONEAL ROBOT-ASSISTED
RADICAL PROSTATECTOMY IN THE
SETTING OF PRIOR ABDOMINAL OR
PELVIC SURGERY
David Horovitz*, Changyong Feng, Edward
M. Messing, Jean V. Joseph, Rochester, NY
MP69-18 PROSTATE CANCER TUMOR-VOLUME
HAS INDEPENDENT PROGNOSTIC VALUE
FOLLOWING RADICAL PROSTATECTOMY
Björn Löppenberg*, Christian von Bodman,
Florian Roghmann, Marko Brock, Joachim
Noldus, Jüri Palisaar, Herne, Germany
MP69-15
MP69-20 THE IMPACT OF PROTON-PUMP
INHIBITORS ON OUTCOMES FOLLOWING
Mary E. Westerman*, Vidit Sharma, R.
IMPACT OF WEEKDAY ON RADICAL
PROSTATECTOMY OUTCOMES
Julian Hanske*, Christopher Allard, Gally
Reznor, Christian Meyer, Steven Chang,
Adam Kibel, Quoc-Dien Trinh, Mark Preston,
Boston, MA
CREDITTM
Monday, May 9, 2016
10:30 am - 12:30 pm
INFERTILITY: BASIC RESEARCH & PATHOPHYSIOLOGY
Moderators: Marc Goldstein, Craig Niederberger and Dolores Lamb
ABSTRACT
NUMBER TITLE
MP70-01 IFT140 IS A NOVEL CANDIDATE GENE
FOR IMPAIRED SPERMATOGENESIS:
IDENTIFICATION BY WHOLE EXOME
SEQUENCING AND VALIDATION WITH
SANGER SEQUENCING
Amin Herati*, Peter Butler, Cenk Cengiz,
Matthew Bainbridge, James Lupski, Richard
Gibbs, Larry Lipshultz, Dolores Lamb,
Houston, TX
ABSTRACT
NUMBER TITLE
MP70-03 RHOXF2 AS A GUARDIAN OF THE HUMAN
MALE GERMLINE STEM CELLS
Hye-Won Song*, David Skarbrevik, Eric
Babajanian, Tung-Chin Hsieh, Miles
Wilkinson, San Diego, CA
MP70-04 MELANOMA ANTIGEN PROTEIN MAGEC1
MUTATION IDENTIFIED IN FAMILIAL NONOBSTRUCTIVE AZOOSPERMIA
Alexander W. Pastuszak*, Cenk Cengiz, Mir
Reza Bekheirnia, Larry I. Lipshultz, Dolores J.
Lamb, Houston, TX
MP70-02 EXPRESSION OF TEN-ELEVENTRANSLOCATION (TET) ENZYMES IS
ASSOCIATED WITH MALE FERTILITY
Klaus Steger*, Ni Kai, Temuujin
Dansranjavin, Giessen, Germany, Nina
Rogenhofer, München, Germany, Johanna
Deuker, Martin Bergmann, Hans-Christian
Schuppe, Florian Wagenlehner, Wolfgang
Weidner, Undraga Schagdarsurengin,
Giessen, Germany
*Presenting author
MP70-05
235
DEVELOPMENT OF A NOVEL 3
DIMENSIONAL (3D) TESTICULAR
ORGANOID MODEL FOR THE STUDY OF
HUMAN SPERMATOGENESIS AND
GENOTOXICITY IN VITRO
Samuel Pendergraft, Hooman SadriArdekani*, Tanya Reid, Anthony Atala, Colin
Bishop, Winston-Salem, NC
MONDAY
MP69-19 INCIDENCE, RISK FACTORS AND
OUTCOMES FOR RECTAL INJURY
DURING RADICAL PROSTATECTOMY
Shane Pearce*, Andrew Cohen, Vignesh
Packiam, Charles Nottingham, Joseph
Pariser, Scott Eggener, Chicago, IL
MP69-14 RADICAL CYSTECTOMY AS INITIAL PART
OF MULTIMODALITY TREATMENT IN CT4
VERY HIGH-RISK PROSTATE CANCER –
RESULTS OF A MULTI-INSTITUTIONAL
STUDY OF 62 PATIENTS
Martin Spahn*, Silvan Boxler, Bern,
Switzerland, Joniau Steven, Leuven, Belgium,
Alberto Briganti, Milan, Italy, Pia Bader,
Karlsruhe, Germany, Paolo Gontero, Turin,
Italy, Karnes Jeffrey R., Rochester, MN
MP70-06 A NOVEL TRANSCRIPTIONAL FACTOR
NKAPL IS A GERM CELL-SPECIFIC
SUPPRESSOR OF NOTCH SIGNALING
AND MAY BE A CANDIDATE CAUSATIVE
GENE OF COMPLETE MATURATION
ARREST
Yasushi Miyagawa*, Hidenobu Okuda, Tetsuji
Soda, Kentaro Takezawa, Shinichiro
Fukuhara, Hiroshi Kiuchi, Suita, Japan, Akira
Tsujimura, Urayasu, Japan, Masahito Ikawa,
Suita, Japan, Hiromitsu Tanaka, Nagasaki,
Japan, Norio Nonomura, Suita, Japan
MP70-14 EFFECTS OF DECURSIN EXTRACTED
FROM ANGELICA GIGAS VIA NRF2/HO-1
SIGNALLING PATHWAY IN
CRYPTORCHIDISM-INDUCED INFERTILITY
RAT MODEL
Woong Jin Bae*, Jin Bong Choi, Kang Sup
Kim, Sae Woong Choi, Su Jin Kim, Hyuk Jin
Cho, U-Syn Ha, Sung-Hoo Hong, Ji Youl Lee,
Sae Woong Kim, Seoul, Korea, Republic of
MP70-15
MP70-07 PROTEOMIC ANALYSIS TO DETERMINE
ORIGIN OF VASAL FLUID IN VASECTOMY
REVERSAL PATIENTS
Theodore Saitz*, Portland, OR, Kevin
Ostrowski, Seattle, WA, Ann Martinez
Acevedo, Jasper Bash, Jennifer Cunliffe,
Eugene Fuchs, Larry David, Jason Hedges,
Portland, OR
PROFILING SIGNALING PROTEINS IN
HUMAN SPERMATOZOA: BIOMARKER
IDENTIFICATION FOR SPERM QUALITY
EVALUATION
Antonio Patricio*, Joana Silva, Nuno Maia,
Saul Almeida, Joao Lourenço, Margarida
Fardilha, Aveiro, Portugal, Steven Pelech,
Vancouver, Canada
MP70-16 THE MECHANISM OF ENVIRONMENTAL
ENDOCRINE DISRUPTORS (DEHP)
INDUCES EPIGENETIC
TRANSGENERATIONAL INHERITANCE OF
CRYPTORCHIDISM
Geng Xiong*, Tao Lin, Guanghui Wei,
chongqing, China, People’s Republic of
MP70-08 TRIMETAZIDINE HAS PROTECTIVE
EFFECTS ON SPERMATOGENESIS IN A
STREPTOZOTOCIN INDUCED DIABETIC
RAT MODEL
Muhammet F. Ozcan*, Emine Hekimoglu,
Kemal Ener, Mehmet Namuslu, Ankara,
Turkey, Ramazan Altintas, Malatya, Turkey,
Huseyin Celik, Ziya Akbulut, Serkan Altinova,
Ankara, Turkey
MP70-17 RECOVERY OF SPERMATOGENESIS
AFTER TESTICULAR DAMAGE VIA COLD
ISCHEMIA IN RATS WITH AND WITHOUT
VARICOCELES
Aaron Bernie*, Bobby Najari, Nicholas
Hauser, Jennifer Reifsnyder, Brian Robinson,
New York, NY, Barry Zirkin, Haolin Chen,
Baltimore, MD, Philip Li, Peter Schlegel, Marc
Goldstein, New York, NY
MP70-09 INDICATORS OF INFLAMMASOME
ACTIVATION IN MEN WITH ABNORMAL
SEMEN PARAMETERS
Emad Ibrahim*, Karen Ibrahim, Michael
Jurewicz, Teodoro Aballa, George Attia,
Charles Lynne, Nancy Brackett, Miami, FL
MP70-18 SEMINAL LEVEL OF CLUSTERIN IN
INFERTILE MEN AS A SIGNIFICANT
BIOMARKER REFLECTING
SPERMATOGENESIS
Teruo Fukuda*, Hideaki Miyake, Noritoshi
Enatsu, Kei Matsushita, Masato Fujisawa,
Kobe, Japan
MP70-10 IMPACTS OF COMMON SEMEN HANDLING
METHODS ON SPERM FUNCTION
Alexander Travis*, Ithaca, NY, Cristina
Cardona, Melissa Moody, Alana Simpson, G.
Charles Ostermeier, Mountainside, NJ
MP70-11 EVIDENCE OF SPERMATOGONIAL STEM
CELL PRESENCE IN MEN WITH SERTOLI
CELL-ONLY SYNDROME
Phil Bach*, Anna Mielnik, Alexander
Bolyakov, Bobby Najari, Peter Schlegel,
Darius Paduch, New York, NY
MP70-19 THE ROLE OF UROCORTIN IN THE
APOPTOSIS OF GERM CELLS AFTER
EXPERIMENTAL TESTICULAR ISCHEMIAREPERFUSION IN THE RAT
Kenta Sumii*, Koji Chiba, Noritoshi Enatsu,
Hideaki Miyake, Masato Fujisawa, Kobe,
Japan
MP70-12 DIFFERENTIAL AUTOSOMAL DNA
METHYLATION PATTERNS AND
PHENOTYPIC VARIATIONS IN PATIENTS
WITH KLINEFELTER SYNDROME
Phil Bach*, Anna Mielnik, Alexander
Bolyakov, Lindsay Dow, Peter Schlegel,
Darius Paduch, New York, NY
MP70-20 VALIDATION OF MEASURING OXIDATIONREDUCTION POTENTIAL IN FRESH AND
FROZEN SEMEN SAMPLES WITH
MIOXSYS DIAGNOSTIC SYSTEM
Ashok Agarwal*, Rakesh Sharma, Cleveland,
OH, Stefan Du Plessis, Tygerberg, South
Africa, Edmund Sabanegh, Cleveland, OH
MP70-13 HUMAN CAPPING PROTEIN 〉3, A NOVEL
ISOFORM OF TESTIS-SPECIFIC ACTIN
CAPPING PROTEIN 〉3 SUBUNIT; THE
DYNAMIC TRANSCRIPTIONAL PROFILES
DURING SPERMATOGENESIS AND
POSSIBLE IMPLICATIONS OF MALE
INFERTILITY
Tetsuji Soda*, Yasushi Miyagawa, Norichika
Ueda, Kentaro Takezawa, Shinichiro
Fukuhara, Hiroshi Kiuchi, Suita, Japan,
Hiromitsu Tanaka, Sasebo, Japan, Norio
Nonomura, Suita, Japan
CREDITTM
236
Monday, May 9, 2016
10:30 am - 12:30 pm
KIDNEY CANCER: BASIC RESEARCH & PATHOPHYSIOLOGY I
Moderators: Wade Sexton and W. Marston Linehan
ABSTRACT
NUMBER TITLE
MP71-01 BLOOD SAMPLING FOR LIQUID BIOPSY
OF RENAL CELL CARCINOMA
OVERCOMES SAMPLING ERROR
ASSOCIATED WITH BIOPSY FOR
MOLECULAR GENOTYPING.
Christopher Keith, Atlanta, GA, Fei Lian,
Boston, MA, Rebecca Arnold, Michael Rossi,
Adeboye Osunkoya, Atlanta, GA, Jeremy
Goecks, John Gaspar, Washington, DC,
Kenneth Ogan, John Pattaras, Viraj Master,
David Roberts, John Petros*, Atlanta, GA
ABSTRACT
NUMBER TITLE
MP71-07 GENETIC CONCORDANCE RATES OF
MATCHED-PAIR RENAL CELL
CARCINOMA SAMPLES PROVIDE
EVIDENCE OF CLONAL EVOLUTION
Daniel M. Tennenbaum*, Brandon J. Manley,
Jozefina Casuscelli, Almedina Redzematovic,
Maria F. Becerra, Maria E. Arcila, Martin H.
Voss, Darren R. Feldman, Robert J. Motzer,
Jonathan A. Coleman, Paul Russo, James J.
Hsieh, A. Ari Hakimi, New York, NY
MP71-09 MUTUAL EXCLUSIVITY OF
CHROMOSOME 9P AND 3P LOSS
PROVIDES NOVEL THERAPEUTIC
TARGET
Chenghen Feng*, Hui Wen, Shanghai, China,
MP71-03 DEVELOPMENT OF A CLEAR CELL RENAL
CELL CARCINOMA XENOGRAFT MODEL:
A CASE FOR THE USE OF BIOPSY TISSUE
OVER SURGICAL TISSUE
Yiyu Dong, Brandon J Manley*, A. Ari Hakimi,
Maria F Becerra, Paul Russo, Jonathan A.
Coleman, James J Hsieh, New York, NY
MP71-10 CLINICAL FEATURES OF RECURRENT
SOMATIC MUTATIONS IN CLEAR CELL
RENAL CELL CARCINOMA: A LARGE
COHORT
Brandon J Manley*, Jozefina Casuscelli,
Daniel M Tennenbaum, Maria F Becerra,
Almedina Redzematovic, Maria E Arcila,
Martin H. Voss, Darren R. Feldman, Jonathan
A. Coleman, Paul Russo, Robert J. Motzer,
James J Hsieh, A. Ari Hakimi, New York, NY
MP71-04 SINGLE NUCLEOTIDE POLYMORPHISMS
ASSOCIATED WITH RECURRENCE AFTER
TREATMENT OF NON-METASTATIC
Justin Gregg*, Zachary Glaser, Curran
Emeruwa, Johnson Wong, Christopher
Johnson, Arturo Holmes, Loren Lipworth,
Peter Clark, Todd Edwards, Nashville, TN
MP71-05
MP71-11 GENOMIC LANSCAPE OF CLEAR CELL
RENAL CELL CARCINOMA METASTASIS
Maria F. Becerra*, Brandon J. Manley,
Jozefina Casuscelli, Almedina Redzematovic,
Daniel M. Tennenbaum, Robert J. Motzer,
Darren R. Feldman, Martin H. Voss, Maria
Arcila, Paul Russo, Jonathan A. Coleman,
James J. Hsieh, A. Ari Hakimi, New York, NY
MOLECULAR SUBTYPING OF RCC AND
METASTASIS PREDICTION BY MIRNA
EXPRESSION
Soum D. Lokeshwar*, Miami, FL, Shenelle N.
Wilson, Augusta, GA, Martin J. P. Hennig,
Lübeck, Germany, Michael Garcia-Roig,
Nicholas Ortiz, Murugesan Manoharan, Mark
S. Soloway, Miami, FL, Vinata B. Lokeshwar,
Augusta, GA
MP71-12 GENOMIC CHARACTERIZATION OF
SARCOMATOID TRANSFORMATION IN
Mark Bi, Siming Zhao, New Haven, CT, Maria
Merino, Bethesda, MD, Jonathan Said, Los
Angeles, CA, Adebowale Adeniran, Cayce
Nawaf, zuoquan Xie, Marta Boeke, NEW
HAVEN, CT, Vladimir Valera, Valhalla, NY,
Allan Pantuck, Arie Belldegrun, Los Angeles,
CA, Harriet Kluger, Richard Lifton, Brian
Shuch*, NEW HAVEN, CT
MP71-06 THE IMPACT OF TERT PROMOTER
REGION MUTATIONS IN RENAL CELL
CARCINOMA
Jozefina Casuscelli*, Brandon J. Manley,
Almedina Redzematovic, Maria F. Becerra,
Daniel M. Tennenbaum, Maria E. Arcila,
Martin H. Voss, Darren R. Feldman, Robert J.
Motzer, Paul Russo, Jonathan A. Coleman,
James J. Hsieh, A. Ari Hakimi, New York, NY
*Presenting author
237
MONDAY
MP71-08 SELECT CONCURRENT CHROMOSOME 3P
MUTATIONS PREDICT WORSE OVERALL
AND RECURRENCE-FREE SURVIVAL IN
CLEAR CELL RENAL CARCINOMA IN THE
CANCER GENOME ATLAS
Christopher Keith, John Petros, Michael
Rossi, Rebecca Arnold*, Atlanta, GA
MP71-02 UTILITY OF CLEAR CELL RENAL CELL
CARCINOMA GENE EXPRESSION
SUBTYPES IN RISK-STRATIFYING T1
RENAL MASSES
Aaron Laviana*, Amirali Salmasi, Los
Angeles, CA, Jim Hu, New York City, NY,
Michael Kuo, Los Angeles, CA, W. Rathmell,
Chapel Hill, NC, Arie Belldegrun, Allan
Pantuck, Los Angeles, CA
MP71-13 GENOMIC CHARACTERIZATION OF
RENAL CELL CARCINOMA WITH
SARCOMATOID DEDIFFERENTIATION
Gabriel Malouf, Paris, France, Siraj Ali, Kai
Wang, Sohail Balasubramanian, Jeffrey Ross,
Vincent Miller, Philip Stephens, Cambridge,
MA, David Khayat, Paris, France, Sumanta
Pal, Duarte, CA, Xiaoping Su, Kanishka
Sircar, Pheroze Tamboli, Eric Jonasch, Nizar
Tannir, Christopher Wood, Jose Karam*,
Houston, TX
MP71-18 A PATIENT-DERIVED ORTHOTOPIC
XENOGRAFT MODEL FOR TARGETING
RCC METASTASIS: IDENTIFYING
PERSONALIZED THERAPEUTIC
STRATEGIES
Stephen Bardot, Jessie Gills, Ravan Moret,
Xin Zhang, Ashley Richman, John Nelson*,
New Orleans, LA, Christudas Morais, Glenda
Gobe, Queensland, Australia, Marc Matrana,
Li Li, Grace Maresh, Sunil Talwar, Maria
Latsis, New Orleans, LA
MP71-14 ANALYSIS OF THE MUTATIONAL
LANDSCAPE OF SARCOMATOID CLEAR
COMPARED TO CONVENTIONAL CLEAR
Jozefina Casuscelli*, Brandon J. Manley, Roy
Mano, Almedina Redzematovic, Maria F.
Becerra, Daniel M. Tennenbaum, Maria E.
Arcila, Martin H. Voss, Darren R. Feldman,
Robert J. Motzer, Jonathan A. Coleman, Paul
Russo, James J. Hsieh, A. Ari Hakimi, New
York, NY
MP71-19 ESTABLISHING AN EXPERIMENTAL
MODEL FOR TARGETING RENAL CELL
CARCINOMA USING MESENCHYMAL
STEM CELLS IN THE AVIAN
CHORIOALLANTOIC MEMBRANE
Zhihao (James) Xu*, Hua Chen, Desmond
Pink, Katia Carmine-Simmen, John Lewis,
Ronald Moore, Edmonton, Canada
MP71-15
MP71-20 PATIENT-DERIVED AVATAR MOUSE
MODELS PREDICTS PROGNOSIS IN
ADVANCED RENAL CELL CARCINOMA.
Enrique Trilla, Lucas Regis*, Pol Servian,
David Lorente, Ana Celma, Carlos Salvador,
Jose Placer, Jacques Planas, Cristina
Suarez, Mar Martinez, Gabriela JimenezValerio, Ines deTorres, Rafael Morales, Jose
Jimenez, Ana Vivancos, Paolo Nuciforo, Joan
Carles, Oriol Casanovas, Juan Morote,
Barcelona, Spain
VHL GENE MUTATION SPECTRUM AND
GENOTYPE-PHENOTYPE
CORRELATIONSHIP OF CHINESE VHL
PATIENTS
Peng Shuanghe*, Li Teng, Wang Jiangyi,
Gong Kan, Beijing, China, People’s Republic
of
MP71-16 INTERMITENT HYPOXIA INCREASES
TUMOR ANGIOGENESIS IN A MOUSE
MODEL OF KIDNEY CANCER
Antoni Vilaseca*, Mireia Musquera, Marta
Torres, Noelia Campillo, Josep M Montserrat,
Barcelona, Spain, Karim Touijer, New York,
NY, Ramon Farre, Isaac Almendros, Antonio
Alcaraz, Barcelona, Spain
CREDITTM
MP71-17 FLCN KNOCKOUT MICE DEVELOP LUNG
TUMORS AND OTHER NEOPLASIA IN
MULTIPLE ORGANS
Jindong Chen*, Sue Schoen, Guang-Qian Xiao,
Rochester, NY, Bin Tean Teh, Singapore,
Singapore, Guan Wu, Rochetser, NY
Monday, May 9, 2016
10:30 am - 12:30 pm
Podium Session 38
BLADDER CANCER: BASIC RESEARCH & PATHOPHYSIOLOGY III
Moderators: Jeffrey Gingrich and Bernard Bochner
ABSTRACT
TIME NUMBER TITLE
10:30 PD38-01 NOTCH2-HEY AXIS PROMOTES TUMOR
GROWTH IN BLADDER CANCER
THROUGH CELL CYCLE PROGRESSION
AND DEDIFFERENTIATION
Tetsutaro Hayashi*, Hiroshima, Japan,
Akihiro Goriki, Htoo Zarni Oo, Roland Seiler,
Tilman Todenhofer, Wolfgang Jaeger,
Shannon Awrey, Manuel Altamirano-Dimas,
Ladan Fazli, Vancouver, Canada, Akio
Matsubara, Hiroshima, Japan, Peter Black,
Vancouver, Canada
ABSTRACT
TIME NUMBER TITLE
10:40 PD38-02 CIRCULATING TUMOR CELLS IN
PATIENTS WITH NON-UROTHELIAL
VERSUS UROTHELIAL BLADDER
CARCINOMA: DETECTION RATE AND
RELATION TO SURVIVAL
Bedeir Ali-El-Dein*, Mahmoud Laimoun,
Mahmoud Zakaria, Ramaila Abdel-Raouf,
Hekmat El-Naggar, Atallah A Shaaban,
Mansoura, Egypt
238
CHARACTERIZATION OF CELL BASED
MODELS FOR THE IN VITRO AND IN VIVO
STUDY OF DISCRETE MOLECULAR
SUBTYPES IN BLADDER CANCER
Wilson Chan*, Joshua Warrick, Lauren
Shuman, Zongyu Zheng, Hironobu
Yamashita, Vasty Osei Amponsa, Jay
Raman, David DeGraff, Hershey, PA
11:00 PD38-04
DUAL TUMOR-SUPPRESSORS (MIR-1455P/MIR-145-3P) INDUCING CANCER CELL
APOPTOSIS VIA DIRECT TARGETING
UHRF1 IN BLADDER CANCER
Ryosuke Matsushita*, Kagoshima City,
Japan, Naohiko Seki, Chiba CIty, Japan,
Hirofumi Yoshino, Kazutaka Miyamoto,
Masaya Yonemori, Kagoshima City, Japan,
Akira Kurozumi, Mayuko Kato, Chiba CIty,
Japan, Hideki Enokida, Masayuki Nakagawa,
Kagoshima City, Japan
11:10 PD38-05
11:20 PD38-06
11:30 PD38-07
*Presenting author
PREDICTIVE MODEL FOR THERAPEUTIC
RESISTANCE USING ERBB2 EXPRESSION
STATUS AND KI-67 LABELING INDEX IN
PATIENTS TREATED WITH
CHEMORADIOTHERAPY-BASED
BLADDER-SPARING PROTOCOL
Masaharu Inoue*, Fumitaka Koga, Soichiro
Yoshida, Hajime Tanaka, Shuichiro
Kobayashi, Minato Yokoyama, Junichiro
Kazutaka Saito, Yasuhisa Fujii, Kazunori
Kihara, Tokyo, Japan
RISK SCORE PREDICTION MODEL FOR
BLADDER CANCER USING COMBINATION
OF IMMUNOSCORE AND PATHOLOGICAL
STAGING
Krishna Vanaja Donkena*, George
Vasmatzis, Prabin Thapa, Robert R. Tarrell,
Igor Frank, Stephen A. Boorjian, R. Jeffrey
Karnes, John C. Cheville, Rochester, MN
GENETIC MUTATIONS IN PATIENTDERIVED BLADDER TUMOR ORGANOIDS
MIMIC PARENTAL TUMOR SAMPLES
Justin T. Matulay*, Lamont J. Barlow, Mark V.
Silva, Chee Wai Chua, Mitchell C. Benson,
James M. McKiernan, Hikmat A. Al-Ahmadie,
David B. Solit, Michael M. Shen, New York,
NY
11:40 PD38-08
SERUM NEURON-SPECIFIC ENOLASE IS A
SIGNIFICANT PROGNOSTIC FACTOR FOR
SMALL CELL CARCINOMA OF THE
URINARY BLADDER
Akihiro Naito*, Satoru Taguchi, Tohru
Nakagawa, Akihiko Matsumoto, Yasushi
Nagase, Jimpei Miyakawa, Motofumi Suzuki,
Hiroaki Nishimatsu, Yutaka Enomoto,
Shintaro Takahashi, Toshikazu Okaneya,
Tokyo, Japan, Daisuke Yamada, Takamitsu
Tachikawa, Chiba, Japan, Shigeru Minowada,
Tetsuya Fujimura, Hiroshi Fukuhara, Haruki
Kume, Yukio Homma, Tokyo, Japan
11:50 PD38-09
STEROID SULFATASE PREDICTS THE
PROGRESSION OF BLADDER CANCER
Minoru Kato*, Min Gi, Taro Iguchi, Satoshi
Tamada, Hideki Wanibuchi, Tatsuya
Nakatani, Osaka, Japan
12:00 PD38-10
BLADDER CANCER EXOSOMES FROM
HIGH-GRADE MUSCLE INVASIVE
BLADDER CANCER CONTAIN LONG NONCODING RNA AND MESSENGER RNA
Claudia Berrondo*, Jonathan Flax, Victor
Kucherov, Aisha Siebert, Thomas Osinski,
Alex Rosenberg, Christopher Fucile, Carla
Beckham, Rochester, NY
12:10 PD38-11
WHOLE TRANSCRIPTOME ANALYSIS
REVEALS MAJOR MOLECULAR
PATHWAYS THAT POTENTIALLY DRIVE
THE PROGRESSION OF CARCINOMA-INSITU TO MUSCLE-INVASIVE BLADDER
CANCER
New York, NY
12:20 PD38-12
BLADDER CANCER PROGRESSION IS
ASSOCIATED WITH THE ACCUMULATION
OF MDSC INDUCED BY DOWNREGULATION OF IL6
guoliang yang*, lianhua zhang, ming cao,
haige chen, juanjie bo, Shanghai, China,
CREDITTM
239
MONDAY
10:50 PD38-03
Monday, May 9, 2016
10:30 am - 12:30 pm
Podium Session 39
BLADDER CANCER: INVASIVE VI
Moderators: Gary Steinberg and Eila Skinner
ABSTRACT
TIME NUMBER TITLE
10:30 PD39-01 PROPHYLACTIC USE OF AN
INTRAPERITONEAL ONLAY MESH
DURING ILEAL CONDUIT URINARY
DIVERSION FOR THE PREVENTION OF
PARASTOMAL HERNIAS. INITIAL
EXPERIENCE
Itay Sternberg*, Daniel Yaffe, Amir Akdam,
Ilan Leibovitch, Kfar Saba, Israel
10:40 PD39-02
EARLY OUTCOMES OF PROPHYLACTIC
MESH PLACEMENT AT RADICAL
CYSTECTOMY TO PREVENT
PARASTOMAL HERNIAS
Timothy F. Donahue*, Eugene K. Cha,
Cristina Falavolti, Simon Y. Kimm, Hebert
Alberto Vargas, Guido Dalbagni, Bernard H.
Bochner, New York, NY
10:50 PD39-03
COMPLICATIONS AFTER TOTALLY
INTRACORPOREAL ROBOT-ASSISTED
RADICAL CYSTECTOMY: RESULTS FROM
THE EUROPEAN ASSOCIATION OF
UROLOGY ROBOTIC UROLOGY SECTION
(ERUS) SCIENTIFIC WORKING GROUP.
Abolfazl Hosseini*, Justin Collins, Christofer
Adding, Tommy Nyberg, Stockholm, Sweden,
Anthony Koupparis, Edward Rowe, Bristol,
United Kingdom, Matthew Perry, Rami Issa,
London, United Kingdom, Martin
Schumacher, Aarau, Switzerland, Carl
Wijburg, Arnham, Netherlands, Erdem Canda,
Ankara, Turkey, Mevlana Balbay, Istanbul,
Turkey, Karel Decaestecker, Ghent, Belgium,
Christian Schwentner, Arnulf Stenzl,
Tubingen, Germany, Sebastian Edeling, Saša
Pokupić, Hanover, Germany, Khurshid Guru,
Buffalo, NY, Alexander Mottrie, Aalst,
Belgium, Peter Wiklund, Stockholm, Sweden
11:00 PD39-04
ABSTRACT
TIME NUMBER TITLE
11:10 PD39-05 ONCOLOGICAL OUTCOMES OF TOTALLY
INTRACORPOREAL ROBOT-ASSISTED
RADICAL CYSTECTOMY: RESULTS FROM
THE EUROPEAN ASSOCIATION OF
UROLOGY ROBOTIC UROLOGY SECTION
(ERUS) SCIENTIFIC WORKING GROUP
Abolfazl Hosseini*, Justin Collins, Christofer
Adding, Tommy Nyberg, Stockholm, Sweden,
Anthony Koupparis, Edward Rowe, Bristol,
United Kingdom, Matthew Perry, Rami Issa,
London, United Kingdom, Martin
Schumacher, Aarau, Switzerland, Carl
Wijburg, Arnham, Netherlands, Erdem Canda,
Ankara, Turkey, Mevlana Balbay, Istanbul,
Turkey, Karel Decaestecker, Ghent, Belgium,
Christian Schwentner, Arnulf Stenzl,
Tubingen, Germany, Sebastian Edeling, Saša
Pokupić, Hanover, Germany, Khurshid Guru,
Buffalo, NY, Alexander Mottrie, Aalst,
Belgium, Peter Wiklund, Stockholm, Sweden
TIMING OF BLOOD TRANSFUSION AND
NOT ABO BLOOD TYPE IS ASSOCIATED
WITH SURVIVAL IN PATIENTS TREATED
WITH RADICAL CYSTECTOMY FOR NONMETASTATIC BLADDER CANCER:
RESULTS FROM A SINGLE HIGH-VOLUME
INSTITUTION
Marco Moschini*, Giorgio Gandaglia, Vito
Cucchiara, Giusy Burgio, Milan, Italy,
Agostino Mattei, Lucerne, Switzerland,
Shahrokh Francois Shariat, Vienna, Austria,
Francesco Cantiello, Rocco Damiano,
Catanzaro, Italy, Andrea Salonia, Alberto
Briganti, Francesco Montorsi, Renzo
Colombo, Andrea Gallina, Milan, Italy
240
11:20 PD39-06
COST DASHBOARDS FOR RADICAL
CYSTECTOMY: ACCOUNTING FOR
SURGEON COST VARIATION
Alan Thong*, Wazim Narain, Donna
Boccamazzo, Peter Sidi, Guido Dalbagni,
Bernard Bochner, New York, NY
11:30 PD39-07
SURGEON VARIATION IN THE COSTS OF
RADICAL CYSTECTOMY
Jeffrey Leow*, Alexander Cole, Steven
Chang, Christian Meyer, Adam Kibel, Boston,
MA, Mani Menon, Detroit, MI, Thomas
Seisen, Boston, MA, Jesse Sammon, Detroit,
MI, Mark Preston, Boston, MA, Benjamin
Chung, Palo Alto, CA, Maxine Sun, QuocDien Trinh, Boston, MA
11:40 PD39-08
PROPENSITY-MATCHED COMPARISON
OF SURVIVAL OUTCOMES IN PATIENTS
VERSUS BLADDER PRESERVING
TRIMODAL THERAPY
Girish Kulkarni*, Thomas Hermanns, Kathy
Li, Yanliang Wei, Bimal Bhindi, Cynthia Kuk,
Srikala Sridhar, Theodorus van der Kwast,
Peter Chung, Robert Bristow, Padraig Warde,
Milosevic Michael, Neil Fleshner, Michael
Jewett, Alexandre Zlotta, Toronto, Canada
11:50 PD39-09
CHEMORADIOTHERAPY IN
OCTOGENARIANS AS PRIMARY
TREATMENT FOR MUSCLE INVASIVE
BLADDER CANCER
Victor McPherson*, George Rodrigues, Glenn
Bauman, Nicholas Power, London, Canada
12:00 PD39-10
DO BLADDER CANCER PATIENTS WITH
CLINICALLY METASTATIC LYMPH NODE
DISEASE BENEFIT FROM RADICAL
CYSTECTOMY?
Bashir Al Hussein Al Awamlh*, Daniel
Nguyen, Michael Shulster, Padriac O’malley,
David M. Golombos, Patrick Lewicki,
Benjamin Stone, Douglas Scherr, New York,
NY
12:10 PD39-11
THE OUTCOME OF POSTCHEMOTHERAPY RETROPERITONEAL
LYMPH NODE DISSECTION IN PATIENTS
WITH METASTATIC UROTHELIAL
CARCINOMA OF THE BLADDER IN THE
RETROPERITONEUM
Nick Liu*, Katie Murray, S. Machele Donat,
Harry Herr, Bernard Bochner, Guido
Dalbagni, New York City, NY
12:20 PD39-12
IMPACT OF DELAY TO CYSTECTOMY IN
NON RESPONDERS TO NEOADJUVANT
CHEMOTHERAPY (NACT) PRIOR TO
RADICAL CYSTECTOMY (RC) IN
PATIENTS WITH MUSCLE INVASIVE
BLADDER CANCER.
Giulia Lane*, Yunhua Fan, Suprita Krishna,
Badrinath Konety, Minneapolis, MN
CREDITTM
Monday, May 9, 2016
10:30 am - 12:30 pm
TRAUMA/RECONSTRUCTION/DIVERSION: URETER (INCLUDING PYELOPLASTY) AND BLADDER RECONSTRUCTION
(INCLUDING FISTULA), AUGMENTATION, SUBSTITUTION, DIVERSION III
Moderators: Richard Hautmann and Leo Doumanian
ABSTRACT
TIME NUMBER TITLE
10:30 PD40-01 MANAGEMENT OF FAILURE AFTER
PYELOPLASTY
Ryan Swearingen*, Sapan Ambani, David. A.
Bloom, Gary J. Faerber, J. Stuart Wolf, Jr.,
Ann Arbor, MI
10:40 PD40-02
10:50 PD40-03
11:00 PD40-04
*Presenting author
ABSTRACT
TIME NUMBER TITLE
11:10 PD40-05 EVALUATION OF LAPAROSCOPIC
PYELOPLASTY AS AN ALTERNATIVE TO
NEPHRECTOMY IN ADULTS WITH
POORLY FUNCTIONING KIDNEYS DUE TO
URETEROPELVIC OBSTRUCTION
Bruno Nascimento*, Eduardo Miranda, Victor
Srougi, Marco Arap, Hiury Andrade, Anuar
Mitre, Rodolfo Bandeira, Miguel Srougi,
Ricardo Duarte, Sao Paulo, Brazil
TRANSPERITONEAL LAPAROSCOPIC
MANAGEMENT OF PELVI-URETERIC
JUNCTION OBSTRUCTION WITH
ASSOCIATED CONGENITAL ANOMALIES
AND SECONDARY CALCULI:OUR
TECHNIQUE AND EXPERIENCE
Anup Kumar*, Gaurav Kumar, Harbinder
Singh, Niraj Kumar, Mikir Patel, New Delhi,
India
OUTCOMES OF PYELOPLASTY IN VERY
POORLY FUNCTIONING KIDNEYS
Rishi Nayyar, Siddarth Yadav, Premnath
Dogra*, New Delhi, India
DIAGNOSTIC ACCURACY OF URINARY
〉2-MICROGLOBULIN, CA19-9, NGAL AND
KIM-1 IN URETEROPELVIC JUNCTION
OBSTRUCTION IN ADULTS
Eduardo Miranda*, José de Bessa Jr.,
Roberto Lopes, Victor Sougi, Hiury Andrade,
Rodolfo Bandeira, Marco Arap, Anuar Mittre,
Nayara Viana, Sabrina dos Reis, Katia Leite,
Miguel Sougi, Ricardo Duarte, Sao Paulo,
Brazil
241
11:20 PD40-06
SURGE IN ADULT PYELOPLASTY:
MEETING PATIENT NEED OR MAXIMIZING
ROBOT UTILIZATION? DATA FROM THE
NATIONWIDE INPATIENT SAMPLE
Marc Colaco*, Susan MacDonald, Ryan
Terlecki, Winston Salem, NC
11:30 PD40-07
EMERGING APPLICATIONS OF
NEPHROPEXY IN URETERAL
RECONSTRUCTION
Hugo Aguilar-Cruz*, Matthias Hofer, Billy
Cordon, Jeremy Scott, Allen Morey, Dallas,
TX
11:40 PD40-08
LAPAROSCOPIC URETERAL
SUBSTITUTION WITH ILEUM AND
APPENDIX
Boris Komyakov, Viktor Ochelenko*, Bahman
Guliev, Saint-Petersburg, Russian Federation
11:50 PD40-09
COMPARISON OF ENDOSCOPIC
BALLOON DILATION VS LAPAROSCOPIC
URETERAL REIMPLANTATION FOR THE
TREATMENT OF ADULT PRIMARY
OBSTRUCTIVE MEGAURETER
Xuesong Li*, Kunlin Yang, Lin Yao, Cuijian
Zhang, Lin Cai, Han Hao, Gang Wang, Liqun
Zhou, Beijing, China, People’s Republic of
MONDAY
Podium Session 40
12:00 PD40-10
RENDEZVOUS PROCEDURE TO TREAT
COMPLEX URETERIC DISCONTINUITIES
Giorgio Mazzon*, Marco Bolgeri, Rebecca
Dale, Vimoshan Arumuham, Clare Allen, Alex
Kirkham, Navin Ramachandran, Sian Allen,
Daron Smith, Tim Philp, Simon Choong,
12:10 PD40-11
TRENDS AND PREDICTORS OF
URETERAL INJURIES IN THE ERA OF
LAPAROSCOPIC AND ROBOTIC SURGERY
Vinay Patel*, New York, NY, Kristian
Stensland, Burlington, MA, Rajiv Jayadevan,
Los Angeles, CA, Karl Coutinho, Simon Hall,
Michael Palese, New York, NY
12:20 PD40-12
IATROGENIC URETERAL INJURY FROM
HYSTERECTOMY IN THE ERA OF
MINIMALLY INVASIVE SURGERY: A
NATIONAL ANALYSIS OF TRENDS, RISK
FACTORS, AND OUTCOMES
Vignesh T. Packiam*, Joseph J. Pariser,
Andrew J. Cohen, Charles U. Nottingham,
Sarah F. Faris, Gregory T. Bales, Chicago, IL
CREDITTM
Monday, May 9, 2016
10:30 am - 12:30 pm
Podium Session 41
KIDNEY CANCER: LOCALIZED: SURGICAL THERAPY IV
Moderators: Michael Blute and Karim Touijer
ABSTRACT
TIME NUMBER TITLE
10:30 PD41-01 THE EFFECT OF TIME ELAPSED FROM
SURGERY ON THE SUBSEQUENT RISK
OF CANCER SPECIFIC MORTALITY IN
RENAL CELL CARCINOMA PATIENTS
Paolo Dell’Oglio, Alessandro Larcher,
Giovanni La Croce*, Paolo Capogrosso,
Alessandro Nini, Armando Stabile, Ettore Di
Trapani, Milan, Italy, Pierre Karakiewicz,
Montreal, Canada, Alberto Briganti,
Francesco Montorsi, Umberto Capitanio,
Roberto Bertini, Milan, Italy
10:40 PD41-02
10:50 PD41-03
ABSTRACT
TIME NUMBER TITLE
11:00 PD41-04 TRANSPERITONEAL APPROACH
ACHIEVES SIMILAR OUTCOMES TO
RETROPERITONEAL APPROACH FOR
POSTERIOR TUMORS
Matthew J. Maurice*, Jihad H. Kaouk, Peter
A. Caputo, Cleveland, OH, Ravi Barod,
Detroit, MI, Sam B. Bhayani, St. Louis, MO,
Mohamad E. Allaf, Baltimore, MD, Craig G.
Rogers, Detroit, MI, Michael D. Stifelman,
New York, NY
NOMOGRAM TO PREDICT RECURRENCE
IN NON-METASTATIC RCC WITH
THROMBUS USING A MULTI-CENTER
CONTEMPORARY SERIES
Michael L. Blute, Jr.*, Madison, WI, Timothy
A. Masterson, Indianapolis, WI, Viraj A.
Master, Atlanta, GA, Vitaly Margulis, Dallas,
TX, C. Adam Lorentz, Atlanta, GA, Tyler M.
Bauman, St. Louis, MO, Jose A. Karam,
Christopher G. Wood, Houston, TX, E. Jason
Abel, Madison, WI
SHOULD PARTIAL NEPHRECTOMY BE
CONSIDERED AN IMPERATIVE
INDICATION IN STAGE II CHRONIC
KIDNEY DISEASE?
Zachary Hamilton*, San Diego, CA, Sumi
Dey, Grand Rapids, MI, Sean Berquist, Abdel Rahman Hassan, Catherine Defour, San
Diego, CA, Alp Tuna Beksac, Ankara, Turkey,
Fang Wan, James Proudfoot, San Diego, CA,
Brian Lane, Grand Rapids, MI, Ithaar
Derweesh, San Diego, CA
242
11:10 PD41-05
FINDINGS AND IMPACT OF EARLY
IMAGING FOLLOWING PARTIAL
NEPHRECTOMY
Ryan Tubre*, Travis Dum, Tim Walmann,
Kansas City, KS, William Parker, Rochester,
MN, Moben Mirza, David Duchene, Kansas
City, KS
11:20 PD41-06
HOSPITAL AND PATIENT RELATED
FACTORS INFLUENCING THE
UTILIZATION OF PARTIAL
NEPHRECTOMY
Arpeet Shah*, Robert Blackwell, Anai Kothari,
Matthew Zapf, Paul Kuo, Gopal Gupta,
Maywood, IL
11:30 PD41-07
EVALUATING THE TIMING OF SURGICAL
COMPLICATIONS FOLLOWING
NEPHRECTOMY
Matthew Macey*, Jason Lomboy, Troy
PATIENTS WHO MAINTAIN NORMAL
GLOMERULAR FILTRATION RATE (GFR)
DESPITE CORONARY ARTERY DISEASE
APPEAR RESISTANT TO MARKED GFR
DECLINE FOLLOWING RADICAL
NEPHRECTOMY
Daniel Parker*, Mohammed Haseebuddin,
Brian Egleston, Nikhil Waingankar, Ben
Ristau, Miki Haifler, Serge Ginzburg, Rosalia
Viterbo, Richard E. Greenberg, David YT
Chen, Marc Smaldone, Robert G. Uzzo,
11:50 PD41-09
ACTUAL VERSUS ESTIMATED CLINICAL
OUTCOMES USING THE ACS SURGICAL
RISK CALCULATOR IN PATIENTS
UNDERGOING PARTIAL NEPHRECTOMY
FOR RENAL CELL CARCINOMA
Brian Blair*, Erik Lehman, Syed Jafri, Jay
Raman, Hershey, PA
12:00 PD41-10
COMPARISON OF WARM AND COLD
ISCHEMIA ON RENAL FUNCTION AFTER
PARTIAL NEPHRECTOMY
Yushi Yamauchi*, Yasuhito Funahashi, Naoto
Sassa, Yasushi Yoshino, Tokunori
Yamamoto, Momokazu Gotoh, Aichi Nagoya
City, Japan
12:10 PD41-11
DIFFERENCES IN OVERALL SURVIVAL
FOR PATIENTS WITH STAGE I-II RENAL
CELL CARCINOMA TREATED WITH
PARTIAL OR RADICAL NEPHRECTOMY
Benjamin Ristau*, Elizabeth Handorf, Robert
Uzzo, David Cahn, Philadelphia, PA, Simon
Kim, Cleveland, OH, Miki Haifler, Nikhil
Waingankar, Mohammed Haseebuddin,
Rosalia Viterbo, David Chen, Richard
Greenberg, Alexander Kutikov, Marc
Smaldone, Philadelphia, PA
12:20 PD41-12
IMPACT OF LYMPH NODE DISSECTION AT
THE TIME OF RADICAL NEPHRECTOMY AND
TUMOR THROMBECTOMY ON
ONCOLOGICAL OUTCOMES OF PATIENTS
WITH RENAL CELL CARCINOMA AND
TUMOR THROMBUS
Derya Tilki, Thenappan Chandrasekar*,
Sacramento, CA, Gaetano Ciancio, Miami,
FL, Siamak Daneshmand, Los Angeles, CA,
Juan Martinez-Salamanca, Madrid, Spain,
Francesco Montorsi, Milano, Italy, Oscar
Rodriguez-Faba, Barcelona, Spain, Carlo
Terrone, Novara, Italy, Richard Zigeuner,
Graz, Austria, John Libertino, Burlington, MA,
Christopher Evans, Sacramento, CA
CREDITTM
MONDAY
11:40 PD41-08
Monday, May 9, 2016
10:30 am - 12:30 pm
Video Session 10
ROBOTICS – BENIGN DISEASE
Moderators: Jim Hu and Robert Figenshau
ABSTRACT
NUMBER TITLE
V10-01
ROBOT ASSISTED SIMPLE
PROSTATECTOMY USING THE MILLIN’S,
FRAYER’S, POSTERIOR, AND COMPLETE
ANATOMIC TECHNIQUES
V10-02
*Presenting author
ABSTRACT
NUMBER TITLE
V10-03
ROBOTIC APPENDICOVESICOSTOMY
REVISION IN A PEDIATRIC NEOBLADDER
PATIENT
Gene Huang*, Rodolfo Elizondo, Jason Au,
Edmond Gonzales, Patricio Gargollo, Houston,
TX
COMPLEX ROBOT-ASSISTED
LAPAROSCOPIC EXTRAVESICAL
URETERAL REIMPLANTATION (RALUR)
FOLLOWING ENDOSCOPIC INJECTION OF
DEXTRONAMER/HYALURONIC ACID FOR
VESICOURETERAL REFLUX
Michael Garcia-Roig*, Jonathan Huang,
Andrew Kirsch, Atlanta, GA
V10-04
243
ROBOTIC ASSISTED
ABDOMINOPERINEAL VESICOURETHRAL
ANASTOMOTIC RECONSTRUCTION WITH
URETHRAL PULL THROUGH
Nicholas Hauser*, Sameer Mittal, Joshua
Halpern, Jonathan Shoag, Rajveer Purohit,
V10-05
TENSION PNEUMOTHORAX FROM
OCCULT DIAPHRAGMATIC HERNIA
DURING ROBOTIC PYELOPLASTY - STEPBY-STEP MANAGEMENT
Michael Kurtz*, Russell Jennings, Amar Nijagal,
Petra Meier, Bartley Cilento, Boston, MA
V10-09
ROBOT-ASSISTED RESERVOIR
CAPSULOTOMY AND MOBILIZATION TO
TREAT AUTO-INFLATION OF AN
Vikram Narayan*, Joshua Bodie, J. Kyle
Anderson, Minneapolis, MN
V10-06
ROBOTIC REDO PYELOPLASTY:
BRIDGING THE GAP WITH BUCCAL
Jennifer J Ahn*, Jonathan S Ellison, Thomas
S Lendvay, Seattle, WA
V10-10
ROBOTIC PREVESICAL RETROPUBIC
EXCISION OF PELVIC MESH
Dunia Khaled*, Gillian Wolff, Scott Delacroix,
Jr., Christian Winters, New Orleans, LA
V10-07
COMPLEX ROBOTIC RECONSTRUCTION
FOR LARGE RADIATION
RECTOURETHRAL FISTULA AND
URETHRAL STRICTURE: SALVAGE
PROSTATECTOMY, POSTERIOR
URETHROPLASTY, LOW ANTERIOR
RESECTION, WITH REANASTOMOSIS
David Canes*, Jason Hall, Alex Vanni,
Burlington, MA
V10-11
ROBOTIC URETEROCALICOSTOMY IN
HORSESHOE KIDNEY
Peter Stuhldreher*, Ardavan Akhavan,
Baltimore, MD
V10-12
ROBOTIC BLADDER NECK CLOSURE AND
MITROFANOFF
Gregory Murphy*, Farmington, CT, Joseph
Wagner, Hartford, CT
V10-08
CREDITTM
COMBINED ROBOTIC ASSISTED
BLADDER DIVERTICULECTOMY AND
THE PROSTATE
Jed-Sian Cheng*, Camden, NJ, Mahdi Zangi,
Shahin Tabatabaei, Boston, MA
Monday, May 9, 2016
11:00 am - 12:00 pm
SURGICAL TECHNIQUES: PERCUTANEOUS NEPHROLITHOTOMY
11:00
SURGICAL TECHNIQUES: PERCUTANEOUS
NEPHROLITHOTOMY
Moderator: Arthur Smith
Panelists: Mantu Gupta
Mitchell Humphreys
Ralph Clayman
12:00
ADJOURN
CREDITTM
Monday, May 9, 2016
12:00 pm - 1:30 pm
YOUNG UROLOGISTS FORUM
12:00
WELCOME & INTRODUCTIONS
Committee Chair: Sean Stroup
1:15
Q&A
Neil Baum
12:05
RECOGNITION OF YU OF THE YEAR AWARD
RECIPIENTS
Committee Chair: Sean Stroup
1:30
ADJOURN
12:15
PRESENTATION: URO-TOPIA: DEVELOPING
THE ALMOST PERFECT UROLOGY PRACTICE
Neil Baum
Monday, May 9, 2016
12:00 pm - 5:15 pm
RESEARCH ON CALCULUS KINETICS SOCIETY (ROCK)
12:00
SPONSORED LUNCH PROGRAM (NON-CME)
1:00
INTRODUCTION
Society President: Stephen Nakada
1:05
SESSION 1: LATEST ON SURGICAL
MANAGEMENT OF STONES
Moderators: Stephen Nakada, Brian Eisner
DISPOSABLE SCOPE UPDATE
Michael Lipkin
244
1:20
DEBATE I: DUST OR EXRACT?
Debaters: Olivier Traxer, Brian Matlaga
3:30
UPDATE ON CYSTINURIA
David Goldfarb
1:50
SURGICAL GUIDELINES UPDATE
Dean Assimos
3:45
BREAK
4:00
12:00
SPONSORED LUNCH PROGRAM (NON-CME)
2:00
DEBATE II: IS SWL DEAD?
Moderator: Timothy Averch
Debaters: Gerhard Fuchs, James Lingeman
SESSION 3: HOT CONTROVERSIES IN STONE
DISEASE
Moderators: Nicole Miller, Demetrius Bagley
SESSION 2: LATEST ON MEDICAL
MANAGEMENT
Moderators: John Lieske, Vernon Pais
MEDICAL GUIDELINES UPDATE
Margaret Pearle
2:45
BEST NUTRITIONAL ASSESSMENT TOOLS
Kristina Penniston
3:00
SHARED MEDICAL APPOINTMENTS
Roy Jhagroo
3:15
UPDATE ON THIAZIDES
Elaine Worcester
4:30
MET IN PREGNANCY
Amy Krambeck
4:45
DEBATE IV: IS MET FOR ALL STONES?
Moderator: Stephen Jackman
Debaters: Glenn Preminger, Stephen Nakada
5:15
ADJOURN
CREDITTM
Monday, May 9, 2016
12:00 pm - 5:30 pm
UROLOGIC SOCIETY FOR TRANSPLANTATION AND RENAL SURGERY (USTRS)
12:00
1:00
NON-CME PORTION OF PROGRAM
2:25
COFFEE BREAK WITH EXHIBITORS
INDUSTRY LUNCH SYMPOSIUM, SPONSORED
BY BAXTER CANADA
2:35
THE ROBOT AND KIDNEY TRANSPLANTATION
INTRODUCTION
John Barry
2:50
ROBOTICALLY-ASSISTED KIDNEY
TRANSPLANTATION: THE IDEAL APPROACH
Mani Menon
3:15
ADDITIONAL USES OF THE ROBOT IN KIDNEY
TRANSPLANTATION
Erik Castle
3:40
STATUS OF THE TISSUE-ENGINEERED
KIDNEY
Anthony Atala
4:00
RESIDENT AND FELLOW ABSTRACT
PRESENTATIONS FOR NOVICK AWARD
Moderator: Evan Vapnek
5:00
USTRS BUSINESS MEETING
5:30
ADJOURN
CME PORTION OF PROGRAM COMMENCES
WELCOME AND INTRODUCTION OF
INTERNATIONAL HOUR
Society Chair: John Barry
1:05
PERSPECTIVE ON KIDNEY
TRANSPLANTATION FROM THE MIDDLE EAST
Raja Khauli
1:20
TRANSPLANTATION FROM INDIA
Arun Chawla
1:35
TRANSPLANTATION FROM BANGLADESH
Waliul Islam
1:50
TRANSPLANTATION FROM CANADA
Anil Kapoor
2:05
CREDITTM
THE DEVELOPMENT AND CURRENT STATUS
OF LIVING DONOR KIDNEY TRANSPLANT
EXCHANGES
Michael Rees
*Presenting author
245
MONDAY
2:30
DEBATE III: BEST STONE ER IMAGING
Moderator: Marshall Stoller
Debaters: Ben Chew, Ojas Shah
Monday, May 9, 2016
12:15 pm - 4:30 pm
AUA/BRAZILIAN/PORTUGUESE UROLOGY PROGRAM (BPUP)
12:15
WELCOME AND INTRODUCTION:
INTRODUCTION OF SBU-AUA SCHOLARS AND
THE APU AND CLU LEADERSHIP
Program Chair: Fernando Kim
2:10
DIAGNOSIS AND TREATMENT OF
OVERACTIVE BLADDER (NON-NEUROGENIC)
IN ADULTS: AUA/SUFU GUIDELINE
Christopher Tessier
12:30
THE ROLE OF CYTOREDUCTIVE
NEPHRECTOMY IN THE ERA OF TARGETED
THERAPY
Robert Flanigan
2:30
THE ROLE OF ESWL IN THE TREATMENT OF
RENAL AND URETERAL STONES
Brian Matlaga
2:50
12:50
WHEN AND HOW SHOULD WE OPERATE
PROSTATE CANCER?
Herbert Lepor
PATIENT SAFETY IN UROLOGY
Fernando Kim
3:10
ABSTRACTS AND Q&A
4:30
ADJOURN
1:10
URETHRAL RECONSTRUCTION UPDATE
Alex Vanni
1:30
GENITO-URINARY ISSUES IN GERIATRIC
POPULATION
Tomas Griebling
1:50
WHEN TO RECOMMEND TESTOSTERONE
REPLACEMENT
John Mulhall
CREDITTM
Monday, May 9, 2016
12:30 pm - 5:40 pm
INTERNATIONAL RUSSIAN-SPEAKING UROLOGICAL SOCIETY (IRUS)
12:30
WELCOME FROM THE IRUS
Society Chairs: Lev Elterman, Dmitriy Nikolavsky
12:33
WELCOME FROM THE AUA
12:36
WELCOME FROM PROF. DMITRY PUSHKAR
Dmitry Pushkar
12:40
RECONSTRUCTIVE UROLOGY
Moderators: Sergey Kotov, Alexei Zhivov
KEYNOTE LECTURE: ACTIVE SURVEILLANCE
FOR PROSTATE CANCER: GOOD IDEA OR
LOST OPPORTUNITY?
Moderator: Oleg Shapiro
Speaker: Laurence Klotz
POSTERIOR URETHRAL RECONSTRUCTION:
TRAUMA AND BEYOND
Hunter Wessells
1:00
PLACEMENT OF PENILE PROSTETICS IN
NEOPHALLUS
Miroslav Djordjevic
1:15
CONTEMPORARY TREATMENT OF
Rafael Carrion
1:30
ROLE OF TISSUE-ENGINEERED URETHRAL
SUBSTITUTION: CLINICAL AND PRECLINICAL
STUDIES
Denis Butnaru
1:45
INTERESTING CASES
Presenters: Lee Zhao, Jay Simhan, Ramon Virasoro,
Krishnan Venkatesan
2:10
BREAK
2:25
UROLOGIC ONCOLOGY
Moderator: Gennady Bratslavsky
246
2:45
ROLE OF RADICAL PROSTATECTOMY IN
Guaram Karazanashvilli
3:00
TREATMENT FOR LOCALLY ADVANCED
PROSTATE CANCER: THE ROLE OF THE
EARLY CHEMOTHERAPY IN MULTIMODAL
TREATMENT
Sergey Polyakov
3:15
ESTABLISHED AND NEW MODELS AND
SCORES FOR MANAGEMENT OF LOCALIZED
RCC
Oleksandr Stakhovskyi
3:30
SURGICAL TREATMENT OF METASTATIC
LESIONS IN RENAL CELL CANCER PATIENTS:
INDICATION AND RESULTS
Boris Alekseev
3:45
2016 CYSTECTOMY AND NEOBLADDER
UPDATE
Ashot Tsaturyan
4:00
PANEL OF EXPERTS DISCUSSION OF
INTERESTING CASES
Moderator: Alexander Kutikov
4:20
BREAK
4:30
ENDOUROLOGY SOCIETY
Moderators: Alexey Martov, Zhamshid Okhunov
5:00
Q&A
5:10
PRACTICAL ADVICE FOR MEDICAL STONE
MANAGEMENT
Glenn Preminger
5:30
Q&A
5:40
ADJOURN
INTRODUCTIONS
4:35
THE PROSTATIC URETHRAL LIFT (PUL):
DEVELOPMENT AND EVIDENCE FOR AN
EFFECTIVE MINIMALLY INVASIVE MALE
LUTS/BPH TREATMENT
Claus Roehrborn
Monday, May 9, 2016
1:00 pm - 3:00 pm
ABSTRACT
NUMBER TITLE
MP72-01 URINE LEVELS OF MACROPHAGE
MIGRATION INHIBITORY FACTOR ARE
INCREASED IN PATIENTS WITH BLADDER
INFLAMMATION
Fei Ma*, Lexington, KY, Dimotrios E.
Kouzoukas, Maywood, IL, Magnus M. Fall,
Gothenburg, Sweden, Robert Moldwin, New
Hyde Park, NY, David M. Preston, Deborah
R. Erickson, Barbara Kahn, Lexington, KY,
Katherine Meyer-Siegler, St. Petersburg, FL,
Pedro L. Vera, Lexington, KY
ABSTRACT
NUMBER TITLE
MP72-05 TOLL-LIKE RECEPTOR ACTIVATION IS
ASSOCIATED WITH BLADDER
INFLAMMATION, PELVIC PAIN AND
VOIDING DYSFUNCTION IN A
TRANSGENIC INTERSTITIAL CYSTITIS/
BLADDER PAIN SYNDROME-LIKE ANIMAL
MODEL: A MAPP RESEARCH NETWORK
ANIMAL MODEL STUDY
Yaoqin Wang, Suming Xu, Michael
O’Donnell, Susan Lutgendorf, Pengchao Li,
Lang Feng, Catherine Bradley, Bradley
Erickson, Vincent Magnotta, Karl Kreder, Yi
Luo*, Iowa City, IA
MP72-02 FREQUENT EXPANSION OF CLONAL BCELLS SUGGESTIVE OF SPECIFIC
IMMUNE RESPONSES IN HUNNER TYPE
Yoshiyuki Akiyama*, Daichi Maeda, Teppei
Morikawa, Aya Niimi, Akira Nomiya, Yukio
Yamada, Jun Kamei, Naoki Aizawa, Yasuhiko
Igawa, Masashi Fukayama, Yukio Homma,
Tokyo, Japan
MP72-06 QUANTITATIVE ANALYSIS OF MAST CELL
INFILTRATION IN INTERSTITIAL
CYSTITIS-IS IT STILL SPECIFIC TO
INTERSTITIAL CYSTITIS?
Yoshiyuki Akiyama*, Daichi Maeda, Teppei
Morikawa, Akiteru Goto, Yasuhiko Igawa,
Masashi Fukayama, Yukio Homma, Tokyo,
Japan
MP72-03 URINARY CHEMOKINES AS PREDICTORS
OF INTERSTITIAL CYSTITIS/BLADDER
PAIN SYNDROME IN PATIENTS WITH
Akira Furuta*, Tokyo, Japan, Tokunori
Yamamoto, Nagoya, Japan, Yusuke Koike,
Yasuyuki Suzuki, Tokyo, Japan, Momokazu
Gotoh, Nagoya, Japan, Shin Egawa, Tokyo,
Japan, Naoki Yoshimura, Pittsburgh, PA
MP72-07 EXPRESSION OF MULTIPLEX URINE
CYTOKINES DISCRIMINATE FUNCTIONAL
BLADDER CAPACITY IN INTERSTITIAL
CYSTITIS PATIENTS
Laura Lamb*, Royal Oak, MI, Yao-Chi
Chuang, Hui-Ying Liu, Kaohsiung, Taiwan,
Bernadette Zwaans, Sarah Bartolone,
Kenneth Peters, Michael Chancellor, Royal
Oak, MI
MP72-04 INCREASED TOXIC URINARY CATIONS IN
MALES WITH INTERSTITIAL CYSTITIS: A
POSSIBLE CAUSE OF BLADDER
SYMPTOMS
Sulabha Argade, Zoltan Berecz, San Diego,
CA, Yongxuan Su, La Jolla, CA, C. Parsons*,
San Diego, CA
MP72-08 URINARY MATRIX
METALLOPROTEINASE-9 AS A
POTENTIAL BIOMARKER FOR
INTERSTITIAL CYSTITIS/PAINFUL
BLADDER SYNDROME
Shilpa Argade*, Mahendra Kashyap,
Christopher Chermansky, Pittsburgh, PA,
Kumaresan Ganabathi, Brookville, PA, Janet
Olonski, Pradeep Tyagi, Pittsburgh, PA
MP72-09 A STANDARDIZED UROLOGICAL
EXAMINATION FOR WOMEN AND MEN
WITH UROLOGIC CHRONIC PELVIC PAIN
SYNDROMES: A MAPP NETWORK SITESPECIFIC STUDY
Claire Yang*, Jane Miller, Adam Omidpanah,
John Krieger, Seattle, WA
*Presenting author
247
MONDAY
INFECTIONS/INFLAMMATION/CYSTIC DISEASE OF THE GENITOURINARY TRACT: INTERSTITIAL CYSTITIS
Moderators: Robert Moldwin and C. Lowell Parsons
MP72-10 CHARACTERIZATION OF NON-HUNNER
TYPE INTERSTITIAL CYSTITIS USING
NARROW BAND IMAGING (NBI)-ASSISTED
CYSTOSCOPY IN 1298 CASES
Tomohiro Ueda*, Noriyuki Kanemitsu, Osamu
Ukimura, Kyoto, Japan, Naoki Yoshimura,
Pittsburgh, PA
MP72-15
MP72-11 DEPRESSION AND CATASTROPHIZING
PREDICTS SUICIDAL IDEATION IN
TERTIARY CARE PATIENTS WITH
INTERSTITIAL CYSTITIS/BLADDER PAIN
SYNDROME (IC/BPS)
Dean Tripp*, J Curtis Nickel, Adrijana
Krsmanovic, Kingston, Canada, Michel
Pontari, Philadelphia, PA, Robert Moldwin,
New Hyde Park, NY, Robert Mayer, Grants
Pass, OR, Lesley K Carr, Toronto, Canada,
Claire C Yang, Seattle, WA, Jorgen Nordling,
Herlev, Denmark
GENE EXPRESSION IN THE BLOOD OF
INTERSTITIAL CYSTITIS PATIENTS AND
CONTROLS DISTINGUISHES PATHWAYS
ASSOCIATED WITH INTERSTITIAL
CYSTITIS AND PREDICTS CLINICAL
RESPONSE TO CYCLOSPORINE THERAPY
Daniel Shoskes*, Karen Keslar, Barbara
Tucky, Robert Fairchild, Cleveland, OH
MP72-16 SAFETY, TOLERABILITY, AND
PRELIMINARY EFFICACY OF LIRIS® 400
MG IN WOMEN WITH ULCERATIVE
Kenneth Peters*, Royal Oak, MI, Yodit Seifu,
Bridgewater, NJ, Chris Cutie, Lexington, MA,
Daniel Radecki, Irvine, CA
MP72-17 EFFECT OF AQX-1125 ON URINARY
BLADDER INFLAMMATION AND PAIN
INDUCED BY CYCLOPHOSPHAMIDE IN
RATS, BY TARGETING THE SHIP1
PATHWAY
Jennifer Cross*, Curtis Harwig, Pat Tam,
Judy Toews, Lloyd Mackenzie, Vancouver,
Canada
MP72-12 NATURAL HISTORY AND PREDICTIVE
FACTORS FOR HOSPITALIZATION IN
PATIENTS WITH RADIATION CYSTITIS
RESULTS FROM A LARGE
RETROSPECTIVE STUDY
Joan Palou*, Francesca Pisano, Salvador
Esquena, Serena Maruccia, Antoni Rosales,
Ruben Parada, Oscar Rodrı́guez, Humberto
MP72-18 ENDOSCOPIC INJECTION OF
TRIAMCINOLONE: A SIMPLE, MINIMALLY
INVASIVE AND EFFECTIVE THERAPY FOR
HUNNER’S LESIONS
Michael Funaro, Alexandra King, Robert
Moldwin, Sonia Bahlani*, New Hyde Park, NY
MP72-13 SHIP-1 ACTIVATION PROVIDES
SIGNIFICANT BENEFIT IN INTERSTITIAL
CYSTITIS/BLADDER PAIN SYNDROME:
RESULTS OF A PHASE 2 RANDOMIZED
PLACEBO CONTROLLED TRIAL
J. Curtis Nickel*, Kingston, Canada, Blair
Egerdie, Kitchener, Canada, Edward Davis,
Glendora, CA, Robert Evans, Winston Salem,
NC, Heidi Biagi, Stephen Shrewsbury,
Vancouver, Canada
MP72-19 IMMUNOTHERAPEUTIC STRATEGY TO
TREAT BLADDER PAINFUL SYNDROME IN
A CHRONIC RAT MODEL
Céline Augé, Philippe Lluel, Nathalie
Vergnolle, Gilles Dietrich*, Toulouse, France
MP72-20 INHIBITION OF ICAM-1 AS A NOVEL
THERAPEUTIC STRATEGY IN A RAT
MODEL OF NON-BACTERIAL CYSTITIS
RESEMBLING INTERSTITIAL CYSTITIS
Xiang Zhang, Yuan Xu, Chao He*, Zhoujun
Shen, Yuan Shao, Shanghai, China, People’S
Republic Of
MP72-14 ORAL CYCLOSPORINE FOR
INTERSTITIAL CYSTITIS: EFFICACY, SIDE
EFFECTS AND IMPACT OF CLINICAL
PHENOTYPE ON OUTCOME
Daniel Shoskes, Iryna Makovey*, Barbara
Tucky, Jianbo Li, Courtenay Moore,
Cleveland, OH
CREDITTM
Monday, May 9, 2016
1:00 pm - 3:00 pm
KIDNEY CANCER: EPIDEMIOLOGY & EVALUATION/STAGING I
Moderators: Robert Flanigan and Christopher Wood
ABSTRACT
NUMBER TITLE
MP73-01 CHARACTERIZATION OF FAVORABLE
AND UNFAVORABLE POST-RADICAL
NEPHRECTOMY RENAL INSUFFICIENCY
Takehiro Sejima*, Matsue, Japan, Tetsuya
Yumioka, Noriya Yamaguchi, Hideto Iwamoto,
Toshihiko Masago, Shuichi Morizane,
Masashi Honda, Atsushi Takenaka, Yonago,
Japan
ABSTRACT
NUMBER TITLE
MP73-02 THE PROGNOSTIC IMPACT OF THE NEW
ISUP GRADING SYSTEM IN PAPILLARY
Rodrigo Ledezma*, Santiago, Chile, Ashwin
Akki, Arieh Shalhav, Scott Eggener, Gladell
Paner, Chicago, IL
248
MP73-03 COMPARISON OF ACCURACY OF RISKSTRATIFICATION OF SMALL RENAL
MASSES (SRMS) WITH ALGORITHM
BASED ON PERCUTANEOUS RENAL
MASS BIOPSY (RMB) AND MASS SIZE
VERSUS NOMOGRAMS BASED ON
R.E.N.A.L. NEPHROMETRY SCORE (RNS)
Takahiro Osawa*, Khaled S. Hafez, David C.
Miller, Jeffrey S. Montgomery, Todd M.
Morgan, Ganesh S. Palapattu, Alon Z.
Weizer, Elaine M. Caoili, James H. Ellis,
Lakshmi P. Kunju, J. Stuart Wolf, Jr., Ann
Arbor, MI
MP73-09 RENAL ANGIOMYOLIPOMAS IN
CHILDREN AND ADOLESCENTS WITH
TUBEROUS SCLEROSIS COMPLEX
Jason Warncke*, Katie Brodie, Erin
Grantham, Salvatore Catarinicchia, Suhong
Tong, Kimi Kondo, Nicholas Cost, Aurora, CO
MP73-04 RACIAL DISPARITIES IN HISPANIC
RENAL CELL CARCINOMA PATIENTS
Alfredo Suarez-Sarmiento, Jr.*, Brian Shuch,
Cayce Nawaf, New Haven, CT
MP73-11 A COMPREHENSIVE COMPETING RISK
CALCULATOR FOR PATIENTS WITH
CORTICAL RENAL MASSES < 10CM: A
NOVEL CLINICAL DECISION AID FOR
SHARED DECISION-MAKING REGARDING
INDIVIDUALIZED TREATMENT
SELECTION
Sarah Psutka*, Chicago, IL, Michael Jewett,
Kamel Fadaak, Antonio Finelli, Toronto,
Canada, R. Houston Thompson, Rochester,
MN, Jeph Herrin, New Haven, CT, Christine
Lohse, Stephen Boorjian, Rochester, MN,
Suzanne Stewart-Merrill, Hershey, PA,
Thomas Atwell, Grant Schmit, Brian Costello,
Rochester, MN, Laura Legere, Toronto,
Canada, Nilay Shah, Bradley Leibovich,
Rochester, MN
WHEN TO PERFORM A STAGING CHESTCT SCAN BEFORE SURGICAL
TREATMENT FOR KIDNEY CANCER
Alessandro Larcher*, Alessandro Nini, Nicola
Fossati, Stefano Corti, Paolo Dell’Oglio,
Francesco Trevisani, Roberto Nicoletti,
Francesco De Cobelli, Federico Dehò,
Francesco Montorsi, Andrea Salonia, Alberto
Briganti, Roberto Bertini, Umberto Capitanio,
Milan, Italy
MP73-06 DIAGNOSIS AND PROGNOSIS OF
EPITHELIOID ANGIOMYOLIPOMA: A 15
YEAR FOLLOW UP AT SINGLE CENTER
Jaeyoon Jung*, Junghyun Shin, Jae Hyeon
Han, Se Young Choi, Sangjun Yoo, Seoul,
Korea, Republic of, Dalsan You, In Gab
Jeong, Choung-Soo Kim, Seoul, Korea,
Republic of
MP73-12 VENOUS THROMBOEMBOLISM AFTER
NEPHRECTOMY: INCIDENCE, TIMING,
AND ASSOCIATED RISK FACTORS FROM
A NATIONAL MULTI-INSTITUTIONAL
DATABASE
Brian Jordan*, Richard Matulewicz, Yousef
Al-Shraideh, Brian Trihn, Irene Helenowski,
Borko Jovanovic, Shilajit Kundu, Chicago, IL
MP73-13 CAN THE RENAL FUNCTION BE
INFLUENCED BY THE PRESENCE OF A
SMALL (<7CM) KIDNEY TUMOUR?
RESULTS OF A RENAL SCANNING STUDY
Cristian Fiori*, Riccardo Bertolo, Daniele
Amparore, Sabrina De Cillis, Giovanni
Cattaneo, Enrico Checcucci, Matteo Manfredi,
Fabrizio Mele, Giulia Ottaviano, Roberta
Aimar, Francesco Porpiglia, Orbassano,
Torino, Italy
MP73-07 PREDICTION OF LYMPH NODE INVASION
IN PATIENTS WITH RENAL CELL
CARCINOMA: RESULTS FROM A LARGE
INTERNATIONAL CONSORTIUM
Paolo Dell’Oglio*, Milan, Italy, Grant Stewart,
Edinburgh, United Kingdom, Tobias Klatte,
Vienna, Austria, Alessandro Volpe, Novara,
Italy, Bulent Akdogan, Ankara, Turkey, Marco
Roscigno, Bergamo, Italy, Hans
Langenhuijsen, Nijmegen, Netherlands,
Martin Marszalek, Vienna, Austria, Oscar
Rodriguez Faba, Barcelona, Spain, Maciej
Salagierski, Canterbury, United Kingdom,
Andrea Minervini, Florence, Italy, Sabine
Brookman-May, Munich, Germany, Umberto
Capitanio, Milan, Italy
MP73-14 WHO WATCHES THE WATCHMEN?:
SYSTEMATIC UNDERESTIMATION OF THE
INCIDENCE OF KIDNEY CANCER IN
CANCER REGISTRY DATA
Roderick Clark*, London, Canada, Matthew
Acker, Miami, FL, Devbani Raha, Ricardo
Rendon, Halifax, Canada
MP73-08 PROTEINURIA IN PATIENTS
UNDERGOING RENAL CANCER
SURGERY: IMPACT ON OVERALL
SURVIVAL AND STABILITY OF RENAL
FUNCTION
Zhiling Zhang, Juping Zhao, Joseph Zabell*,
Erick Remer, Jianbo Li, Jack A. Campbell,
Wen Dong, Diego Aguilar Palacios, Tulsi
Patel, Sevag Demirjian, Steven C. Campbell,
Cleveland, OH
*Presenting author
MP73-15
249
METASTATIC PAPILLARY RENAL
CANCER: DOES HEREDITARY ORIGIN
IMPACT SURVIVAL?
Abhinav Sidana*, Meet Kadakia, Julia Friend,
Akhil Muthigi, Louis Krane, Geri Hawks,
Martha Ninos, W Martson Linehan,
Ramaprasad Srinivasan, Bethesda, MD
MONDAY
MP73-05
MP73-10 MODIFIABLE RISK FACTORS TO REDUCE
RENAL CELL CARCINOMA CANCER
INCIDENCE IN THE PLCO TRIAL
Aashish Kabra*, Jonathan Gelfond, Steven
Madson, Robert Svatek, Dharam Kaushik,
Michael Liss, San Antonio, TX
MP73-16 COMPARATIVE EFFECTIVENESS OF
CYTOREDUCTIVE NEPHRECTOMY
VERSUS TARGETED THERAPY IN THE
INITIAL MANAGEMENT OF METASTATIC
CLEAR CELL KIDNEY CANCER
Liam C. Macleod*, Anobel Y. Odisho, Sarah
K. Holt, Scott S. Tykodi, Jonathan D. Harper,
John L. Gore, Seattle, WA
MP73-19 COMPLICATIONS ASSOCIATED WITH
POST-NEPHRECTOMY TYROSINE KINASE
INHIBITOR USE: RESULTS FROM SEERMEDICARE
Filipe L.F. Carvalho*, Chaoyi Zheng, Kenneth
Witmer, Washington, DC, Saekwon Jeng,
Falls Church, VA, John O’Neill, John H.
Lynch, Keith J. Kowalczyk, Washington, DC
MP73-17 SINGLE-INSTITUTIONAL ANALYSIS OF
PATIENTS WITH CLEAR-CELL PAPILLARY
Jozefina Casuscelli*, Andrew G. Winer,
Eduard Reznik, Jianing Xu, Brandon J.
Manley, Jyoti Chouhan, Victor E. Reuter,
Satish K. Tickoo, Paul Russo, Jonathan A.
Coleman, James J. Hsieh, A. Ari Hakimi,
New York, NY
MP73-20 ANALGESIC USE AND RISK OF RENAL
CELL CANCER: RESULTS FROM TWO
PROSPECTIVE COHORT STUDIES
Mark Preston*, Xuehong Zhang, Boston, MA,
Rebecca Graff, San Francisco, CA,
Alexander Sanchez, Steven Chang, Meir
Stampfer, Toni Choueiri, Kathryn Wilson,
Eunyoung Cho, Boston, MA
CREDITTM
MP73-18 EXTERNAL VALIDATION OF
PREOPERATIVE AST/ALT (DE-RITIS)
RATIO AS A PROGNOSTIC INDICATOR IN
LOCALIZED AND METASTATIC RENAL
CELL CARCINOMA
Dattatraya Patil*, Atlanta, GA, Rishi Sekar,
Jeff Pearl, Yoram baum, Kathryn Wehrmeyer,
Mersiha Torlak, Mehrdad Alemozaffar,
Christopher Filson, Kenneth Ogan, Viraj
Master, Atlanta, GA
Monday, May 9, 2016
1:00 pm - 3:00 pm
URODYNAMICS/LOWER URINARY TRACT DYSFUNCTION/FEMALE PELVIC MEDICINE: NON-NEUROGENIC VOIDING
DYSFUNCTION I
Moderators: Gary Lemack and Deborah Lightner
ABSTRACT
NUMBER TITLE
MP74-01 A RANDOMIZED, DOUBLE-BLIND,
PLACEBO CONTROLLED STUDY OF 2
DOSES OF SER120 (LOW DOSE
DESMOPRESSIN) NASAL SPRAY IN
PATIENTS WITH NOCTURIA
Jed Kaminetsky*, New York, NY, Alan Wein,
Philadelphia, PA, Roger Dmochowski,
Nashville, TN, Samuel Herschkowitz, Maria
Cheng, Milford, PA, Steven Abrams, Irvine,
CA, Seymour Fein, Milford, PA
ABSTRACT
NUMBER TITLE
MP74-05 PERIODIC LIMB MOVEMENTS DURING
SLEEP – DOES IT AFFECT NOCTURNAL
URINE PRODUCTION?
Marie-Astrid Denys*, Els Tobback, An
Mariman, Dirk Vogelaers, Karlien Dhondt,
Johan Vande Walle, Karel Everaert, Gent,
Belgium
MP74-06 ONABOTULINUMTOXINA TREATMENT
RESULTS IN GREATER REDUCTIONS IN
URINARY INCONTINENCE IN PATIENTS
WITH OVERACTIVE BLADDER COMPARED
WITH SOLIFENACIN OR PLACEBO
Sender Herschorn*, Toronto, Canada, Alfred
Kohan, Bethpage, NY, Philip Aliotta,
Williamsville, NY, Kurt McCammon, Norfolk,
VA, Rajagopalan Sriram, Coventry, United
Kingdom, Steve Abrams, Wayne Lam, Irvine,
CA, Karel Everaert, Ghent, Belgium
MP74-02 CONVERGENCE OF NOCTURNAL
POLYURIA DEFINITIONS
Jerald Cherian*, Jeffrey Weiss, John Sullivan,
Komal Mehta, Brooklyn, NY
MP74-03 EAT RIGHT AND WAKE UP LESS?
EXPLORING THE LINK BETWEEN
SOCIOECONOMIC AND DIETARY
FACTORS AND NOCTURIA
Julien Dagenais*, Steven L Chang, Boston,
MA
MP74-04 THE IMPACT OF EXERCISE ON
NOCTURIA: BREAKING DOWN THE
INFLAMMATORY CYCLE
Julien Dagenais*, Steven L Chang, Boston,
MA
250
MP74-14 INTERNATIONAL CONTINENCE SOCIETY
DEFINITION OF DETRUSOR
UNDERACTIVITY; ANALYSIS OF CLINICAL
PARAMETERS AND COMPARISON WITH
CONTRACTILITY GRADING METHODS
Celine ten Donkelaar*, Peter Rosier, Laetitia
de Kort, Utrecht, Netherlands
MP74-07 CONSISTENT AND DURABLE
IMPROVEMENTS IN QUALITY OF LIFE
WITH LONG-TERM
ONABOTULINUMTOXINA TREATMENT IN
PATIENTS WITH OVERACTIVE BLADDER
David Ginsberg*, Los Angeles, CA, Marcus
Drake, Bristol, United Kingdom, Albert
Kaufmann, Mönchengladbach, Germany,
Sidney Radomski, Toronto, Canada, Angelo
Goussse, Miami, FL, Andrew Magyar,
Bridgewater, NJ, Jean Paul Nicandro, Irvine,
CA, Victor Nitti, New York, NY
MP74-15
MP74-08 REAL-WORLD CLEAN INTERMITTENT
CATHETERIZATION RATES AFTER
TREATMENT WITH
ONABOTULINUMTOXINA IN PATIENTS
WITH OVERACTIVE BLADDER
Michael Kennelly*, Charlotte, NC, Lonny
Green, Richmond, VA, Nancy Fathali, Irvine,
CA, Salim Wehbe, Sacramento, CA, John
Joseph Smith III, Winston Salem, NC, Scott
MacDiarmid, Greensboro, NC, Jeffrey
Mangel, Cleveland, OH, Marc Schwartz,
Minnetonka, MN, Tamer Aboushwareb, Irvine,
CA, Brian Murray, Albany, NY
MP74-17 IS UROLOGICAL DYSFUNCTIONS IN
YOUNG WOMEN AN INHERITANCE OF
CHILDHOOD?
Ester Illiano*, Naples, Italy, Antonino
Appignani, Perugia, Italy, Kostantinos
Giannitsas, Patras, Greece, Raffaele
Balsamo, Catanzaro, Italy, Antonella
Giannantoni, Perugia, Italy, Vincenzo Mirone,
Naples, Italy, Franca Natale, Serena
Mariuccia, Rome, Italy, Eleonora Salvini,
Perugia, Italy, Antonio Carbone, Antonio
Pastore, Rome, Latina, Italy, Marianna
Bevacqua, Reggio Calabria, Italy, Marco
Prestipino, Perugia, Italy, Eugenia Fragalà,
Crotone, Italy, Maria Teresa Filocamo,
Savigliano, Cuneo, Italy, Donata Villari,
Florence, Italy, Vittorio Bini, Elisabetta
Costantini, Perugia, Italy
MP74-10 QUANTIFICATION OF RISK FACTORS IN
500 CONSECUTIVE PATIENTS WITH
POSTOPERATIVE URINARY RETENTION
(POUR)
Peter Tsambarlis*, Benjamin Sherer, Karl
Godlewski, Rebecca Deal, Leslie Deane,
Chicago, IL
MP74-11 PREDICTING TIME TO RECOVERY OF
URINARY RETENTION
Kim, Tae-Hyoung Kim, Soon Chul Myung, In
Ho Chang, Seung Hyun Ahn, Jae Duck Choi,
Jung Hoon Kim, Min Soo Kim, Shin Young
MP74-18 URINARY INFECTIONS, ENURESIS AND
VOIDING PROBLEMS IN CHILDHOOD: ARE
THEY RISK FACTORS FOR YOUNG
WOMEN?
Ester Illiano*, Naples, Italy, Antonino
Appignani, Perugia, Italy, Konstantinos
Giannitsas, Patras, Greece, Raffaele
Balsamo, Catanzaro, Italy, Vincenzo Mirone,
Naples, Italy, Franca Natale, Serena
Mariuccia, Rome, Italy, Antonio Carbone,
Giovanni Palleschi, Rome, Latina, Italy,
Marco Prestipino, Perugia, Italy, Eugenia
Fragalà, Crotone, Italy, Maria Teresa
Filocamo, Savigliano, Cuneo, Italy, Donata
Villari, Florence, Italy, Vittorio Bini, Elisabetta
Costantini, Perugia, Italy
MP74-12 DECREASED EXPRESSION OF CAVEOLIN
1 AND 2 IN THE AGING RAT URINARY
BLADDER : POTENTIAL MARKER OF
BLADDER DYSFUNCTION IN THE
ELDERLY POPULATION
Ho Song Yu*, Seong Woong Na, Yang Hyun
Cho, Je Guk Ryu, Bo Sung Shin, Deokhyeon
Nam, Ho Seok Chung, Eu Chang Hwang,
MP74-19 DIAGNOSTIC ACCURACY OF NONINVASIVE PENILE CUFF TEST FOR THE
ASSESSMENT OF BLADDER OUTLET
OBSTRUCTION COMPARING BY
PRESSURE FLOW STUDY IN MEN WITH
LOWER URINARY TRACT SYMPTOM
Kwang Jin Ko, Jae Ho Yoo, Yoon Seok Suh*,
Hyun Hwan Sung, Kyu-Sung Lee, Heung Jae
Park, Seoul, Korea, Republic of
MP74-13 DIABETES SEVERITY, DIABETES
BIOMARKERS AND LUTS: FINDINGS
FROM NHANES
Christopher Tam*, Bradley Erickson, Iowa
City, IA
251
MONDAY
MP74-16 REGULATION OF CPI-17-INDUCED
CONTRACTION IN DETRUSOR SMOOTH
MUSCLE BY MYOCYTE-SPECIFIC
ENHANCER FACTOR (MEF)-2D
Ettickan Boopathi*, Stephan Zderic, Samuel
Chacko, Philadelphia, PA
MP74-09 SURGICAL OUTCOMES IN CATHETERDEPENDENT MEN DUE TO URINARY
RETENTION
Christine Liaw*, Lucas Policastro, Brooklyn,
NY, Jerry Blaivas, New York, NY
*Presenting author
BLADDER OUTLET PROCEDURES ARE AN
EFFECTIVE TREATMENT OPTION FOR
PATIENTS WITH URODYNAMICALLYCONFIRMED DETRUSOR UNDERACTIVITY
WITHOUT BLADDER OUTLET
OBSTRUCTION
Bradley Potts*, Michael Belsante, Andrew
Peterson, Ngoc-Bich Le, Durham, NC
MP74-20 DOES THE APPEARANCE OF THE
URETHRAL PRESSURE PROFILE TRACE
CORRELATE WITH THE SPHINCTER EMG
FINDINGS OR DEGREE OF DIFFICULTY IN
CATHETER REMOVAL REPORTED IN
WOMEN WITH VOIDING DYSFUNCTION
Neha Sihra*, Sachin Malde, Robert Kightley,
Rizwan Hamid, Jeremy Ockrim, Jalesh
Panicker, Tamsin Greenwell, Mahreen
Pakzad, London, United Kingdom
CREDITTM
Monday, May 9, 2016
1:00 pm - 3:00 pm
KIDNEY CANCER: LOCALIZED: SURGICAL THERAPY V
Moderators: Li-Ming Su and Casey Ng
ABSTRACT
NUMBER TITLE
MP75-01 RECURRENCE IN PATHOLOGIC
UPSTAGING TO PT3A IN CT1 RENAL
TUMORS
Vilvapathy Senguttuvan Karthikeyan*, Ashwin
Mallya, Bangalore, India, Arjun Sivaraman,
Rafael Sanchez-Salas, Marc Galiano,
François Rozet, Eric Barret, Xavier
MP75-02
MP75-03
ABSTRACT
NUMBER TITLE
MP75-06 NATIONAL OUTCOMES IN
POSTOPERATIVE COMPLICATIONS AND
READMISSION RATES FOLLOWING OPEN
AND MINIMALLY INVASIVE
NEPHRECTOMY
Ruben M. Pinkhasov*, Brooklyn, NY,
Alexandr Pinkhasov, Michall Abaev, Buffalo,
NY, Zuhair Alhussaini, Mark Cogburn,
Buddima Ranasinghe, Antonio Montgomery,
Ervin Teper, Ciril Godec, David Silver,
Brooklyn, NY
MULTIPLEX PARTIAL NEPHRECTOMY IN
THE MANAGEMENT OF PATIENTS WITH
MULTIFOCAL RENAL CELL CARCINOMA
Michele Fascelli*, Philidelphia, PA, Shawna
Boyle, Spencer Krane, W Marsdon Linehan,
Adam Metwalli, Bethesda, MD
COMPARISON OF THE WIDTH OF
PERITUMORAL SURGICAL MARGIN IN
OPEN AND ROBOTIC PARTIAL
NEPHRECTOMY: A PROPENSITY SCORE
MATCHED ANALYSIS
Jong Jin Oh*, Min Yong Kang, Jung Ki Jo,
Hak Min Lee, Seok-soo Byun, Sang Eun Lee,
Kwangmo Kim, Harim Kook, In Jae Lee, Tae
Jin Kim, Sung Kyu Hong, Seongnam-si,
Korea, Republic of
MP75-04
OFF-CLAMP TECHNIQUE OFFERS
IMPROVED RENAL FUNCTION
OUTCOMES AFTER ROBOTIC PARTIAL
NEPHRECTOMY IN LOW AND
INTERMEDIATE COMPLEXITY TUMORS
Daniel C. Rosen, Boston, MA, David J.
Paulucci, New York, NY, Ronney Abaza,
Dublin, OH, Daniel D. Eun, Philadelphia, PA,
Ashok K. Hemal, Louis S. Krane, WinstonSalem, NC, Ketan K. Badani*, New York, NY
MP75-05
BODY MASS INDEX (BMI) AND THE
CLINICO-PATHOLOGICAL
CHARACTERISTICS OF LOCALIZED
RENAL MASSES – AN INTERNATIONAL
MULTI INSTITUTIONAL STUDY
Matvey Tsivian*, Efrat Tsivian, Kae Jack Tay,
Durham, NC, Ziv Zukerman, Giuseppe
Martorana, Riccardo Schiavina, Bologna,
Italy, Thomas Polascik, Durham, NC
252
MP75-07
MEDICAL RISK FACTORS FOR CHRONIC
KIDNEY DISEASE IN PATIENTS WITH
NORMAL BASELINE KIDNEY FUNCTION
ARE NOT INDEPENDENT PREDICTORS OF
WORSE RENAL FUNCTION OUTCOMES
FOLLOWING ROBOTIC PARTIAL
NEPHRECTOMY
Balaji Reddy*, David Paulucci, Erin Moshier,
New York, NY, Ronney Abaza, Columbus,
OH, Daniel Eun, Philadelphia, PA, Ketan
Badani, New York, NY
MP75-08
COULD PERIRENAL FAT BE MORE
IMPORTANT THAN THE TUMOR ITSELF?
THE MAP SCORE BETTER PREDICTS
PERIOPERATIVE MORBIDITY THAN THE
RENAL SCORE
Zine-Eddine Khene*, Rennes, France Metropolitan, Benoit Peyronnet, Corentin
Robert, Benjamin Prader, rennes, France,
Tanguy Rohou, Romain Mathieu, Gregory
Verhoest, Rennes, France - Metropolitan,
Nathalie Rioux-leclerc, Karim Bensalah,
Rennes, France
MP75-10
THE NATURAL HISTORY OF RENAL
FUNCTION AFTER SURGICAL
MANAGEMENT OF RENAL CELL
CARCINOMA: RESULTS FROM THE
CANADIAN KIDNEY CANCER
INFORMATION SYSTEM
Ross Mason, Halifax, Canada, Anil Kapoor,
Hamilton, Canada, Zhihui Liu, Olli Saarela,
Toronto, Canada, SImon Tanguay, Montreal,
Canada, Michael Jewett, Antonio Finelli,
Toronto, Canada, Louis Lacombe, Quebec
City, Canada, Jun Kawakami, Calgary,
Canada, Ronald Moore, Edmonton, Canada,
Chris Morash, Ottawa, Canada, Peter Black,
Vancouver, Canada, Ricardo Rendon*,
Halifax, Canada
HILAR LOCATION OF RENAL TUMOR
PREDICTS INCIDENCE OF MAJOR
COMPLICATIONS AFTER ROBOTIC
PARTIAL NEPHRECTOMY: A LARGE,
MULTI-INSTITUTIONAL STUDY
Daniel Ramirez*, Matthew J. Maurice,
Cleveland, OH, Ravi Barod, Craig G. Rogers,
Detroit, MI, Sam B. Bhayani, St. Louis, MO,
Michael D. Stifelman, New York, NY,
Mohammad E. Allaf, Baltimore, MD, Jihad H.
Kaouk, Cleveland, OH
MP75-11
PREOPERATIVE PROTEINURIA PREDICTS
WORSENED RENAL FUNCTIONAL
OUTCOMES AFTER KIDNEY SURGERY
Dmitry Volkin*, Varun Vijay, New York, NY,
Scott Gulig, Linthicum, MD, Michael
Stifelman, Samir S Taneja, William C Huang,
New York, NY
MP75-12
MULTICENTER COMPARISON OF
ROBOTIC AND OPEN PARTIAL
NEPHRECTOMY FOR QUALITY
MEASURES CONTROLLING FOR TUMOR
COMPLEXITY
Zachary Hamilton*, Sean Berquist, Abd-el
Rahman Hassan, Catherine Defour, San
Diego, CA, Alp Tuna Beksac, Ankara, Turkey,
Fang Wan, Maria Marquine, San Diego, CA,
Brian Lane, Grand Rapids, MI, Sean Stroup,
Ithaar Derweesh, San Diego, CA
MP75-13
MONITORING CARDIOVASCULAR
EVENTS AFTER TUMOR NEPHRECTOMY
IN YOUNG PATIENTS COMPRISING A
LONG TERM FOLLOW-UP – A SINGLE
CENTER, MATCHED PAIR ANALYSIS
BETWEEN DONOR NEPHRECTOMY AND
RADICAL TUMOUR NEPHRECTOMY
Patrick Levien*, Wolfgang Jaeger, Andreas
Neisius, Christian Thomas, Mohammed
Kamal, Christian Hampel, Joachim Thuroff,
Frederik Roos, Mainz, Germany
MP75-14
ROLE OF NEPHRON-SPARING SURGERY
FOR RENAL CELL CARCINOMA IN THE
SETTING OF VENOUS TUMOR
THROMBUS
Firas Petros*, Debra Zynger, Ahmad
Shabsigh, David Sharp, Geoffrey Box,
Columbus, OH
MP75-15
OPTIMAL OUTCOME AND TRIFECTA OF
ROBOT-ASSISTED PARTIAL
NEPHRECTOMY FOR T1B RENAL MASSES
Dae Keun Kim, Young Eun Yoon, Ibrahim
Alabdulaali, Atalla Alatawi, Abulhasan Sheikh,
Ali Abdel Raheem*, Kyo Chul Goo, Woong
Kyu Han, Byung Ha Chung, Koon Ho Rha,
MP75-16
OUTCOMES OF ROBOT-ASSISTED
PARTIAL NEPHRECTOMY IN PATIENTS
WITH COMPLEX RENAL TUMORS AND
PRE-EXISTING CHRONIC KIDNEY
DISEASE: A MULTI-INSTITUTIONAL
ANALYSIS
Deepansh Dalela*, Ravi Barod, Detroit, MI,
Giorgio Gandaglia, Melle, Belgium, Ronney
Abaza, Dublin, OH, Rajesh Ahlawat,
Gurgaon, India, Nicolomaria Buffi, Rozzano,
Italy, Ben Challacombe, Prokar Dasgupta,
London, United Kingdom, Daniel Moon,
Melbourne, Australia, Dipen Parekh, Miami,
FL, Francesco Porpiglia, Orbassano, Italy,
Sudhir Rawal, New Delhi, India, Giacomo
Novara, Melle, Belgium, Mahendra Bhandari,
Detroit, MI, Alexandre Mottrie, Melle,
Belgium, Craig Rogers, Detroit, MI
MP75-17
THE RISK OF CHRONIC KIDNEY DISEASE
IN THE ELDERLY AFTER RADICAL OR
PARTIAL NEPHRECTOMY FOR MASSES
LARGER THAN PT1A
Lisly Chery*, Mehrad Adibi, Leonardo
Borregales, Jessica Brandt, Devin Gu, Akshat
Kumar, Surena Matin, Jose Karam,
Christopher Wood, Houston, TX
MP75-18
PARTIAL NEPHRECTOMY VERSUS
RADICAL NEPHRECTOMY FOR CLINICAL
T1B AND T2 RENAL MASS: A METAANALYSIS OF OVER 9000 CASES
Maria Carmen Mir*, Ithaar Derweesh,
Cleveland, OH, Francesco Porpiglia, Torino,
Italy, Alessandro Volpe, Novara, Italy,
Giacomo Novara, Padua, Italy, Vincenzo
Ficarra, Udine, Italy, Nicola Pavan, Trieste,
Italy, Humberto Laydner, Jihad Kaouk,
Cleveland, OH, Homi Zargar, Melbourne,
Australia, Riccardo Autorino, Cleveland, OH
MP75-19
COMPARISON OF RETROPERITONEAL
AND TRANSPERITONEAL ROBOTIC
PARTIAL NEPHRECTOMY FOR
PERIOPERATIVE OUTCOMES
Sean Stroup, Zachary Hamilton*, Michael
Marshall, Catherine Defour, Sean Berquist, Abd-el
Rahman Hassan, San Diego, CA, Alp Tuna
Beksac, Ankara, Turkey, Unwanaobong Nseyo,
Fang Wan, Ithaar Derweesh, San Diego, CA
MP75-20
IMPACT OF WARM ISCHEMIA TIME ON
RENAL FUNCTIONAL OUTCOME AFTER
LAPAROSCOPIC PARTIAL
NEPHRECTOMY USING DYNAMIC RENAL
SCINTIGRAPHY
Tetsuo Fujita*, Morihiro Nishi, Daisuke Ishii,
Ken-ichi Tabata, Kazumasa Matsumoto,
Kazunari Yoshida, Masatsugu Iwamura,
Sagamihara, Japan
CREDITTM
*Presenting author
253
MONDAY
MP75-09
Monday, May 9, 2016
1:00 pm - 3:00 pm
Podium Session 42
PROSTATE CANCER: STAGING I
Moderators: Paul Lange and Peter Pinto
TIME
1:00
ABSTRACT
NUMBER TITLE
PD42-01 MAGNETOMETER GUIDED SENTINEL
LYMPHADENECTOMY AFTER
INTRAPROSTATIC INJECTION OF
SUPERPARAMAGNETIC IRON OXIDE
NANOPARTICLES IN INTERMEDIATEAND HIGH-RISK PROSTATE CANCER
PATIENTS
Alexander Winter*, Svenja Engels, Philipp
Goos, Marie-Christin Süykers, Stefan
Gudenkauf, Rolf-Peter Henke, Holger
Gerullis, Friedhelm Wawroschek, Oldenburg,
Germany
1:10
PD42-02
68GA-PSMA HAS HIGH DETECTION RATE
OF PROSTATE CANCER RECURRENCE
OUTSIDE THE PROSTATIC FOSSA IN
PATIENTS BEING CONSIDERED FOR
SALVAGE RADIATION TREATMENT
Pim van Leeuwen*, Louise Emmeett, George
Hruby, Andrew Kneebone, Francis Ting,
Phillip Stricker, Sydney, Australia
1:20
PD42-03
PATHOLOGIC AND BIOCHEMICAL
OUTCOMES AMONG AFRICAN-AMERICAN
AND CAUCASIAN MEN WITH LOW-RISK
PROSTATE CANCER IN THE SEARCH
DATABASE: IMPLICATIONS FOR ACTIVE
SURVEILLANCE CANDIDACY
Michael Leapman*, San Francisco, CA,
Stephen Freedland, William Aaronson, Los
Angeles, CA, Christopher Kane, San Diego,
CA, Martha Terris, Augusta, GA, Kelly
Walker, San Francisco, CA, Christopher
Amling, Portland, OR, Peter Carroll, Matthew
Cooperberg, San Francisco, CA
1:30
1:40
PD42-04
PD42-05
ABSTRACT
TIME NUMBER TITLE
1:50 PD42-06 INTERMEDIATE-TERM OUTCOMES IN
MEN WITH VERY HIGH RISK PROSTATE
CANCER
Antonarakis, Meera Chappidi, Ridwan Alam,
Stephanie Glavaris, Kamyar Ghabili,
Mohamad Allaf, Trinity Bivalacqua, Kenneth
Pienta, Phuoc Tran, Baltimore, MD, Edward
Baltimore, MD
IMPACT OF THE PROSTATE IMAGING
REPORTING AND DATA SYSTEM
VERSION 2 (PI-RADS V2) ON THE
ASSESSMENT OF EXTRACAPSULAR
EXTENSION IN PROSTATE CANCER: A
MULTIREADER STUDY
Yoh Matsuoka*, Junichiro Ishioka, Hiroshi
Tanaka, Masaharu Inoue, Masaya Ito,
Soichiro Yoshida, Minato Yokoyama, Noboru
Numao, Kazutaka Saito, Yasuhisa Fujii,
GROUPING GLEASON SCORE 8 AND
GLEASON SCORE 9-10 PROSTATE
CANCER AS A SINGLE ENTITY RISKS
LOSING PROGNOSTIC INFORMATION
FOR MORTALITY
Won Sik Ham, Seoul, Korea, Republic of,
Heather J. Chalfin*, Zhaoyong Feng, Bruce J.
Trock, Jonathan I. Epstein, Elizabeth
Humphreys, Alan W. Partin, Misop Han,
Baltimore, MD
254
2:00
PD42-07
IMPLEMENTATION OF METHODOLOGY
TO CAPTURE DATA FROM PROSTATE
MRI WITHIN A REGIONAL QUALITYIMPROVEMENT COLLABORATIVE
Tae Kim*, James Montie, Ann Arbor, MI,
James Peabody, Detroit, MI, Dinesh Telang,
Roseville, MI, C. Peter Fischer, Ypsilanti, MI,
Jeffrey O’Connor, Farmington Hills, MI, M.
Hugh Solomon, Ypsilanti, MI, Steven Lucas,
Detroit, MI, Sabry Mansour, Lapeer, MI, Rafid
Yousif, East Lansing, MI, Richard Sarle,
Dearborn, MI, David Miller, Ann Arbor, MI,
Brian Lane, Grand Rapids, MI
2:10
PD42-08
IS PROSTATE CANCER STAGE
MIGRATION CONTINUING FOR BLACK
MEN IN THE PSA ERA?
Ryan Dobbs*, David Greenwald, Harpreet
Wadhwa, Vincent Freeman, Michael Abern,
Chicago, IL
2:20
PD42-09
TUMOR CONTACT LENGTH ON
MULTIPARAMETRIC MRI PREDICTS HIGH
RISK PATHOLOGY AT RADICAL
PROSTATECTOMY
Michael kongnyuy*, Arvin George, Akhil
Muthigi, Abhinav Sidana, Amogh Iyer,
Thomas Frye, Amichai Kilchevsky, Francesca
Mertan, RIchard Ho, Daniel Su, Maria Merino,
Baris Turkbey, Peter Choyke, Bradford Wood,
Peter Pinto, Bethesda, MD
2:30
PD42-10
NUCLEAR GRADE PREDICTS PROSTATE
CANCER OUTCOMES AMONG RADICAL
PROSTATECTOMY PATIENTS
Daniel Kim*, Bethesda, MD, Lauren Hurwitz,
Huai-Ching Kuo, Jennifer Cullen, Sally
Elsamanoudi, Yongmei Chen, Rockville, MD,
Inger Rosner, David McLeod, Bethesda, MD,
Isabel Sesterhenn, Silver Spring, MD
2:40
PD42-11
68GA-PSMA PET/CT PROVIDES
ACCURATE STAGING OF LYMPH NODE
REGIONS PRIOR TO LYMPH NODE
DISSECTION IN PATIENTS WITH
PROSTATE CANCER
Annika Herlemann*, Vera Wenter, Alexander
Kretschmer, Peter Bartenstein, Christian G.
Stief, Christian Gratzke, Wolfgang P. Fendler,
Munich, Germany
2:50
PD42-12
EXTRA-PROSTATIC EXTENSION AND
SEMINAL VESICLE INVASION ARE
EXCEEDINGLY RARE AT RADICAL
PROSTATECTOMY FOR GLEASON 6
PROSTATE CANCER USING ISUP
MODIFIED SCORING CRITERIA
Blake Anderson*, Aria Razmaria, Bonnie
Choy, Gregory Zagaja, Arieh Shalhav, Gladell
Paner, Scott Eggener, Chicago, IL
CREDITTM
Monday, May 9, 2016
1:00 pm - 3:00 pm
Podium Session 43
TIME
1:00
1:10
ABSTRACT
NUMBER TITLE
PD43-01 RESULTS OF TWO RANDOMIZED TRIALS
FOR THE PREVENTION OF
LYMPHOCELES AFTER ROBOTIC PELVIC
LYMPH NODE DISSECTION FOR
PROSTATE CANCER
Sean Henderson, Daniel Gilbert, Janice
Rosenthal, Ronney Abaza, Jatin Gupta*,
Dublin, OH
PD43-02
ARE WE OPERATING ON WHO WE SHOULD?
THE CHANGING CHARACTERISTICS OF
RADICAL PROSTATECTOMY PATIENTS:
RESULTS FROM THE SHARED EQUAL
ACCESS REGIONAL CANCER HOSPITAL
(SEARCH) DATABASE
Kathleen McGinley*, Binghamton, NY, Lauren
Howard, Zinan Chen, Durham, NC, William
Aronson, Los Angeles, CA, Martha Terris,
Augusta, GA, Christopher Kane, San Diego,
CA, Christopher Amling, Portland, OR,
Matthew Cooperberg, San Francisco, CA,
1:20
PD43-03
COMPARISON OF PERIOPERATIVE
OUTCOMES BETWEEN ROBOTIC AND
OPEN PROSTATECTOMY: IS ROBOTIC
PROSTATECTOMY ASSOCIATED WITH
FEWER COMPLICATIONS?
Ann Martinez Acevedo, Jen-Jane Liu,
Christopher Amling*, Portland, OR
1:30
PD43-04
A POPULATION BASED ANALYSIS OF
PROSTATECTOMY – RESULTS FROM A
NATIONAL ADMINISTRATIVE DATABASE
Jan Schmitges*, Jana Rose, Johannes
Pollmanns, Krefeld, Germany, Markus
Graefen, Hamburg, Germany, Benno
Neukirch, Martin Friedrich, Saskia Droesler,
Maria Weyermann, Krefeld, Germany
*Presenting author
ABSTRACT
TIME NUMBER TITLE
1:40 PD43-05 PROSPECTIVE COMPARISON OF OPEN
VERSUS ROBOT-ASSISTED RADICAL
PROSTATECTOMY FOR CLINICALLY
LOCALIZED PROSTATE CANCER: ANALYSIS
OF 1806 CONSECUTIVE MEN TREATED IN A
UNIVERSAL HEALTHCARE SYSTEM
Adrian Fairey, Sunita Ghosh, Niels Jacobsen,
Lucas Dean*, Derek Bochinski, Michael
Chetner, Howard Evans, Michael Hobart,
David Mador, Blair St. Martin, Keith Rourke,
Eric Estey, Edmonton, Canada
255
1:50
PD43-06
THE IMPACT OF SURGICAL TECHNIQUE
ON UNPLANNED REOPERATION
FOLLOWING OPEN AND MINIMALLY
INVASIVE RADICAL PROSTATECTOMY:
ANALYSIS OF THE NATIONAL SURGICAL
(NSQIP) DATABASE
Ahmad Shabsigh*, Columbus, OH
2:00
PD43-07
UPSTAGING ON FINAL PATHOLOGY IN
PATIENTS ELIGIBLE FOR ACTIVE
SURVEILLANCE WITH SUBDIVISION BY
AGE
Mona Yezdani*, Sylvia Yu, Ben Katz, Daniel
Maass, Benjamin Taylor, Alexandra Lee,
Alice McGill, Kelly Monahan, David Lee,
Philadelphia, PA
2:10
PD43-08
PROSPECTIVE LONGITUDINAL
COMPARATIVE STUDY OF LONG-TERM
URINARY AND SEXUAL FUNCTION AFTER
PRIMARY SURGICAL TREATMENT FOR
Homayoun Zargar*, Daniel Moon, Anthony
Costello, Mark Frydenberg, Mari Botti,
MONDAY
PROSTATE CANCER: LOCALIZED: SURGICAL THERAPY VI
Moderators: Ashutosh Tewari and Vipul Patel
2:20
PD43-09
THE SURGICAL APGAR SCORE IS AN
INDEPENDENT PREDICTOR OF HIGH
COMPLICATION BURDEN FOLLOWING
Björn Löppenberg*, Matthias Orberger,
Florian Roghmann, Christian von Bodman,
Marko Brock, Joachim Noldus, Jüri Palisaar,
Herne, Germany
2:40
PD43-11
ADJUVANT MAXIMUM ANDROGEN
BLOCKAGE COMPARED WITH
BICALUTAMIDE 150MG IN PATIENTS
WITH LOCALIZED HIGH-RISK PROSTATE
CANCER AFTER RADICAL
PROSTATECTOMY
Kun Chang*, Xiao-jian Qin, Ding-wei Ye,
Shanghai, China, People’s Republic of
2:30
PD43-10
HYPOGONADISM INDEPENDENTLY
PREDICTS PATHOLOGICAL GLEASON
PATTERN 5 AT THE TIME OF RADICAL
PROSTATECTOMY
Marco Moschini*, Paolo Dell’Oglio, Nicola
Fossati, Giorgio Gandaglia, Alessandro
Larcher, Armando Stabile, Giuseppe Saitta,
Eugenio Ventimiglia, Milan, Italy, Guido
Barbagli, Arezzo, Italy, Shahrokh François
Shariat, Vienna, Austria, Renaud Bollens,
Brussels, Belgium, Francesco Montorsi,
2:50
PD43-12
URINARY CONTINENCE OUTCOMES
AFTER RETZIUS-SPARING ROBOTASSISTED RADICAL PROSTATECTOMY: A
PROSPECTIVE, NON-RANDOMIZED,
IDEAL STAGE 2B (EXPLORATION) STUDY
Dalela, Akshay Sood, Jesse Sammon, Madhu
Ashni-Prasad, Wooju Jeong, James Peabody,
Mani Menon, Detroit, MI
CREDITTM
Monday, May 9, 2016
1:00 pm - 3:00 pm
Podium Session 44
TRAUMA/RECONSTRUCTION/DIVERSION: URETHRAL RECONSTRUCTION (INCLUDING STRICTURE, DIVERTICULUM) III
Moderators: Sean Elliott and Kenneth Angermeier
TIME
1:00
1:10
1:20
1:30
ABSTRACT
NUMBER TITLE
PD44-01 RECONSTRUCTION OF BULBOMEMBRANOUS URETHRAL STRICTURES
AFTER SURGERY FOR BENIGN
PROSTATIC HIPERPLASIA WITH
PRESERVATION OF CONTINENCE
Reynaldo Gomez*, Santiago, Chile, Juan
Carlos Castaño, Medellin, Colombia, Laura
Velarde, Rodrigo Campos, Santiago, Chile
PD44-02
PD44-03
PD44-04
ABSTRACT
TIME NUMBER TITLE
1:40 PD44-05 THE EFFECT OF AN ALIGNING CATHETER
ON URETHROPLASTY FOR PELVIC
FRACTURE URETHRAL INJURIES
Alexandra Bascom*, Keith Rourke,
Edmonton, Canada
LESSONS LEARNED FROM 48 SURGICAL
PROCEDURES FOR THE TREATMENT OF
URETHROVESICAL ANASTOMOTIC
STENOSIS AFTER RADICAL
PROSTATECTOMY
André Cavalcanti*, Carlos Felipe Trujillo,
Henrique Almeida, Felipe Heins, Gabriel
Campos, Bruno Rodrigues, Rio de Janeiro,
Brazil
SHORT AND LONG-TERM
COMPLICATIONS AND OUTCOMES OF
RADIATION AND SURGICALLY INDUCED
RECTOURETHRAL FISTULA REPAIR WITH
BUCCAL MUCOSA GRAFT AND MUSCLE
INTERPOSITION FLAP
Daniel Kaufman*, Brendan Browne, Leonard
Zinman, Burlington, MA, Jill Buckley, San
Diego, CA, Peter Marcello, Alex Vanni,
Burlington, MA
DIAGNOSIS AND MANAGEMENT OF
PUBIC OSTEOMYELITIS ASSOCIATED
WITH GENITOURINARY FISTULA
John Lacy*, Cleveland, OH, Hakan Ilaslan,
Cleveland, OH, Kenneth Angermeier, Hadley
Wood, Cleveland, OH
256
1:50
PD44-06
WHAT CONSTITUTES COMPLEXITY IN
THE SURGICAL RECONSTRUCTION OF
PELVIC FRACTURE-RELATED URETHRAL
INJURIES?
Simon Bugeja, Stella Ivaz*, Anastasia Frost,
Enrique Fes, Felix Campos, Daniela Andrich,
Anthony Mundy, London, United Kingdom
2:00
PD44-07
PELVIC FRACTURE URETHRAL
DISTRACTION DEFECT (PFUDD) WITH
ASSOCIATED RECTAL INJURY: A REVIEW
OF ACUTE AND DEFINITIVE UROLOGIC
MANAGEMENT WITH LONG TERM
OUTCOMES
Brian Montgomery*, Douglas Husmann,
Rochester, MN
2:10
PD44-08
TRANSPERINEAL REANASTOMOSIS FOR
TREATMENT OF RECURRENT
ANASTOMOTIC STRICTURES
Victor Schüttfort*, Philip Reiß, Hamburg,
Germany, Daniel Pfalzgraf, Mannheim,
Germany, Margit Fisch, Roland Dahlem,
Hamburg, Germany
2:20
PD44-09
WHAT’S THE BEST WAY TO PREPARE A
BUCCAL MUCOSA GRAFT FOR
URETHROPLASTY? A HISTOLOGIC
BASED STUDY
Michele Simões, André Cavalcanti, Diogo De
Souza, Bianca Gregório*, Waldemar Costa,
Francisco Sampaio, Rio De Janeiro, Brazil
2:30
PD44-10
REDUCING THE INFLAMMATORY MILIEU
IN A RAT MODEL OF SUBSTITUTION
URETHROPLASTY WITH BONE MARROW
STEM CELLS
Joceline S Liu*, Matthew I Bury, Natalie J
Fuller, Renea Sturm, Nida Ahmad, Arun K
Sharma, Chicago, IL
2:40
PD44-11
KULKARNI TECHNIQUE OF PERINEAL
APPROACH WITH PENILE INVERSION
FOR SURGICAL REPAIR OF ANTERIOR
URETHRAL STRICTURES: FUNCTIONAL
AND COSMETIC OUTCOMES
Francisco Martins*, Lisboa, Portugal, Sanjay
Kulkarni, Pankaj Joshi, Pune, India, João
Marcelino, Tiago Ribeiro de Oliveira, Pedro
Oliveira, David Martinho, Lisboa, Portugal,
Natália Martins, Portalegre, Portugal, Tomé
Lopes, Lisboa, Portugal
2:50
PD44-12
FIRST-STAGE URETHROPLASTY:
FAILURES AND THEIR MANAGEMENT
Lindsay A. Hampson*, Seattle, WA, Keith
Rourke, Edmonton, Canada, Alex J. Vanni,
Burlington, MA, Sean Elliott, Minneapolis,
MN, Jeremy B. Myers, Salt Lake City, UT,
Thomas G. Smith III, Houston, TX, Bryan B.
CREDITTM
Monday, May 9, 2016
1:00 pm - 3:00 pm
ADRENAL/SINGLE PORT SURGERY/LESS/NOTES
Moderator: Lee Richstone
ABSTRACT
NUMBER TITLE
V11-01
REAL-TIME IMAGE GUIDED FOCAL
SURGICAL RESECTION FOR PROSTATE
CANCER: A FEASIBILITY STUDY
Haidar Abdul-Muhsin*, Akira Kawashima,
Alvin Silva, Melissa Stanton, Gianni Moshero,
Erik Castle, Paul Andrews, Mitchell
ABSTRACT
NUMBER TITLE
V11-06
POSTERIOR RETROPERITONEOSCOPIC
BILATERAL ADRENALECTOMY IN
ECTOPIC CUSHINGS SYNDROME
Alberto Jurado Navarro, Patricio Garcia
Marchiñena*, José Ignacio Costabel, Jorge
Jaunarena, Oscar Damia, Guillermo Gueglio,
Ciudad Autónoma de Buenos Aires, Argentina
V11-02
BILATERAL ADRENALECTOMY AND
MULTIPLE TUMORECTOMY IN VON
HIPPEL–LINDAU DESEASE
Juan Antonio Peña*, Joan Palou, Andrés
Kanashiro, Luis Miguel Sierra, Ivan
Schwartzmann, Humberto Villavicencio,
Barcelona, Spain
V11-07
SIMPLIFIED STEP-BY-STEP SURGICAL
PRINCIPLE OF RIGHT
SIMPLE NEPHRECTOMY
Jung Jun Kim*, Seoul, Korea, Republic of,
Seunghee Yum, Gunpo, Korea, Republic of,
Deok Hyun Han, Seoul, Korea, Republic of
V11-03
SELECTIVE ISCHEMIA IN ROBOTASSISTED PARTIAL ADRENALECTOMY
Pietro Grande, Livio Mordaini, Niklas Pelzer,
Hansjörg Danuser, Agostino Mattei*, Lucerne,
Switzerland
V11-08
V11-04
BILATERAL LAPAROSCOPIC ADRENAL
TUMOR RESECTION
Daniel Salas, Joan Palou*, Oscar Rodrı́guez,
Alberto Breda, Juan Antonio Peña, Andrés
Kanashiro, Nicolás Nervo, Humberto
LAPAROSCOPIC ADRENAL
METASTATECTOMY IN TESTICULAR
SEMINOMA: FIRST CASE IN AMERICA
Marino Cabrera Fierro*, Claudia Lucia Ochoa,
Rodolfo Varela, Jorge Alfredo Forero,
German Fabian Godoy, Maria Cristina
Maldonado, Bogota, Colombia
V11-09
EXCISION OF A RETROPERITONEAL
GANGLIONEUROMA
Lucas Burttet*, Gabrielle Varaschin, Fernando
Abreu, Brasil Silva Neto, Milton Berger, Porto
Alegre, Brazil
V11-05
*Presenting author
(LESS) VARICOCELECTOMY USING
INDOCYANINE GREEN FLUORESCENCE
(ICG) ANGIOGRAPHY
Keiji Tomita*, Eiki Hanada, Susumu
Kageyama, Kazuyoshi Johnin, Mitsuhiro
Narita, Akihiro Kawauchi, Otsu-City, Japan
257
MONDAY
Video Session 11
V11-10
V11-11
ROBOT ASSISTED PARTIAL
ADRENALECTOMY FOR FUNCTIONING
ADRENAL MASSES
Giuseppe Simone, Gabriele Tuderti*, Antonio
Stigliano, Rocco Papalia, Mariaconsiglia
Ferriero, Riccardo Mastroianni, Francesco
Minisola, Leonardo Misuraca, Salvatore
Guaglianone, Michele Gallucci, Rome, Italy
V11-12
ROBOTIC ADRENALECTOMY FOR
METASTATIC MELANOMA
Michael Jennings*, Wesley White, Knoxville,
TN
CREDITTM
PURE TRANSVAGINAL NATURAL ORIFICE
TRANSLUMINAL ENDOSCOPIC SURGERY
(NOTES) NEPHRECTOMY (VIDEO)
Zou Xiaofeng*, Zhang Guoxi, Yuan Yuanhu,
Xiao Rihai, Wu Gengqing, Long Dazhi,
Ganzhou, Jiangxi, China, People’S Republic
Of
Monday, May 9, 2016
1:00 pm - 3:00 pm
COURT IS IN SESSION
Attorneys: Barton Hegeler and Clark Hudson
1:00
CASE 1: URETERAL AVULSION
Moderator: Roger Sur
Defendant: Sara Best
Expert Witness (Defense): Arthur Smith
Expert Witness (Plantiff): Brian Eisner
2:20
CASE 3: PREGNANCY AFTER VASECTOMY
Moderator: Jay Sandlow
Defendant: Ira Sharlip
Expert Witness (Defense): Lawrence Ross
Expert Witness (Plantiff): Ed Kim
1:40
CASE 2: DELAYED DIAGNOSIS/TREATMENT
OF CANCER
Moderator: J. Kellogg Parsons
Defendant: Daniel Lin
Expert Witness (Defense): Peter Carroll
Expert Witness (Plantiff): H. Ballentine Carter
3:00
ADJOURN
CREDITTM
Monday, May 9, 2016
1:00 pm - 4:00 pm
EGYPTIAN UROLOGICAL SOCIETY (EUA)
Marina D @ Marriott
1:00
WELCOME
Society President: Mohamed Eissa
1:05
SESSION I: MALE SEXUAL DISORDER
SESSION
Chairmen: Mohamed Eissa, Ibrahim Mokhless,
Ahmed Shoma
SHUNTING FOR ISCHEMIC PRIAPISM: A 50YEAR MISUNDERSTANDING
Tom Lue
1:25
UNSATISFIED PATIENT WITH PENILE
IMPLANT: WHY AND HOW TO MANAGE?
Abdel-Rahman Zahran
1:40
BREAK
1:50
SESSION II: MINIMALLY INVASIVE SURGERY
Chairmen: Saad Saad, Magdy El-Akkad, Osama
Abou Farha
2:10
ROBOTIC UROLOGIC SURGERY IN COMMUNITY
PRACTICE: OUTCOMES AND LESSONS
Ahmed Fawzy
2:30
LAPAROSCOPIC RADICAL CYSTECTOMY: DO
WE REALLY NEED ROBOTIC?
Ahmed Shoma
2:50
NOVEL IMAGING FOR RENAL TUMORS
Mohamad Allaf
3:10
SESSION III: FEMALE UROLOGY DISORDER
Chairmen: Mohamed Elgammal, Mohamad S.E.
Elbadry, Mohammed Shafik
SACRAL NEUROMODULATION IN PELVIC
FLOOR DYSFUNCTION: WHAT WE HAVE
LEARNED IN THE LAST 20 YEARS?
Magdy Hassona
METABOLIC EVALUATION OF THE PATIENT
WITH UROLITHIASIS MADE SIMPLE: “STONE
TREES”
Ralph Clayman
258
3:30
PELVIC FLOOR DYSFUNCTION
Mohamed Salah
3:45
MIDURETHRAL SLING: COMPLICATIONS AND
MANAGEMENT
Hassan Aboulella
4:00
ADJOURN
Monday, May 9, 2016
1:15 pm - 5:00 pm
PAN AFRICAN UROLOGICAL SURGEONS ASSOCIATION (PAUSA) / CARIBBEAN UROLOGICAL ASSOCIATION (CURA)
WELCOME REMARKS
1:30
SESSION 1: GUEST LECTURES
Chairmen: Mobile Kampanga, Emmanuel Jeje
UPDATE ON PROSTATE CANCER GRADING
Adeboye Osunkoya
1:45
ROLE OF G.P.C. IN IMPROVING UROLOGICAL
TRAINING AND PRACTICE WORLDWIDE
Robert Flanigan
2:00
SESSION 2: SURGICAL OUTREACHES IN
AFRICA AND THE CARIBBEAN
Chairmen: Robert Flanigan, E. Oluwabunmi OlapadeOlaopa
PANEL DISCUSSION: SURGICAL
OUTREACHES IN AFRICA AND THE
CARIBBEAN
Panelists: Gary Faerber, Serigne Gueye, Willie
Underwood, William Aiken
2:50
DISCUSSION
3:20
SESSION 3: SURGICAL FRONTIER
Chairmen: Gary Faerber, Serigne Gueye
3:40
ORTHOTOPIC CONTINENT URINARY
DIVERSION: CHOICE AND LIMITATIONS
Ismail Khalaf
3:50
THE EPIDEMIOLOGICAL, CLINICAL AND
THERAPEUTIC ASPECTS OF MALE
CIRCUMCISION COMPLICATIONS IN
CAMEROON IN 10 YEARS
Mbassi Achille Aurele
4:00
KNOWLEDGE, ATTITUDES AND PRACTICE
TOWARDS SAW PALMETTO AND OTHER
HERBAL PRODUCTS AMONG MEN WITH
PROSTATE DISEASE IN A UROLOGY CENTRE
IN TRINIDAD AND TOBAGO
Satyendra Persaud
4:10
VALIDATION OF THE PROSTATE CANCER
PREVENTION TRAIL (PCPT2) RISK
CALCULATOR IN A CARIBBEAN POPULATION:
PRELIMINARY RESULTS
Trudy Kawal
4:20
DISCUSSION
4:30
SESSION 5: AOB
TREATMENT OF STONES IN NIGERIA
Evaristus Azodoh
3:30
MONDAY
1:15
PAUSA/CURA BUSINESS MEETING
5:00
SESSION 4: FREE PAPERS
Chairmen: Mohamed Eissa, Alexander Nwofor
ADJOURN
CREDITTM
ISCHAEMIC PENILE DISEASE IN MEN WITH
ESRD
Michael Scott
Monday, May 9, 2016
2:00 pm - 4:00 pm
PHILIPPINE UROLOGICAL ASSOCIATION (PUA)
Marina E @ Marriott
2:00
WELCOME REMARKS
Society President: Pedro Lantin
2:10
THREE DECADES OF URINARY
INCONTINENCE RESEARCH: LESSONS
LEARNED FROM THE MESA PROJECT
Ananias Diokno
2:30
UROLOGIC PROBLEMS IN THE GRAFT
KIDNEY AND HOW TO MANAGE THEM:
CURRENT ISSUES/CONTROVERSIES IN
DONOR NEPHRECTOMIES
Alvin Wee
2:50
CURRENT TRENDS OF PROSTATE CANCER
TREATMENTS
James Sylorica
3:10
THE CURRENT MANAGEMENT OF
CANCER
Raoul Concepcion
3:30
DIALOGUE MEETING WITH PHILIPPINEAMERICAN SOCIETY
4:00
ADJOURN
Monday, May 9, 2016
2:25 pm - 5:30 pm
SOCIETÀ ITALIANA DI UROLOGIA (SIU) / AMERICAN UROLOGICAL ASSOCIATION (AUA) JOINT MEETING
Marina F @ Marriott
2:25
Society President: Walter Artibani
Society Secretary General: Vincenzo Mirone
AUA: Inderbir Gill
*Presenting author
2:30
259
PROSTATE CANCER BIOLOGY, STAGING AND
GRADING
Moderators: Giuseppe Carrieri, Giuseppe Morgia
PROSTATE CANCER BIOLOGY: WHAT HAVE
WE LEARNED OVER THE YEARS
William Catalona
4:40
POST PROSTATECTOMY INCONTINENCE:
HOW I TREAT IT
Gopal Badlani
2:50
NEW AVENUES IN PROSTATE CANCER
STAGING
Andrew Stephenson
5:00
DISCUSSION
Moderators: Gianluca D’Elia, Bernardo Rocco
5:10
3:10
GLEASON SCORE: THE CHANGING SCENARIO
Gladell Panner
SIU/AUA PARTNERSHIP THE KEY OF
SUCCESS
3:30
DISCUSSION
Moderators: Alberto Briganti, Ricardo Autorino
3:40
PROSTATE CANCER SURGERY
Moderators: Walter Artibani, Vincenzo Mirone
4:00
4:20
NEW STRATEGY AND POLICY OF THE AUA
INTERNATIONAL OFFICE
Inderbir Gill
5:17
EVOLVING CONCEPTS IN SURGICAL
ANATOMY OF THE PROSTATE
Robert Myers
SIU/AUA PARTNERSHIP: PRESENT AND
FUTURE
Vincenzo Mirone
5:24
RADICAL PROSTATECTOMY: PAST, PRESENT
AND FUTURE
Francesco Montorsi
BEST ITALIAN ABSTRACT PRESENTED AT
2016 AUA MEETING AWARD
Walter Artibani
5:31
ADJOURN
ROBOTIC PROSTATECTOMY: THE FINAL
JUDGMENT
Vipul Patel
Monday, May 9, 2016
2:55 pm - 5:00 pm
TOWN HALL: OPTIMIZING QUALITY OF LIFE IN PATIENTS WITH ADVANCED CANCER
2:55
MODERATOR WELCOME AND
ANNOUNCEMENTS
Moderator: Christopher Kane
4:10
SOCIAL WORKER: PRESERVING HOPE AND
REALISM
Christopher Onderdonk
3:00
PALLIATIVE CARE: OPTIMAL CARE FOR
PATIENTS WITH ADVANCED CANCER
William Mitchell
4:25
IMMUNONUTRITION IN GENITOURINARY
CANCERS
Eugene Lee
3:20
MANAGING PAIN AND NAUSEA IN ADVANCED
CANCER PATIENTS
Greg Polston
4:40
ONCOLOGY TOWN HALL: EXPERT ANSWERS
FOR THE UROLOGIC COMMUNITY
5:00
ADJOURN
3:40
SYMPTOM MANAGEMENT
Eric Roeland
3:55
PSYCHIATRIST: TREATING DEPRESSION AND
ANXIETY
Jeremy Hirst
CREDITTM
Monday, May 9, 2016
3:00 pm - 5:30 pm
CLINICAL CONTROVERSIES IN MEN’S HEALTH
3:00
THE DECLINE IN PROSTATE CANCER
DIAGNOSIS FOLLOWING U.S. PREVENTIVE
SERVICES TASK FORCE (USPSTF)
RECOMMENDATIONS AGAINST PSA TESTING
IS A GOOD THING, OR A RETURN TO THE
DARK AGES?
Debater - Pro: Peter Carroll
Debater - Con: E. David Crawford
260
3:50
SHOCK-WAVE TREATMENT IS THE NEXT
BREAKTHROUGH FOR TREATMENT FOR
Debater - Pro: Tom Lue
Debater - Con: Arthur Burnett
4:40
THE FDA WAS RIGHT TO DISCOURAGE THE
USE OF TESTOSTERONE THERAPY FOR AGERELATED TESTOSTERONE DEFICIENCY
Debator - Pro: Philip Hanno
Debater - Con: Culley Carson
5:30
ADJOURN
CREDITTM
Monday, May 9, 2016
3:30 pm - 5:30 pm
ABSTRACT
NUMBER TITLE
MP76-01 CLOMIPHENE CITRATE RESULTS IN A
SIGNIFICANTLY LOWER INCIDENCE OF
POLYCYTHEMIA COMPARED TO
EXOGENOUS TESTOSTERONE
REPLACEMENT IN HYPOGONADAL MEN
Karen Wheeler*, Charlottesville, VA, Raj
Kumar, Orlando, FL, Shaan Setia, Raymond
Costabile, Charlottesville, VA, Parviz
Kavoussi, Austin, TX, Ryan Smith,
Charlottesville, VA
ABSTRACT
NUMBER TITLE
MP76-06 USE AND EFFECTIVENESS OF
PHARMACOLOGIC AND NONPHARMACOLOGIC ERECTILE AIDS
AMONG POST-PROSTATECTOMY
PROSTATE CANCER SURVIVORS
SEEKING TREATMENT FOR ERECTILE
DYSFUNCTION: A PROSPECTIVE,
MULTICENTER STUDY
Ilan Safir*, Martin Sanda, Dattatraya Patil,
Atlanta, GA, Catrina Crociani, Boston, MA,
Larry Hembroff, Michigan, MI, John Wei, Ann
Arbor, MI, Peter Chang, Boston, MA,
Akanksha Mehta, Atlanta, GA
MP76-02 ERECTILE FUNCTION IN 656
HYPOGONADAL MEN: RESULTS OF LONG
TERM TREATMENT WITH
INJECTIONS (TU) IN COMPARISON WITH
CONTROL GROUP
Ahmad Haider*, Karim Haider, Bremerhaven,
Germany, Farid Saad, Berlin, Germany,
Gheorghe Doros, Abdulmaged Traish,
Boston, MA
MP76-07 COMPARISON OF THE EFFECTS OF ORAL
ENCLOMIPHENE CITRATE AND TOPICAL
TESTOSTERONE GELS TREATMENT ON
SERUM HORMONES, ERYTHROCYTOSIS,
LIPIDS, AND PROSTATE SPECIFIC
ANTIGEN
Alexander W. Pastuszak*, Houston, TX,
Ronald D. Wiehle, Gregory Fontenot, Joseph
Podolski, The Woodlands, TX, Larry I.
Lipshultz, Houston, TX
MP76-03 CORRELATION OF ERECTILE FUNCTION
REHABILITATION WITH PRESERVATION
OF NOCTURNAL PENILE TUMESCENSE 6
WEEKS AFTER NERVE-SPARING
RADICAL PROSTATECTOMY – EFFECT OF
DAILY LOW-DOSE SILDENAFIL
Andreas Bannowsky*, Osnabrück, Germany,
Stefan Ückert, Hannover, Germany, Daniar
Osmonov, Klaus-Peter Jünemann, Kiel,
Germany
MP76-08 SERUM LEVELS OF ENCLOMIPHENE AND
ZUCLOMIPHENE IN HYPOGONADAL MEN
ON LONG-TERM CLOMIPHENE CITRATE
TREATMENT
Sevann Helo*, Joseph Mahon, Albany, NY,
Joseph Ellen, Richmond, VA, Greg Fontenot,
Kuang Hsu, Ronald Wiehle, The Woodlands,
TX, Paul Feustel, Charles Welliver, Andrew
McCullough, Albany, NY
MP76-04 ANDROGENIC THERAPY IN TREATING
PATIENTS WITH VASCULOGENIC
Dmitry Kurbatov, Moscow, Russian
Federation, Andrey Erkovich, Novosibirsk,
Russian Federation, Roman Aliev*, Ruslan
Aliev, Barnaul, Russian Federation
MP76-05
*Presenting author
MP76-09 GROWTH HORMONE RELEASING
PEPTIDE TREATMENT IN MEN
INCREASES SERUM INSULIN-LIKE
GROWTH FACTOR-1 LEVELS
John T. Sigalos*, Andrew Allison, Alexander
Pastuszak, Samuel J. Ohlander, Amin Herati,
Mark C. Lindgren, Larry I. Lipshultz, Houston,
TX
TWICE PER WEEK DOSING OF
INTRAMUSCULAR TESTOSTERONE (T) IS
ASSOCIATED WITH GREATER RISK OF
ERYTHROCYTOSIS
Samuel J. Ohlander*, Bibin Varghese, Mark
Jones, Mark C. Lindgren, Andrew L. Allison,
Alexander W. Pastuszak, Larry I. Lipshultz,
Houston, TX
261
MONDAY
SEXUAL FUNCTION/DYSFUNCTION: MEDICAL, HORMONAL & NON-SURGICAL THERAPY I
Moderators: Nelson Bennett, Jr. and Drogo Montague
MP76-10 HYPOGONADAL MEN WITH SEXUAL
FUNCTION DISORDER BENEFIT FROM
LPCN 1021 (ORAL TESTOSTERONE) –
SOAR (STUDY OF ANDROGEN
REPLACEMENT) TRIAL
Culley Carson III*, Chapell Hill, NC, Mohit
Khera, Houston, TX, Adrian Dobs, Baltimore,
MD, Christina Wang, Torance, CA, Jed
Kaminetsky, New York, NY, Martin Miner,
Providence, RI, Irwin Goldstein, San Diego,
CA, Anthony Delconte, Nachiappan
Chidambaram, Satish Nachaegari, Mahesh
Patel, Salt Lake City, UT
MP76-15
EFFECT OF SILODOSIN ON PREMATURE
EJACULATION
Yoshikazu Sato*, Sapporo, Japan, Toshikazu
Otani, Nagoya, Japan, Toshiyasu Amano,
Nagano, Japan, Tohru Araki, Kurashiki,
Japan
MP76-16 A PROSPECTIVE RANDOMIZED STUDY
COMPARING THE EFFICACY AND SAFETY
OF SILDENAFIL WITH DAPOXETINE IN
TREATMENT OF PREMATURE
EJACULATION
Mohamed Elbakary*, Abd Elnaser Elgamasy,
Sami Elmatit, Ahmed Essa, Tanta, Egypt
MP76-11 EFFECTS OF 8-YEAR TREATMENT OF
LONG-ACTING TESTOSTERONE
UNDECANOATE ON METABOLIC
PARAMETER, URINARY SYMPTOMS,
BONE MINERAL DENSITY AND SEXUAL
FUNCTION IN MEN WITH LATE ONSET
HYPOGONADISM
Sompol Permpongkosol*, Kalayanee
Khupulsup, Supatra Leelaphiwat, Sarawan
Pavavattananusorn, Tanoon Pettong,
Nonthaburi Provice, Thailand
MP76-17 PILATES FOR BETTER SEX: CHANGES IN
SEXUAL FUNCTIONING IN HEALTHY
TURKISH WOMEN AFTER PILATES
EXERCISE
Fikret Halis, Sakarya, Turkey, Pelin Yildirim,
Kocaeli, Turkey, Ramazan Kocaaslan, Kursat
Cecen, Kars, Turkey, Ahmet Gokce*,
Sakarya, Turkey
MP76-18 “PARTNER PROSTHESIS PANIC”:
MANAGEMENT OF FEMALE SEXUAL
DYSFUNCTION IN PARTNERS OF MEN
UNDERGOING PENILE PROSTHESIS
IMPLANTATION
Sherita King*, Rose Hartzell, Irwin Goldstein,
San Diego, CA
MP76-12 REGULAR LOW DOSE SILDENAFIL
REDUCES VENOUS LEAK RATES AFTER
Raanan Tal*, Bob Berookhim, Doron S
Stember, Lawrence Jenkins, Joe Narus, D
Garcia, N Wolchasty, John P Mulhall, New
York, NY
MP76-19 THE EFFICACY OF TRIGGER POINT
INJECTIONS IN THE TREATMENT OF
SEXUAL PAIN
Sonia Bahlani-Khanna*, New Hyde Park, NY,
Alexandra King, Hempstead, NY, Robert
Moldwin, New Hyde Park, NY
MP76-13 CANADIAN CONSENSUS GUIDELINES
FOR SEXUAL REHABILITATION
FOLLOWING PROSTATE CANCER
TREATMENT
Dean Elterman*, Brandon Van Asseldonk,
Andrew Matthew, Toronto, Canada, Gerald
Brock, London, Canada, Stacy Elliot,
Vancouver, Canada, Ashley Curtis, Janet
Ellis, Antonio Finelli, Toronto, Canada, Jerzy
Gajewski, Halifax, Canada, Leah Jamnicky,
Keith Jarvi, Anika Petrella, Toronto, Canada,
John Robinson, Lauren Walker, Edmonton,
Canada
MP76-20 PROSPECTIVE LONG-TERM OUTCOME OF
ERECTILE FUNCTION IN MEN TREATED
BY PROSTATE BRACHYTHERAPY
Richard Stock*, New York, NY, Nelson Stone,
Vail, CO
CREDITTM
MP76-14 EFFECTS OF TADALAFIL ONCE DAILY IN
THE TREATMENT OF PREMATURE
EJACULATION
Levent Ozcan, Kocaeli, Turkey, Emre Can
Polat, Istanbul, Turkey, Efe Onen, Kocaeli,
Turkey, Alper Otunctemur, Istanbul, Turkey,
Mustafa Cekmen, Ceyla Eraldemir, Kocaeli,
Turkey, Ramazan Kocaaslan, Kars, Turkey,
Emin Ozbek*, Istanbul, Turkey
262
Monday, May 9, 2016
3:30 pm - 5:30 pm
URODYNAMICS/LOWER URINARY TRACT DYSFUNCTION/FEMALE PELVIC MEDICINE: NON-NEUROGENIC VOIDING
DYSFUNCTION II
Moderators: Michael Kennelly and Michael Chancellor
ABSTRACT
NUMBER TITLE
MP77-01 DIFFERENT SUPRASPINAL RESPONSES
TO AUTOMATED, REPETITIVE BLADDER
FILLING IN OAB PATIENTS COMPARED
TO HEALTHY SUBJECTS - AN FMRI
STUDY
Matthias Walter*, Lorenz Leitner, Lars
Michels, Spyros Kollias, Patrick Freund,
Martina Liechti, Thomas M. Kessler, Ulrich
ABSTRACT
NUMBER TITLE
MP77-08 BRAIN ACTIVATIONS DURING BLADDER
FILLING IN WOMEN WITH REFRACTORY
OVERACTIVE BLADDER
Steven Weissbart*, Rupal Bhavsar, Alan
Wein, John Detre, Lily Arya, Ariana Smith,
Philadelphia, PA
MP77-02 TEMPORAL SUMMATION AS AN
OBJECTIVE MARKER FOR OVERACTIVE
BLADDER IN WOMEN
Elizabeth T. Brown*, Stephen Mock, Joshua
Cohn, Melissa Kaufman, Stephen Bruehl,
Roger Dmochowski, W. Stuart Reynolds,
Nashville, TN
MP77-10 URINARY AGRIN CLEAVAGE PRODUCTS
PROVIDE PHENOTYPIC
CHARACTERIZATION OF INTERSTITIAL
CYSTITIS PATIENTS
Laura Lamb*, Royal Oak, MI, Peter
Levanovich, Detroit, MI, Andrew Vereecke,
Bernadette Zwaans, Sarah Bartolone,
Kenneth Peters, Michael Chancellor, Royal
Oak, MI
MP77-03 THERMAL PAIN THRESHOLD AND
TOLERANCE IN OVERACTIVE BLADDER
(OAB): DO WOMEN WITH OAB
DEMONSTRATE HYPERALGESIA?
Elizabeth T. Brown*, Stephen Mock, Joshua
Cohn, Melissa Kaufman, Stephen Bruehl,
Roger Dmochowski, W. Stuart Reynolds,
Nashville, TN
MP77-11 TIL DEATH DO US PART: THE
RELATIONSHIP BETWEEN URINARY
INCONTINENCE AND MARITAL STATUS
AMONG US WOMEN AND MEN
Evgeniy Kreydin*, Los Angeles, CA, Michelle
Kim, Boston, MA, Janine Oliver, Seth Cohen,
Anne Ackerman, Zaid Chaudhry, My-Linh Thi
Nguyen, Ja-Hong Kim, Shlomo Raz, Los
Angeles, CA
MP77-04 SENSATION DURING FILLING
CYSTOMETRY CORRELATES WITH
DETRUSOR WALL TENSION IN PATIENTS
WITH OVERACTIVE BLADDER
Andrew Colhoun, John Speich, MaryEllen
Dolat, Eugene Bell*, Anna Nagle, Paul Ratz,
Robert Barbee, Adam Klausner, Richmond,
VA
MP77-05
MP77-12 COITAL INCONTINENCE IN WOMEN WITH
URINARY INCONTINENCE: RESULTS
FROM AN INTERNATIONAL CROSSSECTIONAL STUDY
Ervin Kocjancic, Chicago, IL, Ester Illiano,
Naples, Italy, Daniele Tienforti, Rome, Italy,
Konstantinos Giannitsas, Anastasios
Athanasopoulos, Patras, Greece, Raffaele
Balsamo, Catanzaro, Italy, Wally Mahfouz*,
Alexandria, Egypt, Franca Natale, Rome,
Italy, Manuel Di Biase, Perugia, Italy,
Giuseppe Masiello, Molfetta, Italy, Antonio
Carbone, Latina, Italy, Donata Villari,
Florence, Italy, Maria Teresa Filocamo,
Savigliano, Italy, Enrico Finazzi Agrò, Rome,
Italy, Elisabetta Costantini, Perugia, Italy
LOW AMPLITUDE RHYTHMIC
CONTRACTIONS INFLUENCE
SENSATIONS OF URGENCY IN PATIENTS
WITH OVERACTIVE BLADDER SYNDROME
Andrew Colhoun, Adam Klausner, MaryEllen
Dolat, Eugene Bell*, Anna Nagle, Paul Ratz,
Robert Barbee, John Speich, Richmond, VA
MP77-06 DETRUSOR HYPERACTIVITY WITH
IMPAIRED CONTRACTILITY:
URODYNAMIC FINDINGS AND THE NEED
FOR MORE PRECISE DEFINITIONS
Jason K Frankel*, Andrew C Boylan, Phillip P
Smith, Farmington, CT
MP77-07 SAFETY AND EFFICACY OF BOTULINUM
TOXIN A TREATMENT FOR PATIENTS
WITH DETRUSOR OVERACTIVITY AND
INADEQUATE CONTRACTILITY
Shu-Yu Wu*, Hualien, Taiwan, Chung-Cheng
Wang, New Taipei, Taiwan, Hann-Chorng
Kuo, Hualien, Taiwan
*Presenting author
MP77-13 HIGHER URINE LEVELS OF
ENVIRONMENTAL TOXINS ARE
ASSOCIATED WITH INCREASED
INCONTINENCE AND NOCTURIA IN MEN
Michelle Kim*, Boston, MA, Evgeniy Kreydin,
Janine Oliver, Anne Ackerman, Seth Cohen,
Zaid Chaudhry, Mi-Linh Nguyen, Ja-Hong
Kim, Shlomo Raz, Los Angeles, CA
263
MONDAY
MP77-09 CHRONIC PSYCHOLOGICAL STRESS
LEADS TO BLADDER HYRALGESIA VIA
STRESS INDUCED SENSITIZATION OF C
FIBERS AND MECHANORECPTORS
Yunliang Gao*, Rong Zhang, Huiyi Chang,
Larissa Rodriguez, Los Angeles, CA
MP77-14 SACRAL NEUROMODULATION FOR
REFRACTORY OVERACTIVE BLADDER
AFTER PRIOR INTRAVESICAL
ONABOTULINUMTOXINA TREATMENT
Nathan Hoag*, Melbourne, Australia, Sophie
Plagakis, Samantha Pillay, Ailsa Wilson
Edwards, Adelaide, Australia, Johan Gani,
MP77-15
MP77-18 RISK FACTORS FOR LONG-TERM SACRAL
NERVE STIMULATION FAILURES
Kevin Zeeck*, Morgan Schubbe, Anjishnu
Banerjee, Robert O’Connor, Michael
Guralnick, Milwaukee, WI
MP77-19 COMPREHENSION AND CONSTRUCT
VALIDITY OF THE VISUAL PROSTATE
SYMPTOM SCORE (VPSS) BY MEN WITH
OBSTRUCTIVE LOWER URINARY TRACT
SYMPTOMS (LUTS) IN RURAL UGANDA
Lynn Stothers*, Andrew Macnab, Vancouver,
Canada
QUALITY OF LIFE AFTER SACRAL
NEUROMODULATION: DOES IT DIFFER IN
SUBJECTS ACROSS DIFFERENT
OVERACTIVE BLADDER DIAGNOSES?
Karen Noblett*, Riverside, CA, Jeffrey
Mangel, Cleveland, OH, Craig Comiter,
Stanford, CA, Erin Bird, Temple, TX, Tomas
L. Griebling, Kansas City, KS, Suzette E.
Sutherland, Seattle, WA, Kira Q. Stolen,
Fangyu Kan, Minneapolis, MN, Steven
Siegel, Woodbury, MN
MP77-20 IS DETRUSOR CONTRACTION REALLY
NECESSARY FOR FEMALE MICTURITION?
Satoru Kira*, Hideki Kobayashi, Yaburu
Haneda, Norifumi Sawada, Takahiko Mitsui,
Masayuki Takeda, Chuo, Japan
CREDITTM
MP77-16 DOES UPPER MEDIAL PLACEMENT OF A
SACRAL LEAD AFFECT
NEUROMODULATION OUTCOMES? A
RADIOLOGIC STUDY
Natalie Gaines*, Priyanka Gupta, Royal Oak,
MI, Jonathan C. Hu, Rochester, MI, Kim A.
Killinger, Judith A. Boura, Jamie Bartley,
Jason Gilleran, Kenneth M. Peters, Royal
Oak, MI
MP77-17 THE OUTCOMES IN WOMEN WITH NONE
OBSTRUCTIVE URINARY RETENTION
AND DETRUSOR UNDERACTIVITY
TREATED BY SACRAL
NEUROMODULATION
Veronique Phe*, Eskinder Solomon, Julie
Jenks, Neha Sihra, Jalesh Panicker, Rizwan
Hamid, Jeremy Ockrim, Tamsin Greenwell,
Mahreen Pakzad, London, United Kingdom
Monday, May 9, 2016
3:30 pm - 5:30 pm
KIDNEY CANCER: EPIDEMIOLOGY & EVALUATION/STAGING II
Moderators: John Libertino, Tracey Krupski and Pilar Laguna Pes
ABSTRACT
NUMBER TITLE
MP78-01 ECTOPIC LIPID ACCUMULATION IN LIVER
IS ASSOCIATED WITH TUMOR
AGGRESSIVENESS AND POOR
PROGNOSIS IN RENAL CELL CARCINOMA
Daisuke Watanabe*, Akio Horiguchi,
Shinsuke Tasaki, Kenji Kuroda, Akinori
Satoh, Junichi Asakuma, Keiichi Ito,
Tomohiko Asano, Hiroshi Shinmoto, Namiki,
Tokorozawa-City, Saitama, Japan
ABSTRACT
NUMBER TITLE
MP78-03 MRI INTENSITY RATIO CURVE ANALYSIS:
A NEW OBJECTIVE METHOD FOR
CHARACTERIZING SMALL RENAL
MASSES
Shingo Moriyama*, Soichiro Yoshida, Hajime
Tanaka, Masaharu Inoue, Masaya Ito, Minato
Yokoyama, Junichiro Ishioka, Yoh Matsuoka,
Noboru Numao, Kazutaka Saito, Yoshihisa
Fujii, Kazunori Kihara, Tokyo, Japan
MP78-02 URINARY COLLECTING SYSTEM
INVASION IS ASSOCIATED WITH POOR
SURVIVAL IN CLEAR CELL RENAL CELL
CARCINOMA PATIENTS
George Bailey*, Stephen Boorjian, Matthew
Ziegelmann, Mary Westerman, Christine
Lohse, John Cheville, Bradley Leibovich,
Robert Thompson, Rochester, MN
MP78-04 IMPACT OF AN ENSUING DIAGNOSIS OF
RENAL CELL CARCINOMA AMONG
PATIENTS WHO HAD A PREVIOUS
DIAGNOSIS OF A DIFFERENT PRIMARY
NEOPLASM
Joel Slaton*, Winston-Salem, NC, Jet Li,
Ngoc Quyen T Duong, Kai Ding, Oklahoma
City, OK
264
ASSOCIATION OF M2 MACROPHAGE
INVASION WITH C-REACTIVE PROTEIN IN
Takayuki Nakayama*, Kazutaka Saito,
Yasuhisa Fujii, Yuma Waseda, Shingo
Moriyama, Hajime Tanaka, Masaharu Inoue,
Masaya Ito, Soichiro Yoshida, Naoko
Kawamura, Minato Yokoyama, Junichiro
MP78-11 DO SARCOMATOID AND RHABDOID
DIFFERENTIATION HAVE SIMILAR
PROGNOSTIC EFFECTS FOR PATIENTS
WITH GRADE 4 RENAL CELL
CARCINOMA?
Onder Kara*, Homayoun Zargar, Matthew
Maurice, Hiury Andrade, Oktay Akca, Peter
Caputo, Daniel Ramirez, Ercan Malkoc, Brian
Rini, Jihad Kaouk, Cleveland, OH
MP78-12 UTILITY OF CAD DERIVED PEAK
ENHANCEMENT IN DISCRIMINATING
FUHRMAN GRADES I-IV AT FOUR-PHASE
MDCT
Heidi Coy*, Jonathan Young, Michael Douek,
Pechin Lo, Matthew Brown, James Sayre,
Steven Raman, Los Angeles, CA
MP78-06 GENETIC ALTERATIONS IN SPECIFIC
CHROMOSOMAL REGIONS INDICATE
METASTATIC POTENTIAL IN CCRCC
PATIENTS
Julia Grimm, Martin Janssen, Homburg,
Germany, Arndt Hartmann, Christine Stöhr,
Frank Kunath, Erlangen, Germany, Michael
MP78-13 PROSPECTIVE EVALUATION OF 99MTCSESTAMIBI SPECT/CT FOR THE
DIAGNOSIS OF RENAL ONCOCYTOMAS
AND HYBRID ONCOCYTIC/
CHROMOPHOBE TUMORS
Michael A. Gorin*, Steven P. Rowe,
Alexander S. Baras, Lilja B. Solnes, Mark W.
Ball, Phillip M. Pierorazio, Christian P.
Pavlovich, Jonathan I. Epstein, Mehrbod S.
Javadi, Mohamad E. Allaf, Baltimore, MD
MP78-07 BLOOD BASED EXOSOMAL MIRNAS AS
BIOMARKERS FOR DIAGNOSIS AND
PROGNOSIS OF CLEAR CELL RENAL
CELL CANCER
Joana Heinzelmann, Sophie Baumgart,
Seastian Hölters, Martin Janssen, Michael
MP78-08 DIAGNOSTIC POTENTIAL OF PROTON
MAGNETIC RESONANCE SPECTROSCOPY
ON RENAL TUMORS
Masahiro Sumura*, Naoko Arichi, Shigenobu
Nakamura, Hiroaki Yasumoto, Takeshi
Yoshizako, Hajime Kitagaki, Hiroaki Shiina,
Izumo, shimane, Japan
MP78-14 RELATIONSHIP BETWEEN THE GENE
EXPRESSION PROFILES OF RENAL CELL
CARCINOMA AND BOTH PROGNOSTIC
MOLECULAR CLASSIFICATION AND
RESPONSE TO TARGETED THERAPY
Tomohiko Yanagida*, Seiji Hoshi, junya Hata,
Michihiro Yabe, Yuichi Sato, Hidenori
Akaihata, Sohichiro Ogawa, Nobuhiro Haga,
Nobuhiro Kushida, Kei Ishibashi, Emi Ito,
Junichi Imai, Satoshi Waguri, Shinya
Watanabe, Ken Aikawa, Yoshiyuki Kojima,
Fukushima City, Japan
MP78-09 IDENTIFICATION AND VALIDATION OF AN
8-GENE EXPRESSION SIGNATURE FOR
PREDICTING HIGH FUHRMAN GRADE
Fangning Wan*, Yao Zhu, Chengtao Han, Bo
Dai, Hailiang Zhang, Guohai Shi, Dingwei Ye,
Shanghai, China, People’s Republic of
MP78-15
MP78-10 THE INFLUENCE OF GENETIC VARIANTS
ON CLINICAL OUTCOMES AND TOXIC
EFFECTS IN PATIENTS WITH ADVANCED
RENAL CELL CARCINOMA TREATED
WITH SORAFENIB: A MULTI-CENTER
RESEARCH
Chao Qin*, Qiang Cao, Pu Li, Shangqian
Wang, Jian Wang, Meilin Wang, Nanjing,
China, People’S Republic Of, Liqun Zhou,
Beijing, China, People’S Republic Of, Dingwei
Ye, Yiran Huang, Shanghai, China, People’S
Republic Of, Xiaofeng Sun, Qing Zou,
Nanjing, China, People’S Republic Of, Lijiang
Sun, Qingdao, China, People’S Republic Of,
Jian Zhu, Nantong, China, People’S Republic
Of, Fade Liu, Nanjing, China, People’S
Republic Of, Li Cui, Changzhou, China,
People’S Republic Of, Xiaoxiang Wang,
Yangzhou, China, People’S Republic Of, Hu
Zhao, Jiangyin, China, People’S Republic Of,
Jianchun Chen, Wujiang, China, People’S
Republic Of, Zhengdong Zhang, Pengfei
Shao, Xiaobing Ju, Changjun Yin, Nanjing,
*Presenting author
BAP1 IS OVER-EXPRESSED IN BLACK VS.
WHITE PATIENTS WITH MX-M1 CLEAR
CELL RENAL CELL CARCINOMA (CCRCC)
David J. Paulucci, John P. Sfakianos*, Shalini
Singh Yadav, Ketan K. Badani, New York,
NY
MP78-16 CORRELATION OF BAP1 AND PBRM1
MUTATIONAL STATUS AT TIME OF
CYTOREDUCTIVE NEPHRECTOMY WITH
SURVIVAL
Brandon J Manley*, Jozefina Casuscelli,
Daniel M Tennenbaum, Maria F Becerra,
Almedina Redzematovic, Maria E Arcila, Paul
Russo, Jonathan A. Coleman, Martin H.
Voss, Darren R. Feldman, Robert J. Motzer,
James J Hsieh, A. Ari Hakimi, New York, NY
MP78-17 PROGNOSTIC VALUE OF TISSUE BASED
BIOMARKER SIGNATURE IN CLEAR CELL
Ahmed Haddad*, Dallas, TX, Jun-Hang Luo,
Guangzhou, China, People’s Republic of,
Laura-Maria Krabbe, Muenster, Germany,
Oussama Darwish, Bishoy Gayed, Dallas,
TX, Ramy Youssef, Irvine, CA, Payal Kapur,
Dinesh Rakheja, Yair Lotan, Arthur
Sagalowsky, Vitaly Margulis, Dallas, TX
265
MONDAY
MP78-05
PREOPERATIVE C - REACTIVE PROTEIN
AND FUHRMAN NUCLEAR GRADE IN
STAGE T1 RENAL CELL CARCINOMA
Rishi Sekar, Dattatraya Patil, Jeff Pearl*,
Yoram Baum, Stephanie Spetka, Meherdad
Alemozaffar, Christopher Filson, John
Pattaras, Kenneth Ogan, Viraj Master,
Atlanta, GA
MP78-20 PROGNOSTIC UTILITY OF A MULTI-GENE
SIGNATURE (THE CELL CYCLE
PROLIFERATION SCORE) IN PATIENTS
WITH RENAL CELL CARCINOMA (RCC)
AFTER RADICAL NEPHRECTOMY
Adam Feldman*, Boston, MA, Rohit Mehra,
Ann Arbor, MI, Placede Fosso, Salt Lake
City, UT, J. Stuart Wolf, Brian Orr, Ann Arbor,
MI, Shulin Wu, Boston, MA, Zaina Sangale,
Steve Stone, Salt Lake City, UT, Chin-Lee
Wu, Boston, MA, Todd Morgan, Ann Arbor,
MI
MP78-19 DO RENIN-ANGIONTENSIN BLOCKERS
AFFECT RENAL FUNCTION AND
ADVERSE OUTCOMES IN PATIENTS
UNDERGOING PARTIAL NEPHRECTOMY?
Yaw A. Nyame*, Helen Liang, Hans Arora,
Bradley Gill, Peter Caputo, Daniel Ramirez,
Khaled Fareed, Robert Stein, Georges-Pascal
Haber, Andrew J. Stephenson, Amr Fergany,
Jihad Kaouk, Cleveland, OH
CREDITTM
Monday, May 9, 2016
3:30 pm - 5:30 pm
PROSTATE CANCER: STAGING II
Moderators: William Aronson and Douglas Scherr
ABSTRACT
NUMBER TITLE
MP79-01 IDENTIFICATION OF PATHOLOGICALLY
INSIGNIFICANT DISEASE IN PATIENTS
WITH INTERMEDIATE RISK PROSTATE
CANCER: THE MULTICENTER KCAP
REGISTRY-BASED STUDY
Ohseong Kwon*, Yong Hyun Park, Cheol
Kwak, Choung-Soo Kim, Seoul, Korea,
Republic of, Seok-Soo Byun, Seongnam,
Korea, Republic of, Hyun Moo Lee, Byung Ha
Chung, Ji Youl Lee, Hyun Woo Kim, Seoul,
Korea, Republic of
ABSTRACT
NUMBER TITLE
MP79-05 VALIDATION OF THE NOVEL 5-GROUP
GLEASON GRADING SYSTEM: 3ⴙ5
DISEASE RISK MAY BE OVERESTIMATED
Roderick van den Bergh*, Melbourne,
Australia, Theo van der Kwast, Toronto,
Canada, Jeroen de Jong, Amsterdam,
Netherlands, Homi Zargar, Declan Murphy,
Melbourne, Australia, Henk van der Poel,
Amsterdam, Netherlands
MP79-06 CLINICAL IMPACT OF 68GA-PSMA PET/CT
IN PROSTATE CANCER PATIENTS WITH
RISING PSA AFTER TREATMENT WITH
CURATIVE INTENT: PRELIMINARY
ANALYSIS OF 42 CONSECUTIVE
PATIENTS
Simone Albisinni*, Carlos Artigas, Fouad
Aoun, Ibrahim Biaou, Ksenija Limani, Eric
Hawaux, Alexandre Peltier, Patrick Flamen,
Roland van Velthoven, bruxelles, Belgium
MP79-02 EVALUATION OF THE PROGNOSTIC
IMPACT OF 18F-CHOLINE PET/CT IN
PATIENTS WITH SKELETAL
RECURRENCE PROSTATE CANCER
Fabio Zattoni*, Laura Evangelista, Emanuela
Agostini, Francesco Cattaneo, Andrea
Guttilla, Filiberto Zattoni, Padua, Italy
MP79-03 BASELINE PROSTATE ATROPHY IS
ASSOCIATED WITH LOWER TUMOR
VOLUME IN MEN WITH PROSTATE
CANCER ON REPEAT BIOPSY
Daniel Moreira*, Rochester, MN, Gerald
Andriole, St. Louis, MO, Ramiro CastroSantamaria, King of Prussia, PA, Stephen
MP79-07 LYMPH NODE STAGING IN
BIOCHEMOCAL RECURRENT PROSTATE
CANCER: DOES THE TRACER MATTERF18-FLUOROETHYLCHOLINE VERSUS GA68-PSMA-HBED-CC PET/CT
David Pfister*, Aachen, Germany, Daniel
Porres, Cologne, Germany, Florian Steib,
Ruth Knuechel, Aachen, Germany, Axel
Heidenreich, Cologne, Germany, Floroian
Behrend, Frederik Verburg, Aachen,
Germany
MP79-04 GLEASON 6, STAGE T3 PROSTATE
CANCER IS ASSOCIATED WITH LOW
RATES OF RECURRENCE
Scott Wiener*, Peter Haddock, Ilene Staff,
Joseph Cusano, Joseph Wagner, Hartford,
CT
266
MP79-08 INTRAOPERATIVE FLUORESCENCE
IMAGING WITH INDOCYANINE GREEN
FOR SENTINEL LYMPH NODES FOR
PROSTATE CANCER DURING
PROSTATECTOMY
Jun Miki*, Takafumi Yanagisawa, Fumihiko
Urabe, Keiji Yasue, Taro Igarashi, Hayato
Shimada, Kashiwa, Japan, Takahiro Kimura,
Hiroyuki Takahashi, Tokyo, Japan, Kouichi
Kishimoto, Kashiwa, Japan, Shin Egawa,
Tokyo, Japan
MP79-15
RADICAL PROSTATECTOMY AND THE
EFFECT OF CLOSE SURGICAL MARGINS:
ANALYSIS FROM THE SEARCH DATABASE
Sean Stroup*, San Diego, CA, Zinan Chen,
Lauren Howard, Durham, NC, Stephen
Freedland, Los Angeles, CA, Daniel Moreira,
Rochester, MN, Martha Terris, Augusta, GA,
William Aronson, Los Angeles, CA, Matthew
Cooperberg, San Francisco, CA, Christopher
Amling, Portland, OR, Christopher Kane, San
Diego, CA
MP79-17 INCREMENTAL VALUE OF PREOPERATIVE
MRI IN PREDICTING OUTCOME AT
Alessandro Morlacco*, Vidit Sharma,
Laureano J. Rangel, Rachel E. Carlson,
Adam T. Froemming, Boyd R. Viers, R.
MP79-10 PROTON MAGNETIC RESONANCE
IMAGING SPECTROSCOPY IMPROVES
PREDICTION OF HIGH GRADE PROSTATE
CANCER WHEN INTEGRATED IN PI-RADS 2
Michael Leapman, Zhen Wang, Spencer
Behr, John Kurhanewicz, Ronald Zagoria,
Peter Carroll, Cassia Guimarães, Antonio
Westphalen*, San Francisco, CA
MP79-18 EX-VIVO EVALUATION OF
INTRAPROSTATIC TRACER
DISTRIBUTION OF TARGETED VERSUS
TEMPLATE PERINEAL INJECTION OF
FREE INDOCYANINE GREEN FOR
FLUORESCENCE TARGETED PELVIC
LYMPH NODE DISSECTION (F-T PLND) IN
PROSTATE CANCER
Christine Englberger, Tobias Schätz, Thomas
Kunit, Martin Drerup, Matthias Meissnitzer,
Rosemarie Forstner, Esra Foditsch, Peter
Törzsök, Martina Hager, Günter Janetschek,
Karl-Dietrich Sievert, Stephan Hruby*,
Salzburg, Austria
MP79-11 EXTERNAL VALIDATION OF A
PROGNOSTIC GLEASON GRADE
CLASSIFICATION SYSTEM
Michael Leapman*, Janet Cowan, Gray
Roberge, Mohamed Eltemamy, Jeff Simko,
Peter Carroll, Matthew Cooperberg, San
Francisco, CA
MP79-12 CLINICAL SIGNIFICANCE OF
PERCENTAGE OF GLEASON PATTERN 4
IN GLEASON SCORE 7 PROSTATE
CANCER AT RADICAL PROSTATECTOMY
Mohsin Jamal*, Sean R. Williamson, Mireya
Diaz-Insua, Mani Menon, Hans Stricker,
James Peabody, Craig Rogers, Nilesh Gupta,
Detroit, MI
MP79-19 IMPACT OF INTRINSIC AND EXTRINSIC
FACTORS ON THE DETECTION RATE OF
THE PET TRACER FLUCICLOVINE (18F) IN
BIOCHEMICAL RELAPSE OF PROSTATE
CANCER: A MULTI-INSTITUTIONAL
EXPERIENCE
Trond Veld Bogsrud*, Oslo, Norway, Cristina
Nanni, Bologna, Italy, Peter Nieh, Atlanta,
GA, Lucia Zanoni, Bologna, Italy, Tore BachGansmo, H Sletten, K Koren, Jesse Kieboom,
Oslo, Norway, Albert Chau, Penny Ward,
Oxford, United Kingdom, Mark Goodman,
Atlanta, GA, Stefano Fanti, Bologna, Italy,
David Schuster, Atlanta, GA, Frode Willoch,
Oslo, Norway
MP79-13 TESTOSTERONE LEVELS AS A
PREDICTOR FACTOR OF AGRESSIVE
DISEASE IN PATIENTS WITH PROSTATE
CANCER SUBMITTED TO RADICAL
PROSTATECTOMY
George A. M. Lins de Albuquerque*, Giuliano
B. Guglielmetti, José Pontes Jr., Rafael
Locali, Rafael F. Coelho, José Cury, Miguel
Srougi, Wiliam C. Nahas, São Paulo, Brazil
MP79-14 EXTENDED TEMPLATE PELVIC LYMPH
NODE DISSECTION FOR INTERMEDIATEHIGH RISK PROSTATE CANCER: A
THERAPEUTIC UNCERTAINTY
Muammer Altok*, Mary Achim, Surena Matin,
John Davis, Houston, TX
MP79-20 PATHOLOGICAL ANALYSIS OF PATIENTS
UNDERGOING RADICAL PROSTATECTOMY
WHO WERE POTENTIAL CANDIDATES FOR
FOCAL THERAPY
Ricardo Soares*, Robert Laing, Ben
Haagsma, Krishna Patil, Christopher Eden,
Stephen Langley, Guildford, United Kingdom
CREDITTM
*Presenting author
267
MONDAY
MP79-16 INDEPENDENT SURGICAL VALIDATION
OF THE 2015 PROSTATE CANCER GRADE
GROUPING SYSTEM
Daniel Spratt*, Adam Cole, Rohit Mehra,
William Jackson, Shuang Zhao, Jae Lee,
Scott Tomlins, Alon Weizer, Angela Wu,
Jeffery Montgomery, Lakshmi Kunju, David
Miller, Brent Hollenbeck, Ganesh Palapattu,
Felix Feng, Todd Morgan, Ann Arbor, MI
MP79-09 PROSPECTIVE EVALUATION OF 68GAPSMA POSITRON EMISSION
TOMOGRAPHY/COMPUTERIZED
TOMOGRAPHY FOR PREOPERATIVE
LYMPH NODE STAGING IN PROSTATE
CANCER
Pim van Leeuwen*, Louise Emmeett, Francis
Ting, Warick Delprado, Phillip Stricker,
Sydney, Australia
Monday, May 9, 2016
3:30 pm - 5:30 pm
PROSTATE CANCER: LOCALIZED: SURGICAL THERAPY VII
Moderators: Marc Dall’Era and Badrinath Konety
ABSTRACT
NUMBER TITLE
MP80-01 PHOSPHODIESTERASE TYPE 5
INHIBITOR USE IS NOT ASSOCIATED
WITH BIOCHEMICAL RECURRENCE
AFTER DEFINITIVE THERAPY FOR
PROSTATE CANCER
Michael Leapman*, Hao Nguyen, Janet
Cowan, Sima Porten, Maxwell Meng,
Matthew Cooperberg, Peter Carroll, San
Francisco, CA
ABSTRACT
NUMBER TITLE
MP80-07 POSTERIOR RECONSTRUCTION OF THE
RHABDOSPHINCTER IMPROVES EARLY
RECOVERY OF URINARY CONTINENCE
AFTER ROBOT-ASSISTED RADICAL
PROSTATECTOMY
Dmitry Pushkar*, Alexander Govorov, Pavel
Rasner, Konstantin Kolontarev, Moscow,
Russian Federation, Bernardo Rocco, Milan,
Italy
MP80-02 LATE RECOVERY OF ERECTILE
FUNCTION IN MEN TREATED WITH
ROBOTIC-ASSISTED RADICAL
PROSTATECTOMY: A NOVEL NOMOGRAM
DEVELOPMENT AND VALIDATION
Dalela, Jesse Sammon, Akshay Sood,
Detroit, MI, Nicola Fossati, Giorgio Gandaglia,
Nazareno Suardi, Franco Gaboardi,
Giovannialberto Pini, Milan, Italy, Craig
Rogers, Wooju Jeong, James Peabody,
Detroit, MI, Francesco Montorsi, Alberto
Briganti, Milan, Italy, Mani Menon, Detroit, MI
MP80-08 IMPACT OF POSTERIOR
URETHROVESICAL RECONSTRUCTION
ON EARLY RETURN TO CONTINENCE
AFTER ROBOT-ASSISTED RADICAL
PROSTATECTOMY: A RANDOMIZED
CONTROLLED TRIAL
Jen Hoogenes*, Christopher Wu, Yuding
Wang, Lisa Patterson, Edward Matsumoto,
Bobby Shayegan, Hamilton, Canada
MP80-09 IS EXTRAPERITONEAL ROBOT-ASSISTED
CONTRAINDICATED IN THE SETTING OF
PRIOR INGUINAL HERNIA REPAIR WITH
MESH?
David Horovitz*, Changyong Feng, Edward
M. Messing, Jean V. Joseph, Rochester, NY
MP80-03 ORGASMIC FUNCTION AFTER RADICAL
PROSTATECTOMY
Kefu Du*, Chong Zhang, Angela Presson,
Jonathan Tward, William Brant, Christopher
Dechet, Salt Lake City, UT
MP80-10 EVALUATION OF VOIDING SYMPTOM AND
URINARY INCONTINENCE AFTER
LAPAROSCOPIC AND ROBOT-ASSISTED
PROSTATECTOMY: A SINGLE-SURGEON
EXPERIENCE
Ja Yoon Ku*, Chan Ho Lee, Kyung Lee,
Kyoung Hwan Kim, Seung Ryong Baek, Hyo
Jung Park, PUSAN, Korea, Republic of,
Young Ho Kim, Bucheon, Korea, Republic of,
Hong Koo Ha, Pusan, Korea, Republic of
MP80-04 FACTORS INFLUENCING RECOVERY OF
ERECTILE FUNCTION FOLLOWING
RADICAL PROSTATECTOMY (RALP)
Hariharan Palayapalayam Ganapathi*,
Gabriel Ogaya, Travis Rogers, Tracey
Woodlief, Harvey Tadzia, Vladimir Mouraviev,
Vipul Patel, Celebration, FL
MP80-05
NERVE SPARING DURING RADICAL
PROSTATECTOMY DOES NOT
ADVERSELY IMPACT MARGIN STATUS,
COMPLICATIONS, OR LONG-TERM
ONCOLOGIC OUTCOMES
Vidit Sharma*, Boyd R Viers, Matthew K
MP80-11 TUMOR CHARACTERISTICS,
ONCOLOGICAL AND OVERALL OUTCOME
AFTER RADICAL PROSTATECTOMY IN
MEN 75 YEARS AND OLDER
Philipp Mandel*, Hamburg, Germany,
Maximilian Kriegmair, Mannheim, Germany,
Janneke Kleine Kamphake, Felix Chun,
Markus Graefen, Hartwig Huland, Derya Tilki,
Hamburg, Germany
MP80-06 INTRAOPERATIVE BIMANUAL
EXAMINATION AND FROZEN-SECTION
ANALYSIS DURING ROBOT-ASSISTED
RADICAL PROSTATECTOMY: A NOVEL
TECHNIQUE FOR REDUCING POSITIVE
SURGICAL MARGINS
Akshay Sood*, Deepansh Dalela, Wooju
Jeong, Khurshid Ghani, Mireya Diaz-Insua,
Stacey Dusik, Nilesh Gupta, Mani Menon,
James Peabody, Detroit, MI
MP80-12 INTRAOPERATIVE ULTRASONOGRAPHY
NAVIGATION USING PARALLEL-SIDE
DOCKING TECHNIQUE DURING ROBOTICASSISTED PROSTATECTOMY
Toru Harabayashi*, Keita Minami, Norikata
Takada, Satoshi Nagamori, Sapporo, Japan
268
MP80-13 ROLE OF PREOPERATIVE MAGNETIC
RESONANCE IMAGING IN PREDICTING
THE EARLY RECOVERY OF URINARY
CONTINENCE AFTER RADICAL
PROSTATECTOMY
Myungchan Park*, Seung-Kwon Choi, Myong
Kim, Seoul, Korea, Republic of, Won Hee
Park, Incheon, Korea, Republic of, Jongwon
Kim, Cheryn Song, Tai young Ahn, Hanjong
Ahn, Seoul, Korea, Republic of
MP80-18 LOW UTILIZATION OF ADJUVANT
THERAPY FOR ADVERSE PATHOLOGIC
FEATURES FOLLOWING RADICAL
PROSTATECTOMY IN AFRICAN
AMERICANS DOES NOT TRANSLATE TO
AN INCREASED RISK OF BIOCHEMICAL
RECURRENCE
Ahmed Aboumohamed*, Kara Watts, Saman
Moazami, Jacob Taylor, Daniel Pogash,
Masrur Khan, Ilir Agalliu, Reza Ghavamian,
Bronx, NY
MP80-14 MRI PRIOR TO PROSTATECTOMY DOES
NOT IMPROVE SURGICAL OUTCOMES
Eric Kim*, Niraj Badhiwala, Joel Vetter,
Robert Grubb, Gerald Andriole, St. Louis, MO
HISTOLOGICAL MEASUREMENT OF THE
MEMBRANOUS URETHRAL LENGTH IN
PREDICTS POSTPROSTATECTOMY
Yasuo Kohjimoto*, Hidetoshi Umemoto,
Hiroyuki Koike, Shinpei Yamashita, Kazuro
Kikkawa, Akinori Iba, Nagahide Matsumura,
Isao Hara, Wakayama, Japan
MP80-20 LONG-TERM FUNCTIONAL OUTCOMES OF
PROSTATE CANCER PATIENTS TREATED
WITH ROBOT-ASSISTED RADICAL
PROSTATECTOMY
Dalela, Jesse Sammon, Akshay Sood,
Detroit, MI, Nicola Fossati, Giorgio Gandaglia,
Nazareno Suardi, Franco Gaboardi, Milan,
Italy, Craig Rogers, James Peabody, Detroit,
MI, Francesco Montorsi, Alberto Briganti,
Milan, Italy, Mani Menon, Detroit, MI
MP80-16 PREDICTING LOW-RISK PROSTATE
CANCER FROM TRANSPERINEAL
SATURATION BIOPSIES
Amila Siriwardana*, Pim van Leeuwen,
Sydney, Australia, Monique Roobol,
Rotterdam, Netherlands, Francis Ting,
Sydney, Australia, Daan Nieboer, Rotterdam,
Netherlands, James Thompson, Warick
Delprado, Anne-Maree Haynes, Phillip
Brenner, Phillip Stricker, Sydney, Australia
CREDITTM
IN PATIENTS WITH PATHOLOGIC
GLEASON 3ⴙ3 SCORE AT RADICAL
PROSTATECTOMY
Philipp Mandel*, Markus Graefen, Felix Chun,
Hartwig Huland, Derya Tilki, Hamburg,
Germany
Monday, May 9, 2016
3:30 pm - 5:30 pm
SEXUAL FUNCTION/DYSFUNCTION: PENIS/TESTIS/URETHRA: BENIGN DISEASE & MALIGNANT DISEASE II
Moderators: William Waters and Andrew James
ABSTRACT
NUMBER TITLE
MP81-01 UNLIKE AMERICAN MEN, BLACK
AFRICAN MEN RARELY DEVELOP
TESTICULAR CANCER: DATA FROM
SOUTH AFRICA
Farzana Cassim*, Cape Town, South Africa,
Ryan Terlecki, Winston-Salem, NC, Kenny
Du Toit, John Lazarus, Andrè Van Der
Merwe, David Anderson, Cape Town, South
Africa
*Presenting author
ABSTRACT
NUMBER TITLE
MP81-02 CLINICAL EVALUATION OF THE
PULMONARY RESECTION FOR LUNG
METASTASES IN ADVANCED
TESTICULAR CANCER PATIENTS AFTER
CHEMOTHERAPY FROM JAPANESE HIGH
VOLUME CENTER
Hiroyuki Nakanishi*, Terukazu Nakamura,
Syuichi Tahara, Masakatsu Ohishi, Takumi
Shiraishi, Takashi Ueda, Osamu Ukimura,
Kyoto, Japan
269
MONDAY
MP80-15
MP80-19 EVALUATION OF THE Ⰶ QUADRELLA Ⰷ
AT 2 YEARS : NEW INDEX FOR
FUNCTIONAL AND ONCOLOGY
PERFORMANCE SPECIFIC TO PROSTATE
BRACHYTHERAPY
Jean-Baptiste Coquet*, Francky Delage,
Marie-Aimée Perrouin-Verbe, Jean-Pierre
Malhaire, Alexandre Fourcade, Benoit
Rousseau, Maxime Thoulouzan, Pierre
Callerot, Georges Fournier, Antoine Valeri,
Brest, France
MP81-03 SYSTEMIC INFLAMMATORY RESPONSE
MARKERS IN PATIENTS WITH
METASTATIC GERM CELL TUMORS
UNDERGOING CHEMOTHERAPY MIGHT
BE OF PROGNOSTIC VALUE
Christian Fankhauser*, Jörg Beyer, Sophia
Sander, Cedric Poyet, Tullio Sulser, Thomas
Hermanns, Zurich, Switzerland
MP81-11 THE EFFECT OF SOCIODEMOGRAPHIC
FACTORS ON THE MANAGEMENT OF
STAGE I NON-SEMINOMATOUS GERM
CELL TESTICULAR TUMORS
Anand Patel*, Simon Kim, Matthew Maurice,
John Kiechle, Hui Zhu, Robert Abouassaly,
Cleveland, OH
MP81-12 LONG-TERM SEXUAL HEALTH
OUTCOMES IN MEN WITH CLASSIC
BLADDER EXSTROPHY
Ross Everett, Timothy Baumgartner*, Kathy
Lue, Ezekiel Young, Sunil Reddy, Uzoma
Anele, Nilay Gandhi, Cameron Alexander,
Heather Di Carlo, John Gearhart, Baltimore,
MD
MP81-04 IMPROVEMENTS IN SERUM
TESTOSTERONE AFTER
VARICOCELECTOMY IN MEN WITHOUT
INFERTILITY
Bobby Najari*, Michael Schulster, Phil Bach,
Filipe Tenorio Lira Neto, James Kashanian,
Marc Goldstein, New York, NY
MP81-05
MP81-13 ROLE OF 1’38F-FDG PET/CT IN
IDENTIFYING INGUINAL NODAL
METASTASIS IN PATIENTS ON
SURVEILLANCE AFTER PRIMARY
TREATMENT OF PENILE SQUAMOUS
CELL CARCINOMA- SINGLE CENTRE
PROSPECTIVE STUDY
Yuvaraja Thyavihally*, Santosh Waigaonkar,
Abhinav Pednekar, Nikhil Dharmadhikari,
Harshvardhan Rao, Nikhil Gulavani,
Tirathram Kaushik, Mrunal Parab, Kalyan
Chakradhar, Amit Patil, Mumbai, India
RACIAL DISPARITIES DIFFER FOR
AFRICAN AMERICANS AND HISPANICS IN
THE DIAGNOSIS AND TREATMENT OF
PENILE CANCER
Emily Slopnick*, Simon Kim, Jonathan
Kiechle, Chris Gonzalez, Hui Zhu, Robert
Abouassaly, Cleveland, OH
MP81-06 NON-GUIDELINE DIRECTED CARE OF
PATIENTS WITH TESTICULAR CANCER
Kevin Wymer*, Shane Pearce, Chicago, IL,
Kelly Harris, Phillip M. Pierorazio, Baltimore,
MD, Scott Eggener, Chicago, IL
MP81-14 WHEN IS IT APPROPRIATE TO CONSIDER
TESTIS-SPARING SURGERY FOR
UNILATERAL TESTICULAR TUMORS?
Michael Maccini*, Brian Caldwell, Paul
Maroni, Nicholas Cost, Aurora, CO
MP81-07 PATIENT-REPORTED ASSESSMENT OF
ANATOMICAL, NEUROLOGICAL AND
FUNCTIONAL CHANGES OF THE
GENITALIA AFTER ANTERIOR
URETHROPLASTY: INCIDENCE AND
RECOVERY OF FUNCTION
Christopher Tam*, Maria Voznesensky, Iowa
City, IA, Benjamin Breyer, San Francisco,
CA, Sean Elliott, Minneapolis, MN,
Christopher McClung, Columbus, OH, Jeremy
Myers, Salt Lake City, UT, Alex Vanni,
Burlington, MA, Bryan Voelzke, Seattle, WA,
Bradley Erickson, Iowa City, IA
MP81-15
MP81-08 LONG-TERM OUTCOMES IN
PARATESTICULAR SARCOMA: A ROLE
FOR HEMISCROTECTOMY
Lih-Ming Wong*, East Melbourne, Australia,
Brendan Dickson, Charles Catton, Toronto,
Canada, Stanley Yap, Davis, CA, Thamir
Alkasab, Robert Hamilton, Michael Jewett,
Toronto, Canada
GENETIC BASIS FOR CISPLATIN
RESISTANCE IN PATIENTS WITH
ADVANCED GERM CELL TUMORS (GCT)
Aditya Bagrodia*, Byron Lee, William Lee,
Eugene Cha, John Sfakianos, Paul Gao,
Emily Zabor, Irina Ostrovnaya, Samuel
Kaffenberger, Jana Eng, Michael Berger,
Dean Bajorin, Nikolaus Schultz, Joel
Sheinfeld, George Bosl, Hikmat Al-Ahmadie,
David Solit, Darren Feldman, New York, NY
MP81-16 PERIOPERATIVE AND EARLY
ONCOLOGICAL OUTCOMES FOLLOWING
ROBOT ASSISTED RETROPERITONEAL
LYMPH NODE DISSECTION FOR
TESTICULAR CANCER: A MULTIINSTITUTIONAL STUDY
Haidar Abdul-Muhsin*, Phoenix, AZ, Michael
Marshall, Sean Stroup, James L’esperance,
San Diego, CA, Michael Woods, Chapel Hill,
NC, James Porter, Seattle, WA, Erik Castle,
Phoenix, AZ
MP81-09 SECONDARY URETHRAL MALIGNANCIES
FOLLOWING PROSTATE
BRACHYTHERAPY
Shree Agrawal*, John Lacy, Cleveland, OH,
Herman Bagga, Pittsburgh, PA, Kenneth
Angermeier, Jay Ciezki, Rahul Tendulkar,
Hadley Wood, Cleveland, OH
MP81-17 ORCHIECTOMY FOLLOWING
MICROSURGICAL DENERVATION OF THE
SPERMATIC CORD: SINGLE INSTITUTION
REVIEW
Kathryn Lipscomb*, Daniel Williams, IV,
Madison, WI
MP81-10 OUTCOMES OF CO2 LASER FOR PENILE
CARCINOMA IN SITU AT A UK TERTIARY
CENTRE
Luke McGuinness*, Rajan Veeratterapillay,
Newcastle, United Kingdom, Daniel Conaway,
Luke Teo, Sue Asterling, Damien Greene,
Phil Keegan, Sunderland, United Kingdom
270
MP81-18 PERIOPERATIVE AND EARLY
ONCOLOGICAL OUTCOMES IN
POSTCHEMOTHERAPY ROBOT ASSISTED
DISSECTION FOR TESTICULAR CANCER:
A MULTI-INSTITUTIONAL STUDY
Haidar Abdul-Muhsin*, Phoenix, AZ, Michael
Marshall, Sean Stroup, San Diego, CA,
James Porter, Seattle, WA, Michael Woods,
Chapel Hill, NC, James L’esperance, San
Diego, CA, Erik Castle, Phoenix, AZ
MP81-20 IRINOTECAN AND NEDAPLATIN AS
SALVAGE THERAPY FOR PATIENTS WITH
ADVANCED GERM CELL TUMOR
FOLLOWING INTENSIVE TREATMENT
WITH CISPLATIN-BASED COMBINATION
CHEMOTHERAPIES
Masatomo Nishikawa*, Hideaki Miyake,
Masato Fujisawa, Kobe, Japan
CREDITTM
MP81-19 PROGRAMMED DEATH LIGAND-1 (PD-L1)
STATUS IN NORTH AMERICAN COHORT
OF PENILE SQUAMOUS CELL
CARCINOMA
Margaret Cocks, Diana Taheri, Mark W Ball,
Stephania M Bezerra, Alan Meeker, Maria
Del Carmen Rodriguez, Alcides Chaux,
Arthur Burnett, George Netto*, Baltimore, MD
Monday, May 9, 2016
3:30 pm - 5:30 pm
SEXUAL FUNCTION/DYSFUNCTION: PEYRONIE’S DISEASE
Moderators: Gregory Broderick and Ranjith Ramasamy
TIME
3:30
3:40
3:50
4:00
ABSTRACT
NUMBER TITLE
PD45-01 RESTORATION OF PENILE FUNCTION
AND PATIENT SATISFACTION WITH
INTRALESIONAL COLLAGENASE
CLOSTRIDIUM HISTOLYTICUM
INJECTION FOR PEYRONIE’S DISEASE
Matthew Ziegelmann*, Boyd R Viers, Kelly L
McAlvany, George C Bailey, Joshua B
Savage, Landon W Trost, Rochester, MN
PD45-02
PD45-03
PD45-04
*Presenting author
ABSTRACT
TIME NUMBER TITLE
4:10 PD45-05 A SURVEY OF SMSNA MEMBERS
REGARDING COMPLICATIONS
FOLLOWING INTRALESIONAL INJECTION
THERAPY WITH CLOSTRIDIUM
COLLAGENASE HISTOLYTICUM FOR
Faysal A Yafi*, James Anaissie, Jonathan
Zurawin, Suresh C Sikka, Wayne JG
Hellstrom, New Orleans, LA
IMPACT OF NUMBER OF CYCLES OF
COLLAGENASE CLOSTRIDIUM
HISTOLYTICUM ON OUTCOMES IN
PATIENTS WITH PEYRONIE’S DISEASE
James Anaissie*, Faysal A Yafi, Elizabeth J
Traore, Suresh C Sikka, Wayne JG
SURVEY OF PATIENT AND PARTNER
SATISFACTION FOLLOWING
COLLAGENASE CLOSTRIDIUM
HISTOLYTICUM TREATMENT FOR
Elizabeth J Traore*, Faysal A Yafi, James
Anaissie, Suresh C Sikka, Wayne JG
NON-INDUSTRY SPONSORED SAFETY
ANALYSIS FOLLOWING COLLAGENASE
CLOSTRIDIUM HISTOLYTICUM
(XIAFLEX®) INJECTION IN MEN WITH
Ryan Owen*, Chris Winter, Michael Jennings,
Jonathan Angelle, Wesley White, Knoxville,
TN, LeRoy Jones, San Antonio, TX, Edward
Kim, Knoxville, TN
271
4:20
PD45-06
SUPERIOR COST EFFECTIVENESS OF
PENILE PLICATION VERSUS
INTRALESIONAL COLLAGENASE
INJECTION FOR TREATMENT OF
PEYRONIE’S DISEASE DEFORMITIES
Billy Cordon*, Ryan Hutchinson, Matthias
Hofer, Dallas, TX, Gregory Broderick,
Jacksonville, FL, Yair Lotan, Allen Morey,
Dallas, TX
4:30
PD45-07
PRACTICAL COMPUTERIZED SOLUTION
FOR INCISION AND GRAFTING IN
Alexandre Miranda*, Francisco Sampaio, Rio
de Janeiro, Brazil
4:40
PD45-08
EARLY OUTCOMES OF CONCURRENT
TACHOSIL GRAFTING WITH IPP
PLACEMENT
Neil Patel*, Springfield, IL, Michael Butcher,
St. Louis Park, MN, Tobias S Kohler,
Springfield, IL
MONDAY
Podium Session 45
4:50
5:00
PD45-09
PD45-10
PENILE PROSTHESIS CAN SAFELY AND
EASILY BE INSERTED IN PATIENTS WITH
PEYRONIE’S DISEASE: RESULTS OF THE
PROPPER STUDY
Mohit Khera*, Houston, TX, Anthony Bella,
Ottawa, Canada, Edward Karpman, Mountain
View, CA, William Brant, Salt Lake City, UT,
Brian Christine, Homewood, AL, Bryan
Kansas, Austin, TX, LeRoy Jones, San
Antonio, TX, Tobias Kohler, Springfield, IL,
Nelson Bennett, Burlington, MA, Eugene
Rhee, San Diego, CA, Gerard Henry,
Shreveport, LA
5:10
PD45-11
CALCIFIED PEYRONIE’S PLAQUE AND
ALVEOLAR BONE ARE SIMILAR IN
STRUCTURE AND MINERAL DENSITY
Ryan Hsi*, Ling Chen, Feifei Yang, Amanda
Reed-Maldonado, Sunita Ho, Tom Lue,
Marshall Stoller, San Francisco, CA
5:20
PD45-12
NEW EXPERIMENTAL MODEL IN RATS
FOR PEYRONIE’S DISEASE: CHANGES OF
COMPONENTS OF THE EXTRACELLULAR
MATRIX
David Cohen*, Maria Aparecida Pinhal,
Thérese Theodoro, Ana Maria Mader,
Giuliana Petri, Andre Venturini, Sidney Glina,
São Paulo, Brazil
VALIDATION STUDY: PATIENT
REPORTED OUTCOME MEASURE (PROM)
FOR PENILE CURVATURE SURGERY
Angus Campbell*, RIchard Akiboye, Surrey,
United Kingdom, Saheel Mukhtar, Matthew
Jackson, Tet Yap, Nicholas Watkin, London,
United Kingdom
CREDITTM
Monday, May 9, 2016
3:30 pm - 5:30 pm
Video Session 12
RECONSTRUCTION
Moderators: Daniel Dugi, III and Lee Zhao
ABSTRACT
NUMBER TITLE
V12-01
TRANSURETHRAL VENTRAL BUCCAL
MUCOSA GRAFT (BMG) INLAY
URETHROPLASTY FOR DISTAL
URETHRAL STRICTURES
Mourad Abouelleil*, Michael Daneshvar,
Dmitriy Nikolavsky, Syracuse, NY
V12-02
MAGNETIC BOWEL ANASTOMOSIS:
FIRST-IN-HUMAN MAGNAMOSIS
APPLICATION
Claire Graves*, Ryan Hsi, Selma Masic, Jill
Imamura-Ching, Michael Harrison, Marshall
Stoller, San Francisco, CA
V12-03
A NEW LAPAROSCOPIC MINIMALLY
INVASIVE TECHNIQUE OF TRANSPOSING
OMENTUM TO PERINEUM FOR RECTO
URETHRAL FISTULA
Sanjay Kulkarni*, Pune, India, Guido
Barbagli, Arezzo, Italy, Pankaj Joshi,
Sandesh Surana, Atef Homuda, Jyotsna
Kulkarni, Pune, India
V12-04
V12-05
ABSTRACT
NUMBER TITLE
V12-06
TRANSCORPORAL ARTIFICIAL URINARY
SPHINCTER PLACEMENT IN PATIENTS
WITH PRIOR INFLATABLE PENILE
PROSTHESIS UTILIZING 6-PLY
ACELLULAR GRAFT
Melissa Mendez*, Aaron Lentz, Durham, NC
RESECTION & RECONSTRUCTION OF
MASSIVE LYMPHEDEMA OF THE MALE
GENITALIA
Jonathan Witten*, Kim Thai, Daniel Dugi,
Portland, OR
A BONE-ANCHORED TECHNIQUE FOR
PENILE PROSTHESIS INSERTION AFTER
RADIAL FOREARM FREE FLAP
NEOPHALLUS
Joseph J. Pariser*, David M. Hatcher,
Gregory T. Bales, Chicago, IL
272
V12-07
RECONSTRUCTION OF A SIXTEENCENTIMETER ANTERIOR URETHRAL
STRICTURE: DOUBLE DORSAL BUCCAL
MUCOSA GRAFT WITH THE ASOPA
TECHNIQUE
Alvaro Saavedra, Alejandro Rojas, Jose
Arenas, Laura Velarde, Reynaldo Gomez*,
Santiago, Chile
V12-08
SINGLE-STAGE URETHROPLASTY WITH
COMPLETE RETUBULARISATION OF
ORAL GRAFTS FOR DISTAL PENILE
STRICTURES
Felix Campos*, Enrique Fes Ascanio, Simon
Bugeja, Stella Ivaz, Anastasia Frost, Daniela
Andrich, Anthony Mundy, London, United
Kingdom
V12-09
SACROCOLPOPEXY IN PATIENTS WITH
BLADDER EXSTROPHY AND GENITAL
PROLAPSE AFTER URINARY DIVERSION
Nadine Wunder*, Mainz, Germany, Judy J
Branscom, Pulaski, VA, Joachim W Thüroff,
Mainz, Germany, Raimund Stein, Mannheim,
Germany
V12-10
DORSAL AND VENTRAL BUCCAL GRAFTS
FOR BULBAR URETHRAL STRICTUES
WITH UNILATERAL MOBILIZATION
Arun Chawla*, 576104, India, Padmaraj
Hegde, Manipal, India
V12-11
THE USE OF SCAFFOLDING TISSUE
BIOGRAFTS TO BOLSTER THE
VESICOURETHRAL ANASTOMOSIS
DURING SALVAGE ROBOT-ASSISTED
RADICAL PROSTATECTOMY REDUCES
LEAK RATES AND CATHETER TIMES
Yash Kadakia*, Vladimir Mouraviev, Anup
Kumar, Srinivas Samavedi, Rafael F. Coelho,
Bernardo Rocco, Gabriel Ogaya-Pinies,
Hariharan Ganapathi, Jeffrey Marquinez,
Vipul R. Patel, Celebration, FL
*Presenting author
TWO-SIDED DORSAL PLUS VENTRAL
ORAL GRAFT URETHROPLASTY FOR
LONG ANTERIOR URETHRAL
STRICTURES
Fikret Fatih Onol*, Istanbul, Turkey, Sinasi
Yavuz Onol, Istanbul, Turkey, Ahmet Bindayi,
Ahmet Tahra, Eyup Veli Kücük, Ugur Boylu,
Istanbul, Turkey
CREDITTM
REAL PENILE LENGHTENING AND
WIDENING IN PEYRONIE’S DISEASE:
CIRCULAR AND LONGITUDINAL
GRAFTING WITH SIMULTANEOUS PENILE
IMPLANT
Rados Djinovic*, Nikola Stanojevic, Vladislav
Pesic, Milja Mitrovic, Belgrade, Serbia, Marta
Skrodzka, Bialystok, Poland, Antonio Ruffo,
Naples, Italy, Salvatore Sansalone, Rome,
Italy
MONDAY
V12-12
V12-13
273
NOTES
Plenary Session
7:28 am - 4:10 pm
PLENARY I - TUESDAY
7:28
7:30
AUA GUIDELINE: NON-MUSCLE INVASIVE BLADDER CANCER
Sam Chang
7:40
LATE BREAKING ABSTRACTS
PI-LBA 06:
VA CSP#553 CHEMOTHERAPY AFTER PROSTATECTOMY (CAP) FOR HIGH RISK PROSTATE CARCINOMA: A
PHASE III RANDOMIZED STUDY
Daniel Lin*, Seattle, WA, Mark Garzotto, Portland, OR, William Aronson, Los Angeles, CA, Joseph Basler, San
Antonio, TX, Thomas Beer, Portland, OR, Mary Brophy, Boston, MA, Kevin Kelly, Philadelphia, PA, Kelvin Lee, Ying
Lu, Palo Alto, CA, Vivian Markle, Seattle, WA, Valerie McGuire, Palo Alto, CA, Unimye Nseyo, Gainesville, FL, Robert
Ringer, Albuquerque, NM, Steven Savage, Charleston, SC, Mei-Chiung Shih, Patricia Sinnott, Palo Alto, CA, Edward
Uchio, Irvine, CA, Yajie Wang, Palo Alto, CA, Claire Yang, Bruce Montgomery, Seattle, WA
PI-LBA 08:
PRELIMINARY ASESSMENT OF A VALIDATED URINE EXOSOME ASSAY (EXDX PROSTATE (INTELLISCORE)
FOR PREDICTING BIOCHEMICAL RECURRENCE POST-PROSTATECTOMY
James Eastham*, New York City, NY, Michael Donovan, New York, NY, Vip Patel, Celebration, FL, Vince O’Neill,
Cambridge, MA, Stefan Bentink, Martinsreid, Germany, Johan Skog, Cambridge, MA, James McKiernan, New York
City, NY
PI-LBA 09:
IsoPSA: INITIAL CLINICAL PERFORMANCE EVALUATION OF A NOVEL STRUCTURE-BASED BIOMARKER FOR
PROSTATE CANCER IN A MULTICENTER PROSPECTIVE TRIAL FOR GLEASON > 7
Eric Klein*, Mark Stovsky, Cleveland, OH, Robert Di Loreto, Jason Hafron, Kenneth Kernen, Troy, MI, Kannan
Manickam, Baltimore, MD, Victor Kipnis, Bethesda, MD
8:00
SOCIÉTÉ INTERNATIONALE D’UROLOGIE (SIU) LECTURE: IMAGE GUIDED THERAPY FOR PROSTATE
CANCER: QUO VADIS?
Rafael Sanchez Salas
8:20
CRITICAL DISCUSSION: ADVANCED TESTING FOR MALE INFERTILITY: AGE-SPECIFIC GUIDELINES?
Critical
Discussant:
Dolores Lamb
Presenters:
Edmund Ko
James Smith
8:40
POINT-COUNTERPOINT: IS THERE A ROLE FOR NUTRACEUTICALS IN MALE INFERTILITY?
Moderator:
Mark Moyad
Debater - Pro: Ethan Grober
Debater - Con: Craig Niederberger
9:00
PANEL DISCUSSION: STRATIFYING CARE OF THE SMALL RENAL MASS: FROM BENCH TO BEDSIDE AND BACK
Moderator:
Robert Uzzo
Panelists:
Vinata Lokeshwar
Jaime Landman
Vinay Duddalwar
9:25
COMPLEX CASES: INTRAOPERATIVE CONSULT FOR URETERAL INJURY
Presenter:
Sean Elliott
Panelists:
Hadley Wood
Lee Zhao
*Presenting author
275
TUESDAY
PI-LBA 07:
THE DEVELOPMENT AND CLINICAL VALIDATION OF A HIGH SENSITIVITY URINE BIOMARKER TEST FOR THE
DETERMINATION OF RECURRENCE IN UROTHELIAL CARCINOMA PATIENTS
Yair Lotan*, Dallas, TX, Jay Raman, Hershey, PA, Shahrokh Shariat, Vienna, Austria, Laimonis Kavalieris, Dunedin,
New Zealand, Chris Frampton, Christchurch, New Zealand, Henry Crist, Hershey, PA, Elsie Jacobson, Jimmie Suttie,
David Darling, Dunedin, New Zealand, Scott Asroff, Mount Laurel, NJ, Doug Scherr, New York, NY, George Adams,
Birmingham, AL, Evan Goldfischer, Poughkeepsie, NY, Jeffrey Thill, Orlando, FL, Joseph Williams, Meridian, ID,
Joshua Stein, New Britain, CT, Paul O’Sullivan, Dunedin, New Zealand
9:55
COMPLEX CASES: BLADDER CANCER: HIGH GRADE SUPERFICIAL TCCA WHEN THERE IS NO BCG OR BCG
FAILS
Presenter:
Gary Steinberg
Panelists:
Cheryl Lee
Mark Schoenberg
Maria Ribal Caparros
10:25
COMPLEX CASES: STONES: 15 MM LOWER POLE STONE
Presenter:
Mahesh Desai
Panelists:
Kenneth Pace
Michael Wong
Olivier Traxer
10:55
COMPLEX CASES: CHRONIC ORCHIALGIA
Presenter:
Daniel Shoskes
Panelists:
Daniel Williams
Sijo Parekattil
Peter Schlegel
11:25
COMPLEX CASES: PEYRONIE’S DISEASE
Presenter:
Lawrence Hakim
Panelists:
Laurence Levine
Run Wang
Wayne Hellstrom
11:55
BREAK
1:00
AUDIENCE VOTES FOR TOP THREE AWARD WINNING VIDEOS
TAKE HOME MESSAGES
1:30
PROSTATE CANCER
Robert Abouassaly
1:40
BASIC SCIENCE RESEARCH
Trinity Bivalacqua
1:50
INFECTION/INFLAMMATION
Christina Ching
2:00
INFERTILITY/ANDROLOGY
Joseph Alukal
2:10
STONE DISEASE/ENDOUROLOGY
Timothy Averch
2:20
TRANSPLANTATION/VASCULAR SURGERY
Christopher Marsh
2:30
PENILE, TESTIS AND URETHRAL CANCER
Philippe Spiess
2:40
TRAUMA/RECONSTRUCTION/DIVERSION
Ramon Virasoro
2:50
SEXUAL FUNCTION/DYSFUNCTION
Ryan Terlecki
3:00
FEMALE UROLOGY/INCONTINENCE/URODYNAMICS
Benjamin Brucker
3:10
BPH/LUTS
Robert Kovell
3:20
MINIMALLY INVASIVE SURGERY (LAPAROSCOPY/ROBOTICS)
Li-Ming Su
3:30
OUTCOMES ANALYSIS
Christopher Saigal
3:40
KIDNEY CANCER
Jodi Maranchie
3:50
BLADDER CANCER
Byron Lee
276
4:00
IMAGING
Gary Faerber
4:10
SESSION CONCLUDES
TM
APPROVED FOR AMA PRA CATEGORY 1 CREDIT
8:00 am - 10:00 am
STONE DISEASE: EPIDEMIOLOGY & EVALUATION I
Moderators: Darren Beiko, Francis Keeley, Jr. and Michael Lipkin
ABSTRACT
NUMBER TITLE
MP82-01 THE CHANGING EPIDEMIOLOGY AND
PREVALENCE OF RENAL TRACT CALCULI
IN ENGLAND - A TEN-YEAR ANALYSIS
Holly Ni Raghallaigh*, Brighton, United
Kingdom, Robert Radcliffe, East Midlands,
United Kingdom, Ahmed Ali, Andrew Symes,
Brighton, United Kingdom
ABSTRACT
NUMBER TITLE
MP82-07 PRIMARY HYPERPARATHYROIDISM:
CHALLENGES IN SCREENING AND
DIAGNOSIS IN KIDNEY STONE FORMERS
Leslee Matheny*, Tracy Marien, Mustafa
Kadihasanoglu, Nicole L. Miller, Nashville, TN
MP82-02 EVALUATION OF STUDENT ATHLETE
KIDNEY STONE RISK VIA 24 HOUR URINE
COLLECTION
Katherine Theisen*, Omar Ayyash, Matthew
Ferroni, Pittsburgh, PA, Kevin Rycyna, Travis
AFB, CA, Julie Riley, Albuquerque, NM,
Timothy Averch, Michelle Semins, Pittsburgh,
PA
MP82-09 METABOLIC STONE CENTER
EFFECTIVELY DECREASES EMERGENCY
DEPARTMENT VISITS IN HIGH-RISK
PATIENTS
George Turini, III*, Mary Flynn, Christopher
Tucci, Gyan Pareek, Providence, RI
MP82-03 AGE DIFFERENCES IN THE
TEMPERATURE DEPENDENCE OF
KIDNEY STONE PRESENTATION
Gregory Tasian*, Michelle Ross, Philadelphia,
PA, Antonio Gasparrini, London, United
Kingdom, Lihai Song, Philadelphia, PA,
Robert Kopp, New Brunswick, NJ, Susan
Furth, Philadelphia, PA
MP82-10 DEVELOPMENT OF A NOVEL
CURRICULUM IN MEDICAL KIDNEY
STONE PREVENTION
Troy A. Sukhu*, Jason R. Lomboy, Matthew
R. Macey, Davis P. Viprakasit, Chapel Hill,
NC
MP82-04 DOES NIGHT TIME 12 HOUR URINE
COLLECTION CORRELATE TO 24 HOUR
URINE COLLECTION?
Bryan Hinck*, Vishnuvardhan Ganesan,
Sarah Tarplin, Cleveland, OH, John Asplin,
Chicago, IL, Sri Sivalingam, Manoj Monga,
Cleveland, OH
MP82-05
MP82-11 THE PREDICTIVE VALUE OF URINALYSIS
FOR THE DETECTION OF URINARY
TRACT INFECTIONS IN ACUTE
NEPHROLITHIASIS
Matthew D. Lyons*, Jason R. Lomboy,
Christina W. Zhou, Gary G. Koch, Alan Kerr,
Peter H. Gilligan, Davis P. Viprakasit, Chapel
Hill, NC
AN ASSESSMENT OF SERUM
TESTOSTERONE, SERUM ESTROGEN,
VITAMIN D AND BONE MINERAL DENSITY
IN ADULT IDIOPATHIC CALCIGEROUS
RENAL STONE FORMERS
Santosh Kumar*, Siddharth Jain, Shrawan
Kumar Singh, Arup K Mandal, Anupam Lal,
Sanjay Bhadada, Chandigarh, India
MP82-12 INCREASING FUNGAL COLONIZATION
WITH INCREASED DURATION OF
URETERAL STENTS
Mohamed Keheila*, Christian Chan, Salim
Cheriyan, Patrick Yang, Samuel Abourbih,
Nazih Khater, Jim Shen, D. Duane Baldwin,
Loma Linda, CA
MP82-06 A MULTI-INSTITUTIONAL ASSESSMENT
OF THE PREVALENCE OF UNDIAGNOSED
DIABETES MELLITUS AMONG URIC ACID
STONE FORMERS
Scott Wiener*, Farmington, CT, Natalia
Hernandez, Brian Eisner, Boston, MA,
Vernon Pais Jr., Lebanon, NH, Carl Gjertson,
Erica Lambert, Farmington, CT
*Presenting author
MP82-13 POST PCNL SIRS IS NOT A PREDICTOR
OF UNPLANNED READMISSION
Rachel Moses*, Lebanon, NH, Vidit Sharma,
Rochester, MN, Eric Raffin, Lebanon, NH,
Boyd Viers, Deepak Agarwal, Amy Krambeck,
Rochester, MN, Vernon Pais, Jr., Lebanon,
NH
277
TUESDAY
MP82-08 HEALTH RELATED QUALITY OF LIFE IN
PATIENTS WITH UROLITHIASIS –
QUALITATIVE RESEARCH TO AID
DEVELOPMENT OF PATIENT REPORTED
MEASURES AND DECISION AIDS
Aditya Raja*, Fiona Wood, Hrishi Joshi,
MP82-14 TEMPORAL TREND OF MEDICAL
UTILIZATION AND COST FOR UPPER AND
LOWER URINARY TRACT STONE
DISEASES, 2000-2010: A POPULATIONBASED STUDY IN TAIWAN
Han-Yu Weng*, Che-Yuan Hu, Tainan,
Taiwan, Kuo-How Huang, Hong-Chiang
Chang, Taipei, Taiwan
MP82-15
MP82-18 EMERGENCY DEPARTMENT IMAGING
MODALITY AFFECT ON SURGICAL
MANAGEMENT OF NEPHROLITHIASIS
Ian Metzler*, Michelle Mogadassi, Marshall
Stoller, Rebecca Smith Bindman, Tom Chi,
San Francisco, CA
MP82-19 CESSATION OF URETERAL COLIC DOES
NOT NECESSARY MEAN THAT A
URETERAL STONE HAS BEEN EXPELLED
Natalia Hernandez*, Boston, MA, Yan Song,
Shenyang, China, People’s Republic of, Brian
Eisner, Boston, MA
TEMPORAL TRENDS IN DIRECT COSTS
OF NEPHROLITHIASIS, 1997 TO 2012
Gregory Tasian*, Michelle Ross, Lihai Song,
Susan Furth, Philadelphia, PA
MP82-16 CT FOR EVALUATION OF UROLITHIASIS:
IMAGE QUALITY OF ULTRALOW-DOSE
(SUB MSV) CT WITH KNOWLEDGE-BASED
ITERATIVE RECONSTRUCTION AND
DIAGNOSTIC PERFORMANCE OF LOWDOSE CT WITH STATISTICAL ITERATIVE
RECONSTRUCTION
Kim, Tae-Hyoung Kim, Soon Chul Myung,
Seung Hyun Ahn, Jae Duck Choi, Jung Hoon
Kim, Min Soo Kim, Shin Young Lee, Byung
Hoon Chi, In Ho Chang, Seoul, Korea,
Republic of
MP82-20 PROSPECTIVE MID-TERM EVALUATION
OF THE IMPACT OF SILENT URETERAL
STONE TREATMENT ON RENAL
FUNCTION USING 99MTC-DMSA
Giovanni Marchini*, Fábio Vicentini, Fábio
Torricelli, Alexandre Danilovic, Artur Brito,
Cesar Camara, Eduardo Mazzucchi, Miguel
Srougi, Sao Paulo, Brazil
CREDITTM
MP82-17 CAN ULTRASONOGRAPHY BE USED TO
GUIDE THE DIAGNOSIS AND
MANAGEMENT OF NEPHROLITHIASIS?
Troy Larson*, Burlington, VT, Natalia
Hernandez, Brian Eisner, Boston, MA, Jullet
Han, Vernon M Pais Jr., Lebanon, NH, Kevan
M. Sternberg, Burlington, VT
8:00 am - 10:00 am
BLADDER CANCER: BASIC RESEARCH & PATHOPHYSIOLOGY IV
Moderators: Jay Shah and Piyush Agarwal
ABSTRACT
NUMBER TITLE
MP83-01 URINARY SHED BLADDER CANCER
EXOSOMES HAVE DISTINCT MRNA
PROFILES AND HAVE POTENTIAL AS
URINARY BIOMARKERS
Robert H. Blackwell*, Carrie Franzen, Michael
Zilliox, Kimberly E. Foreman, Paul C. Kuo,
Robert C. Flanigan, Gopal N. Gupta,
Maywood, IL
ABSTRACT
NUMBER TITLE
MP83-03 EXPRESSION OF TRANSCRIPTION
FACTOR AP2 (TFAP2) FAMILY MEMBERS
ARE ASSOCIATED WITH THE BASAL
MOLECULAR SUBTYPE OF HUMAN
BLADDER CANCER AND ALTERED
NOTCH PATHWAY ACTIVITY
Wilson Chan*, Truc Tran, Hironobu
Yamashita, Zongyu Zheng, Vasty Osei
Amponsa, Yuka Imamura, Joshua Warrick,
Jay Raman, David DeGraff, Hershey, PA
MP83-02 ADDITION OF EMETINE
DIHYDROCHLORIDE TO PLATINUM
BASED CHEMOTHERAPY INHIBITS
BLADDER CANCER CELL
PROLIFERATION AND REDUCES THE
EFFECTIVE DOSE OF PLATINUM
CHEMOTHERAPY
Valerie J. Davidson*, Robert H. Blackwell,
Kimberly E. Foreman, Paul C. Kuo, Robert C.
Flanigan, Gopal N. Gupta, Maywood, IL
MP83-04 SYNERGISTIC ANTITUMOR EFFECT OF
SATRAPLATIN AND NVP-BEZ235 IN
CISPLATIN-RESISTANT HUMAN BLADDER
CANCER CELLS
Kim, Goyang, Korea, Republic of, Hong Seok
278
GLYCOLYTIC AND INFLAMMATORY
PATHWAY GENES ARE OVEREXPRESSED
IN BLADDER CANCER TUMORS
Benjamin Nelson*, Thomas Osinski, David
Gentile, Edward M Messing, Carla Beckham,
Rochester, NY
MP83-13 ONCOLYTIC VACCINIA VIRUS HAS
SIGNIFICANT ACTIVITY AND INDUCES
ANTI-TUMOR IMMUNITY IN BLADDER
CANCER
Kyle Potts*, Nicole Favis, Chad Irwin, Ronald
Moore, David Evans, Mary Hitt, Edmonton,
Canada
MP83-06 VARIANTS IN THE INFLAMMATORY GENE
PATHWAY ARE PREDICTIVE OF
RECURRENCE AND PROGRESSION IN
PATIENTS WHO RECEIVED BACILLUS OF
CALMETTE AND GUÉRIN (BCG) FOR NONMUSCLE INVASIVE BLADDER CANCER
Stephen Williams*, Ashish Kamat, Chinedu
Mmeje, Edwin Morales, Yuanqing Ye,
Maosheng Huang, David Wang, Colin
Dinney, Xifeng Wu, Houston, TX
MP83-14 GENOMIC EXPRESSION EVIDENCE FOR
ANDROGEN RECEPTOR AXIS
ACTIVATION IN UROTHELIAL
CARCINOMA: DATA FROM THE CANCER
GENOME ATLAS
Edwin E. Morales*, Stephen B. Williams,
Jinesh G. Goodwin, Debasish Sundi, Carolyn
L. Smith, David J. McConkey, Ashish M.
Kamat, Houston, TX
MP83-07 ROLE OF HINT3 IN P21 INDUCED
NECROTIC CELL DEATH UPON BCG
EXPOSURE IN UROTHELIAL CARCINOMA
CELLS
Gopitkumar Shah*, Fanghong Chen,
GuangJian Zhang, William See, Milwaukee,
WI
MP83-15
MP83-16 EMETINE DIHYDROCHLORIDE ENHANCES
CISPLATIN/GEMCITABINE-MEDIATED
GROWTH INHIBITION OF BLADDER
TUMOR CELLS IN VIVO
Kimberly Foreman, Alexandra Mitchell,
Samuel White, Emil Bielecki, Maria Picken,
Gopal Gupta*, Maywood, IL
MP83-08 LOCAL T LYMPHOCYTE SUBPOPULATION RESPONSES TO
INTRAVESICAL BCG AND
CHEMOTHERAPY IN AN IMMUNE
COMPETENT MURINE MODEL OF
BLADDER CANCER
Max Kates*, Nikolai Sopko, Hotaka Matsui,
Xiaopu Liu, Leonardo Reis, Noah Hahn, Alex
Baras, Christina Kochel, Charles Drake,
Trinity Bivalacqua, Baltimore, MD
MP83-17 ELK1 ACTIVITY CORRELATES WITH
BLADDER CANCER CELL GROWTH AS
WELL AS CHEMORESISTANCE
Takashi Kawahara, Hiroki Ide, Baltimore, MD,
Hasanain Khaleel Shareef, Babylon, Iraq,
Satoshi Inoue*, Eiji Kashiwagi, Baltimore,
MD, Yi Li, Hangzhou, China, People’s
Republic of, George Netto, Alexander Baras,
Yichun Zheng, Hiroshi Miyamoto, Baltimore,
MD
MP83-09 TUMOR NECROSIS FACTOR-RELATED
APOPTOSIS-INDUCING LIGAND (TRAIL)
POTENTIATES THE EFFECT OF BACILLUS
CALMETTE-GUÉRIN (BCG) IN
UROTHELIAL CARCINOMA MODEL
Mehrsa Jalalizadeh*, Baltimore, MD,
Leonardo O. Reis, São Paulo, Brazil, John L.
Silberstein, Hiroshi Miyamoto, Armine K.
Smith, Baltimore, MD
MP83-18 FOXO1 AS A POTENTIAL TUMOR
SUPPRESSOR IS INACTIVATED BY
ANDROGENS IN BLADDER CANCER
CELLS
Hiroki Ide*, Satoshi Inoue, Baltimore, MD, Yi
Li, Hangzhou, China, People’s Republic of,
Yichun Zheng, Eiji Kashiwagi, Takashi
Kawahara, George Netto, Hiroshi Miyamoto,
Baltimore, MD
MP83-10 CD44V8-10 INVOLVES ACQUISITION OF
CISPLATIN-RESISTANCE IN UROTHELIAL
CANCER
Masayuki Hagiwara*, Eiji Kikuchi, Takeo
Kosaka, Shuji Mikami, Hideyuki Saya, Tokyo,
Japan, Ken Nakagawa, Chiba, Japan,
MP83-19 UPAR AND MTORC2: COUPLED TARGETS
FOR THERAPEUTICS DEVELOPMENT IN
BLADDER CANCER
Andrew Hau*, Andrew Gilder, Jingjing Hu,
Steven Gonias, Donna Hansel, La Jolla, CA
MP83-11 GAIN-OF-FUNCTION OF P53 POINT
MUTATIONS IN BLADDER CANCER
DEVELOPMENT
Mao-Wen Weng*, Hyun-Wook Lee, Tuxedo
Park, NY, William C Huang, Herbert Lepor,
Xue-Ru Wu, New York, NY, Moon-Shong
Tang, Tuxedo Park, NY
MP83-20 ENZALUTAMIDE AS AN ANDROGEN
RECEPTOR INHIBITOR PREVENTS
UROTHELIAL TUMORIGENESIS
Takashi Kawahara*, Hiroki Ide, Eiji
Kashiwagi, Baltimore, MD, Yi Li, Hangzhou,
China, People’s Republic of, Satoshi Inoue,
Yichun Zheng, Hiroshi Miyamoto, Baltimore,
MD
MP83-12 IN VITRO EFFECTS OF INTERFERON
ALPHA IN BLADDER CANCER: IMMUNE
CHECKPOINT EXPRESSION AND
MICRORNA AND MRNA GENOMIC
PROFILING
Debasish Sundi*, Woonyoung Choi, I-Ling
Lee, Nathaniel Berg, Edwin Morales, David
McConkey, Colin Dinney, Houston, TX
*Presenting author
EFFECT OF GEMCITABINE AND
MITOMYCIN ON CANCER STEM CELLS IN
UROTHELIAL CARCINOMA CELLS
Rani Ojha, Shrawan Singh*, Arup K Mandal,
Vivekanand Jha, Chandigarh, India
CREDITTM
279
TUESDAY
MP83-05
8:00 am - 10:00 am
PROSTATE CANCER: BASIC RESEARCH & PATHOPHYSIOLOGY III
Moderators: Stephen Boorjian and Rosalyn Adam
ABSTRACT
NUMBER TITLE
MP84-01 IN VITRO CULTURE OF PROSTATE
CANCER XENOGRAFTS USING
ORGANOID TECHNOLOGY
Cheryl Nicholson*, Elizabeth Williams, Ian
Vela, Brisbane, Australia
ABSTRACT
NUMBER TITLE
MP84-08 PROTEIN ARGININE
METHYLTRANSFERASE 5 IS A NOVEL
EPIGENETIC REGULATOR OF ANDROGEN
RECEPTOR IN PROSTATE CANCER
Xuehong Deng, Genbao Shao, Huantian
Zhang, West Lafayette, IN, Jiaoti Huang, Los
Angeles, CA, Chang-Deng Hu*, West
Lafayette, IN
MP84-02 IN VIVO QUANTITATIVE
PHOSPHOPROTEOMIC PROFILING
IDENTIFIES YAP1 REGULATORS OF
CANCER STEM CELL GROWTH
Ning Jiang*, Yuanjie Niu, Tianjin, China,
People’S Republic Of
MP84-09 INTERFERENCE WITH GLI BINDING TO
ANDROGEN RECEPTORS ALTERS THE AR
TRANSCRIPTOME AND EFFECTIVELY
INHIBITS ANDROGEN GROWTHINDEPENDENCE OF PROSTATE CANCER
CELLS
Na Li, Sarah Truong, Mannan Nouri, Amy
Lubik, Josselin Caradec, Ralph Buttyan*,
Vancouver, Canada
MP84-03 EXPRESSION OF ANDROGEN RECEPTOR
SPLICE VARIANTS IN A NOVEL
CANCER XENOGRAFT MODEL
Takahiro Kimura*, Mariko Honda, Kojiro
Tashiro, Shigehiro Bando, Hiroshi Sasaki,
Yuko Kamata, Jun Miki, Shin Egawa, Tokyo,
Japan
MP84-10 ERG INDUCES ENDOPLASMIC
RETICULUM STRESS (ER) AND
UNFOLDED PROTEIN RESPONSE (UPR)
TO INITIATE PROSTATE CANCER
CARCINOGENESIS
Taduru L. Sreenath*, Shiela S. Macalindong,
Natallia Mikhalkevich, Shashwat Sharad,
Rockville, MD, Parameet Kumar, Bethesda,
MD, Denise Young, Rishita Gupta, Shilpa
Katta, Ahmed Mohamed, Shyh-Han Tan,
Albert Dobi, Gyorgy Petrovics, Isabell A.
Sesterhenn, Rockville, MD, Charles J.
Bieberich, Baltimore, MD, Peter Nelson,
Seattle, WA, David G. McLeod, Rockville,
MD, Valeri Vasioukhin, Seattle, WA, Shiv
Srivastava, Rockville, MD
MP84-04 GENOMIC SCREEN IDENTIFIES
ACTIONABLE KINASES FOR OBESITY
DRIVEN PROSTATE CANCER
Everardo Macias*, Los Angeles, CA, David
Corcoran, Jen-Tsan Chi, Durham, NC,
MP84-05
THE OESTROGEN RECEPTOR IS
SIGNIFICANTLY DYSREGULATED IN A
MODEL OF DOCETAXEL RESISTANT
PROSTATE CANCER AND TAMOXIFEN
REVERSES APOPTOTIC RESISTANCE TO
DOCETAXEL IN VITRO
Dara Lundon*, Maria Prencipe, Amanda
O’Neill, Sinead Ahearne, Stephen Madden,
Padraig Doolan, William Watson, Dublin,
Ireland
MP84-11 BONE MICROENVIRONMENT TARGETED
NANOPARTICLES FOR METASTATIC
PROSTATE CANCER TREATMENT
Andrew Gdowski*, Amalendu Ranjan,
Anindita Mukerjee, Marjana Sarker, Joe
Kimbell, Jamboor Vishwanatha, Fort Worth,
TX
MP84-06 CXCL8 COULD INDUCE AND MAINTAIN
PROSTATE CANCER STEM CELLS VIA
PI3K/AKT PATHWAY
Yun Cui*, Mengkui Sun, Jixuan Liu, Shuai
Hu, Yu Fan, Tianjing Lv, Wei Yu, Jie Jin,
MP84-12 COMBATTING AR N-TERMINAL VARIANTDRIVEN ENZALUTAMIDE RESISTANT
PROSTATE CANCER BY TARGETING THE
KINASE HIPK2
Russell Ledet, Susan Logan, Michael
Garabedian*, New York, NY
MP84-07 A TALE OF TAILS – A NOVEL APPROACH
TO IMMUNOTHERAPY OF PROSTATE
CANCER
Christine Galustian*, Dorota Smolarek,
Christina Sakellariou, Oussama Elhage,
Richard Smith, Prokar Dasgupta, London,
United Kingdom
280
MP84-13 A NEW APPROACH FOR AN IMPROVED
PSA DOUBLING TIME COMPUTATION FOR
SELECTING PATIENTS CANDIDATE TO
TIMELY SALVAGE RADIOTHERAPY FOR A
BIOCHEMICAL RECURRENCE AFTER
PROSTATECTOMY
Paola Maria Rancoita, Cesare Cozzarini*,
Barbara Noris Chiorda, Alberto Briganti,
Chiara Lucrezia Deantoni, Claudio Fiorino,
Nicola Fossati, Marcella Pasetti, Carla Sini,
Francesco Montorsi, Nadia Di Muzio, Clelia
Di Serio, Milan, Italy
MP84-18 CORRELATION BETWEEN NUCLEAR
PPAR⌫ EXPRESSION AND BIOCHEMICAL
RECURRENCE IN PROSTATE CANCER
Andres Acosta*, Virgilia Macias, Chicago, IL,
Anthony Sisk, Los Angeles, CA, John
Katzenellenbogen, Urbana, IL, Andre
Kajdacsy-Balla, Chicago, IL
MP84-19 ELEVATED EXPRESSION OF 15LIPOXYGENASE-2 (ALOX15B) IS
ASSOCIATED WITH NONAGGRESSIVE
PROSTATE CANCER AND CONFERS A
SURVIVAL BENEFITS
Kevin Ginsburg*, Greg Dyson, Aliccia BolligFischer, Isaac Powell, Detroit, MI
MP84-14 OVERCOMING ENZALUTAMIDERESISTANT WITH A NOVEL ANTI-AR
PEPTIDE IN PROSTATE CANCER CELLS
Daniel Zainfeld*, Ruibao Chen, J Brantley
Thrasher, Benyi Li, Kansas City, KS
MP84-15
MP84-20 BIOINFORMATIC ANALYSIS UTILIZING
THE ANDROGENIC SUPPRESSIVE
EFFECT IDENTIFIED PROMISING
CANDIDATE DRUGS FOR
REPROGRAMMING DOCETAXELRESISTANT CASTRATION-RESISTANT
PROSTATE CANCER
Hiroshi Hongo*, Takeo Kosaka, Yota
Yasumizu, Yasumasa Miyazaki, Eiji Kikuchi,
Japan
PREVENT METASTASIS BY DOUBLE
CHIMERIC ANTIGEN RECEPTOR T CELLS
TARGETING CIRCULATING CANCER
CELLS FOR PROSTATE CANCER
TREATMENT
Wujiang Liu*, Weidong Han, Liqun Zhou,
Yinglu Guo, Beijing, China, People’s Republic
of
CREDITTM
TUESDAY
MP84-16 PHOSPHATIDYLINOSITOL 4-KINASE TYPE
III〈 (PI4KA) AND CXCR4 CROSSTALK IN
PROSTATE CANCER CELLS
Michael Cher*, Diego Sbrissa, Louie Semaan,
Yanfeng Li, Assia Shisheva, Srinivasa Chinni,
Detroit, MI
MP84-17 LUTEOLIN HAS THERAPEUTIC
POTENTIAL THROUGH THE REGULATION
OF OXIDATIVE STRESS IN CASTRATIONRESISTANT PROSTATE CANCER
Taku Naiki*, Aya Naiki-Ito, Toshiki Etani,
Keitaro Iida, Ryosuke Ando, Noriyasu Kawai,
Keiichi Tozawa, Kenjiro Kohri, Satoru
Takahashi, Takahiro Yasui, Nagoya, Japan
8:00 am - 10:00 am
KIDNEY CANCER: BASIC RESEARCH & PATHOPHYSIOLOGY II
Moderators: Rajvir Dahiya and Peter Clark
ABSTRACT
NUMBER TITLE
MP85-01 MYOCYTE ENHANCER FACTOR 2A
(MEF2A) IS UP-REGULATED IN CLEAR
Adam Kinnaird*, Bruno Saleme, Vikram
Gurtu, Sotirios Zervopoulos, Aristeidis
Boukouris, Alois Haromy, Trevor Stenson,
Kristalee Watson, Peter Dromparis,
Evangelos Michelakis, Edmonton, Canada
*Presenting author
ABSTRACT
NUMBER TITLE
MP85-02 OVEREXPRESSION OF VCAN IS
ASSOCIATED WITH METASTASIS AND
UNFAVORABLE PROGNOSIS IN PATIENTS
WITH RENAL CELL CARCINOMA
Yozo Mitsui*, Hiroaki Shiina, Izumo, Japan,
Shinichiro Fukuhara, Osaka, Japan, Miho
Izumo, Japan, Rajvir Dahiya, Yuichiro
Tanaka, San Francisco, CA
281
MP85-03
FABP7 AND 6 AS A POTENTIAL TARGET
AND MARKER IN CLEAR CELL RENAL
CELL CARCINOMA
Kazuhiro Nagao*, Nachi Shinohara, Ube,
Japan, Yuji Owada, Sendai, Japan, Frank
Smit, Nijmegen, Netherlands, Hideyasu
Matsuyama, Ube, Japan, Peter Mulders,
Egbert Oosterwijk, Nijmegen, Netherlands
MP85-04
DE NOVO GTP SYNTHESIS IS CRITICAL
FOR CELL MIGRATION THROUGH IMPDH2
IN RENAL CELL CARCINOMA
Hirofumi Yoshino*, Hideki Hideki, Masayuki
Nakagawa, Kagoshima, Japan, Atsuo Sasaki,
Cincinnati, OH
MP85-05
MP85-06
MP85-07
MP85-08
MP85-09
ALTERNATIVE SPLICING OF EZH2 PREMRNA BY SF3B3 CONTRIBUTES TO THE
TUMORIGENIC POTENTIAL OF RENAL
CANCER
Haibing Xiao*, Ke Chen, Hua Xu, Wuhan,
CYTOCHROME P450 1B1 PROMOTES
TUMORIGENESIS VIA ALTERED
EXPRESSION OF CDC20 AND DAPK1
GENES
Yozo Mitsui*, Izumo, Japan, Inik Chang,
Seoul, Korea, Democratic People’s Republic
of, Shinichiro Fukuhara, Osaka, Japan, Miho
Hiroaki Shiina, Izumo, Japan, Rajvir Dahiya,
Yuichiro Tanaka, San Francisco, CA
URINARY MIRNAS AS A PREDICTOR OF
TUMOR RECURRENCE IN PATIENTS WITH
Rodolfo Borges Dos Reis*, Xian Shu,
Yuanqing Ye, Beatriz Sanchez Espiridion,
Maosheng Huang, Mehrad Adibi, Leonardo
Borregales, Lisly Chery, Jose Karam, Xifeng
Wu, Christopher Wood, Houston, TX
DIRECT REGULATION OF COLLAGEN
CROSS-LINKING ENZYMES (LOXL2 AND
PLOD2) BY TUMOR-SUPPRESSIVE
MICRORNA-26A/B IN RENAL CELL
CARCINOMA
Akira Kurozumi*, Mayuko Kato, Yusuke Goto,
Atsushi Okato, Ryosuke Matsushita, Chiba,
Japan, Hideki Enokida, Masayuki Nakagawa,
Kagoshima, Japan, Tomohiko Ichikawa,
Naohiko Seki, Chiba, Japan
ANGIOGENESIS RELATED MICRORNAS
AND GENE EXPRESSION PROFILE IN
RENAL CELL CARCINOMA, CLEAR CELL
TYPE
Rita de Cássia Oliveira, Nayara Viana, Katia
Leite, Vanessa Guimarães, José Pontes, Sao
Paulo, Brazil, Renato Ivanovic, São Paulo,
Brazil, Caio Moura, Sao Paulo, Brazil, Denis
Reis, São Paulo, Brazil, Nelson Dip, William
Nahas, Miguel Srougi, Sabrina Reis*, Sao
Paulo, Brazil
282
MP85-10
IDENTIFICATION OF WDR20 AS A NEW
TUMOR SUPPRESSOR GENE
PREFERENTIALLY ALTERED IN HIGHGRADE CLEAR CELL RENAL CELL
CARCINOMA
Mika Takahashi*, Tomoki Kai, Yufu, Japan,
Akinori Tokunaga, Nagoya, Japan, Takeo
Nomura, Fuminori Sato, Keiko Matsuura,
Masatsugu Moriyama, Hiromitsu Mimata,
Yufu, Japan
MP85-11
GENETIC DELETION OF SAV1 ENHANCES
PROLIFERATION AND NUCLEAR
IRREGULARITY IN RENAL TUBULAR
EPITHELIAL CELLS
Tomoki Kai*, Keiko Matsuura, Yoshiyuki
Tsukamoto, Mika Takahashi, Naoki Hijiya,
Fuminori Sato, Masatsugu Moriyama,
Hiromitsu Mimata, Yufu-City, Japan
MP85-12
DIOSMETIN ENHANCES TRAIL-INDUCED
APOPTOSIS IN RENAL CARCINOMA
CELLS THROUGH THE UP-REGULATION
OF DEATH RECEPTOR 5
Yu Ren*, Xuping Yao, Xue Wang, Shuaishuai
Huang, Guobin Weng, Ningbo, China,
MP85-13
FNIP CO-CHAPERONES PROTECT THE
TUMOR SUPPRESSOR FLCN FROM
UBIQUITINATION AND DEGRADATION IN
THE PROTEASOME
Mark Woodford, Diana Dunn, Adam Blanden,
Stewart Loh, Dimitra Bourboulia, Syracuse,
NY, Laura Schmidt, W. Marston Linehan,
Bethesda, MD, Gennady Bratslavsky, Mehdi
Mollapour*, Syracuse, NY
MP85-14
ABERRANT METHYLATION OF CCND2 IS
ASSOCIATED WITH LOSS OF
EXPRESSION AND TUMOR
PATHYLOGICAL SUBTYPES IN RENAL
CELL CANCER
Lu Wang*, Yu Fan, Yun Cui, Yang Yang, Jin
Dong Sheng, Qian Zhang, Jie Jin, Beijing,
MP85-15
MYOPODIN METHYLATION CORRELATES
TO TUMOR PROGRESSION AND
PREDICTS ANTIANGIOGENIC RESPONSE
IN KIDNEY CANCER
Alberto Perez-Lanzac, Noemi PompasVeganzones, Vitoria-Gasteiz, Spain, Manuel
Beltran, Cadiz, Spain, Pastora Beardo, Jerez,
Spain, Fernando Vazquez, Jose Cozar,
Granada, Spain, Jose Luis Alvarez-Ossorio,
Marta Sanchez-Carbayo*, Vitoria-Gasteiz,
Spain
MP85-16
STUDY OF ALTERED RATIOS OF PROTEIN
KINASE CK2 CATALYTIC SUBUNITS AND
REGULATORY SUBUNIT (CK2BETA) IN
RENAL CELL CARCINOMA. RELATION
WITH EPITELIAL-TO-MESENCHYMAL
TRANSITION MARKERS (IL-6/STAT3)
Enrique Trilla, Lucas Regis*, David Lorente,
Pol Servian, Carlos Gasanz, Ana Celma,
Carlos Salvador, Jose Placer, Jacques
Planas, Jordi Vilardell, Emili Itarte, Anna
Meseguer, Juan Morote, Barcelona, Spain
MP85-17
MP85-18
EPITHELIAL-TO-MESENCHYMAL
TRANSFORMATION IN THE NEGATIVE
SURGICAL MARGIN MAY PREDICT
RECURRENCE AFTER NEPHRONSPARING SURGERY FOR RENAL CELL
CARCINOMA
Paras Shah*, Oksana Yaskiv, Manaf Alom,
New Hyde Park, NY, Arvin George,
Bethesda, MD, Daniel Moreira, Rochester,
MN, Vinay Patel, Michael Schwartz, Lee
Richstone, Manish Vira, Louis Kavoussi, New
Hyde Park, NY
MP85-19
URINARY PEPTIDOME AND PROTEOME
ALTERATIONS RELATED TO TUMOR
PROGRESSION AND INVASION IN RCC
Clizia Chinello, Marco Grasso*, Marta
Cazzaniga, Gabriele De Sio, Monza, Italy,
Angelica Grasso, Bernardo Rocco, Milano,
Italy, Andrew Smith, Monza, Italy, Italo
Zoppis, Giancarlo Mauri, Milan, Italy, Fulvio
Magni, Monza, Italy
MP85-20
METABOLOMICS AND POSTNEPHRECTOMY RENAL FUNCTION
PREDICTION
Barak Rosenzweig*, Ed Reznik, Roman
Shingarev, Emily C Zabor, New York, NY,
Steven Stirdivant, Durham, NC, Chris Sander,
James J. Hsieh, Edgar A Jaimes, Paul
Russo, A Ari Hakimi, Jonathan A. Coleman,
New York, NY
CIRCULATING FREE GENOMIC AND
MITOCHONDRIAL DNA FRAGMENTS AND
THEIR DIAGNOSTIC AND PROGNOSTIC
POTENTIAL IN CLEAR CELL RENAL CELL
CARCINOMA PATIENTS
Bernhard Ralla*, Luis Hongbiao, Monika
Jung, Kilic Ergin, Nils Budach, Annika
Fendler, Klaus Jung, Jonas Busch, Berlin,
Germany
CREDITTM
8:00 am - 10:00 am
ABSTRACT
NUMBER TITLE
MP86-01 IS HYPERHOMOCYSTEINEMIA AN EARLY
PREDICTOR OF ERECTILE
DYSFUNCTION? EVALUATION OF
INTERNATIONAL INDEX OF ERECTILE
FUNCTION (IIEF) AND PENILE DOPPLER
ULTRASOUND
Gian Maria Busetto*, Riccardo Giovannone,
Gabriele Antonini, Vincenzo Gentile, Ettore
De Berardinis, Roma, Italy
ABSTRACT
NUMBER TITLE
MP86-05 TISSUE-SPECIFIC EXPRESSION OF
CONNEXIN 43 IN CORPORA CAVERNOSA
MAY BE RESPONSIBLE FOR ERECTILE
DYSFUNCTION PRECEDING CARDIACCEREBRAL VASCULAR DISEASE
Yan-Ping Huang*, Bin Chen, Ping Ping,
Hong-Xiang Wang, Yi-Ran Huang, Shanghai,
MP86-06 COMBINATION THERAPY USING HUMAN
ADIPOSE-DERIVED STEM CELLS ON THE
CAVERNOUS NERVE AND LOW-ENERGY
SHOCKWAVES ON THE CORPUS
CAVERNOSUM IN A RAT MODEL OF
POSTPROSTATECTOMY ERECTILE
DYSFUNCTION
MP86-02 A PROSPECTIVE EXAMINATION OF
ERECTILE FUNCTION PRESERVATION
AFTER RADIATION THERAPY
Lawrence C. Jenkins*, Michael J. Zelefsky,
Christian J. Nelson, Marisa A. Kollmeier,
John P. Mulhall, New York, NY
MP86-03 THE INFLUENCE OF MACA (LEPIDIUM
MEYENII) ON THE GLUCOSE
METABOLISM AND ERECTILE FUNCTION
IN TYPE 1 DIABETIC RATS
Masaki Kimura*, Amr Abdelhamed, Takahiro
Noguchi, Takeshi Ashizawa, Hisashi Hirano,
Hideki Koyasu, Kazutaka Terai, Keisuke
Saito, Hisamitsu Ide, Satoru Muto, Raizo
Yamaguchi, Shigeo Horie, Tokyo, Japan
MP86-07 IMPACT OF TISSUE SEALING SHEET ON
ERECTILE DYSFUNCTION IN A RAT
MODEL OF NERVE-SPARING RADICAL
PROSTATECTOMY
Shinichi Yamashita*, Yoshihiro Kamiyama,
Shinji Fujii, Emi Endo, Yoshihide Kawasaki,
Hideaki Izumi, Naoki Kawamorita, Koji
Mitsuzuka, Hisanobu Adachi, Yasuhiro Kaiho,
Akihiro Ito, Yoichi Arai, Sendai, Japan
MP86-04 COMPARING TRADITIONAL CULTURE
METHODS AND NEW MOLECULAR
TESTING TECHNIQUES TO ANALYZE
BIOFILM COMPOSITION ON UNINFECTED
IPPS
Martin Gross*, Gerard Henry, Shreveport, LA
*Presenting author
283
TUESDAY
SEXUAL FUNCTION/DYSFUNCTION: BASIC RESEARCH & PATHOPHYSIOLOGY I
Moderators: Carol Podlasek and Ryan Terlecki
MP86-08 EFFECT OF COMBINATION THERAPY
WITH NERVE GROWTH FACTOR AND
BASIC FIBROBLAST GROWTH FACTOR IN
A RAT MODEL OF CAVERNOUS NERVE
INJURY
Lee, Seoul, Korea, Republic of, Joon Hwa
Noh, Gwangju, Korea, Republic of, Byung Il
Yoon, Incheon, Korea, Republic of
MP86-15
MIRABEGRON ELICITS SMOOTH MUSCLE
RELAXATION OF HUMAN AND RAT
CORPUS CAVERNOSUM TISSUES VIA
NON NITRIC OXIDE-CGMP PATHWAYS
Faysal A Yafi*, New Orleans, LA, Serap Gur,
Ankara, Turkey, Taylor Peak, Philip J
Kadowitz, Suresh C Sikka, Wayne JG
MP86-16 DOES NEOADJUVANT ANDROGEN
DEPRIVATION THERAPY IMPACT
ERECTILE FUNCTION RECOVERY POSTRADICAL PROSTATECTOMY?
Lawrence C. Jenkins*, A. Karim Touijer,
Dana Rathkopf, Christian J. Nelson, John P.
Mulhall, New York, NY
MP86-09 WATER JET DISSECTION OF THE
CAVERNOUS NERVES: A COMPARATIVE
STUDY TO BLUNT CAVERNOUS NERVE
INJURY IN A RAT MODEL AND ITS
IMPLICATION ON ERECTILE FUNCTION
Husain Alenezi*, Ling X De Young, Gerald
Brock, Stephen E Pautler, London, Canada
MP86-17 EFFECTS OF EUPATILIN ON THE
CONTRACTILITY OF CORPUS
CAVERNOSAL SMOOTH MUSCLE
THROUGH NITRIC OXIDE INDEPENDENT
PATHWAYS
Seol Ho Choo*, Suwon-si, Korea, Republic
of, Sin Woo Lee, Deok Hyun Han, Sung Won
MP86-10 MELATONIN ADMINISTRATION
REORGANIZES CAVERNOUS TISSUE,
UPREGULATES SIRT-1 GENES, AND
DECREASES OXIDATIVE DAMAGE IN
DIABETIC RATS
Ahmet Şahan, Cem Akbal*, Hasan Huseyin
Tavukçu, Sule Cetinel, Yiloren Tanidir, Levent
Kabasakal, Istanbul, Turkey, Ozge Cevik,
Sivas, Turkey, Goksel Sener, Ferruh Simsek,
Istanbul, Turkey
MP86-18 RESEARCH ON THE MECHANISM OF
ANDROGEN REPLACEMENT THERAPY
IMPROVING ERECTILE DYSFUNCTION
ASSOCIATED WITH LATE-ONSET
HYPOGONADISM
Kai Cui*, Rui Li, Tao Wang, Jihong Liu, Ke
Rao, Wuhan, China, People’s Republic of
MP86-11 IS THERE A RELATIONSHIP BETWEEN
PHOSPHODIESTERASE TYPE 5
INHIBITORS (PDE5I) AND PROSTATE
CANCER BIOCHEMICAL RECURRENCE?
Lawrence C. Jenkins*, James A. Eastham,
Vincent P. Laudone, Peter T. Scardino,
Christian J. Nelson, John P. Mulhall, New
York, NY
MP86-19 EFFECT OF SLEEP DEPRIVATION ON
HORMONAL AXIS AND ERECTILE
FUNCTION
Dongsup Lee*, Seung-ju Lee, Suwon, Korea,
Republic of, Dong-wan Sohn, Seoul, Korea,
Republic of
MP86-12 HUMAN TISSUE KALLIKREIN 1
RESTORES ERECTILE FUNCTION OF
STREPTOZOTOCIN- INDUCED DIABETIC
RATS BY ACTIVATING PI3K/ENOS
PATHWAY, INHIBITING OXIDATIVE
STRESS AND APOPTOSIS IN THE
CORPUS CAVERNOSUM
Yang Luan*, Yajun Ruan, Tao Wang, Yan
Zhang, Kai Cui, Rui Li, Jun Yang, Ruibao
Chen, Shaogang Wang, Jihong Liu,
Republic of
MP86-20 NEURAL INNERVATION AND SONIC
HEDGEHOG REGULATION OF COLLAGEN
IN THE PENIS
Shawn Choe, Dorina Veliceasa, Christopher
Bond, Chicago, IL, Daniel Harrington,
Houston, TX, Samuel Stupp, Chicago, IL,
Kevin McVary, Springfield, IL, Carol
Podlasek*, Chicago, IL
CREDITTM
MP86-13 IMPACT OF TESTOSTERONE DEFICIENCY
ON ERECTILE FUNCTION RECOVERY
POST-RADICAL PROSTATECTOMY
Lawrence C. Jenkins*, James A. Eastham,
Vincent P. Laudone, Christian J. Nelson,
John P. Mulhall, New York, NY
MP86-14 TREATMENT OF DIABETES MELLITUSINDUCED ERECTILE DYSFUNCTION
USING ENDOTHELIAL PROGENITOR
CELLS GENETICALLY MODIFIED WITH
HUMAN TELOMERASE REVERSE
TRANSCRIPTASE
Yan Zhang, Tao Wang, Jun Yang, Rui Li, Zhi
Chen, Shaogang Wang, Jihong Liu*,
Republic of
284
8:00 am - 10:00 am
ABSTRACT
NUMBER TITLE
MP87-01 ANALYSIS OF CLINICAL AND
MORPHOMETRIC RISK FACTORS
ASSOCIATED WITH URETHRAL ATROPHY
Matthias D Hofer*, Nirmish Singla, Billy H
Cordon, Jeremy M Scott, Allen F Morey,
Dallas, TX
ABSTRACT
NUMBER TITLE
MP87-07 DIABETES MELLITUS AND
ANTICOAGULANT THERAPY DO NOT
INFLUENCE DRY RATE OR SURGICAL
REVISION RATE AFTER ARTIFICIAL
URINARY SPHINCTER IMPLANTATION
FOR POST PROSTATECTOMY
INCONTINENCE – RESULTS OF A MULTIINSTITUTIONAL STUDY
Manuela Tutolo*, Leuven, Belgium, Giulia
Castagna, Milan, Italy, Marcus J. Drake,
Bristol, United Kingdom, Nikseh Tiruchelvam,
Cambridge, United Kingdom, Kari A. O.
Tikkinen, Helsinki, Finland, Alexander
Bachmann, Basel, Switzerland, Juan I.
Martinez-Salamanca, Madrid, Spain, Giorgio
Bozzini, Milan, Italy, Ricarda M. Bauer,
Munich, Germany, John Heesakkers,
Nijmegen, Netherlands, Michele Favro,
Novara, Italy, Richard K. Lee, New York, NY,
Stéphane Larré, Reims, France, Cosimo De
Nunzio, Rome, Italy, François Haab, Paris,
France, Sascha A. Ahyai, Hamburg,
Germany, Thomas Pichon, Angers, France,
Frank Van Der Aa, Leuven, Belgium, JeanNicolas Cornu, Paris, France
MP87-02 SACRAL NERVE STIMULATION IN MALES:
WHAT DIFFERS FROM FEMALES?
Bradley Gill*, Javier Pizarro⫺Berdichevsky,
Anna Faris, Marisa Clifton, Henry Okafor,
Elodi Dielubanza, Adrienne Quirouet,
Courtenay Moore, Howard Goldman, Sandip
Vasavada, Raymond Rackley, Cleveland, OH
MP87-03 DOUBLEⴚLAYER VESICOURETHRAL
ANASTOMOSIS ASSOCIATED WITH
IMPROVED EARLY CONTINENCE AFTER
ROBOTIC RADICAL PROSTATECTOMY
Juan Guzman*, Ricardo Sanchez-Ortiz,
Guaynabo, Puerto Rico
MP87-04 NATIONAL TRENDS IN UTILIZATION OF
SURGICAL THERAPIES FOR POSTPROSTATECTOMY STRESS URINARY
INCONTINENCE
Yahir Santiago-Lastra*, J. Quentin Clemens,
Bahaa S. Malaeb, Ann Arbor, MI
MP87-05
MP87-08 DOES THE ISTOP TOMS™ MALE SLING
REMAIN EFFICIENT OVER TIME?
philippe Grise*, Benoit Malval, rouen, France,
Renaud Vautherin, Sainte Colombe, France,
Christian Saussine, Strasbourg, France, Jean
Nicolas Cornu, Rouen, France
PERIOPERATIVE COMPLICATIONS AFTER
MALE INCONTINENCE SURGERY:
RESULTS FROM A NATIONALLY
VALIDATED MULTI CENTER COHORT
Allen Simms*, Daniel Davenport, Samuel
Belknap, Stephen Strup, Shubham Gupta,
Lexington, KY
MP87-09 PRIOR RADIATION THERAPY DECREASES
TIME TO IDIOPATHIC EROSION OF
ARTIFICIAL URINARY SPHINCTER: A
MULTI-INSTITUTIONAL ANALYSIS
Melissa R. Kaufman*, Nashville, TN, Gerard
Henry, Shreveport, LA, Niels V. Johnsen,
Nashville, TN, Mario A. Cleves, Little Rock,
AR, Joshua A. Broghammer, Kansas City,
KS, William O. Brant, Salt Lake City, UT,
Martin S. Gross, Shreveport, LA, Jeffrey D.
Brady, Orlando, FL, LeRoy Jones, San
Antonio, TX, Douglas F. Milam, Nashville, TN
MP87-06 THERAPEUTIC EFFICACY AND SAFETY
OF SHIFTING FROM ANTIMUSCARINICS
TO BETA-3 ADRENOCEPTOR AGONIST –
WHICH PATIENTS BENEFIT MOST FROM
THE CHANGE?
Chun-Hou Liao*, New Taipei, Taiwan, HueihLing Ong, Hann-Chorng Kuo, Hualien,
Taiwan
MP87-10 PERIOPERATIVE COMPLICATIONS OF
PLACEMENT AMONG THE ELDERLY
Valary Raup*, Pamela Lu, Bjoern
Loeppenberg, Malte Vetterlein, Christian
Meyer, Quoc-Dien Trinh, Jairam Eswara,
Boston, MA
MP87-11 EFFECTS OF BARIATRIC SURGERY ON
MALE LOWER URINARY TRACT
SYMPTOMS AND SEXUAL FUNCTION
Asnat Groutz*, David Gordon, Pinhas
Schachter, Hadar Amir, Mordechai Shimonov,
Tel Aviv, Israel
*Presenting author
285
TUESDAY
URODYNAMICS/LOWER URINARY TRACT DYSFUNCTION/FEMALE PELVIC MEDICINE: MALE INCONTINENCE: THERAPY I
Moderators: Fred Govier and Brian Flynn
MP87-12 THE ADVANCE TRANSOBTURATOR MALE
SLING: SURGICAL TIPS THAT PREDICT
SUCCESSFUL RETURN OF CONTINENCE
Brian Christine*, Mountain Brook, AL,
Anthony J. Bella, Ottawa, Canada
MP87-18 PREOPERATIVE COMPLICATIONS OF
ADVANCE AND ADVANCEXP
RETROURETHRAL TRANSOBTURATOR
MALE SLING: RESULTS OF A LARGE
MULTI-CENTER COHORT STUDY
Alexander Kretschmer*, Munich, Germany,
Tanja Hüsch, Frauke Thomsen, Dominik
Kronlachner, Frankfurt, Germany, Alice
Obaje, Jena, Germany, Ralf Anding, Bonn,
Germany, Tobias Pottek, Hamburg, Germany,
Achim Rose, Duisburg, Germany, Roberto
Olianas, Lüneburg, Germany, Alexander
Friedl, Vienna, Austria, Wilhelm Hübner,
Korneuburg, Austria, Roland Homberg,
Hamm, Germany, Jesco Pfitzenmaier,
Bielefeld, Germany, Ulrich Grein, Hamm,
Germany, Fabian Queissert, Münster,
Germany, Carsten M. Naumann, Kiel,
Germany, Josef Schweiger, Erfurt, Germany,
Carola Wotzka, Stuttgart, Germany, Joanne
N. Nyarangi-Dix, Heidelberg, Germany,
Torben Hofmann, Schwäbisch Hall, Germany,
Alexander Buchner, Munich, Germany, Axel
Haferkamp, Frankfurt, Germany, Ricarda M.
Bauer, Munich, Germany
MP87-13 TRADITIONAL OR ECTOPIC ARTIFICIAL
URINARY SPHINCTER PRESSURE
REGULATING BALLOON LOCATION: IS
THERE A PRESSURE DIFFERENCE?
Hajar Ayoub*, O. Lenaine Westney, Houston,
TX
MP87-14 PREDICTORS OF POOR PATIENT
SATISFACTION FOLLOWING PRIMARY
AUS PLACEMENT AMONG MEN WITH AND
WITHOUT A PRIOR HISTORY OF
RADIATION
Marcelino Rivera*, Boyd Viers, Brian Linder,
Laureano Rangel, Matthew Ziegelmann,
Daniel Elliott, Rochester, MN
MP87-15
LONG-TERM QUALITY OF LIFE AND
FUNCTIONAL OUTCOMES AMONG
PRIMARY AND SECONDARY ARTIFICIAL
URINARY SPHINCTER IMPLANTATIONS
IN MEN WITH STRESS URINARY
INCONTINENCE
Boyd Viers*, Brian Linder, Marcelino Rivera,
Laureano Rangel, Matthew Ziegelmann,
Daniel Elliott, Rochester, MN
MP87-19 THE IMPACT OF STEROID USE ON
REOPERATION
Roderick Clark*, Jennifer Winick-Ng, Andrew
McClure, Blayne Welk, London, Canada
MP87-16 PERINEAL FIXATION IS INFERIOR TO
PURELY TRANSOBTURATOR
PLACEMENT OF MALE SLING:
MULTICENTER STUDY OF SURGICAL
ESCALATION.
Ryan Terlecki*, Winston Salem, NC, Kurt
McCammon, Jack Zuckerman, Norfolk, VA,
Brian Flynn, Aurora, CO, Joshua
Broghammer, Kansas City, KS, Gopal
Badlani, Marc Colaco, Winston Salem, NC
MP87-20 THE EFFICACY AND SAFETY OF
PROXIMAL ARTIFICIAL URINARY
SPHINCTER PLACEMENT IN REVISION
CASES: A SINGLE INSTITUTION
EXPERIENCE
Lanette Rickborn, Catherine Chen*, Scott
Swanson, Christopher Wolter, Phoenix, AZ
CREDITTM
MP87-17 ADJUVANT RADIOTHERAPY HAS NO
IMPACT ON DRY RATE AND SURGICAL
REVISION RATE AFTER ARTIFICIAL
URINARY SPHINCTER IMPLANTATION
FOR STRESS URINARY INCONTINENCE
Manuela Tutolo*, Leuven, Belgium, Giulia
Castagna, Milan, Italy, Marcus J. Drake,
Bristol, United Kingdom, Nikseh Tiruchelvam,
Cambridge, United Kingdom, Kari A. O.
Tikkinen, Helsinki, Finland, Alexander
Bachmann, Basel, Switzerland, Juan I.
Martinez-Salamanca, Madrid, Spain, Giorgio
Bozzini, Milan, Italy, Ricarda M. Bauer,
Munich, Germany, John Heesakkers,
Nijmegen, Netherlands, Michele Favro,
Novara, Italy, Richard K. Lee, New York, NY,
Stéphane Larré, Reims, France, Cosimo De
Nunzio, Rome, Italy, François Haab, Paris,
France, Sascha A. Ahyai, Hamburg,
Germany, Thomas Pichon, Angers, France,
Jean-Nicolas Cornu, Paris, France, Frank
Van Der Aa, Leuven, Belgium
286
8:00 am - 10:00 am
Podium Session 46
KIDNEY CANCER: LOCALIZED: ABLATIVE THERAPY & ACTIVE SURVEILLANCE
Moderators: Ithaar Derweesh and Anil Kapoor
ABSTRACT
NUMBER TITLE
PD46-01 COMPARISON OF RADIATION DOSAGES
BETWEEN CT-GUIDED AND
ULTRASOUND-FACILITATED CT-GUIDED
PERCUTANEOUS CRYOABLATION OF
SMALL RENAL CORTICAL NEOPLASMS
Rahul Dutta*, Kamaljot Kaler, Simone L
Vernez, Zhamshid Okhunov, Ramy F
Youssef, Jaime Landman, Kari Nelson,
Orange, CA
8:10
PD46-02
INITIAL CLINICAL EXPERIENCE WITH
PERCUTANEOUS IRREVERSIBLE
ELECTROPORATION OF RENAL TUMORS
Noah Canvasser*, Aaron Lay, Monica Morgan,
Asim Ozayar, Jeffrey Gahan, Clayton Trimmer,
Jeffrey Cadeddu, Dallas, TX
8:20
PD46-03
EVALUATION OF SKIN-TO-TUMOR
DISTANCE AS A PREDICTOR OF TUMOR
RECURRENCE FOLLOWING
PERCUTANEOUS CRYOABLATION OF
RENAL CORTICAL NEOPLASMS
Simone L Vernez*, Zhamshid Okhunov,
Rahul Dutta, Kamaljot Kaler, Orange, CA,
Arvin George, Daniel Moreira, Louis
Kavoussi, New Hyde Park, NY, Ralph V
Clayman, Jaime Landman, Orange, CA
8:30
8:40
8:50
PD46-04
PD46-05
PD46-06
*Presenting author
ABSTRACT
TIME NUMBER TITLE
9:00 PD46-07 A NOVEL APPROACH TO DIFFERENTIATE
CHROMOPHOBE RENAL CELL
CARCINOMA FROM ONCOCYTOMA WITH
THE AID OF RADIOGRAPHIC
ENHANCEMENT
Jay Amin*, Shervin Badkhshan, Terry
Creighton, Daniel Abbotoy, Christine
Murekeyisoni, Bo Xu, Thomas Schwaab, Eric
Kauffman, Buffalo, NY
COMPARING OUTCOMES FOR
PERCUTANEOUS MICROWAVE
ABLATION, CRYOABLATION AND
SURGERY FOR TREATMENT OF
SPORADIC RCC < 4CM
Matthew D. Grimes*, Tyler A. Wittmann, Sara
L. Best, J. Louis Hinshaw, Fred T. Lee, Jr.,
Meghan G. Lubner, Timothy J. Ziemlewicz,
Shane A. Wells, Stephen Y. Nakada, E.
Jason Abel, Madison, WI
SALVAGE PERCUTANEOUS
CRYOABLATION FOR LOCALLY
RECURRENT RENAL CELL CARCINOMA
AFTER PRIMARY CRYOABLATION
Zhamshid Okhunov*, Joshua Chamberlin, Daniel
M. Moreira, Orange, CA, Arvin George, Long
Island, NY, Kamaljot Kaler, Ramy Youssef,
Orange, CA, Louis Kavoussi, Long Island, NY,
NANOTECHNOLOGY COMBINATION
THERAPY FOR RENAL CELL CARCINOMA:
GOLD NANORODS BOUND WITH
TYROSINE KINASE INHIBITOR
PRODUCES SYNERGISTIC TREATMENT
RESPONSE WHEN COMBINED WITH
LASER THERMAL ABLATION IN AN
ANIMAL MODEL
Weil Lai*, Caleb Abshire, Sree Harsha
Mandava, Connor Carry, James Liu, Andrew
Gabrielson, Matthew Tarr, Benjamin Lee,
New Orleans, LA
9:10
PD46-08
FACTORS THAT PREDICT GROWTH
KINETICS IN SOLID SMALL RENAL
MASSES (<4CM) ON ACTIVE
SURVEILLANCE
Catherine Paterson*, Yew-Fung Chin, Clare
Sweeney, Dundee, United Kingdom, Michael
Jewett, Toronto, Canada, Ghulam Nabi,
Dundee, United Kingdom
9:20
PD46-09
HOW TO BALANCE THE RISK OF CANCER
SPECIFIC MORTALITY AND OTHER
CAUSE MORTALITY IN THE DECISION
BETWEEN SURGERY OR OBSERVATION
FOR PATIENTS WITH T1 KIDNEY CANCER
Alessandro Larcher, Vincent Trudeau*,
Montreal, Canada, Paolo Dell’Oglio, Milan,
Italy, Katharina Boehm, Hamburg, Germany,
Zhe Tian, Montreal, Canada, Nicola Fossati,
New York, NY, Umberto Capitanio, Alberto
Briganti, Francesco Montorsi, Milan, Italy,
Pierre Karakiewicz, Montreal, Canada
9:30
PD46-10
DEVELOPING AN OBJECTIVE SCORING
SYSTEM TO STRATIFY PATIENTS WITH
SMALL RENAL MASSES INTO THOSE
MOST SUITABLE FOR PRIMARY
TREATMENT AND ACTIVE
SURVEILLANCE
Ayodeji E. Sotimehin*, Mark Riffon, Mark W.
Ball, Michael A. Gorin, Michael H. Johnson,
Christian P. Pavlovich, Mohammad E. Allaf,
Phillip M. Pierorazio, Baltimore, MD
9:40
PD46-11
ACTIVE SURVEILLANCE OF RENAL
MASSES – THE MEMORIAL SLOANKETTERING EXPERIENCE
Nick Liu*, Cheryn Song, Katie Murray, Alan
Thong, Paul Russo, Jonathan Coleman, New
York City, NY
9:50
PD46-12
OFFICE BASED ULTRASOUND GUIDED
RENAL CORE BIOPSY IS SAFE AND
EFFICACIOUS IN THE MANAGEMENT OF
SMALL RENAL MASSES
Chirag Dave*, Brian Seifman, Rene Frontera,
Ryan Nelson, Heather Crossley, Travis
Washington, Preston Kerr, Edward Schervish,
Royal Oak, MI
CREDITTM
287
TUESDAY
TIME
8:00
10:30 am - 12:30 pm
BLADDER CANCER: BASIC RESEARCH & PATHOPHYSIOLOGY V
Moderators: Neema Navai and Vinata Lokeshwar
ABSTRACT
NUMBER TITLE
MP88-01 DUAL TUMOR-SUPPRESSORS MIR-1395P/-3P DERIVED FROM PRE-MIR-139 VIA
TARGETING MATRIX
METALLOPROTEASE 11 (MMP11) IN
BLADDER CANCER
Masaya Yonemori*, Kagoshima, Japan,
Naohiko Seki, Chiba, Japan, Ryosuke
Matsushita, Kazutaka Miyamoto, Hirofumi
Yoshino, Kagoshima, Japan, Yusuke Goto,
Mayuko Kato, Akira Kurozumi, Chiba, Japan,
Masayuki Nakagawa, Hideki Enokida,
Kagoshima, Japan
ABSTRACT
NUMBER TITLE
MP88-07 RSPH9 METHYLATION PATTERN AS A
PROGNOSTIC INDICATOR IN PATIENTS
WITH NON-MUSCLE INVASIVE BLADDER
CANCER
Yong-June Kim*, Ho-Won Kang, Sung Phil
Seo, Cheonju, Korea, Republic of, Hoon
Jang, Daejeon, Korea, Republic of,
Tongwook Kim, Cheongju, Korea, Republic
of, Won Tae Kim, Seok Joong Yun, SangCheol Lee, Wun-Jae Kim, Cheonju, Korea,
Republic of
MP88-08 GPX2 HAS THERAPEUTIC POTENTIAL
THROUGH THE REGULATION OF
OXIDATIVE STRESS IN BLADDER
CANCER
Taku Naiki*, Aya Naiki-Ito, Toshiki Etani,
Keitaro Iida, Ryosuke Ando, Noriyasu Kawai,
Kenjiro Kohri, Satoru Takahashi, Takahiro
MP88-02 EXPRESSION OF FORKHEAD BOX P3 IN
BLADDER CANCER CELLS MODULATES
SENSITIVITY TO HISTONE DEACETYLASE
INHIBITORS
Kris Prado*, Hanwei Zhang, Arnold Chin, Los
Angeles, CA
MP88-03 POTENTIAL ROLE OF G1P3 IN
DEVELOPMENT OF CHEMORESISTANCE
IN HIGH GRADE BLADDER CANCER
Syed Alam*, Dharamainder Choudhary,
Farmington, CT, Garrett Dancik, Willimantic,
CT, Carol Pilbeam, John Taylor, III,
Farmington, CT
MP88-09 PRECLINICAL MODEL OF DUAL-SPECIFIC,
MTOR COMPLEX 1 (TORC1) AND MTOR
COMPLEX 2 (TORC2) INHIBITORS FOR
BLADDER CANCER TREATMENT
Vladimir A. Valera*, Sensuke Konno,
Muhammad Choudhury, John L. Phillips,
Valhalla, NY
MP88-04 ANTI-TUMOR EFFECT OF NEW TYROSIN
KINASE INHIBITORS (BOSUTINIB,
NINTEDANIB, VATALANIB) IN HUMAN
Kwangmo Kim*, Beyong do Song, JinNyoung Ho, Jong Jin Oh, Sung Kyu Hong,
Sang Eun Lee, Seok-Soo Byun, Sang Chul
Lee, Seong-Jin Jeong, Seongnam, Korea,
Republic of
MP88-05
MP88-10 DIFFERENTIATION BETWEEN NORMAL
AND CANCEROUS HUMAN UROTHELIAL
CELL LINES USING REAL-TIME MICROELECTRICAL IMPEDANCE
SPECTROSCOPY AT AN OPTIMAL
FREQUENCY
Hyeon Woo Kim*, Yangkyu Park, Joho Yun,
Gwangju, Korea, Republic of, Dong Gil Shin,
Jeong Zoo Lee, Busan, Korea, Republic of,
Jong-Hyun Lee, Gwangju, Korea, Republic of,
Wan Lee, Chang Yell Lee, Busan, Korea,
Republic of
OSTEOPONTIN – A POTENTIAL MARKER
FOR CHEMOTHERAPY RESISTANCE IN
BLADDER CANCER
Nora Gibson*, Dharamainder Choudhary,
Carol Pilbeam, John Taylor, III, Farmington,
CT
MP88-11 THERAPEUTIC EFFECTS OF A
MICRORNA-21 CHEMICAL INHIBITOR ON
BLADDER CANCER PRECLINICAL
MODELS
Alexandra Drakaki*, Neil O’Brien, Christina
Vorvis, Dimitrios Iliopoulos, Dennis Slamon,
Los Angeles, Ca
MP88-06 ANTICANCER AND CHEMOSENSITIZING
EFFECTS OF 2-DEOXYGLUCOSE
TARGETING GLYCOLYSIS IN HUMAN
Vladimir Valera*, Derek Prabharasuth,
Jonathan Bloom, John Phillips, Muhammad
Choudhury, Sensuke Konno, Valhalla, NY
MP88-12 HIGHLY SENSITIVE AND SPECIFIC NOVEL
BIOMARKERS FOR THE DIAGNOSIS OF
TRANSITIONAL BLADDER CARCINOMA
Hong Koo Ha*, PUSAN, Korea, Republic of,
Prashant Kumar, Sayantani Nandi, Tuan Zea
Tan, Siok Ghee Ler, Kee Seng Chia, WeiYen Lim, singapore, Singapore, Ja Yoon Ku,
Chan Ho Lee, Kyung Lee, Kyoung Hwan
Kim, Seung Ryong Baek, Hyo Jung Park,
Jeong Zoo Lee, PUSAN, Korea, Republic of,
Jean Paul Thiery, singapore, Singapore
288
MP88-13 MUTATIONAL LANDSCAPE OF PRIMARY
BLADDER AND URACHAL
ADENOCARCINOMA
Byron Lee*, Emmet Jordan, Helen Won,
Aditya Bagrodia, Neil Desai, Dean Bajorin,
Jonathan Rosenberg, Bernard Bochner,
Wonkyu Kim, Michael Berger, David Solit,
Hikmat Al-Ahmadie, Gopa Iyer, New York,
NY
MP88-17 IMMUNOHISTOCHEMISTRY OF
ANDROGEN RECEPTOR AND ESTROGEN
RECEPTOR-〉 IN BLADDER CANCER AS
PREDICTORS OF CHEMOSENSITIVITY
Eiji Kashiwagi*, Hiroki Ide, Takashi
Kawahara, Satoshi Inoue, Mehsa Jalalizadeh,
George Netto, Alexander Baras, Hiroshi
Miyamoto, Baltimore, MD
MP88-18 HYAL4: A MOLECULAR MARKER AND
DETERMINANT OF BLADDER CANCER
PROGRESSION
Martin J. P. Hennig*, Lübeck, Germany,
Soum D. Lokeshwar, Miami, FL, Shenelle N.
Wilson, Augusta, GA, Judith Knapp, Marie C.
Hupe, Lübeck, Germany, Andre R. Jordan,
Murugesan Manoharan, Miami, FL, Mario W.
Kramer, Axel S. Merseburger, Lübeck,
Germany, Luis E. Lopez, Vinata B.
Lokeshwar, Augusta, GA
MP88-14 ROLE OF STEROID HORMONE
RECEPTORS IN FORMATION AND
PROGRESSION OF BLADDER
CARCINOMA: A CASE-CONTROL STUDY
Gholamreza Pourmand*, Rahil Mashhadi,
Farid Kosari, Abdolrasoul Mehrsai, Sepehr
Salem, Mohammad Reza Pourmand,
Sudabeh Alatab, Mehdi Khonsari, Fariba
Heydari, Laleh Beladi, Farimah Alizadeh,
Tehran, Islamic Republic of Iran
LOW EXPRESSION OF TOLL LIKE
RECEPTOR 4 IS ASSOCIATED WITH
SQUAMOUS DIFFERENTIATION IN
BLADDER CANCER
Terumichi Shintani*, Kei Daizumoto, Kento
Hirayama, Dondoo Tsogt-Ochir, Megumi
Tsuda, Yoshito Kusuhara, Hidehisa Mori,
Junichiro Kagawa, Tomoya Fukawa, Yasuyo
Yamamoto, Kunihisa Yamaguchi, Tomoharu
Fukumori, Masayuki Takahashi, Hiro-omi
Kanayama, Tokushima, Japan
MP88-19 URINARY MICROBIOME PATTERNS
APPEARS TO BE CORRELATIVE TO
INTRAVESICAL RECURRENCE OF NONMUSCLE INVASIVE BLADDER CANCER
Yige Bao*, Chengdu, China, People’s
Republic of, Hassan Razvi, Gregory Gloor,
Gregor Reid, John Denstedt, Jeremy Burton,
London, Canada
MP88-20 EVALUATION OF THE BIOLOGICAL BASIS
OF UROTHELIAL CARCINOMA WITH
SQUAMOUS DIFFERENTIATION
Thomas Sanford*, Maxwell Meng, Sima
Porten, San Francisco, CA
MP88-16 ROLE OF GLUCOCORTICOID RECEPTOR
(GR) SIGNALING IN UROTHELIAL
TUMORIGENESIS: INHIBITION BY
COMPOUND A (CPDA) VIA BOTH GR AND
ANDROGEN RECEPTOR (AR) PATHWAYS
Hiroki Ide*, Satoshi Inoue, Yichun Zheng, Eiji
Kashiwagi, Takashi Kawahara, Hiroshi
Miyamoto, Baltimore, MD
CREDITTM
10:30 am - 12:30 pm
SEXUAL FUNCTION/DYSFUNCTION: BASIC RESEARCH & PATHOPHYSIOLOGY II
Moderators: Tom Lue and Run Wang
ABSTRACT
NUMBER TITLE
MP89-01 VASOHIBIN-1 IS A NOVEL THERAPEUTIC
TARGET FOR DIABETIC ERECTILE
DYSFUNCTION IN MICE
Woo Jean Kim, Kang-Moon Song, Jin-Mi
Park, Anita Limanjaya, Kalyan Ghatak,
Nguyen Nhat Minh, Soo-Hwan Park, WonHee Park, Jiyeon Ock, Guo Nan Yin, Ji-Kan
Ryu*, Jun-Kyu Suh, Incheon, Korea, Republic
of, In Rae Cho, Gyunggido, Korea, Republic
of
*Presenting author
ABSTRACT
NUMBER TITLE
MP89-02 IS THERE A NON-HORMONAL
MECHANISM IN THE DIABETES-INDUCED
DYSFUNCTION OF THE VASA
DEFERENTIA IN THE RAT?
Panagiota Tsounapi*, Masashi Honda,
Yonago, Japan, Fotios Dimitriadis, Ioannina,
Greece, Shogo Shimizu, Nankoku, Japan,
Bunya Kawamoto, Michiyo Iguchi, Masaki
Imanishi, Shinji Matsunaga, Katsuya Hikita,
Kuniyasu Muraoka, Takehiro Sejima, Yonago,
Japan, Motoaki Saito, Nankoku, Japan,
Shuhei Tomita, Yonago, Japan, Nikolaos
Sofikitis, Ioannina, Greece, Atsushi
Takenaka, Yonago, Japan
289
TUESDAY
MP88-15
MP89-03 LOCAL DELIVERY OF RECOMBINANT
HUMAN HEPATOCYTE GROWTH FACTOR
PROTEIN RESCUES ERECTILE FUNCTION
BY ENHANCING CAVERNOUS
ANGIOGENESIS IN DIABETIC MOUSE
Nando Dulal Das, Min Ji Choi, Mi-Hye Kwon,
Anita Limanjaya, Kalyan Ghatak, Nguyen
Nhat Minh, Kang-Moon Song, Soo-Hwan
Park*, Won Hee Park, Guo Nan Yin, Ji-Kan
Ryu, Jun-Kyu Suh, Incheon, Korea, Republic
of
MP89-10 CAVEOLIN REGULATION OF PENILE
HEMODYNAMICS: POSSIBLE ROLE IN
Jay Parikh*, Dimosthenis Giamouridis, TungChin (Mike) Hsieh, Jan Schilling, Valmik
Bhargava, Hemal Patel, M. Raj Rajasekaran,
San Diego, CA
MP89-11 PKA AGONIST COLFORSIN PRESERVES
ERECTILE FUNCTION AND PROMOTES
NNOS SIGNALING IN THE PENIS AND
MAJOR PELVIC GANGLIA IN CAVERNOUS
NERVE INJURY RAT MODEL
Serkan Karakus*, Biljana Musicki, Justin La
Favor, Arthur Burnett, Baltimore, MD
MP89-04 CF602 IMPROVES ERECTILE
DYSFUNCTION IN DIABETIC RATS
Shira Cohen*, Pnina Fishman, Petach Tikva,
Israel
MP89-05
MP89-12 NEUROTROPHIC EFFECT OF ADIPOSE
TISSUE-DERIVED STEM CELLS ON
ERECTILE FUNCTION RECOVERY BY
PIGMENT EPITHELIUM-DERIVED FACTOR
SECRETION IN A RAT MODEL OF
CAVERNOUS NERVE INJURY
Xin Chen*, Qiyun Yang, Guihua Liu, Chunhua
Deng, Guangzhou, China, People’s Republic
of
EFFECT OF ICARISIDE II ON MIR-126
PATHWAY ON HUMAN CAVERNOUS
ENDOTHELIAL CELLS EXPOSED TO A
DIABETIC-LIKE ENVIRONMENT
Ruili Guan, Hongen Lei, Bicheng Yang,
Zhezhu Gao, Lin Wang, Huixi Li, Zhongcheng
Xin*, Beijing, China, People’s Republic of
MP89-06 THERAPEUTIC EFFECTS OF ADIPOSEDERIVED STEM CELLS-BASED MICROTISSUES ON ERECTILE DYSFUNCTION IN
STREPTOZOTOCIN-INDUCED DIABETIC
RATS
Bicheng Yang, Yu Hui, Hongen Lei, Ruili
Guan, Zhezhu Gao, Zhongcheng Xin*,
MP89-13 DIAGNOSTICS OF PENILE
MICROCIRCULATION DISORDERS IN
PATIENTS WITH VASCULOGENIC
Dmitry Kurbatov, Moscow, Russian
Federation, Roman Aliev*, Ruslan Aliev,
Barnaul, Russian Federation
MP89-07 THE MECHANISMS OF NANOPARTICLE
IMPROVING ADIPOSE DERIVED STEM
CELLS THERAPY FOR ERECTILE
DYSFUNCTON
Haocheng Lin*, beijing, China, People’s
Republic of, Nadeem Dhanani, Hubert Tseng,
Glauco Souza, Grace Wang, Yanna Cao,
Tien Ko, Houston, TX, Hui Jiang, beijing,
China, People’s Republic of, Run Wang,
Houston, TX
MP89-14 CATEGORY III PROSTATITIS AFFECT
PREMATURE EJACULATION THROUGH
BRAIN AND SPINAL CORD SEROTONIN
SYSTEM: A PRELIMINARY STUDY
Yadong Zhang*, Tao Zheng, Xiangan Tu,
Qiyun Yang, Kunlong Lv, Minkuan Zhou, Kai
Xia, Xiangzhou Sun, Chunhua Deng,
Guangzhou City, China, People’s Republic of
MP89-15
MP89-08 POST-FINASTERIDE SYNDROME: REAL
OR IMAGINED?
Michael Butcher, Wesley Baas*, Aye Lwin,
Bradley Holland, Michelle Herberts, Joseph
Clemons, Kristin Delfino, Springfield, IL,
Stanley E Althof, West Palm Beach, FL,
Tobias S Kohler, Kevin T McVary, Springfield,
IL
MP89-09 STROMAL DERIVED FACTOR-1
TREATMENT AUGMENTS NERVE
REGENERATION VIA CXCR4 ACTIVATION
OF NEUROTROPHIC FACTORS IN THE
MAJOR PELVIC GANGLION IN A DOSEDEPENDENT FASHION
Nikolai Sopko*, Hotaka Matsui, Max Kates,
Denver Lough, Xiaopu Liu, Baltimore, MD,
Emmanuel Weyne, Maarten Albersen,
Leuven, Belgium, Kenneth Pienta, Trinity
Bivalacqua, Baltimore, MD
INHIBITION OF JUN N-TERMINAL KINASE
RESTORES ERECTILE FUNCTION BY
SUPPRESSION OF CORPORAL
APOPTOSIS IN A RAT MODEL OF
CAVERNOUS NERVE INJURY
Jung Kwon Kim*, Juhyun Park, Gyoo Hwan
Jung, Won Hoon Song, Byung Soo Kim, Ho
Young Ryu, Sang Heon Lee, Sung Yong
Cho, Min Chul Cho, Kwanjin Park,
Hwancheol Son, Hyeon Jeong, Soo Woong
Kim, Jae-Seung Paick, Seoul, Korea,
Republic of
MP89-16 INCREASE IN TNF-ALPHA LEADS TO
APOPTOSIS OF NITRERGIC NEURONS IN
MAJOR PELVIC GANGLION AFTER
BILATERAL CAVERNOUS NERVE INJURY
Hotaka Matsui*, Nikolai A. Sopko, Baltimore,
MD, Johanna L. Hannan, Greenville, NC,
Allison A. Reinhardt, Ripon, WI, Emmanuel
Weyne, Leuven, Belgium, Max Kates, Xiaopu
Liu, Baltimore, MD, Maarten Albersen,
Leuven, Belgium, Trinity J. Bivalacqua,
Baltimore, MD
290
MP89-17 NEUROTOXIC M1 MACROPHAGES ARE
PREDOMINANTLY RECRUITED TO MAJOR
PELVIC GANGLION FOLLOWING
BILATERAL CAVERNOUS NERVE INJURY,
LEADING TO IMPAIRED
PARASYMPATHETIC-MEDIATED
RELAXATION OF CORPUS CAVERNOSUM
Hotaka Matsui*, Nikolai A. Sopko, Baltimore,
MD, Johanna L. Hannan, Greenville, NC,
Allison A. Reinhardt, Ripon, WI, Xiaopu Liu,
Max Kates, Baltimore, MD, Emmanuel
Weyne, Maarten Albersen, Leuven, Belgium,
Trinity J. Bivalacqua, Baltimore, MD
MP89-19 ALTERED CAVEOLIN EXPRESSION IN
DIABETIC PENIS: POSSIBLE ROLE IN
M. Raj Rajasekaran*, Johnny Fu, Adam
Kassan, Alice Zemljic-Harpf, Valmik
Bhargava, San Diego, CA, Karnam S Murthy,
Richmond, VA, Hemal Patel, San Diego, CA
MP89-20 TRACTION APPLIED TO PEYRONIE’S
DISEASE CELLS REDUCES CELLULAR
FIBROSIS
Jeffrey Campbell*, Ling DeYoung, Eric
Chung, Gerald Brock, London, Canada
CREDITTM
MP89-18 ERECTILE FUNCTION CHANGES IN
PATIENTS ENROLLED IN AN ACTIVE
SURVEILLANCE PROGRAM FOR
PROSTATE CANCER
Lawrence C. Jenkins, James A. Eastham,
Peter T. Scardino, Christian J. Nelson, John
P. Mulhall*, New York, NY
10:30 am - 12:30 pm
ABSTRACT
NUMBER TITLE
MP90-01 SERUM CHOLESTEROL LEVELS IMPACT
TUMOR PROGRESSION IN A PTENDEFICIENT TRANSGENIC MOUSE MODEL
OF PROSTATE CANCER
Emma Allott, Chapel Hill, NC, Elizabeth
Masko, Durham, NC, Everardo Macias, Los
Angeles, CA, Kristine Pelton, Keith Solomon,
Boston, MA, Elahe Mostaghel, Seattle, WA,
George Thomas, Portland, OR, Michael
Freeman, Los Angeles, CA, Salvadore Pizzo,
Durham, NC, Stephen Freedland*, Los
Angeles, CA
ABSTRACT
NUMBER TITLE
MP90-04 A ROLE FOR HISTONE DEMETHYALASE
JMJD1A IN THE DNA DAMAGE
RESPONSE OF PROSTATE CANCER
CELLS
Lingling Fan, Guihong Peng, Baltimore, MD,
Natasha Sahgal, London, United Kingdom,
Ladan Fazli, Martin Gleave, Vancouver,
Canada, Yuji Zhang, Baltimroe, MD, Arif
Hussain, Feyruz Rassool, jianfei qi*,
Baltimore, MD
MP90-05
MP90-02 CARBOHYDRATE RESTRICTION
OPPOSES TUMOR-PROMOTING EFFECTS
OF OBESITY IN THE HI-MYC TRANSGENIC
MOUSE MODEL OF PROSTATE CANCER.
Emma Allott, Chapel Hill, NC, Everardo
Macias, Los Angeles, CA, George Thomas,
Portland, OR, Stephen Hursting, Chapel Hill,
NC, Stephen Freedland*, Los Angeles, CA
MP90-03 REACTIVE OXYGEN SPECIES INDUCTION
BY CABAZITAXEL VIA INHIBITION OF
THE SESTRIN FAMILY IN CASTRATIONRESISTANT PROSTATE CANCER
Takeo Kosaka*, Hiroshi Hongo, Yasumasa
Miyazaki, Eiji Kikuchi, Akira Miyajima,
*Presenting author
291
PROSTATE CANCER GENE EXPRESSION
SIGNATURES ASSOCIATED WITH
CAPSULE AND SEMINAL VESICLE
INVASION AND BIOCHEMICAL
RECURRENCE AFTER RADICAL
PROSTATECTOMY
Travis Allemang*, Norfolk, VA, Michael
Williams, Virginia Beach, VA, Shilpa Katta,
Gyorgy Petrovics, Rockville, MD, Inger
Rosner, Rockville, MD, Albert Dobi,
Rockville, MD
TUESDAY
PROSTATE CANCER: BASIC RESEARCH & PATHOPHYSIOLOGY IV
Moderators: Mark Garzotto and Christopher Evans
MP90-06 FULL EXOME SEQUENCING, COPY
NUMBER VARIATION AND
TRANSCRIPTOME ANALYSES REVEALS
DIVERSITY AND MUTATIONAL
EVOLUTION IN A LONGITUDINAL SERIES
OF SURGICAL PROSTATE CANCER BONE
METASTASES FROM A PATIENT WITH
PROGRESSIVELY THERAPY-RESISTANT
CANCER
Christina Jamieson*, Michelle Muldong, La
Jolla, CA, Michael A. Liss, San Antonio, TX,
Seung Chol Park, Iksan, Korea, Republic of,
Theresa Mendoza, Abigail Gallegos, Lee
Edsall, Unwanaobong Nseyo, Olga
Miakicheva, Brittany Burton, Danielle Burner,
Amy Strasner, Christopher J. Kane, Anna A.
Kulidjian, Theresa Gaasterland, La Jolla, CA
MP90-12 INHERITED RISK FOR OTHER TYPES OF
CANCER AMONG MEN WITH OR WITHOUT
PROSTATE CANCER BASED ON THE
GENETIC RISK SCORE
Deke Jiang*, Evanston, IL, Haitao Chen,
Shanghai, China, People’s Republic of, Brian
Helfand, Carly Conran, S.Lilly Zheng, Charles
Brendler, Jianfeng Xu, Evanston, IL
MP90-13 CIRCULATING TUMOR CELLS-DERIVED
PATIENT XENOGRAFTS: A NOVEL
APPROACH TO STUDY PROSTATE
CANCER LETHAL PROGRESSION
Gina C. Y. Chu*, Ruoxiang Wang, Haiyen E.
Zhau, Edwin M. Posadas, Leland W. K.
Chung, Los Angeles, CA
MP90-14 DISTINCT BIOLOGICAL FEATURES OF
PROSTATE TUMORS IN THE CONTEXT OF
RACE/ETHNICITY AND ERG STATUS
Jennifer Cullen*, Denise Young, Yongmei
Chen, Michael Degon, Wagner Baptist,
James Farrell, Jason Sedarsky, Claire HuaiChing Kuo, Rockville, MD, Jacob Kagan,
Sudhir Srivastava, Bethesda, MD, Inger
Rosner, Gyorgy Petrovics, Albert Dobi, David
McLeod, Shiv Srivastava, Rockville, MD,
Isabell Sesterhenn, Silver Spring, MD
MP90-07 THE PHENOMENON OF EPITHELIALMESENCHYMAL TRANSITION IS
ASSOCIATED WITH THE PROGRESSION
OF PROSTATE CANCER
Jose Pontes, Jr.*, Rafael Coelho, Mauricio
Cordeiro, Giuliano Betoni, Luiz Oliveira,
Sabrina Reis, Katia Leite, Miguel Srougi,
William Nahas, Sao Paulo, Brazil
MP90-08 THE RELATIONSHIP OF B7H3
EXPRESSION TO ANDROGEN AND
PROSTATE CANCER OUTCOMES IN A
LARGE NATURAL HISTORY COHORT OF
MEN UNDERGOING PROSTATECTOMY
Benjamin Benzon, Baltimore, MD, George
(Shuang) Zhao, Dearborn, MI, Michael
Haffner, Baltimore, MD, Mandeep Takhar,
Nicholas Erho, Kasra Yousefi, Vancouver,
Canada, Paula Hurley, Jennifer Bishop,
Jeffrey Tosoian, Kamyar Ghabili, Kamyar
Ghabili, Baltimore, MD, Mohammed
Alshalalfa, Vancouver, Canada, Stephanie
Glavaris, Brian Simons, Phuoc Tran,
Baltimore, MD, Elai Davicioni, Vancouver,
Canada, R. Jeffrey Karnes, Rochester, MN,
Edward Schaeffer, Chicago, IL, Charles
Drake, Baltimore, MD, Felix Feng, Ann Arbor,
MI, Ashley Ross*, Baltimore, MD
MP90-15
GALECTIN-3 IS IMPLICATED IN THE
PROGRESSION OF CASTRATIONRESISTANT PROSTATE CANCER
THROUGH THE REGULATION OF
ANGIOGENESIS AND ANDROGEN
RECEPTOR SIGNALING
Tomoharu Fukumori*, Kei Daizumoto,
Dondoo Tsogt-Ochir, Yasuyo Yamamoto,
Kunihisa Yamaguchi, Masayuki Takahashi,
Hiro-omi Kanayama, Tokushima, Japan
MP90-16 THE ROLE OF PARP2 IN PROSTATE
CANCER GROWTH AND PROGRESSION
Bin Gui, Adam Kibel, Li Jia*, Boston, MA
PREOPERATIVE MEMBRANOUS
URETHRAL LENGTH AND TIME TO
ACHIEVE CONTINENCE AFTER RADICAL
PROSTATECTOMY: A SYSTEMATIC
REVIEW WITH META ANALYSIS
Sean Mungovan*, Westmead, Australia,
Jaspreet Sandhu, Oguz Akin, New York, NY,
Neil Smart, Westmead, Australia, Petra
Graham, Manish Patel, Sydney, Australia
MP90-09 A NEW STRATEGY FOR THE TREATMENT
OF PROSTATE CANCER BY TARGETING
VASOHIBIN-2
Yasumasa Miyazaki*, Takeo Kosaka, Shuji
Mikami, Yota Yasumizu, Nobuyuki Tanaka,
Eiji Kikuchi, Akira Miyajima, Tokyo, Japan,
Yasufumi Sato, Sendai, Japan, Mototsugu
Oya, Tokyo, Japan
MP90-18 SIGNALING PATHWAYS IN HUMAN
PROSTATE CARCINOGENESIS:
DIFFERENTIAL PROTEIN EXPRESSION
PATTERNS BETWEEN NORMAL AND
CANCER TISSUES
Antonio Patricio*, Joana Silva, Juliana
Felgueiras, Aveiro, Portugal, Steven Pelech,
Vancouver, Canada, Nuno Maia, Saul
Almeida, Joao Lourenço, Margarida Fardilha,
Aveiro, Portugal
MP90-10 SERUM TESTOSTERONE LEVELS PRIOR
TO PROSTATE CANCER DIAGNOSIS
Jen-Jane Liu*, Portland, OR, H. Ballentine
Carter, Edward Schaeffer, Baltimore, MD
MP90-11 INDUCTION OF NEUROENDOCRINE
DIFFERENTIATION IN PROSTATE
CANCER CELLS BY DOVITINIB (TKI-258)
AND ITS ASSOCIATED THERAPEUTIC
IMPLICATIONS
Shalini S Yadav*, Jinyi Li, Bryan Herzog,
Jennifer Stockert, James O’Connor, Luis
Garzon Manco, Cordelia Elaiho, Kenneth
Haines, Ashutosh K Tewari, Kamlesh K
Yadav, New York, NY
292
MP90-19 EXPRESSION OF MTOR PATHWAY
PARAMETERS IN PROSTATE CANCER
SHOWS SIGNIFICANT INTRATUMORAL
HETEROGENEITY
Moritz Schanz*, Jörg Hennenlotter, Johannes
Dlugosch, Ursula Kuehs, Tübingen, Germany,
Matthias Dettmer, Bern, Switzerland, David
Schilling, München, Germany, Christian
Schwentner, Arnulf Stenzl, Tilman
Todenhöfer, Tübingen, Germany
MP90-20 IMPLICATIONS OF SOX2 STAINING IN
HIGH GRADE PROSTATE CANCER AND
PELVIC LYMPH NODE METASTASES
REMOVED AT RADICAL
PROSTATECTOMY
Blake Anderson*, Charles Nottingham,
Steven Kregel, Gregory Zagaja, Gladell
Paner, Donald Vander Griend, Chicago, IL
CREDITTM
10:30 am - 12:30 pm
INFERTILITY: EPIDEMIOLOGY & EVALUATION
Moderators: Larry Lipshultz and Raymond Costabile
ABSTRACT
NUMBER TITLE
MP91-08 TRANSCRIPTOME ANALYSIS OF
TESTICULAR TISSUES IN MEN WITH
NON-OBSTRUCTIVE AZOOSPERMIA WITH
VARICOCELE AND PREDICTIVE FACTORS
OF SPERM RECOVERY AFTER
VARICOCELECTOMY
Koji Shiraishi*, Shintaro Oka, Hideyasu
Matsuyama, Ube, Japan
MP91-02 LOWER COGNITIVE FUNCTION IS
ASSOCIATED WITH MALE INFERTILITY
Alexander W. Pastuszak*, Peter R. Butler,
Stephen R. McCauley, Dolores J. Lamb,
Larry I. Lipshultz, Houston, TX
MP91-09 DO TESTICLES INVOLVED WITH GERMCELL TUMORS CONTRIBUTE TO
FERTILITY?
Igal Shpunt*, Uri Lindner, Sergey Ikher,
Alexey Kovalyonok, Yuval Avda, Morad
Jaber, Abraham Bercovich, Dan Leibovici,
Rehovot, Israel
MP91-03 INCREASED RISK OF AUTOIMMUNE
DISORDERS IN INFERTILE MEN:
ANALYSIS OF U.S. CLAIMS DATA
William D. Brubaker*, Shufeng Li, Laurence
C. Baker, Michael L. Eisenberg, Stanford, CA
MP91-10 THE EARLY AND LATE EFFECTS OF
CANCER ON MALE FERTILITY
Saad Abumelha*, Chris Poullis, Fahad Al
Mashat, Tet Yap, Elizabeth Williamson, David
Ralph, Suks Minhas, London, United
Kingdom
MP91-04 HEALTH-RELEVANT AND CORRECTABLE
PATHOLOGY IN INFERTILE MEN WITH
NORMAL AND ABNORMAL SEMEN
PARAMETERS
Christopher Gaffney*, Matthew Pagano, Peter
Stahl, New York, NY
MP91-05
MP91-11 REPRODUCTIVE KNOWLEDGE AND
ATTITUDES OF PATIENTS UNDERGOING
Nelson Bennett, Jr.*, Burlington, MA,
Alexander Muller, Zurich, Switzerland,
Patricia Guhring, John Mulhall, New York, NY
DO ALCOHOL, SMOKING AND MALE AGE
AFFECT SEMEN PARAMETERS AND IVF/
ICSI OUTCOMES?
Fahad AlMashat*, Saad Abumelha, Chris
Poullis, Tet Yap, Nagla Rushwan, Hossam
Abdalla, Meen Yau Thum, Suks Minhas,
MP91-12 VASECTOMY AND RISK OF PROSTATE
CANCER IN A SCREENING TRIAL
Jonathan Shoag*, Sameer Mittal, Joshua
Halpern, New York, NY, Daniel Shoag,
Cambridge, MA, Daniel Lee, Padraic
O’Malley, Bobby Najari, New York, NY, Brian
Eisner, Boston, MA, Jim Hu, Douglas Scherr,
Peter Schlegel, Christopher Barbieri, New
York, NY
MP91-06 VARICOCELES ARE ASSOCIATED WITH
INCREASED RISK OF CARDIAC DISEASE
AND OTHER COMORBIDITIES: AN
ANALYSIS OF U.S. CLAIMS DATA
Kai B. Dallas*, Nancy N. Wang, ShuFeng Li,
Laurence C. Baker, Michael Eisenberg,
Stanford, CA
MP91-13 MARKETSCAN® EVALUATION OF
VASECTOMY TRENDS IN THE UNITED
STATES
Kevin Ostrowski*, Sarah Holt, Brandon
Haynes, Seattle, WA, Eugene Fuchs,
Portland, OR, Tom Walsh, Seattle, WA
MP91-07 FERTILITY IN PROFESSIONAL SOLDIERS
POPULATION WITH VARICOCELE
Guy Verhovsky*, Zerifin, Israel, Amnon
Zisman, Zerifin, Israel
*Presenting author
293
TUESDAY
ABSTRACT
NUMBER TITLE
MP91-01 THE NOVEL SCREENING METHOD FOR
MALE INFERTILITY WITH SINGLE-BALL
LENS MICROSCOPE AND SMARTPHONE
Yoshitomo Kobori*, Hiroshi Okada,
Koshigaya, Japan, Ugo Buy, Gail Prins, Peter
Pfanner, Craig Niederberger, Chicago, IL
MP91-14 PREGNANCY RATES IN COUPLES WITH A
MALE HISTORY OF UNILATERAL
TESTICULAR TORSION
Shilo Rosenberg*, Ilan Gielchinsky, Efrat
Suraqui, Guy Hidas, Ezekiel H Landau,
Alexander Simon, Vladimir Yutkin, Mordechai
Duvdevani, Ofer N Gofrit, Dov Pode,
Jerusalem, Israel
MP91-15
MP91-17 IMPROVING SURVEILLANCE OF MALE
FACTOR INFERTILITY IN THE US:
UPDATES FROM CDC’S NATIONAL ART
SURVEILLANCE SYSTEM (NASS)
Lee Warner*, Sheree Boulet, Dmitry Kissin,
Atlanta, GA
MP91-18 LITIGATION INVOLVING SPERM BANKING
IN THE UNITED STATES
Amin Herati*, Thomas Stout, Andrew Allison,
Peter Cook, Dolores Lamb, Larry Lipshultz,
Houston, TX
LEYDIG CELL ULTRASOUND FEATURES:
A USEFUL TOOL FOR A PROPER
PREOPERATIVE COUNSELLING
Giorgio Bozzini*, Mauro Seveso, Castellanza
VA, Italy, Marco Provenzano, NicoloMaria
Buffi, Giorgio Guazzoni, Rozzano MI, Italy,
Oliviero de Francesco, Pietro Bono, Alberto
Mandressi, Gianluigi Taverna, Castellanza
VA, Italy
MP91-19 FINANCIAL BURDENS OF FERTILITY
CARE: HOW TREATMENT COSTS IMPACT
FINANCIAL DIFFICULTY
Samuel Washington*, Patricia Katz, James
Smith, San Francisco, CA
MP91-20 KARYOTYPE AND Y-CHROMOSOME
MICRODELETION FOR MEN WITH
TESTICULAR FAILURE: SUBSEQUENTLY
OR SIMULTANEOUSLY? A COSTEFFECTIVENESS ANALYSIS
Taylor P. Kohn*, Stephen M. Pickett,
Houston, TX, Ranjith Ramasamy, Miami, FL,
Larry L. Lipshultz, Dolores J. Lamb, Houston,
TX
MP91-16 FIRST REPORT FROM THE ANDROLOGY
RESEARCH CONSORTIUM
Keith Jarvi*, Susan Lau, Kirk Lo, Ethan
Grober, Toronto, Canada, James Hotaling,
Salt Lake City, UT, Victor Chow, North
Vancouver, Canada, Armand Zini, Montreal,
Canada, Aaron Spitz, Laguna Hills, CA, Marc
Anthony Fischer, Hamilton, Canada, Scott
Zeitlin, Los Angeles, CA, Eugene Fuchs,
Portland, OR, Mary Samplaski, Los Angeles,
CA, Jay Sandlow, Milwaukee, WI, Robert
Brannigan, Chicago, IL, Marc Goldstein, New
York, NY, James Smith, San Francisco, CA,
Edmund Ko, Loma Linda, CA
CREDITTM
10:30 am - 12:30 pm
KIDNEY CANCER: BASIC RESEARCH & PATHOPHYSIOLOGY III
Moderators: Mark Gonzalgo and Jodi Maranchie
ABSTRACT
NUMBER TITLE
MP92-01 PD-1 EXPRESSION ON CLASSICAL
MONOCYTES (CM) IS AN INDEPENDENT
PREDICTOR OF CANCER SPECIFIC
SURVIVAL IN CLEAR CELL RENAL
CARCINOMA (CCRCC)
Mohammed Haseebuddin*, Alexander
MacFarlane IV, Karen Ruth, Robert Uzzo,
Elizabeth Plimack, Mowafaq JIllab, Essel
Dulaimi, Tahseen Al-Saleem, Kerry Campbell,
Mohammed Haseebuddin, Philadelphia, PA
ABSTRACT
NUMBER TITLE
MP92-03 B-LYMPHOCYTES (BL) DIFFERENTIATION
IS ATYPICAL IN CLEAR CELL RENAL
CELL CARCINOMA (CCRCC) AND LOW
PREOPERATIVE BL COUNT IS
ASSOCIATED WITH POOR CANCER
SPECIFIC SURVIVAL (CSS)
Mohammed Haseebuddin*, Alexander
MacFarlane IV, Karen Ruth, Robert Uzzo,
Elizabeth Plimack, Mowafaq Jillab, Essel
Dulaimi, Tahseen Al-Saleem, Kerry Campbell,
Philadelphia, PA
MP92-02 EVALUATION OF TUMOR PD-1
EXPRESSION AS A PROGNOSTIC
BIOMARKER IN PATIENTS WITH
LOCALIZED CLEAR CELL RENAL CELL
CARCINOMA
Rishi Sekar, Michelle DiMarco, Dattatraya
Patil, Adeboye Osunkoya, Gabriel Sica,
Haydn Kissick, Brian Pollack, Viraj Master,
Kyu Kim*, Atlanta, GA
MP92-04 PROTUMOR CONVERSION OF NATURAL
KILLER CELLS BY TRANSFORMING
GROWTH FACTOR-〉 AND HYPOXIA IN
Yue Guan, Christopher B. Chambers, Max
Nutt*, Springfield, IL, Britnie James,
Minneapolis, MN, Kathy Robinson, Shaheen
Alanee, Springfield, IL, Thomas Griffith,
Minneapolis, MN, Donald Torry, Andrew
Wilber, Springfield, IL
294
MP92-11 TKI INDUCES GLUT1 EXPRESSION
THROUGH IL-6 SECRETION ON RENAL
CELL CARCINOMA CELLS
Kei Ishibashi*, Michihiro Yabe, Seiji Hoshi,
Junya Hata, Hidenori Akaihata, Yuichi Sato,
Soichiro Ogawa, Nobuhiro Haga, Nobuhiro
Kushinda, Tomohiko Yanagida, Ken Aikawa,
Fukushima, Japan, Joachim W Thüroff,
Walburgis Brenner, Mainz, Germany,
Yoshiyuki Kojima, Fukushima, Japan
GROWTH INHIBITORY EFFECT OF AN
INJECTABLE HYALURONIC ACIDTYRAMINE HYDROGELS
INCORPORATING HUMAN NATURAL
INTERFERON-〈 AND SORAFENIB ON
RENAL CELL CARCINOMA CELLS
Kosuke Ueda*, Jun Akiba, Sachiko
Ogasawara, Keita Todoroki, Masamichi
Nakayama, Akiko Sumi, Hironori Kusano,
Sakiko Sanada, Shigetaka Suekane, Kurume,
Japan, Keming Xu, Ki Bae, Motoichi
Kurisawa, Singapore, Singapore, Tsukasa
Igawa, Hirohisa Yano, Kurume, Japan
MP92-12 ANTI-ANDROGEN THERAPY
SUPPRESSES TUMOR GROWTH IN
ANDROGEN RECEPTOR-POSITIVE RENAL
CELL CARCINOMA: A XENOGRAFT
STUDY
Christopher Han*, Geun Taek Lee, Rutveej
Patel, Parth Modi, Seok Joo Kwon, Izak
Faiena, Neal Patel, Eric Singer, Isaac Kim,
New Brunswick, NJ
MP92-06 LDL CHOLESTEROL COMPROMISES
EFFICACY OF MULTITARGETED
TYROSINE KINASE INHIBITORS AGAINST
Sei Naito*, Yamagata, Japan, Petr Makhov,
Vladimir Kolenko, Robert Uzzo, Philadelphia,
PA, Norihiko Tsuchiya, Yamagata, Japan
MP92-13 NOVEL COMBINATION TREATMENT
(OGX427/ SORAFENIB) ENHANCES
SENSITIVITY IN RENAL CELL
CARCINOMA.
Sebastian Frees*, Claudia Chavez-Munoz,
Peter Raven, Betty Zhou, Martin Gleave, Kim
Chi, Alan So, Vancouver, Canada
MP92-07 NETRIN-1: A NOVEL PROTEIN IDENTIFIED
IN DISEASE PROGRESSION OF SUNITINIB
RESISTANT RENAL CELL CARCINOMA
Sebastian Frees*, Claudia Chavez-Munoz,
Betty Zhou, Alexander Wong, Peter Raven,
Alan So, Vancouver, Canada
MP92-14 INHIBITION OF MTOR/AKT PATHWAY
ENHANCES CELL DEATH VIA
AUTOPHAGY IN RENAL CELL
CARCINOMA
Hua Chen, Kyle Potts, Allan Murray, Ronald
Moore*, Edmonton, Canada
MP92-08 CLUSTERIN INHIBITION USING OGX-011
SYNERGISTICALLY ENHANCES
ANTITUMOUR ACTIVITY OF AXITINIB IN A
HUMAN RENAL CELL CARCINOMA
MODEL
Satoshi Imai*, Kobe, Japan, Hideaki Miyake,
Hamamatsu, Japan, Martin Gleave,
Vancouver, Canada, Masato Fujisawa, Kobe,
Japan
MP92-15
MP92-09 COMBINATION THERAPY USING
MOLECULAR-TARGETED DRUGS
INHIBITING PLATELET-DERIVED
GROWTH FACTOR RECEPTORS IN THE
TUMOR MICROENVIRONMENT OF RENAL
CELL CARCINOMA
Hiroyuki Kitano*, Jun Teishima, Ryo Yuge,
Syunsuke Shinmei, Hirotaka Nagamatsu,
Keisuke Goto, Kouichi Shoji, Syogo Inoue,
Tetsutaro Hayashi, Kazuhiro Sentani,
Yasuhiko Kitadai, Wataru Yasui, Akio
Matsubara, Hiroshima, Japan
MP92-16 RITONAVIR AND DELANZOMIB INHIBIT
RENAL CANCER GROWTH IN VITRO AND
IN VIVO BY INDUCING ENDOPLASMIC
RETICULUM STRESS SYNERGISTICALLY
Makoto Isono*, Akinori Sato, Kazuki Okubo,
Takako Asano, Keiichi Ito, Tomohiko Asano,
Tokorozawa, Japan
MP92-17 NELFINAVIR INDUCES ENDOPLASMIC
RETICULUM STRESS AND SENSITIZES
RENAL CANCER CELLS TO TUMOR
NECROSIS FACTOR-RELATED
APOPTOSIS-INDUCING LIGAND
Kazuki Okubo*, Akinori Sato, Takako Asano,
Makoto Isono, Keiichi Ito, Tomohiko Asano,
Tokorozawa, Japan
MP92-10 REGULATION OF UHRF1-MEDIATED
PATHWAYS BY TUMOR-SUPPRESSIVE
MICRORNA-101 IN MOLECULAR
TARGETED THERAPY RESISTANT RENAL
CELL CARCINOMA
Yusuke Goto*, Akira Kurozumi, Mayuko Kato,
Atsushi Okato, Chiba, Japan, Satoko Kojima,
Ichihara, Japan, Ryosuke Matsushita,
Hirofumi Yoshino, Hideki Enokida, Masayuki
Nakagawa, Kagoshima, Japan, Yukio Naya,
Ichihara, Japan, Tomohiko Ichikawa, Naohiko
Seki, Chiba, Japan
*Presenting author
SUPPRESSION OF CHAPERONEMEDIATED AUTOPHAGY: A NOVEL
MECHANISM OF ACTION OF SILIBININ
AGAINST BLADDER AND RENAL CANCER
Jin Zeng*, Wei Liu, Feng Li, Yi Sun, Lei Li,
Xinyang Wang, Dalin He, Xi’an, China,
MP92-18 GOLPH3 IS OVEREXPRESSED AND
CONTRIBUTES TO APOPTOTICRESISTANCE AND METASTASIS IN
Dong Zhang*, Yan Xue, Xiaojie Yang,
Hongliang Li, Tie Chong, Xi’an, China,
295
TUESDAY
MP92-05
MP92-19 EXPERIMENTAL IMAGING IN
ORTHOTOPIC XENOGRAFT MODELS OF
RENAL CELL CARCINOMA:
COMPARATIVE EVALUATION OF HIGHRESOLUTION ULTRASONOGRAPHY, INVIVO MICRO-CT AND 9.4T MRI
Johannes Linxweiler*, Christina Körbel,
Andreas Müller, Volker Jung, Homburg/Saar,
Germany, Eva Jüngel, Frankfurt/Main,
Germany, Stefan Siemer, Michael Stöckle,
Kerstin Junker, Michael D. Menger, Matthias
Saar, Homburg/Saar, Germany
MP92-20 DIFFERENTIATION BETWEEN NORMAL
AND CANCEROUS RENAL TISSUES
USING ELECTRICAL IMPEDANCE
SPECTROSCOPY NEEDLE.
Hyeon Woo Kim*, Joho Yun, Yangkyu Park,
Gwangju, Korea, Republic of, Dong Gil Shin,
Jeong Zoo Lee, Busan, Korea, Republic of,
Jong-Hyun Lee, Gwangju, Korea, Republic of,
Wan Lee, Chang Yell Lee, Busan, Korea,
Republic of
CREDITTM
10:30 am - 12:30 pm
Podium Session 47
STONE DISEASE: EPIDEMIOLOGY & EVALUATION II
Moderators: Charles Scales, Jr. and Sero Andonian
ABSTRACT
TIME NUMBER TITLE
10:30 PD47-01 ASSESSING THE VOLUME-OUTCOME
RELATIONSHIP FOR PCNL IN 2014ANALYSIS USING UK NATIONAL
REGISTRY DATA OF OVER 2000 CASES
John Withington*, London, United Kingdom,
William Finch, Norwich, United Kingdom,
Sarah Fowler, London, United Kingdom,
James Armitage, Cambridge, United
Kingdom, Jonathan Glass, London, United
Kingdom, Stuart Irving, Neil Burgess,
Norwich, United Kingdom, Kay Thomas,
London, United Kingdom, Oliver Wiseman,
Cambridge, United Kingdom
10:40 PD47-02
GLOBAL TRENDS IN UROLITHIASIS
MORBIDITY AND MORTALITY FROM 19902010
David Bayne*, Tom Chi, Catherine Harris,
San Francisco, CA, Anobel Odisho, Seattle,
WA
10:50 PD47-03
RELATIONSHIP BETWEEN
SPONTANEOUS PASSAGE RATES OF
URETERAL STONES LESS THAN 10 MM
AND SERUM C-REACTIVE PROTEIN
LEVEL AND NEUTROPHIL PERCENTAGE
Maged Elsayed*, Mohamed Radwan, tanta,
Egypt, Nader Elkhamisy, Kafr Elsheikh,
Egypt, Mohamed Abo El-enen, Salah Naglah,
Magdy Sabaa, tanta, Egypt
11:00 PD47-04
IMPACT OF REGIONAL VARIATION IN
URETERAL STENT INSERTION
PRECEDING STONE CLEARANCE ON
REPEAT SURGERY: ADMINISTRATIVE
CLAIMS ANALYSIS
Andrew Portis*, St Paul, MN, Jia Wang, Scott
Guillemette, Eden Prairie, MN, Suzanne
Neises, St Paul, MN
11:10 PD47-05
ABSTRACT
TIME NUMBER TITLE
11:20 PD47-06 DISPROPORTIONATE USE OF INPATIENT
CARE BY OLDER ADULTS WITH URINARY
STONE DISEASE
Eugene B Cone*, Brad Hammill, Adam G
Kaplan, Joanne Dale, Jonathan C Routh,
Michael E Lipkin, Glenn M Preminger,
Kenneth Schmader, Charles D Scales,
Durham, NC
THE IMPORTANCE OF AN
ENDOUROLOGIST LOOKING AT IMAGES
AND FILMS PRIOR TO DECISION-MAKING
Haresh Thummar, Vincent Olorunnisommo*,
Aryeh Stock, Rohit Chugh, Mantu Gupta,
New York, NY
296
11:30 PD47-07
DEVELOPMENT AND IMPLEMENTATION
OF AN ELECTRONIC MEDICAL RECORDBASED PROSPECTIVE URINARY STONE
REGISTRY: RESKU, THE REGISTRY FOR
STONES OF THE KIDNEY & URETER
David T. Tzou*, Helena Chang, Manint
Usawachintachit, Ryan S. Hsi, Marshall L.
Stoller, Tom Chi, San Francisco, CA
11:40 PD47-08
CORONARY ARTERY CALCIUM SCORE
AND ASSOCIATION WITH RECURRENT
NEPHROLITHIASIS: THE MULTI-ETHNIC
STUDY OF ATHEROSCLEROSIS
Ryan Hsi*, San Francisco, CA, Andrew
Spieker, Seattle, WA, Marshall Stoller, San
Francisco, CA, David Jacobs, Minneapolis,
MN, Alex Reiner, Robyn McClelland, Seattle,
WA, Arnold Kahn, Novato, CA, Thomas Chi,
San Francisco, CA, Moyses Mzklo, Baltimore,
MD, Mathew Sorensen, Seattle, WA
11:50 PD47-09
FOLLOW-UP CARE AFTER ED VISITS FOR
KIDNEY STONES—A MISSED
OPPORTUNITY
Amy Luckenbaugh*, Phyllis Yan, J. Stuart
Wolf Jr., Khurshid Ghani, Brent Hollenbeck,
John Hollingsworth, Ann Arbor, MI
12:00 PD47-10
PREDICTING URETERAL STONES IN
EMERGENCY DEPARTMENT PATIENTS
WITH FLANK PAIN: AN EXTERNAL
VALIDATION OF THE STONE SCORE
Natalia Hernandez*, Bosotn, MA, Yan Song,
Shenyang, China, People’s Republic of, Vicki
Noble, Brian Eisner, Boston, MA
12:10 PD47-11
PREDICTORS OF EMERGENCY
DEPARTMENT REVISITS FOR URETERAL
STONES
Vishnu Ganesan*, Christopher Loftus, Bryan
Hinck, Daniel Greene, Yaw Nyame, Sri
Sivalingam, Manoj Monga, Cleveland, OH
12:20 PD47-12
PREDICTORS OF INFECTION IN PATIENTS
PRESENTING TO THE EMERGENCY
DEPARTMENT WITH OBSTRUCTING
URETERAL CALCULI
Christopher Morrison*, Amanda Chi, Aziz
Khambati, Borko Jovanovic, Robert Nadler,
Chicago, IL
CREDITTM
10:30 am - 12:30 pm
Podium Session 48
KIDNEY CANCER: LOCALIZED: SURGICAL THERAPY VI
Moderators: Paul Russo and Moben Mirza
10:40 PD48-02
10:50 PD48-03
11:00 PD48-04
*Presenting author
ABSTRACT
TIME NUMBER TITLE
11:10 PD48-05 INCREASED B4GALT1 EXPRESSION IS
ASSOCIATED WITH ADVERSE
ONCOLOGIC OUTCOMES IN LOCALIZED
Huyang Xie*, Qiang Fu, Xiaoqun Yang, Jiejie
Xu, Dingwei Ye, Shanghai, China, People’s
Republic of
PERIOPERATIVE OUTCOMES OF OPEN
AND MINIMALLY INVASIVE
NEPHROURETERECTOMY AND PREOPERATIVE PREDICTORS OF
COMPLICATIONS: AN ANALYSIS USING
THE NATIONAL SURGICAL QUALITY
IMPROVEMENT PROGRAM DATABASE
Nachiketh Soodana Prakash*, Nicola Pavan,
Raymond Balise, Bruno Nahar, Samarpit Rai,
Chad Ritch, Sanoj Punnen, Ramgopal
Satyanarayana, Dipen Parekh, Mark
Gonzalgo, Miami, FL
PARTIAL AND RADICAL NEPHRECTOMY
OFFER EQUIVALENT ONCOLOGIC
OUTCOMES FOR CT1 TO PT3 UPSTAGED
RENAL MASSES
Mark Ball*, Michael Gorin, Phillip Pierorazio,
Mohamad Allaf, Baltimore, MD
PROSPECTIVE RANDOMIZED TRIAL
COMPARING OPEN TO LAPAROSCOPIC
PARTIAL NEPHRECTOMY, INTERIM
ANALYSIS (NCT01809119)
Giuliano Guglielmetti*, Sanarelly Adonias,
Sao Paulo, Brazil, Rafael Coelho, São Paulo,
Brazil, Mauricio Cordeiro, Leonardo Borges,
José Roberto Colombo, Rodrigo Pessoa, Luiz
Neves, José Pontes, Adriano Nesrallah,
Miguel Srougi, William Nahas, Sao Paulo,
Brazil
297
11:20 PD48-06
THE ROLE OF METASTASECTOMY IN
PATIENTS WITH RENAL CELL
CARCINOMA WITH SARCOMATOID
DEDIFFERENTIATION: A MATCHED
CONTROLLED ANALYSIS
Arun Thomas*, Mehrad Adibi, Rebecca Slack,
Borregales Leonardo, Megan Merrill, Pheroze
Tamboli, Kanishka Sircar, Eric Jonasch,
Surena Matin, Christopher Wood, Jose
Karam, Houston, TX
11:30 PD48-07
COMPARISON OF PERCUTANEOUS
RADIOFREQUENCY ABLATION AND
PARTIAL NEPHRECTOMY FOR TREATING
T1A RCC IN SOLITARY KIDNEY PATIENTS
Stephanie Boret*, Hedrik Dendooven,
Maarten Albseren, Hein Van Poppel, Ben
Van Cleynenbreugel, Liesbeth Dewever,
Steven Joniau, Wouter Everaerts, Leuven,
Belgium
11:40 PD48-08
EN BLOC STAPLING OF THE RENAL
HILUM DURING LAPAROSCOPIC
NEPHRECTOMY: A MULTIINSTITUTIONAL ANALYSIS OF SAFETY
AND EFFICACY
Alexander Chow*, Chicago, IL, Matthew
Newsome, Charleston, SC, Benjamin Sherer,
Christopher Coogan, Chicago, IL, Sandip
Prasad, Charleston, SC, Kalyan
Latchamsetty, Chicago, IL
11:50 PD48-09
CANCER-SPECIFIC SURVIVAL IS NOT
AFFECTED BY HISTOLOGY OF T1
TUMORS UNDERGOING PARTIAL
NEPHRECTOMY
Michael Daugherty*, Michael Daneshvar,
Oleg Shapiro, Syracuse, NY
TUESDAY
ABSTRACT
TIME NUMBER TITLE
10:30 PD48-01 THE IMPACT OF PERIOPERATIVE BLOOD
TRANSFUSION ON CANCER
RECURRENCE AND SURVIVAL
FOLLOWING NEPHRECTOMY FOR NONMETASTATIC RENAL CELL CARCINOMA
(RCC)
Yasmin Abu-Ghanem*, Zohar Dotan, Ramat
Gan, Israel, Issac Kaver, Tel Hashomer,
Israel, Dorit E Zilberman, Ramat Gan, Israel,
Jacob Ramon, Tel Hashomer, Israel
12:00 PD48-10
12:10 PD48-11
EXAMINATION OF PERIOPERATIVE
OUTCOMES FOLLOWING PARTIAL
NEPHRECTOMY PERFORMED ON
PATIENTS REMAINING ON
ANTIPLATELET THERAPY
Timothy Ito, Philip Abbosh*, Philadelphia, PA,
Serge Ginzburg, Elkins Park, PA, Ithaar
Derweesh, Omer Raheem, Hossein
Mirheydar, Zachary Hamilton, La Jolla, CA,
David Chen, Marc Smaldone, Alexander
Kutikov, Richard Greenberg, Rosalia Viterbo,
Robert Uzzo, Philadelphia, PA
12:20 PD48-12
PROGNOSTIC STRATIFICATION OF
PATHOLOGIC STAGE T3A RENAL CELL
CARCINOMA AFTER RADICAL
NEPHRECTOMY
Manaf Alom, Paras Shah*, Daniel Moreira,
Arvin George, Nikhil Waingankar, Sophie
Sohval, Fatima-Zahra Jelloul, Oksana Yaskiv,
Michael Schwartz, Manish Vira, Joph Steckel,
Lee Richstone, Louis Kavoussi, New Hyde
Park, NY
CREDITTM
ALLOGENEIC BLOOD TRANSFUSION IS
ASSOCIATED WITH MORTALITY AND
INFECTIOUS COMPLICATIONS AFTER
OPEN NEPHRECTOMY
Jen-Jane Liu*, Ann Martinez Acevedo,
Christopher L Amling, Portland, OR
10:30 am - 12:30 pm
Podium Session 49
URODYNAMICS/LOWER URINARY TRACT DYSFUNCTION/FEMALE PELVIC MEDICINE: MALE INCONTINENCE: THERAPY II
Moderator: Elizabeth Takacs and Kathleen Kobashi
ABSTRACT
TIME NUMBER TITLE
10:30 PD49-01 LONG-TERM OUTCOMES FOLLOWING
PLACEMENT: AN ANALYSIS OF 1082
CASES AT MAYO CLINIC
Brian Linder*, Marcelino Rivera, Matthew
Ziegelmann, Daniel Elliott, Rochester, MN
10:40 PD49-02
ABSTRACT
TIME NUMBER TITLE
11:20 PD49-06 INCREASED RATES OF FAILURE WITH A
3.5CM CUFF IN THE ARTIFICIAL URINARY
SPHINCTER
Uwais Zaid*, Garjae Lavien, Andrew
MAGNETIC ARTIFICIAL SPHINCTER
(MARS): A NOVEL URINARY SPHINCTER
FOR STRESS URINARY INCONTINENCE
Navneet Mander*, Detroit, MI, Mahdi
Mohammadi, Mohsen Shahinpoor, Orono,
ME, Krishna Bhatta, Bangor, ME, Nivedita
Dhar, Detroit, MI
10:50 PD49-03
MECHANICAL FAILURES: IS IT BETTER
TO REPLACE THE ENTIRE DEVICE OR
JUST THE MALFUNCTIONING
COMPONENT?
Brian Linder*, Boyd Viers, Matthew
Ziegelmann, Marcelino Rivera, Laureano
Rangel, Daniel Elliott, Rochester, MN
11:00 PD49-04
INCREASED AUS RESERVOIR VOLUMES
DO NOT CORRELATE WITH INCREASED
PRESSURE DELIVERY
Katie Cunningham*, O. Lenaine Westney,
Houston, TX
11:10 PD49-05
DEVICE SURVIVAL FOLLOWING PRIMARY
IMPLANTATION OF THE AMS 800
ARTIFICIAL URINARY SPHINCTER FOR
MALE STRESS URINARY INCONTINENCE
Faysal A Yafi*, Carrie Stewart, Jason Chiang,
New Orleans, LA, Premsant Sangkum,
Bangkok, Thailand, Wayne JG Hellstrom,
New Orleans, LA
298
11:30 PD49-07
URETHRAL MOBILITY STUDY WITH A
COMPUTATIONAL MODEL OF THE MALE
PELVIS
Nicholas Dias, Yun Peng, Brian Miles, Rose
Khavari, Vivian MacDonnell, Timothy Boone,
Yingchun Zhang*, Houston, TX
11:40 PD49-08
TREATMENT OF COMPLICATIONS AFTER
PROACT® IMPLANTATION IN MEN WITH
STRESS URINARY INCONTINENCE
FOLLOWING RADICAL PROSTATECTOMY:
A RETROSPECTIVE ANALYSIS OF 252
IMPLANTS IN A SINGLE CENTRE
Maria Abbinante*, Marta Rossanese,
Alessandro Crestani, Mattia Calandriello,
Vincenzo Ficarra, Gianluca Giannarini, Udine,
Italy
11:50 PD49-09
MANAGEMENT OF SPHINCTER
WEAKNESS INCONTINENCE (SWI) IN
PATIENTS WITH CONCOMITANT
BLADDER NECK CONTRACTURES (BNC)
AFTER THE TREATMENT OF PROSTATE
CANCER
Simon Bugeja*, Stella Ivaz, Anastasia Frost,
Felix Campos, Enrique Fes, Daniela Andrich,
Anthony Mundy, London, United Kingdom
12:00 PD49-10
PATTERNS OF MALE INCONTINENCE
PROCEDURES IN THE VETERANS
AFFAIRS (VA) POPULATION
Samuel Belknap*, Jonathan Walker,
Lexington, KY, John Lacy, Cleveland, OH,
Shubham Gupta, David Preston, Lexington,
KY
12:10 PD49-11
IS THE GOLD STANDARD SHIFTING?
NATIONAL TRENDS IN ANTIINCONTINENCE SURGERY FOR MEN
BASED ON THE NATIONAL INPATIENT
SAMPLE
Susan MacDonald*, Marc Colaco, Ryan
Terlecki, Winston-Salem, NC
12:20 PD49-12
OUTCOMES OF TRANSOBTURATOR
SLING PLACEMENT IN MEN WITH
INCONTINENCE SECONDARY TO
RADICAL PROSTATECTOMY AND
CANCER: A SYSTEMATIC REVIEW
Divya Ajay*, Bradley Potts, Durham, NC,
Cynthia Feltner, Chapel Hill, NC, Andrew
CREDITTM
10:30 am - 12:30 pm
Podium Session 50
ABSTRACT
TIME NUMBER TITLE
10:30 PD50-01 PREVALENCE AND PREDICTORS FOR
TESTOSTERONE DEFICIENCY IN THE
UNITED STATES
Julien Dagenais*, Ye Wang, Adam Althaus,
Martin Kathrins, Steven L Chang, Boston, MA
10:40 PD50-02
10:50 PD50-03
11:00 PD50-04
11:10 PD50-05
*Presenting author
ABSTRACT
TIME NUMBER TITLE
11:20 PD50-06 LONG-TERM SAFETY AND TOLERABILITY
OF ORAL TESTOSTERONE (LPCN 1021) IN
HYPOGONADAL MEN: RESULTS FROM
THE 52-WEEK PHASE 3 STUDY
Mohit Khera*, Houston, TX, Christina Wang,
Torance, CA, Jed Kaminetsky, New York,
NY, Martin Miner, Providence, RI, Adrian
Dobs, Baltimore, MD, Anthony Delconte,
Nachiappan Chidambaram, Satish
Nachaegari, Mahesh Patel, Salt Lake City,
UT
EFFECTS OF LONG-TERM
INJECTIONS (TU) ON URINARY AND
SEXUAL FUNCTION IN HYPOGONADAL
MEN: REAL-LIFE DATA FROM A
CONTROLLED REGISTRY STUDY
Ahmad Haider*, Karim Sultan Haider,
Bremerhaven, Germany, Gheorghe Doros,
Abdulmaged Traish, Boston, MA
CARDIOVASCULAR EVENTS AND
PROSTATE CANCER DIAGNOSES IN MEN
TREATED WITH TESTOSTERONE
REPLACEMENT THERAPY
Christopher Wallis*, Kirk Lo, Yuna Lee,
Yonah Krakowsky, Alaina Garbens, Raj
Satkunasivam, Sender Herschorn, Ronald
Kodama, Patrick Cheung, Steven Narod,
Robert Nam, Toronto, Canada
EFFICACY AND TOLERABILITY OF
DAPOXETINE AND SERTRALINE FOR THE
TREATMENT OF CHINESE PATIENTS
WITH PREMATURE EJACULATION
Lin Yang*, Dalin He, Xian, China, People’s
Republic of
IS THERE A PROTECTIVE ROLE OF
TESTOSTERONE AGAINST HIGH-GRADE
PROSTATE CANCER? INCIDENCE AND
SEVERITY OF PROSTATE CANCER IN 553
PATIENTS UNDERGOING PROSTATE
BIOPSY IN A PROSPECTIVE DATA
REGISTER
Aksam Yassin*, Dresden, Germany,
Mahmoud Salman, Yousef Almehmadi,
Norderstedt-Hamburg, Germany
299
11:30 PD50-07
SAFETY OF TESTOSTERONE THERAPY IN
PATIENTS ON ACTIVE SURVEILLANCE
FOR PROSTATE CANCER
Lawrence C. Jenkins*, Rahul Krishnan,
Boback M. Berookhim, Jonathan Coleman,
James A. Eastham, Behfar Ehdaie, Vincent
P. Laudone, Christian J. Nelson, John P.
Mulhall, New York, NY
11:40 PD50-08
IMPROVEMENT OF ARTERIAL
ENDOTHELIAL FUNCTION FOLLOWING
INITIATION OF TESTOSTERONE
REPLACEMENT THERAPY
Daniel Shoskes*, Kathryn Dunlap, Barbara
Tucky, Cleveland, OH
11:50 PD50-09
HEAVY TESTOSTERONE USE AMONG
BODYBUILDERS: AN UNCOMMON
COHORT OF ILLICIT SUBSTANCE USERS
Mary E. Westerman*, Cameron M.
Charchenko, Matthew J. Ziegelmann, George
C. Bailey, Todd B. Nippoldt, Landon Trost,
Rochester, MN
TUESDAY
SEXUAL FUNCTION/DYSFUNCTION: MEDICAL, HORMONAL & NON-SURGICAL THERAPY II
Moderators: Abraham Morgentaler and John Mulhall
12:00 PD50-10
12:10 PD50-11
LONGITUDINAL RECOVERY PATTERNS
OF PENILE LENGTH AND THE
UNDEREXPLORED BENEFIT OF LONGTERM PHOSPHODIESTERASE INHIBITOR
USE AFTER RADICAL PROSTATECTOMY
Young Suk Kwon*, Nicholas Farber, Jiwoong
Yu, Christopher Han, Paul Lee, Jongmyung
Kim, New Brunswick, NJ, Wun-Jae Kim,
Cheongju, Korea, Republic of, Isaac Kim,
New Brunswick, NJ
12:20 PD50-12
EFFECT OF URECHIS UNICINCTUS ON
SEXUAL BEHAVIOR IN MALE RATS
Sung Hyun Paick*, Woo Suk Choi, Dong
Yeub Ham, Hyoung Keun Park, Hyeong Gon
Kim, Seoul, Korea, Republic of
CREDITTM
A COMPARISON OF BASELINE ERECTILE
FUNCTION AFTER ON-DEMAND 20 MG
TADALAFIL VS. DAILY 5 MG TADALAFIL
IN MEN WITH ERECTILE DYSFUNCTION
AND DIABETES: A PROSPECTIVE,
OBSERVATIONAL 2-YEAR STUDY
Hyun Jun Park*, Nam Cheol Park, Busan,
Korea, Republic of, Du Geon Moon, Seoul,
Korea, Republic of
300
2016 Annual Meeting Exhibits
(as of March 29, 2016)
Booth(s)
21st Century Oncology LLC
3422
3D Systems, Healthcare
4011
A&E Endoscopy
4806
A.M.I. Gmbh
3517
AbbVie
3233
Accordion Medical
5107
Adako USA
2123
Advanced Endoscopy Devices, Inc.
4307
Allen Medical Systems
5413
Allergan
4017
AmbiMedInc.
4606
AME Publishing Company
2218
American College of Cryo Surgery
4909
American HIFU
4006
American Medical Endoscopy / Strauss
Surgical
4132
American Society of Clinical
Oncology (ASCO)
5148
Androvia LifeSciences
4152
Armune BioScience, Inc.
3756
Ashlar Medical, LLC
2124
ASSI-Accurate Surgical & Scientific Inst 3845
Astellas Pharma US
2817
AUA Exhibitor Lounge
1810
AUA History Booth
4533
AUA International Societies
4752
4754
4756
AUA RESIDENTS BOWL
2545
AUA Sales Office
1609
Augmenix
4047
Aytu BioScience, Inc.
3655
Bard
3433
Bayer
4802
Bayer HealthCare
4623
Beckman Coulter, Inc.
4241
Beijing Weili New Century Science &
Technology Co.
3455
Beloit Health System, Inc.
3957
Best Medical International
3707
biolitec biomedical technology, GmbH 2217
BK Ultrasound - Powered by Analogic 3216
Blue Earth Diagnostics, Inc
5245
Boothwyn Pharmacy
3603
Boston Scientific
2516
Bostwick Laboratories
5025
Bristol-Myers Squibb
5355
Brookhaven Medical, Inc.
5449
Business Bistro
5524
Byram Healthcare
5113
Cafe
5507
Canadian Urological Association
4942
Cardinal Health Specialty Solutions
5437
Care Credit
4550
Case Recruiters
4310
Chinese Urological Association
4750
Clarus Medical, Clearwater, Inspektor 5444
Clear Optix
3602
Clear Optix
4452
Cogentix Medical
5019
Cold Genesys, Inc.
2145
Colegio Mexicano de Urologı́a
Nacional A.C.
4653
Coloplast Corp.
3821
Community Health Systems
4706
Compulink Business Systems
4147
Confederacion Americana de Urologia 4649
Conmed
4141
ContextMedia: Health
3554
Convergent Laser Technologies
5033
Cook Medical
2632
CoreTherm Medical, Inc.
4136
CoxHealth
4404
CryoProbe
5536
CS Surgical, Inc
4647
D.A. Surgical
3956
dBMEDx, Inc.
4613
Dendreon Pharmaceuticals
3633
Designs for Vision, Inc.
4007
Dianon-Litholink Corporation
4743
Booth(s)
Digital Medical Arts LLC
Diplomat
Direx
Dornier MedTech
DSE Healthcare Solutions - Prelief &
Urinozinc
Dysaer
Ecleris USA
EDAP-TMS
EDDA Technology
Egyptian Urological Association
Eigen
Elite Medical Scribes
ELMED Medical Systems
Elsevier
Empower Pharmacy
EMS Electro Medical Systems S.A.
Encore, Inc.
Endo Pharmaceuticals Inc.
Endocure Technologies
ENDOSYS TECHNOLOGIES
Endourological Society, Inc.
Enova Illumination
Epic Sciences
Ethicon Biosurgery
European Association of Urology
Exact Imaging (formerly Imagistx)
Exosome Diagnostics
FDA Office of New Drugs
Ferring Pharmaceuticals Inc.
FMD, LLC
Focal Healthcare, Inc.
Food Court
Galil Medical USA
GE Healthcare
Genentech
Genicon
GenomeDx Biosciences
Genomic Health, Inc.
Global Medical Endoscopy, Inc.
GOTOP Medical, Inc.
Greenwald Surgical Company, Inc.
Grip-Lok/TIDI Products
Hawaiian Moon
HealthTronics
HIFU Solution, LLC
HIFU USA
Hitachi Aloka Medical
HR Pharmaceuticals
ICU Theater
iData Research Inc.
Imprimis Pharmaceuticals, Inc.
INEX Surgical Inc.
Infinite Therapeutics
Infinite Trading
InnovaQuartz
InPracSys
International Kidney Stone Institute
International Society for Sexual
Medicine
IntrinsiQ Specialty Solutions
Intuitive Surgical
Invivo
IU Kelley School Business of Medicine
MBA
IVUmed
Janssen Biotech, Inc.
Japanese Urological Association
Jena Surgical
Kaiser Permanente
KARL STORZ Endoscopia - Latino
America
KARL STORZ Endoscopy - America, Inc.
Keeler Instruments Inc.
Klein Surgical, Inc
Koelis
LABORIE
Leavitt Medical, Inc.
Lenus Pharma
LEONI Fiber Optics, Inc.
301
4353
2127
5325
3222
5345
4403
4911
4107
5538
4748
5223
4355
4817
3317
3417
5006
4852
2833
3345
2138
4753
4451
5302
5252
4810
5443
5254
4855
3421
3616
5249
1733
5013
2449
5548
4057
5233
5217
5419
4450
4843
3754
4746
2325
4850
4548
5423
2450
2933
2353
3448
4311
5532
5204
2222
5255
4106
4822
3649
3619
5333
4354
4150
4833
4654
3452
4506
2251
2433
4407
3516
3911
4133
5143
3344
5433
Booth(s)
Liebel-Flarsheim, a Guerbet company
Lilium Otsuka
Lipocine, Inc
LISA Laser USA
Llorens
LocumTenens.com
LP Surgical Fibers (formerly Laser
Peripherals)
Lumenis, Inc.
Luna America, LLC
Magic Race LLC
Marina Medical Instruments
Marley Drug
MasterPharm Compounding Pharmacy
Mayo Clinic
McAirlaid’s Inc.
Mcube Technology Co., Ltd.
MDxHealth
Med Fibers, Inc.
Meda Co., LTD
Medical Lasers Direct
Medicapture, Inc.
Medifix Inc.
Mediplus
Medispec Ltd.
Medivation, Inc.
Med-Sonics
Medtronic
MERCK & CO.
MERCK & COMPANY
Mercy Clinic
Meridian Health
Metamark Genetics, Inc.
Mezzion Pharma Co., Ltd.
Mianyang Meike Electronic
Equipment Co., Ltd
MIM Software Inc.
MiMedx
MiMedx
Mimic Technologies, Inc.
Mindray North America
Miraca Life Sciences
Mission Pharmacal Company
Modernizing Medicine
My Urology Doc
Myriad Genetic Laboratories, Inc.
Nanosonics
Nanovibronix
National Death Index
Neoscope 2020
NeoTract, Inc.
Neuwave Medical, Inc.
New York Section, AUA
NextMed
Novartis
NxThera, Inc.
Olympus America Inc.
One Stop Bedwetting
OPKO Health INC.
Optical Integrity, Inc.
Otto Trading
Pacific Edge Diagnostics
Path MD Labs
PDLabs
PercuVision, LLC
Perineologic
Photocure
Physician Owned Surgery Centers
PracticeLink.com
Predicine, Inc.
Procept BioRobotics
Profound Medical
Progenics Pharmaceuticals, Inc.
Prometheus Laboratories Inc.
Prostate Conditions Education Council
Prosurg, Inc.
QDX Pathology Services
Quanta System SPA
Raja and Associates
Rational Surgical Solutions
3449
4356
4455
3711
4409
4303
3907
4519
4454
3807
5243
2242
2117
4154
2452
4010
5133
2349
3944
4751
4255
2355
3702
5121
4333
4757
4733
4003
3904
2125
4702
5007
3951
5051
5313
3351
4304
3443
4950
2841
5207
5307
4952
4617
4949
5049
5104
2122
4321
4604
4755
4138
4502
2317
3833
4948
5041
2448
3349
4711
4257
2136
4943
3353
2333
4351
5212
5250
3849
4811
4415
5050
4306
2244
3813
2243
4053
4809
REFLEXONIC, LLC
Retrophin
RG Medical
Richard Wolf Medical Instruments
Richard Wolf Medical Instruments
Rose Micro Solutions
RosettaGX
Russer Brasil Ltda
Sagent Pharmaceuticals
Sanofi Genzyme
SBH
ScanMed
ScribeAmerica
Sedation Systems LLC
SEYYONE Healthcare BPO Services
SH Medical Corporation
SheerVision
Siemens Healthcare
Sigma Tau Pharmaceuticals
Signostics Inc.
Simulated Surgical Systems, LLC
SIUI Ultrasound
Skills Workshops
Skills Workshops
Snap On Optics
Snap On Optics
Sociedad Argentina de Urología
Sociedad Mexicana de Urología, A.C.
3613
5213
4906
2133
2134
2132
4213
4820
5533
4707
2223
4056
5342
2144
5439
4447
4410
4704
4910
5048
4823
5407
3757
4508
5449
1848
2148
3909
4512
4657
4651
Sociedad Peruana de Urología
Sociedade Brasileira de Urologia
Société Internationale d’Urologie
Society of Government Service
Urologists
Solace Therapeutics
Sonacare Medical
Sontec Instruments
Sony Electronics
Special Surgery Resources &
Repair, Inc.
SPECTRUM Pharmaceuticals
SpermCheck
Springer
SRS Medical Corp.
Staff Care, Inc.
Stryker Endoscopy
Supramedical LLC
Surgical Laser Inc.
Surgical Tables, Inc.
SurgiTel/General Scientific
Swan Valley Medical
TaeWoong Medical Co., LTD.
Tax Saving Professionals
TEAC
Tecnofarma
Teleflex
The Applied Technology Lab for
Advanced Surgery
The Prometheus Group
Theranostix Inc.
302
4655
4555
4146
4408
4413
4547
4207
4153
4546
5202
2216
4703
4917
4854
4824
2119
4357
2454
4507
4110
4009
4851
4156
3749
5103
3604
4511
5535
Tolmar Pharmaceuticals
Trios Health
Typenex Surgical
UFM Underwear for Men
United Endoscopy
United Medical Systems, Inc.
United Urologic Innovations
Universal Hospital Services
University of Tennessee Physician
Executive MBA Program
Unysen Health, Inc.
UroGen Pharma
UroGyn Medical, Inc.
Urological Society of India
Urology Times
Uromedica, Inc.
Utah Medical Products, Inc.
Valeant-Women’s Health
Vascular Technology
Vasectomy.com
Verathon Medical
Vesiflo, Inc.
Well Lead Medical Co. Ltd.
Western Section, AUA
Wiley
Wolters Kluwer Health
Xodus Medical
YouCare Technology Co., Ltd (Wuhan)
Zephyr Surgical Implants
Zymo Research Corp
3641
2120
2443
4803
4607
4708
3857
4807
4804
2142
3902
2343
4656
4411
4849
4055
4853
3607
5150
5319
4247
5349
4406
5312
4907
4412
2143
2224
5151
V ⫽ video, p ⫽ page
AUTHOR INDEX
A
Aaltonen, Riikka .................................... PD25-01
Aaronson, David .................................... MP4-02
Aaronson, William ................................. PD42-03
Abaev, Michall .................... MP12-19, MP75-06
Abalajon, Mark .................................... MP57-05
Aballa, Teodoro ................................... MP70-09
Abascal, Jose Maria ............................ MP45-12
Abaza, Ronney ... MP23-02, MP75-04, MP75-07,
MP75-16, PD27-04, PD30-03, PD43-01, p53,
p189
Abbinante, Maria ................. MP13-16, PD49-08
Abbosh, Philip ....................................... PD48-10
Abbotoy, Daniel ................................... PD46-07
Abbott, Joel E. ..................... MP26-14, MP51-20
Abboud, Tara ....................................... MP21-18
Abdalla, Hossam .................... MP91-05, PD5-08
Abdalla, Medhat ................................. MP22-05
Abdel Azim, Mohamed ....................... MP19-11
Abdel Raheem, Ali ............. MP40-13, MP69-04,
MP75-15
Abdelaal, Mohamed ........................... PD14-02
Abdel-Aziz, Azza ................................... PD35-11
Abdelgawad, Osama .......................... PD36-11
Abdelhafez, Mohamed ...... MP22-05, MP38-09
Abdelhalim, Ahmed ............................. PD33-04
Abdelhamed, Amr ............................... MP86-03
Abdel-Karim, Aly .................................. MP23-16
Abdelrahman, Hossam ........................ PD23-05
Abdel-Raouf, Ramaila .......................... PD38-02
Abd-Eltawab, Mohamed .................... MP13-06
Abdelwahab, Khalid ............................ PD23-05
Abdi, Hamidreza ................... PD12-12, PD27-09
Abdollah, Firas .......... MP2-06, MP7-07, MP7-20,
MP14-12, MP21-05, MP21-06, MP21-07,
MP21-08, MP21-10, MP21-11, MP25-08,
MP37-02, MP39-14, MP50-12, MP69-11,
MP80-02, MP80-20, PD15-01, PD15-03,
PD37-01, PD37-03, PD43-12, PI-04
Abdou, Abdelali ..................................... PD6-07
Abdul Karim Khan, Nurzalina .................... ST-62
Abdulmaksood, Mahmoud ................. PD23-06
Abdulmoneim, Ahmad ........................ MP54-19
Abdul-Muhsin, Haidar ......... MP19-10, MP23-09,
MP33-09, MP42-08, MP81-16, MP81-18, PD2110, V1-10, V8-03, V11-01
Abdulwahab, Khalid ............................ PD23-06
Abe, Takashige ...................................... MP6-19
Abe, Takaya ............................... MP49-13, ST-18
Abel, E. Jason ........ MP13-12, MP64-15, PD4-10,
PD29-02, PD41-02, PD46-04, p15
Abell, Jill .................................................. MP4-02
Abern, Michael ......... MP1-09, PD9-08, PD42-08
Abhyankar, Nikita ....... PD5-12, PD7-12, PD9-08
Abo El-enen, Mohamed ...... MP34-08, PD47-03
Abo El-Ghar, Mohamed ...................... MP54-01
Aboalsamh, Ghaleb ............................ MP32-07
Abolbashari, Mehran ........................... MP29-11
Abol-Enein, Hassan .............. PD27-04, PD27-11,
PD33-04, PD33-12, p83, p84
Abou El-Ghar, Mohamed .................... PD11-11
Abou Elgreed, Tamer ........................... PD14-02
Abou Farha, Osama .................................. p258
Abou-Ramadan, Ahmed .................... MP13-06
Abouassaly, Robert ............ MP10-07, MP38-10,
MP46-15, MP64-05, MP81-05, MP81-11,
PD27-05, PD29-04, PD32-10, p276
Abouella, Wasim .................................. MP56-09
Abouelleil, Mourad ................................. V12-01
Abou-Haidar, Hiba ............................... PD28-07
Aboulela, Waseem .............. MP32-03, MP33-08
Aboulella, Hassan ...................................... p258
Aboumarzouk, Omar ............................ PD31-04
Aboumohamed, Ahmed .... MP15-16, MP80-18
Abourbih, Samuel .... MP22-14, MP51-13, MP5816, MP82-12
Aboushwareb, Tamer .......... MP29-11, MP74-08
Aboyanc, Ruben .................................. MP52-20
Aboyoussif, Tamer ................................ MP32-06
Abraham, George P. ................................ V6-12
Abraham, Nitya ........................................ V1-07
Abraham

Meeting Program - AUA2016 Annual Meeting

Transcription

Similar documents

Diapositiva 1

Presentazione di PowerPoint

new orleans - AUA2015 Annual Meeting

View entire article. - Faculty of Arts and Science

ROAD MAP PILOT PROJECT PENGEMBANGAN INDUSTRI OBAT

scelta dell`intervento

1988-04-14 - The Law Society of Upper Canada

View entire article. - Faculty of Arts and Science

- DigitalCommons@URI

Ghosts PS4 Manual

Vescica iperattiva di origine neurogena

Our Donors - North Carolina School of Science and Mathematics

Preservazione fertilità carcinoma mammario

Documento PDF - Padua@Research - Università degli Studi di

Ambiente e rappresentazione della natura nei manifesti del Giappone